Citrus Sinensis ID: 038905
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 709 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.974 | 0.830 | 0.394 | 1e-151 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.372 | 0.318 | 0.442 | 7e-63 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.361 | 0.311 | 0.473 | 3e-62 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.880 | 0.753 | 0.288 | 4e-62 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.403 | 0.327 | 0.405 | 6e-58 | |
| O64777 | 806 | G-type lectin S-receptor- | no | no | 0.921 | 0.810 | 0.258 | 2e-53 | |
| O64776 | 792 | G-type lectin S-receptor- | no | no | 0.905 | 0.810 | 0.258 | 4e-51 | |
| O64770 | 804 | G-type lectin S-receptor- | no | no | 0.950 | 0.838 | 0.267 | 6e-51 | |
| O64780 | 814 | G-type lectin S-receptor- | no | no | 0.887 | 0.772 | 0.262 | 9e-51 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.346 | 0.308 | 0.428 | 1e-50 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 535 bits (1378), Expect = e-151, Method: Compositional matrix adjust.
Identities = 327/829 (39%), Positives = 449/829 (54%), Gaps = 138/829 (16%)
Query: 1 MASAKFYFIFLLFLFPYDLHLAIAQT--NGTVPVGSTLTAGTD---SSPWLSPSGDFTFG 55
M S I L+ + +Q NG+VPVG +LTA SS W SPSGDF FG
Sbjct: 1 MGSLSCSIIHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFG 60
Query: 56 FHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNP-VVPRGSQVKLTADQGLVLND 114
F ++ ND F+LSI+++KI K +VW+ + +VP GS+V LTAD GLV+ D
Sbjct: 61 FRKI----QPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIAD 116
Query: 115 PQGKQVWSS---------------KLILVQSFSSSR---LWDSFSNPTDTLLPGKMMETE 156
P+G+++W + +L + S LW SF NPTDTLLP + +E
Sbjct: 117 PRGQELWRALSGGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVG 176
Query: 157 QGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQ 216
+ L S +++T+F +GRF RL D NL L+ N T D Y ++ + +N G Q
Sbjct: 177 RNLSSRRTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPNNPGIQ 236
Query: 217 VMFNESGYMYILRRNGRRFDLTTER---VVPAADFYHRATLNFDGVFVQSFYLKNGNGNW 273
++FN+SG +Y+L+RN RF + +R AA FY + + G
Sbjct: 237 LVFNQSGEIYVLQRNNSRF-VVKDRDPDFSIAAPFYISTGFLLSTIIPKEARRIVGG--- 292
Query: 274 SVVWSQPENICVNIGGELGSGAYGFNSIC------------PKGYSLLDENEKYGSCKAD 321
++ +N+C + LG+ A G+N+IC P+ + L D + +YG C D
Sbjct: 293 CLLGLCRDNMC-SPDDALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPD 351
Query: 322 FEL-SCNGGRQ----------------------DYELSRPYDEVQCKNNCLSDCFCVVAI 358
FE+ +C Q DYE YDE +CK +CLSDC C I
Sbjct: 352 FEMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAVI 411
Query: 359 F---RGDSCWSKKLPLSNGRAHSSVNGKAFLKYKKGDDPDPPSVPSPPDPED-------- 407
F R CW KK PLS+G + F+K + D P + D
Sbjct: 412 FGTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVRNRSIADVPVTGNRAKKLDWLIIACSV 471
Query: 408 -------------------KKKRNMM-----NVTRSVLLGSSVFVNFTLV--GVIQTSTR 441
KK +NMM ++ R+ ++ +N + G + +TR
Sbjct: 472 LLGTSAFVIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATR 531
Query: 442 -------------------------TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNL 476
+ VKKLDR+ D EKEFKNEV +IGQ +HKNL
Sbjct: 532 DFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNL 591
Query: 477 VRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS 536
VRL+GFC+EGQ++++VY+FL GTLA+FLF +P W R NIA IARG+L+LH CS
Sbjct: 592 VRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHEECSE 651
Query: 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST 596
QIIHCDIKPQNILLD+YY +ISDFGLAKLL +NQ+ + IRGTKGYVA PEWFRNS
Sbjct: 652 QIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTN-IRGTKGYVA-PEWFRNSP 709
Query: 597 ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656
IT+ VDVYS+GV+LLEI+ C+K+ D+ E+ IL +WA+DC+R G+L+DL E D EAMN
Sbjct: 710 ITSKVDVYSYGVMLLEIVCCKKAVDL---EDNVILINWAYDCFRQGRLEDLTEDDSEAMN 766
Query: 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDVPPNPSTFS 705
D++ VE+ V ++IWCIQE+ +RP MR V+QMLE V++V PPNPS +S
Sbjct: 767 DMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPYS 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (618), Expect = 7e-63, Method: Compositional matrix adjust.
Identities = 120/271 (44%), Positives = 176/271 (64%), Gaps = 7/271 (2%)
Query: 440 TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
T TV+ VK+L+ + Q GEK+F+ EV I T+H NLVRL+GFC +G++RLLVY+F+ NG
Sbjct: 504 TNRTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNG 562
Query: 500 TLASFLFENLKP---GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
+L +FLF W R NIA A+G+ +LH C I+HCDIKP+NIL+DD + A
Sbjct: 563 SLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAA 622
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISC 616
++SDFGLAKLL ++ ++RGT+GY+A PEW N IT+ DVYS+G++LLE++S
Sbjct: 623 KVSDFGLAKLLNPKDNRYNMSSVRGTRGYLA-PEWLANLPITSKSDVYSYGMVLLELVSG 681
Query: 617 RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM--EAMNDIKCVEKLVMVSIWCIQE 674
+++FD+ + + WA++ + G +++ + + D++ V ++V S WCIQE
Sbjct: 682 KRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQE 741
Query: 675 DPSLRPTMRKVSQMLEVVVEVDVPPNPSTFS 705
P RPTM KV QMLE + E+ P P T S
Sbjct: 742 QPLQRPTMGKVVQMLEGITEIKNPLCPKTIS 772
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 126/266 (47%), Positives = 176/266 (66%), Gaps = 10/266 (3%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+ VKKL+ + Q G+KEF+ EV +IG +H +LVRL GFC EG +RLL Y+FL+ G+L +
Sbjct: 518 LAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERW 576
Query: 505 LFENLKPG-----WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
+F K G W+ R NIA A+GL +LH +C ++I+HCDIKP+NILLDD +NA++S
Sbjct: 577 IFRK-KDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVS 635
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFGLAKL+T QS +RGT+GY+A PEW N I+ DVYS+G++LLE+I RK+
Sbjct: 636 DFGLAKLMTREQSHVF-TTMRGTRGYLA-PEWITNYAISEKSDVYSYGMVLLELIGGRKN 693
Query: 620 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI-KCVEKLVMVSIWCIQEDPSL 678
+D E +AF GKL D+V+G M+ ++ + V++ + ++WCIQED
Sbjct: 694 YDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQT 753
Query: 679 RPTMRKVSQMLEVVVEVDVPPNPSTF 704
RP+M KV QMLE V V PP+ ST
Sbjct: 754 RPSMSKVVQMLEGVFPVVQPPSSSTM 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (611), Expect = 4e-62, Method: Compositional matrix adjust.
Identities = 224/776 (28%), Positives = 343/776 (44%), Gaps = 152/776 (19%)
Query: 46 LSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLT 105
+S G + GF + G +N F + ++Y ++ + I+ + N D+ S K++
Sbjct: 39 VSSDGTYEMGFFKPGSSSN----FYIGMWYKQLSQTIL--WVANRDKAVSDKNSSVFKIS 92
Query: 106 ADQGLVLNDPQGKQVWSSKL----------ILVQ------------SFSSSRLWDSFSNP 143
++L+ VWS+ L ++Q S S++ LW SF +P
Sbjct: 93 NGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHP 152
Query: 144 TDTLLPG------KMMETEQGLFSGKSDTNFSRGRFQFRLLKDS--NLVLNIANLPTDLA 195
DT LPG K Q L S KS + S G F L + + ++ N +N
Sbjct: 153 GDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKILWNGSN------ 206
Query: 196 YDAYYISGTYD-STNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERVVPAADFYH---- 250
Y+ SG ++ + +S ++ N Y+Y N F TT+ + +
Sbjct: 207 --EYWSSGPWNPQSRIFDSVPEMRLN---YIY----NFSFFSNTTDSYFTYSIYNQLNVS 257
Query: 251 RATLNFDGVFVQSFYLKNGNGNWSVVWSQPENICVNIGGELGSGAYGFNS-------ICP 303
R ++ G Q +L+ GN W++ WSQP C G++G S CP
Sbjct: 258 RFVMDVSGQIKQFTWLE-GNKAWNLFWSQPRQQCQVY---RYCGSFGICSDKSEPFCRCP 313
Query: 304 KGYSLL-----DENEKYGSCKADFELSCNGGRQDYELSRPYDEVQ-------------CK 345
+G+ + D + C EL C+ G + P ++ C
Sbjct: 314 QGFRPMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKLADNSEVLTRTSLSICA 373
Query: 346 NNCLSDCFCVVAIFRGDS----CWSKKLPLSNGRAHSSVNGKAFLKYKKGDDPDPPSVPS 401
+ C DC C + S WSK + N + N + + Y + D P+V +
Sbjct: 374 SACQGDCSCKAYAYDEGSSKCLVWSKDVL--NLQQLEDENSEGNIFYLRLAASDVPNVGA 431
Query: 402 PPDPEDK---------------------------------------------KKRNMMNV 416
+K R + N
Sbjct: 432 SGKSNNKGLIFGAVLGSLGVIVLVLLVVILILRYRRRKRMRGEKGDGTLSAFSYRELQNA 491
Query: 417 TR--SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHK 474
T+ S LG F + G + S+ I VK+L+ + Q GEK+F+ EVV IG H
Sbjct: 492 TKNFSDKLGGGGFGS-VFKGALPDSSD---IAVKRLEGISQ-GEKQFRTEVVTIGTIQHV 546
Query: 475 NLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF-----ENLKPGWNLRANIAFQIARGLLH 529
NLVRL GFC EG +LLVY ++ NG+L S LF E + GW LR IA ARGL +
Sbjct: 547 NLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAY 606
Query: 530 LHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASP 589
LH C IIHCDIKP+NILLD + +++DFGLAKL+ + S+ + +RGT+GY+A P
Sbjct: 607 LHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVL-TTMRGTRGYLA-P 664
Query: 590 EWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY-RNGKLDDLV 648
EW ITA DVYS+G++L E++S R++ + E+ WA ++G + LV
Sbjct: 665 EWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLV 724
Query: 649 EGDMEA-MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDVPPNPST 703
+ +E DI+ V + V+ WCIQ++ S RP M +V Q+LE V+EV+ PP P +
Sbjct: 725 DPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPRS 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (575), Expect = 6e-58, Method: Compositional matrix adjust.
Identities = 123/303 (40%), Positives = 180/303 (59%), Gaps = 17/303 (5%)
Query: 411 RNMMNVTR--SVLLGSSVFVNFTLVGVIQTSTRT--TVIVVKKLDRVFQDGEKEFKNEVV 466
R++ N T S LLGS F G + T T++ VK+LDR GE+EF EV
Sbjct: 523 RDLQNCTNNFSQLLGSGGF------GTVYKGTVAGETLVAVKRLDRALSHGEREFITEVN 576
Query: 467 MIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPG----WNLRANIAFQ 522
IG +H NLVRL G+C E +RLLVY+++ NG+L ++F + + W R IA
Sbjct: 577 TIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVA 636
Query: 523 IARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGT 582
A+G+ + H C ++IIHCDIKP+NILLDD + ++SDFGLAK++ S + IRGT
Sbjct: 637 TAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVT-MIRGT 695
Query: 583 KGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642
+GY+A PEW N IT DVYS+G+LLLEI+ R++ D+ E WA+ NG
Sbjct: 696 RGYLA-PEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELTNG 754
Query: 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV-EVDVPPNP 701
V+ ++ + + + V K + V+ WCIQ++ S+RP+M +V ++LE E+++PP P
Sbjct: 755 TSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMP 814
Query: 702 STF 704
T
Sbjct: 815 QTI 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64777|Y1643_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61430 OS=Arabidopsis thaliana GN=At1g61430 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 213/825 (25%), Positives = 332/825 (40%), Gaps = 172/825 (20%)
Query: 1 MASAKFYFIFLLFLFPYDLHLAIAQTNGTVP--VGSTLTAGTDSSPWLSPSGDFTFGFHQ 58
M + F L F + + A P +G TL+ S +G + GF
Sbjct: 1 MGKKRIVFFAYLPFFTIFMSFSFAGITKESPFSIGQTLS---------SSNGVYELGFFS 51
Query: 59 LGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGK 118
L NNS + + L I++ I ++VVW + E PV + + ++++ L+L++ +
Sbjct: 52 L---NNSQNQY-LGIWFKSIIPQVVVWVANRE--KPVTDSAANLGISSNGSLLLSNGKHG 105
Query: 119 QVWSS-----------------KLILVQSFSSSRLWDSFSNPTDTLLPGKMME------T 155
VWS+ L+ + S LW SF + +TLLP +M
Sbjct: 106 VVWSTGDIFASNGSRAELTDHGNLVFIDKVSGRTLWQSFEHLGNTLLPTSIMMYNLVAGE 165
Query: 156 EQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTD----LAYDAYYISGTYDSTNSS 211
++GL + KS T+ S G F + L +P+ YY +G + T +
Sbjct: 166 KRGLTAWKSYTDPSPGEF---------VALITPQVPSQGIIMRGSTRYYRTGPWAKTRFT 216
Query: 212 NSGYQVMFNESGYMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSFYLKNGNG 271
S S ++ NG + ER P+ R L +G + NG
Sbjct: 217 GSPQMDESYTSPFILTQDVNGSGYFSFVERGKPS-----RMILTSEGTM--KVLVHNGM- 268
Query: 272 NWSVVWSQPENICVNIGGELGSGAYGFNSICPKGYSLLDENEKYG----------SCKAD 321
+W + P N C +I G G SI PK K+ C
Sbjct: 269 DWESTYEGPANSC-DIYGVCGPFGLCVVSIPPKCKCFKGFVPKFAKEWKKGNWTSGCVRR 327
Query: 322 FELSCNGGRQD-----------------YELSRPYDEVQCKNNCLSDCFCVV-AIFRGDS 363
EL C G YE + + +C NCL +C C+ + G
Sbjct: 328 TELHCQGNSSGKDANVFYTVPNIKPPDFYEYANSQNAEECHQNCLHNCSCLAFSYIPGIG 387
Query: 364 C--WSKKLPLSNGRAHSSVNGKAFLKYKKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSVL 421
C WSK L + R S+ ++ + + D KR M V +V
Sbjct: 388 CLMWSKD--LMDTRQFSAAGELLSIRLARSE-------------LDVNKRKMTIVASTVS 432
Query: 422 LGSSVFVNFTLVG-----------------------------------VIQTSTRTTVI- 445
L V F G IQT+T +
Sbjct: 433 LTLFVIFGFAAFGFWRCRVEHNAHISNDAWRNFLQSQDVPGLEFFEMNAIQTATNNFSLS 492
Query: 446 ----------VVKKLDRVFQDG---------------EKEFKNEVVMIGQTYHKNLVRLL 480
V K + QDG ++EF NE+V+I + H+NLVR+L
Sbjct: 493 NKLGPGGFGSVYKARNGKLQDGREIAVKRLSSSSGQGKQEFMNEIVLISKLQHRNLVRVL 552
Query: 481 GFCDEGQNRLLVYKFLNNGTLASFLFE---NLKPGWNLRANIAFQIARGLLHLHVNCSSQ 537
G C EG +LL+Y FL N +L +F+F+ L+ W R I IARGLL+LH + +
Sbjct: 553 GCCVEGTEKLLIYGFLKNKSLDTFVFDARKKLELDWPKRFEIIEGIARGLLYLHRDSRLR 612
Query: 538 IIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI 597
+IH D+K NILLD+ N +ISDFGLA++ Q + + + GT GY+ SPE+
Sbjct: 613 VIHRDLKVSNILLDEKMNPKISDFGLARMFQGTQYQEKTRRVVGTLGYM-SPEYAWTGVF 671
Query: 598 TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657
+ D+YSFGVLLLEIIS +K GEE L +A++C+ + + ++ + +
Sbjct: 672 SEKSDIYSFGVLLLEIISGKKISSFSYGEEGKALLAYAWECWCETREVNFLDQALADSSH 731
Query: 658 IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDVPPNPS 702
V + V + + C+Q +P+ RP ++ ML ++ +P P+
Sbjct: 732 PSEVGRCVQIGLLCVQHEPADRPNTLELLSMLTTTSDLPLPKKPT 776
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64776|Y1144_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61440 OS=Arabidopsis thaliana GN=At1g61440 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 203 bits (517), Expect = 4e-51, Method: Compositional matrix adjust.
Identities = 215/831 (25%), Positives = 335/831 (40%), Gaps = 189/831 (22%)
Query: 4 AKFYFIFLLFL-FPYDLHLAIAQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKE 62
K + LLF+ F Y A + +G TL+ S +G + GF
Sbjct: 2 GKKRIVLLLFISFSY----AEITKESPLSIGQTLS---------SSNGVYELGFFSF--- 45
Query: 63 NNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWS 122
NNS + + + I++ I ++VVW + E PV + + +++ L+L + + VWS
Sbjct: 46 NNSQNQY-VGIWFKGIIPRVVVWVANRE--KPVTDSAANLVISSSGSLLLINGKHDVVWS 102
Query: 123 S-----------------KLILVQSFSSSRLWDSFSNPTDTLLPGKMME------TEQGL 159
+ L++ + + LW+SF + +TLLP M ++GL
Sbjct: 103 TGEISASKGSHAELSDYGNLMVKDNVTGRTLWESFEHLGNTLLPLSTMMYNLVTGEKRGL 162
Query: 160 FSGKSDTNFSRGRFQFRLLKD--SNLVLNIANLPTDLAYDAYYISGTYDSTNSS-----N 212
S KS T+ S G F ++ S + + P YY +G + T + +
Sbjct: 163 SSWKSYTDPSPGDFWVQITPQVPSQGFVMRGSTP-------YYRTGPWAKTRYTGIPQMD 215
Query: 213 SGYQVMF------NESGYMYILRRNGR--RFDLTTERVVPAADFYHRATLNFDGVFVQSF 264
Y F N SGY R+ + R LT+E + L ++G+
Sbjct: 216 ESYTSPFSLHQDVNGSGYFSYFERDYKLSRIMLTSEGSM--------KVLRYNGL----- 262
Query: 265 YLKNGNGNWSVVWSQPENICVNIGGELGSGAYG----------FNSICPKGYSLLDENEK 314
+W + P N C +I G G + F PK
Sbjct: 263 -------DWKSSYEGPANSC-DIYGVCGPFGFCVISDPPKCKCFKGFVPKSIEEWKRGNW 314
Query: 315 YGSCKADFELSCNGGRQD-----------------YELSRPYDEVQCKNNCLSDCFCVV- 356
C EL C G YE + D C +CL +C C+
Sbjct: 315 TSGCARRTELHCQGNSTGKDANVFHTVPNIKPPDFYEYANSVDAEGCYQSCLHNCSCLAF 374
Query: 357 AIFRGDSC--WSKKLPLSNGRAHSSVNGKAFLKYKKGDDPDPPSVPSPPDPEDKKKRNMM 414
A G C WSK L S G+ S+ D KR M
Sbjct: 375 AYIPGIGCLMWSKDL---MDTMQFSAGGEIL------------SIRLAHSELDVHKRKMT 419
Query: 415 NVTRSVLLGSSVFVNFTLVG------------------------------VIQTSTRT-- 442
V +V L V + F G IQT+T
Sbjct: 420 IVASTVSLTLFVILGFATFGFWRNRVKHHDAWRNDLQSQDVPGLEFFEMNTIQTATSNFS 479
Query: 443 ---------------------TVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLG 481
I VK+L + G++EF NE+V+I + H+NLVR+LG
Sbjct: 480 LSNKLGHGGFGSVYKGKLQDGREIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLG 539
Query: 482 FCDEGQNRLLVYKFLNNGTLASFLF---ENLKPGWNLRANIAFQIARGLLHLHVNCSSQI 538
C EG+ +LL+Y+F+ N +L +F+F + L+ W R +I I RGLL+LH + ++
Sbjct: 540 CCVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLRV 599
Query: 539 IHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTIT 598
IH D+K NILLD+ N +ISDFGLA+L +Q + + + GT GY+ SPE+ +
Sbjct: 600 IHRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTRRVVGTLGYM-SPEYAWTGVFS 658
Query: 599 ANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658
D+YSFGVLLLEIIS K GEE L + ++C+ + +L++ ++ +
Sbjct: 659 EKSDIYSFGVLLLEIISGEKISRFSYGEEGKALLAYVWECWCETRGVNLLDQALDDSSHP 718
Query: 659 KCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDVPPNPSTFSCSKR 709
V + V + + C+Q P+ RP ++ ML ++ +P P TF+ R
Sbjct: 719 AEVGRCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPLPKQP-TFAVHTR 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64770|Y1649_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61490 OS=Arabidopsis thaliana GN=At1g61490 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (515), Expect = 6e-51, Method: Compositional matrix adjust.
Identities = 218/815 (26%), Positives = 342/815 (41%), Gaps = 141/815 (17%)
Query: 1 MASAKFYFIFLLFLFPYDLHLAIAQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLG 60
M + F L LF L + A P+ T S +G + GF
Sbjct: 1 MGKKRIVFFACLLLFTVLLRFSYAGITTESPLSVEQTLS-------SSNGIYELGFFS-- 51
Query: 61 KENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQV 120
NNS +L+ + I++ I ++VVW + E P + + ++++ L+L + + V
Sbjct: 52 -PNNSQNLY-VGIWFKGIIPRVVVWVANRE--TPTTDTSANLAISSNGSLLLFNGKHGVV 107
Query: 121 WS-----------------SKLILVQSFSSSRLWDSFSNPTDTLLP--GKMMETEQG--- 158
WS L+++ + S LW+SF + DT+LP M G
Sbjct: 108 WSIGENFASNGSRAELTDNGNLVVIDNASGRTLWESFEHFGDTMLPFSSLMYNLATGEKR 167
Query: 159 -LFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQV 217
L S K+DT+ S G F ++ + I T YY +G + T + G +
Sbjct: 168 VLTSWKTDTDPSPGVFVGQITPQVPSQVLIMRGST-----RYYRTGPWAKTRFT--GIPL 220
Query: 218 MFNESGYMYILRR--NGRRFDLTTERVVPAADFYHRATLNFDGVFVQSFYLKNGNGNWSV 275
M + + L++ NG F +R + R ++ +G + + NG +W +
Sbjct: 221 MDDTYASPFSLQQDANGSGFFTYFDRSFKLS----RIIISSEGSMKR--FRHNGT-DWEL 273
Query: 276 VWSQPENICVNIGGELGSGAYGFNSI-----CPKGYSLLDENEKY------GSCKADFEL 324
+ P N C +I G G S+ C KG+ + E++ G C EL
Sbjct: 274 SYMAPANSC-DIYGVCGPFGLCIVSVPLKCKCLKGF-VPHSTEEWKRGNWTGGCARLTEL 331
Query: 325 SCNGGRQD-----------------YELSRPYDEVQCKNNCLSDCFCVV-AIFRGDSC-- 364
C G YE D +C +CL +C C+ A G C
Sbjct: 332 HCQGNSTGKDVNIFHPVTNVKLPDFYEYESSVDAEECHQSCLHNCSCLAFAYIHGIGCLI 391
Query: 365 WSKKLP-----------LSNGRAHSSVNGK------------------------AFLKYK 389
W++ L LS AHS + G F +Y+
Sbjct: 392 WNQNLMDAVQFSAGGEILSIRLAHSELGGNKRNKIIVASTVSLSLFVILTSAAFGFWRYR 451
Query: 390 KG-----------DDPDPPSVPSPPDPE-DKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQ 437
+D VP E + + N + S LG F + G +Q
Sbjct: 452 VKHKAYTLKDAWRNDLKSKEVPGLEFFEMNTIQTATNNFSLSNKLGQGGFGS-VYKGKLQ 510
Query: 438 TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497
I VK+L G++EF NE+V+I + H+NLVR+LG C EG+ +LL+Y+F+
Sbjct: 511 DGKE---IAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFML 567
Query: 498 NGTLASFLFE---NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
N +L +F+F+ L+ W R +I IARGLL+LH + ++IH D+K NILLD+
Sbjct: 568 NKSLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKM 627
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
N +ISDFGLA++ Q + + + GT GY+ SPE+ + D+YSFGVLLLEII
Sbjct: 628 NPKISDFGLARMYEGTQCQDKTRRVVGTLGYM-SPEYAWTGVFSEKSDIYSFGVLLLEII 686
Query: 615 SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQE 674
K GEE L +A++ + K DL++ D+ V + V + + C+Q
Sbjct: 687 IGEKISRFSYGEEGKTLLAYAWESWGETKGIDLLDQDLADSCRPLEVGRCVQIGLLCVQH 746
Query: 675 DPSLRPTMRKVSQMLEVVVEVDVPPNPSTFSCSKR 709
P+ RP ++ ML ++ P P TF R
Sbjct: 747 QPADRPNTLELLAMLTTTSDLPSPKQP-TFVVHSR 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64780|Y1614_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61400 OS=Arabidopsis thaliana GN=At1g61400 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 202 bits (513), Expect = 9e-51, Method: Compositional matrix adjust.
Identities = 214/815 (26%), Positives = 346/815 (42%), Gaps = 186/815 (22%)
Query: 19 LHLAIAQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKI 78
L + I+ ++ + S L+ G S S +G + GF NNS + + + I + I
Sbjct: 25 LSIFISFSSAEITEESPLSIGQTLS---SSNGVYELGFFSF---NNSQNQY-VGISFKGI 77
Query: 79 PKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWSS--------------- 123
++VVW + E PV + + ++++ L L + + VWSS
Sbjct: 78 IPRVVVWVANRE--KPVTDSAANLVISSNGSLQLFNGKHGVVWSSGKALASNGSRVELLD 135
Query: 124 --KLILVQSFSSSRLWDSFSNPTDTLLPGKMME------TEQGLFSGKSDTNFSRGRFQF 175
L++++ S LW+SF + DTLLP + ++GL S KS T+ S G F
Sbjct: 136 SGNLVVIEKVSGRTLWESFEHLGDTLLPHSTIMYNVHTGEKRGLTSWKSYTDPSPGDF-- 193
Query: 176 RLLKDSNLVLNIANLPTD----LAYDAYYISGTYDSTNSS-----NSGYQVMF------N 220
+VL +P+ Y+ SG + T + + Y F N
Sbjct: 194 -------VVLITPQVPSQGFLMRGSTPYFRSGPWAKTKFTGLPQMDESYTSPFSLTQDVN 246
Query: 221 ESGYMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSFYLKNGNGNWSVVWSQP 280
SGY R+ +R + R+ P L ++G+ +W + P
Sbjct: 247 GSGYYSYFDRDNKRSRI---RLTPDGSM---KALRYNGM------------DWDTTYEGP 288
Query: 281 ENICVNIGGELGSGAYGFNSICPKGYSLLD------ENEKYGS----CKADFELSCNGGR 330
N C +I G G + S+ PK E K G+ C EL C G
Sbjct: 289 ANSC-DIYGVCGPFGFCVISVPPKCKCFKGFIPKSIEEWKTGNWTSGCVRRSELHCQGNS 347
Query: 331 QD-----------------YELSRPYDEVQCKNNCLSDCFCVV-AIFRGDSC--WSKKLP 370
YE + D +C+ NCL++C C+ A G C WSK L
Sbjct: 348 TGKDANVFHTVPNIKPPDFYEYADSVDAEECQQNCLNNCSCLAFAYIPGIGCLMWSKDLM 407
Query: 371 LSNGRAHSSVNGKAFLKYKKGDDPDPPSVPSPPDPEDKKKRNMMNVTRS----VLLGSSV 426
+ +++ G + + +K+K+ ++ +T S V+LG +
Sbjct: 408 DT-------------VQFAAGGELLSIRLARSELDVNKRKKTIIAITVSLTLFVILGFTA 454
Query: 427 F-----------------------------VNFTLVGVIQTSTRTTVIVVKKLDRVF--- 454
F + + + IQT+T + K F
Sbjct: 455 FGFWRRRVEQNALISEDAWRNDLQTQDVPGLEYFEMNTIQTATNNFSLSNKLGHGGFGSV 514
Query: 455 -----QDGEK---------------EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494
QDG + EF NE+V+I + H+NLVR+LG C EG +LL+Y+
Sbjct: 515 YKGKLQDGREIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYE 574
Query: 495 FLNNGTLASFLFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
F+ N +L +F+F++ L+ W R +I IARGLL+LH + +IIH D+K NILLD
Sbjct: 575 FMKNKSLDTFVFDSKKRLEIDWPKRFDIIQGIARGLLYLHRDSRLRIIHRDLKVSNILLD 634
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611
+ N +ISDFGLA++ + + + + GT GY+ SPE+ + D+YSFGVLLL
Sbjct: 635 EKMNPKISDFGLARMFHGTEYQDKTRRVVGTLGYM-SPEYAWAGVFSEKSDIYSFGVLLL 693
Query: 612 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC----VEKLVMV 667
EIIS K GEE L +A++C+ + +L++ +A+ D C V + V +
Sbjct: 694 EIISGEKISRFSYGEEGKTLLAYAWECWCGARGVNLLD---QALGD-SCHPYEVGRCVQI 749
Query: 668 SIWCIQEDPSLRPTMRKVSQMLEVVVEVDVPPNPS 702
+ C+Q P+ RP ++ ML ++ +P P+
Sbjct: 750 GLLCVQYQPADRPNTLELLSMLTTTSDLPLPKQPT 784
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (512), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 111/259 (42%), Positives = 153/259 (59%), Gaps = 13/259 (5%)
Query: 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
+T + VK+L+R GE EF+ EV IG H NLVRL GFC E +RLLVY ++ G+L
Sbjct: 484 STFVAVKRLERP-GSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSL 542
Query: 502 ASFLFENLKP--GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
+S+L W R IA A+G+ +LH C IIHCDIKP+NILLD YNA++S
Sbjct: 543 SSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVS 602
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFGLAKLL + S+ + +RGT GYVA PEW IT DVYSFG+ LLE+I R++
Sbjct: 603 DFGLAKLLGRDFSRVL-ATMRGTWGYVA-PEWISGLPITTKADVYSFGMTLLELIGGRRN 660
Query: 620 FDIE---MGEEYAILTDWAFDCYR-----NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
+ +GE+ W F + G +D +V+ + + + V ++ V+IWC
Sbjct: 661 VIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWC 720
Query: 672 IQEDPSLRPTMRKVSQMLE 690
IQ++ +RP M V +MLE
Sbjct: 721 IQDNEEIRPAMGTVVKMLE 739
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 709 | ||||||
| 109676362 | 2037 | CCHC-type integrase [Populus trichocarpa | 0.895 | 0.311 | 0.536 | 0.0 | |
| 224073224 | 699 | predicted protein [Populus trichocarpa] | 0.898 | 0.911 | 0.537 | 0.0 | |
| 224143661 | 691 | predicted protein [Populus trichocarpa] | 0.895 | 0.918 | 0.535 | 0.0 | |
| 356575025 | 800 | PREDICTED: G-type lectin S-receptor-like | 0.976 | 0.865 | 0.477 | 0.0 | |
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.937 | 0.830 | 0.474 | 0.0 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.954 | 0.847 | 0.475 | 0.0 | |
| 224057535 | 775 | predicted protein [Populus trichocarpa] | 0.928 | 0.849 | 0.483 | 0.0 | |
| 224053032 | 752 | predicted protein [Populus trichocarpa] | 0.905 | 0.853 | 0.484 | 0.0 | |
| 255544746 | 800 | ATP binding protein, putative [Ricinus c | 0.930 | 0.825 | 0.480 | 0.0 | |
| 356555196 | 869 | PREDICTED: G-type lectin S-receptor-like | 0.912 | 0.744 | 0.453 | 1e-179 |
| >gi|109676362|gb|ABG37663.1| CCHC-type integrase [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1927), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/755 (53%), Positives = 498/755 (65%), Gaps = 120/755 (15%)
Query: 21 LAIAQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPK 80
+A+AQTNG VP G+++TA DS W S SG+F FGF QL + D F LSI+Y KIP+
Sbjct: 51 MAVAQTNGRVPTGASITATDDSPSWPSASGEFAFGFRQL----ENKDYFLLSIWYEKIPE 106
Query: 81 KIVVWYTDNED--QNPVVPRGSQVKLTADQGLVLNDPQGKQVWSSKL------------- 125
K VVWY ED +P VPRGS+++LT D+GL+L DPQG Q+WSS +
Sbjct: 107 KTVVWYAIGEDPTDDPAVPRGSKLELTDDRGLLLADPQGNQIWSSGIPPGAAVSSGVMND 166
Query: 126 ---ILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSN 182
++Q+ +S RLW+SF+NPTDTLLP ++ME + S +++TNFS GRFQ RLL + N
Sbjct: 167 TGNFVLQNRNSFRLWESFNNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLLDNGN 226
Query: 183 LVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERV 242
LVLN NLPT YD YY S T D++NSSNSGY+++FNESGYMYILRRNG DL T+
Sbjct: 227 LVLNYMNLPTKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDL-TKTA 285
Query: 243 VPAADFYHRATLNFDGVFVQSFYLK--NGNGNWSVVWSQPENICVNIGGELGSGAYGFNS 300
+P DFYHRATLNFDGVF Q FY K +GN +WS VWS+P++ICVN+G +LGSGA G+NS
Sbjct: 286 LPTIDFYHRATLNFDGVFTQYFYPKASSGNRSWSSVWSKPDDICVNMGADLGSGACGYNS 345
Query: 301 I------------CPKGYSLLDENEKYGSCKADFELSCNGG------------------- 329
I CP+G+SLLD+N+KYGSC DFELSC
Sbjct: 346 ICNLKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDW 405
Query: 330 -RQDYELSRPYDEVQCKNNCLSDCFCVVAIFRGDSCWSKKLPLSNGRAHSSVNGKAFLKY 388
DYE +P +E +C+ +CL+DC C VAIFR D CW KKLPLSNGR +NGKAFLK+
Sbjct: 406 PTSDYERYKPINEDECRKSCLNDCLCSVAIFR-DGCWKKKLPLSNGRFDIGMNGKAFLKF 464
Query: 389 KKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGV------------- 435
KG P P P P +KKK ++ +T SV+LG+SVFVNF LVG
Sbjct: 465 PKG--YVPLDRPPPQLPGEKKKPDIKFITGSVVLGTSVFVNFVLVGAFCLTSSFIYRKKT 522
Query: 436 ---------IQTSTR----------------------------------TTVIVVKK-LD 451
++T+ R +T +V K LD
Sbjct: 523 EKVKEGGSGLETNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAGSTRVVAVKKLD 582
Query: 452 RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKP 511
+V QDGEKEFK EV +IGQT+HKNLVRLLGFCDEGQNRLLVY+FL+NGTLA+FLF KP
Sbjct: 583 KVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKP 642
Query: 512 GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571
W R IAF IARGLL+LH C +QIIHCDIKPQNILLD+YYNA+ISDFGLAKLL ++Q
Sbjct: 643 NWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQ 702
Query: 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE-EYAI 630
SK + AIRGTKGYVA PEWFRN IT VDVYSFGV+LLEII CR++ D+E+GE E +
Sbjct: 703 SKT-QTAIRGTKGYVA-PEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPV 760
Query: 631 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLV 665
LTDWA+DCY +G LD L+ D EA NDI +E+L+
Sbjct: 761 LTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLL 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224073224|ref|XP_002304031.1| predicted protein [Populus trichocarpa] gi|222841463|gb|EEE79010.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/740 (53%), Positives = 491/740 (66%), Gaps = 103/740 (13%)
Query: 21 LAIAQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPK 80
+A+AQTNG VPVG+++TA DS WLS SG+F FGF QL + D F LSI+Y KIP+
Sbjct: 1 MAVAQTNGRVPVGASITATDDSPSWLSASGEFAFGFRQL----ENKDYFLLSIWYEKIPE 56
Query: 81 KIVVWYTDNED--QNPVVPRGSQVKLTADQGLVLNDPQGKQVWSSKLIL----------- 127
K VVWY ED +P VPRGS+V+LT D+GL+L DPQG +W+S+++L
Sbjct: 57 KTVVWYAIGEDPTDDPAVPRGSKVELTDDRGLLLADPQGNLIWTSRILLGAVSSGVMNDT 116
Query: 128 ----VQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNL 183
+Q+ +S RLW+SF+NPTDTLLP ++ME + S +++TNFS GRFQ RLL + NL
Sbjct: 117 GNFVLQNRNSERLWESFNNPTDTLLPTQIMEAGGVVSSRRTETNFSLGRFQLRLLDNGNL 176
Query: 184 VLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERVV 243
VLN NL T AYD YY SGT D++NSSN+GY+++FNESGY IL R + +
Sbjct: 177 VLNSMNLSTKFAYDDYYRSGTSDASNSSNTGYRLLFNESGY--ILWRP-----PPSPSSL 229
Query: 244 PAADFYHRATLNFDGVFVQSFYLKNGNGNWSVVWSQPENICVNIGGELGSGAYGFNSIC- 302
+AD + ++QS WS VWS+P++ICVN+G +LGSGA G+NSIC
Sbjct: 230 ISADIH----------YIQS---------WSSVWSKPDDICVNMGADLGSGACGYNSICN 270
Query: 303 -----------PKGYSLLDENEKYGSCKADFELSCNGG--------------------RQ 331
P+G+SLLD+N+KYGSC DFELSC
Sbjct: 271 LKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTS 330
Query: 332 DYELSRPYDEVQCKNNCLSDCFCVVAIFRGDSCWSKKLPLSNGRAHSSVNGKAFLKYKKG 391
DYE +P +E +C+ +CL+DC C VAIFR D CW KKLPLSNGR +NGKAFLK+ KG
Sbjct: 331 DYERYKPINEDECRKSCLNDCLCSVAIFR-DGCWKKKLPLSNGRFDIGMNGKAFLKFPKG 389
Query: 392 DD-----PDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIV 446
+ D +D+ R V G IQ + T V+
Sbjct: 390 YTNLRYFTYKELAEATNDFKDEVGRGGFGVVYK--------------GTIQAGS-TRVVA 434
Query: 447 VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF 506
VKKLD+V QDGEKEFK EV +IGQT+HKNLVRLLGFCDEGQNRLLVY+FL+NGTLA+FLF
Sbjct: 435 VKKLDKVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLF 494
Query: 507 ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566
KP W R IAF IARGLL+LH C +QIIHCDIKPQNILLD+YYNA+ISDFGLAKL
Sbjct: 495 GCSKPNWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKL 554
Query: 567 LTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE 626
L ++QSK + AIRGTKGYVA PEWFRN IT VDVYSFGV+LLEII CR++ D+E+GE
Sbjct: 555 LVMDQSKT-QTAIRGTKGYVA-PEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGE 612
Query: 627 -EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKV 685
E +LTDWA+DCY +G LD L+ D EA NDI +E+L+ V IWCIQEDPSLRPTMRKV
Sbjct: 613 VENPVLTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKV 672
Query: 686 SQMLEVVVEVDVPPNPSTFS 705
+QMLE VVEV PNP +S
Sbjct: 673 TQMLEGVVEVPAAPNPFPYS 692
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143661|ref|XP_002336066.1| predicted protein [Populus trichocarpa] gi|222869874|gb|EEF07005.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1829), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/732 (53%), Positives = 474/732 (64%), Gaps = 97/732 (13%)
Query: 27 NGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWY 86
NG++PVG+ +TA D+ WLS SG+F FGF L D F LSI+Y KIP+K +VWY
Sbjct: 1 NGSMPVGAFITATDDAPSWLSSSGEFAFGFQPL----EYKDHFLLSIWYAKIPEKTIVWY 56
Query: 87 TDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWSSKLIL---------------VQSF 131
+ + NP PR S+V+L D GLVL DPQG +WSS +L +Q+
Sbjct: 57 ANGD--NPA-PRESKVELRGDSGLVLTDPQGNLIWSSGSLLGTVSSGVMNDTGNFVLQNS 113
Query: 132 SSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLP 191
+S RLW+SFSNPTDTLLP ++ME + S +++TNFS GRFQ RLL + NLVLN NLP
Sbjct: 114 NSFRLWESFSNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLLDNGNLVLNYMNLP 173
Query: 192 TDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERVVPAADFYHR 251
T YD YY S T D++NSSNSGY+++FNESGYMYILRRNG DLT + +P DFYHR
Sbjct: 174 TKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDLT-KTALPTIDFYHR 232
Query: 252 ATLNFDGVFVQSFYLKNGNGNWSVVWSQPENICVNIGGELGSGAYGFNSIC--------- 302
ATLNFD +LGSGA G+NSIC
Sbjct: 233 ATLNFDA-------------------------------DLGSGACGYNSICNLKADKRPE 261
Query: 303 ---PKGYSLLDENEKYGSCKADFELSCNGG--------------------RQDYELSRPY 339
P+G+SLLD+N+KYGSC DFELSC DYE +P
Sbjct: 262 CKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTSDYERYKPI 321
Query: 340 DEVQCKNNCLSDCFCVVAIFRGDSCWSKKLPLSNGRAHSSVNGKAFLKYKKGDDPDPPSV 399
+E +C+ +CL+DC C VAIFR D CW KKLPLSNGR +NGKAFLK+ KG +
Sbjct: 322 NEDECRKSCLNDCLCSVAIFR-DGCWKKKLPLSNGRFDIGMNGKAFLKFPKGYKTEKVKE 380
Query: 400 PSPPDPEDKKKRNMMNVTRSV-----LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF 454
+ + + + +G F G IQ + T V+ VKKLD+V
Sbjct: 381 GGSGLETNLRYFTYKELAEATNDFKDEVGRGGF-GVVYKGTIQAGS-TRVVAVKKLDKVV 438
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWN 514
QDGEKEFK EV +IGQT+HKNLVRLLGFCDEGQNRLLVY+FL+NGTLA+FLF KP W
Sbjct: 439 QDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWK 498
Query: 515 LRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574
R IAF IARGLL+LH C +QIIHCDIKPQNILLD+YYNA+ISDFGLAKLL ++QSK
Sbjct: 499 QRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKT 558
Query: 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTD 633
+ AIRGTKGYVA PEWFRN IT VDVYSFGV+LLEII CR++ D+E+GE E +LTD
Sbjct: 559 -QTAIRGTKGYVA-PEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTD 616
Query: 634 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693
WA+DCY +G LD L+ D EA NDI +E+L+ V IWCIQEDPSLRPTMRKV+QMLE VV
Sbjct: 617 WAYDCYMDGSLDVLIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVV 676
Query: 694 EVDVPPNPSTFS 705
EV PNP +S
Sbjct: 677 EVPAAPNPFPYS 688
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575025|ref|XP_003555643.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/806 (47%), Positives = 499/806 (61%), Gaps = 114/806 (14%)
Query: 1 MASAKFYFIFLLFLFPYDLHLAIAQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLG 60
MA+ + L P ++ TN V +G TL AG WLSPS DF FGFHQL
Sbjct: 1 MAAKTVLVCVTVILLPLLQLPYVSATN--VSIGETLVAGNGGKRWLSPSEDFAFGFHQL- 57
Query: 61 KENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQV 120
NDL+ L+I Y IP+ +WY + + NP P+GS+++L GLVL PQG ++
Sbjct: 58 ----DNDLYLLAISYQNIPRDSFIWYANGD--NPA-PKGSKLELNQYTGLVLKSPQGVEL 110
Query: 121 WSSKLI---------------LVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSD 165
W+S+LI + +S LWDSFSNPTDTL+P ++ME + L S + +
Sbjct: 111 WTSQLISGTISYGLMNDTGNFQLLDENSQVLWDSFSNPTDTLVPTQIMEVKGTLSSRQKE 170
Query: 166 TNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYM 225
NFSRGRFQFRLL D N VLN NLPT+ YDA+YIS TYDSTN++NSG+QV+F+ SG +
Sbjct: 171 ANFSRGRFQFRLLPDGNAVLNPINLPTNYTYDAHYISATYDSTNTTNSGFQVIFDNSG-L 229
Query: 226 YILRRNGRRFDLTTERVVPAAD-FYHRATLNFDGVFVQSFYLKN--GNGNWSVVWSQPEN 282
YIL+R+G + +T + + D +Y+RAT+NFDG F S Y KN N +W+V+ + P+N
Sbjct: 230 YILKRSGEKVYITNPKDALSTDSYYYRATINFDGTFTISNYPKNPASNPSWTVMKTLPDN 289
Query: 283 ICVN-IGGELGSGAYGFNSI------------CPKGYSLLDENEKYGSCKADFELSCNGG 329
IC+N +G GSG GFNSI CP+GYS LD ++YGSCK + EL C
Sbjct: 290 ICMNLLGNTGGSGVCGFNSICTLKADQRPKCSCPEGYSPLDSRDEYGSCKPNLELGCGSS 349
Query: 330 RQ--------------------DYELSRPYDEVQCKNNCLSDCFCVVAIFRGDSCWSKKL 369
Q DYEL +PY+ CK +CL DC C V+IFR DSC+ KKL
Sbjct: 350 GQSLQGDLYFMKEMANTDWPVSDYELYKPYNSEDCKTSCLQDCLCAVSIFRDDSCYKKKL 409
Query: 370 PLSNGRAHSSVNGKAFLKYKKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVN 429
PLSNGR +V AF+K K P P + + KK ++ + SVLLG SVF N
Sbjct: 410 PLSNGRRDRAVGASAFIKLMKNGVSLSPPNPFIEEKKYKKDQDTLITVISVLLGGSVFFN 469
Query: 430 ------------------------------FTLVGVIQT-------------------ST 440
FT ++Q +T
Sbjct: 470 LVSAVWVGFYFYYNKKSSTNKTATESNLCSFTFAELVQATDNFKEELGRGSCGIVYKGTT 529
Query: 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
I VKKLD+V +D +KEFK EV +IGQT+HK+LVRLLG+CDE Q+R+LVY+FL+NGT
Sbjct: 530 NLATIAVKKLDKVLKDCDKEFKTEVNVIGQTHHKSLVRLLGYCDEEQHRILVYEFLSNGT 589
Query: 501 LASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD 560
LA+FLF + KP WN R IAF IARGL++LH C +QIIHCDIKPQNILLD+ YNA+ISD
Sbjct: 590 LANFLFGDFKPNWNQRVQIAFGIARGLVYLHEECCTQIIHCDIKPQNILLDEQYNARISD 649
Query: 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
FGL+KLL +N+S + IRGTKGYVA P+WFR++ IT VDVYSFGVLLLEII CR++
Sbjct: 650 FGLSKLLKINESHT-ETGIRGTKGYVA-PDWFRSAPITTKVDVYSFGVLLLEIICCRRNV 707
Query: 621 DIEMG-EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLR 679
D E+G EE AILTDWA+DCYR G++D L+E D EA++D +E+ VMV+IWC+QEDPSLR
Sbjct: 708 DGEVGNEEKAILTDWAYDCYRAGRIDILLENDDEAIDDTNRLERFVMVAIWCLQEDPSLR 767
Query: 680 PTMRKVSQMLEVVVEVDVPPNPSTFS 705
P M+KV MLE + V +PP+PS ++
Sbjct: 768 PPMKKVMLMLEGIAPVTIPPSPSPYT 793
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1791), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/792 (47%), Positives = 494/792 (62%), Gaps = 127/792 (16%)
Query: 8 FIFLLFLFPYDLHLAIAQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSND 67
F L+ L P+ A++QT G + VG++L+ ++S WLSPSGDF FGFH L +
Sbjct: 10 FSLLIMLPPF----AVSQTGGNITVGASLSTSENTS-WLSPSGDFAFGFHPL---YGNKY 61
Query: 68 LFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWSSKLIL 127
LF L+I+Y+KIP+K +VWY + + P GS+ LTA++G+ L DPQG+++W S+ I+
Sbjct: 62 LFLLAIWYDKIPEKTIVWYANGDKP---APTGSKAVLTANRGISLTDPQGRELWRSETII 118
Query: 128 ---------------VQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGR 172
+Q S +LW+SF NP DTLLP ++++ L S +S+ NFS GR
Sbjct: 119 GVVAYGAMTDKGNFVLQDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSENNFSMGR 178
Query: 173 FQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRNG 232
FQ +L D NL L NLP+D + YY SGT +SS+ GYQV+FNESGY+YILR N
Sbjct: 179 FQLKLTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILREND 238
Query: 233 RRFDLTTERVVPAADFYHRATLNFDGVFVQSFYLKNGNGN--WSVVWSQPENICVNIGGE 290
+ F LT DFY RATLNFDG+F Q ++ K GN W+ +WSQP+NIC
Sbjct: 239 QIFSLTQRVTASTGDFYRRATLNFDGLFTQYYHPKASTGNERWTPIWSQPDNICQASFVS 298
Query: 291 LGSGAYGFNSI------------CPKGYSLLDENEKYGSCKADFELSCNGGR-------- 330
GSG GFNS+ CP GYSLLD +++YGSC+ ++ SC
Sbjct: 299 SGSGTCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVAPVEDLY 358
Query: 331 ------------QDYELSRPYDEVQCKNNCLSDCFCVVAIFR-GDSCWSKKLPLSNGRAH 377
DY L +P+ E +C+ +CL+DC C VAIFR GD CW KKLPLSNGR
Sbjct: 359 DFEELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRVQ 418
Query: 378 SSVNGKAFLKYKKGD-DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--- 433
++++GKA LK ++ + +P P P+ +KK R+ + + SV LG SVFVNF LV
Sbjct: 419 TNLDGKALLKVRRSNVNPRSPYFPN-----NKKDRDGLILVGSVFLGCSVFVNFLLVCAI 473
Query: 434 -------------------GVIQTSTR--------------------------------- 441
G ++T+ R
Sbjct: 474 FMCFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVYKGVVHI 533
Query: 442 --TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
+ V+ VKKL+ V +D +EFK EV +IGQT+HKNLVRLLGFC+EG RLLVY+F++NG
Sbjct: 534 GSSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNG 593
Query: 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
+L+SF+F++ KPGW +R IAF +ARGLL+LH CS+QIIHCDIKPQNILLD+YYNA+IS
Sbjct: 594 SLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLDEYYNARIS 653
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFGLAKLL L+QS+ AIRGTKGYVA PEWFRN +T VDVYS+GVLLLEII CR++
Sbjct: 654 DFGLAKLLLLDQSQT-HTAIRGTKGYVA-PEWFRNLPVTVKVDVYSYGVLLLEIICCRRN 711
Query: 620 FDIEMG-EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSL 678
D + EE AILTDWA+DCYR G LD LV D A++DI+ +E+ +M++ WCIQEDPSL
Sbjct: 712 VDSKATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWCIQEDPSL 771
Query: 679 RPTMRKVSQMLE 690
RPTMRKV+QMLE
Sbjct: 772 RPTMRKVTQMLE 783
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1769), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/806 (47%), Positives = 502/806 (62%), Gaps = 129/806 (16%)
Query: 8 FIFLLFLFPYDLHLAIAQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSND 67
F L+ L P+ A++QT G + VG++L+ +D++ WLSPSGDF FGF+QL + D
Sbjct: 10 FSLLIMLPPF----AVSQTGGNITVGASLST-SDNTSWLSPSGDFAFGFYQL---YGNKD 61
Query: 68 LFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWSSKLIL 127
LF L+I+Y+KIP K +VWY + + P GS+ LTA++G+ L DPQG+++W S+ I+
Sbjct: 62 LFLLAIWYDKIPDKTIVWYANGDKP---APTGSKAVLTANRGISLTDPQGRELWRSETII 118
Query: 128 ---------------VQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGR 172
++ S +LW+SF NP DTLLP ++++ L S +S+TNFS GR
Sbjct: 119 GDVAYGAMTDTGNFVLRDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSETNFSMGR 178
Query: 173 FQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRNG 232
FQ +L D NLVL NLP+D + YY SGT +SS+ GYQV+FNESGY+YILR+N
Sbjct: 179 FQLKLRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRKND 238
Query: 233 RRFDLTTERVVPAADFYHRATLNFDGVFVQSFYLKNGNGN--WSVVWSQPENICVNIGGE 290
+ F LT DFYHRATLNFDGVF Q ++ K GN W+ +WSQP+NIC
Sbjct: 239 QIFSLTQRVTASTGDFYHRATLNFDGVFTQYYHPKASTGNERWTPIWSQPDNICQASSVS 298
Query: 291 LGSGAYGFNSI------------CPKGYSLLDENEKYGSCKADFELSCNGGR-------- 330
GSG GFNS+ CP GYSLLD +++YGSC+ ++ SC
Sbjct: 299 AGSGTCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVAPVEDLY 358
Query: 331 ------------QDYELSRPYDEVQCKNNCLSDCFCVVAIFR-GDSCWSKKLPLSNGRAH 377
DY L +P+ E +C+ +CL+DC C VAIFR GD CW KKLPLSNGR
Sbjct: 359 DFEELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRVQ 418
Query: 378 SSVNGKAFLKYKKGD-DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--- 433
+ V+ KA LK ++ + +P SP P +KK R+ + + SV LG SVFVNF LV
Sbjct: 419 TIVDAKALLKVRRSNVNPR-----SPYFPNNKKDRDGLILVGSVFLGCSVFVNFLLVCAI 473
Query: 434 -------------------GVIQTSTR--------------------------------- 441
G ++T+ R
Sbjct: 474 CMGFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVYRGVVHI 533
Query: 442 --TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
+ V+ VKKL+ V +D +EFK EV +IGQT+HKNLVRLLGFC+EG RLLVY+F++NG
Sbjct: 534 GSSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNG 593
Query: 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
+L+SF+F++ KPGW +R IAF +ARGLL+LH + SQIIHCDIKPQNILLD+ NA+IS
Sbjct: 594 SLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHED--SQIIHCDIKPQNILLDESLNARIS 651
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFGLAKLL +Q+K AIRGTKGYVA PEWF+N +T VD YSFG+LLLE++ CRK+
Sbjct: 652 DFGLAKLLKTDQTKTT-TAIRGTKGYVA-PEWFKNLPVTTKVDTYSFGILLLELVCCRKN 709
Query: 620 FDI-EMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSL 678
F+I M E +L DWA DC + GKL+ LVE D EAM D+K VE+ VMV+IWCIQEDPSL
Sbjct: 710 FEINAMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWCIQEDPSL 769
Query: 679 RPTMRKVSQMLEVVVEVDVPPNPSTF 704
RP M+KV QMLE V+V VPP+PS+F
Sbjct: 770 RPGMKKVVQMLEGGVQVSVPPDPSSF 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224057535|ref|XP_002299255.1| predicted protein [Populus trichocarpa] gi|222846513|gb|EEE84060.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1756), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/810 (48%), Positives = 490/810 (60%), Gaps = 152/810 (18%)
Query: 6 FYFIFLLFLFPYDLHLAIAQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNS 65
YF FLLF P L +AQ NG VG +LTAG +++ WLSP+ DF FGF QL K+
Sbjct: 9 LYFFFLLF--PSSL---VAQRNGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKK--- 60
Query: 66 NDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWSSKL 125
DL+ L+I+YNKIP K +VWY + + P+ S VKLTA+ G+VLN+PQG ++W S
Sbjct: 61 -DLYLLAIWYNKIPDKTIVWYANGDRP---APKKSTVKLTAELGVVLNNPQGGEIWKSGP 116
Query: 126 ---------------ILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSR 170
LV + + +LW SF TDTLLP ++ME L S S+TNFS+
Sbjct: 117 GNGEAAYGFMNDTGNFLVANANGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQ 176
Query: 171 GRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRR 230
GRFQFRL+ D N VLN NLPT Y+AY+ S T DS NSSN+GYQV+FNESGY+Y+LR
Sbjct: 177 GRFQFRLIPDGNAVLNTINLPTGFPYEAYFWSKTVDS-NSSNAGYQVVFNESGYLYVLRA 235
Query: 231 NGRRFDLTTERVVPAADFYHRATLNFDGVFVQSFYLKN--GNGNWSVVWSQPENICVNIG 288
N R LT RVVPA + YHRATL+FDGVFV + KN GN NWSVV + PENIC +
Sbjct: 236 NNTREALTLGRVVPATENYHRATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVR 295
Query: 289 GELGSGAYGFNSI------------CPKGYSLLDENEKYGSCKADF-------------- 322
G GSG G+N + CP+ +SLLD ++ YG CK DF
Sbjct: 296 GLKGSGPCGYNGVCTISTDKRAICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPE 355
Query: 323 --EL----SCNGGRQDYELSRPYDEVQCKNNCLSDCFCVVAIFRGDSCWSKKLPLSNGRA 376
EL + + DYE+ PY+ CK CL D FC V +F +CW K+LPLSNGR
Sbjct: 356 DYELVPLTNIDWPESDYEMYTPYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQ 415
Query: 377 HSSVNGKAFLKYKKGDD--PDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVG 434
SVNG +F+K +KG+ P PP +P K+N++ V SVLLG SVF NF LVG
Sbjct: 416 GESVNGASFMKVRKGNYTLPGPPPIP---------KKNLLVV--SVLLGGSVFFNFVLVG 464
Query: 435 VIQTS---------TRTTVI---------------------------------------- 445
V+ + TRT +
Sbjct: 465 VVSFAFFFIYHNKFTRTPQVERAVQSNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLT 524
Query: 446 --------VVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497
+KK+DR ++ +KEFK EV +I GFCDEGQ+R+LVY+FL+
Sbjct: 525 QIGSGVPVAIKKVDRFVKESDKEFKTEVDVI------------GFCDEGQHRMLVYEFLS 572
Query: 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
NG LASFLF ++K WN R IAF IARGLL+LH CS+QIIHCDIKPQNILLD++Y+A+
Sbjct: 573 NGALASFLFGDVKLSWNQRTQIAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDAR 632
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
I+DFGLAKL Q K GTKGYVA PEWFRN IT VDVY+FGVLLLEII CR
Sbjct: 633 IADFGLAKLFRNPQHK-------GTKGYVA-PEWFRNMLITVKVDVYNFGVLLLEIICCR 684
Query: 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPS 677
+S D E+GEE AILTDWA+DCY+ G + LVE D EA+ND+K +E+ VMV+IWCIQEDP+
Sbjct: 685 RSVDTEVGEERAILTDWAYDCYQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPN 744
Query: 678 LRPTMRKVSQMLEVVVEVDVPPNPSTFSCS 707
LRPTM+ V MLE +++V VPP PS FS +
Sbjct: 745 LRPTMKMVMLMLEGIIQVPVPPCPSPFSIA 774
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053032|ref|XP_002297673.1| predicted protein [Populus trichocarpa] gi|222844931|gb|EEE82478.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1727), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/789 (48%), Positives = 479/789 (60%), Gaps = 147/789 (18%)
Query: 27 NGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWY 86
NG VG +LTAG +++ WLSP+ DF FGF QL K+ DL+ L+I+YNKIP K +VWY
Sbjct: 2 NGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKK----DLYLLAIWYNKIPDKTIVWY 57
Query: 87 TDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWSSKL---------------ILVQSF 131
+ + P+ S VKLTA+ G+VLN+PQG ++W S LV +
Sbjct: 58 ANGDRP---APKKSTVKLTAELGVVLNNPQGGEIWKSGPGNGEAAYGFMNDTGNFLVANA 114
Query: 132 SSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLP 191
+ +LW SF TDTLLP ++ME L S S+TNFS+GRFQFRL+ D N VLN NLP
Sbjct: 115 NGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQGRFQFRLIPDGNAVLNTINLP 174
Query: 192 TDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERVVPAADFYHR 251
T Y+AY+ S T DS NSSN+GYQV+FNESGY+Y+LR N R LT RVVPA + YHR
Sbjct: 175 TGFPYEAYFWSKTVDS-NSSNAGYQVVFNESGYLYVLRANNTREALTLGRVVPATENYHR 233
Query: 252 ATLNFDGVFVQSFYLKN--GNGNWSVVWSQPENICVNIGGELGSGAYGFNSI-------- 301
ATL+FDGVFV + KN GN NWSVV + PENIC + G GSG G+N +
Sbjct: 234 ATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVRGLKGSGPCGYNGVCTISTDKR 293
Query: 302 ----CPKGYSLLDENEKYGSCKADF----------------EL----SCNGGRQDYELSR 337
CP+ +SLLD ++ YG CK DF EL + + DYE+
Sbjct: 294 AICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPEDYELVPLTNIDWPESDYEMYT 353
Query: 338 PYDEVQCKNNCLSDCFCVVAIFRGDSCWSKKLPLSNGRAHSSVNGKAFLKYKKGDD--PD 395
PY+ CK CL D FC V +F +CW K+LPLSNGR SVNG +F+K +KG+ P
Sbjct: 354 PYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQGESVNGASFMKVRKGNYTLPG 413
Query: 396 PPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTS---------TRTTVI- 445
PP +P K+N++ V SVLLG SVF NF LVGV+ + TRT +
Sbjct: 414 PPPIP---------KKNLLVV--SVLLGGSVFFNFVLVGVVSFAFFFIYHNKFTRTPQVE 462
Query: 446 -----------------------------------------------VVKKLDRVFQDGE 458
+KK+DR ++ +
Sbjct: 463 RAVQSNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLTQIGSGVPVAIKKVDRFVKESD 522
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN 518
KEFK EV +I GFCDEGQ+R+LVY+FL+NG LASFLF ++K WN R
Sbjct: 523 KEFKTEVDVI------------GFCDEGQHRMLVYEFLSNGALASFLFGDVKLSWNQRTQ 570
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
IAF IARGLL+LH CS+QIIHCDIKPQNILLD++Y+A+I+DFGLAKL Q K
Sbjct: 571 IAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDARIADFGLAKLFRNPQHK----- 625
Query: 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638
GTKGYVA PEWFRN IT VDVY+FGVLLLEII CR+S D E+GEE AILTDWA+DC
Sbjct: 626 --GTKGYVA-PEWFRNMLITVKVDVYNFGVLLLEIICCRRSVDTEVGEERAILTDWAYDC 682
Query: 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDVP 698
Y+ G + LVE D EA+ND+K +E+ VMV+IWCIQEDP+LRPTM+ V MLE +++V VP
Sbjct: 683 YQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPNLRPTMKMVMLMLEGIIQVPVP 742
Query: 699 PNPSTFSCS 707
P PS FS +
Sbjct: 743 PCPSPFSIA 751
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544746|ref|XP_002513434.1| ATP binding protein, putative [Ricinus communis] gi|223547342|gb|EEF48837.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/779 (48%), Positives = 476/779 (61%), Gaps = 119/779 (15%)
Query: 24 AQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIV 83
AQ T+ VG L A + WLSPSGDF FGF QL +N L+ L+I YNKI K +
Sbjct: 23 AQNGDTIIVGDFLAAADPAESWLSPSGDFAFGFRQLENKN----LYLLAICYNKISDKTI 78
Query: 84 VWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWSSKLIL---------------V 128
VWY + +D P GS+V+LTAD+GLVL PQGK++W S + + +
Sbjct: 79 VWYANGDDP---APTGSKVELTADRGLVLTSPQGKEIWKSGINIGDAARGMMNDTGNFRI 135
Query: 129 QSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGK-SDTNFSRGRFQFRLLKDSNLVLNI 187
+ +LW +F +P DTLLPG+ +E + S + +TNFSRGRFQFRL+ D N VLN
Sbjct: 136 VNTGGEKLWQTFDDPKDTLLPGQALERGGKILSSRLRETNFSRGRFQFRLIPDGNGVLNA 195
Query: 188 ANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERVVPAAD 247
NL T AYDAYY + T D+ N SN+G +++FNESGY+Y LR + +R +T ERVVP +
Sbjct: 196 NNLRTGDAYDAYYWTNTVDA-NLSNAGLRIVFNESGYLYTLRASNKRELITPERVVPTTE 254
Query: 248 FYHRATLNFDGVFVQSFYLKNG--NGNWSVVWSQPENICVNIGGELGSGAYGFNSIC--- 302
+YHR TLNFDGV Q + KN NGNWS+++S PENIC I ++G+G GFNS+C
Sbjct: 255 YYHRVTLNFDGVLTQYSHPKNSTDNGNWSIIFSAPENICFLIT-DIGTGPCGFNSVCQLN 313
Query: 303 ---------PKGYSLLDENEKYGSCKADFELS-CNGG-------------------RQDY 333
P +S +D + Y CK DF C DY
Sbjct: 314 ADQRAICRCPPRFSSVDPGDDYAGCKPDFSTQFCEDAPSTSPEDYDFLELTNTDWPTSDY 373
Query: 334 ELSRPYDEVQCKNNCLSDCFCVVAIFRGDSCWSKKLPLSNGRAHSSVNGKAFLKYKKGDD 393
E Y+ +C+ C+ DCFC V +FRG SCW KKLPLSNGR VNG+AF+K +K DD
Sbjct: 374 ERYDSYNIEECQKACIQDCFCNVVVFRG-SCWKKKLPLSNGRQSEKVNGRAFIKVRK-DD 431
Query: 394 PDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSV---FVNFTLV----------------- 433
+P P P K+ ++ + + SVLLGSSV F+ LV
Sbjct: 432 YMGRGLPPRPFPNAKEDQDSLVLVISVLLGSSVFINFILIGLVTFCFLFFYHKKSTGIPQ 491
Query: 434 -----------------------------------GVIQTSTRTTVIVVKKLDRVFQDGE 458
G+I+ T T + VKKLDRV + GE
Sbjct: 492 GEKSNLRCFSYKELVEATKGFKEELGRGSFGIVYKGLIEMGT-TVPVAVKKLDRVVEYGE 550
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN 518
KE+K EV IGQT+HKNLV+LLGFCDEGQ +LLVY+ L+NGTLA+FLF + K W R
Sbjct: 551 KEYKAEVKAIGQTHHKNLVQLLGFCDEGQQKLLVYELLSNGTLANFLFGDTKLSWKQRTQ 610
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
IAF IARGL++LH C++QIIHCDIKPQNIL+D+YY+A+ISDFGLAKLL L+QS+
Sbjct: 611 IAFGIARGLVYLHEECNTQIIHCDIKPQNILVDEYYDAKISDFGLAKLLLLDQSQTF-TT 669
Query: 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638
IRGTKGYVA PEWFRN IT VD YSFGVLLLEII R+S D E+ E AILTDWA+DC
Sbjct: 670 IRGTKGYVA-PEWFRNVPITVKVDAYSFGVLLLEIICSRRSVDTEISGERAILTDWAYDC 728
Query: 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDV 697
Y G++DDLVE D EA++D+K VE+ +MV+IWCIQEDP+LRPTM+ V MLE +++V V
Sbjct: 729 YMEGRIDDLVENDEEALSDLKKVERFLMVAIWCIQEDPTLRPTMKTVILMLEGIIQVAV 787
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555196|ref|XP_003545921.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1637), Expect = e-179, Method: Compositional matrix adjust.
Identities = 348/768 (45%), Positives = 473/768 (61%), Gaps = 121/768 (15%)
Query: 38 AGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVP 97
AG +S WLSPSGDF FGF+QL N+ F L+++Y+K+P K ++W+ + ++ P+
Sbjct: 2 AGNGTSRWLSPSGDFAFGFYQL-----PNEFFLLAVWYDKMPNKTIIWFANGDNPAPI-- 54
Query: 98 RGSQVKLTADQGLVLNDPQGKQVWSSKLILVQSFS---------------SSRLWDSFSN 142
GS+++L D GLVLN+PQG ++W S F+ + LW++F++
Sbjct: 55 -GSRLELN-DSGLVLNNPQGLELWRSNFASGTIFNGLMNDDGNFQLLDQNAVSLWETFTH 112
Query: 143 PTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYIS 202
PTDTL+P ++ME LFS + + NFS GRF+ L +D NLVL++ NLP++ +Y+ YY +
Sbjct: 113 PTDTLVPNQVMELNGKLFSRRGEFNFSHGRFKLHLQEDVNLVLSLINLPSNYSYEPYYDT 172
Query: 203 GTYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTT-ERVVPAADFYHRATLNFDGVFV 261
GT D+ N +N G +++F++SG++YIL+++G +F +T + DFY++AT+N+DGVF
Sbjct: 173 GTADANNQTNIGMKLIFDKSGFLYILKKSGEKFYITKPNETISTNDFYYKATINYDGVFT 232
Query: 262 QSFY---LKNGNGNWSVVWSQPENICVNIGGELGSGAYGFNSIC------------PKGY 306
S+Y L+ G G W + PENIC++ G G GFNSIC P+ Y
Sbjct: 233 VSYYPKDLRKGQG-WVTTKTIPENICLSSTFTDGEGVCGFNSICNLKADQRPICNCPERY 291
Query: 307 SLLDENEKYGSCKADFELSCNGG--------------------RQDYELSRPYDEVQCKN 346
SL+D N YG C +F++ C GG DYE PY +C
Sbjct: 292 SLIDSNNMYGGCVPNFQVVCQGGGYMVSQDDYIMKELRNTDWPTSDYETLSPYSLKECTK 351
Query: 347 NCLSDCFCVVAIFRGDSCWSKKLPLSNGRAHSSVNGKAFLKYKKGDDPDPPSVPSPPDPE 406
+CL DC CV+ F G SCW KKLPL+NGR VN + +K K D + S P+P
Sbjct: 352 SCLQDCLCVLVTFSGSSCWKKKLPLTNGRRDKGVNATSVIKLMKND----YLLTSFPNPN 407
Query: 407 DKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQ----------TSTRT-------------- 442
KK +++ V SVLL SV + LVG + S+RT
Sbjct: 408 GKKDHDVLIVVLSVLLAGSVLIILMLVGALYFGFSCNRKKIESSRTNKSVAKKNLHDFTF 467
Query: 443 -----------------------------TVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH 473
T + VKKLD++FQD ++EF+ EV +IGQT+H
Sbjct: 468 KELVEATNNFREELGRGSFSIVYKGTIEMTSVAVKKLDKLFQDNDREFQTEVNVIGQTHH 527
Query: 474 KNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVN 533
+NLVRLLG+C+EGQ+R+LVY+F++NGTLASFLF +LK W R +IA IARGL++LH
Sbjct: 528 RNLVRLLGYCNEGQHRILVYEFMSNGTLASFLFSSLKSNWGQRFDIALGIARGLVYLHEE 587
Query: 534 CSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFR 593
C +QIIHCDIKPQNILLDD YNA+ISDFGLAKLL +NQS+ + IRGTKGYVA P+WFR
Sbjct: 588 CCTQIIHCDIKPQNILLDDQYNARISDFGLAKLLLINQSRT-ETGIRGTKGYVA-PDWFR 645
Query: 594 NSTITANVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKLDDLVEGDM 652
++ ITA VD YSFGVLLLEII CRK+ + E+ EE ILTDWA+DCY+ +L+ L+E D
Sbjct: 646 SAPITAKVDTYSFGVLLLEIICCRKNVEKELVNEEKGILTDWAYDCYKTRRLEILLENDD 705
Query: 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDVPPN 700
EA+NDIK EKLVM++IWCIQE PSLRPTM+KV MLE VEV PP+
Sbjct: 706 EAINDIKSFEKLVMIAIWCIQEHPSLRPTMKKVLLMLEGNVEVLTPPS 753
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 709 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.372 | 0.318 | 0.435 | 2.1e-69 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.369 | 0.319 | 0.456 | 1.2e-63 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.383 | 0.328 | 0.423 | 7.9e-56 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.370 | 0.309 | 0.376 | 4.8e-50 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.344 | 0.299 | 0.379 | 6.5e-47 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.342 | 0.295 | 0.382 | 2.1e-46 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.370 | 0.332 | 0.369 | 6e-46 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.359 | 0.395 | 0.395 | 1e-45 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.361 | 0.316 | 0.384 | 4.7e-45 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.369 | 0.325 | 0.375 | 6.1e-45 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 586 (211.3 bits), Expect = 2.1e-69, Sum P(2) = 2.1e-69
Identities = 118/271 (43%), Positives = 174/271 (64%)
Query: 440 TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
T TV+ VK+L+ + Q GEK+F+ EV I T+H NLVRL+GFC +G++RLLVY+F+ NG
Sbjct: 504 TNRTVVAVKQLEGIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNG 562
Query: 500 TLASFLF--ENLK-PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
+L +FLF ++ K W R NIA A+G+ +LH C I+HCDIKP+NIL+DD + A
Sbjct: 563 SLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAA 622
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISC 616
++SDFGLAKLL ++ ++RGT+GY+A PEW N IT+ DVYS+G++LLE++S
Sbjct: 623 KVSDFGLAKLLNPKDNRYNMSSVRGTRGYLA-PEWLANLPITSKSDVYSYGMVLLELVSG 681
Query: 617 RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM--EAMNDIKCVEKLVMVSIWCIQE 674
+++FD+ + + WA++ + G +++ + + D++ V ++V S WCIQE
Sbjct: 682 KRNFDVSEKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQE 741
Query: 675 DPSLRPTMRKVSQMLXXXXXXXXXXNPSTFS 705
P RPTM KV QML P T S
Sbjct: 742 QPLQRPTMGKVVQMLEGITEIKNPLCPKTIS 772
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 577 (208.2 bits), Expect = 1.2e-63, Sum P(3) = 1.2e-63
Identities = 127/278 (45%), Positives = 179/278 (64%)
Query: 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVR 478
SV LG F + G + +R + VKKL+ + Q G+KEF+ EV +IG +H +LVR
Sbjct: 496 SVKLGQGGFGS-VYEGTLPDGSR---LAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVR 550
Query: 479 LLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPG-----WNLRANIAFQIARGLLHLHVN 533
L GFC EG +RLL Y+FL+ G+L ++F K G W+ R NIA A+GL +LH +
Sbjct: 551 LRGFCAEGAHRLLAYEFLSKGSLERWIFRK-KDGDVLLDWDTRFNIALGTAKGLAYLHED 609
Query: 534 CSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFR 593
C ++I+HCDIKP+NILLDD +NA++SDFGLAKL+T QS +RGT+GY+A PEW
Sbjct: 610 CDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFT-TMRGTRGYLA-PEWIT 667
Query: 594 NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653
N I+ DVYS+G++LLE+I RK++D E +AF GKL D+V+G M+
Sbjct: 668 NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMK 727
Query: 654 AMNDI--KCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689
+ D+ + V++ + ++WCIQED RP+M KV QML
Sbjct: 728 NV-DVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQML 764
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 526 (190.2 bits), Expect = 7.9e-56, Sum P(2) = 7.9e-56
Identities = 122/288 (42%), Positives = 171/288 (59%)
Query: 411 RNMMNVTR--SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMI 468
R + N T+ S LG F + G + S+ I VK+L+ + Q GEK+F+ EVV I
Sbjct: 486 RELQNATKNFSDKLGGGGFGS-VFKGALPDSSD---IAVKRLEGISQ-GEKQFRTEVVTI 540
Query: 469 GQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF-----ENLKPGWNLRANIAFQI 523
G H NLVRL GFC EG +LLVY ++ NG+L S LF E + GW LR IA
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600
Query: 524 ARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTK 583
ARGL +LH C IIHCDIKP+NILLD + +++DFGLAKL+ + S+ + +RGT+
Sbjct: 601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLT-TMRGTR 659
Query: 584 GYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY-RNG 642
GY+A PEW ITA DVYS+G++L E++S R++ + E+ WA ++G
Sbjct: 660 GYLA-PEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDG 718
Query: 643 KLDDLVEGDMEA-MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689
+ LV+ +E DI+ V + V+ WCIQ++ S RP M +V Q+L
Sbjct: 719 DIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQIL 766
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 456 (165.6 bits), Expect = 4.8e-50, Sum P(3) = 4.8e-50
Identities = 101/268 (37%), Positives = 156/268 (58%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
I VK+L G EFKNE+++I + H+NLVRLLG C EG+ ++LVY+++ N +L F
Sbjct: 554 IAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFF 613
Query: 505 LFENLKPG---WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
LF+ K W LR +I IARGLL+LH + +IIH D+K N+LLD N +ISDF
Sbjct: 614 LFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDF 673
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
G+A++ NQ++A + GT GY+ SPE+ + DVYSFGVLLLEI+S +++
Sbjct: 674 GMARIFGGNQNEANTVRVVGTYGYM-SPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTS 732
Query: 622 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681
+ E+ L +A+ Y +G+ ++LV+ + + + + V++ C+Q+ + RP
Sbjct: 733 LR-SSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPN 791
Query: 682 MRKVSQMLXXXXXXXXXXNPSTFSCSKR 709
M V ML TF+ ++R
Sbjct: 792 MASVLLMLESDTATLAAPRQPTFTSTRR 819
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 6.5e-47, Sum P(4) = 6.5e-47
Identities = 94/248 (37%), Positives = 148/248 (59%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
I +K+L G +EF NE+++I + H+NLVRLLG C EG+ +LL+Y+F+ N +L +F
Sbjct: 526 IAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTF 585
Query: 505 LFENLKP---GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
+F++ K W R I IA GLL+LH + +++H D+K NILLD+ N +ISDF
Sbjct: 586 IFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDF 645
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
GLA++ Q +A + + GT GY+ SPE+ + D+Y+FGVLLLEII+ ++
Sbjct: 646 GLARMFQGTQHQANTRRVVGTLGYM-SPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISS 704
Query: 622 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681
+GEE L ++A+D + DL++ D+ + V + V + + CIQ+ RP
Sbjct: 705 FTIGEEGKTLLEFAWDSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPN 764
Query: 682 MRKVSQML 689
+ +V ML
Sbjct: 765 IAQVMSML 772
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 427 (155.4 bits), Expect = 2.1e-46, Sum P(3) = 2.1e-46
Identities = 96/251 (38%), Positives = 153/251 (60%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
I VK+L G +EF NE+ +I + H+NL+RLLG C +G+ +LLVY+++ N +L F
Sbjct: 523 IAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIF 582
Query: 505 LFE---NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
+F+ L+ W R NI IARGLL+LH + +++H D+K NILLD+ N +ISDF
Sbjct: 583 IFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDF 642
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
GLA+L NQ + ++ GT GY+ SPE+ T + D+YSFGVL+LEII+ ++
Sbjct: 643 GLARLFHGNQHQDSTGSVVGTLGYM-SPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISS 701
Query: 622 IEMGEEYAILTDWAFDCY-RNGKLDDLVEGDMEAMNDIKCVE--KLVMVSIWCIQEDPSL 678
G++ L +A+D + NG ++ L++ D++ + + VE + V + + C+Q
Sbjct: 702 FSYGKDNKNLLSYAWDSWSENGGVN-LLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAID 760
Query: 679 RPTMRKVSQML 689
RP +++V ML
Sbjct: 761 RPNIKQVMSML 771
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 433 (157.5 bits), Expect = 6.0e-46, Sum P(4) = 6.0e-46
Identities = 99/268 (36%), Positives = 154/268 (57%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
I VK+L + G++EF NE+V+I + H+NLVR+LG C EG+ +LL+Y+F+ N +L +F
Sbjct: 503 IAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTF 562
Query: 505 LF---ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
+F + L+ W R +I I RGLL+LH + ++IH D+K NILLD+ N +ISDF
Sbjct: 563 VFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPKISDF 622
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
GLA+L +Q + + + GT GY+ SPE+ + D+YSFGVLLLEIIS K
Sbjct: 623 GLARLFQGSQYQDKTRRVVGTLGYM-SPEYAWTGVFSEKSDIYSFGVLLLEIISGEKISR 681
Query: 622 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681
GEE L + ++C+ + +L++ ++ + V + V + + C+Q P+ RP
Sbjct: 682 FSYGEEGKALLAYVWECWCETRGVNLLDQALDDSSHPAEVGRCVQIGLLCVQHQPADRPN 741
Query: 682 MRKVSQMLXXXXXXXXXXNPSTFSCSKR 709
++ ML P TF+ R
Sbjct: 742 TLELLSMLTTTSDLPLPKQP-TFAVHTR 768
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 1.0e-45, P = 1.0e-45
Identities = 106/268 (39%), Positives = 162/268 (60%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+ VK+L + GEKEF+NEVV++ + H+NLV+LLG+C EG+ ++LVY+F+ N +L F
Sbjct: 351 VAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHF 410
Query: 505 LFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
LF++ +K W R I IARG+L+LH + IIH D+K NILLDD N +I+DF
Sbjct: 411 LFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADF 470
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
G+A++ ++Q++A+ + + GT GY+ SPE+ + DVYSFGVL+LEIIS K+
Sbjct: 471 GMARIFGMDQTEAMTRRVVGTYGYM-SPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSS 529
Query: 622 I-EMGEEYAILTDWAFDCYRNGKLDDLVE---GDMEAMNDI-KCVEKLVMVSIWCIQEDP 676
+ +M E L + + + NG +LV+ GD ++I +C+ +++ C+QED
Sbjct: 530 LYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIH----IALLCVQEDA 585
Query: 677 SLRPTMRKVSQMLXXXXXXXXXXNPSTF 704
RPTM + QML P F
Sbjct: 586 EDRPTMSSIVQMLTTSLIALAEPRPPGF 613
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 434 (157.8 bits), Expect = 4.7e-45, Sum P(4) = 4.7e-45
Identities = 102/265 (38%), Positives = 157/265 (59%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
I VK+L G++EF NE+V+I + HKNLVR+LG C EG+ RLLVY+FL N +L +F
Sbjct: 521 IAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTF 580
Query: 505 LFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
LF++ L+ W R NI IARGL +LH + ++IH D+K NILLD+ N +ISDF
Sbjct: 581 LFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDF 640
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
GLA++ + + + + GT GY+A PE+ + D+YSFGV+LLEII+ K
Sbjct: 641 GLARMYQGTEYQDNTRRVAGTLGYMA-PEYAWTGMFSEKSDIYSFGVILLEIITGEKISR 699
Query: 622 IEMGEEYAILTDWAFDCY-RNGKLDDLVEGDM-EAMNDIKCVEKLVMVSIWCIQEDPSLR 679
G + L +A++ + +G +D L++ D+ ++ + ++ VE+ V + + C+Q P+ R
Sbjct: 700 FSYGRQGKTLLAYAWESWCESGGID-LLDKDVADSCHPLE-VERCVQIGLLCVQHQPADR 757
Query: 680 PTMRKVSQMLXXXXXXXXXXNPSTF 704
P ++ ML P TF
Sbjct: 758 PNTMELLSMLTTTSDLTSPKQP-TF 781
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 428 (155.7 bits), Expect = 6.1e-45, Sum P(4) = 6.1e-45
Identities = 101/269 (37%), Positives = 154/269 (57%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
I VK+L G++EF NE+V+I + H+NLVR+LG C EG+ +LL+Y+F+ N +L +F
Sbjct: 515 IAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTF 574
Query: 505 LFE---NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
+F+ L+ W R +I IARGLL+LH + ++IH D+K NILLD+ N +ISDF
Sbjct: 575 VFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDF 634
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
GLA++ Q + + + GT GY+ SPE+ + D+YSFGVLLLEII K
Sbjct: 635 GLARMYEGTQCQDKTRRVVGTLGYM-SPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISR 693
Query: 622 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDM-EAMNDIKCVEKLVMVSIWCIQEDPSLRP 680
GEE L +A++ + K DL++ D+ ++ ++ V + V + + C+Q P+ RP
Sbjct: 694 FSYGEEGKTLLAYAWESWGETKGIDLLDQDLADSCRPLE-VGRCVQIGLLCVQHQPADRP 752
Query: 681 TMRKVSQMLXXXXXXXXXXNPSTFSCSKR 709
++ ML P TF R
Sbjct: 753 NTLELLAMLTTTSDLPSPKQP-TFVVHSR 780
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 709 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-19 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-17 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-10 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-06 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 8e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-05 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 4e-38
Identities = 58/180 (32%), Positives = 92/180 (51%), Gaps = 10/180 (5%)
Query: 443 TVIVVKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
+ +K + + E E+ ++ + H N+V+L G ++ + LV ++ G+L
Sbjct: 19 KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78
Query: 502 ASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQIS 559
L EN + I QI GL +LH S+ IIH D+KP+NILLD D +++
Sbjct: 79 KDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLA 135
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPE-WFRNSTITANVDVYSFGVLLLEIISCRK 618
DFGL+KLLT K++ K I GT Y+A PE + D++S GV+L E+ +
Sbjct: 136 DFGLSKLLT--SDKSLLKTIVGTPAYMA-PEVLLGKGYYSEKSDIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 74/262 (28%), Positives = 116/262 (44%), Gaps = 40/262 (15%)
Query: 439 STRTTVIVVKKLDRVFQDGEKE--FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496
T V VK L + + +K+ + E+ ++ + H N+VRL+ ++ + LV ++
Sbjct: 22 GTGKIV-AVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYC 80
Query: 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
G L +L + IA QI RGL +LH N IIH D+KP+NILLD+
Sbjct: 81 EGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDENGVV 137
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEW-FRNSTITANVDVYSFGVLLLEIIS 615
+I+DFGLAK L + S GT Y+A PE + VDV+S GV+L E+++
Sbjct: 138 KIADFGLAKKLLKSSSSL--TTFVGTPWYMA-PEVLLGGNGYGPKVDVWSLGVILYELLT 194
Query: 616 CRKSFD----------IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLV 665
+ F I + D + + DL++
Sbjct: 195 GKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK---------------- 238
Query: 666 MVSIWCIQEDPSLRPTMRKVSQ 687
C+ +DPS RPT ++ Q
Sbjct: 239 ----KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 32/260 (12%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493
T V +K + + ++E E+ ++ + H N+VRL ++ LV
Sbjct: 18 ARDKKTGKLV-AIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVM 76
Query: 494 KFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
++ G L L + L QI L +LH S I+H D+KP+NILLD
Sbjct: 77 EYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLH---SKGIVHRDLKPENILLD 131
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611
+ + +++DFGLA+ L+ + + + GT Y+A PE VD++S GV+L
Sbjct: 132 EDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMA-PEVLLGKGYGKAVDIWSLGVILY 187
Query: 612 EIISCRKSF--DIEMGEEYAILTDWAFDC-YRNGKLDDLVEGDMEAMNDIKCVEKLVMVS 668
E+++ + F D ++ E + + + EA + I+
Sbjct: 188 ELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP------EAKDLIRK-------- 233
Query: 669 IWCIQEDPSLRPTMRKVSQM 688
+ +DP R T + Q
Sbjct: 234 --LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 32/262 (12%)
Query: 436 IQTSTRTTVIV-VKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493
V V VK L + + +EF E ++ + H N+V+LLG C E + ++V
Sbjct: 21 KGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80
Query: 494 KFLNNGTLASFLFENLKPGWNLR--ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
+++ G L +L +N +L + A QIARG+ +L S IH D+ +N L+
Sbjct: 81 EYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVG 137
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA--SPEWFRNSTITANVDVYSFGVL 609
+ +ISDFGL++ L K +G K + +PE + T+ DV+SFGVL
Sbjct: 138 ENLVVKISDFGLSRDLY---DDDYYKV-KGGKLPIRWMAPESLKEGKFTSKSDVWSFGVL 193
Query: 610 LLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD-MEAMNDIKCVEKLVMV 667
L EI + +GEE Y +++ + L +G + + C +L +
Sbjct: 194 LWEIFT--------LGEEPYPGMSN--AEVLE-----YLKKGYRLPKPPN--CPPELYKL 236
Query: 668 SIWCIQEDPSLRPTMRKVSQML 689
+ C EDP RPT ++ ++L
Sbjct: 237 MLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 71/249 (28%), Positives = 118/249 (47%), Gaps = 30/249 (12%)
Query: 447 VKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
VK L + + +EF E ++ + H N+V+LLG C E + +V +++ G L S+L
Sbjct: 33 VKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL 92
Query: 506 FENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
+N + + A QIARG+ +L S IH D+ +N L+ + +ISDFGL+
Sbjct: 93 RKNRPKLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLS 149
Query: 565 KLLTLNQSKAIKKAIRGTKGYVA--SPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDI 622
+ L + RG K + +PE + T+ DV+SFGVLL EI +
Sbjct: 150 RDLY---DDDYYRK-RGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT------- 198
Query: 623 EMGEE-YAILTDWAFDCYRNGKLDDLVEGD-MEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680
+GE+ Y +++ + L G + C +L + + C EDP RP
Sbjct: 199 -LGEQPYPGMSN--EEVLE-----YLKNGYRLPQPP--NCPPELYDLMLQCWAEDPEDRP 248
Query: 681 TMRKVSQML 689
T ++ ++L
Sbjct: 249 TFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 72/258 (27%), Positives = 118/258 (45%), Gaps = 32/258 (12%)
Query: 439 STRTTVIVVKKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497
T T V VK L + E+ EF E ++ + H N+VRLLG C +G+ +V +++
Sbjct: 26 GTETKV-AVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMP 84
Query: 498 NGTLASFL---FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
G L FL E L +A QIA+G+ +L S +H D+ +N L+ +
Sbjct: 85 GGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENL 139
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA--SPEWFRNSTITANVDVYSFGVLLLE 612
+ISDFGL++ + + G K + +PE ++ T+ DV+SFGVLL E
Sbjct: 140 VVKISDFGLSRDI---YEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWE 196
Query: 613 IIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
I + + + EE + + D YR + + C ++L + + C
Sbjct: 197 IFTLGEQPYPGMSNEE---VLELLEDGYR-----------LPRPEN--CPDELYELMLQC 240
Query: 672 IQEDPSLRPTMRKVSQML 689
DP RPT ++ + L
Sbjct: 241 WAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 46/276 (16%)
Query: 434 GVIQTSTRTTVIV-VKKLDRVFQDGE-KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
G ++ T V VK L + E K+F E ++ + H N+VRLLG C E + L
Sbjct: 14 GKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL 73
Query: 492 VYKFLNNGTLASFLFENLKP---------GWNLRANIAFQIARGLLHLHVNCSSQIIHCD 542
V +++ G L +L ++ + A QIA+G+ +L S + +H D
Sbjct: 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRD 130
Query: 543 IKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV----ASPEWFRNSTIT 598
+ +N L+ + +ISDFGL++ + + + T G + +PE ++ T
Sbjct: 131 LAARNCLVGEDLVVKISDFGLSRDVYDDDY-----YRKKTGGKLPIRWMAPESLKDGIFT 185
Query: 599 ANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDMEAMN 656
+ DV+SFGVLL EI + +G + + + R G +
Sbjct: 186 SKSDVWSFGVLLWEIFT--------LGATPYPGLSNEEVLEYLRKGYR-------LPKP- 229
Query: 657 DIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
C ++L +M+S W Q DP RPT ++ + LE
Sbjct: 230 -EYCPDELYELMLSCW--QLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 67/259 (25%), Positives = 122/259 (47%), Gaps = 28/259 (10%)
Query: 438 TSTRT-TVIVVKK--LDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC-DEGQNRLLVY 493
T ++ VK L ++ + + E+ ++ H N+VR G DE +N L ++
Sbjct: 20 LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79
Query: 494 -KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD 552
++++ G+L+S L + K + QI GL +LH S+ I+H DIK NIL+D
Sbjct: 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDS 136
Query: 553 YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
+++DFG AK L ++ ++RGT ++A PE R D++S G ++E
Sbjct: 137 DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA-PEVIRGEEYGRAADIWSLGCTVIE 195
Query: 613 IISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG-DMEAMNDIKCVEKLVMVSIWC 671
+ + + + E+G A L +G+ ++ E EA + ++ C
Sbjct: 196 MATGKPPWS-ELGNPMAALYKIGS----SGEPPEIPEHLSEEAKDFLRK----------C 240
Query: 672 IQEDPSLRPTMRKVSQMLE 690
++ DP RPT ++L+
Sbjct: 241 LRRDPKKRPT---ADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 40/228 (17%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANI--AFQIARGLLHL 530
H NLV+LLG +G +V +++ G+L +L + L + A + G+ +L
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 531 HVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPE 590
+H D+ +N+L+ + A++SDFGLAK + Q K ++ T +PE
Sbjct: 119 E---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG-KLPVKWT-----APE 169
Query: 591 WFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650
R + DV+SFG+LL EI S + Y L D+V
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PYPRIPLKDVVPH 211
Query: 651 -----DMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEV 691
MEA C ++ VM W + DP+ RPT +++ + L +
Sbjct: 212 VEKGYRMEAPE--GCPPEVYKVMKDCWEL--DPAKRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 54/185 (29%), Positives = 99/185 (53%), Gaps = 16/185 (8%)
Query: 444 VIVVKKLDRVFQDGE----KEFKNEVVMIGQTYHKNLVRLLGFCDE--GQNRLLVYKFLN 497
+ VK L+ GE +F+ E+ ++ H+N+V+ G C++ G++ L+ ++L
Sbjct: 35 QVAVKSLNH---SGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLP 91
Query: 498 NGTLASFLFENLKPGWNLRANI--AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
+G+L +L + + NL+ + + QI +G+ +L S + IH D+ +NIL++
Sbjct: 92 SGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDL 147
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
+ISDFGLAK+L ++ K + + +PE R S ++ DV+SFGV L E+ +
Sbjct: 148 VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
Query: 616 -CRKS 619
S
Sbjct: 208 YGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-20
Identities = 70/233 (30%), Positives = 116/233 (49%), Gaps = 20/233 (8%)
Query: 463 NEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQ 522
+E+ +G+ H N+V+L+G C + L+++++ L+ L NL W R IA
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-RNLS--WERRRKIAIG 788
Query: 523 IARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGT 582
IA+ L LH CS ++ ++ P+ I++D + L LL + I A
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA---- 843
Query: 583 KGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642
YVA PE IT D+Y FG++L+E+++ + D E G +I+ +WA CY +
Sbjct: 844 --YVA-PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV-EWARYCYSDC 899
Query: 643 KL----DDLVEGDMEAMNDIKCVEKLVM-VSIWCIQEDPSLRPTMRKVSQMLE 690
L D + GD+ ++N + VE VM +++ C DP+ RP V + LE
Sbjct: 900 HLDMWIDPSIRGDV-SVNQNEIVE--VMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.1 bits (227), Expect = 7e-20
Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 43/283 (15%)
Query: 429 NFTLVGVIQTSTRTTV--------IVVKKLDRVFQDGEKE---FKNEVVMIGQTYH-KNL 476
++ ++ + + V + +K L + + KE F E+ ++ H N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 477 VRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR----ANIAFQIARGLLHLHV 532
V+L F + + LV ++++ G+L L + + L I QI L +LH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLH- 118
Query: 533 NCSSQIIHCDIKPQNILLDDYYN-AQISDFGLAKLLTLNQSKAI----KKAIRGTKGYVA 587
S IIH DIKP+NILLD ++ DFGLAKLL S + GT GY
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY-M 175
Query: 588 SPEWFRNST---ITANVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCY 639
+PE + +++ D++S G+ L E+++ F+ E I+ +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682
+ E +A +D+ ++K + +DP R +
Sbjct: 236 ASPLSPSNPELISKAASDL--LKK-------LLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 7/158 (4%)
Query: 456 DGEKEFKNEVVMIGQTYHKNLVRLLG-FCDEGQNRLLVYKFLNNGTLASFLFENLKPGWN 514
+ K+ E+ + +V+ G F EG+ + V ++++ G+LA L + K
Sbjct: 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEP 99
Query: 515 LRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574
+ A IA QI +GL +LH IIH DIKP N+L++ +I+DFG++K L +
Sbjct: 100 VLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLD 155
Query: 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
GT Y+ SPE + + + D++S G+ LLE
Sbjct: 156 QCNTFVGTVTYM-SPERIQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 63/252 (25%), Positives = 115/252 (45%), Gaps = 34/252 (13%)
Query: 446 VVKKLDRVFQDGEKEFK---NEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
V+K++D + EKE + NEV ++ + H N+++ +E +V ++ + G L+
Sbjct: 29 VLKEID-LSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLS 87
Query: 503 SFLFENLKPGWNLRA----NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
+ + K G + Q+ L +LH S +I+H DIKPQNI L ++
Sbjct: 88 QKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKL 144
Query: 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK 618
DFG++K L+ + + K + GT Y+ SPE +N D++S G +L E+ + +
Sbjct: 145 GDFGISK--VLSSTVDLAKTVVGTPYYL-SPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
Query: 619 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI--KCVEKLVMVSIWCIQEDP 676
F+ GE L +++G + + LV +Q+DP
Sbjct: 202 PFE---GENLLEL------------ALKILKGQYPPIPSQYSSELRNLVS---SLLQKDP 243
Query: 677 SLRPTMRKVSQM 688
RP++ ++ Q
Sbjct: 244 EERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 86/318 (27%), Positives = 135/318 (42%), Gaps = 59/318 (18%)
Query: 402 PPDPEDKKKRNMMNVTRSVLLGSSVF---VNFTLVGVIQTSTRTTVIVVKKL--DRVFQD 456
P DPE + R+ + + + LG F V VG + T+ + VK L D
Sbjct: 2 PLDPEWELPRDRLTLGK--PLGEGAFGQVVKAEAVG-LDNPNETSTVAVKMLKDDAT--- 55
Query: 457 GEKEFKNEVV------MIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLK 510
EK+ + V MIG+ HKN++ LLG C + +V ++ +G L FL
Sbjct: 56 -EKDLSDLVSEMEMMKMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRP 112
Query: 511 PGWNLRANI----------------AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
PG + A+Q+ARG+ L S + IH D+ +N+L+ + +
Sbjct: 113 PGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDH 169
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV-ASPEWFRNSTITANVDVYSFGVLLLEI 613
+I+DFGLA+ ++ +K G +PE + T DV+SFGVLL EI
Sbjct: 170 VMKIADFGLAR--DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227
Query: 614 ISCRKSFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCI 672
+ G Y I + F + G ME C ++L + C
Sbjct: 228 FTLG-------GSPYPGIPVEELFKLLKEGY-------RME--KPQNCTQELYHLMRDCW 271
Query: 673 QEDPSLRPTMRKVSQMLE 690
E PS RPT +++ + L+
Sbjct: 272 HEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA- 517
+EF E ++ + H NLV+LLG C ++ +F+ G L +L E + N
Sbjct: 47 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 106
Query: 518 -NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA-- 574
+A QI+ + +L IH D+ +N L+ + + +++DFGL++L+T + A
Sbjct: 107 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163
Query: 575 -IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAIL 631
K I+ T +PE + + DV++FGVLL EI + I++ + Y +L
Sbjct: 164 GAKFPIKWT-----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
Query: 632 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
G + EG C K+ + C Q +PS RP+ ++ Q E
Sbjct: 219 --------EKGYRMERPEG---------CPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 15/180 (8%)
Query: 438 TSTRTTVIV-VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496
RT V +K + ++ +++ NE+ ++ + H N+V+ G + +V +F
Sbjct: 20 RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79
Query: 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLL----HLHVNCSSQIIHCDIKPQNILLDD 552
+ G+L L ++ + IA+ + + LL +LH S+ IIH DIK NILL
Sbjct: 80 SGGSLKD-LLKSTNQTLTE-SQIAY-VCKELLKGLEYLH---SNGIIHRDIKAANILLTS 133
Query: 553 YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
++ DFGL+ L+ +KA + GT ++A PE D++S G+ +E
Sbjct: 134 DGEVKLIDFGLSA--QLSDTKARNTMV-GTPYWMA-PEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 29/237 (12%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN---LKPGWN 514
E +F E ++ + H NLV+L G C + + +V +++ NG L ++L E L W
Sbjct: 43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL 102
Query: 515 LRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574
L ++ + + +L S+ IH D+ +N L+ + ++SDFGLA+ + +Q +
Sbjct: 103 L--DMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157
Query: 575 IKKAIRGTKGYV--ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 632
+ GTK V A PE F S ++ DV+SFGVL+ E+ S K
Sbjct: 158 SQ----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM------------- 200
Query: 633 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689
++ + N ++ + V ++ + C E P RP +K+ L
Sbjct: 201 --PYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 17/150 (11%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN----IAFQIARGLL 528
H LV+L C E + +V ++++ G+L FL G LR +A QIA G+
Sbjct: 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMA 117
Query: 529 HLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA---IKKAIRGTKGY 585
+L S IH D+ +NIL+ + +I+DFGLA+L+ ++ A K I+ T
Sbjct: 118 YLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT--- 171
Query: 586 VASPEWFRNSTITANVDVYSFGVLLLEIIS 615
+PE T DV+SFG+LL EI++
Sbjct: 172 --APEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 47/205 (22%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLG-FCDEGQNRLLVYKFLNNGTLA 502
+I KK+ V EKE V+ H +++L F DE +N V ++ NG L
Sbjct: 39 LIKEKKVKYVKI--EKE-----VLTRLNGHPGIIKLYYTFQDE-ENLYFVLEYAPNGELL 90
Query: 503 SFLFENLKPGWNLRANIAFQIAR--------GLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
++ ++ + R L +LH S IIH D+KP+NILLD
Sbjct: 91 QYI--------RKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDM 139
Query: 555 NAQISDFGLAKLLTLNQ--------SKAIKKAIR----------GTKGYVASPEWFRNST 596
+ +I+DFG AK+L N + I I GT YV SPE
Sbjct: 140 HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV-SPELLNEKP 198
Query: 597 ITANVDVYSFGVLLLEIISCRKSFD 621
+ D+++ G ++ ++++ + F
Sbjct: 199 AGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 23/190 (12%)
Query: 434 GVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493
G+ + R + ++K D + Q +F+ EV + + HK+L+ L C G+ ++
Sbjct: 25 GLWKNRVRVAIKILKSDDLLKQQ---DFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81
Query: 494 KFLNNGTLASFLFENLKPGWNLRA----NIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
+ + G+L +FL G L ++A Q+A G+ +L IH D+ +NIL
Sbjct: 82 ELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNIL 136
Query: 550 LDDYYNAQISDFGLAKLLT----LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYS 605
+ + +++DFGLA+L+ L+ K I + T +PE + T + DV+S
Sbjct: 137 VGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWT-----APEAASHGTFSTKSDVWS 189
Query: 606 FGVLLLEIIS 615
FG+LL E+ +
Sbjct: 190 FGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 62/179 (34%), Positives = 93/179 (51%), Gaps = 14/179 (7%)
Query: 448 KKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL-LVYKFLNNGTLAS 503
KKLD+ + GE+ NE ++ + + L + E ++ L LV +N G L
Sbjct: 24 KKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKY 82
Query: 504 FLFENLKPGWNLRANI--AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
++ +PG+ I A QI GL HLH +I++ D+KP+N+LLDD+ N +ISD
Sbjct: 83 HIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDL 139
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
GLA + L K IK GT GY+A PE + +VD ++ G L E+I+ R F
Sbjct: 140 GLA--VELKGGKKIKGRA-GTPGYMA-PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 34/207 (16%)
Query: 432 LVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
L G + + T+V + + ++EF+ E ++ H N+V LLG C + Q +
Sbjct: 26 LTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85
Query: 492 VYKFLNNGTLASFLFEN------------------LKPGWNLRANIAFQIARGLLHLHVN 533
++++L +G L FL N L L +IA QIA G+ +L
Sbjct: 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL--HIAIQIAAGMEYL--- 140
Query: 534 CSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN-----QSKAIKKAIRGTKGYVAS 588
S +H D+ +N L+ + +ISDFGL++ + QSK++ +R
Sbjct: 141 SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL-LPVRWM-----P 194
Query: 589 PEWFRNSTITANVDVYSFGVLLLEIIS 615
PE T D++SFGV+L EI S
Sbjct: 195 PEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 63/257 (24%), Positives = 113/257 (43%), Gaps = 46/257 (17%)
Query: 443 TVIVVKKLDRVFQDGE----KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498
++ VK++ QD + KE +E+ ++ H NLV+ G + + ++ +
Sbjct: 26 ELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83
Query: 499 GTLASFLFENLKPGWNLRANI----AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
GTL L + G L ++ Q+ GL +LH S I+H DIKP NI LD
Sbjct: 84 GTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNG 136
Query: 555 NAQISDFGLAKLLTLNQSKAIK--KAIRGTKGYVASPEWFRNSTITAN---VDVYSFGVL 609
++ DFG A L N + + +++ GT Y+A PE + D++S G +
Sbjct: 137 VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA-PEVITGGKGKGHGRAADIWSLGCV 195
Query: 610 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-----KLDDLVEGDMEAMNDIKCVEKL 664
+LE+ + ++ + E+ E+ I+ + G + D ++ E + +
Sbjct: 196 VLEMATGKRPWS-ELDNEFQIM-------FHVGAGHKPPIPDSLQLSPEGKDFLD----- 242
Query: 665 VMVSIWCIQEDPSLRPT 681
C++ DP RPT
Sbjct: 243 -----RCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-15
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 23/168 (13%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQ---NRLL-VYKFLNNGTLASFLFEN--LKPG 512
F+ E + + YH N+V LL D G+ L V++++ TL L + L G
Sbjct: 23 ARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 513 WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFGLAKLLTL 569
R + Q+ L H I+H D+KPQNI++ +A++ DFG+ LL
Sbjct: 80 ETGR--LMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPG 134
Query: 570 NQSKAIKKAIR-----GTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
+ + R GT Y +PE R +T N D+Y++G++ LE
Sbjct: 135 VRDADVATLTRTTEVLGTPTY-CAPEQLRGEPVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 43/172 (25%), Positives = 70/172 (40%), Gaps = 28/172 (16%)
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577
I Q+ RGL LH +I+H D+K NILL +I D G++K+L K + K
Sbjct: 107 RIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAK 159
Query: 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWA 635
GT Y +PE ++ + D++S G LL E+ + F+ ++ Y +
Sbjct: 160 TQIGTPHY-MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR--- 215
Query: 636 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687
GK + + + + +Q P LRP K+
Sbjct: 216 ------GKYPPIPPIYSQDLQ------NFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 58/231 (25%), Positives = 103/231 (44%), Gaps = 32/231 (13%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL--FENLKPGWNLR 516
K E+ ++ H N+V+ +G + + ++ ++ NG+L + F +L
Sbjct: 44 KSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF--PESLV 101
Query: 517 ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
A +Q+ +GL +LH +IH DIK NIL +++DFG+A LN
Sbjct: 102 AVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDD 156
Query: 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS-FDIE-MGEEYAILTDW 634
++ GT Y +PE S + D++S G ++E+++ +D+ M + I+ D
Sbjct: 157 ASVVGTP-YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD- 214
Query: 635 AFDCYRNGKLDDLVEGDMEAMND-IKCVEKLVMVSIWCIQEDPSLRPTMRK 684
D L EG + D + C Q+DP+LRPT ++
Sbjct: 215 --DHPP------LPEGISPELKDFLMQ----------CFQKDPNLRPTAKQ 247
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 60/232 (25%), Positives = 110/232 (47%), Gaps = 27/232 (11%)
Query: 461 FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIA 520
F E ++ + +HKNLVRLLG +V + ++ G L +FL + ++ +
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104
Query: 521 F--QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
F +A G+ +L S +++H D+ +NIL+ + A++SDFGLA++ S + +
Sbjct: 105 FSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNS 157
Query: 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638
K +PE ++ ++ DV+S+GVLL E+ S ++ +M + + +
Sbjct: 158 KLPVKW--TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKG 213
Query: 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
YR ME ++M S W + +P RP+ K+ + LE
Sbjct: 214 YR-----------MEPPEGCPADVYVLMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 43/99 (43%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
QI GL HLH +II+ D+KP+N+LLD+ N +ISD GLA L QSK K G
Sbjct: 105 QIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT--KGYAG 159
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
T G++A PE + +VD ++ GV L E+I+ R F
Sbjct: 160 TPGFMA-PELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 76/273 (27%), Positives = 127/273 (46%), Gaps = 31/273 (11%)
Query: 421 LLGSSVF--VNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVR 478
LLGS VF V+ + S + V + DR + +E + ++ +G H +VR
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 479 LLGFCDEGQNRLLVYKFLNNGTLASFLFEN---LKPGWNLRANIAFQIARGLLHLHVNCS 535
LLG C G + LV + G+L + ++ L P N QIA+G+ +L +
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQIAKGMYYLEEHR- 129
Query: 536 SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS 595
++H ++ +NILL QI+DFG+A LL + K + ++A E
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL-ESILFG 186
Query: 596 TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-GDMEA 654
T DV+S+GV + E++S E YA + R ++ DL+E G+ A
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYG-------AEPYAGM--------RPHEVPDLLEKGERLA 231
Query: 655 MNDIKCVE-KLVMVSIWCIQEDPSLRPTMRKVS 686
I ++ +VMV W I E+ +RPT ++++
Sbjct: 232 QPQICTIDVYMVMVKCWMIDEN--VRPTFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 54/174 (31%), Positives = 75/174 (43%), Gaps = 35/174 (20%)
Query: 463 NEVVMIGQTYHKNLVRL-LGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAF 521
NE ++ + H LV L F DE +N LV L G L ++L + F
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLR----------YHLSQKVKF 97
Query: 522 Q----------IARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT--- 568
I L +LH S IIH DIKP NILLD+ + I+DF +A +T
Sbjct: 98 SEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154
Query: 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDI 622
L S + GT GY+A PE + VD +S GV E + ++ +
Sbjct: 155 LTTSTS------GTPGYMA-PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 463 NEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN---- 518
+E ++ + ++R + +V ++ NG L L ++ G L +
Sbjct: 48 DEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLL--KMQRGRPLPEDQVWR 105
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
QI GL HLH S +I+H DIK N+ LD Y N +I D G+AKLL+ N + A
Sbjct: 106 FFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA--NT 160
Query: 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIE 623
I GT Y+ SPE + DV++ GV+L E + + FD
Sbjct: 161 IVGTPYYL-SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 34/266 (12%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC-DEGQNRL-LVYKFLNNGTL 501
V+ VKKL + ++F+ E+ ++ H N+V+ G C G+ L LV ++L G+L
Sbjct: 35 VVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSL 94
Query: 502 ASFLFENLKPGWNLRANI--------AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY 553
+L ++ R + A QI +G+ +L S + +H D+ +NIL++
Sbjct: 95 RDYLQKH-------RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESE 144
Query: 554 YNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
+I DFGL K+L ++ + + + +PE S + DV+SFGV+L E+
Sbjct: 145 NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
Query: 614 IS-CRKS------FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVM 666
+ KS F MG + Y L +L++ + C ++
Sbjct: 205 FTYSDKSCSPPAEFMRMMGND----KQGQMIVYH---LIELLKNNGRLPAPPGCPAEIYA 257
Query: 667 VSIWCIQEDPSLRPTMRKVSQMLEVV 692
+ C DPS RP+ +++ +E +
Sbjct: 258 IMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 56/230 (24%), Positives = 107/230 (46%), Gaps = 23/230 (10%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENL-KPGWNLRA 517
KE +E ++ H ++VRLLG C L+ + + G L ++ + G
Sbjct: 54 KEILDEAYVMASVDHPHVVRLLGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLL 112
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577
N QIA+G+ +L +++H D+ +N+L+ + +I+DFGLAKLL +++ + +
Sbjct: 113 NWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE 169
Query: 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637
+ ++A E + T DV+S+GV + E+++ G + ++
Sbjct: 170 GGKVPIKWMA-LESILHRIYTHKSDVWSYGVTVWELMT--------FGAK-------PYE 213
Query: 638 CYRNGKLDDLVE-GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVS 686
++ DL+E G+ I C + MV + C D RPT +++
Sbjct: 214 GIPAVEIPDLLEKGERLPQPPI-CTIDVYMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 48/160 (30%), Positives = 82/160 (51%), Gaps = 8/160 (5%)
Query: 460 EFKNEVVMIGQTYHKNLVRLLGFCDEGQNR--LLVYKFLNNGTLASFLFENLKPGWNLRA 517
+ K E+ ++ YH+N+V+ G C E L+ +FL +G+L +L N K NL+
Sbjct: 52 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQ 110
Query: 518 --NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575
A QI +G+ +L S Q +H D+ +N+L++ + +I DFGL K + ++
Sbjct: 111 QLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167
Query: 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
K + + +PE S DV+SFGV L E+++
Sbjct: 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 48/132 (36%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 491 LVYKFLNNGTLASFLFENLKPGWN-LRANI-AFQIARGLLHLHVNCSSQIIHCDIKPQNI 548
LV +N G L ++ PG++ RA A +I GL LH +I++ D+KP+NI
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENI 133
Query: 549 LLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGV 608
LLDDY + +ISD GLA + + + + I+ + GT GY+A PE +N T + D + G
Sbjct: 134 LLDDYGHIRISDLGLA--VEIPEGETIRGRV-GTVGYMA-PEVVKNERYTFSPDWWGLGC 189
Query: 609 LLLEIISCRKSF 620
L+ E+I + F
Sbjct: 190 LIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 56/178 (31%), Positives = 84/178 (47%), Gaps = 22/178 (12%)
Query: 446 VVKKLDRVFQDGEKEF-KNEVVMIGQTYHKNLVRLL-GFCDEGQNRL-LVYKFLNNGTLA 502
V+KK ++ + E E E ++ + H +V+L F E +L LV ++ G L
Sbjct: 25 VLKK-KKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLEYAPGGELF 81
Query: 503 SFL--FENLKPGWNLRANIAF---QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
S L F +I L +LH S II+ D+KP+NILLD + +
Sbjct: 82 SHLSKEGRFSEER-----ARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIK 133
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
++DFGLAK L+ S+ GT Y+A PE VD +S GVLL E+++
Sbjct: 134 LTDFGLAKELSSEGSRT--NTFCGTPEYLA-PEVLLGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 49/164 (29%), Positives = 84/164 (51%), Gaps = 10/164 (6%)
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLK-PGW 513
G+KEF E ++ Q H +VRL+G C +G+ +LV + G L +L + + P
Sbjct: 37 AAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVS 95
Query: 514 NLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573
+L +A Q+A G+ +L S +H D+ +N+LL + + A+ISDFG+++ L
Sbjct: 96 DL-KELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
Query: 574 AIKKAIRGTKGYVA--SPEWFRNSTITANVDVYSFGVLLLEIIS 615
+A + + +PE ++ DV+S+GV L E S
Sbjct: 152 Y--RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 81/321 (25%), Positives = 133/321 (41%), Gaps = 53/321 (16%)
Query: 402 PPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVI----QTSTRTTVIVVKKL-----DR 452
P DP+ + R + + + LG F + I + + VK L D+
Sbjct: 2 PADPKWELSRTRLTLGKP--LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK 59
Query: 453 VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPG 512
D E + + MIG+ HKN++ LLG C + ++ ++ + G L +L PG
Sbjct: 60 DLSDLVSEME-MMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 513 WNLR----------------ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
+ + A+Q+ARG+ +L S + IH D+ +N+L+ +
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVM 173
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYV-ASPEWFRNSTITANVDVYSFGVLLLEIIS 615
+I+DFGLA+ ++ KK G +PE + T DV+SFGVLL EI +
Sbjct: 174 KIADFGLAR--DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
Query: 616 CRKSFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQE 674
G Y I + F + G D C +L M+ C
Sbjct: 232 LG-------GSPYPGIPVEELFKLLKEGHRMD---------KPANCTHELYMIMRECWHA 275
Query: 675 DPSLRPTMRKVSQMLEVVVEV 695
PS RPT +++ + L+ V+ V
Sbjct: 276 VPSQRPTFKQLVEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 430 FTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG 486
F V +Q + KKLD+ + GEK E ++ + +V L +
Sbjct: 6 FGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK 65
Query: 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAF--QIARGLLHLHVNCSSQIIHCDIK 544
+ LV +N G L ++ + G + I + QI G+LHLH S I++ D+K
Sbjct: 66 THLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMK 122
Query: 545 PQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVY 604
P+N+LLDD N ++SD GLA + L K I + GT GY+A PE + + VD +
Sbjct: 123 PENVLLDDQGNCRLSDLGLA--VELKDGKTITQRA-GTNGYMA-PEILKEEPYSYPVDWF 178
Query: 605 SFGVLLLEIISCRKSF 620
+ G + E+++ R F
Sbjct: 179 AMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 49/175 (28%), Positives = 92/175 (52%), Gaps = 20/175 (11%)
Query: 447 VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL-LVYKFLNNGTLASFL 505
+KK+ R+ + ++ NE++++ H N+V + L +V ++++ G+L +
Sbjct: 49 IKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDII 106
Query: 506 FENLKPGWNLRAN---IAF---QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
+N +R N IA+ ++ +GL +LH S +IH DIK NILL + +++
Sbjct: 107 TQN-----FVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLA 158
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
DFG A LT +SK + ++ GT Y +PE + VD++S G++ +E+
Sbjct: 159 DFGFAAQLTKEKSK--RNSVVGTP-YWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 68/269 (25%), Positives = 125/269 (46%), Gaps = 43/269 (15%)
Query: 434 GVIQTSTRTTVIVVKKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492
GV++ T V +K ++ E+ EF NE ++ + ++VRLLG +GQ L++
Sbjct: 29 GVVKDEPETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87
Query: 493 YKFLNNGTLASFLFENLK-----------PGWNLRANIAFQIARGLLHLHVNCSSQIIHC 541
+ + G L S+L +L+ P +A +IA G+ +L+ N + +H
Sbjct: 88 MELMTRGDLKSYL-RSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHR 143
Query: 542 DIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA----SPEWFRNSTI 597
D+ +N ++ + + +I DFG+ + + ++ +K G KG + SPE ++
Sbjct: 144 DLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK---GGKGLLPVRWMSPESLKDGVF 198
Query: 598 TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK-LDDLVEGDMEAMN 656
T DV+SFGV+L EI A L + + N + L ++EG +
Sbjct: 199 TTYSDVWSFGVVLWEI---------------ATLAEQPYQGMSNEQVLRFVMEGGLLDKP 243
Query: 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKV 685
D C + L + C Q +P +RP+ ++
Sbjct: 244 D-NCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 67/246 (27%), Positives = 117/246 (47%), Gaps = 39/246 (15%)
Query: 460 EFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL------FENL--K 510
EF NE VM G T H ++VRLLG +GQ L+V + + +G L S+L EN +
Sbjct: 55 EFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 511 PGWNLRANI--AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568
P L+ I A +IA G+ +L+ + + +H D+ +N ++ + +I DFG+ +
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--D 168
Query: 569 LNQSKAIKKAIRGTKGYVA----SPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEM 624
+ ++ +K G KG + +PE ++ T + D++SFGV+L EI S
Sbjct: 169 IYETDYYRK---GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------- 216
Query: 625 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRK 684
L + + N ++ V C E++ + C Q +P +RPT +
Sbjct: 217 ------LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLE 270
Query: 685 VSQMLE 690
+ +L+
Sbjct: 271 IVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 52/160 (32%), Positives = 83/160 (51%), Gaps = 14/160 (8%)
Query: 461 FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF--ENLKPGWNLRAN 518
F E ++ Q H LVRL + + ++ +++ NG+L FL E +K N +
Sbjct: 48 FLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+A QIA G+ + IH D++ NIL+ + +I+DFGLA+L+ N+ A + A
Sbjct: 107 MAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA 163
Query: 579 ---IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
I+ T +PE T T DV+SFG+LL EI++
Sbjct: 164 KFPIKWT-----APEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKN 475
+T +GS F +G + + K R E++F E ++ + H
Sbjct: 6 LTLVQEIGSGQF-GLVWLGYWLEKRKVAI----KTIREGAMSEEDFIEEAQVMMKLSHPK 60
Query: 476 LVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHLHVN 533
LV+L G C E LV++F+ +G L+ +L + ++ + + G+ +L +
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 534 CSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV--ASPEW 591
+IH D+ +N L+ + ++SDFG+ + + +Q + GTK V +SPE
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEV 172
Query: 592 FRNSTITANVDVYSFGVLLLEIIS 615
F S ++ DV+SFGVL+ E+ S
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 58/179 (32%), Positives = 84/179 (46%), Gaps = 30/179 (16%)
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWN 514
+ E +F E +++ + H+N+VRL+G E R ++ + + G L SFL EN +P
Sbjct: 50 EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLREN-RPRPE 108
Query: 515 ----LRA----NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY---YNAQISDFGL 563
L A +A+G +L N IH DI +N LL A+I+DFG+
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGM 165
Query: 564 AKLLTLNQSKAIKKAIRGTKGYVA-------SPEWFRNSTITANVDVYSFGVLLLEIIS 615
A + I +A KG A PE F + T+ DV+SFGVLL EI S
Sbjct: 166 A--------RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (178), Expect = 8e-14
Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 11/145 (7%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR--ANIAFQIARGLLHL 530
H N+V+LL + LV+++ + L +L + + +I +Q+ RGL +
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 531 HVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPE 590
H + +I+H D+KPQNIL++ +++DFGLA+ + + + T Y A PE
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRA-PE 168
Query: 591 WFRNSTI-TANVDVYSFGVLLLEII 614
S + VD++S G + E+I
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 57/321 (17%)
Query: 402 PPDPEDKKKRNMMNVTRSVLLGSSVFVNFTL---VGVIQTSTRTTVIVVKKLDRVFQDG- 457
P DP + R+ + + + LG F + +G+ + + V V K+ +D
Sbjct: 5 PEDPRWEFSRDKLTLGKP--LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM---LKDDA 59
Query: 458 -EKEFKNEVV------MIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLK 510
EK+ + V MIG+ HKN++ LLG C + ++ ++ + G L +L
Sbjct: 60 TEKDLSDLVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 117
Query: 511 PGWNLRANIA----------------FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
PG +IA +Q+ARG+ +L S + IH D+ +N+L+ +
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENN 174
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV-ASPEWFRNSTITANVDVYSFGVLLLEI 613
+I+DFGLA+ +N KK G +PE + T DV+SFGVL+ EI
Sbjct: 175 VMKIADFGLAR--DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
Query: 614 ISCRKSFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCI 672
+ G Y I + F + G D C +L M+ C
Sbjct: 233 FTLG-------GSPYPGIPVEELFKLLKEGHRMD---------KPANCTNELYMMMRDCW 276
Query: 673 QEDPSLRPTMRKVSQMLEVVV 693
PS RPT +++ + L+ ++
Sbjct: 277 HAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 48/244 (19%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL--FENLKPGWNLR 516
K+ + E+ ++ + H N+V+ LG E N + + + G+LA L + + +
Sbjct: 47 KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE--PVI 104
Query: 517 ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
QI GL +LH +H DIK NIL+D +++DFG+AK +
Sbjct: 105 RLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV-------- 153
Query: 577 KAIRGTKGYVASPEWFRNSTI------TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 630
K + SP W I D++S G +LE+ + + + E A
Sbjct: 154 -EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL--EGVAA 210
Query: 631 LTDWAFDCYRNGKL----DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVS 686
+ F R+ +L D L EA + I + C+Q DPSLRPT +
Sbjct: 211 V----FKIGRSKELPPIPDHL---SDEAKDFI----------LKCLQRDPSLRPT---AA 250
Query: 687 QMLE 690
++LE
Sbjct: 251 ELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 67/263 (25%), Positives = 122/263 (46%), Gaps = 26/263 (9%)
Query: 444 VIVVKKLDR-VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE--GQNRLLVYKFLNNGT 500
++ VK L R Q +K E+ ++ YH+N+V+ G C E G+ L+ +++ G+
Sbjct: 35 MVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94
Query: 501 LASFLFENLKPGWNLRANIAF--QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
L +L ++ NL + F QI G+ +LH S IH D+ +N+LLD+ +I
Sbjct: 95 LRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKI 148
Query: 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII---- 614
DFGLAK + + + + + E + + + DV+SFGV L E++
Sbjct: 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCD 208
Query: 615 ---SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
S K F+ +G + +T +L +L+E M C +++ ++ C
Sbjct: 209 SKQSPPKKFEEMIGPKQGQMTVV--------RLIELLERGMRLPCPKNCPQEVYILMKNC 260
Query: 672 IQEDPSLRPTMRKVSQMLEVVVE 694
+ + RPT R + +L+ +
Sbjct: 261 WETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 62/242 (25%), Positives = 97/242 (40%), Gaps = 42/242 (17%)
Query: 463 NEVVMIG-QTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPG--------- 512
+EV +I Q H N+VR E +V + L F +LK
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERI 115
Query: 513 WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572
WN I Q+ L +LH +I+H D+ P NI+L + I+DFGLAK Q
Sbjct: 116 WN----IFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQP 166
Query: 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 632
++ ++ GT Y + PE +N DV++FG +L ++ + + F
Sbjct: 167 ESKLTSVVGTILY-SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF------------ 213
Query: 633 DWAFDCYRNGKLD---DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689
Y L +VE E + + E + V C+ D RP + +VS M+
Sbjct: 214 ------YSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
Query: 690 EV 691
Sbjct: 268 SD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 56/192 (29%), Positives = 90/192 (46%), Gaps = 15/192 (7%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
I +K++ + E+ + H+N+V+ LG E + + + G+L++
Sbjct: 36 IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL 95
Query: 505 LFENLKPGWNLRANIAF---QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA-QISD 560
L P + I F QI GL +LH N QI+H DIK N+L++ Y +ISD
Sbjct: 96 LRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISD 152
Query: 561 FGLAKLLT-LNQSKAIKKAIRGTKGYVASPEWFRNST--ITANVDVYSFGVLLLEIISCR 617
FG +K L +N + GT Y+A PE A D++S G ++E+ + +
Sbjct: 153 FGTSKRLAGIN---PCTETFTGTLQYMA-PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
Query: 618 KSFDIEMGEEYA 629
F IE+GE A
Sbjct: 209 PPF-IELGEPQA 219
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 65/248 (26%), Positives = 111/248 (44%), Gaps = 43/248 (17%)
Query: 460 EFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL--------FENLK 510
EF NE VM H ++VRLLG GQ L+V + + G L S+L
Sbjct: 55 EFLNEASVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 511 --PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568
P +A +IA G+ +L + + +H D+ +N ++ + +I DFG+ + +
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI- 169
Query: 569 LNQSKAIKKAIRGTKGYVA----SPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEM 624
++ +K G KG + +PE ++ T DV+SFGV+L E+ + +
Sbjct: 170 -YETDYYRK---GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--------L 217
Query: 625 GEE-YAILT-DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682
E+ Y L+ + +G DL E C +KL+ + C Q +P +RPT
Sbjct: 218 AEQPYQGLSNEEVLKFVIDGGHLDLPEN---------CPDKLLELMRMCWQYNPKMRPTF 268
Query: 683 RKVSQMLE 690
++ L+
Sbjct: 269 LEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 27/253 (10%)
Query: 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
TT + VK L D K+F E ++ + H L++L C + +V + + G+L
Sbjct: 30 TTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL 88
Query: 502 ASFLFENLKPGWNL--RANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
+L L ++A Q+A G+ +L + IH D+ +N+L+ + +++
Sbjct: 89 LEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVA 145
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYV--ASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
DFGLA+++ + I +A G K + +PE + + DV+SFG+LL EI++
Sbjct: 146 DFGLARVIKED----IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG 201
Query: 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPS 677
+ Y +T N ++ V+ C ++L + + C +EDP
Sbjct: 202 RM-------PYPGMT--------NAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPD 246
Query: 678 LRPTMRKVSQMLE 690
RPT + LE
Sbjct: 247 DRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 30/236 (12%)
Query: 463 NEVVMIGQTYHKNLVRLLG-FCDEGQNRL-LVYKFLNNGTLASFL----FENLKPGWNLR 516
+EV ++ + H N+VR D L +V ++ G LA + E
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 517 ANIAFQIARGLLHLH--VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574
I Q+ L H + + ++H D+KP NI LD N ++ DFGLAK+L + S A
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 634
K GT Y+ SPE + + D++S G L+ E+ + F L
Sbjct: 168 --KTYVGTPYYM-SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASK 221
Query: 635 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ GK + +N V+ S + DP RP+ ++L+
Sbjct: 222 I----KEGKFRRIPYRYSSELN-------EVIKS--MLNVDPDKRPS---TEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 70/274 (25%), Positives = 125/274 (45%), Gaps = 46/274 (16%)
Query: 443 TVIVVKKLDRVFQDGE-KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
T + VK L E ++ +E ++ Q H ++++L G C + LL+ ++ G+L
Sbjct: 31 TTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 90
Query: 502 ASFLFENLK--PGW---------------NLRA-------NIAFQIARGLLHLHVNCSSQ 537
SFL E+ K P + + RA + A+QI+RG+ +L +
Sbjct: 91 RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMK 147
Query: 538 IIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI 597
++H D+ +N+L+ + +ISDFGL++ + S + R ++A E +
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMA-IESLFDHIY 206
Query: 598 TANVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMN 656
T DV+SFGVLL EI++ G Y I + F+ + G + E
Sbjct: 207 TTQSDVWSFGVLLWEIVTLG-------GNPYPGIAPERLFNLLKTGYRMERPE------- 252
Query: 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
C E++ + + C +++P RPT +S+ LE
Sbjct: 253 --NCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 68/267 (25%), Positives = 123/267 (46%), Gaps = 36/267 (13%)
Query: 434 GVIQTSTRTTVIV-VKKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
G ++ + + V +K L D ++ +F E ++GQ H N++RL G + + ++
Sbjct: 23 GRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82
Query: 492 VYKFLNNGTLASFLFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548
+ +++ NG+L FL EN G + + IA G+ +L +H D+ +NI
Sbjct: 83 ITEYMENGSLDKFLRENDGKFTVGQLVG--MLRGIASGMKYLSEMNY---VHRDLAARNI 137
Query: 549 LLDDYYNAQISDFGLAKLLTLNQS----KAIKKAIRGTKGYVASPEWFRNSTITANVDVY 604
L++ ++SDFGL++ L +++ K K IR T +PE T+ DV+
Sbjct: 138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT-----APEAIAYRKFTSASDVW 192
Query: 605 SFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 663
SFG+++ E++S GE Y D + N + VE + C
Sbjct: 193 SFGIVMWEVMS--------YGERPYW---DMS-----NQDVIKAVEDGYRLPPPMDCPSA 236
Query: 664 LVMVSIWCIQEDPSLRPTMRKVSQMLE 690
L + + C Q+D + RPT ++ L+
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 47/172 (27%), Positives = 85/172 (49%), Gaps = 10/172 (5%)
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWN 514
+D +NE ++ H N++ E + ++V ++ GTLA ++ + +
Sbjct: 40 KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD 99
Query: 515 LRANIAF--QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN-AQISDFGLAKLLTLNQ 571
+ F QI L H+H + I+H D+K QNILLD + +I DFG++K+L+
Sbjct: 100 EDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS--- 153
Query: 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIE 623
SK+ + GT Y+ SPE D+++ G +L E+ S +++F+
Sbjct: 154 SKSKAYTVVGTPCYI-SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 26/193 (13%)
Query: 441 RTTVIVVKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
R + + + +D ++F E+ V+ +H N++ LLG C+ L ++ +G
Sbjct: 34 RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 93
Query: 500 TLASFLFENLKPGWNLRANIAFQIA---------RGLLHLHVNCS--------SQIIHCD 542
L FL + L + AF IA + LLH + + Q IH D
Sbjct: 94 NLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 149
Query: 543 IKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVD 602
+ +NIL+ + Y A+I+DFGL++ Q +KK + + E S T N D
Sbjct: 150 LAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD 205
Query: 603 VYSFGVLLLEIIS 615
V+S+GVLL EI+S
Sbjct: 206 VWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 417 TRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEK---EFKNEVVMIGQTYH 473
+ LG+ F + ++T T V V + + E+ + E+ ++ + H
Sbjct: 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 474 KNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL-----FENLKPGWNLRANIAFQIARGLL 528
+++R+LG E + L +++ G+++ L F+ + N Q+ RGL
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-----AVIINYTEQLLRGLS 117
Query: 529 HLHVNCSSQIIHCDIKPQNILLDDY-YNAQISDFGLAKLLTLNQSKA--IKKAIRGTKGY 585
+LH N QIIH D+K N+L+D +I+DFG A L + A + + GT +
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 586 VASPEWFRNSTITANVDVYSFGVLLLEI 613
+A PE R + DV+S G +++E+
Sbjct: 175 MA-PEVLRGEQYGRSCDVWSVGCVIIEM 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 49/268 (18%)
Query: 443 TVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
T+++VK L + ++ + EF+ E+ M + HKN+VRLLG C E + ++ ++ + G L
Sbjct: 36 TLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 502 ASFL------FENLKPGWNL----RANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
FL E LKP L + + QIA G+ HL +++ +H D+ +N L+
Sbjct: 96 KQFLRATKSKDEKLKPP-PLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVS 151
Query: 552 DYYNAQISDFGLAK------LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYS 605
++S L+K L + +R +PE + + DV+S
Sbjct: 152 SQREVKVSLLSLSKDVYNSEYYKLRNALI---PLRWL-----APEAVQEDDFSTKSDVWS 203
Query: 606 FGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL 664
FGVL+ E+ + GE + L+D L+ L G +E C +L
Sbjct: 204 FGVLMWEVFT--------QGELPFYGLSDEEV-------LNRLQAGKLELPVPEGCPSRL 248
Query: 665 --VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+M W + +P RP+ ++ L
Sbjct: 249 YKLMTRCWAV--NPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 57/231 (24%), Positives = 107/231 (46%), Gaps = 25/231 (10%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLK-PGWNLR 516
E EF E ++ + H+ LV+L G C + + +V ++++NG L ++L E+ K +
Sbjct: 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL 102
Query: 517 ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
+ + G+ +L S Q IH D+ +N L+DD ++SDFGL++ + ++ +
Sbjct: 103 LEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159
Query: 577 KAIRGTKGYV--ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 634
G+K V + PE S ++ DV++FGVL+ E+ S L
Sbjct: 160 ----GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS---------------LGKM 200
Query: 635 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKV 685
++ + N + + V + EK+ + C E RPT +++
Sbjct: 201 PYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 80/320 (25%), Positives = 132/320 (41%), Gaps = 55/320 (17%)
Query: 402 PPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVI----QTSTRTTVIVVKKLDRVFQDG 457
P DP + R+ + + + LG F + I + R T + VK L
Sbjct: 8 PEDPRWEVPRDRLVLGKP--LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS--DAT 63
Query: 458 EKEFKNEVV------MIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKP 511
EK+ + + MIG+ HKN++ LLG C + ++ ++ + G L +L P
Sbjct: 64 EKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 121
Query: 512 GWNLRAN----------------IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
G N A+Q+ARG+ +L S + IH D+ +N+L+ +
Sbjct: 122 GMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNV 178
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYV-ASPEWFRNSTITANVDVYSFGVLLLEII 614
+I+DFGLA+ ++ KK G +PE + T DV+SFGVLL EI
Sbjct: 179 MKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 615 SCRKSFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQ 673
+ G Y + + F + G D C +L M+ C
Sbjct: 237 TLG-------GSPYPGVPVEELFKLLKEGHRMD---------KPSNCTNELYMMMRDCWH 280
Query: 674 EDPSLRPTMRKVSQMLEVVV 693
PS RPT +++ + L+ ++
Sbjct: 281 AVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 49/144 (34%), Positives = 80/144 (55%), Gaps = 10/144 (6%)
Query: 480 LGFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANI--AFQIARGLLHLHVNCSS 536
L + E ++ L LV +N G L ++ + G+ + A +I GL LH
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QE 121
Query: 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST 596
+I++ D+KP+NILLDD+ + +ISD GLA + + + + IK + GT GY+A PE +N
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMA-PEVVKNER 177
Query: 597 ITANVDVYSFGVLLLEIISCRKSF 620
T + D ++ G LL E+I+ + F
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 48/236 (20%)
Query: 473 HKNLVRLLGFCDEGQNRLLV-YKFLNNGTLASFLFE-NLKPGWNLRA-------NIAFQI 523
H+N++ +L C E V Y ++N G L FL + L N +A ++A QI
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 524 ARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK--------LLTLNQSKAI 575
A G+ +LH +IH DI +N ++D+ +I+D L++ L N+++ +
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTD 633
K + E N ++ DV+SFGVLL E+++ ++ +I+ E A L D
Sbjct: 184 K---------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD 234
Query: 634 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689
YR + I C ++L V C DP RP+ ++ Q L
Sbjct: 235 G----YRLAQ-------------PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 461 FKNEVVMIGQTYHKNLVRLLGFCDEGQNRL-LVYKFLNNGTLASFLFENLKP--GWNLRA 517
F E ++ Q H NLV+LLG E + L +V +++ G+L +L + G +
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577
+ + + +L N +H D+ +N+L+ + A++SDFGL K + Q K
Sbjct: 106 KFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KL 161
Query: 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
++ T +PE R + DV+SFG+LL EI S
Sbjct: 162 PVKWT-----APEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 48/144 (33%), Positives = 76/144 (52%), Gaps = 10/144 (6%)
Query: 480 LGFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANI--AFQIARGLLHLHVNCSS 536
L + E ++ L LV +N G L ++ PG+ + A +I GL LH
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RE 121
Query: 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST 596
++ D+KP+NILLDDY + +ISD GLA + + + ++I+ + GT GY+A PE N
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV-GTVGYMA-PEVLNNQR 177
Query: 597 ITANVDVYSFGVLLLEIISCRKSF 620
T + D + G L+ E+I + F
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 57/257 (22%), Positives = 109/257 (42%), Gaps = 42/257 (16%)
Query: 445 IVVKKLD--RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
+V K+++ R+ + ++ NE+V++ H N++ + L+ ++ N GTL
Sbjct: 28 VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLY 87
Query: 503 SF-------LFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
LFE W L FQI + ++H + I+H DIK NI L
Sbjct: 88 DKIVRQKGQLFEEEMVLWYL-----FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGL 139
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
++ DFG++K+ L ++ + + GT Y+ SPE + D+++ G +L E+++
Sbjct: 140 IKLGDFGISKI--LGSEYSMAETVVGTPYYM-SPELCQGVKYNFKSDIWALGCVLYELLT 196
Query: 616 CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME---AMNDIKCVEKLVMVSIWCI 672
+++FD +LV ++ +L+ + +
Sbjct: 197 LKRTFDAT-------------------NPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL 237
Query: 673 QEDPSLRPTMRKVSQML 689
Q+DP RPT +V
Sbjct: 238 QQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 49/142 (34%), Positives = 73/142 (51%), Gaps = 15/142 (10%)
Query: 482 FCDEGQNRLLVYKFLNNGTLASFL--FENLKPGWNLRANIAFQIARGLLHLHVNCSSQII 539
F + +N LV ++L G LAS L +L R IA +I L +LH S+ II
Sbjct: 62 FQGK-KNLYLVMEYLPGGDLASLLENVGSL-DEDVARIYIA-EIVLALEYLH---SNGII 115
Query: 540 HCDIKPQNILLDDYYNAQISDFGLAKL----LTLNQSKAIKKAIR--GTKGYVASPEWFR 593
H D+KP NIL+D + +++DFGL+K+ +N + K+ R GT Y+A PE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA-PEVIL 174
Query: 594 NSTITANVDVYSFGVLLLEIIS 615
+ VD +S G +L E +
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 22/174 (12%)
Query: 458 EKEF-KNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS-------FLF-EN 508
EKE K EV+++ + H N+V E +V ++ + G L LF E+
Sbjct: 42 EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED 101
Query: 509 LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFGLAKLL 567
W + QI+ GL H+H +I+H DIK QNI L + A++ DFG+A+
Sbjct: 102 QILSWFV------QISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-- 150
Query: 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
LN S + GT Y+ SPE +N D++S G +L E+ + + F+
Sbjct: 151 QLNDSMELAYTCVGTPYYL-SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 422 LGSSVF---VNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKE-FKNEVVMIGQT-YHKNL 476
LG+ F V T G+ ++ V VK L E+E +E+ ++ H+N+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 477 VRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAF--QIARGLLHLHVNC 534
V LLG C G L++ ++ G L +FL + L ++F Q+A+G+ L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---A 158
Query: 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN 594
S IH D+ +N+LL +I DFGLA+ + + + +K R ++A PE N
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA-PESIFN 217
Query: 595 STITANVDVYSFGVLLLEIIS 615
T DV+S+G+LL EI S
Sbjct: 218 CVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 39/239 (16%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANI------------- 519
HKN++ LLG C + ++ ++ G L FL PG + +I
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 520 ---AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
A+Q+ARG+ +L S + IH D+ +N+L+ + +I+DFGLA+ ++ K
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYK 191
Query: 577 KAIRGTKGYV-ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW 634
K G +PE + T DV+SFG+L+ EI + G Y I +
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG-------GSPYPGIPVEE 244
Query: 635 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693
F R G M+ ++ C +L M+ C P+ RPT +++ + L+ V+
Sbjct: 245 LFKLLREGH-------RMDKPSN--CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 473 HKNLVRLLG-FCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRAN------IAFQIA 524
+V+ G F DE + + + ++ G+L S + K G R IA +
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRG--GRIGEKVLGKIAESVL 115
Query: 525 RGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKG 584
+GL +LH S +IIH DIKP NILL ++ DFG++ L + + GT
Sbjct: 116 KGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSF 168
Query: 585 YVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
Y+A PE + + DV+S G+ LLE+ R F
Sbjct: 169 YMA-PERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 45/193 (23%), Positives = 86/193 (44%), Gaps = 24/193 (12%)
Query: 439 STRTTVIV-VKKLDRVFQDGEKEFKN--EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495
T IV +KK+ F+ E+ ++ + H N+++LL + LV++F
Sbjct: 20 DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79
Query: 496 LNNGTLASFLFENLKPGWNLR-ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
++ L + + + + +Q+ +GL H S I+H D+KP+N+L++
Sbjct: 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEG 135
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-------TANVDVYSFG 607
+++DFGLA+ R YV + W+R + + VD++S G
Sbjct: 136 VLKLADFGLARSFGSPV--------RPYTHYVVT-RWYRAPELLLGDKGYSTPVDIWSVG 186
Query: 608 VLLLEIISCRKSF 620
+ E++S R F
Sbjct: 187 CIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 59/267 (22%), Positives = 115/267 (43%), Gaps = 46/267 (17%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
++ VK L + K+F E ++ H+++V+ G C EG ++V++++ +G L
Sbjct: 37 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 96
Query: 504 FLFENLKPGWNLRA--------------NIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
FL + P L A +IA QIA G+++L S +H D+ +N L
Sbjct: 97 FLRAH-GPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCL 152
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASP-EWFRNSTI-----TANVDV 603
+ + +I DFG+++ + + G+ P W +I T DV
Sbjct: 153 VGENLLVKIGDFGMSRDVYSTDYYRV-------GGHTMLPIRWMPPESIMYRKFTTESDV 205
Query: 604 YSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 663
+S GV+L EI + K Y + + +C G++ C ++
Sbjct: 206 WSLGVVLWEIFTYGKQ------PWYQLSNNEVIECITQGRV---------LQRPRTCPKE 250
Query: 664 LVMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ + + C Q +P +R ++++ +L+
Sbjct: 251 VYDLMLGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 56/214 (26%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIV-VKKLDRVFQDGEK-EFKNEVVMIGQTYH 473
+T+ ++G+ F G+++ R V V +K L + + ++ +F +E ++GQ H
Sbjct: 7 ITKQKVIGAGEFGE-VFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65
Query: 474 KNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL------FENLKPGWNLRANIAFQIARGL 527
N++RL G + + +++ +++ NG L +L F + + LR IA G+
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG-----IAAGM 120
Query: 528 LHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL------TLNQSKAIKKAIRG 581
+L +H D+ +NIL++ ++SDFGL+++L T S K IR
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG-KIPIRW 176
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
T +PE T+ DV+SFG+++ E++S
Sbjct: 177 T-----APEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVV----MIGQTYHKNLV 477
LGS F G+ + + VK L + + K+E++ ++ Q + +V
Sbjct: 3 LGSGNFGT-VKKGMYKMKKSEKTVAVKILKN--DNNDPALKDELLREANVMQQLDNPYIV 59
Query: 478 RLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ 537
R++G C E ++ +LV + G L FL +N + Q++ G+ +L +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETN 115
Query: 538 IIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS--KAIKKAIRGTKGYVASPEWFRNS 595
+H D+ +N+LL + A+ISDFGL+K L +++ KA K Y +PE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY--APECMNYY 173
Query: 596 TITANVDVYSFGVLLLEIIS 615
++ DV+SFGVL+ E S
Sbjct: 174 KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 51/168 (30%), Positives = 88/168 (52%), Gaps = 18/168 (10%)
Query: 462 KNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY-KFLNNGTLASFL-----FENLKPGWNL 515
E+ ++ + H+N+V+ LG + L ++ +++ G++A+ L FE L
Sbjct: 54 AREIALLKELQHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEE-----TL 107
Query: 516 RANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ-SKA 574
N QI +GL +LH + IIH DIK NIL+D+ +ISDFG++K L N S
Sbjct: 108 VRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK 164
Query: 575 IKKAIRGTKGYV--ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
A +G V +PE + ++ T D++S G L++E+++ + F
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 62/268 (23%), Positives = 110/268 (41%), Gaps = 44/268 (16%)
Query: 443 TVIVVKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
++ VK L + D K+F+ E ++ H+N+V+ G C EG ++V++++ +G L
Sbjct: 36 ELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDL 95
Query: 502 ASFLFENLKPGWNLRAN---------------IAFQIARGLLHLHVNCSSQIIHCDIKPQ 546
FL + P + IA QIA G+++L S +H D+ +
Sbjct: 96 NKFLRSH-GPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATR 151
Query: 547 NILLDDYYNAQISDFGLAKLLTLNQSKAIKKA----IRGTKGYVASPEWFRNSTITANVD 602
N L+ +I DFG+++ + + IR PE T D
Sbjct: 152 NCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM-----PPESIMYRKFTTESD 206
Query: 603 VYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVE 662
V+SFGV+L EI + K + E I +C G+L C
Sbjct: 207 VWSFGVVLWEIFTYGKQPWYGLSNEEVI------ECITQGRLLQRPRT---------CPS 251
Query: 663 KLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
++ + + C + DP R ++ + + L+
Sbjct: 252 EVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 22/166 (13%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA--NIAF 521
EV ++ Q H+N+V L LV++++ L L E G A + +
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIW 107
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ + + + H S IIH DIKP+NIL+ + ++ DFG A+ L + +
Sbjct: 108 QLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD---- 160
Query: 582 TKGYVASPEWFR-------NSTITANVDVYSFGVLLLEIISCRKSF 620
YVA+ W+R ++ VDV++ G ++ E++ F
Sbjct: 161 ---YVAT-RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 69/276 (25%), Positives = 126/276 (45%), Gaps = 27/276 (9%)
Query: 416 VTRSVLLGSSVF-VNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEK---EFKNEVVMIGQT 471
+ R +LGS F + + V + T + +K L+ G K EF +E +++
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASM 66
Query: 472 YHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKP-GWNLRANIAFQIARGLLHL 530
H +LVRLLG C +L V + + +G L ++ E+ G L N QIA+G+++L
Sbjct: 67 DHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 531 HVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPE 590
+++H D+ +N+L+ + +I+DFGLA+LL ++ + + ++A E
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL-E 181
Query: 591 WFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650
T DV+S+GV + E+++ G+ Y D ++ DL+E
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFG-------GKPY--------DGIPTREIPDLLEK 226
Query: 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVS 686
C + MV + C D RP ++++
Sbjct: 227 GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 60/264 (22%), Positives = 113/264 (42%), Gaps = 36/264 (13%)
Query: 443 TVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
++ VK L + ++F+ E ++ H+++VR G C EG+ L+V++++ +G L
Sbjct: 36 MLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 503 SFLF------------ENLKPG---WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQN 547
FL E++ PG IA QIA G+++L S +H D+ +N
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRN 152
Query: 548 ILLDDYYNAQISDFGLAK-LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSF 606
L+ +I DFG+++ + + + + + + + PE T D++SF
Sbjct: 153 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW--MPPESILYRKFTTESDIWSF 210
Query: 607 GVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVM 666
GV+L EI + K Y + A +C G+ E C ++
Sbjct: 211 GVVLWEIFTYGKQ------PWYQLSNTEAIECITQGR---------ELERPRTCPPEVYA 255
Query: 667 VSIWCIQEDPSLRPTMRKVSQMLE 690
+ C Q +P R ++ + L+
Sbjct: 256 IMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 61/261 (23%), Positives = 119/261 (45%), Gaps = 36/261 (13%)
Query: 441 RTTVIVVKKLDRVFQDGE-KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
R + +K L + + + ++F +E ++GQ H N++ L G + + +++ +F+ NG
Sbjct: 31 REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENG 90
Query: 500 TLASFLFEN------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY 553
L SFL +N ++ LR IA G+ +L +H D+ +NIL++
Sbjct: 91 ALDSFLRQNDGQFTVIQLVGMLRG-----IAAGMKYL---SEMNYVHRDLAARNILVNSN 142
Query: 554 YNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV--ASPEWFRNSTITANVDVYSFGVLLL 611
++SDFGL++ L + S + G K + +PE T+ DV+S+G+++
Sbjct: 143 LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 202
Query: 612 EIISC--RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSI 669
E++S R +D+ N + + +E D + C L + +
Sbjct: 203 EVMSYGERPYWDMS-----------------NQDVINAIEQDYRLPPPMDCPTALHQLML 245
Query: 670 WCIQEDPSLRPTMRKVSQMLE 690
C Q+D + RP ++ L+
Sbjct: 246 DCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 7/157 (4%)
Query: 461 FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIA 520
F E ++ H LVRL + + ++ +++ G+L FL + L I
Sbjct: 48 FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID 107
Query: 521 F--QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
F QIA G+ ++ IH D++ N+L+ + +I+DFGLA+++ N+ A + A
Sbjct: 108 FSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164
Query: 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
K +PE + T DV+SFG+LL EI++
Sbjct: 165 KFPIKW--TAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 15/185 (8%)
Query: 446 VVKKLDRVFQDGEKEFKNE-VVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
V+KK D + ++ K E +M+ Q + +L LV ++LN G AS
Sbjct: 28 VLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASL 87
Query: 505 L--FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562
+ L W + IA ++ G+ LH IIH DIKP+N+L+D + +++DFG
Sbjct: 88 IKTLGGLPEDW-AKQYIA-EVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFG 142
Query: 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDI 622
L++ N K GT Y+A PE D +S G ++ E + F
Sbjct: 143 LSRNGLEN------KKFVGTPDYLA-PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195
Query: 623 EMGEE 627
E +
Sbjct: 196 ETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 12/163 (7%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN 518
E + EV + Q H N+V+ G LV +L+ G+L + + G A
Sbjct: 44 DELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI 103
Query: 519 IAF---QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL---TLNQS 572
IA ++ +GL +LH N IH DIK NILL + + +I+DFG++ L
Sbjct: 104 IATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160
Query: 573 KAIKKAIRGTKGYVASPEWFRNST-ITANVDVYSFGVLLLEII 614
K +K GT ++A PE D++SFG+ +E+
Sbjct: 161 KV-RKTFVGTPCWMA-PEVMEQVHGYDFKADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 52/167 (31%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ + H+H S +IH DIK NILL ++ DFG +K+ S + + G
Sbjct: 151 QVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641
T YVA PE +R + D++S GVLL E+++ ++ FD E EE T
Sbjct: 208 TPYYVA-PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-------LA 259
Query: 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688
G+ D L M +I V L + DP RP+ K+ M
Sbjct: 260 GRYDPLPPSISPEMQEI--VTAL-------LSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 47/172 (27%), Positives = 90/172 (52%), Gaps = 18/172 (10%)
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY-KFLNNGTLASFLFENLKPGW 513
+D K ++E+ + H N+V+ LGF + + L ++ +++ G++ S L +
Sbjct: 49 KDMVKALRSEIETLKDLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE 107
Query: 514 NLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573
L Q+ GL +LH S I+H D+K N+L+D +ISDFG++K +S
Sbjct: 108 QLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK-----KSD 159
Query: 574 AI-----KKAIRGTKGYVASPEWFRNST--ITANVDVYSFGVLLLEIISCRK 618
I +++G+ ++A PE + + +A VD++S G ++LE+ + R+
Sbjct: 160 DIYDNDQNMSMQGSVFWMA-PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 41/203 (20%)
Query: 443 TVIVVKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
T++ VK L + D + +F+ E ++ + H N+V+LLG C G+ L+++++ G L
Sbjct: 36 TMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95
Query: 502 ASFLFENLKPGWNLRAN-----------------------IAFQIARGLLHLHVNCSSQI 538
FL P + IA Q+A G+ +L +
Sbjct: 96 NEFLRHR-SPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KF 151
Query: 539 IHCDIKPQNILLDDYYNAQISDFGL------AKLLTLNQSKAIKKAIRGTKGYVASPEWF 592
+H D+ +N L+ + +I+DFGL A +++ AI IR PE
Sbjct: 152 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI--PIRWM-----PPESI 204
Query: 593 RNSTITANVDVYSFGVLLLEIIS 615
+ T DV+++GV+L EI S
Sbjct: 205 FYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 59/268 (22%), Positives = 115/268 (42%), Gaps = 47/268 (17%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
++ VK L K+F+ E ++ H+++V+ G C +G ++V++++ +G L
Sbjct: 37 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK 96
Query: 504 FLFEN------LKPGWNLRAN----------IAFQIARGLLHLHVNCSSQIIHCDIKPQN 547
FL + L G +A IA QIA G+++L S +H D+ +N
Sbjct: 97 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRN 153
Query: 548 ILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASP-EWFRNSTI-----TANV 601
L+ +I DFG+++ + + G+ P W +I T
Sbjct: 154 CLVGANLLVKIGDFGMSRDVYSTDYYRV-------GGHTMLPIRWMPPESIMYRKFTTES 206
Query: 602 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCV 661
DV+SFGV+L EI + K ++ I +C G++ + C
Sbjct: 207 DVWSFGVILWEIFTYGKQPWFQLSNTEVI------ECITQGRVLERPR---------VCP 251
Query: 662 EKLVMVSIWCIQEDPSLRPTMRKVSQML 689
+++ + + C Q +P R ++++ ++L
Sbjct: 252 KEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 74/291 (25%), Positives = 134/291 (46%), Gaps = 45/291 (15%)
Query: 421 LLGSSVFVNF---TLVGVIQTSTRTTVIVVKKLDRVFQDGEK-EFKNEVVMIGQTYHKNL 476
LGS F T ++ + + VK L + D EK EF E ++ H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 477 VRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLK-----PGWNLR--ANIAFQIARGLLH 529
V+LLG C + + ++ + + G L S+L + P L+ +I +A+G ++
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 530 LHVNCSSQIIHCDIKPQNILLDDY-YNA----QISDFGLAKLLTLNQSKAIKKAIRGTKG 584
L IH D+ +N L+ + Y+A +I DFGLA+ + +S +K G +G
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRK--EG-EG 173
Query: 585 YV----ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCY 639
+ +PE + T DV+SFGVL+ EI++ +G++ Y L + +
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT--------LGQQPYPALNN--QEVL 223
Query: 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
++ G ++ + C +K+ + C +DPS RPT ++ ++L+
Sbjct: 224 QHVT----AGGRLQKPEN--CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 454 FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGW 513
D +++F E ++ Q H N+V+L+G C + Q +V + + G+L +FL K
Sbjct: 32 PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL---RKKKN 88
Query: 514 NLRANIAFQI----ARGLLHLHV-NCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568
L Q+ A G+ +L NC IH D+ +N L+ + +ISDFG+++
Sbjct: 89 RLTVKKLLQMSLDAAAGMEYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR--- 141
Query: 569 LNQSKAIKKAIRGTKGYV---ASPEWFRNSTITANVDVYSFGVLLLEIIS 615
+ I G K +PE T+ DV+S+G+LL E S
Sbjct: 142 -EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 65/253 (25%), Positives = 110/253 (43%), Gaps = 28/253 (11%)
Query: 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
T + VK L E F E ++ + H LV+L E + +V ++++ G+L
Sbjct: 30 NTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSL 87
Query: 502 ASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
FL + G L+ ++A Q+A G+ ++ IH D++ NIL+ D +
Sbjct: 88 LDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCK 142
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
I+DFGLA+L+ N+ A + A K +PE T DV+SFG+LL E+++
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFPIKW--TAPEAALYGRFTIKSDVWSFGILLTELVTKG 200
Query: 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPS 677
+ + N ++ + VE C L + + C ++DP
Sbjct: 201 RV---------------PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPE 245
Query: 678 LRPTMRKVSQMLE 690
RPT + LE
Sbjct: 246 ERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 23/232 (9%)
Query: 461 FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIA 520
F E ++ H LV+L + + ++ +F+ G+L FL + L I
Sbjct: 48 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 106
Query: 521 F--QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
F QIA G+ + IH D++ NIL+ +I+DFGLA+++ N+ A + A
Sbjct: 107 FSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 163
Query: 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638
K +PE + T DV+SFG+LL+EI++ + Y ++
Sbjct: 164 KFPIKW--TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-------PYPGMS------ 208
Query: 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
N ++ +E C E+L + + C + P RPT + +L+
Sbjct: 209 --NPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 68/274 (24%), Positives = 119/274 (43%), Gaps = 36/274 (13%)
Query: 422 LGSSVFVNFTLVGVIQTST-RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLL 480
LGS F GV+ R + V K E++F E ++ + H LV+L
Sbjct: 12 LGSGQF------GVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 481 GFCDEGQNRLLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQII 539
G C + + +V +F+ NG L ++L + K ++ ++ + G+ +L N I
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFI 122
Query: 540 HCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ---SKAIKKAIRGTKGYVASPEWFRNST 596
H D+ +N L+ ++SDFG+ + + ++ S K ++ + PE F S
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS-----PPEVFNFSK 177
Query: 597 ITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 655
++ DV+SFGVL+ E+ + + F+ + E + F YR KL A
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP-KL---------AS 227
Query: 656 NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689
+ VM S W E P RPT ++ + +
Sbjct: 228 MTV----YEVMYSCW--HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 425 SVFVNFTLVG-------VIQTSTRTTVIV-VKKLDRVFQDGEKEFKNEVVMIGQTYHKNL 476
S NF +G I T T V VKK+D Q + NEVV++ H N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 477 VRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS 536
V + G +V +FL G L + + + A + + + L LH +
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH---AQ 134
Query: 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST 596
+IH DIK +ILL ++SDFG ++ + +K++ GT Y +PE
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTP-YWMAPEVISRLP 191
Query: 597 ITANVDVYSFGVLLLEII 614
VD++S G++++E++
Sbjct: 192 YGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 25/189 (13%)
Query: 439 STRTTVIVVKKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497
R + +K L + + ++ +F +E ++GQ H N++ L G + + ++V +++
Sbjct: 29 GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88
Query: 498 NGTLASFL------FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
NG+L +FL F ++ LR IA G+ +L +H D+ +NIL++
Sbjct: 89 NGSLDAFLRKHDGQFTVIQLVGMLRG-----IASGMKYL---SDMGYVHRDLAARNILVN 140
Query: 552 DYYNAQISDFGLAKLLTLNQSKAI-----KKAIRGTKGYVASPEWFRNSTITANVDVYSF 606
++SDFGL+++L + A K IR T +PE T+ DV+S+
Sbjct: 141 SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT-----APEAIAYRKFTSASDVWSY 195
Query: 607 GVLLLEIIS 615
G+++ E++S
Sbjct: 196 GIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 17/175 (9%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+ VKK+D Q + NEVV++ +H+N+V + G +V +FL G L
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD- 108
Query: 505 LFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
+ + + A + + R L +LH + +IH DIK +ILL ++SDFG
Sbjct: 109 IVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFC 165
Query: 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTIT-----ANVDVYSFGVLLLEII 614
+ K + K V +P W I+ VD++S G++++E+I
Sbjct: 166 --------AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 62/255 (24%), Positives = 105/255 (41%), Gaps = 32/255 (12%)
Query: 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
T V V + + D + +F E ++ Q H N+VRL+G C + Q +V + + G
Sbjct: 21 TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80
Query: 502 ASFLFENLKPGWNLRANIAFQI----ARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
+FL G L+ Q+ A G+ +L IH D+ +N L+ + +
Sbjct: 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKHC---IHRDLAARNCLVTEKNVLK 134
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYV---ASPEWFRNSTITANVDVYSFGVLLLEII 614
ISDFG+++ + + + G K +PE ++ DV+SFG+LL E
Sbjct: 135 ISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF 190
Query: 615 SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQE 674
S YA L+ N + + +E + C + + + C +
Sbjct: 191 SLGAV-------PYANLS--------NQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 675 DPSLRPTMRKVSQML 689
DP RP+ V Q L
Sbjct: 236 DPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA--NIAF 521
E+ M+ Q H+NLV L+ + LV++F+++ L E G + F
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLF 107
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
QI RG+ H + IIH DIKP+NIL+ ++ DFG A+ TL +
Sbjct: 108 QILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVA 162
Query: 582 TKGYVASPEWFRNSTITAN-VDVYSFGVLLLEIIS 615
T+ Y A PE T VD+++ G L+ E+++
Sbjct: 163 TRWYRA-PELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 430 FTLVGVIQTSTRTTVIVVKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488
F G + + ++ VK L V + +F E+ ++ + + N++RLLG C
Sbjct: 32 FLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP 91
Query: 489 RLLVYKFLNNGTLASFLFE-NLKPGWNLRANI-----------AFQIARGLLHLHVNCSS 536
++ +++ NG L FL + ++ + NI A QIA G+ +L S
Sbjct: 92 LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASL 148
Query: 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASP-EWFRNS 595
+H D+ +N L+ ++Y +I+DFG+++ L I +G P W
Sbjct: 149 NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI-------QGRAVLPIRWMAWE 201
Query: 596 TI-----TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 633
+I T DV++FGV L E+ + K + Y++L+D
Sbjct: 202 SILLGKFTTASDVWAFGVTLWEMFTLCKE------QPYSLLSD 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN 518
+ E+ ++ H+ +V+ G + + + +++ G++ + LK L
Sbjct: 49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVK----DQLKAYGALTET 104
Query: 519 IA----FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK-LLTLNQSK 573
+ QI G+ +LH N I+H DIK NIL D N ++ DFG +K L T+ S
Sbjct: 105 VTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
K++ GT Y SPE DV+S G ++E+++
Sbjct: 162 TGMKSVTGTP-YWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 18/183 (9%)
Query: 442 TTVIVVKKLDRVFQDGEKEFKN-----EVVMIGQTYHKNLVRLLG-FCDEGQNRLLVYKF 495
T I+ K R+ + E K +++ + +V G F + G + + ++
Sbjct: 25 TGKIMAVKTIRLEIN-EAIQKQILRELDILH--KCNSPYIVGFYGAFYNNGDISICM-EY 80
Query: 496 LNNGTLASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
++ G+L L E + IA + +GL +LH +IIH D+KP NIL++
Sbjct: 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRG 138
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
++ DFG++ L S A K GT Y+A PE + + + D++S G+ L+E+
Sbjct: 139 QIKLCDFGVSGQLV--NSLA--KTFVGTSSYMA-PERIQGNDYSVKSDIWSLGLSLIELA 193
Query: 615 SCR 617
+ R
Sbjct: 194 TGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 46/144 (31%), Positives = 77/144 (53%), Gaps = 10/144 (6%)
Query: 480 LGFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANI--AFQIARGLLHLHVNCSS 536
L + E ++ L LV +N G L ++ PG++ + I A ++ GL L
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RE 121
Query: 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST 596
+I++ D+KP+NILLDD + +ISD GLA + + + + ++ + GT GY+A PE N
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRV-GTVGYMA-PEVINNEK 177
Query: 597 ITANVDVYSFGVLLLEIISCRKSF 620
T + D + G L+ E+I + F
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 18/178 (10%)
Query: 445 IVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLGF------CDEGQNRLLVYKFL 496
+ VKKL R FQ+ K E+V++ HKN++ LL +E Q+ LV + +
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
+ L + L + + +Q+ G+ HLH S+ IIH D+KP NI++
Sbjct: 109 D-ANLCQVIHMELDH--ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 162
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+I DFGLA+ N R Y +PE NVD++S G ++ E++
Sbjct: 163 KILDFGLARTACTNFMMTPYVVTR----YYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 40/226 (17%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR-ANIAFQIARGLLHLH 531
H N+V+ D ++ +F++ G+L E A++A QI G+ +LH
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVARQILSGIAYLH 185
Query: 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEW 591
I+H DIKP N+L++ N +I+DFG++++ L Q+ + GT Y+ SPE
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYM-SPER 239
Query: 592 FRNSTITANV------DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA----FDCYRN 641
N+ + D++S GV +LE R F +G + DWA C
Sbjct: 240 I-NTDLNHGAYDGYAGDIWSLGVSILEFYLGR--FPFGVGRQ----GDWASLMCAICMSQ 292
Query: 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687
+ E + I C C+Q +P+ R + ++ Q
Sbjct: 293 PP-EAPATASREFRHFISC----------CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 47/149 (31%), Positives = 78/149 (52%), Gaps = 17/149 (11%)
Query: 473 HKNLVRLLGFC-----DEGQNRLLVYKFLNNGTLASFLFENLKPG---WNLRANIAFQIA 524
H N+VRLL C D LV++ ++ LA++L + KPG ++ ++ Q+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLL 117
Query: 525 RGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKG 584
RG+ LH + I+H D+KPQNIL+ +I+DFGLA++ + + ++ T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT---SVVVTLW 171
Query: 585 YVASPEWFRNSTITANVDVYSFGVLLLEI 613
Y A PE S+ VD++S G + E+
Sbjct: 172 YRA-PEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 11/175 (6%)
Query: 447 VKKLDRVFQDGE-KEFKNEVVMIGQTYHKNLVRLLGFC--DEGQNRLLVYKFLNNGTLAS 503
VK L+R+ E ++F E +++ H N++ LLG C EG L+V ++ +G L +
Sbjct: 28 VKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSP-LVVLPYMKHGDLRN 86
Query: 504 FL-FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562
F+ E P Q+A+G+ +L S + +H D+ +N +LD+ + +++DFG
Sbjct: 87 FIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFG 143
Query: 563 LAKLLTLNQSKAI--KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
LA+ + + ++ + ++A E + T DV+SFGVLL E+++
Sbjct: 144 LARDIYDKEYYSVHNHTGAKLPVKWMAL-ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-10
Identities = 36/108 (33%), Positives = 48/108 (44%), Gaps = 23/108 (21%)
Query: 83 VVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWSS---------KLIL------ 127
VVW + NP+ + L +D LVL D G+ VWSS +L
Sbjct: 4 VVWVANRL--NPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGNL 61
Query: 128 -VQSFSSSRLWDSFSNPTDTLLPGKMMET-----EQGLFSGKSDTNFS 169
+ S LW SF +PTDTLLPG+ + L S KS+T+ S
Sbjct: 62 VLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 7/183 (3%)
Query: 432 LVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
+V + + ++ VKK+D Q + NEVV++ H+N+V + G +
Sbjct: 35 IVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 94
Query: 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
V +FL G L + + + A + + + L LH + +IH DIK +ILL
Sbjct: 95 VMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLT 150
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611
++SDFG +++ +K++ GT Y +PE VD++S G++++
Sbjct: 151 HDGRVKLSDFGFCA--QVSKEVPRRKSLVGTP-YWMAPELISRLPYGPEVDIWSLGIMVI 207
Query: 612 EII 614
E++
Sbjct: 208 EMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 62/250 (24%), Positives = 108/250 (43%), Gaps = 42/250 (16%)
Query: 460 EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF------------- 506
EF+ E ++ + +H N+V LLG + Q +++++LN G L FL
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 507 ------ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD 560
+L G L +IA QIA G+ +L S +H D+ +NIL+ + + +ISD
Sbjct: 113 EDGTVKSSLDHGDFL--HIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISD 167
Query: 561 FGLAK-LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
GL++ + + + + K++ + PE +++ D++SFGV+L EI
Sbjct: 168 LGLSREIYSADYYRVQPKSLLPIRW--MPPEAIMYGKFSSDSDIWSFGVVLWEI------ 219
Query: 620 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLR 679
F + Y + R +L E C ++ + C QE PS R
Sbjct: 220 FSFGLQPYYGFSNQEVIEMVRKRQLLPCSE---------DCPPRMYSLMTECWQEGPSRR 270
Query: 680 PTMRKVSQML 689
P + + L
Sbjct: 271 PRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 69/253 (27%), Positives = 109/253 (43%), Gaps = 28/253 (11%)
Query: 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
TT + +K L E F E ++ + H LV L E + +V +F+ G+L
Sbjct: 30 TTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSL 87
Query: 502 ASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
FL E G L+ ++A QIA G+ ++ IH D++ NIL+ D +
Sbjct: 88 LDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCK 142
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
I+DFGLA+L+ N+ A + A K +PE T DV+SFG+LL E+++
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFPIKW--TAPEAALYGRFTIKSDVWSFGILLTELVTKG 200
Query: 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPS 677
+ + N ++ + VE C E L + C ++DP
Sbjct: 201 RV---------------PYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPD 245
Query: 678 LRPTMRKVSQMLE 690
RPT + LE
Sbjct: 246 ERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 46/184 (25%), Positives = 88/184 (47%), Gaps = 10/184 (5%)
Query: 434 GVIQTSTRTTV---IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490
G + T+ + +K+++ Q ++ NE++++ + + N+V L G
Sbjct: 33 GTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
+V ++L G+L + E + A + + + L LH N Q+IH DIK N+LL
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLHAN---QVIHRDIKSDNVLL 148
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+ +++DFG +T QSK + + GT Y +PE VD++S G++
Sbjct: 149 GMDGSVKLTDFGFCAQITPEQSK--RSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 611 LEII 614
+E++
Sbjct: 206 IEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 28/253 (11%)
Query: 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
TT + +K L E F E ++ + H+ LV+L E + +V ++++ G+L
Sbjct: 30 TTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 87
Query: 502 ASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
FL + G LR ++A QIA G+ ++ +H D++ NIL+ + +
Sbjct: 88 LDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCK 142
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
++DFGLA+L+ N+ A + A K +PE T DV+SFG+LL E+ +
Sbjct: 143 VADFGLARLIEDNEYTARQGAKFPIKW--TAPEAALYGRFTIKSDVWSFGILLTELTTKG 200
Query: 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPS 677
+ + N ++ D VE +C E L + C +++P
Sbjct: 201 RV---------------PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 245
Query: 678 LRPTMRKVSQMLE 690
RPT + LE
Sbjct: 246 ERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 3e-10
Identities = 51/188 (27%), Positives = 86/188 (45%), Gaps = 12/188 (6%)
Query: 430 FTLVGVIQTSTRTTVIVVKKLDR---VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG 486
F V +++ +K L + V + NE ++ H LV L G +
Sbjct: 14 FGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD 73
Query: 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQ 546
N LV +++ G L S L ++ + + A Q+ L +LH S I++ D+KP+
Sbjct: 74 SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPE 130
Query: 547 NILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSF 606
N+LLD +I+DFG AK + K + GT Y+A PE + VD ++
Sbjct: 131 NLLLDSDGYIKITDFGFAKRV-----KGRTYTLCGTPEYLA-PEIILSKGYGKAVDWWAL 184
Query: 607 GVLLLEII 614
G+L+ E++
Sbjct: 185 GILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 35/107 (32%), Positives = 56/107 (52%), Gaps = 16/107 (14%)
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
+QI RGL ++H S+ ++H D+KP N+LL+ + +I DFGLA++
Sbjct: 113 YQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT-----G 164
Query: 581 GTKGYVASPEWFRNSTI-------TANVDVYSFGVLLLEIISCRKSF 620
YVA+ W+R I T +D++S G +L E++S R F
Sbjct: 165 FLTEYVAT-RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 61/258 (23%), Positives = 111/258 (43%), Gaps = 39/258 (15%)
Query: 449 KLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR------LLVYKFLNNGTLA 502
KLD +EF +E + H N+++L+G C E + +++ F+ +G L
Sbjct: 36 KLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLH 95
Query: 503 SFLF----ENLKPGWNLRANIAF--QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
SFL L L+ + F IA G+ +L + IH D+ +N +L +
Sbjct: 96 SFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTV 152
Query: 557 QISDFGLAKLL----TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
++DFGL+K + Q + K ++ ++A E + T+ DV++FGV + E
Sbjct: 153 CVADFGLSKKIYSGDYYRQGRIAKMPVK----WIAI-ESLADRVYTSKSDVWAFGVTMWE 207
Query: 613 IISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCI 672
I + G+ + N ++ D + C+++L + C
Sbjct: 208 IAT--------RGQT-------PYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCW 252
Query: 673 QEDPSLRPTMRKVSQMLE 690
+ DP RPT K+ ++LE
Sbjct: 253 RADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 24/196 (12%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494
I T + V+K D + + E+ M+ + H N+V G +V +
Sbjct: 24 DIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80
Query: 495 FLNNGTLASFLFENLKPGWNLR-ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY 553
+ G+L P L+ A + + +GL +LH + IH DIK NILL +
Sbjct: 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTED 137
Query: 554 YNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWF---RNSTITANVDVYSFGVLL 610
+ +++DFG++ LT +K +K+ GT ++A PE R D+++ G
Sbjct: 138 GDVKLADFGVSAQLTATIAK--RKSFIGTPYWMA-PEVAAVERKGGYDGKCDIWALG--- 191
Query: 611 LEIISCRKSFDIEMGE 626
I+ IE+ E
Sbjct: 192 ---ITA-----IELAE 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 18/176 (10%)
Query: 444 VIVVKKLDRVFQDGEKEFKN---EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
V+ +K +D ++ E E ++ E+ ++ Q + R G +G ++ ++L G+
Sbjct: 31 VVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88
Query: 501 LASFLFENLKPGWNLRANIAF---QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
L KPG IA +I +GL +LH S + IH DIK N+LL + + +
Sbjct: 89 ALDLL----KPGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVK 141
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
++DFG+A LT Q K + GT ++A PE + S D++S G+ +E+
Sbjct: 142 LADFGVAGQLTDTQIK--RNTFVGTPFWMA-PEVIKQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 36/101 (35%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
+QI RGL +LH S+ I+H DIKP N+L++ +I DFGLA++ ++SK + + +
Sbjct: 110 YQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV- 165
Query: 581 GTKGYVASPEWFRNST-ITANVDVYSFGVLLLEIISCRKSF 620
Y +PE S T+ VD++S G + E++ R F
Sbjct: 166 -VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 25/182 (13%)
Query: 473 HKNLVRLLGFC-----DEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIAR 525
H N+VRL+ C D LV++ ++ L ++L + PG ++ Q R
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 526 GLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGY 585
GL LH NC I+H D+KP+NIL+ +++DFGLA++ + A+ + +
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVV--VTLW 172
Query: 586 VASPEWFRNSTITANVDVYSFGVLLLEIIS-----CRKSFDIEMGEEYAIL-----TDWA 635
+PE ST VD++S G + E+ C S ++G+ + ++ DW
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232
Query: 636 FD 637
D
Sbjct: 233 RD 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 45/170 (26%), Positives = 84/170 (49%), Gaps = 7/170 (4%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+ VK +D Q + NEVV++ H+N+V + G+ ++ +FL G L
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108
Query: 505 LFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
+ + + A + + + L +LH S +IH DIK +ILL ++SDFG
Sbjct: 109 VSQ-TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFC 164
Query: 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
++ + K +K++ GT Y +PE + VD++S G++++E++
Sbjct: 165 AQISKDVPK--RKSLVGTP-YWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 55/173 (31%), Positives = 83/173 (47%), Gaps = 24/173 (13%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
+FQ+ARG+ L S + IH D+ +NILL + +I DFGLA+ + + K +
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFD 637
R ++A PE + T DV+SFGVLL EI S S +++ EE+
Sbjct: 237 RLPLKWMA-PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--------- 286
Query: 638 CYRNGKLDDLVEGD-MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689
C R L +G M A + +M++ W Q DP RPT + ++L
Sbjct: 287 CQR------LKDGTRMRAPENATPEIYRIMLACW--QGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 24/173 (13%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN 518
+E + EV ++ H N+V+ +E N +V + G L + N +
Sbjct: 44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI--------NAQRG 95
Query: 519 IAF----------QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568
+ F QI L H+H +I+H DIK QNI L ++ DFG+A++
Sbjct: 96 VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV-- 150
Query: 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
LN + + + GT Y+ SPE N D+++ G +L E+ + + +F+
Sbjct: 151 LNSTVELARTCIGTPYYL-SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQ 546
++ V ++LN G L + + + A +I GL LH II+ D+K
Sbjct: 69 EHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLD 125
Query: 547 NILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSF 606
N+LLD + +I+DFG+ K + KA GT Y+A PE + +VD +SF
Sbjct: 126 NVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIA-PEILKGQKYNESVDWWSF 182
Query: 607 GVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641
GVLL E++ + F E +E FD N
Sbjct: 183 GVLLYEMLIGQSPFHGEDEDEL-------FDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 11/142 (7%)
Query: 432 LVGVIQTSTRTTVIVVKKL--DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489
++G + + +VVK+L Q+ + +F E H NL++ LG C E
Sbjct: 12 ILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY 70
Query: 490 LLVYKFLNNGTLASFL-----FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIK 544
LLV +F G L +L E + P +A +IA GLLHLH N IH D+
Sbjct: 71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLA 127
Query: 545 PQNILLDDYYNAQISDFGLAKL 566
+N LL +I D+GL+
Sbjct: 128 LRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 32/103 (31%), Positives = 55/103 (53%), Gaps = 16/103 (15%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+QI RGL +LH S+ +IH D+KP NIL++ + +I DFGLA+ + ++ +
Sbjct: 108 FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK---- 160
Query: 579 IRGTKGYVASPEWFR-------NSTITANVDVYSFGVLLLEII 614
YV + W+R +S T +D++S G + E++
Sbjct: 161 -GFLTEYVVT-RWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 24/174 (13%)
Query: 520 AFQIARGLLHLHV-NCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+ Q+A+G+ L NC IH D+ +N+LL D A+I DFGLA+ + + + +K
Sbjct: 218 SSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273
Query: 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFD 637
R ++A PE + T DV+S+G+LL EI S KS Y IL + F
Sbjct: 274 ARLPVKWMA-PESIFDCVYTVQSDVWSYGILLWEIFSLGKS-------PYPGILVNSKF- 324
Query: 638 CYRNGKLDDLVEGDMEAMNDIKCVE-KLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
Y+ K G + D E +M W + +P+ RPT ++SQ+++
Sbjct: 325 -YKMVK-----RGYQMSRPDFAPPEIYSIMKMCWNL--EPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 40/139 (28%), Positives = 61/139 (43%), Gaps = 9/139 (6%)
Query: 432 LVGVIQTSTRTTVIVVKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490
L+G +VVK+L D + F EV + H N+++ LG C E L
Sbjct: 12 LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71
Query: 491 LVYKFLNNGTLASFL-----FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKP 545
LV +F G L ++L ++ +A ++A GLL LH IH D+
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLAL 128
Query: 546 QNILLDDYYNAQISDFGLA 564
+N L + +I D+GLA
Sbjct: 129 RNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 35/236 (14%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENL-KPGWNLRA 517
KE +E ++ + ++ RLLG C +L + + + G L ++ E+ G
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLL 112
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577
N QIA+G+ +L +++H D+ +N+L+ + +I+DFGLAKLL A +K
Sbjct: 113 NWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-----ADEK 164
Query: 578 AIRGTKGYVA----SPEWFRNSTITANVDVYSFGVLLLEIISC-RKSFD-IEMGEEYAIL 631
G V + E + T DV+S+GV + E+++ K +D I E +IL
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224
Query: 632 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVE-KLVMVSIWCIQEDPSLRPTMRKVS 686
+G+ I ++ ++MV W I D RP R++
Sbjct: 225 E----------------KGERLPQPPICTIDVYMIMVKCWMI--DADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 473 HKNLVRLLGFC-----DEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIAR 525
H N+VRL C D LV++ ++ L ++L + +PG ++ FQ+ R
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 526 GLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGY 585
GL LH S +++H D+KPQNIL+ +++DFGLA++ + + ++ T Y
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 175
Query: 586 VASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
A PE S+ VD++S G + E+ + F
Sbjct: 176 RA-PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 37/94 (39%), Positives = 58/94 (61%), Gaps = 6/94 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
++A L HLH S II+ D+KP+NILLD+ + +++DFGL+K ++ KA + G
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCG 160
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
T Y+A PE T + D +SFGVL+ E+++
Sbjct: 161 TVEYMA-PEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 420 VLLGSSVFVNFTLV--GVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHK--- 474
V LGS NF V GV + + + +K L + EK ++E++ + H+
Sbjct: 1 VELGSG---NFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMHQLDN 54
Query: 475 -NLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF--ENLKPGWNLRANIAFQIARGLLHLH 531
+VR++G C E + +LV + + G L FL ++ N+ + Q++ G+ +L
Sbjct: 55 PYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV-VELMHQVSMGMKYLE 112
Query: 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS--KAIKKAIRGTKGYVASP 589
+H D+ +N+LL + + A+ISDFGL+K L + S KA K Y +P
Sbjct: 113 ---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY--AP 167
Query: 590 EWFRNSTITANVDVYSFGVLLLEIIS 615
E ++ DV+S+G+ + E S
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 45/170 (26%), Positives = 85/170 (50%), Gaps = 7/170 (4%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+ +K+++ Q ++ NE++++ + + N+V L G +V ++L G+L
Sbjct: 47 VAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 106
Query: 505 LFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
+ E + A + + + L LH S+Q+IH DIK NILL + +++DFG
Sbjct: 107 VTETCMDEGQIAA-VCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162
Query: 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+T QSK + + GT Y +PE VD++S G++ +E++
Sbjct: 163 AQITPEQSK--RSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 18/115 (15%)
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
+QI GL ++H S+ ++H D+KP N+L++ +I DFGLA+ + N +
Sbjct: 112 YQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF--- 165
Query: 581 GTKGYVASPEWFR-------NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY 628
YVA+ W+R + T +DV+S G +L E++ + F G++Y
Sbjct: 166 -MTEYVAT-RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF---KGKDY 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 18/182 (9%)
Query: 444 VIVVKK--LDRVFQDG-EKEFKN---EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497
+I VK+ LD EKE++ EV ++ H N+V+ LG C + + +F+
Sbjct: 26 LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVP 85
Query: 498 NGTLASFL--FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
G+++S L F L P QI G+ +LH NC ++H DIK N++L
Sbjct: 86 GGSISSILNRFGPL-PEPVFC-KYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGI 140
Query: 556 AQISDFGLAKLL---TLNQSKA-IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611
++ DFG A+ L L+ + + + K++ GT Y +PE S D++S G +
Sbjct: 141 IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP-YWMAPEVINESGYGRKSDIWSIGCTVF 199
Query: 612 EI 613
E+
Sbjct: 200 EM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 45/170 (26%), Positives = 85/170 (50%), Gaps = 7/170 (4%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+ +++++ Q ++ NE++++ + + N+V L G +V ++L G+L
Sbjct: 48 VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 505 LFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
+ E + A + + + L LH S+Q+IH DIK NILL + +++DFG
Sbjct: 108 VTETCMDEGQIAA-VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+T QSK + + GT Y +PE VD++S G++ +E+I
Sbjct: 164 AQITPEQSK--RSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 51/182 (28%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
+T V V + + Q+ + +F +E ++ Q H N+V+L+G C + Q +V + + G
Sbjct: 19 KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78
Query: 501 LASFLF---ENLKPGWNLRANIAFQIARGLLHLHV-NCSSQIIHCDIKPQNILLDDYYNA 556
SFL + LK ++ A A G+ +L NC IH D+ +N L+ +
Sbjct: 79 FLSFLRKKKDELKTKQLVK--FALDAAAGMAYLESKNC----IHRDLAARNCLVGENNVL 132
Query: 557 QISDFGLAKLLT--LNQSKAIKK-AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
+ISDFG+++ + S +K+ I+ T +PE ++ DV+S+G+LL E
Sbjct: 133 KISDFGMSRQEDDGIYSSSGLKQIPIKWT-----APEALNYGRYSSESDVWSYGILLWET 187
Query: 614 IS 615
S
Sbjct: 188 FS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 44/204 (21%)
Query: 440 TRTTVIVVKKLDRVFQ---DGEKEFKNEVVMIGQ-TYHKNLVRLLGFCDEGQNRLLVYKF 495
T+ V +KK+ F+ D ++ F+ E++ + + H N+V+LL V K
Sbjct: 31 TKEVV-ALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLLN----------VIKA 78
Query: 496 LNNGTLASFL-FENLKPGWN--LRAN---------IAFQIARGLLHLHVNCSSQIIHCDI 543
N+ + +L FE ++ + +RAN I +Q+ + L ++H S +IH D+
Sbjct: 79 ENDKDI--YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDL 133
Query: 544 KPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI------ 597
KP NILL+ +++DFGLA+ +L++ + + T YVA+ W+R I
Sbjct: 134 KPSNILLNSDCRVKLADFGLAR--SLSELEENPENPVLTD-YVAT-RWYRAPEILLGSTR 189
Query: 598 -TANVDVYSFGVLLLEIISCRKSF 620
T VD++S G +L E++ + F
Sbjct: 190 YTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 8/186 (4%)
Query: 434 GVIQTSTRTTVIV-VKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
G TS + V VK L D +F E ++ H+NL+RL G ++
Sbjct: 14 GEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMM 72
Query: 492 VYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
V + G+L L ++ + + + A QIA G+ +L S + IH D+ +NIL
Sbjct: 73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNIL 129
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVL 609
L +I DFGL + L N+ + + +PE R T + DV+ FGV
Sbjct: 130 LASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVT 189
Query: 610 LLEIIS 615
L E+ +
Sbjct: 190 LWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 47/167 (28%), Positives = 84/167 (50%), Gaps = 24/167 (14%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRL-LVYKFLNNGTLASFLFENLKPG--WNLRANIA 520
E+ ++ + H N+V+LL +N+L LV++FL+ L F+ + G L +
Sbjct: 49 EISLLKELNHPNIVKLLDVI-HTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYL 106
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
FQ+ +GL H S +++H D+KPQN+L++ +++DFGLA +A +R
Sbjct: 107 FQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVR 155
Query: 581 GTKGYVASPEWFRNSTI-------TANVDVYSFGVLLLEIISCRKSF 620
V + W+R I + VD++S G + E+++ R F
Sbjct: 156 TYTHEVVT-LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 21/228 (9%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENL-KPGWNLRA 517
KE +E ++ + RLLG C +L V + + G L ++ EN + G
Sbjct: 54 KEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLL 112
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577
N QIA+G+ +L +++H D+ +N+L+ + +I+DFGLA+LL +++++
Sbjct: 113 NWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD 169
Query: 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637
+ ++A T DV+S+GV + E++ +F + +D
Sbjct: 170 GGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELM----TFGAK-----------PYD 213
Query: 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKV 685
++ DL+E C + M+ + C D RP R++
Sbjct: 214 GIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFREL 261
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 37/199 (18%)
Query: 440 TRTTV-IVVKKLDRVFQD--GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496
T+T + + VKKL R FQ K E+ ++ H+N++ LL ++ +
Sbjct: 39 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS----LEEF 94
Query: 497 NNGTLASFL----FENLKPGWNLRAN----IAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548
N+ L + L N+ L + + +QI RGL ++H S+ IIH D+KP N+
Sbjct: 95 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNL 151
Query: 549 LLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN-------V 601
+++ +I DFGLA+ + GYVA+ W+R I N V
Sbjct: 152 AVNEDCELKILDFGLARHTDDEMT-----------GYVAT-RWYRAPEIMLNWMHYNQTV 199
Query: 602 DVYSFGVLLLEIISCRKSF 620
D++S G ++ E+++ R F
Sbjct: 200 DIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 46/178 (25%), Positives = 88/178 (49%), Gaps = 20/178 (11%)
Query: 443 TVIVVKKLDRVFQDGEKEFKN---EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
V+ +K +D ++ E E ++ E+ ++ Q + + G +G ++ ++L G
Sbjct: 30 QVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87
Query: 500 TLASFL----FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
+ L F+ + L+ +I +GL +LH S + IH DIK N+LL + +
Sbjct: 88 SALDLLRAGPFDEFQIATMLK-----EILKGLDYLH---SEKKIHRDIKAANVLLSEQGD 139
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
+++DFG+A LT Q K + GT ++A PE + S + D++S G+ +E+
Sbjct: 140 VKLADFGVAGQLTDTQIK--RNTFVGTPFWMA-PEVIQQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 50/184 (27%), Positives = 89/184 (48%), Gaps = 8/184 (4%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490
T+ I +T V +K+++ Q ++ NE++++ + H N+V L G
Sbjct: 34 TVYTAIDVATGQEV-AIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
+V ++L G+L + E + A + + + L LH N Q+IH DIK NILL
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIHRDIKSDNILL 148
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+ +++DFG +T QSK + + GT Y +PE VD++S G++
Sbjct: 149 GMDGSVKLTDFGFCAQITPEQSK--RSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 611 LEII 614
+E++
Sbjct: 206 IEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
+FQ+ARG+ L S + IH D+ +NILL + +I DFGLA+ + + K
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
R ++A PE + T DV+SFGVLL EI S
Sbjct: 236 RLPLKWMA-PESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 10/117 (8%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
A +I GL LH II+ D+K N+LLD + +I+DFG+ K L
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STF 156
Query: 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY---AILTD 633
GT Y+A PE VD ++ GVLL E+++ + F+ + E+ +IL D
Sbjct: 157 CGTPDYIA-PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSILED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 36/113 (31%), Positives = 57/113 (50%), Gaps = 30/113 (26%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA----KLLTLNQSKA 574
+ +QI RGL ++H S+ IIH D+KP NI +++ +I DFGLA +T
Sbjct: 123 LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT------ 173
Query: 575 IKKAIRGTKGYVASPEWFRNSTITAN-------VDVYSFGVLLLEIISCRKSF 620
GYVA+ W+R I N VD++S G ++ E+++ + F
Sbjct: 174 ---------GYVAT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 33/197 (16%)
Query: 440 TRT-TVIVVKKLDRVFQDG--EKEFKNEVVMIGQTYHKNLVRLLGF------CDEGQNRL 490
RT + +KKL R FQ K E+ ++ H+N++ LL D +
Sbjct: 37 RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
LV F+ GT L ++ K + + +Q+ +GL ++H ++ IIH D+KP N+ +
Sbjct: 97 LVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAV 151
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-------TANVDV 603
++ +I DFGLA ++ GYV + W+R + T VD+
Sbjct: 152 NEDCELKILDFGLA-----------RQTDSEMTGYVVT-RWYRAPEVILNWMHYTQTVDI 199
Query: 604 YSFGVLLLEIISCRKSF 620
+S G ++ E+++ + F
Sbjct: 200 WSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 27/195 (13%)
Query: 441 RTTVIVVKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
+T + +K L D+ +EFK+E +M + H N+V LLG + Q +++ + ++
Sbjct: 34 QTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 500 TLASFLF------------------ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHC 541
L FL L+P + +I QIA G+ L S ++H
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV--HIVTQIAAGMEFL---SSHHVVHK 148
Query: 542 DIKPQNILLDDYYNAQISDFGLAK-LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN 600
D+ +N+L+ D N +ISD GL + + + K + ++ + SPE + +
Sbjct: 149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRW--MSPEAIMYGKFSID 206
Query: 601 VDVYSFGVLLLEIIS 615
D++S+GV+L E+ S
Sbjct: 207 SDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 44/215 (20%)
Query: 430 FTLVGVIQTST----------RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQ-TYHKNLVR 478
F LV V+ T +T + K+ V +D E+E K E+ M+ + ++H+N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 479 LLG-FCDE---GQNR--LLVYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLL 528
G F + G + LV +F G++ + LK W A I +I RGL
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLA 135
Query: 529 HLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVAS 588
HLH + ++IH DIK QN+LL + ++ DFG+ S + + + ++ +
Sbjct: 136 HLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV--------SAQLDRTVGRRNTFIGT 184
Query: 589 PEWFR----------NSTITANVDVYSFGVLLLEI 613
P W ++T D++S G+ +E+
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 46/216 (21%)
Query: 430 FTLVGVIQTST----------RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQ-TYHKNLVR 478
F LV VI T +T +V K+ + +D E+E K E ++ + + H N+
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIAT 67
Query: 479 LLG-------FCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRAN-IAF---QIARG 526
G ++ Q L LV + G++ + K G L+ IA+ + RG
Sbjct: 68 FYGAFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 527 LLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV 586
L +LH N ++IH DIK QNILL ++ DFG++ L + R T ++
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR------RNT--FI 174
Query: 587 ASPEWF----------RNSTITANVDVYSFGVLLLE 612
+P W +++ A DV+S G+ +E
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 51/216 (23%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 429 NFTLVGVIQTSTRTTVIVVKKLDR----VFQDGEKEFK-NEVVMIGQTYHKNLVRLLGFC 483
+T++ + + V V K + V + G+K E +++ H +++R+
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTL 126
Query: 484 DEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAF----QIARGLLHLHVNCSSQII 539
G +V ++ L ++L + +P L + A QI GL +LH + +II
Sbjct: 127 VSGAITCMVLPHYSS-DLYTYLTKRSRP---LPIDQALIIEKQILEGLRYLH---AQRII 179
Query: 540 HCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA--SPEWFRNSTI 597
H D+K +NI ++D I D G A Q + A G G V +PE
Sbjct: 180 HRDVKTENIFINDVDQVCIGDLGAA------QFPVVAPAFLGLAGTVETNAPEVLARDKY 233
Query: 598 TANVDVYSFGVLLLEIISCRKS-FDIE--MGEEYAI 630
+ D++S G++L E+++ + F+ EEY
Sbjct: 234 NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269
|
Length = 357 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 47/176 (26%), Positives = 87/176 (49%), Gaps = 18/176 (10%)
Query: 444 VIVVKKLDRVFQDGEKEFKN---EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
V+ +K +D ++ E E ++ E+ ++ Q + + G + ++ ++L G+
Sbjct: 31 VVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88
Query: 501 LASFLFENLKPG---WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
L +PG A I +I +GL +LH S + IH DIK N+LL ++ +
Sbjct: 89 ALDLL----EPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVK 141
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
++DFG+A LT Q K + GT ++A PE + S + D++S G+ +E+
Sbjct: 142 LADFGVAGQLTDTQIK--RNTFVGTPFWMA-PEVIKQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 22/172 (12%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
+FQ+A+G+ L S + IH D+ +NILL + +I DFGLA+ + + K
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFD 637
R ++A PE + T DV+SFGVLL EI S S +++ EE+
Sbjct: 242 RLPLKWMA-PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--------- 291
Query: 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689
C R L EG D E + + C +PS RPT ++ + L
Sbjct: 292 CRR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 33/97 (34%), Positives = 56/97 (57%), Gaps = 6/97 (6%)
Query: 517 ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
A I +Q +GL +LH S++ IH DIK NILL++ A+++DFG++ LT +K +
Sbjct: 102 AAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--R 156
Query: 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
+ GT ++A PE + D++S G+ +E+
Sbjct: 157 NTVIGTPFWMA-PEVIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 18/173 (10%)
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577
+ ++Q+A+G+ L S IH D+ +NILL +I DFGLA+ + + + +K
Sbjct: 218 SFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637
R ++A PE N T DV+S+G+LL EI S S M + +
Sbjct: 275 NARLPVKWMA-PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-----YK 328
Query: 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ G E M DI M S W DP RPT +++ Q++E
Sbjct: 329 MIKEGYRMLSPECAPSEMYDI-------MKSCW--DADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 50/178 (28%), Positives = 86/178 (48%), Gaps = 18/178 (10%)
Query: 445 IVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLGF------CDEGQNRLLVYKFL 496
+ +KKL R FQ+ K E+V++ HKN++ LL +E Q+ LV + +
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104
Query: 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
+ L + ++ + + +Q+ G+ HLH S+ IIH D+KP NI++
Sbjct: 105 D-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 158
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+I DFGLA+ T S + + Y +PE NVD++S G ++ E++
Sbjct: 159 KILDFGLAR--TAGTSFMMTPYV--VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 61/258 (23%), Positives = 122/258 (47%), Gaps = 65/258 (25%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANIA-- 520
E+ ++ + H N+V L + ++RL L+++FL+ L +L ++L G + A +
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKS 105
Query: 521 --FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+QI +G+L H S +++H D+KPQN+L+D+ +++DFGLA +A
Sbjct: 106 YLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLA--------RAFGIP 154
Query: 579 IRGTKGYVASPE----WFRNSTI-------TANVDVYSFGVLLLEIISCRKSF--DIEMG 625
+R V + E W+R + + VD++S G + E+ + + F D E+
Sbjct: 155 VR-----VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID 209
Query: 626 EEYAI-----------------LTDW--AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVM 666
+ + I L D+ F ++ G L V+ +++ + + +EK+++
Sbjct: 210 QLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVK-NLDE-DGLDLLEKMLI 267
Query: 667 VSIWCIQEDPSLRPTMRK 684
DP+ R + +K
Sbjct: 268 Y-------DPAKRISAKK 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 18/198 (9%)
Query: 437 QTSTRTTVIVVKKLDRVFQDGEKE---FKNEVVMIGQTYHKNLVRLLGFCDEGQNRL-LV 492
+ + I + K D + QD + E + V+ + + L C + +RL V
Sbjct: 22 KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP--FLTQLHSCFQTMDRLYFV 79
Query: 493 YKFLNNGTLASFLFENLKPGWNLRANIAF---QIARGLLHLHVNCSSQIIHCDIKPQNIL 549
+++N G L ++ + G + F +IA GL LH S II+ D+K N++
Sbjct: 80 MEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVM 133
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVL 609
LD + +I+DFG+ K + GT Y+A PE +VD ++FGVL
Sbjct: 134 LDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIA-PEIIAYQPYGKSVDWWAFGVL 190
Query: 610 LLEIISCRKSFDIEMGEE 627
L E+++ + FD E +E
Sbjct: 191 LYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 49/179 (27%), Positives = 87/179 (48%), Gaps = 25/179 (13%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR--ANIAF 521
E+ ++ + H N+VRL + LV+++L+ L + + N R +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA-QISDFGLAKLLTLNQSKAIKKAIR 580
QI RG+ + H S +++H D+KPQN+L+D NA +++DFGLA +A +R
Sbjct: 110 QILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLA--------RAFGIPVR 158
Query: 581 GTKGYVASPEWFRNSTI-------TANVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 630
V + W+R I + VD++S G + E+++ + F D E+ E + I
Sbjct: 159 TFTHEVVT-LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216
|
Length = 294 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 49/196 (25%), Positives = 90/196 (45%), Gaps = 29/196 (14%)
Query: 442 TTVIVVKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
++ VK L + ++F EV ++ + N+ RLLG C ++ +++ NG
Sbjct: 46 PVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 501 LASFLFENLKPGWNLRAN-----------IAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
L FL +++ L N +A QIA G+ +L S +H D+ +N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCL 162
Query: 550 LDDYYNAQISDFGLAK-LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-----TANVDV 603
+ Y +I+DFG+++ L + + + ++G W ++ T DV
Sbjct: 163 VGKNYTIKIADFGMSRNLYSSDYYR-----VQGRA--PLPIRWMAWESVLLGKFTTKSDV 215
Query: 604 YSFGVLLLEIIS-CRK 618
++FGV L EI++ CR+
Sbjct: 216 WAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 28/176 (15%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
IA I + L +LH S +IH D+KP N+L++ ++ DFG++ L + +K I
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA- 164
Query: 579 IRGTKGYVASPEWFRNSTITA--NV--DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 634
G K Y+A PE +V DV+S G+ ++E+ A +
Sbjct: 165 --GCKPYMA-PERINPELNQKGYDVKSDVWSLGITMIEL---------------ATGR-F 205
Query: 635 AFDCYRN--GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688
+D ++ +L +VE + K + C++++ RP ++ Q
Sbjct: 206 PYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 50/178 (28%), Positives = 86/178 (48%), Gaps = 18/178 (10%)
Query: 445 IVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLGF------CDEGQNRLLVYKFL 496
+ +KKL R FQ+ K E+V++ HKN++ LL +E Q+ +V + +
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
+ L + ++ + + +Q+ G+ HLH S+ IIH D+KP NI++
Sbjct: 112 D-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 165
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+I DFGLA+ T S + + Y +PE NVD++S G ++ E+I
Sbjct: 166 KILDFGLAR--TAGTSFMMTPYV--VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 3e-08
Identities = 32/104 (30%), Positives = 60/104 (57%), Gaps = 8/104 (7%)
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577
+I +QI +GL H+H + H D+KP+N+L+ +I+DFGLA+ + +S+
Sbjct: 103 SIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYT 156
Query: 578 AIRGTKGYVASPEWF-RNSTITANVDVYSFGVLLLEIISCRKSF 620
T+ Y A PE R+++ ++ VD+++ G ++ E+ + R F
Sbjct: 157 DYVSTRWYRA-PEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 39/157 (24%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN-IAFQIARGLLHLH 531
H +V+LL G +LV +++ L+ L + +P + + +G+ ++H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEW 591
++ I+H D+KP N+L+ +I+DFGLA+L + + + + T+ Y A PE
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRA-PEL 171
Query: 592 FRNS-TITANVDVYSFGVLLLEIISCRKSF----DIE 623
+ VD+++ G + E+++ F DIE
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
+Q+ RGL ++H S+ ++H D+KP N+LL+ + +I DFGLA+ T ++
Sbjct: 115 YQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYV 169
Query: 581 GTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
T+ Y A S T +DV+S G + E++
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 26/172 (15%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR------LLVYKFLNNGTLASFLFEN---- 508
++F +E V + + H N++RL+G C + +++ F+ +G L SFL +
Sbjct: 45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104
Query: 509 ---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
P L + IA G+ +L S IH D+ +N +L++ N ++DFGL+K
Sbjct: 105 CPQYLPTQMLVKFMT-DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
Query: 566 LL----TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
+ Q + K ++ ++A E + T DV+SFGV + EI
Sbjct: 161 KIYNGDYYRQGRIAKMPVK----WIAI-ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 47/178 (26%), Positives = 69/178 (38%), Gaps = 43/178 (24%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ L H+H S +I+H DIKP N+ + ++ D GL + + + A G
Sbjct: 114 QLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--G 168
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF------------DIEMGEEYA 629
T Y+ SPE + D++S G LL E+ + + F IE +Y
Sbjct: 169 TPYYM-SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYP 226
Query: 630 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687
L D Y + +L DLV CI DP RP + V Q
Sbjct: 227 PLPA---DHY-SEELRDLVSR--------------------CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 7/101 (6%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
A +I GL H+H + +++ D+KP NILLD++ + +ISD GLA + SK A
Sbjct: 103 ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 155
Query: 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
GT GY+A + + ++ D +S G +L +++ F
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 33/107 (30%), Positives = 60/107 (56%), Gaps = 15/107 (14%)
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
+Q+ RGL ++H S+ +IH D+KP N+L+++ +I DFG+A+ L+ S +
Sbjct: 114 YQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS---SSPTEHKYF 167
Query: 581 GTKGYVASPEWFRNSTI-------TANVDVYSFGVLLLEIISCRKSF 620
T+ YVA+ W+R + T +D++S G + E++ R+ F
Sbjct: 168 MTE-YVAT-RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 15/161 (9%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLL--VYKFLNNGTLASFLFENLKPGWNLRANI-- 519
E+ ++ H+ +V+ G + R L + + G++ + LK L N+
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTR 109
Query: 520 --AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK-LLTLNQSKAIK 576
QI G+ +LH N I+H DIK NIL D N ++ DFG +K L T+ S
Sbjct: 110 KYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166
Query: 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
K++ GT Y SPE D++S G ++E+++ +
Sbjct: 167 KSVTGTP-YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 5e-08
Identities = 20/47 (42%), Positives = 30/47 (63%), Gaps = 3/47 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568
Q+ GL +LH N I+H DIK NIL+++ +++DFGLA+ T
Sbjct: 108 QLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 34/194 (17%)
Query: 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQ-TYHKNLVRLLG-FCDEGQNRL-----LVY 493
+T + K+ V D E+E K E+ M+ + ++H+N+ G F + + LV
Sbjct: 29 KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88
Query: 494 KFLNNGTLASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
+F G++ L +N K G L+ A I +I RGL HLH ++IH DIK QN+L
Sbjct: 89 EFCGAGSVTD-LIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVL 143
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN--------- 600
L + ++ DFG+ S + + + ++ +P W I +
Sbjct: 144 LTENAEVKLVDFGV--------SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF 195
Query: 601 -VDVYSFGVLLLEI 613
D++S G+ +E+
Sbjct: 196 KSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 44/175 (25%), Positives = 82/175 (46%), Gaps = 18/175 (10%)
Query: 455 QDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN----L 509
++ ++F E+ V+ +H N++ LLG C+ + ++ G L FL ++
Sbjct: 43 ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLET 102
Query: 510 KPGWNLRANIAFQI-ARGLLHLHVNCSS--------QIIHCDIKPQNILLDDYYNAQISD 560
P + A + ++ LL + ++ Q IH D+ +N+L+ + ++I+D
Sbjct: 103 DPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD 162
Query: 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
FGL++ + +KK + + E S T DV+SFGVLL EI+S
Sbjct: 163 FGLSR----GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKN-EVVMIGQTYHKNLVR 478
++LG F L T + ++KK D V QD + E E ++ + +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKK-DVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 479 LLGFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANIAF---QIARGLLHLHVNC 534
L C + +RL V +++N G L +++ + G + F +IA GL LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH--- 118
Query: 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN 594
S II+ D+K N++LD + +I+DFG+ K + K GT Y+A PE
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIA-PEIIAY 175
Query: 595 STITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627
+VD ++FGVLL E+++ + F+ E +E
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 7/104 (6%)
Query: 530 LHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASP 589
LH + II+ D+KP+N+LLD ++ DFG AK L +S GT YVA P
Sbjct: 109 LH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVA-P 161
Query: 590 EWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 633
E N +VD +S G+LL E+++ R F + + I D
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 47/133 (35%), Positives = 70/133 (52%), Gaps = 10/133 (7%)
Query: 490 LLVYKFLNNGTLASFLFENLKPGWNL-RANI-AFQIARGLLHLHVNCSSQIIHCDIKPQN 547
V +FLN G L + + K ++L RA A +I GL LH S II+ D+K N
Sbjct: 72 FFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDN 126
Query: 548 ILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFG 607
++LD + +I+DFG+ K ++A GT Y+A PE + T +VD +SFG
Sbjct: 127 VMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIA-PEILQGLKYTFSVDWWSFG 183
Query: 608 VLLLEIISCRKSF 620
VLL E++ + F
Sbjct: 184 VLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 53/192 (27%), Positives = 82/192 (42%), Gaps = 33/192 (17%)
Query: 446 VVKKLD--RVFQDGEKEFKNEVVMIGQTYHKNLVR--------------LLGFCDEGQNR 489
V+KKL+ + K + E ++ Q H N+V ++GFC+ G
Sbjct: 29 VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGD-- 86
Query: 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
+Y L L EN W + QIA L +LH I+H D+K QN+
Sbjct: 87 --LYHKLKEQK-GKLLPENQVVEWFV------QIAMALQYLH---EKHILHRDLKTQNVF 134
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVL 609
L ++ D G+A++L NQ I GT Y SPE F N DV++ G
Sbjct: 135 LTRTNIIKVGDLGIARVLE-NQCDMASTLI-GTP-YYMSPELFSNKPYNYKSDVWALGCC 191
Query: 610 LLEIISCRKSFD 621
+ E+ + + +F+
Sbjct: 192 VYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 21/165 (12%)
Query: 460 EFKNEVVMIGQTYH---KNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR 516
+ + EV ++ Q N+ + G +G ++ ++ G++ + + K G
Sbjct: 45 DIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAE 100
Query: 517 ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
I+ I L+ L +IH DIK NIL+ + N ++ DFG+A LL N SK
Sbjct: 101 KYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--- 157
Query: 577 KAIRGTKGYVASPEWFRNSTIT------ANVDVYSFGVLLLEIIS 615
R T +V +P W IT D++S G+ + E+ +
Sbjct: 158 ---RST--FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT 197
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
A +I GL H+H +++ D+KP NILLD++ + +ISD GLA + SK A
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 155
Query: 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
GT GY+A + ++ D +S G +L +++
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 49/146 (33%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
LV F+N G L F +L + G + F A L L +I+ D+KP+NIL
Sbjct: 70 LVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENIL 125
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVL 609
LD + + DFGL KL + K GT Y+A PE T VD ++ GVL
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDDKT--NTFCGTPEYLA-PELLLGHGYTKAVDWWTLGVL 182
Query: 610 LLEIISCRKSF-DIEMGEEY-AILTD 633
L E+++ F D + E Y IL +
Sbjct: 183 LYEMLTGLPPFYDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 51/175 (29%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 455 QDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN----L 509
+D ++F E+ V+ +H N++ LLG C+ L ++ +G L FL ++
Sbjct: 36 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 95
Query: 510 KPGWNLRANIAFQIA-RGLLHLHVNCSS--------QIIHCDIKPQNILLDDYYNAQISD 560
P + + + A ++ + LLH + + Q IH D+ +NIL+ + Y A+I+D
Sbjct: 96 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155
Query: 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
FGL++ Q +KK + + E S T N DV+S+GVLL EI+S
Sbjct: 156 FGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 42/196 (21%)
Query: 439 STRTTVIVVKKLDRVFQD--GEKEFKNEVVMIGQTYHKNLVRLLG-FC-----DEGQNRL 490
+ + +KKL R FQ+ K E+V++ HKN++ LL F +E Q+
Sbjct: 38 TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97
Query: 491 LVYKF------------LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQI 538
LV + L++ ++ L+ Q+ G+ HLH S+ I
Sbjct: 98 LVMELMDANLCQVIQMDLDHERMSYLLY---------------QMLCGIKHLH---SAGI 139
Query: 539 IHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTIT 598
IH D+KP NI++ +I DFGLA+ T S + + T+ Y A PE
Sbjct: 140 IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRYYRA-PEVILGMGYK 195
Query: 599 ANVDVYSFGVLLLEII 614
NVD++S G ++ E+I
Sbjct: 196 ENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 35/199 (17%)
Query: 438 TSTRTTVIVVKKLDRVFQD--GEKEFKNEVVMIGQTYHKNLVRLLGF---CDEGQNRLLV 492
T R V VKKL R FQ + E+ ++ H+N++ LL +N V
Sbjct: 37 TRLRQKV-AVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95
Query: 493 YKFLNNGTLASFLFENLKPGWNLRAN----IAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548
Y N L N+ L + +Q+ RGL ++H S+ IIH D+KP N+
Sbjct: 96 YLVTN---LMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNV 149
Query: 549 LLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN-------V 601
+++ +I DFGLA ++A GYVA+ W+R I N V
Sbjct: 150 AVNEDCELRILDFGLA-----------RQADDEMTGYVAT-RWYRAPEIMLNWMHYNQTV 197
Query: 602 DVYSFGVLLLEIISCRKSF 620
D++S G ++ E++ + F
Sbjct: 198 DIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 47/170 (27%), Positives = 85/170 (50%), Gaps = 31/170 (18%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFE--NLKPGWNLRANIAF 521
EV ++ H N+V L + LV+++L++ L +L NL N++ F
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMF 110
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ RGL + H +I+H D+KPQN+L+++ +++DFGLA+ +K++
Sbjct: 111 QLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR------AKSVP----- 156
Query: 582 TKGYVASPE----WFR-------NSTITANVDVYSFGVLLLEIISCRKSF 620
TK Y S E W+R ++ + +D++ G +L E+ + R F
Sbjct: 157 TKTY--SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKE--FKNEVVMIGQTYHKNLVR 478
+LG F L + ++ V V+KK D + QD + E + ++ H L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 479 LLGFCDEGQNRLL-VYKFLNNGTLASFLFENLKPGWNLRANI-AFQIARGLLHLHVNCSS 536
L C + +RL V +F+N G L F + + RA A +I L+ LH
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARFYAAEITSALMFLH---DK 115
Query: 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST 596
II+ D+K N+LLD + +++DFG+ K N GT Y+A PE +
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIA-PEILQEML 172
Query: 597 ITANVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 633
+VD ++ GVLL E++ F+ E ++ AIL D
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 10/97 (10%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANI----AFQIARGLL 528
H N+VRLL LV++FL+ L ++ + P L + +Q+ +G+
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 529 HLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
+ H S +++H D+KPQN+L+D +++DFGLA+
Sbjct: 114 YCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 37/128 (28%), Positives = 53/128 (41%), Gaps = 15/128 (11%)
Query: 505 LFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-YNAQIS 559
LF+ LK L I Q+ L LH + IIH DIK +N+L D +
Sbjct: 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
D+GL K GT Y SPE + + D ++ GVL E+++ +
Sbjct: 153 DYGLCK------IIGTPSCYDGTLDYF-SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
Query: 620 FDIEMGEE 627
F + EE
Sbjct: 206 FKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 36/199 (18%)
Query: 445 IVVKKLDRVFQDG--EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
+ +KKL R FQ K E+ ++ H+N++ LL D + + +F + +
Sbjct: 43 VAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL---DVFTSAVSGDEFQDFYLVM 99
Query: 503 SFLFENLKP--GWNLRAN----IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
++ +L+ G L + + +Q+ GL ++H S+ IIH D+KP N+ +++
Sbjct: 100 PYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCEL 156
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN-------VDVYSFGVL 609
+I DFGLA + A GYV + W+R + N VD++S G +
Sbjct: 157 KILDFGLA-----------RHADAEMTGYVVT-RWYRAPEVILNWMHYNQTVDIWSVGCI 204
Query: 610 LLEIISCRKSFDIEMGEEY 628
+ E+++ + F G++Y
Sbjct: 205 MAEMLTGKTLFK---GKDY 220
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 30/176 (17%)
Query: 514 NLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573
++ I + + +GL L IIH D+KP N+L++ ++ DFG++ N
Sbjct: 102 DVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG----NLVA 155
Query: 574 AIKKAIRGTKGYVASPEWFR------NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627
++ K G + Y+A PE + N T T DV+S G+ +LE+ R + E
Sbjct: 156 SLAKTNIGCQSYMA-PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--- 211
Query: 628 YAILTDWAFDCYRN--GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681
Y N +L +V+GD + + V+ C+ + P+ RPT
Sbjct: 212 -----------YANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 464 EVVMIGQTYHKNLVRLLG-FCDEGQNRLLVY-KFLNNGTLASFLFENLKPGWNLRANIAF 521
E+ ++ H+ +V+ G D + L ++ +++ G++ + LK L ++
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTR 109
Query: 522 ----QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK-LLTLNQSKAIK 576
QI G+ +LH N I+H DIK NIL D N ++ DFG +K L T+ S
Sbjct: 110 KYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
+++ GT Y SPE DV+S G ++E+++
Sbjct: 167 RSVTGTP-YWMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 45/134 (33%), Positives = 64/134 (47%), Gaps = 6/134 (4%)
Query: 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQ 546
+N V ++LN G L + K A +I GL LH S I++ D+K
Sbjct: 69 ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLD 125
Query: 547 NILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSF 606
NILLD + +I+DFG+ K L +K GT Y+A PE +VD +SF
Sbjct: 126 NILLDTDGHIKIADFGMCKENMLGDAKT--CTFCGTPDYIA-PEILLGQKYNTSVDWWSF 182
Query: 607 GVLLLEIISCRKSF 620
GVLL E++ + F
Sbjct: 183 GVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 9/211 (4%)
Query: 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKN-EVVMIGQTYHKNLV 477
++LG F L T + ++KK D V QD + E E ++ +
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKK-DVVIQDDDVECTMVEKRVLALQDKPPFL 63
Query: 478 RLLGFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS 536
L C + +RL V +++N G L + + K A +I+ GL LH
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RR 120
Query: 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST 596
II+ D+K N++LD + +I+DFG+ K ++ + GT Y+A PE
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIA-PEIIAYQP 177
Query: 597 ITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627
+VD +++GVLL E+++ + FD E +E
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 16/163 (9%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
IA + +GL +L S +I+H D+KP N+L++ ++ DFG++ L +I K
Sbjct: 100 IAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKT 152
Query: 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638
GT Y+A PE + DV+S G+ +E+ R + + +++ C
Sbjct: 153 YVGTNAYMA-PERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC 211
Query: 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681
+V+ D + + EK V C+++ P RP
Sbjct: 212 --------IVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 45/237 (18%)
Query: 456 DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNL 515
EK F E ++ Q H ++V+L+G E +V + G L S+L N K +L
Sbjct: 50 VREK-FLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDL 106
Query: 516 RANI--AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573
+ I ++Q++ L +L S + +H DI +N+L+ ++ DFGL++ L + +
Sbjct: 107 ASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDE 160
Query: 574 AIKKAIRGTKGYVA----SPEWFRNSTITANVDVYSFGVLLLEIISC-RKSFD------- 621
+ KA +KG + +PE T+ DV+ FGV + EI+ K F
Sbjct: 161 SYYKA---SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV 217
Query: 622 ---IEMGEE-----------YAILTD-WAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 663
IE GE Y+++T WA+D + + +L ++DI EK
Sbjct: 218 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELK----AQLSDILQEEK 270
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 59/271 (21%), Positives = 105/271 (38%), Gaps = 64/271 (23%)
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN------ 508
++ +F EV ++ + N++RLLG C + ++ +++ NG L FL +
Sbjct: 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119
Query: 509 -------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
++ ++A QIA G+ +L S +H D+ +N L+ +
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLT 176
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASP-EWFRNSTI-----TANVDVYSFGVL 609
+I+DFG+++ L I +G P W I T DV++FGV
Sbjct: 177 IKIADFGMSRNLYAGDYYRI-------QGRAVLPIRWMAWECILMGKFTTASDVWAFGVT 229
Query: 610 LLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK--------- 659
L EI+ C++ + Y LTD + ++E E D
Sbjct: 230 LWEILMLCKE-------QPYGELTD-----------EQVIENAGEFFRDQGRQVYLFRPP 271
Query: 660 -CVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689
C + L + + C D RP+ + L
Sbjct: 272 PCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 58/264 (21%), Positives = 112/264 (42%), Gaps = 55/264 (20%)
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWN 514
++ +F E+ ++ + N++RLL C ++ +++ NG L FL +
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 515 LRAN-----------IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563
+A+ +A QIA G+ +L S +H D+ +N L+ Y +I+DFG+
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-----TANVDVYSFGVLLLEIIS-CR 617
++ N I+G V W +I T DV++FGV L EI++ C+
Sbjct: 177 SR----NLYSGDYYRIQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230
Query: 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK----------CVEKLVMV 667
+ + Y+ L+D + ++E E D C + L +
Sbjct: 231 E-------QPYSQLSD-----------EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKL 272
Query: 668 SIWCIQEDPSLRPTMRKV-SQMLE 690
+ C + + RP+ +++ + +LE
Sbjct: 273 MLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 38/160 (23%), Positives = 83/160 (51%), Gaps = 9/160 (5%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPG---WNLRANIA 520
E+ ++ + H+N+VRL +LV+++++ L ++ + G N +
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
+Q+ +G+ H N +++H D+KPQN+L++ +++DFGLA+ + + + +
Sbjct: 107 YQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV- 162
Query: 581 GTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
T Y A + T + ++D++S G ++ E+I+ R F
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 54/241 (22%), Positives = 98/241 (40%), Gaps = 43/241 (17%)
Query: 461 FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL-----------FENL 509
F E + +GQ H N+VRL G G ++V ++++NG L SFL +
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112
Query: 510 KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569
PG +A G+ +L +H + +L++ +IS F L
Sbjct: 113 LPG----------LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQE 156
Query: 570 NQSKAIKKAIRGTKGYV-ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY 628
++S+AI + G + A+PE + ++ DV+SFG+++ E++S + +M +
Sbjct: 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216
Query: 629 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688
I VE C L + + C Q++ RP ++ +
Sbjct: 217 VI---------------KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSI 261
Query: 689 L 689
L
Sbjct: 262 L 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 29/102 (28%), Positives = 53/102 (51%), Gaps = 3/102 (2%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQI 523
E+ ++ + HKN+VRL + LV+++ + F N + + FQ+
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL 108
Query: 524 ARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
+GL H S ++H D+KPQN+L++ +++DFGLA+
Sbjct: 109 LKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 45/170 (26%), Positives = 86/170 (50%), Gaps = 31/170 (18%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFE--NLKPGWNLRANIAF 521
EV ++ H N+V L ++ LV+++L+ L ++ + N+ N++ + +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-Y 111
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
QI RGL + H +++H D+KPQN+L+++ +++DFGLA+ +K++
Sbjct: 112 QILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR------AKSVP----- 157
Query: 582 TKGYVASPE----WFR-------NSTITANVDVYSFGVLLLEIISCRKSF 620
TK Y S E W+R +S + +D++ G + E+ S R F
Sbjct: 158 TKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 517 ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
A I ++ GL +LH IH DIK NILL + + +++DFG++ LT SK +
Sbjct: 101 AFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--R 155
Query: 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
GT ++A PE + S D++S G+ +E+
Sbjct: 156 NTFVGTPFWMA-PEVIKQSGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 22/102 (21%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
+QI RGL ++H S+ ++H D+KP NIL+++ + +I DFGLA++ +
Sbjct: 114 LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT------- 163
Query: 580 RGTKGYVASPEWFRNSTIT-------ANVDVYSFGVLLLEII 614
GYV S ++R I VD++S G + E++
Sbjct: 164 ----GYV-STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 467 MIGQTYHKNLVRLLGF----CDEGQNRL-LVYKFLNNGTLASFLFENLK-PGWNLRANIA 520
M+ ++ + +VRLL G+ L LV+++L++ L F+ N + PG L A
Sbjct: 56 MLSESIY--IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTI 112
Query: 521 ----FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA-QISDFGLAKLLTLNQSKAI 575
+Q+ +G+ H H ++H D+KPQN+L+D +I+D GL + ++
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+ + T Y A ++ + VD++S G + E+
Sbjct: 170 HEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 48/177 (27%), Positives = 86/177 (48%), Gaps = 31/177 (17%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFE--NLKPGWNLRANIAF 521
EV ++ H N+V L ++ LV+++L+ L +L + N N++ + F
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-F 111
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ RGL + H +++H D+KPQN+L+++ +++DFGLA+ +K+I
Sbjct: 112 QLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR------AKSIP----- 157
Query: 582 TKGYVASPE----WFRNSTI-------TANVDVYSFGVLLLEIISCRKSFDIEMGEE 627
TK Y S E W+R I + +D++ G + E+ + R F EE
Sbjct: 158 TKTY--SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 11/137 (8%)
Query: 491 LVYKFLNNGTLASFLF--ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548
L+ ++N G L + L+ E+ +R IA +I L HLH II+ DIK +NI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLH---QLGIIYRDIKLENI 136
Query: 549 LLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN--VDVYSF 606
LLD + ++DFGL+K + + GT Y+A PE R + + VD +S
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMA-PEVIRGGSGGHDKAVDWWSL 194
Query: 607 GVLLLEIISCRKSFDIE 623
GVL E+++ F ++
Sbjct: 195 GVLTFELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 493 YKFLNNGTLASFLFENLKPGWNLRANIAF--QIARGLLHLHVNCSSQIIHCDIKPQNILL 550
YK N+ + + L ++ G ++F Q+ARG+ L S +H D+ +N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+I DFGLA+ + ++ S + K +PE ++ T DV+S+G+LL
Sbjct: 271 AQGKIVKICDFGLARDI-MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329
Query: 611 LEIISCRKSFDIEMGEEY-AILTDWAF-----DCYRNGKLDDLVEGDMEAMNDIKCVEKL 664
EI S G Y ++ D F YR K D A ++
Sbjct: 330 WEIFSLG-------GTPYPGMIVDSTFYNKIKSGYRMAKPD-------HATQEV----YD 371
Query: 665 VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+MV W +P RP+ +S ++E
Sbjct: 372 IMVKCW--NSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 31/118 (26%), Positives = 62/118 (52%), Gaps = 7/118 (5%)
Query: 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
++ G+L L E + + ++ + RGL +L QI+H D+KP NIL++
Sbjct: 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGE 142
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
++ DFG++ L ++ + GT+ Y++ PE + + + D++S G+ L+E+
Sbjct: 143 IKLCDFGVSGQLI----DSMANSFVGTRSYMS-PERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 31/165 (18%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWN--LRANIAF 521
E+ M+ Q H NLV L+ + LV+++ ++ T+ + L +N + G L I +
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPR-GVPEHLIKKIIW 107
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q + + H IH D+KP+NIL+ ++ DFG A++LT G
Sbjct: 108 QTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILT------------G 152
Query: 582 TKG----YVASPEWFR-------NSTITANVDVYSFGVLLLEIIS 615
YVA+ W+R ++ VDV++ G + E+++
Sbjct: 153 PGDDYTDYVAT-RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 10/99 (10%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+ I + L +L +IH D+KP NILLD N ++ DFG++ L SKA ++
Sbjct: 119 MTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRS 174
Query: 579 IRGTKGYVASPEWFRNSTITAN----VDVYSFGVLLLEI 613
G Y+A PE DV+S G+ L+E+
Sbjct: 175 -AGCAAYMA-PERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 53/188 (28%), Positives = 80/188 (42%), Gaps = 34/188 (18%)
Query: 447 VKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGF------CDEGQNRLLVYKFLNNG 499
VK LD + D ++E + E ++ H N+V+ G GQ LV + N G
Sbjct: 52 VKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGG 109
Query: 500 TLASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
++ + L G L + I + GL HLH N +IIH D+K NILL
Sbjct: 110 SVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTIT----------ANVDVYS 605
++ DFG++ LT + + R T V +P W I A DV+S
Sbjct: 167 VKLVDFGVSAQLTSTRLR------RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWS 218
Query: 606 FGVLLLEI 613
G+ +E+
Sbjct: 219 LGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 6/99 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ G+ H+H +++H DIK +NI L ++ DFG A+LLT + A G
Sbjct: 108 QMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--G 162
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
T YV PE + N D++S G +L E+ + + F
Sbjct: 163 TPYYV-PPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 54/187 (28%), Positives = 83/187 (44%), Gaps = 32/187 (17%)
Query: 447 VKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGF-----CDEGQNRLLVYKFLNNGT 500
VK LD + D ++E + E ++ + H N+V+ G G LV + N G+
Sbjct: 48 VKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGS 106
Query: 501 LASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
+ + LK G + A I + GL HLHVN + IH D+K NILL
Sbjct: 107 VTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFR----------NSTITANVDVYSF 606
++ DFG++ LT + + R T V +P W +ST A DV+S
Sbjct: 164 KLVDFGVSAQLTSTRLR------RNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSL 215
Query: 607 GVLLLEI 613
G+ +E+
Sbjct: 216 GITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 36/97 (37%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 521 FQIARGLL---HLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL-LTLNQSKAIK 576
F IA +L HLH I++ D+KP+NILLD + + DFGL+K LT N
Sbjct: 100 FYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---KTT 153
Query: 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
GT Y+A T +VD +S GVL+ E+
Sbjct: 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 20/172 (11%)
Query: 455 QDGEKE---FKNEVVMIGQTYHKNLVRLLGFC--DEGQNRLLVY-KFLNNGTLASFLFEN 508
Q+ KE + E+ ++ H +V+ G C D + +L ++ +++ G++ +
Sbjct: 42 QETSKEVNALECEIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIK----DQ 96
Query: 509 LKPGWNLRANIAF----QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
LK L N+ QI +G+ +LH S+ I+H DIK NIL D N ++ DFG +
Sbjct: 97 LKAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153
Query: 565 K-LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
K + T+ S K++ GT Y SPE DV+S ++E+++
Sbjct: 154 KRIQTICMSGTGIKSVTGTP-YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 15/161 (9%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA 517
E+ NE ++ + H ++RL + + ++ +++ G L S+L N N
Sbjct: 45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTG 103
Query: 518 NI-AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
A +I L +LH S +I++ D+KP+NILLD + +++DFG AK K
Sbjct: 104 LFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK-------KLRD 153
Query: 577 K--AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
+ + GT Y+A PE ++ VD ++ G+L+ E++
Sbjct: 154 RTWTLCGTPEYLA-PEVIQSKGHNKAVDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 12/99 (12%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
A +IA L +LH S II+ D+KP+NILLD + ++DFGL K + K
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGIEHSKTT 153
Query: 580 R---GTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
GT Y+A PE R VD + G +L E++
Sbjct: 154 STFCGTPEYLA-PEVLRKQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
IA + GL +L+ +I+H DIKP NIL++ ++ DFG++ L +I
Sbjct: 108 IAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADT 161
Query: 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
GT Y+ SPE + T DV+S G+ ++E+ + F
Sbjct: 162 FVGTSTYM-SPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 12/181 (6%)
Query: 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
T +++K LD+ ++ + F M+ Q HK+LV G C G ++V +++ G+
Sbjct: 26 HKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGS 85
Query: 501 LASFLFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
L ++L +N + W L +A Q+A L L + H ++ +N+LL + +
Sbjct: 86 LDTYLKKNKNLINISWKLE--VAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRK 140
Query: 558 ISDFGLAKLLTLNQSKAI--KKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEII 614
+ KL S + K+ + +V PE N ++ D +SFG L EI
Sbjct: 141 TGNPPFIKLSDPGISITVLPKEILLERIPWVP-PECIENPQNLSLAADKWSFGTTLWEIF 199
Query: 615 S 615
S
Sbjct: 200 S 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 33/122 (27%), Positives = 52/122 (42%), Gaps = 16/122 (13%)
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577
Q+ G+ +LH N I+H DIK NIL+D+ +I+DFGLA+
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 578 AIRGTKGY--VASPEWFRNSTI-------TANVDVYSFGVLLLEIISCRKSF----DIEM 624
GT+ Y + W+R + T VD++ G + E+ + R DI+
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235
Query: 625 GE 626
Sbjct: 236 LH 237
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 7/106 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I L HLH I++ DIK +NILLD + ++DFGL+K L++ K + G
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCG 168
Query: 582 TKGYVASPEWFRNSTITAN-VDVYSFGVLLLEIISCRKSFDIEMGE 626
T Y+A PE R VD +S G+L+ E+++ F +E GE
Sbjct: 169 TIEYMA-PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE-GE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 56/252 (22%), Positives = 111/252 (44%), Gaps = 43/252 (17%)
Query: 459 KEFKNEVVMIGQTYHKNLVRLLGFC--DEGQNRL----LVYKFLNNGTLASFLFENL--K 510
+EF E + + H N+++L+G + RL ++ F+ +G L +FL + +
Sbjct: 46 EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE 105
Query: 511 PGWNLRANIAFQ----IARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566
+ L + IA G+ +L S IH D+ +N +L++ ++DFGL+K
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKK 162
Query: 567 L----TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS--F 620
+ Q A K ++ ++A E ++ T + DV++FGV + EI++ ++
Sbjct: 163 IYSGDYYRQGCASKLPVK----WLAL-ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217
Query: 621 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680
+E E Y L++G+ C+E + + C +P RP
Sbjct: 218 GVENSEIYNY----------------LIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRP 260
Query: 681 TMRKVSQMLEVV 692
+ + + LE++
Sbjct: 261 SFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 17/108 (15%)
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
+Q+ R L ++H ++ + H D+KP+NIL + +I DFGLA++ + AI
Sbjct: 110 YQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-- 164
Query: 581 GTKGYVASPEWFRN--------STITANVDVYSFGVLLLEIISCRKSF 620
YVA+ W+R S T +D++S G + E+++ + F
Sbjct: 165 ---DYVAT-RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 16/153 (10%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLL 528
H N++ LL N LV++F+ T + ++ L P ++++ RGL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFM--ETDLEKVIKDKSIVLTPA-DIKS-YMLMTLRGLE 116
Query: 529 HLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVAS 588
+LH N I+H D+KP N+L+ +++DFGLA+ K + + T+ Y A
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRA- 170
Query: 589 PEWFRNSTI-TANVDVYSFGVLLLEIISCRKSF 620
PE + VD++S G + E++ R F
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 32/111 (28%), Positives = 58/111 (52%), Gaps = 27/111 (24%)
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
FQ+ RGL + H +++H D+KPQN+L+ + +++DFGLA+ +K++
Sbjct: 110 FQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR------AKSVP---- 156
Query: 581 GTKGYVASPE----WFR------NST-ITANVDVYSFGVLLLEIISCRKSF 620
+K Y S E W+R ST + ++D++ G + E+ + R F
Sbjct: 157 -SKTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 42/176 (23%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 454 FQDGEK--EFKNEVVMIGQTYHKNLVRLL-GFCDEGQNRLLVYKFLNNGTLASFLFENLK 510
+ E+ +F E+ ++ + H N+V L + E + +L+ +F + G L S + E L+
Sbjct: 40 IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLE-LE 97
Query: 511 PGWNLRANIAF---QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567
G I + Q+ L LH S ++IH D+K NILL + +++DFG++
Sbjct: 98 RGLT-EPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153
Query: 568 TLNQSKAIKKAIRGTKGYVASPEW----------FRNSTITANVDVYSFGVLLLEI 613
K ++ ++ +P W F+++ D++S G+ L+E+
Sbjct: 154 --------KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 514 NLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573
N+ I+ + RGL +L +I+H D+KP NIL++ ++ DFG++ L
Sbjct: 99 NILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----D 152
Query: 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
++ + GT+ Y+ SPE + + T D++S G+ L+E+
Sbjct: 153 SMANSFVGTRSYM-SPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 63/265 (23%), Positives = 104/265 (39%), Gaps = 43/265 (16%)
Query: 429 NFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKN---EVVMIGQTYHKNLVRLLGFCDE 485
+F V S V+ VKK+ + +++++ EV + Q H N + G +
Sbjct: 33 SFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92
Query: 486 GQNRLLVYKFLNNGTLASFLFENLKPGWNLR-ANIAFQIARGLLHLHVNCSSQIIHCDIK 544
LV ++ G+ + L + KP + A I +GL +LH + +IH DIK
Sbjct: 93 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIK 148
Query: 545 PQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITA----- 599
NILL + +++DFG A + S +V +P W I A
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPANS------------FVGTPYWMAPEVILAMDEGQ 196
Query: 600 ---NVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656
VDV+S G I+C IE+ E L F+ L + + D +
Sbjct: 197 YDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNDSPTLQ 241
Query: 657 DIKCVEKLVMVSIWCIQEDPSLRPT 681
+ + +C+Q+ P RP
Sbjct: 242 SNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 21/148 (14%)
Query: 473 HKNLVRLL-GFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANIA-FQIARGLL- 528
H +V ++ F DE NR+ + +F+ G L F +L+ ++A F A +L
Sbjct: 77 HPFIVNMMCSFQDE--NRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYHAELVLA 130
Query: 529 --HLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV 586
+LH S II+ D+KP+N+LLD+ + +++DFG AK + + GT Y+
Sbjct: 131 FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-----TLCGTPEYL 182
Query: 587 ASPEWFRNSTITANVDVYSFGVLLLEII 614
A PE ++ VD ++ GVLL E I
Sbjct: 183 A-PEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEF-KNEVVMIGQTYHKNLVRL 479
++G + LV + +T + VVKK + V D + ++ + E + Q + +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKK-ELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 480 LGFCDEGQNRLL-VYKFLNNGTLASFLFENLK-PGWNLRANIAFQIARGLLHLHVNCSSQ 537
L C + ++RL V +++N G L + K P + R A +I+ L +LH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERG 116
Query: 538 IIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI 597
II+ D+K N+LLD + +++D+G+ K + GT Y+A PE R
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNYIA-PEILRGEDY 173
Query: 598 TANVDVYSFGVLLLEIISCRKSFDI 622
+VD ++ GVL+ E+++ R FDI
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+ Q+ RGL +LH N IIH D+K N+LL D +I+DFGLA+ L K
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+ T Y A +T T +D+++ G +L E++
Sbjct: 170 V--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 40/167 (23%), Positives = 71/167 (42%), Gaps = 19/167 (11%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ L H+H S +++H DIKP N+ + ++ D GL + + + A ++ G
Sbjct: 114 QLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVG 168
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641
T Y SPE + D++S G LL E+ + + F + Y++ C +
Sbjct: 169 TP-YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-------CKK- 219
Query: 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688
+ + D + E+L + CI DP RP + V +
Sbjct: 220 -----IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-06
Identities = 31/114 (27%), Positives = 40/114 (35%), Gaps = 24/114 (21%)
Query: 46 LSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLT 105
+S F GF +L I Y + VVW N D NP + L
Sbjct: 11 VSSGSLFELGFFKLI----MQSRDYNLILYKGSSRT-VVWVA-NRD-NPS-GSSCTLTLQ 62
Query: 106 ADQGLVLNDPQGKQVWSSK---------LIL-------VQSFSSSRLWDSFSNP 143
+D LV+ D G VWSS L+L + + LW SF P
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 20/143 (13%)
Query: 432 LVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY----HKNLVRLLGFCDEGQ 487
L+ I T T +VVK+L KE +NE + G Y H N+++ LG C E
Sbjct: 12 LLSEIYTDTGVARVVVKELKA--NASSKE-QNEFLQQGDPYRILQHPNILQCLGQCVEAI 68
Query: 488 NRLLVYKFLNNGTLASFLFENLKPGWNLR-------ANIAFQIARGLLHLHVNCSSQIIH 540
LLV+++ G L S+L + W+ R +A +IA G+ H+H +H
Sbjct: 69 PYLLVFEYCELGDLKSYLSQE---QWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLH 122
Query: 541 CDIKPQNILLDDYYNAQISDFGL 563
D+ +N L ++ D+G+
Sbjct: 123 SDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 42/140 (30%), Positives = 69/140 (49%), Gaps = 10/140 (7%)
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
L+ ++N G L + L + + + +I L HLH II+ DIK +NILL
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILL 138
Query: 551 DDYYNAQISDFGLAK-LLTLNQSKAIKKAIRGTKGYVASPEWFR--NSTITANVDVYSFG 607
D + ++DFGL+K +A + GT Y+A P+ R + VD +S G
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMA-PDIVRGGDGGHDKAVDWWSMG 195
Query: 608 VLLLEIISCRKSFDIEMGEE 627
VL+ E+++ F ++ GE+
Sbjct: 196 VLMYELLTGASPFTVD-GEK 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I+ L HLH II+ D+KP+NILLD + +++DFGL K + G
Sbjct: 108 EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTHTFCG 162
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIE 623
T Y+A PE S VD +S G L+ ++++ F E
Sbjct: 163 TIEYMA-PEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 483 CDEGQNRL-LVYKFLNNGTLASFLFENLK-PGWNLRANIAFQIARGLLHLHVNCSSQIIH 540
C + ++RL V +F++ G L + K P + R F A L L+ II+
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHAR----FYSAEISLALNFLHERGIIY 119
Query: 541 CDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA-----IRGTKGYVASPEWFRNS 595
D+K N+LLD + +++D+G+ K + I+ GT Y+A PE R
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTSTFCGTPNYIA-PEILRGE 171
Query: 596 TITANVDVYSFGVLLLEIISCRKSFDI 622
+VD ++ GVL+ E+++ R FDI
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 33/103 (32%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 514 NLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573
+ IA + L +L +IIH D+KP NILLD N ++ DFG++ L
Sbjct: 107 EILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDS 161
Query: 574 AIKKAIRGTKGYVASPEWFRNSTITA---NVDVYSFGVLLLEI 613
K G + Y+A PE S DV+S G+ L E+
Sbjct: 162 IAKTRDAGCRPYMA-PERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 28/107 (26%), Positives = 47/107 (43%), Gaps = 25/107 (23%)
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577
+ +Q+ + L H+H N I H DIKP+NIL+ D +++DFG +
Sbjct: 104 SYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSC------------R 147
Query: 578 AIRGTKGYVA--SPEWFR-------NSTITANVDVYSFGVLLLEIIS 615
I Y S W+R + +D+++ G + EI+S
Sbjct: 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 7/141 (4%)
Query: 483 CDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHC 541
C + +RL LV +++N G L + K A +I L LH II+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYR 120
Query: 542 DIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANV 601
D+K N+LLD + +++D+G+ K GT Y+A PE R +V
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYIA-PEILRGEEYGFSV 177
Query: 602 DVYSFGVLLLEIISCRKSFDI 622
D ++ GVL+ E+++ R FDI
Sbjct: 178 DWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 23/229 (10%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL--FENLKPGWNLRANIAF 521
E+ ++ Q H N+++ L E +V + + G L+ + F+ K R +
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 522 --QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
Q+ + H+H S +++H DIKP N+ + ++ D GL + + + A ++
Sbjct: 112 FVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSL 166
Query: 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639
GT Y SPE + D++S G LL E+ + + F G++ + + C
Sbjct: 167 VGTP-YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLFS----LCQ 218
Query: 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688
+ + + D + EKL + CI DP RP + V Q+
Sbjct: 219 K------IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 28/112 (25%), Positives = 60/112 (53%), Gaps = 23/112 (20%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFGLAKLLTLNQSKAIKKA 578
+Q+ RGL ++H S+ ++H D+KP N+ ++ + +I DFGLA+++ + S
Sbjct: 120 MYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH----- 171
Query: 579 IRGTKGYVA---SPEWFRNSTI-------TANVDVYSFGVLLLEIISCRKSF 620
KGY++ +W+R+ + T +D+++ G + E+++ + F
Sbjct: 172 ----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 12/207 (5%)
Query: 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLL 480
L+G F +V T + V+KK + Q+ F+ E ++ + + +L
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 481 GFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIA-FQIARGLLHLHVNCSSQII 539
+ N LV ++ G L S L ++A F +A +L +H +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAIHSVHQMGYV 124
Query: 540 HCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFR------ 593
H DIKP+N+L+D + +++DFG A LT N+ K GT Y+A PE
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIA-PEVLTTMNGDG 182
Query: 594 NSTITANVDVYSFGVLLLEIISCRKSF 620
T D +S GV+ E+I R F
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 38/161 (23%), Positives = 73/161 (45%), Gaps = 21/161 (13%)
Query: 462 KNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR-ANIA 520
+ E+ M+ + H N+V G + + ++ G+L ++ P L+ A +
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVC 112
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
+ +GL +LH S +H DIK NILL D + +++DFG+A +T +K
Sbjct: 113 RETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK------- 162
Query: 581 GTKGYVASPEWF--------RNSTITANVDVYSFGVLLLEI 613
K ++ +P W +N D+++ G+ +E+
Sbjct: 163 -RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 403 PDPEDKKKRNMMNVTRSVLLGSSVFV--------NFTLVGVIQTSTRTTVIVVKKLDRVF 454
P ++K K N R++ GS V +F V I+ ++ +I K++D VF
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVA-IKRFEKSKIIKQKQVDHVF 79
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWN 514
E++ N + H V L G + LV +F+ G +FL N + +
Sbjct: 80 S--ERKILNYI------NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND 131
Query: 515 LRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574
+ A QI +L S I++ D+KP+N+LLD +++DFG AK++
Sbjct: 132 VGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY-- 186
Query: 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+ GT Y+A PE N D ++ G+ + EI+
Sbjct: 187 ---TLCGTPEYIA-PEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 8/201 (3%)
Query: 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLL 480
LLG F LV + + ++KK + +D E ++ T H L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 481 GFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQII 539
+ + ++RL V +++N G L L + +I L +LH S +I+
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIV 117
Query: 540 HCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITA 599
+ D+K +N++LD + +I+DFGL K + A K GT Y+A PE ++
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLA-PEVLEDNDYGR 174
Query: 600 NVDVYSFGVLLLEIISCRKSF 620
VD + GV++ E++ R F
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 20/118 (16%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ------- 571
I +I + ++H S ++H D+KP NILL + I D+G A L +
Sbjct: 118 IFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 572 ---------SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
S I I GT Y+A PE + + D+Y+ GV+L ++++ +
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMA-PERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 54/190 (28%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 429 NFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488
+F V V+Q T ++KK ++ E+ V++ H LV L +
Sbjct: 21 SFYAVKVLQKKT-----ILKKKEQNHIMAERN-----VLLKNLKHPFLVGLHYSFQTAEK 70
Query: 489 RLLVYKFLNNGTLASFLFEN---LKPGWNLRANI-AFQIARGLLHLHVNCSSQIIHCDIK 544
V ++N G L L L+P RA A ++A + +LH S II+ D+K
Sbjct: 71 LYFVLDYVNGGELFFHLQRERCFLEP----RARFYAAEVASAIGYLH---SLNIIYRDLK 123
Query: 545 PQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVY 604
P+NILLD + ++DFGL K + + GT Y+A PE R VD +
Sbjct: 124 PENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEYLA-PEVLRKEPYDRTVDWW 180
Query: 605 SFGVLLLEII 614
G +L E++
Sbjct: 181 CLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 39/161 (24%), Positives = 81/161 (50%), Gaps = 31/161 (19%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPG----WNLRANIAFQIARGLL 528
H N+V L + V+++++ LA ++ ++ PG +N+R FQ+ RGL
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQH--PGGLHPYNVRL-FMFQLLRGLA 117
Query: 529 HLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVAS 588
++H I+H D+KPQN+L+ +++DFGLA+ +K+I ++ Y +
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR------AKSIP-----SQTYSSE 163
Query: 589 --PEWFR-------NSTITANVDVYSFGVLLLEIISCRKSF 620
W+R + ++ +D++ G + +E++ + +F
Sbjct: 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 34/107 (31%), Positives = 46/107 (42%), Gaps = 8/107 (7%)
Query: 518 NIAFQIARGLL----HLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573
A I R LL +LH IIH D+K +NI LD+ NA + DFG A L +
Sbjct: 185 EQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
GT SPE A D++S G++L E+ +
Sbjct: 242 PQCYGWSGTL-ETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 28/100 (28%), Positives = 37/100 (37%), Gaps = 9/100 (9%)
Query: 40 TDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRG 99
+ +S + F GF L ND I Y + VVW + + NPV
Sbjct: 5 SSGQTLVSGNSLFELGFFTLI---MQNDY--NLILYKSSSRT-VVWVANRD--NPV-SDS 55
Query: 100 SQVKLTADQGLVLNDPQGKQVWSSKLILVQSFSSSRLWDS 139
+ L +D LVL D G+ VWSS L D
Sbjct: 56 CTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDD 95
|
Length = 114 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 23/105 (21%)
Query: 517 ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
A I +GL +LH S + IH DIK NILL + +++DFG A L++ S
Sbjct: 118 AAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS---- 170
Query: 577 KAIRGTKGYVASPEWFRNSTITA--------NVDVYSFGVLLLEI 613
+V +P W I A VDV+S G+ +E+
Sbjct: 171 --------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 38/160 (23%), Positives = 76/160 (47%), Gaps = 11/160 (6%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIA--- 520
E ++ H N+V L + LV+++++ L ++ + PG N+
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYM--DKHPGGLHPENVKLFL 109
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
FQ+ RGL ++H I+H D+KPQN+L+ D +++DFGLA+ ++ + +
Sbjct: 110 FQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV- 165
Query: 581 GTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
T Y ++ + +D++ G + +E+I +F
Sbjct: 166 -TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 19/53 (35%), Positives = 31/53 (58%), Gaps = 7/53 (13%)
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ----ISDFGLAKL 566
++ +QI G+ +LH S+ ++H D+KP NIL+ + I D GLA+L
Sbjct: 112 SLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-05
Identities = 18/82 (21%), Positives = 27/82 (32%), Gaps = 16/82 (19%)
Query: 322 FELSCNGGRQDYEL--------------SRPYDEVQCKNNCLSDCFCVVAIFRGDS--CW 365
L+C G +C+ CLS+C C + S C
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCL 60
Query: 366 SKKLPLSNGRAHSSVNGKAFLK 387
L+N R+ SS G +L+
Sbjct: 61 LWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 35/236 (14%)
Query: 462 KNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR-ANIA 520
+ E++M+ H N+V G + +F G+L ++ P + A ++
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVS 112
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
+ +GL +LH S +H DIK NILL D + +++DFG+ S I I
Sbjct: 113 RETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGV--------SAQITATIA 161
Query: 581 GTKGYVASPEWF--------RNSTITANVDVYSFGVLLLEIISCRKS-FDIEMGEEYAIL 631
K ++ +P W R D+++ G+ +E+ + FD+ ++
Sbjct: 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221
Query: 632 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687
T F + KL D M+ N K+ + ++P RPT K+ Q
Sbjct: 222 TKSNF---QPPKLKD----KMKWSNSFHHFVKMALT------KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 34/116 (29%), Positives = 61/116 (52%), Gaps = 8/116 (6%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
A ++ L+ LH + +I+ D+K NILLD + +++DFG+ K LN
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTF 156
Query: 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 633
GT Y+A PE + +VD ++ GVL+ E+++ + F+ + ++ +IL D
Sbjct: 157 CGTPDYIA-PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 58/251 (23%), Positives = 106/251 (42%), Gaps = 24/251 (9%)
Query: 383 KAFLKYKKGDDPDP-PSVPSPPD----PEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQ 437
+AF KY DP+ P+ PE R M V +++ + F
Sbjct: 32 EAFEKYCADLDPEAYKKCVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFV------ 85
Query: 438 TSTRTTVI---VVKKLDRVFQDGEKEF-KNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493
+TR + VV K + + + + ++E+ + H +V+ LL+
Sbjct: 86 -ATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 494 KFLNNGTLASFLFENLK---PGWNLRANIAF-QIARGLLHLHVNCSSQIIHCDIKPQNIL 549
++ + G L + + LK P + F QI L +H S +++H D+K NI
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIF 201
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVL 609
L ++ DFG +K + + S + + GT Y+A PE + + D++S GV+
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA-PELWERKRYSKKADMWSLGVI 260
Query: 610 LLEIISCRKSF 620
L E+++ + F
Sbjct: 261 LYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 38/233 (16%)
Query: 393 DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR 452
DP+ + DPE + R + GS F V + V+ +KK+
Sbjct: 11 DPEIAELFFKEDPE-----KLFTDLREIGHGS-----FGAVYFARDVRTNEVVAIKKMSY 60
Query: 453 VFQDGEKEFKN---EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENL 509
+ +++++ EV + + H N + G LV ++ G+ + L +
Sbjct: 61 SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK 119
Query: 510 KPGWNLR-ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568
KP + A I +GL +LH S +IH DIK NILL + +++DFG A + +
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176
Query: 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITA--------NVDVYSFGVLLLEI 613
S +V +P W I A VDV+S G+ +E+
Sbjct: 177 PANS------------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
++Q+A G+ L S +H D+ +N+L+ + +I DFGLA+ + + S I K
Sbjct: 245 SYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYISKGS 300
Query: 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
+PE N+ T DV+SFG+LL EI +
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 29/109 (26%), Positives = 50/109 (45%), Gaps = 15/109 (13%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK-------LLTLNQ 571
I QI GL LH +H D+ P NI ++ +I+DFGLA+ TL++
Sbjct: 124 ILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 572 SKAIKKAIRGTKGYVA----SPEWFRNST-ITANVDVYSFGVLLLEIIS 615
+ +++ T V +PE + VD++S G + E+++
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 44/125 (35%), Positives = 60/125 (48%), Gaps = 8/125 (6%)
Query: 491 LVYKFLNNGTLASFL-FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
V F+N G L L E P R A +IA L +LH S I++ D+KP+NIL
Sbjct: 73 FVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINIVYRDLKPENIL 128
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVL 609
LD + ++DFGL K + QS GT Y+A PE R VD + G +
Sbjct: 129 LDSQGHVVLTDFGLCK-EGIAQSDT-TTTFCGTPEYLA-PEVIRKQPYDNTVDWWCLGAV 185
Query: 610 LLEII 614
L E++
Sbjct: 186 LYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 36/165 (21%)
Query: 454 FQDGEKEFKNEVVM--IGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKP 511
F+ EK VVM I QT HK + + NN L FL +
Sbjct: 133 FKKNEKNIFLNVVMEFIPQTVHK---------------YMKHYARNNHALPLFLVKLY-- 175
Query: 512 GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFGLAKLLTLN 570
++Q+ R L ++H S I H D+KPQN+L+D + + ++ DFG AK L
Sbjct: 176 --------SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
Query: 571 QSKAIKKAIRGTKGYVASPEWFRNST-ITANVDVYSFGVLLLEII 614
Q R + +PE +T T ++D++S G ++ E+I
Sbjct: 225 QRSVSYICSR----FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 29/118 (24%), Positives = 62/118 (52%), Gaps = 7/118 (5%)
Query: 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
++ G+L L + + + ++ + +GL +L +I+H D+KP NIL++
Sbjct: 85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGE 142
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
++ DFG++ L ++ + GT+ Y+ SPE + + + D++S G+ L+E+
Sbjct: 143 IKLCDFGVSGQLI----DSMANSFVGTRSYM-SPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 5e-05
Identities = 29/103 (28%), Positives = 43/103 (41%), Gaps = 28/103 (27%)
Query: 539 IHCDIKPQNILLDDYYNAQISDFGLAKLL---------------------------TLNQ 571
IH DIKP NIL+D + +++DFGL K + Q
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+ + GT Y+A PE R + D +S GV+L E++
Sbjct: 183 RRVRANSTVGTPDYIA-PEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I L +LH S +++ DIK +N++LD + +I+DFGL K + A K G
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCG 157
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
T Y+A PE ++ VD + GV++ E++ R F
Sbjct: 158 TPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 40/188 (21%), Positives = 80/188 (42%), Gaps = 22/188 (11%)
Query: 437 QTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496
Q + K +D ++ +++ E+ ++ H N+V+LL N ++ +F
Sbjct: 25 QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84
Query: 497 NNGTLASFLFENLKPGWNLRANIAF-QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
G + + + E +P + + Q L +LH N +IIH D+K NIL +
Sbjct: 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGD 141
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANV----------DVYS 605
+++DFG++ T + I+ ++ +P W + DV+S
Sbjct: 142 IKLADFGVSAKNT--------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 193
Query: 606 FGVLLLEI 613
G+ L+E+
Sbjct: 194 LGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 11/105 (10%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL-LTLNQSKAIKK 577
I + R + +LH N +IIH DIK +NI ++ + + DFG A + +N +K
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK---- 239
Query: 578 AIRGTKGYVA--SPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
G G +A +PE VD++S G++L E+ +C S
Sbjct: 240 -YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 33/186 (17%)
Query: 464 EVVMIGQTYHKNLVRLLG-FCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANIAF 521
EV ++ + HKN+VR + F ++ +L ++ +F + G L+ + + K + +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 522 QIARGLLHLHVNCSS--------QIIHCDIKPQNILLDDYYN-----------------A 556
I R LLH C + +++H D+KPQNI L A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN--VDVYSFGVLLLEII 614
+I DFGL+K + + +++ + GT Y SPE + T + + D+++ G ++ E+
Sbjct: 182 KIGDFGLSKNIGI---ESMAHSCVGTP-YYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 615 SCRKSF 620
S + F
Sbjct: 238 SGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 43/205 (20%)
Query: 450 LDRVFQDGEKE-FK----NEVVMIGQTYHKNLVRL----------LGFCDEGQNRLLVYK 494
L +V D EKE F E+ ++ Q H+N+V L L F + LV++
Sbjct: 37 LKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFE 96
Query: 495 FLNN---GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
++++ G L S L + + + Q+ GL + H +H DIK NILL+
Sbjct: 97 YMDHDLMGLLESGLVHFSE---DHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLN 150
Query: 552 DYYNAQISDFGLAKLLTLNQSKA-IKKAIRGTKGYVASPEWFRNSTI-------TANVDV 603
+ +++DFGLA+L +S+ K I W+R + +DV
Sbjct: 151 NKGQIKLADFGLARLYNSEESRPYTNKVI---------TLWYRPPELLLGEERYGPAIDV 201
Query: 604 YSFGVLLLEIISCRKSF--DIEMGE 626
+S G +L E+ + + F + E+ +
Sbjct: 202 WSCGCILGELFTKKPIFQANQELAQ 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 30/136 (22%), Positives = 53/136 (38%), Gaps = 15/136 (11%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVM---IGQTYHKNLV-RLLGFCDEGQNRL 490
V T+ V+K ++ + + EV + + + V ++L +
Sbjct: 14 VYLLGTKDEDYVLKINPS--REKGADREREVAILQLLAR--KGLPVPKVLASGESDGWSY 69
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
L+ +++ TL E + +IA Q+A L LH + H D+ P NIL+
Sbjct: 70 LLMEWIEGETLDEVSEEEKE-------DIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV 122
Query: 551 DDYYNAQISDFGLAKL 566
DD I D+ A
Sbjct: 123 DDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 23/180 (12%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+++K LD +D F M+ Q HK++V L G C ++V +F+ G L F
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF 94
Query: 505 LF---ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL-----DDYYNA 556
+ + L W +A Q+A L +L ++H ++ +NILL D
Sbjct: 95 MHRKSDVLTTPWKF--KVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGP 149
Query: 557 --QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEI 613
++SD G+ + L++ + +++ ++A PE +S ++ D +SFG L EI
Sbjct: 150 FIKLSDPGIP-ITVLSRQECVERI-----PWIA-PECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
A +IA L +LH S I++ D+KP+NILLD + ++DFGL K +
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNGTTSTF 156
Query: 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
GT Y+A PE VD + G +L E++
Sbjct: 157 CGTPEYLA-PEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+V+K L +D F ++ Q HK+LV+L G C +N ++V +++ G L F
Sbjct: 33 VVLKVLGSDHRDSL-AFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVF 90
Query: 505 LFENLKPGWNL-RANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN-------A 556
L + ++A Q+A L +L +++H ++ +NIL+ Y
Sbjct: 91 LHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFI 147
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEII 614
++SD G+ + + R + +PE RN +++T D +SFG LLEI
Sbjct: 148 KLSDPGIPI-------TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200
Query: 615 S 615
S
Sbjct: 201 S 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 28/182 (15%)
Query: 444 VIVVKKLDRVFQDGEKEFKN---EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
V+ +KK+ + +++++ EV + + H N ++ G LV ++ G+
Sbjct: 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GS 100
Query: 501 LASFLFENLKPGWNLR-ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
+ L + KP + A + +GL +LH S +IH D+K NILL + ++
Sbjct: 101 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG 157
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITA--------NVDVYSFGVLLL 611
DFG A ++ +V +P W I A VDV+S G+ +
Sbjct: 158 DFGSASIMAPANX------------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
Query: 612 EI 613
E+
Sbjct: 206 EL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 20/131 (15%)
Query: 450 LDRVFQDGEKE-FK----NEVVMIGQTYHKNLVRLLGFCD---EGQNR-----LLVYKFL 496
L +V + EKE F E+ ++ H+N+V L+ C NR LV++F
Sbjct: 42 LKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC 101
Query: 497 NNGTLASFLFENLKPGWNLR--ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
+ LA L N + L + + GL ++H N +I+H D+K NIL+
Sbjct: 102 EH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDG 156
Query: 555 NAQISDFGLAK 565
+++DFGLA+
Sbjct: 157 ILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 39/184 (21%), Positives = 80/184 (43%), Gaps = 14/184 (7%)
Query: 446 VVKKLDRVFQDGEK----EFKNEVVMIGQTYHKNLVRLLGF----CDEGQNRLLVYKFLN 497
V+ + + F G K +NE+ + + N++++ GF D+ L+ ++
Sbjct: 46 VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105
Query: 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
G L L + + + ++A +GL +L+ + + ++ + L+ + Y +
Sbjct: 106 RGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLK 163
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
I GL K+L+ K + + Y + F TI D+YS GV+L EI + +
Sbjct: 164 IICHGLEKILSSPPFKNVNFMV--YFSYKMLNDIFSEYTIKD--DIYSLGVVLWEIFTGK 219
Query: 618 KSFD 621
F+
Sbjct: 220 IPFE 223
|
Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I L +LH S +++ D+K +N++LD + +I+DFGL K A K G
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCG 157
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
T Y+A PE ++ VD + GV++ E++ R F
Sbjct: 158 TPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 56/248 (22%), Positives = 97/248 (39%), Gaps = 38/248 (15%)
Query: 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLL 480
++G F LV T + +++K D + ++ + E ++ + +V++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 481 GFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIH 540
+ N L+ +FL G + + L +K F IA +L + IH
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124
Query: 541 CDIKPQNILLDDYYNAQISDFGLAKLL----------TLNQS------------------ 572
DIKP N+LLD + ++SDFGL L LN S
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 573 -----KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627
+ + + GT Y+A PE F + D +S GV++ E++ F E +E
Sbjct: 185 WKRNRRQLAFSTVGTPDYIA-PEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
Query: 628 -YAILTDW 634
Y + +W
Sbjct: 244 TYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 35/110 (31%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 526 GLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGY 585
GL +LH N +I++ D+K N+LLD +I+DFGL K + GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--STFCGTPEF 167
Query: 586 VASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 633
+A PE ++ T VD + GVL+ E++ F + EE +I+ D
Sbjct: 168 LA-PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 25/161 (15%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ G+ ++H +I+H D+K +NI L + +I DFG+++LL S + G
Sbjct: 114 QLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTG 167
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641
T Y+ SPE ++ + D++S G +L E+ +F E L+
Sbjct: 168 TPYYM-SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-----EGQNFLS--------- 212
Query: 642 GKLDDLVEGDMEAMNDIKCVE-KLVMVSIWCIQEDPSLRPT 681
+ +VEG ++ + + +M S+ + +DPSLRP+
Sbjct: 213 -VVLRIVEGPTPSLPETYSRQLNSIMQSM--LNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I L +LH +++ D+K +N++LD + +I+DFGL K + A K G
Sbjct: 103 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI--KDGATMKTFCG 158
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
T Y+A PE ++ VD + GV++ E++ R F
Sbjct: 159 TPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 34/130 (26%), Positives = 51/130 (39%), Gaps = 37/130 (28%)
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL------------- 567
F IA +L + IH DIKP N+LLD + ++SDFGL L
Sbjct: 105 FYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 568 -------------TLNQSKAI---KKAIR-------GTKGYVASPEWFRNSTITANVDVY 604
++ + K+ R GT Y+A PE F + D +
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIA-PEVFLQTGYNKECDWW 223
Query: 605 SFGVLLLEII 614
S GV++ E++
Sbjct: 224 SLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 58/248 (23%), Positives = 101/248 (40%), Gaps = 38/248 (15%)
Query: 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLL 480
++G F LV T + +++K D + ++ + E ++ + +V++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 481 GFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIH 540
+ +N L+ +FL G + + L +K F IA +L + IH
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124
Query: 541 CDIKPQNILLDDYYNAQISDFGLA------------KLLTLN--------------QSKA 574
DIKP N+LLD + ++SDFGL + LT N +++
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 575 IKKAIR-------GTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627
KK R GT Y+A PE F + D +S GV++ E++ F E +E
Sbjct: 185 WKKNRRQLAYSTVGTPDYIA-PEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
Query: 628 -YAILTDW 634
Y + +W
Sbjct: 244 TYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 444 VIVVKKLDRVFQDGE--KEFKN----EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497
++ +KK F+D E +E K E+ M+ +N+V L LV++++
Sbjct: 28 IVAIKK----FKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83
Query: 498 NGTLASFLFENLKPGW---NLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
L L E + G +R+ I +Q+ + + H N I+H DIKP+N+L+
Sbjct: 84 KNMLE--LLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN---DIVHRDIKPENLLISHND 137
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
++ DFG A+ L+ + + + T+ Y SPE + VD++S G +L E+
Sbjct: 138 VLKLCDFGFARNLSEGSNANYTEYV-ATRWY-RSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 43/171 (25%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 446 VVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
++ KL+ V + E ++ T + LV+LL + + L +++ G + L
Sbjct: 38 LLFKLNEV-----RHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL 92
Query: 506 FENLKPGWNLRANIA-FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
NL L + A F +A + IH D+KP+N L+D + +++DFGL+
Sbjct: 93 -NNLG---VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
Query: 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
K ++ G+ Y+A PE R VD +S G +L E +
Sbjct: 149 K-----GIVTYANSVVGSPDYMA-PEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 40/180 (22%), Positives = 86/180 (47%), Gaps = 28/180 (15%)
Query: 448 KKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLG-FCDEGQNRLLVYKFLNNGTLASFLF 506
K ++ ++ +++ E+ ++ H +V+LLG F +G+ +++ +F G + + +
Sbjct: 43 KVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIML 101
Query: 507 ENLKPGWN---LRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563
E L G ++ I Q+ L +LH S +IIH D+K N+LL + +++DFG+
Sbjct: 102 E-LDRGLTEPQIQV-ICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGV 156
Query: 564 AKLLTLNQSKAIKKAIRGTKGYVASPEW----------FRNSTITANVDVYSFGVLLLEI 613
S K ++ ++ +P W +++ D++S G+ L+E+
Sbjct: 157 --------SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 42/141 (29%), Positives = 64/141 (45%), Gaps = 15/141 (10%)
Query: 491 LVYKFLNNGTLASFL--FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548
LV + G L + L FE+ P R F IA +L +H +H DIKP N+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 549 LLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR-GTKGYVASPEWFRN-----STITANVD 602
LLD + +++DFG L +NQ ++ ++ GT Y+ SPE + D
Sbjct: 134 LLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYI-SPEILQAMEDGMGKYGPECD 190
Query: 603 VYSFGVLLLEIISCRKSFDIE 623
+S GV + E++ F E
Sbjct: 191 WWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK-KAI 579
F A +L L S +IH D+KP N+LLD + + +++DFG + ++++ ++
Sbjct: 146 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTA 203
Query: 580 RGTKGYVASPEWFR----NSTITANVDVYSFGVLLLEII 614
GT Y+ SPE + + D +S GV L E++
Sbjct: 204 VGTPDYI-SPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 44/173 (25%), Positives = 66/173 (38%), Gaps = 37/173 (21%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIA-FQIARGLL--- 528
H L L LV + G L L +PG L +A F A LL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLALE 117
Query: 529 HLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL---------TLNQSKAIKKAI 579
+LH+ I++ D+KP+NILL + + +SDF L+K L +
Sbjct: 118 YLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 580 R------------------GTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
GT+ Y+A PE + VD ++ G+LL E++
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIA-PEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 19/138 (13%)
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRANIA-FQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
+V +++ G A+ L +N+ L ++A A +L L + I+H D+KP N+L
Sbjct: 78 MVMEYVEGGDCAT-LLKNIGA---LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLL 133
Query: 550 LDDYYNAQISDFGLAKL----LTLNQSKA---------IKKAIRGTKGYVASPEWFRNST 596
+ + +++DFGL+K+ LT N + + K + GT Y+A PE
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIA-PEVILRQG 192
Query: 597 ITANVDVYSFGVLLLEII 614
VD ++ G++L E +
Sbjct: 193 YGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 46/185 (24%), Positives = 77/185 (41%), Gaps = 33/185 (17%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+V+K LD +D F ++ Q H +L + G C G ++V +F+ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 505 LFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
L + + W + +A Q+A L +L ++H ++ +NILL +
Sbjct: 107 LRKEKGRVPVAWKI--TVAQQLASALSYLE---DKNLVHGNVCAKNILL--------ARL 153
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVAS------------PEWFRN-STITANVDVYSFGV 608
GLA+ S IK + G S PE ++++ D +SFG
Sbjct: 154 GLAE----GTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGT 209
Query: 609 LLLEI 613
LLEI
Sbjct: 210 TLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 515 LRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN---- 570
L NI + L ++H I H DIKP+NI++D I D+G+A ++
Sbjct: 127 LIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
Query: 571 -QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
SK K RGT Y A + + +T D+ S G +L+
Sbjct: 184 EYSKEQKDLHRGTL-YYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 23/119 (19%), Positives = 39/119 (32%), Gaps = 16/119 (13%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRL-------LGFCDEGQNRLLVYKFLNNGTLASFLFENLK 510
E + + + L RL L + RL + + L E L
Sbjct: 84 RPLDPAERGALLEALARLLARLHSVPPEALPLARRLRRRLKLLRQLAAALRRLVAAELLD 143
Query: 511 PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS---DFGLAKL 566
L + + L L ++H D+ P N+L+D +++ DF A L
Sbjct: 144 RLAELWERLLAALLALLPALP----LVLVHGDLHPGNLLVDP--GGRVTGVIDFEDAGL 196
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 523 IARGLLHL--HVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
+AR LL +++ IIH DIK +N+L++ + + DFG A + S I
Sbjct: 265 VARQLLSAIDYIHGEG-IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 581 GTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
GT A PE T +VD++S G+++ E
Sbjct: 324 GTVDTNA-PEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 31/99 (31%), Positives = 46/99 (46%), Gaps = 6/99 (6%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
F A +L L S IH D+KP N+LLD + +++DFG + N A+
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204
Query: 580 RGTKGYVASPEWFRNSTITA----NVDVYSFGVLLLEII 614
GT Y+ SPE ++ D +S GV L E++
Sbjct: 205 -GTPDYI-SPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 709 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.6 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.59 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.56 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.55 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.52 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.15 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.01 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.93 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.88 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.82 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.79 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.69 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.69 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.44 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.39 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 98.31 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.21 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.18 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.1 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.07 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.79 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.74 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.72 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.68 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.52 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.5 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.47 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.3 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.12 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 97.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.02 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 96.94 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.92 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 96.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.72 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 96.72 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.68 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.3 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.28 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.21 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.21 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.03 | |
| PLN02236 | 344 | choline kinase | 95.89 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.85 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.71 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.46 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 95.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.25 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.05 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.56 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.31 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.51 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.45 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.24 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=437.53 Aligned_cols=288 Identities=40% Similarity=0.634 Sum_probs=248.7
Q ss_pred CCCCCChhhHhhhcccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeE
Q 038905 399 VPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVR 478 (709)
Q Consensus 399 ~~~~~~~~~~~~~~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~ 478 (709)
...|++.+++.+ |++|+....+|.|||+.| |+|.+ .++..||||++.....+..++|.+|+.++.+++|||||+
T Consensus 62 ~~~fs~~el~~A--T~~Fs~~~~ig~Ggfg~V-YkG~l---~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~ 135 (361)
T KOG1187|consen 62 LRSFSYDELRKA--TNNFSESNLIGEGGFGTV-YKGVL---SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVK 135 (361)
T ss_pred cceeeHHHHHHH--HhCCchhcceecCCCeEE-EEEEE---CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCccc
Confidence 346889999999 999997666666666655 78888 455999999987654331567999999999999999999
Q ss_pred EEeEEEcCC-eEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC
Q 038905 479 LLGFCDEGQ-NRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555 (709)
Q Consensus 479 l~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 555 (709)
|+|||.+.+ +++||||||++|+|.++|+... .++|..|.+|+.++|+||+|||+.|...|||||||++|||||++++
T Consensus 136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999999999 5999999999999999999865 7999999999999999999999998889999999999999999999
Q ss_pred eEEccccccccccccccccceecc-ccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHH
Q 038905 556 AQISDFGLAKLLTLNQSKAIKKAI-RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 634 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~~~~~~~-~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 634 (709)
+||+|||+|+......... ... .||.+|++ ||++..+..+.|+|||||||+|+||++|+++.+.........+..|
T Consensus 216 aKlsDFGLa~~~~~~~~~~--~~~~~gt~gY~~-PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSV--STTVMGTFGYLA-PEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred EEccCccCcccCCccccce--eeecCCCCccCC-hhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999999997655411111 222 89999999 9999999999999999999999999999999987654445558889
Q ss_pred HHHhhhcCCccccccCccc-ccCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccC
Q 038905 635 AFDCYRNGKLDDLVEGDME-AMNDI-KCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEV 695 (709)
Q Consensus 635 ~~~~~~~g~~~~l~~~~~~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 695 (709)
++..+..+++.+++|+.+. ..... .+..++..++..|++.+|.+||+|.||+++|+.+...
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999999999986 44443 6888999999999999999999999999999665433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=376.09 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=216.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc---ccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR---VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..|.++..+|.|||+.+|-...+ ..+..+|+|++.+ ......+.+.+|++|.++|+|||||+++++|++.+..|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~---~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL---DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc---CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 56888999999999999887777 5788999998865 23445678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||.|+|++++|..++.++..+++.+++.++.||+.||.||| +.+|||||||..|++|++++++||+|||||..+..+
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999999998889999999999999999999999 999999999999999999999999999999999876
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.++. .++||||.|+| ||++.....+..+||||+|||||-|+.|++||+...-.+ .++.+...+..
T Consensus 172 ~Erk--~TlCGTPNYIA-PEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y~----- 236 (592)
T KOG0575|consen 172 GERK--KTLCGTPNYIA-PEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEYS----- 236 (592)
T ss_pred cccc--ceecCCCcccC-hhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCcc-----
Confidence 5544 78999999999 999999999999999999999999999999998654333 22222222211
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+...+....++|..+|+.||.+|||+++|+.
T Consensus 237 -----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 -----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12245567889999999999999999999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=362.57 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=206.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-------hHHHHHHHHHHHhccCcCceeEEEeEEEcCC
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-------GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ 487 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~ 487 (709)
.+.....+|+|+|+.|-++... .+++.||||++++..-. ......+|+++|++|+|||||++++++.+.+
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~---~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEK---KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEc---ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3445677888888877666655 68999999998643211 2234679999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC---CCeEEcccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY---YNAQISDFGLA 564 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla 564 (709)
..|+||||++||+|.+++-.++.+.+..-..++.|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999999999999999999999999999999 9999999999999999766 77999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCC---CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI---TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~---s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 641 (709)
+..+.. ..+.+.||||.|+| ||++.+..+ ..++|+||+|||||-+++|.+||..+..... +.+++..
T Consensus 327 K~~g~~---sfm~TlCGTpsYvA-PEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQI~~ 396 (475)
T KOG0615|consen 327 KVSGEG---SFMKTLCGTPSYVA-PEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQILK 396 (475)
T ss_pred hccccc---eehhhhcCCccccC-hhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHHHhc
Confidence 988632 23378999999999 999987653 3478999999999999999999986543321 2234444
Q ss_pred CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
|+... ........+++..+++.+||+.||++|||++|+++
T Consensus 397 G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Ccccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 44332 11223467889999999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=352.55 Aligned_cols=250 Identities=23% Similarity=0.294 Sum_probs=205.2
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC-eEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ-NRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~-~~~lV~ 493 (709)
+.....+|.|.-|.|+.+.+. .++...|+|.+... .....+++.+|++++++.+||+||+++|.|.... ...++|
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk---~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHK---PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEc---CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 333344455555555555555 68999999998533 3445689999999999999999999999999888 599999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
|||++|||+.++...+++++....+|+.+|++||.|||+ +++||||||||+|||++..|.+||+|||.++.+...
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999999999988899999999999999999999994 389999999999999999999999999999987654
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccch--hhHHhHHHHHHHhhhcCCccccccCc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMG--EEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
...++.||..||| ||.+.+..|+.++||||||++++|+..|+.|+..... .....+. ..+..+....+.+
T Consensus 233 -~a~tfvGT~~YMs-PERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll----~~Iv~~ppP~lP~-- 304 (364)
T KOG0581|consen 233 -IANTFVGTSAYMS-PERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL----CAIVDEPPPRLPE-- 304 (364)
T ss_pred -hcccccccccccC-hhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH----HHHhcCCCCCCCc--
Confidence 2278999999999 9999999999999999999999999999999987522 1222221 1122222222221
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..++.+++.++..||++||.+|||++|+++
T Consensus 305 ------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 305 ------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ------ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 147788999999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.68 Aligned_cols=247 Identities=31% Similarity=0.469 Sum_probs=203.1
Q ss_pred ecCeeEEEEEEEEEEecCCCceE-EEEEEcccccchh--HHHHHHHHHHHhccCcCceeEEEeEEEcCC-eEEEEEeecC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTV-IVVKKLDRVFQDG--EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ-NRLLVYKFLN 497 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~-~~~lV~Ey~~ 497 (709)
+|.|++++| |++.. .++. ||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus 49 iG~G~~g~V-~~~~~----~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 49 LGSGSFGTV-YKGKW----RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred cccCCceeE-EEEEe----CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 555555555 67777 3445 9999987643222 569999999999999999999999999888 7999999999
Q ss_pred CCCHHHHHhh--CCCCChHHHHHHHHHHHHHHHHhhhcCCCC-eEecCCCCCceeecCCC-CeEEccccccccccccccc
Q 038905 498 NGTLASFLFE--NLKPGWNLRANIAFQIARGLLHLHVNCSSQ-IIHCDIKPQNILLDDYY-NAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 498 ~gsL~~~l~~--~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~ 573 (709)
+|+|..++++ ...+++..+.+++.+||+|+.||| +.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 9999999998 467999999999999999999999 777 99999999999999998 99999999998765432
Q ss_pred cceeccccCccccccccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 574 AIKKAIRGTKGYVASPEWFR--NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~--~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
...+...||+.||| ||++. ...|+.|+|||||||+||||++|+.||....... .+......+....+
T Consensus 199 ~~~~~~~GT~~wMA-PEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v~~~~~Rp~~---- 267 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMA-PEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAVVVGGLRPPI---- 267 (362)
T ss_pred ccccCCCCCccccC-hhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCCCCCC----
Confidence 11145789999999 99999 5699999999999999999999999998665421 12222333332222
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+......+..++..||+.||..||++.+++.+|+.+..
T Consensus 268 -----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 268 -----PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 22266788899999999999999999999999998653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=350.61 Aligned_cols=243 Identities=25% Similarity=0.282 Sum_probs=208.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc---ccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR---VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
...|.....+|.|+||+|+.+... .+++..|+|.+++ ......+..++|..||.+++||+||+++-.|++.+++
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~---dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKK---DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEc---ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 678999999999999999998888 5677777777653 3444567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
|||+||+.||.|..+|.+++.+++.....++.+|+.||.||| +++||||||||+|||||++|+++|+||||++..-.
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999999996554
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... +.++|||+.||| ||++.+..|+..+|+||||+++|||++|.+||..+...+ ..+.+..++...
T Consensus 178 ~~~~--t~tfcGT~eYmA-PEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k~~~--- 244 (357)
T KOG0598|consen 178 DGDA--TRTFCGTPEYMA-PEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGKLPL--- 244 (357)
T ss_pred CCCc--cccccCCccccC-hHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCcCCC---
Confidence 4333 267999999999 999999999999999999999999999999998765433 223333333111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCC
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 680 (709)
.+......+++++...++.||++|.
T Consensus 245 ------~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 ------PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ------CCccCCHHHHHHHHHHhccCHHHhc
Confidence 1223566788999999999999995
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=347.21 Aligned_cols=204 Identities=26% Similarity=0.381 Sum_probs=180.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.+|.....+|.|.|+.||...+. ..+..||||.+... .....+-+..|+.+|++++|||||++++++.+++..+|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~---~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHK---KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccceehhhccCcceEEEEEeEec---cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 45555455788888877655555 46699999998765 45566778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC------CCeEEccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY------YNAQISDFGLAK 565 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~------~~~kl~DFGla~ 565 (709)
|||||.||+|..||..++.+++...+.++.|||.||++|| +++||||||||+||||+.. -.+||+|||+|+
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999999999999999999999999999999 9999999999999999764 569999999999
Q ss_pred cccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhh
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~ 627 (709)
.+.... ...+.||+|-||| ||+++.+.|+.|+|+||+|++||+|++|+.||+.....+
T Consensus 164 ~L~~~~---~a~tlcGSplYMA-PEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMA-PEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hCCchh---HHHHhhCCccccC-HHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 987443 2378999999999 999999999999999999999999999999998766554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=335.93 Aligned_cols=256 Identities=22% Similarity=0.296 Sum_probs=210.6
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc--ccchhHHHHHHHHHHHhccCcCceeEEEe-EEEcCCe-EE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR--VFQDGEKEFKNEVVMIGQTYHKNLVRLLG-FCDEGQN-RL 490 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nlv~l~~-~~~~~~~-~~ 490 (709)
+|.....+|.|.|++||.+..+ .++..+|.|+++- ........+..|+.+|++|+|||||++++ .+.++.+ ++
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~---~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCL---LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHcCCcchheEEeeec---cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 4555667888999999888888 6789999998863 34455678999999999999999999998 4555555 88
Q ss_pred EEEeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCceeecCCCCeEEccccccc
Q 038905 491 LVYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNCSS-QIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
||||||.+|+|...+.+. ..++++.+++++.|+++||.++|....+ -|+||||||.||+|+.+|.+||+||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999988743 3589999999999999999999953323 38999999999999999999999999999
Q ss_pred cccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
.+....... ...+|||.||+ ||.+++.+|+.|+||||+||++|||+.-+.||....-. ...+.+.+|+..
T Consensus 177 ~l~s~~tfA--~S~VGTPyYMS-PE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~-------~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 177 FLSSKTTFA--HSLVGTPYYMS-PERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL-------SLCKKIEQGDYP 246 (375)
T ss_pred HhcchhHHH--HhhcCCCcccC-HHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH-------HHHHHHHcCCCC
Confidence 987655433 78999999999 99999999999999999999999999999999865211 133455566544
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
.+. ....++.+..|+..|+..||+.||+...+++-+..
T Consensus 247 ~~p--------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 PLP--------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCc--------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 332 24678899999999999999999996555554433
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=326.86 Aligned_cols=238 Identities=26% Similarity=0.303 Sum_probs=209.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+||.|.++... ..+...|+|++++. .....+...+|..+|+.+.||+++++++.+.+.+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k---~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREK---HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEc---cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 567888899999999999988888 45777888887653 334456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+|||||++||.|.+++++.+++++...+.++.||+.||.||| +.+|++|||||+|||||.+|++||+|||+|+.+..
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999999998764
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
. +-+.||||.|+| ||++..+++..++|+|||||++|||+.|.+||....... +++.+.+|++..
T Consensus 197 r-----T~TlCGTPeYLA-PEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v~f--- 260 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLA-PEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKVKF--- 260 (355)
T ss_pred c-----EEEecCCccccC-hHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCcccC---
Confidence 4 278999999999 999999999999999999999999999999998665422 455566665432
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCC
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLR 679 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 679 (709)
+......+.+++...||.|-.+|
T Consensus 261 -------P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 -------PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -------CcccCHHHHHHHHHHHhhhhHhh
Confidence 33455678889999999999999
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=353.87 Aligned_cols=257 Identities=27% Similarity=0.389 Sum_probs=205.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
...+.+.+|.|.||.| +.|.. .....||+|.+... ....+.|.+|+++|++|+|+|||+++|+|..+..++||
T Consensus 207 ~l~l~~~LG~G~FG~V---~~g~~---~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEV---WLGKW---NGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred HHHHHHHhcCCccceE---EEEEE---cCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 3344455555555555 66776 34557888887654 33567899999999999999999999999998899999
Q ss_pred EeecCCCCHHHHHhh--CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFE--NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+.|+|.++|.+ ...+...+.+.++.|||+|++||+ ++++|||||.+.|||++++..+||+|||||+....+
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999999997 346889999999999999999999 999999999999999999999999999999965544
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.-... ..-.-...|.| ||.+....++.|+|||||||+|+||+| |+.|+......+.. + .++
T Consensus 357 ~Y~~~-~~~kfPIkWtA-PEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~-------~---------~le 418 (468)
T KOG0197|consen 357 EYTAS-EGGKFPIKWTA-PEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL-------E---------LLE 418 (468)
T ss_pred ceeec-CCCCCCceecC-HHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH-------H---------HHh
Confidence 32211 22222344666 999999999999999999999999998 66676655433321 2 233
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCCC
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDV 697 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 697 (709)
...+...+..++..+.+|+..||+.+|++|||++.+...|+.+.+...
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 344444566789999999999999999999999999999988765443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.59 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=215.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.|.....+|+|..|.||.+... ..++.||||+++...+...+-+.+|+.+|+..+|+|||+++..+..++++++|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~---~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKI---STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeec---cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4556677889989988888887 5788899999998877788889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
||+||+|.+.+.+. .+++.++..|++++++||+||| .++|+|||||.+||||+.+|.+||+|||++..+.......
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 99999999988654 5899999999999999999999 9999999999999999999999999999999887665433
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
.+++|||.||| ||+.....|.+|+||||||++++||+-|.+||-.+..-....+ ...+|.. ..
T Consensus 427 --~TmVGTPYWMA-PEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL------Ia~ng~P--------~l 489 (550)
T KOG0578|consen 427 --STMVGTPYWMA-PEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTP--------KL 489 (550)
T ss_pred --ccccCCCCccc-hhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH------HhhcCCC--------Cc
Confidence 78999999999 9999999999999999999999999999999986554332222 1222322 22
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......+..+.+++.+||+.|+++|+++.|+++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 224456778999999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=341.54 Aligned_cols=257 Identities=25% Similarity=0.324 Sum_probs=215.9
Q ss_pred cccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc---ccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCC
Q 038905 412 NMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR---VFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQ 487 (709)
Q Consensus 412 ~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~ 487 (709)
...+|..+..+|.|++.+|+.+... ..++.+|||++++ ..+...+-+..|-.+|.+| .||.||+|+-.|++..
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~---~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREK---ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred ChhhcchhheeccccceeEEEeeec---CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 3778888888889999988888877 5789999999864 3344556688899999999 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
.+|+|+||+++|+|.++|.+.+.+++...+.++.+|+.||.||| +.|||||||||+|||||+||++||+|||.|+.+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999999999999999999999999999999999 999999999999999999999999999999988
Q ss_pred cccccc---------cc--eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH
Q 038905 568 TLNQSK---------AI--KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 636 (709)
Q Consensus 568 ~~~~~~---------~~--~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 636 (709)
...... .. ...++||..|++ ||++.+...++.+|+|+|||+||.|+.|.+||.... ++..+..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVS-PElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyliFqk--- 298 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVS-PELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYLIFQK--- 298 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccC-HHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHHHHHH---
Confidence 643221 11 145999999999 999999999999999999999999999999997654 3332221
Q ss_pred HhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHccc
Q 038905 637 DCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVV 692 (709)
Q Consensus 637 ~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~ 692 (709)
+.. +........++.+.+|+.+.|..||.+|+|.+|+-+ +++++
T Consensus 299 --I~~----------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 299 --IQA----------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred --HHH----------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 111 111123345578889999999999999999998877 34443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=329.08 Aligned_cols=257 Identities=25% Similarity=0.357 Sum_probs=204.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC--eEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--NRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--~~~ 490 (709)
..++.....+|.|.++.|++.... .++...|||..........+.+.+|+.+|.+++|||||+.+|.....+ ..+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~---~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNK---KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEec---CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 345666778888999988777666 447888999887654334677999999999999999999999855444 688
Q ss_pred EEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-CCCeEEcccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-YYNAQISDFGLAKLLT 568 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~ 568 (709)
++|||+++|+|.+++.+.+ ++++..+..+++||++||.||| +++||||||||+|||++. ++.+||+|||+++...
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999877 7999999999999999999999 999999999999999999 7999999999998776
Q ss_pred cccc-ccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 569 LNQS-KAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 569 ~~~~-~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
.... ......+.||+.||| ||++.+. ....++|||||||++.||+||.+||.... ............+....
T Consensus 170 ~~~~~~~~~~~~~Gtp~~ma-PEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~~~P~ 243 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMA-PEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGREDSLPE 243 (313)
T ss_pred cccccccccccccCCccccC-chhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccCCCCC
Confidence 4111 122256899999999 9999963 34459999999999999999999997421 01111222222222221
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
.+...+....+++..|++.||++|||++++++..-
T Consensus 244 ---------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 244 ---------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 23336678899999999999999999999998543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=312.38 Aligned_cols=264 Identities=19% Similarity=0.233 Sum_probs=204.8
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.|......|.|++|.|+..... .+++.||||++....+ ...+-..+|+++|++++|+|||.++++|......+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk---~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNK---DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred HHhhhhccccCcceEEEEeccC---CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 3455556777777766555444 6899999999854322 2335578999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
+|||+..-|.++-.....++.+...+++.|+++|+.|+| +.++|||||||+|||++.++.+||||||+|+.+.....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 999998666665444457899999999999999999999 99999999999999999999999999999998875332
Q ss_pred ccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH--------HhhhcCC
Q 038905 573 KAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCYRNGK 643 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~g~ 643 (709)
..+..+.|+.|.| ||.+.+ ..|...+||||+||++.||++|.+-|...++.+..+.+.... ..+....
T Consensus 157 --~YTDYVATRWYRa-PELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 157 --NYTDYVATRWYRA-PELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --hhhhhhhhhhccC-hhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2267888999998 999887 789999999999999999999999998877755444332221 1111111
Q ss_pred ------ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 ------LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ------~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+.+.-+........+.....+.+++..|++.||.+|++.+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111110011112235567899999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.98 Aligned_cols=261 Identities=20% Similarity=0.266 Sum_probs=210.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchh-HHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDG-EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
...|.....+|.|..+.||.+... ..+..||||+++...-+. .+.+++|+..|+.++||||++++..|..++.+++
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~---p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCI---PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeec---ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 455666677788877888887777 567999999997654433 4889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
||.||.+||+.+.++..- .+++..+..|++++++||.||| .+|.||||||+.||||+.+|.+||+|||.+--+-.
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999998753 4899999999999999999999 99999999999999999999999999998755443
Q ss_pred cccc-cce-eccccCcccccccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 570 NQSK-AIK-KAIRGTKGYVASPEWFRNS--TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 570 ~~~~-~~~-~~~~Gt~~y~aaPE~~~~~--~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
...+ ... ..+.||+.||| ||+++.. .|+.|+||||||++..||.+|..||.......... +-.++...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmA-PEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-------~tLqn~pp 250 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMA-PEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-------LTLQNDPP 250 (516)
T ss_pred cCceeeEeeccccCcccccC-hHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-------HHhcCCCC
Confidence 3322 112 56899999999 9996543 69999999999999999999999997544322111 11234444
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+.-..+...........+.+++..|++.||++|||+.++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 333222333334445668889999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=334.31 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=207.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc----cc-hhHHHHHHHHHHHhccC-cCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV----FQ-DGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~ 486 (709)
..++.....+|.|+|++|+.+.+. .++..||+|.+++. .. ...+.+.+|+.++++++ ||||++++.++...
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~---~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHR---LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeec---cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 557777888899999988777777 45699999977653 11 34567789999999999 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-CCeEEccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-YNAQISDFGLAK 565 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~ 565 (709)
.+.++||||+.||+|.+++.+.+++.+.....++.|++.|+.||| +++|+||||||+||||+.+ +++||+|||++.
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 999999999999999999999889999999999999999999999 9999999999999999999 999999999999
Q ss_pred ccc-ccccccceeccccCcccccccccccCCC-CC-cccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 566 LLT-LNQSKAIKKAIRGTKGYVASPEWFRNST-IT-ANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 566 ~~~-~~~~~~~~~~~~Gt~~y~aaPE~~~~~~-~s-~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
... .+. ...+.+||+.|+| ||++.+.. |+ .++||||+||+||-|++|+.||+...... .+..+..+
T Consensus 170 ~~~~~~~---~l~t~cGsp~Y~a-PEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki~~~ 238 (370)
T KOG0583|consen 170 ISPGEDG---LLKTFCGSPAYAA-PEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKIRKG 238 (370)
T ss_pred ccCCCCC---cccCCCCCcccCC-HHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHHhcC
Confidence 884 222 2278999999999 99999987 86 78999999999999999999998633211 12222222
Q ss_pred CccccccCcccccCCHHH-HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 643 KLDDLVEGDMEAMNDIKC-VEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... . +... +..+..++..|++.||.+|+|+.+++.
T Consensus 239 ~~~--------~--p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 EFK--------I--PSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred Ccc--------C--CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 211 0 1112 678899999999999999999999984
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.79 Aligned_cols=249 Identities=24% Similarity=0.280 Sum_probs=207.4
Q ss_pred hhcccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCe
Q 038905 410 KRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQN 488 (709)
Q Consensus 410 ~~~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~ 488 (709)
..+..+|.....+|.|+||+|+++....+++..+.+|+||-.....+..+..+.|.+|+.... ||.|++++.+++..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344678999999999999999888888544444444444444556778888999999988875 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
+++||||+.||++ .++.+...+++.....++..|+.||.||| .++||+||||.+|||||.+|++||+||||+|...
T Consensus 444 l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999993 33445568999999999999999999999 9999999999999999999999999999999765
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... +.++||||.||| ||++.+..|+..+|+|||||+||||+.|..||...++++. ++.+...
T Consensus 520 ~~g~~--TsTfCGTpey~a-PEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-------FdsI~~d------ 583 (694)
T KOG0694|consen 520 GQGDR--TSTFCGTPEFLA-PEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-------FDSIVND------ 583 (694)
T ss_pred CCCCc--cccccCChhhcC-hhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcC------
Confidence 44433 389999999999 9999999999999999999999999999999987765552 2222211
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 682 (709)
+..++...+.+.+.|+..++..+|++|.-+
T Consensus 584 ----~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 ----EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 122345567888999999999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=335.12 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=212.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.-++-++.+|.|+.+.|.++.+. .+++..|||++.+.. ......+.+|+.||+.+.|||++++++++++..++|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~---~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHA---ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcc---cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 34566778899999966666665 789999999987652 223356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||.||+++|.|.+++.+++++.+++..+++.||+.|+.|+| ..+|+||||||+|+|||.++++||+|||||.+-..+
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999999999999999999999999999999999 899999999999999999999999999999864433
Q ss_pred ccccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
. ...+-||+|.|.+ ||++.+.+| ..++||||.|||||.|++|+.||+...-. ....++..|..+-
T Consensus 166 k---lLeTSCGSPHYA~-PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-------~LLlKV~~G~f~M--- 231 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAA-PEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-------VLLLKVQRGVFEM--- 231 (786)
T ss_pred c---cccccCCCcccCC-chhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCcccC---
Confidence 2 2267899999998 999999998 56899999999999999999999833211 1223344443321
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHcccccC
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVVVEV 695 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~ 695 (709)
+...+.++.+|+..|+..||++|.|++||++ .|.+...+
T Consensus 232 -------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 232 -------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred -------CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 2345667889999999999999999999998 45554443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=348.96 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=210.6
Q ss_pred ccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+...+..+|.|.||+||.+..... .+....||||.++....+ ...+|++|+++++.++|||||+|+|+|.+++..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 334444555566666654443322 256788999999876655 77899999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC--------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeE
Q 038905 492 VYKFLNNGTLASFLFENL--------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~--------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 557 (709)
|+|||..|+|.+||..+. +++..+.+.|+.|||.|+.||- ++.+|||||..+|+|+.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence 999999999999998432 2677889999999999999999 89999999999999999999999
Q ss_pred EccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHH
Q 038905 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 636 (709)
Q Consensus 558 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 636 (709)
|+||||++.+-..+-......-.-...||+ ||.+...+|++++||||||||||||++ |+.|+.....++ +.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMp-pEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VI 715 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMP-PESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VI 715 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCC-HHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HH
Confidence 999999986543221111111222457898 999999999999999999999999998 778987766555 34
Q ss_pred HhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccC
Q 038905 637 DCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEV 695 (709)
Q Consensus 637 ~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 695 (709)
+.+++|++ ...+..++.++..|+..||+.+|++||++.||-..|+.....
T Consensus 716 e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 716 ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 45555554 233556889999999999999999999999999999876543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.14 Aligned_cols=262 Identities=26% Similarity=0.348 Sum_probs=202.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcC-C
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEG-Q 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~-~ 487 (709)
.++|.....+|.|+++.||.+.... .......||||++.... ....+.+.+|+.++.++ +|||||++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 3456666778888888887665432 22345789999986533 23446789999999999 899999999988764 4
Q ss_pred eEEEEEeecCCCCHHHHHhhC-----------------------------------------------------------
Q 038905 488 NRLLVYKFLNNGTLASFLFEN----------------------------------------------------------- 508 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~----------------------------------------------------------- 508 (709)
..++||||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999998753
Q ss_pred ---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCccc
Q 038905 509 ---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGY 585 (709)
Q Consensus 509 ---~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y 585 (709)
..+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||+++.+.............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 13667788899999999999999 899999999999999999999999999999876443322222345567889
Q ss_pred ccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHH
Q 038905 586 VASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL 664 (709)
Q Consensus 586 ~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l 664 (709)
+| ||++.+..++.++||||||+++|||++ |..||......+. .......+..... ....+..+
T Consensus 243 ~a-PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~l 306 (338)
T cd05102 243 MA-PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRMRA---------PENATPEI 306 (338)
T ss_pred cC-cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCCCC---------CCCCCHHH
Confidence 98 999999999999999999999999997 9999875432221 1111222221111 12345678
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 665 VMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 665 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.+++..||+.||.+|||+.+++++|+.+.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=323.04 Aligned_cols=265 Identities=20% Similarity=0.195 Sum_probs=210.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC--Ce
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~ 488 (709)
...|.+...+|.|.++.||.+... .+++.||+|++.... ........+|+.||++|.||||++|.+...+. ..
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~---~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDL---ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeec---ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 456777778899999999887777 689999999987554 34456778999999999999999999998766 68
Q ss_pred EEEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
+|||+|||++ +|.-++...+ .++..++..++.|++.||.|+| .++|+|||||.+|||||.+|.+||+|||||+++
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999999988 8888887644 7999999999999999999999 999999999999999999999999999999988
Q ss_pred cccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH-----Hhhhc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----DCYRN 641 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~ 641 (709)
........ +..+-|..|.+ ||.+.+. .|+.++|+||.||||.||+.|++.+....+.+....+-.+- ..|..
T Consensus 269 ~~~~~~~~-T~rVvTLWYRp-PELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 269 TPSGSAPY-TSRVVTLWYRP-PELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred cCCCCccc-ccceEEeeccC-hHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 77665544 66677999998 9998875 69999999999999999999999998876644332221110 11221
Q ss_pred CCccc--cccC------cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 GKLDD--LVEG------DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 g~~~~--l~~~------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.++.. +..+ .+.. .....+....+|+..+|..||.+|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 12211 1111 0111 12234566788999999999999999998876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=321.68 Aligned_cols=245 Identities=18% Similarity=0.294 Sum_probs=197.6
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchh---HHHHHHHHHHHhccCcCceeEEEeEEEc----CCeEEEE
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDG---EKEFKNEVVMIGQTYHKNLVRLLGFCDE----GQNRLLV 492 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nlv~l~~~~~~----~~~~~lV 492 (709)
..+|.|+++.| |.+.. +++.||||++....... .+.+.+|+.++.+++|||||+++|++.+ ....++|
T Consensus 26 ~~i~~g~~~~v-~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 26 VLIKENDQNSI-YKGIF----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred eEEeeCCceEE-EEEEE----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 55666677666 55555 57899999987653333 4678899999999999999999999876 3567899
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCC-CCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCS-SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++|+|.+++.+...+++.....++.+++.||.||| + .+++||||||+|||+++++.+||+|||+++.+....
T Consensus 101 ~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 101 LEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred EEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999999988888999999999999999999999 5 488899999999999999999999999998764332
Q ss_pred cccceeccccCcccccccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
....|+..|+| ||++.+ ..++.++|||||||++|||++|+.||......+. ...+..+...
T Consensus 178 -----~~~~~~~~y~a-PE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~---- 240 (283)
T PHA02988 178 -----FKNVNFMVYFS-YKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-------YDLIINKNNS---- 240 (283)
T ss_pred -----ccccCcccccC-HHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcCCC----
Confidence 34568899998 999976 6899999999999999999999999975543221 1111111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
...+...++.+.+++.+||+.||++|||++++++.|+...
T Consensus 241 ----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 ----LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ----CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0112235667999999999999999999999999998653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=314.44 Aligned_cols=246 Identities=19% Similarity=0.308 Sum_probs=206.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|.+|+|-.+.. ...++.||||.+.+. .++..-.+++|++||..|+||||++++++|+..+...|
T Consensus 54 RyE~~etLGkGTYGKVk~A~e---~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYE---HKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred HHHHHHHhcCCcccceeehhh---ccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 455555677777775544443 367999999988654 33444578999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||..+|.|.+|+.+.+.+++.+...+++||..|+.|+| ..+++|||||.+|||||+++++||+||||+-++..+.
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999998876544
Q ss_pred cccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.. .++||+|-|.+ ||++.+.+| .+.+|.|||||+||-|+.|..||+..+... ..+++..|...+
T Consensus 208 fL---qTFCGSPLYAS-PEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvrQIs~GaYrE---- 272 (668)
T KOG0611|consen 208 FL---QTFCGSPLYAS-PEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVRQISRGAYRE---- 272 (668)
T ss_pred HH---HHhcCCcccCC-ccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHHHhhcccccC----
Confidence 33 78999999998 999999998 578999999999999999999998754322 223333343322
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
+..+....-+|+|||..+|++|.|+.+|...
T Consensus 273 -------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 -------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 2234456789999999999999999999774
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.49 Aligned_cols=253 Identities=18% Similarity=0.285 Sum_probs=208.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.+.|.....+|.|+||.||++... .++..+|+|++.+. .....+.++.|-.+|....+++||+|+-.|++.+.+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk---~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKK---DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cccchhheeeccccceeEEEEEEc---cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 678888899999999999999888 57888888888754 344567789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
||||||++||++..+|.+.+.+++.....++.+++.|+..+| +.|+|||||||+|+|||..|++||+||||++-+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999999863321
Q ss_pred c-----------------------cc-----c-----------------cceeccccCcccccccccccCCCCCcccchH
Q 038905 570 N-----------------------QS-----K-----------------AIKKAIRGTKGYVASPEWFRNSTITANVDVY 604 (709)
Q Consensus 570 ~-----------------------~~-----~-----------------~~~~~~~Gt~~y~aaPE~~~~~~~s~k~Dvw 604 (709)
. .. . ......+|||-|+| ||++.+..|+..+|+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiA-PEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIA-PEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccc-hHHHhcCCCCccccHH
Confidence 0 00 0 00123679999999 9999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCccchhh-HHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC--
Q 038905 605 SFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-- 681 (709)
Q Consensus 605 SlGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-- 681 (709)
|||||+|||+.|.+||..+...+ +..+..|... +..........+..++|..|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 99999999999999999877644 3333322110 1111122234788899999999 9999965
Q ss_pred -HHHHHH
Q 038905 682 -MRKVSQ 687 (709)
Q Consensus 682 -~~ev~~ 687 (709)
++||-+
T Consensus 438 G~~EIK~ 444 (550)
T KOG0605|consen 438 GAEEIKK 444 (550)
T ss_pred cHHHHhc
Confidence 566554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=340.69 Aligned_cols=259 Identities=22% Similarity=0.396 Sum_probs=221.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.......+|+|.||+|+.......++....||||.++... +....+|..|..||++++||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3446678899999999777666677888999999998654 345578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||+||+|+.+|+++. ++.+.+...++++|+.|++||. +.++|||||.+.|||++.+...|++||||++.+.++..
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 9999999999998764 7999999999999999999999 89999999999999999999999999999998877663
Q ss_pred ccceeccccC--cccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 573 KAIKKAIRGT--KGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 573 ~~~~~~~~Gt--~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ++.-|. ..|-| ||.+.-.+++.++||||||+||||.++ |.+|+-....++-. +.++
T Consensus 787 ~~y-tt~GGKIPiRWTA-PEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI----------------kaIe 848 (996)
T KOG0196|consen 787 AAY-TTLGGKIPIRWTA-PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----------------KAIE 848 (996)
T ss_pred ccc-cccCCccceeecC-hhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----------------HHHH
Confidence 332 333332 34666 999999999999999999999999987 88998655444421 2234
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
...+...+++++..|.+|+++|||+|-.+||.+.|++.+|.++..
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 455566688999999999999999999999999999999998653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.83 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=200.5
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
....+|+|.||+| |+|.. .-.||||+++.. ..+..+.|++|+..+++.+|.||+-++|+|..... .+|+.+
T Consensus 396 l~~rIGsGsFGtV-~Rg~w-----hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 396 LGERIGSGSFGTV-YRGRW-----HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred ccceeccccccce-eeccc-----ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 3445666666666 77777 456899988644 34466889999999999999999999999988777 999999
Q ss_pred cCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 496 LNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 496 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
|+|.+|..+|+... +++....+.|++||++|+.||| .++|||||||..||+|++++.|||+||||+..-..-....
T Consensus 469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 99999999998654 7999999999999999999999 9999999999999999999999999999997543322111
Q ss_pred ceeccccCcccccccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 575 IKKAIRGTKGYVASPEWFRN---STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
......|..-||| ||+++. .+|+..+||||||+|+|||++|..||.....+... |.-|+..-..|.
T Consensus 546 q~~qp~gsilwmA-PEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi---------fmVGrG~l~pd~- 614 (678)
T KOG0193|consen 546 QLEQPHGSLLWMA-PEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII---------FMVGRGYLMPDL- 614 (678)
T ss_pred ccCCCccchhhhc-HHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE---------EEecccccCccc-
Confidence 1244567888999 999974 46999999999999999999999999843322211 111221111111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.....+....+.+|+..||..++++||.+.+|+.+|+.+..
T Consensus 615 --s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 615 --SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred --hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11134567789999999999999999999999998877554
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.95 Aligned_cols=241 Identities=25% Similarity=0.396 Sum_probs=201.7
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
...-+|+|..|.| +.|.+ .+..||||+..... ..+++.|++|+|+||+.+.|+|......+||||||.
T Consensus 128 ELeWlGSGaQGAV-F~Grl----~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 128 ELEWLGSGAQGAV-FLGRL----HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhccCcccce-eeeec----cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 3345677777766 56666 48899999865432 467889999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
.|-|...|.....+.......+..+||.|+.||| .++|||||||.-|||+..+..+||+|||.++......+ +-
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kM 269 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KM 269 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hh
Confidence 9999999999888999999999999999999999 88999999999999999999999999999987765422 25
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
.++||..||| ||++++.++++|+||||||||||||+||..|+..-...- .+| |-. ...+....+
T Consensus 270 SFaGTVaWMA-PEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIw-----GVG----sNsL~LpvP 333 (904)
T KOG4721|consen 270 SFAGTVAWMA-PEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIW-----GVG----SNSLHLPVP 333 (904)
T ss_pred hhhhhHhhhC-HHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEE-----ecc----CCcccccCc
Confidence 7899999999 999999999999999999999999999999996432110 001 100 112233345
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
..+++-+.-|+++||+..|..||++.+++..|+-.
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 56788899999999999999999999999999654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.69 Aligned_cols=261 Identities=25% Similarity=0.331 Sum_probs=202.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
.++|.....+|.|+|+.||.+.... .......||||+++... ....+.+.+|+.++..+ +|||||++++++.++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 3456667778888888886654321 22456789999986432 33456789999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC-----------------------------------------------------------
Q 038905 489 RLLVYKFLNNGTLASFLFENL----------------------------------------------------------- 509 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 509 (709)
.++||||+++|+|.+++.+..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986421
Q ss_pred ----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 510 ----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 510 ----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
.+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 3677888999999999999999 889999999999999999999999999999876544332
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
.......++..|+| ||++.+..++.++||||||+++|||++ |..||........ ..+.+..+....
T Consensus 271 ~~~~~~~~~~~y~a-PE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~------ 337 (375)
T cd05104 271 VVKGNARLPVKWMA-PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMIKEGYRML------ 337 (375)
T ss_pred cccCCCCCCcceeC-hhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHHHhCccCC------
Confidence 22233455678998 999999999999999999999999998 8888864432211 111222221110
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.....+..+.+++.+||+.||++|||+.||+++|+..
T Consensus 338 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 ---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=348.45 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=208.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCC--ceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTR--TTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+......+|.|.||.||.......... ...||||.+.+. ..+.+.+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 34455667788888888855544432222 456999999765 445668999999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhC------C-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccc
Q 038905 490 LLVYKFLNNGTLASFLFEN------L-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~------~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 562 (709)
++++|||++|+|..+|++. . .++....+.++.+||+|+.||+ +++.|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999986 2 4889999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhc
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN 641 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 641 (709)
||+.+-..+--.....-.-...||| ||.+++..++.|+|||||||+||||++ |..||...+..+... .....
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~-PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMP-PESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCC-HHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhC
Confidence 9995433221111011122357998 999999999999999999999999998 777876554433211 11122
Q ss_pred CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 642 g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
| +...+..+++.+.+|+..||+.+|++||++..+++.+..+.
T Consensus 921 g----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 921 G----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred C----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 2 22236678899999999999999999999999999888765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.04 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=207.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchh-HHHHHHHHHHHhccC-cCceeEEEeEEEcCC-eE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDG-EKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQ-NR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~-~~ 489 (709)
.++|.....+|.|.||.||++... ..+..||||++++-...- +-.-.+|+..|++|+ |||||++.+++.+.+ .+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~---~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSK---ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeec---CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 455666667888888888877777 577889999987643322 223468999999999 999999999998888 99
Q ss_pred EEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++|||||+. .|.+++.++. .+++..+..|+.||++||+|+| ++|+.|||+||||||+.....+||+|||+|+.+.
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc
Confidence 999999976 8999998775 5899999999999999999999 9999999999999999999999999999999887
Q ss_pred ccccccceeccccCccccccccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HHHHH----HHhhhcC
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFR-NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWA----FDCYRNG 642 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~~~----~~~~~~g 642 (709)
..... +..+.|+.|.| ||++. ...|+.++|+|++|||++|+.+-++.|.+..+.+... +.+.+ .+.|.+|
T Consensus 162 SkpPY---TeYVSTRWYRA-PEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 162 SKPPY---TEYVSTRWYRA-PEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cCCCc---chhhhcccccc-hHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 65543 67788999999 99975 5679999999999999999999999998766543222 11111 1111111
Q ss_pred ---------CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 643 ---------KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 643 ---------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
+.....-..+.... ...+.++.+++..|+..||.+|||++|++++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111111111 2377889999999999999999999999884
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.72 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=202.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
.++|.....+|.|+|+.||.+..... ......||||++.... .+..+.+.+|+.+++++ +|+|||++++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34566667788888888866554322 2344679999987543 33456789999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC-----------------------------------------------------------
Q 038905 489 RLLVYKFLNNGTLASFLFENL----------------------------------------------------------- 509 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 509 (709)
.++||||+++|+|.+++.+..
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986421
Q ss_pred -----------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceec
Q 038905 510 -----------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578 (709)
Q Consensus 510 -----------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 578 (709)
++++..+.+++.||+.||.||| +++|+||||||+|||+++++.+||+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 3677788999999999999999 89999999999999999999999999999987654332222233
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
..++..|+| ||++.+..++.++|||||||++|||++ |+.||........ .......+... ...
T Consensus 274 ~~~~~~y~a-PE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~---------~~~ 337 (374)
T cd05106 274 ARLPVKWMA-PESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQM---------SRP 337 (374)
T ss_pred CCCccceeC-HHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcccCc---------cCC
Confidence 445678998 999999999999999999999999997 9999865432221 11111111100 001
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
...+..+.+++..||+.||.+|||+++|+++|+.+
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=314.66 Aligned_cols=265 Identities=23% Similarity=0.356 Sum_probs=199.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEec-------------CCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQT-------------STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRL 479 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~-------------~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l 479 (709)
.+|.....+|.|+++.||.+..... ......||+|.+.... .....++.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 3455566678888888866543211 1244579999986542 3345689999999999999999999
Q ss_pred EeEEEcCCeEEEEEeecCCCCHHHHHhhCC-------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 038905 480 LGFCDEGQNRLLVYKFLNNGTLASFLFENL-------------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIH 540 (709)
Q Consensus 480 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-------------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH 540 (709)
++++.+.+..++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999986532 2567788999999999999999 889999
Q ss_pred cCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh--CCC
Q 038905 541 CDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS--CRK 618 (709)
Q Consensus 541 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt--g~~ 618 (709)
|||||+|||++.++.+||+|||+++.+.............++..|+| ||++.+..++.++||||||+++|||++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMA-WECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccC-HHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999986644332222234556788998 999998899999999999999999987 455
Q ss_pred CCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 619 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 619 p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
||......+.. ..+...+........ .......+..+.+++.+||+.+|++|||+++|.++|++
T Consensus 241 p~~~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQVI---ENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHHH---HHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 66543322211 111111111110000 00122345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.56 Aligned_cols=241 Identities=23% Similarity=0.260 Sum_probs=194.6
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
+|.|+++.||.+... .++..+|+|.+... .......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKR---DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 467777877666554 46788999988643 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceec
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 578 (709)
++|.+++.....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 152 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNT 152 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--ccc
Confidence 999999988888999999999999999999999 899999999999999999999999999999864332221 245
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCH
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~ 658 (709)
..||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. .+....+... .+.
T Consensus 153 ~~gt~~y~a-PE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-------~~~~~~~~~~----------~~~ 214 (312)
T cd05585 153 FCGTPEYLA-PELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-------YRKILQEPLR----------FPD 214 (312)
T ss_pred ccCCcccCC-HHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-------HHHHHcCCCC----------CCC
Confidence 789999999 9999999999999999999999999999999975433221 1111121111 112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 659 KCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 659 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..+..+.+++..||+.||.+||++..+.++
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 345678899999999999999865444333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=310.80 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=204.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+|+.||.+...........||+|.++.... ...+.+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 3456666677888888886554444445678999999876432 334678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999874 46899999999999999999999 889999999999999999999999999987654322
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ......++..|+| ||.+.+..++.++||||||+++|||++ |..||......+.. +....+...
T Consensus 161 ~~~-~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~-------~~~~~~~~~---- 227 (266)
T cd05064 161 AIY-TTMSGKSPVLWAA-PEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-------KAVEDGFRL---- 227 (266)
T ss_pred chh-cccCCCCceeecC-HHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCCCC----
Confidence 111 1122345678998 999999999999999999999999775 99999755432211 111122111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
......+..+.+++..||+.+|.+||+++++.+.|+.+
T Consensus 228 -----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11223566789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.54 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=211.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..|.....+|.|.|+.||..... ..++.||+|.++... .+..+++.+|+.++.+++++||.+++|.+..+..+.++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~---~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDN---KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeec---cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 34666677888888877655554 689999999997653 34568899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||||.||++.+.+.....+++..+.-++++++.||.||| .++.+|||||+.|||+..+|.+|++|||.+..+.....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999999987777788888999999999999999 89999999999999999999999999999998876654
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
+. .+++|||.||| ||++.+..|+.|+||||||++.+||.+|.+|+...++... ..++-...
T Consensus 167 rr--~tfvGTPfwMA-PEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------------lflIpk~~ 227 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMA-PEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------------LFLIPKSA 227 (467)
T ss_pred cc--ccccccccccc-hhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------------EEeccCCC
Confidence 44 78999999999 9999999999999999999999999999999976554221 12222222
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...........+.+++..||+.||+.||++.++++
T Consensus 228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22223366778999999999999999999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.28 Aligned_cols=246 Identities=20% Similarity=0.238 Sum_probs=202.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.+|||.+.... ....+.+.+|+.++.+++||||+++++++.+++..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHK---GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 456776777888888888766655 567889999886431 23446789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++++|.+++.+...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999999998888999999999999999999999 89999999999999999999999999999987643
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.. ....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ .++....+....
T Consensus 171 ~~-----~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~~~--- 234 (329)
T PTZ00263 171 RT-----FTLCGTPEYLA-PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRLKF--- 234 (329)
T ss_pred Cc-----ceecCChhhcC-HHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCcCC---
Confidence 22 34679999999 999999999999999999999999999999997543322 122222332110
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
+...+..+.+++..||+.||.+||+ +++++.
T Consensus 235 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 235 -------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1123456889999999999999997 677764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=318.66 Aligned_cols=241 Identities=24% Similarity=0.323 Sum_probs=202.6
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch--hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD--GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
..+|.|++|.| |+|..+ .+.+.||+|.+.+..+. ..+.+.+|++|+++++|||||.+++.|+...+.++|.||
T Consensus 8 e~iG~Gsfg~V---YKgrrK--~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 8 EMIGEGSFGRV---YKGRRK--YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred HHhcCCcccee---eecccc--cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 44455555555 777764 57899999998765432 346689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+.| +|..+|...+.++++.+..++.+++.||.||| +.+|+|||+||+||||+..+++|++|||+|+.+..+. ..
T Consensus 83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~v 156 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SV 156 (808)
T ss_pred hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc--ee
Confidence 988 99999999999999999999999999999999 9999999999999999999999999999999887644 33
Q ss_pred eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccccc
Q 038905 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 655 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~ 655 (709)
.+.+.|||.||| ||...+.+|+..+|+||+||++|||.+|++||....-.. ..+.+...+..
T Consensus 157 ltsikGtPlYmA-PElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-------Lv~~I~~d~v~---------- 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMA-PELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-------LVKSILKDPVK---------- 218 (808)
T ss_pred eeeccCcccccC-HHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-------HHHHHhcCCCC----------
Confidence 478999999999 999999999999999999999999999999997432111 11122111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 656 NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 656 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+......+..++.-.++.||..|.|-.+++.
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 13356677889999999999999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.50 Aligned_cols=245 Identities=22% Similarity=0.246 Sum_probs=201.0
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... .+++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDR---ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEc---CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 4555666778888877666554 468889999986432 2244678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|.+++.....+++.....++.||+.||.||| +++|+||||||+|||+++++.+||+|||+++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999999988888999999999999999999999 8999999999999999999999999999998764321
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
....|++.|+| ||++.+..++.++|||||||++|||++|+.||......+ ..+....++..
T Consensus 156 -----~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~------ 216 (291)
T cd05612 156 -----WTLCGTPEYLA-PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKLE------ 216 (291)
T ss_pred -----ccccCChhhcC-HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCcC------
Confidence 35679999998 999999999999999999999999999999997654322 11222222211
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQM 688 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~~ 688 (709)
.+......+.+++.+||+.||.+||+ ++++++.
T Consensus 217 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 ----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 01123457889999999999999995 8888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=318.18 Aligned_cols=262 Identities=18% Similarity=0.253 Sum_probs=205.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+... ..+..+|+|.+.... ....+++.+|++++++++|+||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHK---PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEEC---CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 467777778888888888766655 567889999886542 2345679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS-QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++.....+++..+..++.|++.||.||| ++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999999988888999999999999999999999 54 6999999999999999999999999999766432
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC---Cccc-
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDD- 646 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g---~~~~- 646 (709)
. .....|++.|+| ||++.+..++.++|||||||++|||++|+.||......+.... .......+ ....
T Consensus 158 ~----~~~~~g~~~y~a-PE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 158 M----ANSFVGTRSYMS-PERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEEGEPHSI 229 (331)
T ss_pred c----cccCCCCcCcCC-HhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hcccccccccCCcccc
Confidence 2 145679999999 9999999999999999999999999999999975543221111 00000000 0000
Q ss_pred ------------------------------cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 647 ------------------------------LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 647 ------------------------------l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
+................+.+++.+||+.||++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000111345679999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.36 Aligned_cols=241 Identities=22% Similarity=0.243 Sum_probs=196.6
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
.+|.|+++.||.+... .+++.+|||.+.... .....++.+|+.++++++||||+++++++.+++..++||||++
T Consensus 2 ~lG~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 2 LLGKGTFGKVILVREK---ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred eeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 3577777777766655 568889999886432 2344577899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
+++|..++.....+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~ 153 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 153 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc--cc
Confidence 9999999988888999999999999999999999 899999999999999999999999999999754322211 14
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
..+||+.|+| ||++.+..++.++|||||||++|||++|+.||......... .....+... .+
T Consensus 154 ~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------~~~~~~~~~----------~p 215 (323)
T cd05571 154 TFCGTPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEEIR----------FP 215 (323)
T ss_pred ceecCccccC-hhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-------HHHHcCCCC----------CC
Confidence 5789999999 99999999999999999999999999999999754332211 111111111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
......+.+++..||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 23456788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.17 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=202.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--------------hhHHHHHHHHHHHhccCcCceeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--------------DGEKEFKNEVVMIGQTYHKNLVR 478 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~nlv~ 478 (709)
.++|..+.-+|.|.+|.|-++... .+++.+|||++.+... ...+...+|+.||++++|+|||+
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~---~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDE---VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred hhheehhhhhcCCccceEEEEeec---CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 677888888888888855555444 6899999999864211 11257899999999999999999
Q ss_pred EEeEEEc--CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCe
Q 038905 479 LLGFCDE--GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556 (709)
Q Consensus 479 l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 556 (709)
|+++..+ .+.+|||+|||..|.+...=-....++..+.++++++++.||.||| .++||||||||+|+||+++|++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 9999865 4678999999998886543322223889999999999999999999 9999999999999999999999
Q ss_pred EEccccccccccccc---cccceeccccCcccccccccccCCC----CCcccchHHHHHHHHHHHhCCCCCCccchhhHH
Q 038905 557 QISDFGLAKLLTLNQ---SKAIKKAIRGTKGYVASPEWFRNST----ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA 629 (709)
Q Consensus 557 kl~DFGla~~~~~~~---~~~~~~~~~Gt~~y~aaPE~~~~~~----~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~ 629 (709)
||+|||.+....... .........|||.|+| ||...+.. .+.+.||||+||+||.|+.|+.||......+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~A-PE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-- 326 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFA-PELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-- 326 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccc-hHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH--
Confidence 999999998662221 1122256889999999 99988733 3568899999999999999999997554322
Q ss_pred hHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 630 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 630 ~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.+ .+++...+......+..+.+.+|++.+|++||+.|.++.+|....--..+
T Consensus 327 -----l~--------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 327 -----LF--------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred -----HH--------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11 22333334333345678899999999999999999999999876544333
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=288.53 Aligned_cols=265 Identities=17% Similarity=0.165 Sum_probs=206.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|.++.||.+... .+++.||||++.... +.......+|++.|+.++|+||+.++++|...+...||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~---~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDT---ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEec---CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 3455566778888877766665 689999999987532 22245789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
+|||+. +|+..+.++. .++..++..++.++++||+||| ++.|+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 999976 9999998765 5889999999999999999999 9999999999999999999999999999999988655
Q ss_pred cccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC---cccc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---LDDL 647 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~---~~~l 647 (709)
... +..+-|..|.| ||.+.+. .|+..+|+||.||++.||+-+.+-|....+-+.....-.+..-..... +..+
T Consensus 156 ~~~--~~~V~TRWYRA-PELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 156 RIQ--THQVVTRWYRA-PELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccc--ccceeeeeccC-hHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 433 33477899998 9988764 699999999999999999999988877766443322211111111110 1111
Q ss_pred ccCc--------ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038905 648 VEGD--------MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689 (709)
Q Consensus 648 ~~~~--------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 689 (709)
.|.. ............+.+++..++..||.+|+++.|++++=
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 1110 01112334666779999999999999999999998863
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=289.31 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=210.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|..++.+|.|-||.||++... ...-.||+|++.+. ..+..+++++|++|-..|+||||+++++++.+....
T Consensus 21 l~dfeigr~LgkgkFG~vYlarek---ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREK---KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred hhhccccccccCCccccEeEeeec---cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 567888888899999999888877 57889999998543 334557899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHh--hCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 490 LLVYKFLNNGTLASFLF--ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~--~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
||++||..+|+|...|+ ...++++.....+..|+|.||.|+| .++||||||||+|+|++.++.+||+|||-+..-
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999 4457999999999999999999999 999999999999999999999999999999765
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
.... ..++|||.-|++ ||+..+...+..+|+|++|++.||++.|.+||......+ .++.+..-++.
T Consensus 175 p~~k----R~tlcgt~dyl~-pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k~~~~-- 240 (281)
T KOG0580|consen 175 PSNK----RKTLCGTLDYLP-PEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRKVDLK-- 240 (281)
T ss_pred CCCC----ceeeecccccCC-HhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHHcccc--
Confidence 4221 278999999999 999999999999999999999999999999998655322 22222221111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.+......+.+++..|+..+|.+|.+..|++..
T Consensus 241 --------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 --------FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 123455678899999999999999999998763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.77 Aligned_cols=249 Identities=24% Similarity=0.268 Sum_probs=198.8
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
|.....+|.|+++.||.+... .+++.+|+|.+.... ......+.+|+.++.+++|+|++++++++.+.+..++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe---cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 555667888888888776666 568899999876432 22345678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++|+|..++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999999888653 35889999999999999999999 899999999999999999999999999999875432
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.. .....||+.|+| ||++.+..++.++|||||||++|||++|+.||.......... ..........
T Consensus 156 ~~---~~~~~g~~~y~a-PE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~------- 221 (285)
T cd05631 156 ET---VRGRVGTVGYMA-PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKEDQ------- 221 (285)
T ss_pred Ce---ecCCCCCCCccC-HhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhccc-------
Confidence 21 134579999999 999999999999999999999999999999997654321110 0111111111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
.......+..+.+|+..||+.||.+||+ ++++++
T Consensus 222 ---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0112234567889999999999999997 788877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.28 Aligned_cols=262 Identities=22% Similarity=0.408 Sum_probs=209.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||.+..... ..+...+|+|.+........+.+.+|++++.+++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 44666677788888888877754321 2345678999987766566778999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC-------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeE
Q 038905 491 LVYKFLNNGTLASFLFENL-------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 557 (709)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 9999999999999997543 3889999999999999999999 88999999999999999999999
Q ss_pred EccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHH
Q 038905 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 636 (709)
Q Consensus 558 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 636 (709)
|+|||+++...............++..|+| ||++.+..++.++||||||++++||++ |..||......+ ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~ 232 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMP-PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VI 232 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccC-HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH
Confidence 999999986643332222234456788998 999999999999999999999999998 888886544322 11
Q ss_pred HhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 637 DCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 637 ~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.....+..... ....+..+.+++..|++.+|.+|||+++|++.|+.+..
T Consensus 233 ~~i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 233 ECITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 22223322111 11234568999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=293.23 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=201.7
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--------hhHHHHHHHHHHHhccC-cCceeEEEeEEEcC
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--------DGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEG 486 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~ 486 (709)
+..+..+|+|+...|.-..+. .++...|+|++..... .-.+.-.+|+.||+++. ||+|+++.++++..
T Consensus 19 y~pkeilgrgvss~vrRci~k---~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHK---ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred cChHHHhcccchhhhhhhhhc---ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 344455666665544333344 5677788888753211 11244577999999985 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++|+|.|+.|.|.++|.+...++++...+|.+|+.+|+.||| .+.||||||||+|||+|++.++||+|||+|+.
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeec
Confidence 999999999999999999999889999999999999999999999 99999999999999999999999999999999
Q ss_pred ccccccccceeccccCcccccccccccC------CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh
Q 038905 567 LTLNQSKAIKKAIRGTKGYVASPEWFRN------STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 640 (709)
Q Consensus 567 ~~~~~~~~~~~~~~Gt~~y~aaPE~~~~------~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 640 (709)
+...+.. ...||||+|+| ||.+.. ..|+..+|+|+.||+||-++.|.+||..... -.+.+++.
T Consensus 173 l~~GekL---relCGTPgYLA-PEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~Im 241 (411)
T KOG0599|consen 173 LEPGEKL---RELCGTPGYLA-PETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIM 241 (411)
T ss_pred cCCchhH---HHhcCCCcccC-hhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHH
Confidence 8876544 67899999999 999864 3578899999999999999999999963221 12445666
Q ss_pred cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 641 NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 641 ~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+|+...- ...-.+.+....+++.+|||.||++|.|++|+++
T Consensus 242 eGkyqF~------speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EGKYQFR------SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hcccccC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 7765421 1112356678899999999999999999999976
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=320.24 Aligned_cols=253 Identities=17% Similarity=0.220 Sum_probs=203.6
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..++.||||++.... .+..+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKK---DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 4666667788888888666554 467889999986532 2344678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~- 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY- 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc-
Confidence 9999999999999988888999999999999999999999 889999999999999999999999999999865431
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+... .+.... ..+...
T Consensus 155 ----~~~~~gt~~y~a-PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-------~i~~~~--~~~~~~ 220 (333)
T cd05600 155 ----ANSVVGSPDYMA-PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-------NLKYWK--ETLQRP 220 (333)
T ss_pred ----cCCcccCccccC-hhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH-------HHHhcc--ccccCC
Confidence 155679999998 999999999999999999999999999999997654333111 111100 001110
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.........+..+.+++..||+.+|.+||+++++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0010112346678899999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.64 Aligned_cols=250 Identities=20% Similarity=0.259 Sum_probs=199.3
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
|.....+|.|+++.||.+.... .....||+|++..........+.+|+.+++.++|||||++++++..++..+|||||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~--~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGS--DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcC--CCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 5555566777777776665442 22567888877655444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 496 LNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 496 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
+++|+|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988764 335888899999999999999999 8999999999999999999999999999998765443
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
........+||++|+| ||++.+..++.++|||||||++|||++|+.||......+. ......+....+
T Consensus 224 ~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~-------~~~~~~~~~~~~---- 291 (478)
T PTZ00267 224 SLDVASSFCGTPYYLA-PELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI-------MQQVLYGKYDPF---- 291 (478)
T ss_pred ccccccccCCCccccC-HhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCCC----
Confidence 3223356789999999 9999999999999999999999999999999975433221 111122222111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+...+..+.+++..||+.+|++||++.+++.
T Consensus 292 -----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 -----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1123467889999999999999999999864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.62 Aligned_cols=254 Identities=28% Similarity=0.359 Sum_probs=201.3
Q ss_pred eeecCeeEEEEEEEEEEecCCC-ceE-EEEEEccc---ccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTR-TTV-IVVKKLDR---VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~-~~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
..+|.|.||.| +.|.+..... ... ||||.... .......+|.+|.++|++++|||||+++|++...+.+++|||
T Consensus 163 kkLGeGaFGeV-~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 163 KKLGEGAFGEV-FKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred ceeecccccEE-EEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 34455555555 6666644322 223 89999875 446677899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 495 FLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 495 y~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
+|+||+|.++|.+.+ .++..++..++.+.|.||.||| ++++|||||-++|+|++.++.+||+||||++.-......
T Consensus 242 l~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~ 318 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK 318 (474)
T ss_pred ecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcceeec
Confidence 999999999999887 4999999999999999999999 999999999999999999999999999998754311111
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhh-hcCCccccccCc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY-RNGKLDDLVEGD 651 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~-~~g~~~~l~~~~ 651 (709)
. ....-...|+| ||.+....|+.++|||||||++||+++ |..|+......+. ...+ .++.
T Consensus 319 ~--~~~klPirWLA-PEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v-------~~kI~~~~~-------- 380 (474)
T KOG0194|consen 319 K--FLKKLPIRWLA-PETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV-------KAKIVKNGY-------- 380 (474)
T ss_pred c--ccccCcceecC-hhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-------HHHHHhcCc--------
Confidence 0 11123457888 999999999999999999999999998 7889876654331 1111 2221
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCC
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVD 696 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 696 (709)
....+...+..+..++.+|++.+|++||+|.++.+.|+.+....
T Consensus 381 -r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 381 -RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred -cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 11122356677888999999999999999999999998876443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.88 Aligned_cols=261 Identities=22% Similarity=0.412 Sum_probs=209.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.+|.....+|.|+++.||.+..... ......+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3466666778888888876654421 23566799999877665566789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC
Q 038905 492 VYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 555 (709)
||||+++++|.+++.... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999997542 3788999999999999999999 899999999999999999999
Q ss_pred eEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHH
Q 038905 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 634 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 634 (709)
+||+|||+++...............++..|+| ||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------- 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP-PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------- 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecC-hHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 99999999986644332222234557788998 999999999999999999999999998 999986544322
Q ss_pred HHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 635 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 635 ~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..+....+..... ....+..+.+++.+||+.+|.+|||+++|+++|+.+..
T Consensus 234 ~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 VIECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1122223322211 11245678899999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.11 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=203.3
Q ss_pred ccceeeeecCeeEEEEEEEEEEecC--CCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTS--TRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.|.....+|.|+++.||.+.....+ .....+++|.+.... .....++.+|+.++.+++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4555556677777777655544321 234689999886433 2345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC
Q 038905 492 VYKFLNNGTLASFLFEN----------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 555 (709)
+|||+++++|.+++... ..+++.....++.|++.||.||| +.+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCc
Confidence 99999999999999764 34678888999999999999999 889999999999999999999
Q ss_pred eEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHH
Q 038905 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 634 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 634 (709)
+||+|||+++...............+++.|+| ||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------ 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMP-PEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------ 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccC-HHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 99999999986543332222244567888999 999998899999999999999999998 9999875443321
Q ss_pred HHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 635 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 635 ~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
...+..+.... .....+..+.+++.+||+.+|.+||++++|++.|++
T Consensus 236 -~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 -IEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 12222222211 123456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=317.50 Aligned_cols=241 Identities=22% Similarity=0.235 Sum_probs=196.8
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
+|.|+++.||.+... ..++.+|+|++... ......++.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 3 lG~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 3 LGKGTFGKVILVREK---ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred eeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 577777777766655 56889999998643 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceec
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 578 (709)
++|..++.....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~~~ 154 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--MKT 154 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--ccc
Confidence 999999988888999999999999999999999 899999999999999999999999999999764322211 145
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCH
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~ 658 (709)
..||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.. .....+.. ..+.
T Consensus 155 ~~gt~~y~a-PE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-------~~~~~~~~----------~~p~ 216 (328)
T cd05593 155 FCGTPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEDI----------KFPR 216 (328)
T ss_pred ccCCcCccC-hhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-------HHhccCCc----------cCCC
Confidence 679999999 99999999999999999999999999999999754332211 11111111 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038905 659 KCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 688 (709)
Q Consensus 659 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 688 (709)
.....+.+++..||+.||++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3456788999999999999997 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.58 Aligned_cols=241 Identities=23% Similarity=0.239 Sum_probs=195.6
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
.+|.|+++.||.+... .++..||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||++
T Consensus 2 ~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 2 LLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred eeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 3577777777666554 56889999998643 22344567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
+++|..++.+...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~ 153 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 153 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--cc
Confidence 9999999988888999999999999999999999 889999999999999999999999999998754322211 14
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
...||+.|+| ||++.+..++.++|||||||++|||++|+.||......... .....+... .+
T Consensus 154 ~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-------~~~~~~~~~----------~p 215 (323)
T cd05595 154 TFCGTPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILMEEIR----------FP 215 (323)
T ss_pred cccCCcCcCC-cccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCCC----------CC
Confidence 5679999999 99999999999999999999999999999999754432211 111111110 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
...+..+.+++..||+.||.+|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 23456788999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=311.20 Aligned_cols=265 Identities=16% Similarity=0.184 Sum_probs=200.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+... .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHK---ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CceEEEEecccCCEEEEEEEEC---CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 4566666777888877665554 567889999886432 23446788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||++++.+..+......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 999999888766555557899999999999999999999 88999999999999999999999999999987654332
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH--------Hhh-hcCC
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCY-RNGK 643 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~-~~g~ 643 (709)
.. .....|++.|+| ||++.+..++.++|||||||++|||++|+.||......+......... ..+ ....
T Consensus 156 ~~-~~~~~~~~~y~a-PE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 AN-YTEYVATRWYRS-PELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cc-ccccccccccCC-cHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 21 145679999999 999999899999999999999999999999997654322211111100 000 0000
Q ss_pred ccccccCcccc------cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 LDDLVEGDMEA------MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ~~~l~~~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......+.... ......+..+.+++..||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01110000000 001124567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.85 Aligned_cols=248 Identities=21% Similarity=0.230 Sum_probs=202.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+.... .....||+|++... .....+.+.+|+.++..++|||||++++++.++...
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEEC--CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 4567777778888888886665442 33468999988543 223456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++|+|.+++.+...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999999998888999999999999999999999 89999999999999999999999999999987643
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.. ....||+.|+| ||++.+..++.++|||||||++|||++|+.||....... .......+...
T Consensus 184 ~~-----~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~---- 246 (340)
T PTZ00426 184 RT-----YTLCGTPEYIA-PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGIIY---- 246 (340)
T ss_pred Cc-----ceecCChhhcC-HHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCC----
Confidence 22 45679999999 999999999999999999999999999999997544321 11222222211
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 688 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 688 (709)
.+...+..+.+++.+|++.||++|+ +++++++.
T Consensus 247 ------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 ------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0112345678999999999999995 89988764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=307.83 Aligned_cols=248 Identities=30% Similarity=0.469 Sum_probs=191.1
Q ss_pred eecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 421 LLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
.+|.|.|+.| +.+... .+.....|+||.++... .+..+++.+|++++++++||||++++|++...+..++|+||++
T Consensus 6 ~ig~G~fg~v-~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 6 QIGEGSFGKV-YRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEESSEEE-EEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred EEccCCCcEE-EEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 3445555555 455554 55678899999996533 3347899999999999999999999999998888999999999
Q ss_pred CCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 498 NGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 498 ~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+|+|.++|... ..+++..+..++.||++||.||| +++++|+||+++||++++++.+||+|||+++..........
T Consensus 85 ~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 85 GGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp TEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999987 57999999999999999999999 78999999999999999999999999999987733322222
Q ss_pred eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
.....+...|+| ||.+.+..++.++||||||+++|||++ |+.|+......+. ...+..+....
T Consensus 162 ~~~~~~~~~~~a-PE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~-------~~~~~~~~~~~-------- 225 (259)
T PF07714_consen 162 DSSQQLPLRYLA-PEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI-------IEKLKQGQRLP-------- 225 (259)
T ss_dssp STTSESGGGGS--HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH-------HHHHHTTEETT--------
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccc-------cccccccccce--------
Confidence 234557778998 999999999999999999999999999 6788765433221 11122222111
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 689 (709)
.....+..+.+++..||..+|++|||+.++++.|
T Consensus 226 -~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1223466788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=304.27 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=206.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+.....+.....||||.+.... .....++.+|+.++.+++|+||+++++++.+....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 456776677788888877666554443456789999987543 3345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+|+||||+||++++++.+||+|||+++.+...
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999764 36899999999999999999999 899999999999999999999999999999987532
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..........++..|++ ||.+.+..++.++||||||+++|||++ |..||......+. ......+...
T Consensus 160 ~~~~~~~~~~~~~~y~~-Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~---- 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTA-PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-------IKAVEDGYRL---- 227 (266)
T ss_pred ccceeccCCCCCccccC-hhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-------HHHHHcCCCC----
Confidence 22221123345678998 999999899999999999999999998 9999864432221 1111111110
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
......++.+.+++.+|++.+|++||++++|+++|+.+
T Consensus 228 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01123456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.59 Aligned_cols=244 Identities=24% Similarity=0.288 Sum_probs=197.7
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEccccc----chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeec
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF----QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
.+|.|+++.||.+........++.+|||.+.... ......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 82 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL 82 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence 4677788888776655444578899999986432 123356789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 497 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
++++|.+++.+...+.+.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~ 157 (323)
T cd05584 83 SGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV--T 157 (323)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc--c
Confidence 99999999988888888999999999999999999 899999999999999999999999999999754332221 1
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
....||+.|+| ||++.+..++.++||||||+++|||++|+.||........ ......+... .
T Consensus 158 ~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-------~~~~~~~~~~----------~ 219 (323)
T cd05584 158 HTFCGTIEYMA-PEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-------IDKILKGKLN----------L 219 (323)
T ss_pred cccCCCccccC-hhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCC----------C
Confidence 45679999999 9999998999999999999999999999999975543221 1111222111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
+...+..+.+++..||+.+|++|| +++++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 122346788999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.17 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=207.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe-EE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN-RL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~-~~ 490 (709)
++|.....+|.|+||.++++.+. .+...+|+|++... .....+...+|+.++++++|||||.+.+.+.+++. .+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk---~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHK---SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhc---cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 34555556777777777777666 56779999988644 33344578999999999999999999999998888 89
Q ss_pred EEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
|||+|++||+|++.|.+.. .++++.+..++.|++.|+.||| ++.|+|||||+.||++..+..+||+|||+|+.+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999999998765 4889999999999999999999 8999999999999999999999999999999998
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.+.... .+..|||.|+. ||.+.+.+|..|+|||||||++|||++-+++|...+...... ....+.
T Consensus 158 ~~~~~a--~tvvGTp~Ymc-PEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~-------ki~~~~----- 222 (426)
T KOG0589|consen 158 PEDSLA--STVVGTPYYMC-PEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL-------KINRGL----- 222 (426)
T ss_pred Cchhhh--heecCCCcccC-HHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH-------HHhhcc-----
Confidence 765332 78899999999 999999999999999999999999999999998665433111 111111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
-...+..++..+..++..|++.+|+.||++.+++.+
T Consensus 223 ----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 ----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111233567789999999999999999999999874
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.48 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=202.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEcccccc-hhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~ 488 (709)
.++|.....+|.|+|+.||.+..... ......||||++..... ...+.+.+|+.++.++. |||||++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 45666666777888887765543321 13345799999975432 33467999999999996 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhC------------------------------------------------------------
Q 038905 489 RLLVYKFLNNGTLASFLFEN------------------------------------------------------------ 508 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 508 (709)
.+|||||+++|+|.+++.+.
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999988642
Q ss_pred ------------------------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC
Q 038905 509 ------------------------------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD 552 (709)
Q Consensus 509 ------------------------------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~ 552 (709)
..+++..+..++.||++||.||| +.+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 12567778899999999999999 889999999999999999
Q ss_pred CCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhH
Q 038905 553 YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 631 (709)
Q Consensus 553 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 631 (709)
++.+||+|||+++.+.............+++.|+| ||.+.+..++.++||||||+++|||++ |..||........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMA-PESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEC-hhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---
Confidence 99999999999987654332222234557788998 999999999999999999999999997 8889865432211
Q ss_pred HHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 632 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 632 ~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.......+... ......+..+.+++.+||+.+|++|||+.+|+++|+.+.
T Consensus 349 ---~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 ---FYNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11112222110 012234567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.54 Aligned_cols=261 Identities=20% Similarity=0.256 Sum_probs=211.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEE-Ec-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFC-DE----- 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~-~~----- 485 (709)
..++.....+..|||+.||++... ..+..+|+|++-...+++.+.+++|+++|++|+ |+|||.+++.. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~---~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDV---KGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEec---CCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 345556677788888888777776 344999999998777888899999999999998 99999999932 11
Q ss_pred -CCeEEEEEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccc
Q 038905 486 -GQNRLLVYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562 (709)
Q Consensus 486 -~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 562 (709)
.-+.+|.||||+||+|-+++..+ .+|++.++++|+.++++|+++||. +...|||||||-|||||+.+++.||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 24678999999999999999865 369999999999999999999993 25569999999999999999999999999
Q ss_pred cccccccccccc-----c--eeccccCcccccccccc---cCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHH
Q 038905 563 LAKLLTLNQSKA-----I--KKAIRGTKGYVASPEWF---RNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 632 (709)
Q Consensus 563 la~~~~~~~~~~-----~--~~~~~Gt~~y~aaPE~~---~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~ 632 (709)
-|...-...... . .-...-|+.|.+ ||++ .+.++++|+|||+|||+||-|+....||+..-
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRs-PEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------- 262 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRS-PEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------- 262 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccC-hHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------
Confidence 986433222110 0 012335899999 9997 57889999999999999999999999997321
Q ss_pred HHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCCC
Q 038905 633 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDV 697 (709)
Q Consensus 633 ~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 697 (709)
...|++..........+..++.+||..||+.||.+||++-||+..+..+...+.
T Consensus 263 -----------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 263 -----------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred -----------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 234556666555567899999999999999999999999999999888765433
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.27 Aligned_cols=254 Identities=21% Similarity=0.261 Sum_probs=196.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..++.+|||++.... ......+.+|+.++.+++|+||+++++.+.+....++
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKK---DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEEC---CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 5666777888888888777665 567899999986432 2334578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++|+|.+++.+...+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999999998888999999999999999999999 8999999999999999999999999999998653211
Q ss_pred cc---------------------------------cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCC
Q 038905 572 SK---------------------------------AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK 618 (709)
Q Consensus 572 ~~---------------------------------~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~ 618 (709)
.. ......+||+.|+| ||++.+..++.++|||||||++|||++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a-PE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIA-PEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccC-HHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 00124579999999 999999999999999999999999999999
Q ss_pred CCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcc--cCCCCCCCCHHHHHHH
Q 038905 619 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCI--QEDPSLRPTMRKVSQM 688 (709)
Q Consensus 619 p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl--~~dP~~RPs~~ev~~~ 688 (709)
||......+. +..+...+.. +..+. .....+.+.+++..++ ..++..||+++|+++.
T Consensus 235 Pf~~~~~~~~-------~~~i~~~~~~-~~~p~-----~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQET-------YKKVMNWKET-LIFPP-----EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHH-------HHHHHcCcCc-ccCCC-----cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9975543221 1111111110 10110 1112344556655533 3345567999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.89 Aligned_cols=270 Identities=21% Similarity=0.247 Sum_probs=215.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
...|...+.+|.|..|.||++... ......|+|++++.. .....+...|-+||+.++||.|+.|++.++.....
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~---~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELR---GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEec---CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 456777788999999999988887 456899999987643 33456788899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
+||||||+||+|..+++++. .+++..++.++.+|+-||+||| ..|||.|||||+||||.++|++.|+||.|+...
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999998764 5999999999999999999999 999999999999999999999999999987533
Q ss_pred cc---------------------------------ccc---------------------ccceeccccCccccccccccc
Q 038905 568 TL---------------------------------NQS---------------------KAIKKAIRGTKGYVASPEWFR 593 (709)
Q Consensus 568 ~~---------------------------------~~~---------------------~~~~~~~~Gt~~y~aaPE~~~ 593 (709)
.. ... ......++||-.|+| ||++.
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA-PEvI~ 308 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA-PEVIR 308 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc-ceeee
Confidence 10 000 011135789999999 99999
Q ss_pred CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhccc
Q 038905 594 NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQ 673 (709)
Q Consensus 594 ~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~ 673 (709)
+...+.++|+|+|||++|||+.|..||......+... .++............+..+.+||+..|.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 9999999999999999999999999998776544221 1222222222233566789999999999
Q ss_pred CCCCCCCC----HHHHHH--HHcccc----cCCCCC-CCCCC
Q 038905 674 EDPSLRPT----MRKVSQ--MLEVVV----EVDVPP-NPSTF 704 (709)
Q Consensus 674 ~dP~~RPs----~~ev~~--~L~~~~----~~~~p~-~p~~~ 704 (709)
+||++|.- +.||-+ +++++. ....|| .|+..
T Consensus 374 KdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~ 415 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPV 415 (459)
T ss_pred cChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcc
Confidence 99999988 777765 455532 344444 35543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=307.29 Aligned_cols=265 Identities=17% Similarity=0.218 Sum_probs=198.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+... .++..||+|.+.... ......+.+|+.++++++|+||+++++++.+....++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSK---LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEEC---CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 445666677788888877655544 567889999886432 2234577899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++ +|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9999985 8998887654 4788899999999999999999 899999999999999999999999999999765432
Q ss_pred ccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH-----Hhhhc---
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----DCYRN--- 641 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~--- 641 (709)
... .....|++.|+| ||++.+ ..++.++|||||||++|||++|+.||......+......... ..+..
T Consensus 157 ~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 157 TKT--YSNEVVTLWYRP-PDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred Ccc--ccCceecccccC-hHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 211 144578999999 999865 568999999999999999999999997654433221111100 00000
Q ss_pred -CCccccccCcccc----cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 -GKLDDLVEGDMEA----MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 -g~~~~l~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........+.... .........+.+++..|++.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000011110000 001123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.24 Aligned_cols=261 Identities=17% Similarity=0.258 Sum_probs=201.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+... .++..+|+|.+... .....+++.+|++++++++|+|||++++++.++++.++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHK---PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEEC---CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 456777777888888888766554 56788899987653 23345679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|.+++.+...+++.....++.+++.||.|||+ ..+|+||||||+|||+++++.+||+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999999999887788999999999999999999993 2479999999999999999999999999997654321
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc----
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL---- 647 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l---- 647 (709)
.....|+..|+| ||++.+..++.++|||||||++|||++|+.||......+.... ......+.....
T Consensus 159 ----~~~~~~~~~y~a-PE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 159 ----ANSFVGTRSYMS-PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM----FGCPVEGDPAESETSP 229 (333)
T ss_pred ----cccCCCCccccC-HHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH----hcCcccCCccccccCc
Confidence 144679999999 9999998999999999999999999999999975443221110 000000100000
Q ss_pred -----------------------------ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 648 -----------------------------VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 648 -----------------------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+...............+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000000000123456889999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=302.14 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=201.8
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.|.....+|.|+++.||.+... ..+..+|+|.+... ....+++.+|++++.+++|+||+++++++......++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEe---cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 3555566777777777665554 46888999998754 3345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 495 FLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 495 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999997643 5889999999999999999999 88999999999999999999999999999987654322
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. .....++..|+| ||.+.+..++.++||||||+++|||++ |..|+......+. +.....+..
T Consensus 160 ~~-~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~------- 223 (263)
T cd05052 160 TA-HAGAKFPIKWTA-PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKGYR------- 223 (263)
T ss_pred ec-cCCCCCccccCC-HHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCC-------
Confidence 11 122334667998 999999999999999999999999998 8889865433221 111221110
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.......+..+.+++.+|++.+|++|||+.+++++|+.+
T Consensus 224 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 --MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=303.86 Aligned_cols=256 Identities=24% Similarity=0.420 Sum_probs=201.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.|.....+|.|+++.||.+..... ......+|||.+...... ..+.+.+|++++.+++|+|++++++++..+...++
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 85 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence 344445566777777765544322 245678999998765443 55789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC--------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeE
Q 038905 492 VYKFLNNGTLASFLFENL--------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~--------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 557 (709)
||||+++++|.+++.... .+++.....++.|++.||.||| +.+++||||||+||+++.++.+|
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeEE
Confidence 999999999999997542 3678888999999999999999 88999999999999999999999
Q ss_pred EccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHH
Q 038905 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 636 (709)
Q Consensus 558 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 636 (709)
|+|||+++...............+++.|+| ||++.+..++.++||||||+++|||++ |..||......+. .
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-------~ 234 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMP-PESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-------I 234 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecC-hhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------H
Confidence 999999986543322211234456788998 999999999999999999999999998 9999865443321 1
Q ss_pred HhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 637 DCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 637 ~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
.....+..... ....+..+.+++..||+.||++||+++||++.|+
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11222222111 1234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=301.62 Aligned_cols=260 Identities=20% Similarity=0.367 Sum_probs=206.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+.....+.....+++|++.... ....+++.+|++++.+++|+|++++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457777788888888888776665444556789999987542 3345679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++.+. ..+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999764 46899999999999999999999 889999999999999999999999999999866543
Q ss_pred ccccce-eccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 571 QSKAIK-KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 571 ~~~~~~-~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
...... .....+..|++ ||++....++.++||||||+++|||++ |+.||......+. ......+..
T Consensus 161 ~~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~-------~~~i~~~~~---- 228 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTA-PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-------MKAINDGFR---- 228 (268)
T ss_pred cccceeccCCCcCceecC-HHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-------HHHHhcCCC----
Confidence 322111 11223457888 999998889999999999999999997 9999865443221 111111110
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.......+..+.+++.+|++.+|++||++.+|+++|+++
T Consensus 229 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 -----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.36 Aligned_cols=254 Identities=20% Similarity=0.218 Sum_probs=200.1
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc----chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF----QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~ 490 (709)
|.....+|.|+++.||.+........++.+|+|.+.... ....+.+.+|+.++.++ +|+||+++++++.+....+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 556667888888888877665444678899999886431 22345688999999999 5999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||+++|+|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999999988888999999999999999999999 889999999999999999999999999999865433
Q ss_pred ccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... .....||+.|+| ||++.+. .++.++|||||||++|||++|+.||.......... .........+
T Consensus 159 ~~~~-~~~~~gt~~y~a-PE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~~------ 227 (332)
T cd05614 159 EKER-TYSFCGTIEYMA-PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKCD------ 227 (332)
T ss_pred CCCc-cccccCCccccC-HHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhcCC------
Confidence 3222 245689999999 9999875 47899999999999999999999996443211100 0111111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
.. .....+..+.+++..||+.||++|| +++++++
T Consensus 228 ~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 PP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11 1122456688999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=304.73 Aligned_cols=259 Identities=22% Similarity=0.389 Sum_probs=204.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.+++..+..+|.|+++.||.+.... .......+++|.+........+.+.+|+++++.++|+||+++++++.++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 4456666777888888887664321 22456789999988766666788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC---------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC
Q 038905 491 LVYKFLNNGTLASFLFENL---------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~---------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 555 (709)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence 9999999999999997642 3788899999999999999999 899999999999999999999
Q ss_pred eEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHH
Q 038905 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 634 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 634 (709)
+||+|||+++.+.............+++.|+| ||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----- 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP-PESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI----- 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccC-HHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH-----
Confidence 99999999976543322211133445778998 999999999999999999999999998 88888644332211
Q ss_pred HHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 635 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 635 ~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
.....+.... .....+..+.+++.+||+.||++||++++|++.|+.
T Consensus 235 --~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 --ECITQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --HHHHcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111111110 111244668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.59 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=200.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+.... .......+|||++.... .....++.+|+.++++++|+||+++++++.++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 4567766777888888776554321 11345779999886432 23446789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC----------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEc
Q 038905 490 LLVYKFLNNGTLASFLFENL----------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~----------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
++||||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999987532 2567788999999999999999 8899999999999999999999999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||+++.+.............+++.|+| ||++.+..++.++||||||+++|||++ |..||......+. .+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~-------~~~ 233 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMS-PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV-------LRF 233 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcC-hhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHH
Confidence 9999976543322211123455788998 999999899999999999999999999 6788865433221 111
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
...+....+ ....+..+.+++.+|++.+|++|||+.|++++|++
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 222221111 11234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=299.37 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=193.0
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+|.|+++.||.+... .+++.+|+|..... ..+....+.+|++++++++|+||+++++++......++||||+++++
T Consensus 3 lg~g~~g~vy~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 3 IGRGNFGEVFSGRLR---ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred cCcccCccEEEEEEe---cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 566677777555544 46788999987543 23455789999999999999999999999999999999999999999
Q ss_pred HHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceecc
Q 038905 501 LASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579 (709)
Q Consensus 501 L~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 579 (709)
|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...............
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999997654 5889999999999999999999 889999999999999999999999999999765432111110112
Q ss_pred ccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCH
Q 038905 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658 (709)
Q Consensus 580 ~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~ 658 (709)
.++..|+| ||.+.+..++.++||||||+++|||++ |..|+......... .....+. ......
T Consensus 157 ~~~~~y~a-PE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-------~~~~~~~---------~~~~~~ 219 (252)
T cd05084 157 QIPVKWTA-PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQGV---------RLPCPE 219 (252)
T ss_pred CCceeecC-chhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCC---------CCCCcc
Confidence 23456888 999999899999999999999999998 88888644332211 1111110 011122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 659 KCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 659 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
..+..+.+++.+|++.+|++|||+++|.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 34567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=299.65 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=197.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+.|.....+|.|+++.||.+ .. .....+|+|.+.... ...+++.+|+.++++++||||+++++++.+....++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~-~~---~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLG-KW---RAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEE-Ee---ccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 44665666788888877655 44 245678999876432 34568899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999998754 46889999999999999999999 88999999999999999999999999999986543322
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. .....++..|+| ||++.+..++.++||||||+++|||++ |+.||......+.. .....+.... .
T Consensus 156 ~~-~~~~~~~~~y~a-PE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~-------~~i~~~~~~~--~-- 222 (256)
T cd05114 156 TS-SSGAKFPVKWSP-PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-------EMISRGFRLY--R-- 222 (256)
T ss_pred ec-cCCCCCchhhCC-hhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCCCC--C--
Confidence 11 122345567998 999998899999999999999999999 88998755432211 1112221110 0
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
+...+..+.+++.+||+.+|.+||++++++++|.
T Consensus 223 -----~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 -----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1113457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=311.79 Aligned_cols=236 Identities=23% Similarity=0.324 Sum_probs=191.7
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeec
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
.+|.|+++.||.+... .+++.+|||.+... .....+.+..|..++..+ +||||+++++++.+.+..++||||+
T Consensus 2 ~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 2 VLGKGSFGKVMLARLK---ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred eeeeCCCeEEEEEEEc---CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 3567777777666554 56789999988643 223456678888888876 6999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 497 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
++++|..++.+...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~--~ 153 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--T 153 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--c
Confidence 99999999988888999999999999999999999 899999999999999999999999999998764322211 2
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. .+.+..+... .
T Consensus 154 ~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~----------~ 215 (320)
T cd05590 154 STFCGTPDYIA-PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEAILNDEVV----------Y 215 (320)
T ss_pred cccccCccccC-HHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCCC----------C
Confidence 45689999999 9999999999999999999999999999999976543221 1222222211 0
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCH
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTM 682 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~ 682 (709)
+...+..+.+++..||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11245678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=303.79 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=199.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEec-CCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQT-STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.|+....+|.|+++.||.+..... ......+++|.+.... .+...++.+|+.++++++|+||+++++++..+...++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 455555667777777765543322 2456889999987432 33446789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC-----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC
Q 038905 493 YKFLNNGTLASFLFENL-----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 555 (709)
|||+++++|.+++.... .+++.....++.|++.||.||| +++|+||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCc
Confidence 99999999999986321 3677888999999999999999 889999999999999999999
Q ss_pred eEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHH
Q 038905 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 634 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 634 (709)
+||+|||+++...............++..|++ ||++.+..++.++||||||++++||++ |..||......+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~------ 235 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMP-PEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV------ 235 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecC-hHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 99999999987644332222234556778998 999998889999999999999999998 8888865432221
Q ss_pred HHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 635 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 635 ~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
.+....+.... .....+..+.+++.+|++.+|++||+++++.++|.+
T Consensus 236 -~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 -IEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11222222111 112345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.94 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=194.8
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+|.|+++.||.+... ..++.+|||.++... ....+.+.+|..++.++ +||||+++++++.+....++||||++
T Consensus 3 lG~G~~g~V~~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 3 IGRGSYAKVLLVELK---KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred EeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 567777777666555 567889999886532 22345688999999988 69999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
+++|..++.+...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTS 154 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccc
Confidence 9999999988888999999999999999999999 89999999999999999999999999999975322211 124
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhh--HHhHHHHHHHhhhcCCccccccCccccc
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDMEAM 655 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~g~~~~l~~~~~~~~ 655 (709)
...||+.|+| ||++.+..++.++|||||||++|||++|+.||+.....+ ......+..+....+...
T Consensus 155 ~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 223 (329)
T cd05588 155 TFCGTPNYIA-PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---------- 223 (329)
T ss_pred cccCCccccC-HHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC----------
Confidence 5789999999 999999999999999999999999999999996432111 111112222222222211
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 038905 656 NDIKCVEKLVMVSIWCIQEDPSLRPT------MRKVSQ 687 (709)
Q Consensus 656 ~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~ev~~ 687 (709)
.+...+..+.+++..||+.||.+||+ ++++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 01123457889999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=299.53 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=199.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
..|.....+|.|+++.||.+ .. .....+|+|.+.... ...+++.+|+.++++++|+|++++++++...+..++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~-~~---~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEG-LW---NNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hheeeEEEecccCCccEEEE-Ee---cCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 44565666777777777654 44 245679999986543 34677999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999997654 6899999999999999999999 8899999999999999999999999999998776332
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... ......+..|+| ||++.+..++.++||||||++++||++ |+.||........ ......+..
T Consensus 158 ~~~-~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~------ 222 (261)
T cd05068 158 YEA-REGAKFPIKWTA-PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-------LQQVDQGYR------ 222 (261)
T ss_pred ccc-cCCCcCceeccC-ccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC------
Confidence 111 122233457998 999999999999999999999999999 8889865432221 111111110
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
.......++.+.+++.+|++.+|.+||+++++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01122345678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=310.64 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=202.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCC-CceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTST-RTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
...|.....+|.|+++.||.+.....+. ....||+|.++... ....+++.+|+.+++.++|+||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3467777788888888886655443322 23458999986543 34457899999999999999999999999764 577
Q ss_pred EEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+|+||+++|+|.+++.+.. .+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.+..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 9999999999999998754 5888999999999999999999 88999999999999999999999999999997765
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
...........++..|++ ||++.+..++.++||||||+++|||++ |+.||......+.. .....+...
T Consensus 162 ~~~~~~~~~~~~~~~y~a-pE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~--- 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGERL--- 230 (316)
T ss_pred CCcceeccCCccceeecC-hHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHhCCCCC---
Confidence 433222123344678998 999999999999999999999999998 99998754332211 111111110
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.........+.+++..||+.+|.+||++.+++..|..+.
T Consensus 231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001123456889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.18 Aligned_cols=241 Identities=25% Similarity=0.269 Sum_probs=195.4
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
.+|.|+++.||.+........++.+|+|++..... .....+.+|++++.+++||||+++++++.+....++||||+++
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 82 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence 46777777787666554445788999999875322 2335678899999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceec
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 578 (709)
++|.+++.+...+++..+..++.||++||.||| +.+|+||||||+||++++++.+||+|||+++........ ...
T Consensus 83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~~ 157 (318)
T cd05582 83 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYS 157 (318)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--eec
Confidence 999999988888999999999999999999999 889999999999999999999999999999865433222 245
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCH
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~ 658 (709)
..|++.|+| ||++.+..++.++||||||+++|||++|+.||......+.. .....+... .+.
T Consensus 158 ~~g~~~y~a-PE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-------~~i~~~~~~----------~p~ 219 (318)
T cd05582 158 FCGTVEYMA-PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM-------TMILKAKLG----------MPQ 219 (318)
T ss_pred ccCChhhcC-HHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH-------HHHHcCCCC----------CCC
Confidence 789999999 99999989999999999999999999999999755432211 111111110 112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHH
Q 038905 659 KCVEKLVMVSIWCIQEDPSLRPTMRK 684 (709)
Q Consensus 659 ~~~~~l~~l~~~Cl~~dP~~RPs~~e 684 (709)
..+..+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23567889999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=317.12 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=197.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.|.....+|.|+++.||.+... .+++.+|||++... .....+.+.+|+.++.+++|+|||++++++.+.+..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV---DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence 4666677888888888776655 57889999998643 23345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++|+|.+++.+...+++.....++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999999988888999999999999999999999 8999999999999999999999999999986442110
Q ss_pred cc---------------------------------------------cceeccccCcccccccccccCCCCCcccchHHH
Q 038905 572 SK---------------------------------------------AIKKAIRGTKGYVASPEWFRNSTITANVDVYSF 606 (709)
Q Consensus 572 ~~---------------------------------------------~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSl 606 (709)
.. .......||+.|+| ||++.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a-PE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIA-PEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccC-HHHHcCCCCCCccceeeh
Confidence 00 00124579999999 999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHh--cccCCCCCCCCHHH
Q 038905 607 GVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIW--CIQEDPSLRPTMRK 684 (709)
Q Consensus 607 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~e 684 (709)
||++|||++|+.||......+... . ...... ..........+..+.+++.+ |+..+|..||++++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~------~-i~~~~~------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQL------K-VINWEN------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHH------H-HHcccc------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 999999999999997654322111 0 000000 00000111234566677766 55667777999999
Q ss_pred HHHH
Q 038905 685 VSQM 688 (709)
Q Consensus 685 v~~~ 688 (709)
+++.
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.20 Aligned_cols=242 Identities=22% Similarity=0.234 Sum_probs=195.6
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
.+|.|+++.||.+... .++..+|+|.+... ......++.+|++++..++||||+++++++.+.+..++||||++
T Consensus 2 ~lG~G~~g~V~~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 2 LLGKGTFGKVILVKEK---ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred eeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 3577777777766554 56889999988653 22344677889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCC-CCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCS-SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
+++|..++.....+++..+..++.||+.||.||| + .+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 153 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 153 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--c
Confidence 9999999988888999999999999999999999 6 69999999999999999999999999998754322211 1
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.. .....+... .
T Consensus 154 ~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-------~~i~~~~~~----------~ 215 (325)
T cd05594 154 KTFCGTPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEEIR----------F 215 (325)
T ss_pred ccccCCcccCC-HHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-------HHHhcCCCC----------C
Confidence 45679999999 99999999999999999999999999999999755432211 111111110 0
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 688 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 688 (709)
+......+.+++.+||+.||++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 112345688999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=317.43 Aligned_cols=252 Identities=19% Similarity=0.247 Sum_probs=199.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... .+++.||||++.... ......+.+|+.++..++|+||+++++++.+++..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKK---DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CceEEEEEEecCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 5677777888888888777665 567899999986432 2344568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++|+|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999999988888999999999999999999999 8999999999999999999999999999997653221
Q ss_pred ccc------------------------------------ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh
Q 038905 572 SKA------------------------------------IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615 (709)
Q Consensus 572 ~~~------------------------------------~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt 615 (709)
... .....+||+.|+| ||++....++.++|||||||++|||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIA-PEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccC-HHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0013569999999 999999999999999999999999999
Q ss_pred CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 038905 616 CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT---MRKVSQ 687 (709)
Q Consensus 616 g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ev~~ 687 (709)
|..||......+.. ......... + ........++.+.+++..|+. +|.+|++ ++++++
T Consensus 235 G~~Pf~~~~~~~~~-------~~i~~~~~~-~-----~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQETY-------RKIINWKET-L-----QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHHH-------HHHHcCCCc-c-----CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999765432211 111111100 0 000011234567788888986 8999997 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.48 Aligned_cols=262 Identities=25% Similarity=0.341 Sum_probs=201.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEc-CCe
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDE-GQN 488 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~-~~~ 488 (709)
++|.....+|.|+++.||.+.... ....++.||+|++.... ....+.+..|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 356666667777777776654332 22345789999987543 23346788899999999 89999999998864 456
Q ss_pred EEEEEeecCCCCHHHHHhhC------------------------------------------------------------
Q 038905 489 RLLVYKFLNNGTLASFLFEN------------------------------------------------------------ 508 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 508 (709)
.+++|||+++++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999998642
Q ss_pred -CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCccccc
Q 038905 509 -LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA 587 (709)
Q Consensus 509 -~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~a 587 (709)
..+++..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 24788889999999999999999 88999999999999999999999999999987654333222234566778998
Q ss_pred ccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHH
Q 038905 588 SPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVM 666 (709)
Q Consensus 588 aPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~ 666 (709)
||++.+..++.++|||||||+++||++ |..||......+. .......+.... ........+.+
T Consensus 244 -PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~ 307 (337)
T cd05054 244 -PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMR---------APEYATPEIYS 307 (337)
T ss_pred -cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCC---------CCccCCHHHHH
Confidence 999999999999999999999999998 9999865332221 111111211111 11234467899
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 667 VSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 667 l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
++.+||+.+|++||+++||+++|+.+.+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=316.71 Aligned_cols=258 Identities=17% Similarity=0.129 Sum_probs=197.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+... ..++.||+|+.. ...+.+|++++++++|||||++++++......++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~---~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDN---KTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEEC---CCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 456887788888888888777665 578899999743 23568999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
+|++. ++|..++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 99985 689998887778999999999999999999999 88999999999999999999999999999975432221
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchh-----hHHhHHHHHHHhh--------
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE-----EYAILTDWAFDCY-------- 639 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~-------- 639 (709)
. ......||+.|+| ||++.+..++.++|||||||++|||++|+.|+...... ....+. .+....
T Consensus 238 ~-~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~-~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 N-KYYGWAGTIATNA-PELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK-LIIRRSGTHPNEFP 314 (391)
T ss_pred c-ccccccCccCCCC-hhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH-HHHHHhcCChhhcC
Confidence 1 1145689999998 99999999999999999999999999999876533210 000000 000000
Q ss_pred --------------hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 640 --------------RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 640 --------------~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....... ...+.........+..+.+++.+||+.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRK-PGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCC-CCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0000000001134567899999999999999999999986
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.90 Aligned_cols=241 Identities=22% Similarity=0.297 Sum_probs=194.3
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+|.|+++.||.+... ..++.+|||.+... ..+..+.+..|.+++..+ +||||+++++++.+....++||||++
T Consensus 3 lG~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 3 LGKGSFGKVMLAELK---GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred cccCCCeEEEEEEEC---CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 567777777655544 56788999988653 223445678899888866 79999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
+++|..++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--~~ 154 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TT 154 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--cc
Confidence 9999999988888999999999999999999999 889999999999999999999999999999754322211 24
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
...||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ......+... .+
T Consensus 155 ~~~gt~~y~a-PE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-------~~~i~~~~~~----------~p 216 (321)
T cd05591 155 TFCGTPDYIA-PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-------FESILHDDVL----------YP 216 (321)
T ss_pred ccccCccccC-HHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCC----------CC
Confidence 5679999999 9999999999999999999999999999999976543321 1112222111 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-------CHHHHHHH
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRP-------TMRKVSQM 688 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RP-------s~~ev~~~ 688 (709)
...+..+.+++..||+.||++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 12346788999999999999999 77777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=305.37 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=205.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecC--CCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTS--TRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+++.||.+...... .....+|+|.+.... .....++.+|+.++.++ +|+||+++++++..+..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456777777888888888776654322 345789999887532 23446789999999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC
Q 038905 489 RLLVYKFLNNGTLASFLFEN----------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD 552 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~ 552 (709)
.++||||+++++|..++... ..+++..+..++.|++.||.||| +.+|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence 99999999999999999642 34788899999999999999999 889999999999999999
Q ss_pred CCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhH
Q 038905 553 YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 631 (709)
Q Consensus 553 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 631 (709)
++.+||+|||+++.+.............++..|+| ||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMA-PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccC-HHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence 99999999999987654332221133345677998 999999999999999999999999997 8888865433221
Q ss_pred HHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 632 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 632 ~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.+....+... ..+......+.+++..|++.+|++|||++++++.|+.+.
T Consensus 244 ----~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ----FKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111221111 112234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.35 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=196.2
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~g 499 (709)
+|.|+++.|| .+......++..+|+|+++... ....+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 3 lg~G~~g~v~-~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 3 LGSGNFGTVK-KGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred CCCcCCcceE-EeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 4566666664 4444334567889999986443 234578999999999999999999999885 45678999999999
Q ss_pred CHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc-eec
Q 038905 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI-KKA 578 (709)
Q Consensus 500 sL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 578 (709)
+|.+++.....+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||+++.+........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999988778999999999999999999999 88999999999999999999999999999987654432211 122
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
..++..|+| ||.+....++.++|+||||+++|||++ |..||......+. ......+.... .+
T Consensus 158 ~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~i~~~~~~~---------~~ 220 (257)
T cd05116 158 GKWPVKWYA-PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-------TQMIESGERME---------CP 220 (257)
T ss_pred CCCCccccC-HhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCCCCC---------CC
Confidence 334578998 999988889999999999999999998 9999975433221 11222222111 12
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
...+..+.+++.+||+.||++||++++|+++|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2345678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.07 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=200.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
++|.....+|.|+++.||.+. . .....+|+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~-~---~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGY-Y---NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred HHeEEeeecCCcCCceEEEEE-e---cCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 456666777888888886654 4 245679999876533 34578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999754 35788899999999999999999 8899999999999999999999999999998765432
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... .....++..|+| ||++....++.++||||||+++|||++ |+.||......+.. ..+..+...
T Consensus 158 ~~~-~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~~~~----- 223 (261)
T cd05072 158 YTA-REGAKFPIKWTA-PEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-------SALQRGYRM----- 223 (261)
T ss_pred eec-cCCCccceecCC-HHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH-------HHHHcCCCC-----
Confidence 211 133446678998 999998889999999999999999998 89998654322211 111111100
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
......+..+.+++.+|++.+|++||++++++++|+.
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112245678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=311.81 Aligned_cols=243 Identities=22% Similarity=0.282 Sum_probs=190.9
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeec
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
.+|.|+++.||.+... .+++.+|+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 2 ~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 2 VIGRGSYAKVLLVRLK---KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred eeeeCCCeEEEEEEEC---CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 3567777777666555 56788999988653 223445678899888776 7999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 497 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
++++|..++.+...+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||+++........ .
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~--~ 153 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--T 153 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--c
Confidence 99999999988888999999999999999999999 889999999999999999999999999999754322211 1
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchh--hHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
....||+.|+| ||++.+..++.++||||||+++|||++|+.||...... .......+..+....+...
T Consensus 154 ~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~--------- 223 (329)
T cd05618 154 STFCGTPNYIA-PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR--------- 223 (329)
T ss_pred ccccCCccccC-HHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---------
Confidence 45789999999 99999999999999999999999999999999632111 0111111222222222211
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTM 682 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 682 (709)
.+......+.+++..||+.||++||+.
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 122345678899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=310.76 Aligned_cols=243 Identities=23% Similarity=0.279 Sum_probs=192.9
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeec
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
.+|.|+++.||.+... ..++.+|+|.+.... ....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+
T Consensus 2 ~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 2 VIGRGSYAKVLLVRLK---KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred eeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 3677777777766555 567889999987532 23445688999999888 6999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 497 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
++++|..++.....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TT 153 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ce
Confidence 99999999988788999999999999999999999 88999999999999999999999999999975322211 12
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
...+||+.|+| ||++.+..++.++|||||||++|||++|+.||......................... .
T Consensus 154 ~~~~gt~~y~a-PE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 222 (327)
T cd05617 154 STFCGTPNYIA-PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------I 222 (327)
T ss_pred ecccCCcccCC-HHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------C
Confidence 45789999999 999999999999999999999999999999996533222111122222222222111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCH
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTM 682 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~ 682 (709)
+...+..+.+++..||+.||.+|+++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 12234668899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=324.32 Aligned_cols=253 Identities=25% Similarity=0.299 Sum_probs=203.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--- 487 (709)
..+|.....+|.|+++.||++... .+++.||||.+... .......+.+|+.++..++|+|+++++..+....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRV---SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEc---CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 567777778888888888877766 56889999988643 3345567889999999999999999988775432
Q ss_pred -----eEEEEEeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEE
Q 038905 488 -----NRLLVYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558 (709)
Q Consensus 488 -----~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 558 (709)
..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence 367999999999999998753 35888899999999999999999 899999999999999999999999
Q ss_pred ccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 559 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
+|||+++.+.............||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ...
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~a-PE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~-------~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVA-PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-------MHK 256 (496)
T ss_pred EecccCeeccccccccccccccCCcceeC-HHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHH
Confidence 99999987654433333356789999999 9999999999999999999999999999999975543221 112
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
...+....+ +...+..+.+++..||+.||.+||++.++++.
T Consensus 257 ~~~~~~~~~---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDPL---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222222111 22345678899999999999999999999864
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.34 Aligned_cols=241 Identities=23% Similarity=0.268 Sum_probs=193.7
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcC-ceeEEEeEEEcCCeEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHK-NLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-nlv~l~~~~~~~~~~~l 491 (709)
|.....+|.|+++.||.+... ..++.+|||.+... .....+.+..|.+++..++|+ +|+++++++.+.+..++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERK---GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred ceEEEEEeeccCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 555667788888888766554 46788999988643 223456788899999999765 58889999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|..++.....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999999988888999999999999999999999 8899999999999999999999999999987543222
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
. ......||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.. .........
T Consensus 156 ~--~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-------~~i~~~~~~------ 219 (324)
T cd05587 156 K--TTRTFCGTPDYIA-PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------QSIMEHNVS------ 219 (324)
T ss_pred C--ceeeecCCccccC-hhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCCC------
Confidence 1 1245689999999 99999999999999999999999999999999765432211 111111110
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 682 (709)
.+...+..+.+++..||+.||.+|++.
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 ----YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111245678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.04 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=197.5
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe------EE
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN------RL 490 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~------~~ 490 (709)
...+|.|+++.||.+...........+|||++... .....+++.+|+++++.++|+|++++++++.+.+. .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 34567777777766655544345688999998643 23345689999999999999999999999866554 79
Q ss_pred EEEeecCCCCHHHHHhhC------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 491 LVYKFLNNGTLASFLFEN------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
+|+||+++++|..++... ..+++.....++.|++.||.||| +.+++||||||+||++++++.+||+|||++
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccce
Confidence 999999999999998543 24788899999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
+.+.............++..|++ ||.+.+..++.++||||||+++|||++ |..||......+. ......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~-pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~~ 232 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIA-IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI-------YDYLRHGN 232 (273)
T ss_pred eeccccccccccccccCCccccC-HhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC
Confidence 87654332211122345678998 999998899999999999999999999 8888865432221 11112221
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
... .....+..+.+++.+|++.||.+|||+.++++.|+.+
T Consensus 233 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 1223456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.78 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=203.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... .+++.+|||++.... ......+.+|+.++..++|+||+++++++.+++..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEEC---CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 4666677888888888766655 468899999986432 2345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|.+++.+...++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999999998888999999999999999999999 8999999999999999999999999999998765433
Q ss_pred ---------------------------cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 038905 572 ---------------------------SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEM 624 (709)
Q Consensus 572 ---------------------------~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~ 624 (709)
.........||+.|+| ||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIA-PEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccC-HHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 0011135679999998 999999999999999999999999999999997654
Q ss_pred hhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 038905 625 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-MRKVSQM 688 (709)
Q Consensus 625 ~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~~ 688 (709)
..+.. ..+.... ...........+..+.+++..|++ +|.+||+ ++++++.
T Consensus 235 ~~~~~-------~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQETY-------NKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHH-------HHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 32211 1111100 000010111145678899999998 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=314.85 Aligned_cols=254 Identities=18% Similarity=0.243 Sum_probs=200.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .++..+|+|.+... .....+.+.+|+.+++.++||||+++++++.++...
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 567777777888888888776665 56888999998642 223445678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++|+|.+++... .++......++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999988653 5788888899999999999999 89999999999999999999999999999987653
Q ss_pred cccccceeccccCcccccccccccCC----CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNS----TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~----~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
..... ....+||+.|+| ||++.+. .++.++|||||||++|||++|+.||....... .+..+..+...
T Consensus 195 ~~~~~-~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~ 265 (370)
T cd05596 195 NGMVR-CDTAVGTPDYIS-PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMDHKNS 265 (370)
T ss_pred CCccc-CCCCCCCcCeEC-HHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCCCc
Confidence 32211 145679999999 9998754 47899999999999999999999997654322 11112111110
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSL--RPTMRKVSQM 688 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~ 688 (709)
.........+..+.+++..||+.+|.+ ||+++++++.
T Consensus 266 ------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 ------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 011111234577889999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.02 Aligned_cols=260 Identities=24% Similarity=0.330 Sum_probs=199.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCC-ceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTR-TTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..|.....+|.|+++.||.+.....+.. ...+++|...... .....++..|+.+++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 3455566678888887765554432221 2357888875432 2234678889999999999999999998854 55789
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
++||+++|+|.+++... ..+++..+..++.||+.||.||| +++++||||||+||++++++.+||+|||+++.+...
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999764 46899999999999999999999 889999999999999999999999999999876443
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..........++..|++ ||++.+..++.++||||||+++|||++ |..||......... +.+..+.... .
T Consensus 163 ~~~~~~~~~~~~~~y~~-pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~--~ 232 (279)
T cd05111 163 DKKYFYSEHKTPIKWMA-LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-------DLLEKGERLA--Q 232 (279)
T ss_pred CcccccCCCCCcccccC-HHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCcCC--C
Confidence 32222234567788998 999998899999999999999999998 99998755432211 1122222111 1
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.......+.+++..|++.+|++|||+.|+++.|+.+..
T Consensus 233 -------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 -------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11234567889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=311.83 Aligned_cols=271 Identities=18% Similarity=0.233 Sum_probs=196.7
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC-----Ce
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG-----QN 488 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~-----~~ 488 (709)
|.....+|.|+++.||.+... .++..||||++.... .....++.+|+.++++++||||+++++++... ..
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred eEEEEEEeecCCeEEEEEEEC---CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 444556677777777655544 568899999886432 23345788999999999999999999988543 35
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||||+. ++|.+++.....+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 799999995 689999988778999999999999999999999 8899999999999999999999999999998654
Q ss_pred ccccc-cceeccccCcccccccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHH--------HHH
Q 038905 569 LNQSK-AIKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AFD 637 (709)
Q Consensus 569 ~~~~~-~~~~~~~Gt~~y~aaPE~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~--------~~~ 637 (709)
..... .......||+.|+| ||++.+ ..++.++|||||||++|||++|+.||.............. ...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRA-PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred cccCccccccCCCCCCCcCC-HHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 11134679999999 999876 6789999999999999999999999975543211110000 000
Q ss_pred hhhcCCccccccC---cccc---cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hccccc
Q 038905 638 CYRNGKLDDLVEG---DMEA---MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEVVVE 694 (709)
Q Consensus 638 ~~~~g~~~~l~~~---~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~~ 694 (709)
.+...+....+.. .... .........+.+++..||+.||++|||++|+++. +.+...
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 1111110000000 0000 0011234567899999999999999999999973 444433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.07 Aligned_cols=251 Identities=21% Similarity=0.254 Sum_probs=199.6
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..++.+|+|.+.... .+..+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CceEEEEEEeccCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 4666677788888888766655 567889999886532 2345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++.+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999999876 57899999999999999999999 899999999999999999999999999999876543
Q ss_pred ccccceeccccCccccccccccc------CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFR------NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~------~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
... ......||+.|+| ||++. ...++.++|||||||++|||++|+.||........ ...+....
T Consensus 156 ~~~-~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~- 225 (330)
T cd05601 156 KMV-NSKLPVGTPDYIA-PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------YNNIMNFQ- 225 (330)
T ss_pred Cce-eeecccCCccccC-HHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------HHHHHcCC-
Confidence 322 1144579999999 99987 45678999999999999999999999975543221 11111111
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+ ........+..+.+++..|++ +|.+|||++++++
T Consensus 226 -~~~----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 -RFL----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -Ccc----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 001112345668889999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.14 Aligned_cols=239 Identities=24% Similarity=0.281 Sum_probs=189.7
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhc-cCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQ-TYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+|.|+++.||.+... ..++.||||.+.... ....+.+..|..++.. .+||||+++++++..+...++||||++
T Consensus 3 lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 3 LGKGSFGKVMLAELK---GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred eeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 567777777666554 567889999886432 2234456667777765 489999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
+++|..++.....+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~ 154 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KAS 154 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--ccc
Confidence 9999999988888999999999999999999999 88999999999999999999999999999986543221 124
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
...||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.. ..+..... ..+
T Consensus 155 ~~~gt~~y~a-PE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~~~----------~~~ 216 (316)
T cd05592 155 TFCGTPDYIA-PEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-------DSILNDRP----------HFP 216 (316)
T ss_pred cccCCccccC-HHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCC----------CCC
Confidence 5789999999 99999999999999999999999999999999765432211 11111110 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMR-KVS 686 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~ 686 (709)
......+.+++..||+.+|.+||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22445678999999999999999976 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.66 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=207.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe----cCCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ----TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~ 486 (709)
..+|.....+|.|+++.||.+.... .......+|+|.+.... ....+++.+|+.++..+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 3456666777888888887665432 12345689999886432 34457899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee
Q 038905 487 QNRLLVYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll 550 (709)
...++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 99999999999999999997642 3677888999999999999999 8899999999999999
Q ss_pred cCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHH
Q 038905 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 629 (709)
Q Consensus 551 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~ 629 (709)
++++.+||+|||+++.+.............+++.|+| ||++.+..++.++||||||+++|||++ |..|+......+.
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~- 248 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMA-PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 248 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeC-chhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-
Confidence 9999999999999987654332222233456778998 999999899999999999999999998 7778764432221
Q ss_pred hHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCCC
Q 038905 630 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDV 697 (709)
Q Consensus 630 ~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 697 (709)
......+.... .....+..+.+++..||+.+|.+|||+.++++.|+.+..+..
T Consensus 249 ------~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 249 ------FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred ------HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 11222221111 112345678899999999999999999999999998776544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.70 Aligned_cols=241 Identities=23% Similarity=0.279 Sum_probs=193.2
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~l 491 (709)
|.....+|.|+++.||.+... .+++.+|||.+.... ....+.+..|..++..+ +|++|+++++++.+.+..++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERK---GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 555666778888888666554 567889999886432 22345567788888777 58999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++|+|..++.....+++..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999999988888999999999999999999999 8899999999999999999999999999997543222
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
. ......||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ...+..+...
T Consensus 156 ~--~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-------~~~i~~~~~~------ 219 (323)
T cd05616 156 V--TTKTFCGTPDYIA-PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQSIMEHNVA------ 219 (323)
T ss_pred C--ccccCCCChhhcC-HHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC------
Confidence 1 1245789999999 9999999999999999999999999999999976543221 1111121110
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 682 (709)
.+...+..+.+++..|++.+|.+|++.
T Consensus 220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 ----YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 112345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.12 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=199.5
Q ss_pred cceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
|.....+|.|+++.||.+..... ......+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 34445567777777755544321 1233678888876443 23456799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC------------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCce
Q 038905 493 YKFLNNGTLASFLFEN------------------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NI 548 (709)
+||+.+++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheE
Confidence 9999999999998642 23678888999999999999999 88999999999999
Q ss_pred eecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhh
Q 038905 549 LLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEE 627 (709)
Q Consensus 549 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~ 627 (709)
|+++++.+||+|||+++...............++..|++ ||++.+..++.++||||||++++||++ |..||......+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a-pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMA-IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccC-HHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999986543332211133456778998 999998899999999999999999998 988986543322
Q ss_pred HHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 628 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 628 ~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
. +.....+. ........+..+.+++.+|++.+|++||+++++++.|+.+..
T Consensus 238 ~-------~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 L-------FNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H-------HHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 11111111 011122345678899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=303.18 Aligned_cols=268 Identities=25% Similarity=0.360 Sum_probs=200.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe-cCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEc--CCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ-TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE--GQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~--~~~~ 489 (709)
...|.....+|.|+++.||.+.... ....+..+|+|++........+++.+|++++.+++|+||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 3456666677888888776554321 235678999999877666667789999999999999999999998753 3467
Q ss_pred EEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++|+||+++++|.+++.+. ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.+.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 8999999999999999764 35899999999999999999999 8899999999999999999999999999998765
Q ss_pred ccccccc-eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC----
Q 038905 569 LNQSKAI-KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---- 643 (709)
Q Consensus 569 ~~~~~~~-~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~---- 643 (709)
....... .....++..|++ ||++.+..++.++||||||++++||++|..++....... . +......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~-------~~~~~~~~~~~ 230 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-M-------RMMGNDKQGQM 230 (284)
T ss_pred CCCcceeecCCCCCceEeeC-HHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-h-------hhccccccccc
Confidence 4332111 111223445888 999999899999999999999999999877654221100 0 0000000
Q ss_pred ----ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 644 ----LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 644 ----~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
+.+.+............+..+.+++.+||+.+|++|||+++|++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0001111111111233456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.34 Aligned_cols=263 Identities=17% Similarity=0.204 Sum_probs=195.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+... .+++.+|||++..... .....+.+|+.++++++||||+++++++.+....++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK---VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC---CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 466777777888888888766554 5688899999864432 233567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||++ ++|.+++... ..++...+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 999996 5777777654 46888999999999999999999 899999999999999999999999999999754332
Q ss_pred ccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC------
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------ 643 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~------ 643 (709)
.. ......|++.|+| ||++.+ ..++.++|||||||++|||++|..||........ ....+........
T Consensus 157 ~~--~~~~~~~~~~y~a-PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 157 SH--TYSNEVVTLWYRP-PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred Cc--cCCCCcccCCCCC-hHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccc
Confidence 21 1144678999999 999875 4588999999999999999999999976433111 0011111100000
Q ss_pred ---ccccccCccccc---------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 ---LDDLVEGDMEAM---------NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ---~~~l~~~~~~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
............ ........+.+++..|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000 00012356789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=300.41 Aligned_cols=258 Identities=25% Similarity=0.303 Sum_probs=200.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+..... ......+++|...... ......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 45677777788888888876655421 1156789999876433 33456799999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC-------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC---CeEEc
Q 038905 490 LLVYKFLNNGTLASFLFENL-------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY---NAQIS 559 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~-------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 559 (709)
++||||+++++|.+++.+.. .+++..+..++.||+.||.||| +.+++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999997653 4788999999999999999999 88999999999999998765 59999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||+++.+..............+..|+| ||++.+..++.++|||||||++|||++ |..||......+.. ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-------~~ 233 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMP-PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-------EF 233 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCC-HHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HH
Confidence 9999987643221111122334567998 999999999999999999999999997 88998754432211 11
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
...+.. ...+...+..+.+++.+|++.+|++|||+.+|++.|.
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111100 0112234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.37 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=191.7
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+|.....+|.|+++.||.+... .+++.||||.+.... ....+++.+|++++++++|+||+++++++.+....++||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHR---PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEEC---CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 3445556777888878666554 567899999986432 234567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+++++|... ....+..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++.+......
T Consensus 152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99999998653 23566778889999999999999 889999999999999999999999999999876543221
Q ss_pred cceeccccCcccccccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRN-----STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~-----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.....||..|+| ||++.. ...+.++|||||||++|||++|+.||......+...+... ...+..
T Consensus 225 --~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~---- 293 (353)
T PLN00034 225 --CNSSVGTIAYMS-PERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----ICMSQP---- 293 (353)
T ss_pred --ccccccCccccC-ccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----HhccCC----
Confidence 145679999999 998743 2345689999999999999999999974333222211110 000000
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..........+.+++..||+.||++|||++|+++.
T Consensus 294 -----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122345678999999999999999999999984
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.36 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=205.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
.++|.....+|.|+++.||.+.... .......+|||+++... ....+.+.+|+.+++++ +|+||+++++++.....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 4567777777888888887665432 22356689999887543 23446789999999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
.++||||+.+++|.+++.... .+++.++..++.|++.||.||| +.+|+|+||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997643 3899999999999999999999 88999999999999999999999999999987
Q ss_pred ccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 567 LTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 567 ~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
+.............++..|+| ||.+.+..++.++||||||+++|||++ |..||......+.. ......+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------~~~~~~~~~~ 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMA-PESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKLIKEGYRM 263 (302)
T ss_pred ccCCCceeecCCCCcccccCC-HhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH------HHHHHcCCcC
Confidence 654432222233456788998 999999999999999999999999998 89998654322211 1111111110
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
......+..+.+++.+|++.+|++|||++|+++.|+..
T Consensus 264 ---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 ---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01112346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=280.94 Aligned_cols=260 Identities=24% Similarity=0.245 Sum_probs=206.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ----- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~----- 487 (709)
.++|..+..+|.|||.-|+++..+ .+...+|+|++.....++.+..++|++..++++|||+++++++...+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~---s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGL---STGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeeccc---CcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 556777777777888877777766 678899999998777778899999999999999999999998875443
Q ss_pred eEEEEEeecCCCCHHHHHhhCC----CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENL----KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
..||++.|...|+|.+.+.... .+++.+.+.|+.+|++||++||+. ...+.||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 4899999999999999997542 489999999999999999999932 22499999999999999999999999999
Q ss_pred cccccccccc-------cceeccccCcccccccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHH
Q 038905 564 AKLLTLNQSK-------AIKKAIRGTKGYVASPEWFRN---STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 633 (709)
Q Consensus 564 a~~~~~~~~~-------~~~~~~~Gt~~y~aaPE~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 633 (709)
++...-.-.. .......-|..|.| ||.+.- ..+++++|||||||+||+|+.|..||+....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRA-PELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRA-PELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccC-chheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------
Confidence 8765321110 11133556888998 999864 4578999999999999999999999974322
Q ss_pred HHHHhhhcCCcc--ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 634 WAFDCYRNGKLD--DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 634 ~~~~~~~~g~~~--~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.|... .+....+........++.+.+++.+|+|.||.+||++.+++..++.+
T Consensus 247 -------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 -------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 22211 12233333333344889999999999999999999999999988754
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.24 Aligned_cols=264 Identities=22% Similarity=0.357 Sum_probs=202.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecC-------------CCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTS-------------TRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRL 479 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~-------------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l 479 (709)
..|.....+|.|+++.||.+.....+ .....+|+|++.... ....+++.+|++++.+++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 44555666777777777665543221 233668999987543 3456789999999999999999999
Q ss_pred EeEEEcCCeEEEEEeecCCCCHHHHHhhCC-----------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCce
Q 038905 480 LGFCDEGQNRLLVYKFLNNGTLASFLFENL-----------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548 (709)
Q Consensus 480 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NI 548 (709)
++++..+...++|+||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence 999999999999999999999999998765 6889999999999999999999 88999999999999
Q ss_pred eecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh--CCCCCCccchh
Q 038905 549 LLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS--CRKSFDIEMGE 626 (709)
Q Consensus 549 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt--g~~p~~~~~~~ 626 (709)
+++.++.+||+|||+++.+.............+++.|+| ||.+.+..++.++||||||+++|||++ +..|+......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMA-WESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecC-HHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999986644332222245567788998 999998889999999999999999998 56677543222
Q ss_pred hHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 627 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 627 ~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
+. .......+..+....... .....++.+.+++.+|++.||++|||+.+|++.|+
T Consensus 241 ~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QV---IENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21 111111111111111111 12234567999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=316.09 Aligned_cols=253 Identities=21% Similarity=0.245 Sum_probs=196.5
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... .++..+|||++... ..+..+++.+|++++.+++|||||++++++.+....++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKK---DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CceEeEEEeecCCEEEEEEEEC---CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 4666677788888888766655 56788999987543 22344678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++|+|.+++.....+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999999988888999999999999999999999 8999999999999999999999999999996432110
Q ss_pred cc---------------------------------------------cceeccccCcccccccccccCCCCCcccchHHH
Q 038905 572 SK---------------------------------------------AIKKAIRGTKGYVASPEWFRNSTITANVDVYSF 606 (709)
Q Consensus 572 ~~---------------------------------------------~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSl 606 (709)
.. ......+||+.|+| ||++.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIA-PEIFLQQGYGQECDWWSL 234 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccC-HHHHccCCCCCceeeEec
Confidence 00 00012579999999 999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCC---CCHH
Q 038905 607 GVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLR---PTMR 683 (709)
Q Consensus 607 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~ 683 (709)
||++|||++|+.||......+.. ....... .. +........+..+.+++..|++ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~-------~~i~~~~-~~-----~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETY-------RKIINWR-ET-----LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHH-------HHHHccC-Cc-----cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999999765432211 1111100 00 0000111234567889999997 66665 6999
Q ss_pred HHHHH
Q 038905 684 KVSQM 688 (709)
Q Consensus 684 ev~~~ 688 (709)
++++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.35 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=198.0
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+|.|+++.||.+...........+|+|.+..... ...+++.+|+++++++.|+|+|++++++. .+..++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~ 81 (257)
T cd05060 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGP 81 (257)
T ss_pred cCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCc
Confidence 5667777776554443333457899999875433 35578999999999999999999999876 456899999999999
Q ss_pred HHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc-eecc
Q 038905 501 LASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI-KKAI 579 (709)
Q Consensus 501 L~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 579 (709)
|.+++.....+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||+++.+........ ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 82 LLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence 9999988778999999999999999999999 88999999999999999999999999999987654332211 1122
Q ss_pred ccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCH
Q 038905 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658 (709)
Q Consensus 580 ~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~ 658 (709)
.++..|+| ||.+.+..++.++||||||+++|||++ |..||......+.. .....+... ..+.
T Consensus 159 ~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-------~~~~~~~~~---------~~~~ 221 (257)
T cd05060 159 RWPLKWYA-PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-------AMLESGERL---------PRPE 221 (257)
T ss_pred cccccccC-HHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHHcCCcC---------CCCC
Confidence 34567998 999999999999999999999999998 99999755432211 111122111 1122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 659 KCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 659 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
..+..+.+++.+|++.+|.+||++.+++++|++..
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 34567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.85 Aligned_cols=271 Identities=24% Similarity=0.354 Sum_probs=200.1
Q ss_pred ceeeeecCeeEEEEEEEEEE-ecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcC--CeEEEE
Q 038905 417 TRSVLLGSSVFVNFTLVGVI-QTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QNRLLV 492 (709)
Q Consensus 417 ~~~~~~G~g~~~~v~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~~~lV 492 (709)
.....+|.|+++.||..... ....++..+|+|.+.... ....+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 44556677777777544321 222467789999987543 23457789999999999999999999988653 457899
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||+++++|.+++.+. .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.+.....
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999764 5899999999999999999999 88999999999999999999999999999987654332
Q ss_pred cc-ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KA-IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~-~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. ......++..|++ ||.+.+..++.++||||||++++||++|..|+........ ................++++..
T Consensus 163 ~~~~~~~~~~~~~~~~-PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 163 YYRVREDGDSPVFWYA-VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhccCCCCCCCceeeC-HhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcC
Confidence 11 1122345566887 9999988999999999999999999999999864322110 0000000000011111112222
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.........+..+.+++..|++.+|++|||+++++++|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 221223345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.49 Aligned_cols=240 Identities=23% Similarity=0.285 Sum_probs=194.2
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+|.|+++.||.+... .++..+|||.+... .....+.+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus 3 lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 3 LGKGSFGKVLLAELK---GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred eeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 566777777665554 56788999988643 223446678899998887 69999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
+++|..++.+...+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++........ ..
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~ 154 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TS 154 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--cc
Confidence 9999999988888999999999999999999999 899999999999999999999999999998753322211 14
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
..+|++.|+| ||++.+..++.++|||||||++|||++|+.||........ ......+... .+
T Consensus 155 ~~~g~~~y~a-PE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-------~~~i~~~~~~----------~~ 216 (318)
T cd05570 155 TFCGTPDYIA-PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-------FQSILEDEVR----------YP 216 (318)
T ss_pred ceecCccccC-HHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCC----------CC
Confidence 5679999999 9999999999999999999999999999999975543221 1111121111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTM-----RKVSQ 687 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~-----~ev~~ 687 (709)
...+..+.+++.+||+.||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2245678899999999999999999 88765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.45 Aligned_cols=244 Identities=22% Similarity=0.251 Sum_probs=190.9
Q ss_pred ceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHH---hccCcCceeEEEeEEEcCCeEE
Q 038905 417 TRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMI---GQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 417 ~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.....+|.|+++.||.+... .+++.||||.++... ....+.+.+|+.++ .+++||||+++++++.+++..+
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred eEEEEEeecCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 34455677777777665554 567889999986432 22345677776655 5678999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||+++++|..++.+ ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999999999988854 46899999999999999999999 899999999999999999999999999998754322
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... .....|++.|+| ||++.+..++.++|||||||++|||++|+.||......+.. ..+..+...
T Consensus 155 ~~~--~~~~~g~~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~-------~~i~~~~~~----- 219 (324)
T cd05589 155 GDR--TSTFCGTPEFLA-PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF-------DSIVNDEVR----- 219 (324)
T ss_pred CCc--ccccccCccccC-HhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC-----
Confidence 211 245789999999 99999999999999999999999999999999755432211 111121111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
.+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 220 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 -----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1122356788999999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.00 Aligned_cols=239 Identities=25% Similarity=0.305 Sum_probs=190.8
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+|.|+++.||.+... .++..+|+|.++... ....+.+..|..++..+ +|+||+++++++.+.++.++||||++
T Consensus 3 lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 3 LGKGSFGKVLLAELK---GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred eeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 567777777666555 567889999886532 23445677788887754 89999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
+++|..++.+...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS 154 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence 9999999988888999999999999999999999 89999999999999999999999999999875322221 125
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
...||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. .+....+.. .. +
T Consensus 155 ~~~gt~~y~a-PE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-------~~~~~~~~~------~~----~ 216 (316)
T cd05620 155 TFCGTPDYIA-PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-------FESIRVDTP------HY----P 216 (316)
T ss_pred ccCCCcCccC-HHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC------CC----C
Confidence 6789999999 9999999999999999999999999999999975543221 111111110 00 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMR-KVS 686 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~ 686 (709)
......+.+++..||+.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12345688999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=296.36 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=203.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+..... +.....+|+|.+.... .....++.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 34566667778888887765554432 2456889999986442 23456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC----------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEc
Q 038905 490 LLVYKFLNNGTLASFLFENL----------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~----------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999997532 3677889999999999999999 8999999999999999999999999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||+++.+.............++..|+| ||.+.+..++.++||||||+++|||++ |..||......+.. +.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-------~~ 233 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMA-PESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL-------KF 233 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccC-HHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH-------HH
Confidence 9999986654332222234557788998 999998889999999999999999998 88888654433211 11
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
...+..... +...+..+.+++..||+.+|++|||+.++++.|+.
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 112221111 11235678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.01 Aligned_cols=244 Identities=26% Similarity=0.295 Sum_probs=193.3
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
+|.|+++.||.+... .+++.+|+|++.... ....+.+..|+.++++++|+||+++.+++......++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMR---ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEc---cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 477788888766555 567899999986432 22335678899999999999999999999999999999999999
Q ss_pred CCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 499 GTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 499 gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
|+|..++.. ...+++..+..++.||+.||.||| +.+|+||||||+||++++++.+||+|||+++.+......
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~- 153 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK- 153 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-
Confidence 999988753 235889999999999999999999 889999999999999999999999999999876543322
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
.....||+.|+| ||++.+..++.++||||||+++|||++|+.||.......... ........+. .
T Consensus 154 -~~~~~g~~~y~a-PE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~--------~-- 218 (280)
T cd05608 154 -TKGYAGTPGFMA-PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRILNDS--------V-- 218 (280)
T ss_pred -ccccCCCcCccC-HHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---HHHHhhcccC--------C--
Confidence 145679999999 999999999999999999999999999999997543211000 0111111110 0
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
......+..+.+++..||+.||++|| +++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11223556788999999999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=286.50 Aligned_cols=251 Identities=21% Similarity=0.250 Sum_probs=200.7
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcc--cccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLD--RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
++++....+|+|.|..|+...+. .+++..|+|.++ +....+.+++.+|+.|-+.|+|||||++...+.+....||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~---~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhc---cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 44444445666666644333333 567777777654 2233467889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC---CCeEEcccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY---YNAQISDFGLAKLLT 568 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla~~~~ 568 (709)
|+|+|.|++|..-|-.+...++.......+||++||.|+| .++|||||+||+|+||... .-+||+|||+|..+.
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999999887766666778888889999999999999 9999999999999999643 349999999999888
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
... ......|||+||| ||+++..+|+..+|||+-||+||-|+.|++||..+...+ +++.+..|+..-
T Consensus 165 ~g~---~~~G~~GtP~fma-PEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~yd~-- 231 (355)
T KOG0033|consen 165 DGE---AWHGFAGTPGYLS-PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAYDY-- 231 (355)
T ss_pred Ccc---ccccccCCCcccC-HHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhccccCC--
Confidence 322 2267899999999 999999999999999999999999999999998755433 455566665432
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....-....+...+++..||..||.+|.|+.|.+.
T Consensus 232 ----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 ----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11112345677889999999999999999988764
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.60 Aligned_cols=240 Identities=26% Similarity=0.294 Sum_probs=190.6
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhc-cCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQ-TYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+|.|+++.||.+... ..++.+|||.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||++
T Consensus 3 lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 3 LGKGSFGKVFLAELK---GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred eeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 566677777655544 567889999886532 2334566778888876 489999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
+|+|..++.....+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~ 154 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TC 154 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--ee
Confidence 9999999988778999999999999999999999 889999999999999999999999999999754322211 24
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
...||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.. +....+.. . .+
T Consensus 155 ~~~gt~~y~a-PE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-------~~i~~~~~------~----~~ 216 (316)
T cd05619 155 TFCGTPDYIA-PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF-------QSIRMDNP------C----YP 216 (316)
T ss_pred eecCCccccC-HHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCC------C----CC
Confidence 5679999999 99999999999999999999999999999999755432211 11111110 0 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMR-KVSQ 687 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~~ 687 (709)
......+.+++.+||+.||++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 12345688999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.16 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=194.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.|.....+|.|+++.||.+... ..++.+|+|++.... ......+.+|+.++++++|+|||++++.+.++...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV---DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC---CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence 4667777888888888776655 568899999986432 2344678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++|+|.+++.+...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999999988778899999999999999999999 8899999999999999999999999999986432100
Q ss_pred c---------------------------------------------ccceeccccCcccccccccccCCCCCcccchHHH
Q 038905 572 S---------------------------------------------KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSF 606 (709)
Q Consensus 572 ~---------------------------------------------~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSl 606 (709)
. .......+||+.|+| ||++.+..++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a-PE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIA-PEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCC-HHHhcCCCCCCeeeEEec
Confidence 0 000123579999999 999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC---HH
Q 038905 607 GVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT---MR 683 (709)
Q Consensus 607 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ 683 (709)
||++|||++|+.||......+... ....... .............+.+++..++ .+|.+|++ ++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~-------~i~~~~~------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQM-------KVINWQT------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHH-------HHHccCC------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 999999999999997654322110 0111000 0000011123345566666655 49999987 77
Q ss_pred HHHH
Q 038905 684 KVSQ 687 (709)
Q Consensus 684 ev~~ 687 (709)
++++
T Consensus 301 ei~~ 304 (382)
T cd05625 301 EIKA 304 (382)
T ss_pred HHhc
Confidence 7765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.38 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=197.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
..|.....+|.|+++.||.. .. .....+|||.+.... ...+++.+|+.++.+++||||+++++++.+....++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~-~~---~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYG-KW---RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEE-Ee---cCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 34555567788888887654 43 234569999876432 34577999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||||+||++++++.+||+|||+++.......
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999999997643 6899999999999999999999 88999999999999999999999999999986644322
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. .....++..|++ ||++.+..++.++||||||+++|||++ |..||......+ .......+.....
T Consensus 156 ~~-~~~~~~~~~y~~-pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~---- 222 (256)
T cd05113 156 TS-SVGSKFPVRWSP-PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRLYR---- 222 (256)
T ss_pred ee-cCCCccChhhCC-HHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCCCC----
Confidence 11 122345667898 999998889999999999999999998 999986543322 1111222211110
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
....+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 223 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -----PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1123578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=291.87 Aligned_cols=248 Identities=25% Similarity=0.307 Sum_probs=200.7
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.||.+... .++..+++|.+... .....+++.+|++++++++|+|++++++++.+....++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRK---ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEc---CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 455556777777777666554 56788999987532 3345678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||+++.+....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999999874 46888999999999999999999 8899999999999999999999999999998765433
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
... ....|++.|+| ||++.+..++.++|+||||++++||++|+.||........ ......+....+
T Consensus 156 ~~~--~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~---- 221 (256)
T cd08529 156 NFA--NTIVGTPYYLS-PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-------ILKIIRGVFPPV---- 221 (256)
T ss_pred chh--hccccCccccC-HHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCCCCC----
Confidence 221 44578899998 9999999999999999999999999999999975542221 111122221111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 -----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.76 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=197.5
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+... .......+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIK-KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred cceeeeeecCCCcceEEEEEec-CCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 4555556777777777544333 2223345788877643 233456789999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCe
Q 038905 493 YKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 556 (709)
+||+++++|.+++.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999997532 3778889999999999999999 8899999999999999999999
Q ss_pred EEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHH
Q 038905 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 635 (709)
Q Consensus 557 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 635 (709)
||+|||++......... .....+..|++ ||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 159 kl~dfg~~~~~~~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------- 227 (297)
T cd05089 159 KIADFGLSRGEEVYVKK---TMGRLPVRWMA-IESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------- 227 (297)
T ss_pred EECCcCCCccccceecc---CCCCcCccccC-chhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence 99999998643221111 12223456998 999999899999999999999999997 9999975543221
Q ss_pred HHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCCC
Q 038905 636 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDV 697 (709)
Q Consensus 636 ~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 697 (709)
......+... ......+..+.+++..|++.+|.+|||++++++.|+.+.+...
T Consensus 228 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 228 YEKLPQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111111111 0112345678899999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=299.86 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=199.0
Q ss_pred cceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
|.....+|.|+++.||....... ......||||++...... ..+++.+|+.++.+++|+||+++++++.+....+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 33344456666777765544422 234678999998754332 346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCe
Q 038905 493 YKFLNNGTLASFLFEN----------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 556 (709)
+||+++++|..++... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence 9999999999998532 23677888999999999999999 8899999999999999999999
Q ss_pred EEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHH
Q 038905 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 635 (709)
Q Consensus 557 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 635 (709)
||+|||+++.+.............+++.|+| ||.+.+..++.++||||||+++|||++ |..||......+ .
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~ 235 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMS-PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------V 235 (283)
T ss_pred EecccccccccccchheeeccCccCCccccC-HHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence 9999999987654332222234556788998 999998889999999999999999998 778886543322 1
Q ss_pred HHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 636 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 636 ~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
.+....++.... ....+..+.+++..|++.+|.+||++++|++.|+.
T Consensus 236 ~~~i~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222223322211 22355678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.96 Aligned_cols=255 Identities=20% Similarity=0.242 Sum_probs=199.7
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+++.||.+... .+++.+|+|++........+.+.+|+.++.+++|+||+++++++..++..++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~---~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNL---HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEEC---CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45665666677777777655544 467899999987554445667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+++++|.+++.....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.+......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999999999987778999999999999999999999 889999999999999999999999999999876433221
Q ss_pred cceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 574 AIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.....|++.|++ ||.+. ...++.++||||||++++||++|+.|+......+... ........ .+
T Consensus 163 --~~~~~~~~~y~~-PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~---~~ 229 (267)
T cd06646 163 --RKSFIGTPYWMA-PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNFQ---PP 229 (267)
T ss_pred --cCccccCccccC-HhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCCC---CC
Confidence 134578899998 99884 4457889999999999999999999985432211100 00000000 00
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 689 (709)
... .....+..+.+++..||+.+|++|||++++++.|
T Consensus 230 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000 0123456889999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.87 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=202.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+++.||.+... .+..+++|.+.........++.+|+.+++.++|+||+++++++.+....++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~----~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWK----NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEec----CCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 34555556677777777655444 37889999987765556678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++++|.+++.+. ..+++..+..++.|++.||.||| +.+|+|+||||+||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999864 35889999999999999999999 8899999999999999999999999999998765432
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... ....++..|++ ||.+....++.++||||||+++++|++ |+.||......+.. .....+..
T Consensus 159 ~~~--~~~~~~~~~~~-PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~------ 222 (261)
T cd05148 159 YLS--SDKKIPYKWTA-PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY-------DQITAGYR------ 222 (261)
T ss_pred ccc--cCCCCceEecC-HHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH-------HHHHhCCc------
Confidence 211 23446678998 999998899999999999999999998 88998654432211 11111110
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.......++.+.+++.+|++.+|++|||++++++.|+.+
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 ---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111223456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=297.11 Aligned_cols=257 Identities=22% Similarity=0.362 Sum_probs=200.8
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
+.....+|.|+++.||.+.....+.....+|||.+... ......+|..|+.++++++||||+++++++.++...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 44455667777777766666655455678999998754 33445789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 495 FLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 495 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999999764 46899999999999999999999 889999999999999999999999999999866543322
Q ss_pred cceec-cc--cCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 574 AIKKA-IR--GTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 574 ~~~~~-~~--Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..... .. .+..|++ ||++.+..++.++||||||+++|||++ |..||......+.. .......
T Consensus 163 ~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~-------~~i~~~~------ 228 (269)
T cd05065 163 PTYTSSLGGKIPIRWTA-PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-------NAIEQDY------ 228 (269)
T ss_pred cccccccCCCcceeecC-HhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcCC------
Confidence 11111 11 2356888 999999999999999999999999886 99998654432211 1111110
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
......+.+..+.+++..||+.+|.+||++++|+++|+.+
T Consensus 229 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ---RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011223456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.22 Aligned_cols=236 Identities=25% Similarity=0.254 Sum_probs=188.4
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHH-HHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVV-MIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+|.|+++.||.+... .+++.||||++.... .....++.+|.. +++.++||||+++++.+.+.+..++||||++
T Consensus 3 lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred eeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 567777777666554 578899999986432 223345555554 5678999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
+++|..++.+...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTS 154 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccc
Confidence 9999999988888999999999999999999999 88999999999999999999999999999975432221 124
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
..+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. .+....+... ..
T Consensus 155 ~~~gt~~y~a-PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~~~----------~~ 216 (323)
T cd05575 155 TFCGTPEYLA-PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-------YDNILNKPLR----------LK 216 (323)
T ss_pred cccCChhhcC-hhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-------HHHHHcCCCC----------CC
Confidence 5789999998 9999999999999999999999999999999975433221 1111122111 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHH
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMR 683 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ 683 (709)
...+..+.+++..|++.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12356788999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=295.25 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=192.1
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcC------CeEEE
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG------QNRLL 491 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~------~~~~l 491 (709)
..+|.|+++.|| .+..........+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ...++
T Consensus 5 ~~ig~G~~g~V~-~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 5 KTLGEGEFGSVM-EGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred cccCcccCceEE-EeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 345666677665 444433233347899987643 234457889999999999999999999987432 24689
Q ss_pred EEeecCCCCHHHHHhhC------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 492 VYKFLNNGTLASFLFEN------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
||||+++++|..++... ..+++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 99999999999987532 24788999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
.+.............+++.|++ ||++.+..++.++||||||+++|||++ |+.||......+ .......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~-pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~ 232 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIA-IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGNR 232 (272)
T ss_pred ccCcccceecCCcccCCcccCC-HHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 7654332111123345678998 999999999999999999999999999 788886543222 1222223221
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
... ....+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 233 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 123445689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.46 Aligned_cols=249 Identities=25% Similarity=0.303 Sum_probs=197.9
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
|.....+|.|+++.||.+... .++..||+|++.... ......+.+|+.++++++|+||+++++.+.+++..++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEc---CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 555666788888888666554 568899999986432 22335678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++++|..++... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999988654 35889999999999999999999 889999999999999999999999999999876433
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... ....|++.|+| ||++.+..++.++||||+|+++|||++|+.||.......... .+......+.
T Consensus 156 ~~~---~~~~~~~~y~a-PE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~------- 221 (285)
T cd05605 156 ETI---RGRVGTVGYMA-PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKEDQ------- 221 (285)
T ss_pred Ccc---ccccCCCCccC-cHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhcc-------
Confidence 211 34578999998 999999999999999999999999999999997543322111 0111111111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
.......+..+.+++..||+.||.+|| +++++++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 111223566788999999999999999 8888866
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=292.86 Aligned_cols=260 Identities=22% Similarity=0.234 Sum_probs=195.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ----- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~----- 487 (709)
+..+.....+|.|+|+.||..... .....||||+.-...+ .-.+|+++|+++.|||||+|.-++....
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~---e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLR---ETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEc---CCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 445666777888888877554444 4589999999754322 3367999999999999999999885332
Q ss_pred eEEEEEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-CCeEEcccc
Q 038905 488 NRLLVYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-YNAQISDFG 562 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFG 562 (709)
...||||||+. +|...+.+ +.+++...+.-+..||.+||+||| +.+|+||||||+|+|+|.+ |.+||||||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 23599999987 89888875 456888888999999999999999 8999999999999999976 999999999
Q ss_pred ccccccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH----
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD---- 637 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~---- 637 (709)
.|+.+..++.. ....-|+.|.| ||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+..+.....--+..
T Consensus 172 SAK~L~~~epn---iSYicSRyYRa-PELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 172 SAKVLVKGEPN---ISYICSRYYRA-PELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred cceeeccCCCc---eeEEEeccccC-HHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 99998766544 34455788888 9998765 699999999999999999999999988765443322211111
Q ss_pred -hhh-------cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 638 -CYR-------NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 638 -~~~-------~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+. +-+...+...............++.+++.++++.+|.+|.++.|+++
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111 11111111111111123346678899999999999999999999886
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=303.49 Aligned_cols=250 Identities=25% Similarity=0.273 Sum_probs=207.7
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc---hhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ---DGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~ 490 (709)
.|.....+|.|.|+.|+.+... .++..+|+|.+.+... ...+.+.+|+.+|++++ |||||++.+.+++....+
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~---~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREK---STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred cEEehhhhCCCCceEEEEEEec---CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3444456777777767666666 4578888888765433 24468999999999999 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC----CCCeEEcccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD----YYNAQISDFGLAKL 566 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DFGla~~ 566 (709)
+|||++.||.|.+.+.+. .+++.....++.|++.|+.||| +.+|+||||||+|+|+.. ++.+|++|||+++.
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999877 4999999999999999999999 899999999999999953 35799999999998
Q ss_pred ccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 567 LTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 567 ~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
..... .....+||+.|+| ||++....|+..+||||+||++|.|++|.+||......... ..+..++.
T Consensus 189 ~~~~~---~~~~~~Gtp~y~A-PEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~-- 255 (382)
T KOG0032|consen 189 IKPGE---RLHTIVGTPEYVA-PEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDF-- 255 (382)
T ss_pred ccCCc---eEeeecCCccccC-chhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCC--
Confidence 87622 2378999999999 99999999999999999999999999999999877643322 13334443
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..........++.+.+++..|+..||.+|+|+.++++.
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22233344568889999999999999999999999994
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=301.34 Aligned_cols=264 Identities=18% Similarity=0.245 Sum_probs=200.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+|.....+|.|+++.||.+... .++..+|+|.+... .....+++.+|++++.+++||||+++++++.+++..++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHR---PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEc---CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 4666667788888888766655 46778899987643 2234467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+++++|.+++.+...+++..+..++.|+++||.|||+ ..+++||||||+||+++.++.+||+|||++..+....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 999999999999888889999999999999999999993 2589999999999999999999999999987653321
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc---------
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL--------- 644 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~--------- 644 (709)
.....|++.|++ ||.+.+..++.++|+||||++++||++|+.||........................
T Consensus 155 --~~~~~~~~~~~a-PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 --ANSFVGTRSYMS-PERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --cccCCCCcCccC-hhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 145678999998 99998888999999999999999999999998654322211110000000000000
Q ss_pred ------------cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 645 ------------DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 645 ------------~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..+................+.+++.+||+.+|++|||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000011245568999999999999999999999885
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=313.56 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=200.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~ 488 (709)
.+++.....+|.|+++.||.+.... .......||||++..... ...+.+.+|+.++.++. |+|||++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 3455556677777777775544321 123457899999975432 23457899999999997 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC-----------------------------------------------------------
Q 038905 489 RLLVYKFLNNGTLASFLFENL----------------------------------------------------------- 509 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 509 (709)
.++||||+++|+|.+++.+..
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996531
Q ss_pred ---------------------------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee
Q 038905 510 ---------------------------------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550 (709)
Q Consensus 510 ---------------------------------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll 550 (709)
.+++.....++.||+.||.||| +.+|+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence 2456667889999999999999 8999999999999999
Q ss_pred cCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHH
Q 038905 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 629 (709)
Q Consensus 551 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~ 629 (709)
++++.+||+|||+++.+.............+++.|++ ||.+.+..++.++||||||++++||++ |..||......+.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMA-PESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeC-hHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 9999999999999986543332211134467888998 999998889999999999999999998 8888864332221
Q ss_pred hHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 630 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 630 ~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.......+... ..+...+..+.+++..||+.+|.+||++++|++.|+.+.
T Consensus 351 -----~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -----FYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111110 011224567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=295.44 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=201.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... .++..++||.+... ......++.+|+.+++.++|+||+++++++.++...++
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCL---LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeec---CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 3454556777777777666554 46788999977542 22344678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 492 VYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
+|||+++++|.+++.. ...+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999998864 235789999999999999999999 899999999999999999999999999999876
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
....... ....|+..|+| ||++.+..++.++|+||||++++||++|..||......... ..........
T Consensus 157 ~~~~~~~--~~~~~~~~~~a-pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~--- 225 (267)
T cd08229 157 SSKTTAA--HSLVGTPYYMS-PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEQCDY--- 225 (267)
T ss_pred ccCCccc--ccccCCcCccC-HHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-----HhhhhhcCCC---
Confidence 5433221 34578899998 99999989999999999999999999999998643321111 0111111111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
........++.+.+++.+|++.+|++||||++|+++++++
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 -----PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -----CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0111223567899999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=298.23 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=200.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+.... .+.....||+|.+.... .....++.+|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4566766778888888776544331 22346689999876433 22345688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC----------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEc
Q 038905 490 LLVYKFLNNGTLASFLFENL----------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~----------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
++||||+++|+|.+++.+.. .+++..+..++.|++.||.||| +++|+||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999997532 2456778899999999999999 8999999999999999999999999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||+++...............++..|++ ||++.+..++.++|||||||++|||++ |..||.....++.. ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~-pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~-------~~ 233 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMA-PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL-------KF 233 (288)
T ss_pred cCCccccccccccccccCCCcccccccC-HHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HH
Confidence 9999986543322211123345678998 999999899999999999999999998 67888654333211 11
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
...+..... ....+..+.+++.+|++.+|++|||+.++++.|+...
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111111111 1123468999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=293.02 Aligned_cols=250 Identities=29% Similarity=0.413 Sum_probs=202.3
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccchh-HHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDG-EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~g 499 (709)
.+|.|+++.||.+...........+++|.+....... .+++.+|++++..++|+|++++++++.+....++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 3567777777655555322348889999987654333 678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhC---------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 500 TLASFLFEN---------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 500 sL~~~l~~~---------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+|.+++... ..+++..+..++.|++.||.||| +++++|+||||+||++++++.+||+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999875 67899999999999999999999 899999999999999999999999999999877654
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..........++..|+| ||.+....++.++||||||++++||++ |..||......+. .+....+...
T Consensus 159 ~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~---- 226 (262)
T cd00192 159 DYYRKKTGGKLPIRWMA-PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------LEYLRKGYRL---- 226 (262)
T ss_pred cccccccCCCcCccccC-HHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCC----
Confidence 32222245668889998 999998899999999999999999999 5889876533221 1111111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
......+..+.+++.+|++.+|++|||++|+++.|+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112233678899999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=296.86 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=202.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCC-ceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTR-TTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
...|.....+|.|+++.||.+.....+.. ...||+|.+... .....+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 45677777778888888866655533222 235899988643 33445788999999999999999999999875 4578
Q ss_pred EEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+++||+++|+|.+++.+. ..+++..+..++.||+.||.||| +++|+||||||+|||+++++.+||+|||+++.+..
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999874 46899999999999999999999 89999999999999999999999999999987754
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
...........+++.|++ ||...+..++.++||||||+++|||++ |..||......... ..+..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~-- 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMA-LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-------DLLEKGERLP-- 231 (279)
T ss_pred ccceeecCCCccchhhCC-HHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCcCC--
Confidence 332211122345677998 999999899999999999999999998 88998654322211 1111221111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCC
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVD 696 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 696 (709)
.....+..+.+++..||+.||++||++.++++.|+.+...+
T Consensus 232 -------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 -------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01224567889999999999999999999999998765444
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.60 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=198.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+++.||.+..... .....+++|++... .....+++.+|+.++.++ +|+||+++++++.++...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccC-CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 45666667778888887766655422 23345678876643 334556889999999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC
Q 038905 491 LVYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~ 554 (709)
+||||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||+++++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCC
Confidence 9999999999999997542 4678899999999999999999 89999999999999999999
Q ss_pred CeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHH
Q 038905 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD 633 (709)
Q Consensus 555 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 633 (709)
.+||+|||+++....... .....++..|+| ||++.+..++.++||||||++++||++ |..||......+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---- 233 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMA-IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---- 233 (303)
T ss_pred cEEeCccccCcccchhhh---cccCCCcccccC-HHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH----
Confidence 999999999864321111 122234567998 999988889999999999999999998 99998654332211
Q ss_pred HHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 634 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 634 ~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.....+... ......+..+.+++.+|++.+|++||++++++++|+.+.
T Consensus 234 ---~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 234 ---EKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred ---HHHhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111100 011123456889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.54 Aligned_cols=237 Identities=22% Similarity=0.229 Sum_probs=188.0
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHH-HHhccCcCceeEEEeEEEcCCeEEEEEeec
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVV-MIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
.+|.|+++.||.+... .+++.+|+|.+.... .....++..|.. +++.++|+||+++++++.+.+..++||||+
T Consensus 2 ~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 2 VIGKGSFGKVLLAKRK---SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred eeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 3567777777666554 568899999886432 223345555654 678899999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 497 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
++++|..++.+...++......++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TT 153 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--cc
Confidence 99999999988778889999999999999999999 88999999999999999999999999999875432221 12
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
....||+.|+| ||++.+..++.++|||||||++|||++|+.||....... .......+.. ..
T Consensus 154 ~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~----------~~ 215 (321)
T cd05603 154 STFCGTPEYLA-PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNILHKPL----------QL 215 (321)
T ss_pred ccccCCcccCC-HHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHhcCCC----------CC
Confidence 45789999999 999999999999999999999999999999997654222 1111111111 01
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHH
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTMR 683 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 683 (709)
+......+.+++.+||+.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 223456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=294.17 Aligned_cols=253 Identities=20% Similarity=0.244 Sum_probs=201.2
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-----chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-----QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
.+|.....+|.|+++.||.+... ..+..+|+|.+.... ......+.+|++++.+++||||+++++++.+++.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~---~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV---DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEc---CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe
Confidence 45777778888888888766554 467889999875332 1123578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++|+||+++++|.+++.....++......++.|++.||.||| +.+|+|+||||+||++++++.+||+|||+++...
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999999988778899999999999999999999 8899999999999999999999999999998654
Q ss_pred ccccccc-eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 569 LNQSKAI-KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 569 ~~~~~~~-~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
....... .....|+..|+| ||++.+..++.++||||||+++|||++|+.||......... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~---- 224 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMS-PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQPT---- 224 (263)
T ss_pred ccccccccccCCCcCccccC-cceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhccCC----
Confidence 3221111 123567889998 99999999999999999999999999999998654322111 11111100
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....+......+.+++..|++.+|.+|||+.++++.
T Consensus 225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011122345678899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.86 Aligned_cols=253 Identities=19% Similarity=0.260 Sum_probs=196.3
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..++.+|||.+.... ......+.+|++++.+++|+||+++++.+.+++..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKV---DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEEC---CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 4666677888888888776655 568899999986432 2234668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++|+|.+++.+...++......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999999988888899999999999999999999 8999999999999999999999999999986432100
Q ss_pred c-----------------------------------------ccceeccccCcccccccccccCCCCCcccchHHHHHHH
Q 038905 572 S-----------------------------------------KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610 (709)
Q Consensus 572 ~-----------------------------------------~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl 610 (709)
. ........||+.|+| ||++.+..++.++|||||||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIA-PEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccC-HHHHcCCCCCcceeeeecccee
Confidence 0 000123579999999 9999999999999999999999
Q ss_pred HHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCC---CHHHHHH
Q 038905 611 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP---TMRKVSQ 687 (709)
Q Consensus 611 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~ev~~ 687 (709)
|||++|+.||......+... ........ .........+..+.+++..|+ .+|.+|+ ++.++++
T Consensus 235 yell~G~~Pf~~~~~~~~~~-------~i~~~~~~------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQL-------KVINWETT------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHH-------HHhccCcc------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999997654332111 01111000 000001123445667777765 4999999 8888876
Q ss_pred H
Q 038905 688 M 688 (709)
Q Consensus 688 ~ 688 (709)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.87 Aligned_cols=237 Identities=24% Similarity=0.236 Sum_probs=189.3
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHH-HHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVV-MIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+|.|+++.||.+... .+++.+|+|.+... ......++..|.. +++.++||||+++++++...+..++||||++
T Consensus 3 lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 3 IGKGSFGKVLLAKRK---LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred eeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 577777777766655 56889999988643 1223345666665 5677999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 498 ~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
+++|..++.....+++..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT 154 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence 9999999988888999999999999999999999 89999999999999999999999999999875432221 124
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
..+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ ..+....+... ..
T Consensus 155 ~~~gt~~y~a-PE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~~~~~~~~----------~~ 216 (325)
T cd05604 155 TFCGTPEYLA-PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------MYDNILHKPLV----------LR 216 (325)
T ss_pred cccCChhhCC-HHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------HHHHHHcCCcc----------CC
Confidence 5789999999 999999999999999999999999999999997544322 11122222111 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHH
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMRK 684 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e 684 (709)
...+..+.+++..|++.+|.+||++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 124456789999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.03 Aligned_cols=259 Identities=21% Similarity=0.363 Sum_probs=203.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.+|.....+|.|+++.||.+.....+.....+|+|.++... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34555666777878878766655444556789999986532 33456889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999997653 5789999999999999999999 8999999999999999999999999999998765433
Q ss_pred cccc-eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 572 SKAI-KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 572 ~~~~-~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... .....++..|++ ||++.+..++.++|+||||++++|+++ |..||......+.. ....++..
T Consensus 161 ~~~~~~~~~~~~~~y~~-pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~-------~~~~~~~~----- 227 (267)
T cd05066 161 EAAYTTRGGKIPIRWTA-PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-------KAIEEGYR----- 227 (267)
T ss_pred ceeeecCCCccceeecC-HhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH-------HHHhCCCc-----
Confidence 2211 012223567998 999999899999999999999999886 99998654332211 11111110
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.......+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001123456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=311.16 Aligned_cols=263 Identities=23% Similarity=0.240 Sum_probs=197.3
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC-----e
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ-----N 488 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~-----~ 488 (709)
|.....+|.|+++.||.+... .+++.||||++.... ....+++.+|+.+++.++|+||+++++++.... +
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDP---RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CcccceeeeCCCEEEEEEEEC---CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 555566778888877665544 578899999986532 234467899999999999999999999998776 7
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++|+||+. ++|...+.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 899999997 588888877778999999999999999999999 8899999999999999999999999999998654
Q ss_pred ccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHH-------------
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW------------- 634 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~------------- 634 (709)
....... ....+++.|+| ||++.+. .++.++|||||||+++||++|+.||......+.......
T Consensus 155 ~~~~~~~-~~~~~~~~y~a-PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDESKHM-TQEVVTQYYRA-PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCccccC-CCCCcCCCcCC-HHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3332221 34568899998 9998874 479999999999999999999999976543221111000
Q ss_pred ---HHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 635 ---AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 635 ---~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....+.... ................++.+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGP-HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCC-CCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 00000000000112235678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=296.94 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=203.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+.... .+.....+|+|.+.... ....+++.+|+.++++++|+||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4567777778888888887665432 12467889999987543 23457799999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC----------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCc
Q 038905 490 LLVYKFLNNGTLASFLFENL----------------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQN 547 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~----------------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~N 547 (709)
++||||+++++|.+++.+.. .+++..+..++.|++.||.||| ..+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999997432 3677888999999999999999 8899999999999
Q ss_pred eeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchh
Q 038905 548 ILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGE 626 (709)
Q Consensus 548 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~ 626 (709)
|++++++.+||+|||++..+.............++..|+| ||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMP-PESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcC-HHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999976543322111123334667998 999998899999999999999999997 87888644332
Q ss_pred hHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 627 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 627 ~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
+. ......++.... ....+..+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 240 ~~-------~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EV-------IYYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH-------HHHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 21 122222322111 11245678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.28 Aligned_cols=240 Identities=25% Similarity=0.255 Sum_probs=189.0
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHH-HHHhccCcCceeEEEeEEEcCCeEEEEEeec
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
.+|.|+++.||.+... .+++.+|+|.+.... .....++..|. .+++.++|+||+++++++.+.+..++||||+
T Consensus 2 ~lg~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 2 VIGKGSFGKVLLARHK---AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred eeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 3567777777666554 567889999886432 12233445554 4567899999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 497 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
++++|..++.....+.......++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~ 153 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TT 153 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cc
Confidence 99999999988778888888999999999999999 89999999999999999999999999999975432221 12
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. +.....+... .
T Consensus 154 ~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~~----------~ 215 (325)
T cd05602 154 STFCGTPEYLA-PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------YDNILNKPLQ----------L 215 (325)
T ss_pred ccccCCccccC-HHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-------HHHHHhCCcC----------C
Confidence 45789999999 9999999999999999999999999999999975443221 1111111111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKVS 686 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~ 686 (709)
....+..+.+++..|++.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 123456788999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.74 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=189.5
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+|.|+++.|| .+....+.....+|+|++.... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 3 lg~G~~g~Vy-~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 3 IGNGWFGKVI-LGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred ccccCCceEE-EEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5666666664 4444344567789999886543 2344578999999999999999999999999999999999999999
Q ss_pred HHHHHhhCC-----CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 501 LASFLFENL-----KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 501 L~~~l~~~~-----~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
|.+++.... ..++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999997532 3566778889999999999999 88999999999999999999999999999976543322222
Q ss_pred eeccccCcccccccccccCC-------CCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 576 KKAIRGTKGYVASPEWFRNS-------TITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~-------~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
.....|++.|+| ||++.+. .++.++|+||||+++|||++ |+.||......+.... ... +....+
T Consensus 159 ~~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~------~~~-~~~~~~ 230 (269)
T cd05087 159 PDQLWVPLRWIA-PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY------TVR-EQQLKL 230 (269)
T ss_pred CCCcCCcccccC-HhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH------Hhh-cccCCC
Confidence 234567888998 9998643 35789999999999999996 9999965443321110 011 111111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
.++... ....+.+.+++..|+ .+|++|||+++|++.|+
T Consensus 231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 122111 123445778899998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.01 Aligned_cols=241 Identities=23% Similarity=0.278 Sum_probs=193.2
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~l 491 (709)
|.....+|.|+++.||.+... .+++.||+|++... .....+.+..|..++..+. |++|+++++++.+.+..++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERK---GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 455566777888888776655 56888999988643 2234466788998888885 5778889999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++|+|..++.+...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999999988888999999999999999999999 8899999999999999999999999999997543322
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
. ......||+.|+| ||++.+..++.++|||||||++|||++|+.||........ .+....+...
T Consensus 156 ~--~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------~~~i~~~~~~------ 219 (323)
T cd05615 156 V--TTRTFCGTPDYIA-PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-------FQSIMEHNVS------ 219 (323)
T ss_pred c--cccCccCCccccC-HHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC------
Confidence 1 1245679999999 9999999999999999999999999999999976543221 1111111111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 682 (709)
.+...+..+.+++.+|++.+|.+|++.
T Consensus 220 ----~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ----YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 112234578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=301.93 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=202.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecC----CCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCC
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTS----TRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQ 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~ 487 (709)
.+|.....+|.|+++.||.+...... .....+|+|.+.... .....++.+|+.++.++ +|+||+++++++.+..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 45666677788888888766554221 234579999987542 33456788999999999 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec
Q 038905 488 NRLLVYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~ 551 (709)
..++||||+++++|.+++.... .+++..+..++.|++.||+||| +.+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999997642 3788899999999999999999 88999999999999999
Q ss_pred CCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHh
Q 038905 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI 630 (709)
Q Consensus 552 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 630 (709)
.++.+||+|||+++...............+++.|+| ||++.+..++.++||||||+++|||++ |..||.....++.
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~-- 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA-PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-- 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeC-hHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence 999999999999986643221111122334568998 999999899999999999999999998 8888864432221
Q ss_pred HHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 631 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 631 ~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
......+.... .....+..+.+++..|++.+|.+|||+.+|++.|+.+..
T Consensus 252 -----~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 252 -----FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred -----HHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11112221111 122345678899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=296.27 Aligned_cols=244 Identities=25% Similarity=0.316 Sum_probs=191.5
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
+|.|+++.||.+... ..++.+|+|.+.... ......+..|++++.+++||||+++++++.++.+.++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVK---NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEc---cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 477888888766655 468899999886421 12344567799999999999999999999999999999999999
Q ss_pred CCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 499 GTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 499 gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
++|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~--- 151 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--- 151 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---
Confidence 99998886543 4788888999999999999999 899999999999999999999999999999876543221
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
....|++.|+| ||++.+..++.++|||||||++|||++|+.||......... .. .......+.... .
T Consensus 152 ~~~~~~~~y~a-PE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~-~~~~~~~~~~~~---------~ 218 (277)
T cd05607 152 TQRAGTNGYMA-PEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EE-LKRRTLEDEVKF---------E 218 (277)
T ss_pred eccCCCCCccC-HHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HH-HHHHhhcccccc---------c
Confidence 34578999999 99999989999999999999999999999999654321110 00 111111111110 0
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....+..+.+++..||+.||++||++.|+++
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 1124567899999999999999999976553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.43 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=196.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEec-----------CCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEe
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQT-----------STRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLG 481 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~-----------~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~ 481 (709)
++|.....+|.|+++.||.+..... ......||+|++... .......+.+|++++.+++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 3455555677777777765443211 123346899998653 2334567999999999999999999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhCC------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcee
Q 038905 482 FCDEGQNRLLVYKFLNNGTLASFLFENL------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549 (709)
Q Consensus 482 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIl 549 (709)
++...+..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999986532 2577888999999999999999 889999999999999
Q ss_pred ecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh--CCCCCCccchhh
Q 038905 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS--CRKSFDIEMGEE 627 (709)
Q Consensus 550 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt--g~~p~~~~~~~~ 627 (709)
+++++.+||+|||+++.+.............++..|+| ||++.+..++.++||||||++++||++ +..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA-WESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecC-hhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999976543322211133455778998 999998899999999999999999998 556765443322
Q ss_pred HHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 628 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 628 ~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
.... ....+....... ........+..+.+++.+|++.+|++|||+++|+++|+
T Consensus 241 ~~~~---~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIEN---TGEFFRNQGRQI------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH---HHHhhhhccccc------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1110 111111110000 00011224568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.59 Aligned_cols=264 Identities=21% Similarity=0.333 Sum_probs=199.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEe-------------cCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQ-------------TSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRL 479 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~-------------~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l 479 (709)
++|+....+|.|+++.||.+.... .......+|+|++... ......++.+|+.++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 456767778888888887653221 1234567999998754 33455789999999999999999999
Q ss_pred EeEEEcCCeEEEEEeecCCCCHHHHHhhCC-----------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCce
Q 038905 480 LGFCDEGQNRLLVYKFLNNGTLASFLFENL-----------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548 (709)
Q Consensus 480 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NI 548 (709)
++++..++..++||||+++++|.+++.... .+++.....++.|++.||.||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999997643 2567789999999999999999 88999999999999
Q ss_pred eecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh--CCCCCCccchh
Q 038905 549 LLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS--CRKSFDIEMGE 626 (709)
Q Consensus 549 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt--g~~p~~~~~~~ 626 (709)
++++++.+||+|||+++.+.............++..|++ ||...+..++.++|||||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~-pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMS-WESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCC-HHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999986643322111123344677888 999888889999999999999999998 66777544332
Q ss_pred hHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 627 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 627 ~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
+.... ..+.+......... .....++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 241 ~~~~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIEN---TGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHH---HHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 21110 11111111000000 011224467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=297.74 Aligned_cols=260 Identities=20% Similarity=0.271 Sum_probs=190.7
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhcc---CcCceeEEEeEEE-----
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQT---YHKNLVRLLGFCD----- 484 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nlv~l~~~~~----- 484 (709)
+|.....+|.|+++.||.+.... ..+..||||++.... ......+.+|+.++.++ +||||+++++++.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcC--CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 34555567778888886665542 346789999876432 22234566777777665 6999999999985
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccc
Q 038905 485 EGQNRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562 (709)
Q Consensus 485 ~~~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 562 (709)
.....++||||+. ++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 3456899999997 58999887543 4888999999999999999999 8999999999999999999999999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh--
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR-- 640 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 640 (709)
+++...... ......||+.|+| ||++.+..++.++|||||||++|||++|++||......+.... +.+...
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~---i~~~~~~~ 228 (290)
T cd07862 156 LARIYSFQM---ALTSVVVTLWYRA-PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLP 228 (290)
T ss_pred ceEeccCCc---ccccccccccccC-hHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHHhCCC
Confidence 998765432 1245679999999 9999998999999999999999999999999986554321111 111000
Q ss_pred -cCCcc-------ccccCccc---ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 641 -NGKLD-------DLVEGDME---AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 641 -~g~~~-------~l~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+.. ........ .......++.+.+++.+|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 00000000 0001134567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=292.82 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=201.5
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc---ccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR---VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... .+++.+|||.+.. ........+.+|+++++.++|||++++++++.+....++
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCL---LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEe---CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 4555566777777777665555 4678899997653 223344678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 492 VYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
|+||+++++|.+++.. ...++...+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999999999988853 234788899999999999999999 899999999999999999999999999999876
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
....... ....|++.|+| ||.+.+..++.++|+||||++++||++|+.||......... ............
T Consensus 157 ~~~~~~~--~~~~~~~~~~a-PE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~- 227 (267)
T cd08228 157 SSKTTAA--HSLVGTPYYMS-PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-----LCQKIEQCDYPP- 227 (267)
T ss_pred cchhHHH--hcCCCCccccC-hhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH-----HHHHHhcCCCCC-
Confidence 5433211 34578899998 99999888999999999999999999999998644321111 111111111111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
......+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 228 -------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 -------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11223557789999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=311.19 Aligned_cols=252 Identities=21% Similarity=0.279 Sum_probs=196.3
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..++.+|||++... .......+.+|+.++.+++|+||+++++.+.+....++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKK---DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4666677888888888776665 56888999988643 22344678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++|+|.+++.+...+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999999988888999999999999999999999 8999999999999999999999999999987553211
Q ss_pred cc---------------------------------cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCC
Q 038905 572 SK---------------------------------AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK 618 (709)
Q Consensus 572 ~~---------------------------------~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~ 618 (709)
.. ......+||+.|+| ||++.+..++.++|||||||++|||++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A-PE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIA-PEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccC-HHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 00124579999999 999999999999999999999999999999
Q ss_pred CCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 038905 619 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT---MRKVSQ 687 (709)
Q Consensus 619 p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ev~~ 687 (709)
||......+. .......+.. +..+ .....++.+.+++..++. +|.+|++ ++++++
T Consensus 235 Pf~~~~~~~~-------~~~i~~~~~~-~~~p-----~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQET-------YRKVMNWKET-LVFP-----PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHHH-------HHHHHcCCCc-eecC-----CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9976543221 1111111100 0000 011134567777777664 9999985 566655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=293.53 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=193.9
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
|.....+|.|+++.||.+ .. .....+|+|.+.... ...+++.+|+.++++++|+||+++++++.+....++||||
T Consensus 6 ~~~~~~lg~G~~~~v~~~-~~---~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 6 LTFLKELGSGQFGVVHLG-KW---RGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred cchhhhhccCCCceEEEe-Ee---cCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 444445666666766554 33 245678999876432 2446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 496 LNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 496 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999764 36889999999999999999999 8899999999999999999999999999998664322111
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
. ....++..|+| ||++.+..++.++||||||+++|||++ |+.||......+.. .....+..
T Consensus 158 ~-~~~~~~~~y~~-Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~--------- 219 (256)
T cd05059 158 S-QGTKFPVKWAP-PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-------ESVSAGYR--------- 219 (256)
T ss_pred c-CCCCCCccccC-HHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-------HHHHcCCc---------
Confidence 1 12233457998 999999999999999999999999998 78898754432211 11111110
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
.......+..+.+++.+|++.+|++|||+++++++|.
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0111234667999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=309.75 Aligned_cols=254 Identities=18% Similarity=0.242 Sum_probs=198.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.+|+|.+... .......+.+|+.+++.++||||+++++++.++...
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 456777777888888888776665 56788999987542 223345688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++|+|.+++... .++......++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++.+..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999999998654 5788899999999999999999 89999999999999999999999999999987643
Q ss_pred cccccceeccccCcccccccccccCCC----CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNST----ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~----~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
..... ....+||+.|+| ||++.+.. ++.++|||||||++|||++|+.||........ ...+.....
T Consensus 195 ~~~~~-~~~~~gt~~Y~a-PE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-------~~~i~~~~~- 264 (370)
T cd05621 195 TGMVR-CDTAVGTPDYIS-PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-------YSKIMDHKN- 264 (370)
T ss_pred CCcee-cccCCCCcccCC-HHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCc-
Confidence 32211 145689999999 99987643 78899999999999999999999975543221 111111110
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSL--RPTMRKVSQM 688 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~ 688 (709)
..........+..+.+++..|++.++.+ |++++|+++.
T Consensus 265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0011112234566788889999866544 8999999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.24 Aligned_cols=251 Identities=23% Similarity=0.284 Sum_probs=201.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+++.||.+... ..++.+++|.+........+.+.+|+.+++.++|+|++++++.+..+.+.++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEEC---CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 45666666778877777655544 567889999987655556678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+++++|.+++.+ ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999999864 45788999999999999999999 889999999999999999999999999998865433221
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
. ....|++.|+| ||.+.+..++.++|||||||++|||++|+.||......... ......+. ..
T Consensus 173 ~--~~~~~~~~y~a-PE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~~-~~------- 235 (296)
T cd06654 173 R--STMVGTPYWMA-PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGT-PE------- 235 (296)
T ss_pred c--CcccCCccccC-HHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCCC-CC-------
Confidence 1 34578899998 99999988999999999999999999999999755432211 11111111 00
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..........+.+++.+||+.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 01122345678899999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=292.09 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=198.5
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+|.|+++.||.+.....+.....+|||.+..... ...+++.+|+.++++++|+||+++++++.+ ...++||||+++++
T Consensus 3 ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~ 81 (257)
T cd05040 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGS 81 (257)
T ss_pred CCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCc
Confidence 5667777776555544334455799999887655 566789999999999999999999999988 88999999999999
Q ss_pred HHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc-ccee
Q 038905 501 LASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK-AIKK 577 (709)
Q Consensus 501 L~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~ 577 (709)
|.+++.+.. .+++.....++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++.+...... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 82 LLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred HHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999998764 5889999999999999999999 899999999999999999999999999999877543321 1112
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
...++..|++ ||++.+..++.++||||||++++||++ |..||......+.... .. ..+.. . ..
T Consensus 159 ~~~~~~~y~~-pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~---~~~~~--~-------~~ 222 (257)
T cd05040 159 HLKVPFAWCA-PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK---ID---KEGER--L-------ER 222 (257)
T ss_pred CCCCCceecC-HHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HH---hcCCc--C-------CC
Confidence 3557788998 999999999999999999999999998 9999865433321110 00 01100 0 01
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
....+..+.+++.+|++.+|++|||++++++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1224567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.75 Aligned_cols=266 Identities=21% Similarity=0.219 Sum_probs=202.6
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEc-----CC
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE-----GQ 487 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~-----~~ 487 (709)
.|.....+|.|.+|.|..+... .+++.||||++... ..-..++..+|+++|+.++|+||+.+.+++.. -+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~---~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDK---RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred eecccccccCcceeeEEEEEEc---CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3444567888888855555554 67799999999844 33345788999999999999999999998854 45
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
..|+|+|+| +.+|...+..+..++..+...+..|+++||+|+| +.+|+||||||.|+|++.+..+||+|||+|+..
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeec
Confidence 689999999 5599999988777999999999999999999999 999999999999999999999999999999988
Q ss_pred cccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH--------HHh
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDC 638 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~ 638 (709)
.........+..+-|..|.| ||.+.. ..|+.+.||||.||++.||++|++-|.+.+..+...++... ...
T Consensus 176 ~~~~~~~~mTeYVaTRWYRA-PElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRA-PELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred cccCcccchhcceeeeeecC-HHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 65422223367788999998 998764 57999999999999999999999999876643322221111 111
Q ss_pred hhcCCccccccCcc--c----ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 639 YRNGKLDDLVEGDM--E----AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 639 ~~~g~~~~l~~~~~--~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
+.+.++...+.... . ....+......++++.+||..||.+|+|++|.++.
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111111111000 0 01112455678899999999999999999999873
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=291.14 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=198.0
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+++.||.+ .. .++.||||.+..... ..+++.+|+.++++++|+|++++++++.+....++||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~-~~----~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLG-DY----RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhccceeeeecCCCceEEEE-Ee----cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 34454555666777766544 33 368899999876543 5678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++++|.+++.... .+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||+++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999998765 6899999999999999999999 8999999999999999999999999999998763322
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
....++..|+| ||++....++.++||||||++++||++ |+.||......+. ......+....
T Consensus 157 -----~~~~~~~~~~a-pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~~---- 219 (256)
T cd05039 157 -----DSGKLPVKWTA-PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPHVEKGYRME---- 219 (256)
T ss_pred -----ccCCCcccccC-chhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHhcCCCCC----
Confidence 22334567888 999998889999999999999999997 9999865433221 11111111100
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
.....++.+.+++.+|++.+|++|||+++++++|+.
T Consensus 220 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 -----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 012245678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.14 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=202.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEec----CCCceEEEEEEcccc-cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCC
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQT----STRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQ 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~ 487 (709)
.+|.....+|.|+++.||.+..... ......+|+|.+... ......++.+|+.++.++ +|+||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 4566667788888888877654321 134567899988743 233456789999999999 6999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec
Q 038905 488 NRLLVYKFLNNGTLASFLFEN----------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~ 551 (709)
..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 999999999999999999753 23788889999999999999999 88999999999999999
Q ss_pred CCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHh
Q 038905 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI 630 (709)
Q Consensus 552 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 630 (709)
+++.+||+|||+++...............++..|++ ||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-- 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMA-PEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-- 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccC-HHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999987653322211122334567998 999999999999999999999999999 8888865433221
Q ss_pred HHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 631 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 631 ~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
......+..... ....+..+.+++.+|++.+|++|||++++++.|..+.
T Consensus 246 -----~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 -----FKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred -----HHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111222211111 1234567889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.66 Aligned_cols=250 Identities=20% Similarity=0.292 Sum_probs=194.0
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
|.....+|.|+++.||.+... ..++.+|+|.+... .....+++.+|+.++.+++||||+++++++...+..++|||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHL---LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred chheeeeccCCCeEEEEEEEc---CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 444556677777777666555 56788999987643 23445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
|+++++|..+. .+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 80 ~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 80 FMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred cCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99999987652 4678888999999999999999 8999999999999999999999999999998664322
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
.....|+..|+| ||++.+..++.++||||||+++|||++|+.||..........................+
T Consensus 150 -~~~~~~~~~y~a-PE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 220 (279)
T cd06619 150 -AKTYVGTNAYMA-PERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL------- 220 (279)
T ss_pred -ccCCCCChhhcC-ceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC-------
Confidence 145679999999 99999999999999999999999999999999653321111000001111111111110
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
........+.+++..|++.+|++||+++++++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111234568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.70 Aligned_cols=252 Identities=22% Similarity=0.249 Sum_probs=198.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
++++.....+|.|+++.||.+... .++..+++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~---~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDL---STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEec---CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 677777677888888877555444 46788999988766556677899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC-CCC--ChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-CCCeEEcccccccccc
Q 038905 493 YKFLNNGTLASFLFEN-LKP--GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-YYNAQISDFGLAKLLT 568 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~-~~l--~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~ 568 (709)
+||+++++|.+++... ..+ +...+..++.||+.||.||| +.+|+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999865 344 77888899999999999999 889999999999999986 6789999999997664
Q ss_pred ccccccceeccccCcccccccccccCCC--CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNST--ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~--~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
..... .....|++.|+| ||++.... ++.++||||||+++++|++|+.|+.......... +.......
T Consensus 161 ~~~~~--~~~~~~~~~~~a-PE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~--- 229 (268)
T cd06624 161 GINPC--TETFTGTLQYMA-PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-----FKVGMFKI--- 229 (268)
T ss_pred cCCCc--cccCCCCccccC-hhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-----hhhhhhcc---
Confidence 32221 134568899998 99986543 7899999999999999999999986432211110 00000000
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....+....+.+.+++.+||+.+|.+|||+.++++
T Consensus 230 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 ------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01112234567889999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=293.50 Aligned_cols=255 Identities=19% Similarity=0.249 Sum_probs=200.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+... .+++.+|+|.++.........+.+|+.+++.++||||+++++.+.+.+..++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNV---NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEc---CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 345666666788888877666555 56788999988765444556788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
+||+++++|.+++.....+++.....++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..+.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999999988888999999999999999999999 88999999999999999999999999999976653322
Q ss_pred ccceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 573 KAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
. .....|++.|+| ||++. ...++.++|+|||||++|||++|..|+.......... .. ...... .
T Consensus 162 ~--~~~~~~~~~y~a-PE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~~-~~~~~~---~ 228 (267)
T cd06645 162 K--RKSFIGTPYWMA-PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LM-TKSNFQ---P 228 (267)
T ss_pred c--cccccCcccccC-hhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------hh-hccCCC---C
Confidence 1 145679999998 99974 4568899999999999999999999986433211110 00 011110 0
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
+.... ....++.+.+++..|++.+|++||+++++++.
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000 11234568899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.83 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=193.7
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+|.|+++.|| .+.......+..||+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 3 ig~G~~g~v~-~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVK-KGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEE-EEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 5666666665 44443224566799998865432 33467999999999999999999999885 457899999999999
Q ss_pred HHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc-eec
Q 038905 501 LASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI-KKA 578 (709)
Q Consensus 501 L~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 578 (709)
|.+++... ..+++..+.+++.|++.||.||| +++++||||||+||+++.++.+||+|||+++.+........ ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999753 46899999999999999999999 88999999999999999999999999999986654332211 112
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
..++..|+| ||++....++.++||||||+++|||++ |..||......+. ...+..+.... .+
T Consensus 158 ~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~~---------~~ 220 (257)
T cd05115 158 GKWPLKWYA-PECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-------MSFIEQGKRLD---------CP 220 (257)
T ss_pred CCCCcccCC-HHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHHCCCCCC---------CC
Confidence 233568998 999998889999999999999999996 9999975443221 12222222111 12
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
...++.+.+++..||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 23467888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.99 Aligned_cols=220 Identities=23% Similarity=0.346 Sum_probs=175.9
Q ss_pred eEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhh-CCCCChHHHHHHHH
Q 038905 443 TVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFE-NLKPGWNLRANIAF 521 (709)
Q Consensus 443 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~ 521 (709)
..|++|.++....+...++.+|+.++++++|+||+++++++.+....++||||+++++|..++.+ ...+++..+..++.
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~ 124 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQ 124 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 56899998765555567889999999999999999999999999999999999999999999976 45689999999999
Q ss_pred HHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-------CeEEccccccccccccccccceeccccCcccccccccccC
Q 038905 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-------NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN 594 (709)
Q Consensus 522 ~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~ 594 (709)
||++||.||| +++|+||||||+|||++..+ .+|++|||++...... ....++..|+| ||.+.+
T Consensus 125 qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~a-Pe~~~~ 194 (274)
T cd05076 125 QLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIA-PECVPG 194 (274)
T ss_pred HHHHHHHHHH---cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccC-chhhcC
Confidence 9999999999 88999999999999997654 3899999998644322 22357788998 998875
Q ss_pred -CCCCcccchHHHHHHHHHHH-hCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcc
Q 038905 595 -STITANVDVYSFGVLLLEII-SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCI 672 (709)
Q Consensus 595 -~~~s~k~DvwSlGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl 672 (709)
..++.++||||||+++|||+ +|..||......+.... ..... . . .......+.+++..||
T Consensus 195 ~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~--~-----~----~~~~~~~~~~li~~cl 256 (274)
T cd05076 195 GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-------YEKKH--R-----L----PEPSCKELATLISQCL 256 (274)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-------HHhcc--C-----C----CCCCChHHHHHHHHHc
Confidence 56899999999999999995 68888865433221110 00000 0 0 0112246889999999
Q ss_pred cCCCCCCCCHHHHHHHHc
Q 038905 673 QEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 673 ~~dP~~RPs~~ev~~~L~ 690 (709)
+.+|++|||+++|++.|+
T Consensus 257 ~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 257 TYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ccChhhCcCHHHHHHhhC
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=281.67 Aligned_cols=269 Identities=18% Similarity=0.165 Sum_probs=202.7
Q ss_pred hHhhhcccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-h-HHHHHHHHHHHhccCcCceeEEEeEEE
Q 038905 407 DKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-G-EKEFKNEVVMIGQTYHKNLVRLLGFCD 484 (709)
Q Consensus 407 ~~~~~~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~nlv~l~~~~~ 484 (709)
+...+...+|...-.++.|.+|.||.+... .++..||+|+++...+. + --.-.+|+.+|.+++|||||.+-.+..
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk---~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDK---KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccC---CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 334444667776666777777766544444 78999999999764321 1 134589999999999999999999875
Q ss_pred --cCCeEEEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccc
Q 038905 485 --EGQNRLLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 485 --~~~~~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
+-+..|+|||||+. +|.+++..-. ++...+...+..|+++|++||| ...|+|||||++|+|+.+.|.+||+||
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEeccc
Confidence 34568999999988 9999998765 7899999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh-
Q 038905 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY- 639 (709)
Q Consensus 562 Gla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~- 639 (709)
|||+.++...... +..+-|..|.| ||.+.+. .|++++|+||+|||+.||+++++.|......+.... +++.+
T Consensus 222 GLAR~ygsp~k~~--T~lVVTLWYRa-PELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~---If~llG 295 (419)
T KOG0663|consen 222 GLAREYGSPLKPY--TPLVVTLWYRA-PELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK---IFKLLG 295 (419)
T ss_pred chhhhhcCCcccC--cceEEEeeecC-HHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH---HHHHhC
Confidence 9999988764332 67778999998 9998876 599999999999999999999999987765332221 11111
Q ss_pred -------hc---CCcc------ccccCcccccCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 640 -------RN---GKLD------DLVEGDMEAMNDIK-CVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 640 -------~~---g~~~------~l~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.. -... ...-..+....... ..+.-.+++..++..||.+|.|++|.++.
T Consensus 296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 0000 00000011100111 34677889999999999999999998763
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.79 Aligned_cols=254 Identities=17% Similarity=0.203 Sum_probs=195.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..++.+|+|.+... .......+.+|..++..++|+||+++++++.+.+..++
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMK---HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4666667788888888766554 56788999988642 22234568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++|+|.+++.+ ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999987 457889999999999999999999 899999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRN-----STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~-----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
.... .....||+.|+| ||++.+ ..++.++||||||+++|||++|+.||......+. ..........
T Consensus 156 ~~~~-~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~ 226 (331)
T cd05624 156 GTVQ-SSVAVGTPDYIS-PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIMNHEER 226 (331)
T ss_pred Ccee-eccccCCcccCC-HHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-------HHHHHcCCCc
Confidence 3221 134679999999 999875 4678999999999999999999999975443221 1111111100
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSL--RPTMRKVSQM 688 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~ 688 (709)
.-+.. .....++.+.+++..|++.++.+ |++++++++.
T Consensus 227 ~~~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 FQFPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccCCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00000 01124567888898888865544 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.12 Aligned_cols=264 Identities=17% Similarity=0.174 Sum_probs=198.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
..|.....+|.|+++.||.+.. ........||||.+... +...+|++++++++|+|||++++++......++||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~-~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTK-HGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEE-cCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4567777778888887765533 23345678999987543 24568999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
|++. ++|..++.....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9996 588888877778999999999999999999999 889999999999999999999999999999876544333
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc--------
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD-------- 645 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~-------- 645 (709)
.......||+.|+| ||++.+..++.++|||||||++|||++|+.||..............+.+........
T Consensus 242 ~~~~~~~gt~~y~a-PE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 242 PQCYGWSGTLETNS-PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred ccccccccccCccC-HhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 22245679999999 999999999999999999999999999999996543221111111111111100000
Q ss_pred ---------ccccCcccc---cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 646 ---------DLVEGDMEA---MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 646 ---------~l~~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....+.... .........+.+++.+|++.||++|||+.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0011234567889999999999999999999875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=307.07 Aligned_cols=253 Identities=18% Similarity=0.231 Sum_probs=198.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.+|+|.+... .......+.+|+.+++.++||||+++++.+.++...
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 567787778888888888776665 56888999987542 223345678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++|+|.+++... .++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 9999999999999998654 5788888999999999999999 89999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCC----CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC-c
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNST----ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK-L 644 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~----~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~-~ 644 (709)
..... .....||+.|+| ||++.... ++.++|||||||++|||++|+.||....... .+..+.... .
T Consensus 195 ~~~~~-~~~~~gt~~y~a-PE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~ 265 (371)
T cd05622 195 EGMVR-CDTAVGTPDYIS-PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHKNS 265 (371)
T ss_pred CCccc-ccCcccCccccC-HHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCc
Confidence 32211 145689999999 99987543 7899999999999999999999997654322 111121111 1
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSL--RPTMRKVSQM 688 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~ 688 (709)
..+ ......+..+.+++..|++.++.+ |++++++++.
T Consensus 266 ~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 LTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111 112234567889999999854443 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.77 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=202.3
Q ss_pred ccceeeeecCeeEEEEEEEEEEecC----CCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTS----TRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
+|.....+|.|+++.||.+...... .....+|+|.+.... ....+++.+|++++.++ +|+||+++++++.++..
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 4555667788888888777654321 123478999886432 33457899999999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC
Q 038905 489 RLLVYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD 552 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~ 552 (709)
.++||||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+|+||||||+||++++
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~ 169 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTE 169 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcC
Confidence 999999999999999997532 3678888999999999999999 899999999999999999
Q ss_pred CCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhH
Q 038905 553 YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 631 (709)
Q Consensus 553 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 631 (709)
++.+||+|||+++...............++..|+| ||++.+..++.++||||||+++|||++ |..||.....++..
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-- 246 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMA-PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-- 246 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcC-HHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH--
Confidence 99999999999986653322211123344567998 999999999999999999999999998 78888654332211
Q ss_pred HHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 632 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 632 ~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.....+..... ....+..+.+++..|++.+|.+|||+.++++.|+.+..
T Consensus 247 -----~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 247 -----KLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred -----HHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11222211111 12345678899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=286.57 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=201.8
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|+....+|.|+++.|+..... .++..+++|++... .....+++.+|++++++++|+||+++++++.+....++||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRT---EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred ceEeeEecccCCceEEEEEEc---CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 555666777777766555544 56888999987643 3345577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++++|.+++.+. ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.+||+|||+++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999999875 35889999999999999999999 8899999999999999999999999999998765443
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. .....|++.|+| ||++.+..++.++||||||++++||++|..||......+.. .....+.....
T Consensus 156 ~~--~~~~~~~~~y~a-pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~-------~~~~~~~~~~~---- 221 (256)
T cd08221 156 SM--AETVVGTPYYMS-PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV-------VKIVQGNYTPV---- 221 (256)
T ss_pred cc--ccccCCCccccC-HhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCCCCCC----
Confidence 21 145678999998 99999888999999999999999999999999754332211 11122222111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 689 (709)
....+..+.+++.+|++.+|.+||+++++++.+
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 123456788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.84 Aligned_cols=242 Identities=19% Similarity=0.300 Sum_probs=204.0
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch--hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeec
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD--GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
...+|.|.|.-|-++.+. -+++.||||++++..-+ ....+.+|++-|+.++|||||+|+++...+..+|||.|.-
T Consensus 23 ekTlG~GHFAVVKLArHV---FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred hhhhcCCceehhhhhhhh---cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 345677788755555555 57999999999875433 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec-CCCCeEEcccccccccccccccc
Q 038905 497 NNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 497 ~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
++|+|.+||.++. .+.+....+++.||+.|+.|+| +..+|||||||+|+.+- .-|-+||.|||++-.+...+..
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL- 175 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL- 175 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh-
Confidence 9999999998775 6999999999999999999999 88999999999998775 5688999999999777655443
Q ss_pred ceeccccCcccccccccccCCCCC-cccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTIT-ANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s-~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
++.||+..|-| ||++.+..|+ +++|||||||+||-|++|++||....+.+... .+.|...
T Consensus 176 --~TsCGSLAYSA-PEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCKY- 236 (864)
T KOG4717|consen 176 --TTSCGSLAYSA-PEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCKY- 236 (864)
T ss_pred --hcccchhhccC-chhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcccc-
Confidence 78999999999 9999999986 57899999999999999999998665544222 2233332
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+...+.++.++|..||+.||.+|.+.++++.
T Consensus 237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 235678889999999999999999999999876
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=288.13 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=204.1
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
++|.....+|.|+++.||.+... ..+..+++|.+........+.+.+|++++++++|+||+++++++.++...+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDI---ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEec---CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 45666677788888888776655 456789999987665556788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++++|.+++... ..++...+..++.|++.||.||| +.+|+|+||||+||++++++.+||+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999999999876 67999999999999999999999 88999999999999999999999999999987654321
Q ss_pred ccceeccccCcccccccccccCC---CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNS---TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~---~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.. ....++..|++ ||.+.+. .++.++|+||||++++||++|+.|+......+.... ....... .
T Consensus 157 ~~--~~~~~~~~y~~-Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~~~~---~ 223 (262)
T cd06613 157 KR--KSFIGTPYWMA-PEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKSNFP---P 223 (262)
T ss_pred cc--ccccCCccccC-chhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhccCC---C
Confidence 11 44678889998 9999877 889999999999999999999999975443221110 0111000 0
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. .......+..+.+++.+||+.+|.+|||+++|+.
T Consensus 224 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 1112345677999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.39 Aligned_cols=261 Identities=25% Similarity=0.322 Sum_probs=203.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecC-CCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEc-CCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTS-TRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE-GQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~-~~~~ 489 (709)
.++|.....+|.|+++.||.+.....+ .....|++|++... .....+.+.+|+.++++++|+|++++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 456666677778888877666555321 23688999988643 23345678999999999999999999998765 5678
Q ss_pred EEEEeecCCCCHHHHHhhC--------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccc
Q 038905 490 LLVYKFLNNGTLASFLFEN--------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~--------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
++++||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998753 34789999999999999999999 889999999999999999999999999
Q ss_pred cccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhh
Q 038905 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 640 (709)
Q Consensus 562 Gla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 640 (709)
|+++.+.............++..|+| ||++.+..++.++||||||++++||++ |+.||......+. ...+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~a-pE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~ 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMA-LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-------AAYLK 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccC-HHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH-------HHHHH
Confidence 99986644332221123456677998 999999899999999999999999999 9999975433221 11111
Q ss_pred cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 641 NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 641 ~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.+.. .......++.+.+++.+||+.+|++|||+.+++++|+.+.
T Consensus 234 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYR---------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCC---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1110 0011223567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.98 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=192.9
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEE-cCCeEEEEEeecCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCD-EGQNRLLVYKFLNNG 499 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~-~~~~~~lV~Ey~~~g 499 (709)
+|.|+++.||.+...........+|+|++.... ....+.+.+|+.+++.++|||++++++++. .+...++|+||+.++
T Consensus 3 lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 82 (262)
T cd05058 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHG 82 (262)
T ss_pred ccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCC
Confidence 567777777666655444567889999986432 334578899999999999999999999875 455678999999999
Q ss_pred CHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc--cce
Q 038905 500 TLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK--AIK 576 (709)
Q Consensus 500 sL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~ 576 (709)
+|.+++.+.. .+++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|||+++.+...... ...
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 83 DLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 9999997643 4677788899999999999999 889999999999999999999999999999865432211 111
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCC-CCCCccchhhHHhHHHHHHHhhhcCCccccccCccccc
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 655 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~ 655 (709)
....++..|+| ||.+.+..++.++||||||+++|||++|. +|+......+ .. .....+....
T Consensus 160 ~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~----~~~~~~~~~~--------- 222 (262)
T cd05058 160 TGAKLPVKWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---IT----VYLLQGRRLL--------- 222 (262)
T ss_pred ccCcCCccccC-hhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhcCCCCC---------
Confidence 23456778998 99999889999999999999999999954 5554332211 11 1111221110
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 656 NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 656 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.....+..+.+++..||+.+|++||++.++++.|+.+.
T Consensus 223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01123457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=324.45 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=198.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.+|.....+|.|+++.||.+... ..++.||||++.... ....+++.+|++++++++||||+++++++.+++..+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~---~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP---VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC---CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence 35666667788888888666544 568899999986432 223467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhC-----------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEc
Q 038905 491 LVYKFLNNGTLASFLFEN-----------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
+||||++|++|.+++... ...++..+..++.||++||.||| +.+|+||||||+||+++.++.+||+
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLi 155 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVIL 155 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEE
Confidence 999999999999988642 13456677889999999999999 8899999999999999999999999
Q ss_pred cccccccccccccc----------------cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 038905 560 DFGLAKLLTLNQSK----------------AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIE 623 (709)
Q Consensus 560 DFGla~~~~~~~~~----------------~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~ 623 (709)
|||+++........ .......||+.|+| ||++.+..++.++|||||||+++||++|+.||...
T Consensus 156 DFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmA-PE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMA-PERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred ecCcceecccccccccccccccccccccccccCCCCCCCCCCCC-HHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999876321110 01123579999999 99999999999999999999999999999999753
Q ss_pred chhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHcccc
Q 038905 624 MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEVVV 693 (709)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~~ 693 (709)
...... .. ... .++ .........+..+.+++.+|++.||++|| +++++.+.|+...
T Consensus 235 ~~~ki~------~~----~~i---~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 235 KGRKIS------YR----DVI---LSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred chhhhh------hh----hhc---cCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 322111 00 000 000 00001123456788999999999999995 6777777776653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.68 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=196.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
+|.....+|.|+++.||.+... ....+|+|++.... ...+++.+|++++.+++|+||+++++++.+ ...++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~----~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEec----CCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 4555566777777777665432 33569999987533 245678999999999999999999998754 56799999
Q ss_pred ecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 495 FLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 495 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|+++++|.+++.+. ..+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||+++.+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999999764 34788999999999999999999 88999999999999999999999999999987654332
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. .....++..|++ ||+..+..++.++||||||+++|||++ |..||......+. ......+..
T Consensus 158 ~~-~~~~~~~~~y~~-PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-------~~~~~~~~~------- 221 (262)
T cd05071 158 TA-RQGAKFPIKWTA-PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGYR------- 221 (262)
T ss_pred cc-ccCCcccceecC-HhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-------HHHHhcCCC-------
Confidence 11 123456678998 999998899999999999999999999 7788865432221 111111110
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.......+..+.+++..|++.+|++||++++++++|+..
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011224556788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=285.05 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=199.5
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch--hHHHHHHHHHHHhccCcCc-eeEEEeEEEcCC----
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD--GEKEFKNEVVMIGQTYHKN-LVRLLGFCDEGQ---- 487 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-lv~l~~~~~~~~---- 487 (709)
.|.....+|.|.++.||.+... .+++.||+|++....++ ......+|+.++++++|+| ||++++++...+
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~---~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSK---RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEe---cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 3444445777777777666555 56799999998765432 3356799999999999999 999999998877
Q ss_pred --eEEEEEeecCCCCHHHHHhhCC----CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccc
Q 038905 488 --NRLLVYKFLNNGTLASFLFENL----KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 488 --~~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
..++|+||++. +|..++.... .++...+..+..||++||.||| +++|+||||||+|||++++|.+||+||
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeecc
Confidence 78899999966 9999998755 4677889999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh
Q 038905 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 640 (709)
Q Consensus 562 Gla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 640 (709)
|+|+.+.-.... .+..++|..|.| ||++.+. .|+..+||||+||++.||++++.-|....+.+... .+++.+-
T Consensus 165 GlAra~~ip~~~--yt~evvTlWYRa-PEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~---~If~~lG 238 (323)
T KOG0594|consen 165 GLARAFSIPMRT--YTPEVVTLWYRA-PEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF---RIFRLLG 238 (323)
T ss_pred chHHHhcCCccc--ccccEEEeeccC-HHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH---HHHHHcC
Confidence 999976644332 266788999998 9999877 79999999999999999999999888766533222 1222211
Q ss_pred c---CC---ccccccCc--ccccC-C-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 641 N---GK---LDDLVEGD--MEAMN-D-------IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 641 ~---g~---~~~l~~~~--~~~~~-~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
. .. ...+.+.. ..... . ........+++.+||+.+|.+|.|++.++++
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 00 01111111 00000 0 1112478899999999999999999999886
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=287.99 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=203.2
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc---ccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR---VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
++|.....+|.|+++.||.+... .+++.+|+|.++. ......+.+.+|++++++++|+|++++++++.+.+..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL---LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc---CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35666666777777777665554 4678899997753 22234568999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 491 LVYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
+||||+++++|..++.+. ..+++..+..++.+++.||.||| +.+|+|+||||+||+++.++.++|+|||++..
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~ 155 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeee
Confidence 999999999999998642 34788999999999999999999 88999999999999999999999999999986
Q ss_pred ccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 567 LTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 567 ~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
+....... ....|++.|.| ||++.+..++.++||||||+++++|++|+.||......... ..+....+....
T Consensus 156 ~~~~~~~~--~~~~~~~~y~a-pE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~ 227 (267)
T cd08224 156 FSSKTTAA--HSLVGTPYYMS-PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEKCDYPP 227 (267)
T ss_pred ccCCCccc--ceecCCccccC-HHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH-----HHhhhhcCCCCC
Confidence 65432221 34568889998 99999989999999999999999999999998644321100 111112222111
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
+ .....+..+.+++.+|++.+|++|||+.+|+++|+.+
T Consensus 228 ~--------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 L--------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C--------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 1124456788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.04 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=190.6
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeecCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFLNNG 499 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~~~g 499 (709)
+|.|+++.||.+... .......+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||++++
T Consensus 3 lg~g~~g~v~~~~~~-~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 3 IGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred CCCCCCceEEEEEEc-CCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 566777767554443 2223345788887643 234556889999999999 7999999999999999999999999999
Q ss_pred CHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 500 TLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 500 sL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
+|.+++.+.. .+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999997542 3678899999999999999999 88999999999999999999999999999
Q ss_pred cccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
+....... .......+..|+| ||++....++.++||||||++++||++ |..||......+. .+....+
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~a-pE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~ 227 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMA-IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------YEKLPQG 227 (270)
T ss_pred ccccchhh---hccCCCCccccCC-hHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-------HHHHhCC
Confidence 86322111 1122234567998 999998899999999999999999997 9999864432221 1111111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.... .....+..+.+++..|++.+|.+|||+.++++.|+.+.
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1100 11223457889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.77 Aligned_cols=257 Identities=22% Similarity=0.341 Sum_probs=201.2
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+..+|.|-|++|.+.... ....||||+++.... +..++|..|+++|.+++|||||+++|+|..++..++|+|||+
T Consensus 543 ~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVE----GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred hhhhcCcccceeEEEEec----CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 334555556666555554 468999999986644 445899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 498 NGTLASFLFENLK--PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 498 ~gsL~~~l~~~~~--l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+|+|.+++.++.. ........|+.||+.|++||. +.++|||||.+.|+|+|.++++||+|||+++-+-..+....
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999998853 345566779999999999999 89999999999999999999999999999996654443333
Q ss_pred eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh--CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
..+.+-...||| +|.+...+++.++|||+||+++|||++ ...||....+++.. +-+......+ ..+. .
T Consensus 696 qgr~vlpiRwma-wEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~-~~~~-----~ 765 (807)
T KOG1094|consen 696 QGRAVLPIRWMA-WESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQ-GRQV-----V 765 (807)
T ss_pred ecceeeeeeehh-HHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCC-Ccce-----e
Confidence 345555678998 999999999999999999999999864 66787644332211 1111111111 1111 1
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
...+.-++..+.++++.||..|-++||+++++...|...
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 222445778899999999999999999999999998764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.33 Aligned_cols=265 Identities=17% Similarity=0.230 Sum_probs=197.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+... ..+..+|+|.++.... .....+.+|+.++++++|+||+++++++..++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSK---LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEec---CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 455777777888888888665544 4678899998864432 233567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++ +|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9999986 8888887654 4788899999999999999999 889999999999999999999999999999765433
Q ss_pred ccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH--------HHhhhc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRN 641 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~ 641 (709)
... .....+++.|+| ||++.+ ..++.++||||||+++|||++|+.||......+........ +..+..
T Consensus 158 ~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 158 TKT--YSNEVVTLWYRP-PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred ccc--cccccccccccC-CHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 221 134568899998 998865 46899999999999999999999999765443322111110 000000
Q ss_pred CC-ccccccCccc----ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 GK-LDDLVEGDME----AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 g~-~~~l~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. ....-.+... .......+..+.+++..||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 0000000000 0001124567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=294.22 Aligned_cols=250 Identities=23% Similarity=0.293 Sum_probs=202.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+++.||.+... ..++.|++|.+........+.+.+|+.+++.++|+|++++++++.++...++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDV---ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEc---CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 45777777888888877665544 568889999987655556678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+++++|..++.+ ..+++.++..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999999998865 36899999999999999999999 889999999999999999999999999998866543322
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
. ....|++.|++ ||.+.+..++.++|||||||++|+|++|+.||........... ....+ ...+
T Consensus 172 ~--~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~------~~~~~-~~~~------ 235 (296)
T cd06655 172 R--STMVGTPYWMA-PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-TPEL------ 235 (296)
T ss_pred C--CCcCCCccccC-cchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhcC-Cccc------
Confidence 1 34578999998 9999998999999999999999999999999976543221110 00111 0000
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......+..+.+++.+||+.+|++||++.++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 012234456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=288.68 Aligned_cols=240 Identities=23% Similarity=0.341 Sum_probs=186.2
Q ss_pred ecCeeEEEEEEEEEEecC----------CCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 422 LGSSVFVNFTLVGVIQTS----------TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.|+++.| |++..... .....|++|.+..........+.+|+.++.+++||||+++++++.+....++
T Consensus 3 lg~G~~~~v-y~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 3 LGRGTRTQI-YAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred cccCCcceE-eeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 456666666 44443211 2234688998876655556688999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC-------eEEccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN-------AQISDFGL 563 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~-------~kl~DFGl 563 (709)
||||+++++|..++... ..+++..+..++.||++||.||| +++|+||||||+|||++.++. +|++|||+
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999998764 46899999999999999999999 899999999999999987664 89999999
Q ss_pred cccccccccccceeccccCccccccccccc-CCCCCcccchHHHHHHHHHHH-hCCCCCCccchhhHHhHHHHHHHhhhc
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFR-NSTITANVDVYSFGVLLLEII-SCRKSFDIEMGEEYAILTDWAFDCYRN 641 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~-~~~~s~k~DvwSlGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 641 (709)
+...... ....|+..|+| ||.+. +..++.++|||||||++|||+ .|..|+......+... ...
T Consensus 159 ~~~~~~~------~~~~~~~~y~a-PE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--------~~~ 223 (262)
T cd05077 159 PITVLSR------QECVERIPWIA-PECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER--------FYE 223 (262)
T ss_pred CccccCc------ccccccccccC-hhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH--------HHh
Confidence 8765322 23457888998 99987 567899999999999999998 5777876433222111 011
Q ss_pred CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 642 g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
+... + .......+.+++..||+.||.+||++.++++.|.
T Consensus 224 ~~~~-~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQCM-L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCcc-C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 0 1112356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=286.78 Aligned_cols=248 Identities=20% Similarity=0.286 Sum_probs=199.8
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
|.....+|.|+++.||.+... .++..+|+|.+... .....+.+.+|+.++++++|+||+++++.+.++...++|||
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHV---NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEc---CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 455567788888888777655 56788999987543 23345778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 495 FLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 495 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|+++++|.+++... ..++......++.|++.||.||| +.+|+|+||||+||++++++.++|+|||++..+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999988653 34788899999999999999999 89999999999999999999999999999986654322
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
. .....|++.|+| ||++.+..++.++|+||||+++++|++|..||........ ......+....+
T Consensus 156 ~--~~~~~~~~~~~a-PE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~----- 220 (255)
T cd08219 156 Y--ACTYVGTPYYVP-PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-------ILKVCQGSYKPL----- 220 (255)
T ss_pred c--cccccCCccccC-HHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-------HHHHhcCCCCCC-----
Confidence 1 135678999998 9999998999999999999999999999999975432221 111222222211
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....+..+.+++.+||+.||++|||+.+++..
T Consensus 221 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=288.17 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=188.3
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+|.|+++.||... .........+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++++
T Consensus 3 lg~G~~g~v~~~~-~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 3 IGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred CCCCcCceEEEEE-EEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5677777775544 3333456678888776433 3355789999999999999999999999999999999999999999
Q ss_pred HHHHHhhCC----CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 501 LASFLFENL----KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 501 L~~~l~~~~----~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
|.+++.+.. ..+......++.||++||.||| +.+++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997642 3556677889999999999999 889999999999999999999999999998643222111112
Q ss_pred eccccCcccccccccccC-------CCCCcccchHHHHHHHHHHHhC-CCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 577 KAIRGTKGYVASPEWFRN-------STITANVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~-------~~~s~k~DvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
....|+..|+| ||++.. ..++.++||||||+++|||+++ ..||......+ .......+....+.
T Consensus 159 ~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLA-PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-------VLNHVIKDQQVKLF 230 (268)
T ss_pred cCCcCcccccC-chhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhhcccccC
Confidence 45678899998 999853 2457899999999999999974 56775433222 11111122222333
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
++.+.. ...+.+.+++..|+ .+|.+||++++|+++|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333322 24456778899999 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=289.18 Aligned_cols=252 Identities=26% Similarity=0.354 Sum_probs=187.4
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+|.|+|+.||.+ ....+...+.+++|.+.... .....++.+|+.+++.++|+||+++++.+.+....++||||+++|+
T Consensus 3 lg~G~fg~v~~~-~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred CCccCCceEEEE-EEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 566667777554 44344566789999876432 3344678899999999999999999999999999999999999999
Q ss_pred HHHHHhhCCC-----CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 501 LASFLFENLK-----PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 501 L~~~l~~~~~-----l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
|.+++..... .++.....++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976432 456778899999999999999 88999999999999999999999999999875433221111
Q ss_pred eeccccCccccccccccc-------CCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 576 KKAIRGTKGYVASPEWFR-------NSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~-------~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
.....++..|+| ||++. ...++.++||||||+++|||++ |..||......+. .......+ ...+
T Consensus 159 ~~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~~-~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLA-PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVREQ-DIKL 230 (269)
T ss_pred cCCCCCcccccC-HHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhhcc-CccC
Confidence 133445677998 99874 3456889999999999999999 7778764432221 11111121 1122
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
..+.. .......+.+++..|+ .||++|||+++|+++|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22221 2234456677888888 49999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=296.54 Aligned_cols=265 Identities=23% Similarity=0.371 Sum_probs=201.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEec-CCCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEc--CCeEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQT-STRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDE--GQNRL 490 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~--~~~~~ 490 (709)
.|.....+|.|+++.||.+..... ...+..+|||.+...... ..+++.+|++++++++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 344445567777777755544321 345789999998765443 46789999999999999999999999877 66789
Q ss_pred EEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999997755 5899999999999999999999 88999999999999999999999999999987763
Q ss_pred cccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHH--------hHHHHHHHhhh
Q 038905 570 NQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTDWAFDCYR 640 (709)
Q Consensus 570 ~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~ 640 (709)
.... .......++..|++ ||.+.+..++.++||||||++++||++|+.|+......... .......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~-Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYA-PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccC-cHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 3221 11112334556888 99999889999999999999999999999987643221100 00000111111
Q ss_pred cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 641 NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 641 ~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
. ..........+..+.+++.+|++.+|++|||+.||+++|+.+
T Consensus 241 ~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 E---------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred c---------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 111111223446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=286.66 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=192.7
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+|.|+++.|| ++.. .+++.+|+|.+..... .....+.+|++++++++|+||+++++++......++||||+++++
T Consensus 3 ig~g~~g~vy-~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 3 LGKGNFGEVF-KGTL---KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred cCCCCCceEE-EEEe---cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 5666666665 4444 3577899998865432 334578999999999999999999999999999999999999999
Q ss_pred HHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceecc
Q 038905 501 LASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579 (709)
Q Consensus 501 L~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 579 (709)
|.+++.... .+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++.......... ....
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 999987543 5789999999999999999999 8899999999999999999999999999997644322111 1223
Q ss_pred ccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCH
Q 038905 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658 (709)
Q Consensus 580 ~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~ 658 (709)
.++..|+| ||++.+..++.++||||||+++|||++ |..||......... .....+... ....
T Consensus 155 ~~~~~y~a-PE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-------~~~~~~~~~---------~~~~ 217 (250)
T cd05085 155 QIPIKWTA-PEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKGYRM---------SCPQ 217 (250)
T ss_pred CCcccccC-HHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcCCCC---------CCCC
Confidence 44567998 999998899999999999999999998 89898654332211 111111110 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 659 KCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 659 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
..+..+.+++.+|++.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 34568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=288.39 Aligned_cols=247 Identities=24% Similarity=0.349 Sum_probs=194.0
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEE-EcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC-DEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~-~~~~~~~lV 492 (709)
.+|.....+|.|+++.||.+ .. .+..+|+|..+.. ...+.+.+|+.++++++|+|++++++++ .+++..++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~-~~----~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLG-DY----RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEE-EE----cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 45555566777777777554 33 3677899987643 2456789999999999999999999975 455678999
Q ss_pred EeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999997654 3788999999999999999999 889999999999999999999999999998765432
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
. ....++..|+| ||++.+..++.++||||||+++|||++ |+.||......+. ......+....
T Consensus 156 ~-----~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~~--- 219 (256)
T cd05082 156 Q-----DTGKLPVKWTA-PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYKMD--- 219 (256)
T ss_pred C-----CCCccceeecC-HHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCCCCC---
Confidence 2 23345667998 999999899999999999999999997 8888864432221 11111111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.....+..+.+++.+|++.+|++|||++++++.|+.+
T Consensus 220 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 ------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1123456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=290.47 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=202.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
++|.....+|.|+++.||.+...........++||...... .+..+.+.+|+.++++++|+||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 34556667778888888665554332345678999887544 3456789999999999999999999999875 557899
Q ss_pred EeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++++|.+++.... .+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 99999999999997644 5899999999999999999999 8899999999999999999999999999998765432
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.... ....++..|+| ||.+....++.++||||||++++||++ |..||......+.. .....+....
T Consensus 162 ~~~~-~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~~~~~---- 228 (270)
T cd05056 162 YYKA-SKGKLPIKWMA-PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-------GRIENGERLP---- 228 (270)
T ss_pred ceec-CCCCccccccC-hhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHcCCcCC----
Confidence 2111 23344567998 999988889999999999999999986 99999755432211 1111221111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.....+..+.+++.+|+..+|.+|||+.++++.|+.+..
T Consensus 229 -----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 -----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 112345678999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=314.54 Aligned_cols=261 Identities=18% Similarity=0.223 Sum_probs=193.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCc------CceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH------KNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nlv~l~~~~~~~ 486 (709)
+.+|.....+|.|+|+.||.+... ..++.||||+++... ...+++..|++++.+++| .+++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDR---KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEc---CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 567887778888888888776665 567889999986532 234456677777777654 4589999988754
Q ss_pred -CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCC-CCeEecCCCCCceeecCCC----------
Q 038905 487 -QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCS-SQIIHCDIKPQNILLDDYY---------- 554 (709)
Q Consensus 487 -~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~iiH~Dlkp~NIll~~~~---------- 554 (709)
.+.++|||++ +++|.+++.+...+++..+..++.||+.||.||| + .+||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 5788999988 7789999988888999999999999999999999 6 4999999999999998765
Q ss_pred ------CeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhH
Q 038905 555 ------NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY 628 (709)
Q Consensus 555 ------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~ 628 (709)
.+||+|||++...... .....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~A-PE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRS-PEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cCCCCceEEECCCCccccCccc-----cccccCCccccC-cHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 4999999988643221 156789999999 9999999999999999999999999999999986654332
Q ss_pred HhHHHHHHH----hhh--------------cCCccccccCcc-------cccCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 038905 629 AILTDWAFD----CYR--------------NGKLDDLVEGDM-------EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMR 683 (709)
Q Consensus 629 ~~~~~~~~~----~~~--------------~g~~~~l~~~~~-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 683 (709)
......... .+. .+......++.. ...........+++|+..||+.||++|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 221111100 000 000000000000 0000111245688999999999999999999
Q ss_pred HHHH
Q 038905 684 KVSQ 687 (709)
Q Consensus 684 ev~~ 687 (709)
|+++
T Consensus 434 e~L~ 437 (467)
T PTZ00284 434 QMTT 437 (467)
T ss_pred HHhc
Confidence 9998
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=288.86 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=197.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+.|.....+|.|+++.||.+. . ..+..+|+|.+.... ...+++.+|+.++++++|+|++++++++. .+..++||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~-~---~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGY-Y---NGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred HHceeeeeeccCccceEEeee-c---CCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 345556667788888776664 3 356789999987543 34568999999999999999999999874 46789999
Q ss_pred eecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999999987543 5888999999999999999999 8899999999999999999999999999998765332
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... .....++..|++ ||++....++.++||||||++++||++ |+.||......+.. .....+...
T Consensus 157 ~~~-~~~~~~~~~y~~-pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~----- 222 (260)
T cd05067 157 YTA-REGAKFPIKWTA-PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-------QNLERGYRM----- 222 (260)
T ss_pred ccc-ccCCcccccccC-HHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-------HHHHcCCCC-----
Confidence 211 133456778998 999998889999999999999999998 99999754332211 111111110
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
......+..+.+++.+|++.+|++||++++++++|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112235679999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.86 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=204.2
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+...+|.|.+|.||-.... .+...+|||.+..-.......+.+|+.+-+.|+|.|||+++|.+.++...-+.||-++
T Consensus 579 ervVLGKGTYG~VYA~RD~---~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 579 ERVVLGKGTYGTVYAARDM---DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred ceEEeecCceeEEEeeccc---cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence 4677888888888555555 5778899999876655667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhC-CCC--ChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec-CCCCeEEccccccccccccccc
Q 038905 498 NGTLASFLFEN-LKP--GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 498 ~gsL~~~l~~~-~~l--~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||||.++|... +++ .+.+...+.+||++||.||| ...|||||||-+|+|++ -.|.+||+|||.++.+..-..
T Consensus 656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP- 731 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP- 731 (1226)
T ss_pred CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc-
Confidence 99999999754 455 77888899999999999999 89999999999999996 568899999999998765433
Q ss_pred cceeccccCcccccccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNS--TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~--~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.+.++-||..||| ||++..+ .|..++|||||||++.||.||++||........+.+ +-|.. .
T Consensus 732 -~TETFTGTLQYMA-PEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--------kVGmy------K 795 (1226)
T KOG4279|consen 732 -CTETFTGTLQYMA-PEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--------KVGMY------K 795 (1226)
T ss_pred -cccccccchhhhC-hHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--------hhcce------e
Confidence 3478899999999 9999765 488999999999999999999999964433222111 11111 1
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....+.+.+.++..+++.|+.+||.+||+++++++
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 123335678889999999999999999999999987
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=289.30 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=195.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
+|.....+|.|+++.||.+ .. ..+..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~-~~---~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMG-TW---NGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HhhhhheeccccCceEEEE-Ee---cCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 4454556777777777665 33 2456689998875432 4567999999999999999999999875 456899999
Q ss_pred ecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 495 FLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 495 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|+++++|.+++.+. ..+++..+..++.+++.||.||| +.+++||||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999764 35889999999999999999999 88999999999999999999999999999987654332
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. .....++..|+| ||.+.+..++.++|+||||++++||++ |..||......+.. ..+..+..
T Consensus 158 ~~-~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~------- 221 (260)
T cd05070 158 TA-RQGAKFPIKWTA-PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL-------EQVERGYR------- 221 (260)
T ss_pred cc-ccCCCCCccccC-hHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCC-------
Confidence 11 122345667998 999988889999999999999999999 88888654322211 11111110
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
.......+..+.+++.+|++.+|++|||+++++++|+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 --MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=290.89 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=204.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecC--CCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTS--TRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+...... ...+.+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 356777777888999988777654321 34578999988754433 457899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC---------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcc
Q 038905 490 LLVYKFLNNGTLASFLFENL---------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD 560 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~---------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 560 (709)
++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999998655 6899999999999999999999 88999999999999999999999999
Q ss_pred ccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhh
Q 038905 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 561 FGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
||+++........ ......++..|++ ||++.+..++.++||||||++++||++ |..||........ ....
T Consensus 161 ~~~~~~~~~~~~~-~~~~~~~~~~y~~-PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~-------~~~~ 231 (275)
T cd05046 161 LSLSKDVYNSEYY-KLRNALIPLRWLA-PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-------LNRL 231 (275)
T ss_pred cccccccCccccc-ccCCceeEEeecC-hhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-------HHHH
Confidence 9998754322211 1133456778998 999998889999999999999999998 7778854332221 1112
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
..+..... .....+..+.+++.+|++.+|++|||+.+++++|.
T Consensus 232 ~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 22222111 11234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.88 Aligned_cols=256 Identities=14% Similarity=0.158 Sum_probs=193.1
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
..+|.|.+++++||.+... .+++.||+|+++... ....+.+.+|+.+++.++|||||++++++..++..++||||
T Consensus 4 ~~ig~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYK---PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhccccccceEEEEEEeec---ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 4566676688888666555 678999999986542 23446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 496 LNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 496 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999999753 35889999999999999999999 889999999999999999999999999876543221111
Q ss_pred -----cceeccccCcccccccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 574 -----AIKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 574 -----~~~~~~~Gt~~y~aaPE~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
.......++..|+| ||++.+ ..++.++|||||||+++||++|+.||......... . . ...+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~----~-~~~~~~~~ 229 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLS-PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--L----E-KLNGTVPC 229 (327)
T ss_pred ccccccccccccceecccC-hHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--H----H-HhcCCccc
Confidence 01122356778998 999976 46899999999999999999999999753321110 0 0 00111111
Q ss_pred cccC------------------------------------cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 647 LVEG------------------------------------DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 647 l~~~------------------------------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+++. .............+.+++..||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 1000 0000011234567889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.42 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=205.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.+.-+..+|+|-++.| |.|+++ +..-.||||.++... -..++|..|..+|+.++|||||+|+|+|..+...|||+|
T Consensus 268 dItMkhKLGGGQYGeV-YeGvWK--kyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEV-YEGVWK--KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccce-eeeeee--ccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 3444556777777777 677775 577889999998654 367899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 495 FLNNGTLASFLFENLK--PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||..|.|.+||.+..+ ++....+.++-||..|+.||. .+.+|||||.+.|+|+.++..+||+||||++++..+.-
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 9999999999998654 666677889999999999999 99999999999999999999999999999999876542
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
. ......-...|.| ||-+.-..++.|+|||+|||+||||.| |..|+...+... ++.++.+ .
T Consensus 421 T-AHAGAKFPIKWTA-PEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEk---------g 482 (1157)
T KOG4278|consen 421 T-AHAGAKFPIKWTA-PESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEK---------G 482 (1157)
T ss_pred e-cccCccCcccccC-cccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhc---------c
Confidence 1 1111222345777 999999999999999999999999987 666775443221 3333333 3
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.+...+..+++.+.+|++.||+.+|.+||++.|+-+.+|.+
T Consensus 483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 33334667889999999999999999999999998888764
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=286.40 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=193.8
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+|.|+++.||.+... . ++.+++|........ ...++.+|++++++++|+||+++++++.+....++||||+++++
T Consensus 3 lg~g~~g~v~~~~~~---~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 3 IGKGNFGDVYKGVLK---G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred cccCCCceEEEEEEe---C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 566677766555443 3 888999988754333 55789999999999999999999999999999999999999999
Q ss_pred HHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceecc
Q 038905 501 LASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579 (709)
Q Consensus 501 L~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 579 (709)
|.+++.+. ..+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++..............
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99999764 45788999999999999999999 889999999999999999999999999999865432211111223
Q ss_pred ccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCH
Q 038905 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658 (709)
Q Consensus 580 ~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~ 658 (709)
.++..|++ ||.+.+..++.++|+||||++++||++ |..||......... .....+. ....+.
T Consensus 156 ~~~~~y~~-PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-------~~~~~~~---------~~~~~~ 218 (251)
T cd05041 156 QIPIKWTA-PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-------ERIESGY---------RMPAPQ 218 (251)
T ss_pred cceeccCC-hHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-------HHHhcCC---------CCCCCc
Confidence 34567998 999998899999999999999999999 78888654332211 1111110 011122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 659 KCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 659 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
..+..+.+++.+|++.+|.+|||++||++.|++
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 345679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=309.45 Aligned_cols=262 Identities=19% Similarity=0.158 Sum_probs=195.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+... ..++.||||... ...+.+|++++++++|+|||++++++..+...++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~---~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHP---DYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEEC---CCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 456777788889988888766555 567889999632 23457899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||++. ++|..++... ..+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 99995 6888888654 46899999999999999999999 8899999999999999999999999999998765433
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccc-hhhHHhHHHHHHHhhhcCCc-----c
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKL-----D 645 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~g~~-----~ 645 (709)
.........||+.|+| ||++.+..++.++|||||||+||||++|..++.... ..........+.+.+..... .
T Consensus 315 ~~~~~~~~~GT~~Y~A-PE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 315 STPFHYGIAGTVDTNA-PEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred ccccccccCCCcCCcC-HHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 2222245679999999 999999999999999999999999999886543221 10000000001111111110 0
Q ss_pred cccc----------------Cccccc---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 646 DLVE----------------GDMEAM---NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 646 ~l~~----------------~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.... +..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 000000 001223468899999999999999999999874
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=303.97 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=199.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEc-CCe
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDE-GQN 488 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~-~~~ 488 (709)
++|.....+|.|+++.||.+.... ....++.||||++.... ......+.+|+.++.++ +|+||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 456666778888888887665432 22457889999987532 23446788999999999 68999999998865 456
Q ss_pred EEEEEeecCCCCHHHHHhhCC-----------------------------------------------------------
Q 038905 489 RLLVYKFLNNGTLASFLFENL----------------------------------------------------------- 509 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 509 (709)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999986421
Q ss_pred --------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceecccc
Q 038905 510 --------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581 (709)
Q Consensus 510 --------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 581 (709)
.+++..+..++.||++||.||| +.+|+||||||+|||+++++.+||+|||+++.+.............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 2567777889999999999999 89999999999999999999999999999987643332222233456
Q ss_pred CcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHH
Q 038905 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 660 (709)
Q Consensus 582 t~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~ 660 (709)
++.|+| ||++.+..++.++||||||++++||++ |..||........ ......++..... +...
T Consensus 244 ~~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~---------~~~~ 307 (343)
T cd05103 244 PLKWMA-PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA---------PDYT 307 (343)
T ss_pred CcceEC-cHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCCC---------CCCC
Confidence 678998 999999899999999999999999997 8888865432211 1111222211111 1112
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 661 VEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 661 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+..+.+++..||+.+|++|||+.+|++.|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3568899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=287.46 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=195.0
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
+|.....+|.|+++.||.+... ....+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~----~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWN----GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEc----CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 4555566777777777655432 33468999876432 34567899999999999999999999875 456889999
Q ss_pred ecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 495 FLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 495 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|+++++|.+++.+.. .+++..+..++.|++.||.||| +.+++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999997643 4788999999999999999999 88999999999999999999999999999987654322
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. .....++..|++ ||...+..++.++||||||+++|||++ |..||......+. ......+...
T Consensus 158 ~~-~~~~~~~~~y~~-Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~------ 222 (260)
T cd05069 158 TA-RQGAKFPIKWTA-PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-------LEQVERGYRM------ 222 (260)
T ss_pred cc-cCCCccchhhCC-HHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCC------
Confidence 11 123456778998 999998899999999999999999999 8889865433221 1111111100
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
......+..+.+++.+||+.+|++||++++|+++|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=290.91 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=195.0
Q ss_pred eecCeeEEEEEEEEEEec---CCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeec
Q 038905 421 LLGSSVFVNFTLVGVIQT---STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~---~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
.+|.|+++.||.+..... +.....+|||.+.... .....++.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 367777777765544321 1234678999875432 235678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-----CeEEcccccc
Q 038905 497 NNGTLASFLFEN-------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-----NAQISDFGLA 564 (709)
Q Consensus 497 ~~gsL~~~l~~~-------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~DFGla 564 (709)
++++|.+++.+. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.+. .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999753 23778899999999999999999 88999999999999999877 8999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
+.+.............++..|++ ||++.+..++.++||||||+++|||++ |+.||......+.. .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~ 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMA-PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL-------QHVTAGG 230 (269)
T ss_pred cccccccccccCcccCCCccccC-HHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH-------HHHhcCC
Confidence 86643322211123445678998 999999999999999999999999998 99998644332211 1111111
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
. .......+..+.+++.+||+.+|.+||++++++++|+.
T Consensus 231 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 R---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 01122345778999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=291.08 Aligned_cols=249 Identities=26% Similarity=0.290 Sum_probs=196.5
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
|.....+|.|+++.||.+... .+++.+|||.+.... ....+.+.+|+.++.+++|+|++++++.+.+.+..++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEc---CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 455566788888888766666 568899999876432 22335678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++++|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999999886543 5888999999999999999999 899999999999999999999999999999765433
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... ....|+..|+| ||++.+..++.++||||||+++|||++|+.||........... ....... ..
T Consensus 156 ~~~---~~~~g~~~y~a-PE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~--~~----- 221 (285)
T cd05630 156 QTI---KGRVGTVGYMA-PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKE--VQ----- 221 (285)
T ss_pred ccc---cCCCCCccccC-hHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhh--hh-----
Confidence 211 34578999998 9999999999999999999999999999999975432110000 0000000 00
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
..........+.+++..||+.||++||| ++|+++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 ---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0011223456889999999999999999 788877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=298.17 Aligned_cols=254 Identities=19% Similarity=0.198 Sum_probs=192.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..++.+|+|.+... .......+.+|+.++..++|+||+++++++.+.+..++
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLK---NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEEC---CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 4555666777777777665544 56788999988542 22233458889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++|+|.+++.+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999999873 56899999999999999999999 899999999999999999999999999999765433
Q ss_pred ccccceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
... ......||+.|+| ||++. ...++.++|||||||++|||++|+.||......+.. .........
T Consensus 156 ~~~-~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~-------~~i~~~~~~ 226 (332)
T cd05623 156 GTV-QSSVAVGTPDYIS-PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHKER 226 (332)
T ss_pred Ccc-eecccccCccccC-HHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCCCcc
Confidence 221 1134679999999 99986 346889999999999999999999999755432211 111111110
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSL--RPTMRKVSQM 688 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~ 688 (709)
.. . .......+..+.+++..|++.++.+ |++++++++.
T Consensus 227 ~~----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQ----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0 0001224566788888887654444 7899999775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=292.13 Aligned_cols=241 Identities=22% Similarity=0.335 Sum_probs=188.2
Q ss_pred ecCeeEEEEEEEEEEecC----CCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 422 LGSSVFVNFTLVGVIQTS----TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
+|.|+++.||.+.....+ .....+++|.+........+++.+|+.+++.++|||++++++++..+...++||||++
T Consensus 3 lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd05078 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVK 82 (258)
T ss_pred CCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCC
Confidence 577777777665543221 1244588888876555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC--------eEEcccccccccc
Q 038905 498 NGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN--------AQISDFGLAKLLT 568 (709)
Q Consensus 498 ~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~DFGla~~~~ 568 (709)
+|+|..++.... .+++..+..++.||+.||.||| +++|+||||||+||+++.++. +|++|||++....
T Consensus 83 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 83 FGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred CCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 999999998654 5889999999999999999999 899999999999999987765 6999999986543
Q ss_pred ccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCC-CCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
.. ....++..|+| ||++.+ ..++.++||||||+++|||++|. .|+........... .... ..
T Consensus 160 ~~------~~~~~~~~y~a-PE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~--------~~~~-~~ 223 (258)
T cd05078 160 PK------EILLERIPWVP-PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF--------YEDR-HQ 223 (258)
T ss_pred Cc------hhccccCCccC-chhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH--------HHcc-cc
Confidence 21 34568889998 999986 45799999999999999999995 55543322211110 0000 00
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
.+......+.+++..||+.+|++|||++++++.|+
T Consensus 224 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=303.93 Aligned_cols=241 Identities=22% Similarity=0.253 Sum_probs=188.7
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhcc---CcCceeEEEeEEEcCCeEEEEEee
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQT---YHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
+|.|+++.||.+... ..++.+|||++.... .....++..|..++... +||||+++++.+.+....++||||
T Consensus 1 lG~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKK---DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEEC---CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 477788888766555 568899999986432 12233455676776655 699999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+++++|..++.+...+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 999999999988888999999999999999999999 889999999999999999999999999999754332221
Q ss_pred eeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 576 KKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
....+||+.|+| ||++.+. .++.++|||||||++|||++|+.||......+. ...+..++.. +.
T Consensus 153 ~~~~~gt~~y~a-PE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~~-~~------ 217 (330)
T cd05586 153 TNTFCGTTEYLA-PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-------YRNIAFGKVR-FP------ 217 (330)
T ss_pred ccCccCCccccC-HHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-------HHHHHcCCCC-CC------
Confidence 245789999999 9998765 489999999999999999999999976543221 1222222211 00
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCC----CHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRP----TMRKVSQ 687 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~ev~~ 687 (709)
....+..+.+++..||+.||.+|| ++.++++
T Consensus 218 --~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 --KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112356778999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=290.48 Aligned_cols=249 Identities=24% Similarity=0.280 Sum_probs=196.4
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
|.....+|.|++++||.+... .+++.+|+|.+.... ......+.+|++++.+++|+|++++.+.+..++..++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR---ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC---CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 455566788888888766555 568899999886432 22335678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++++|..++.... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999998886543 5899999999999999999999 899999999999999999999999999999765432
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... ....|+..|+| ||++.+..++.++|+||||++++||++|..||.......... .+......+..
T Consensus 156 ~~~---~~~~g~~~~~a-PE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~---~~~~~~~~~~~------ 222 (285)
T cd05632 156 ESI---RGRVGTVGYMA-PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EVDRRVLETEE------ 222 (285)
T ss_pred Ccc---cCCCCCcCccC-hHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhhhcccc------
Confidence 211 34578999998 999999999999999999999999999999997544322111 11111111110
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
.........+.+++..|++.||++||+ +++++.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011223456789999999999999999 667766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.77 Aligned_cols=266 Identities=25% Similarity=0.365 Sum_probs=202.0
Q ss_pred cccceeeeecCeeEEEEEEEEEEe-cCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcC--CeE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQ-TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QNR 489 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~~ 489 (709)
+.|.....+|.|+++.||.+.... ....+..+|+|.+.... ......+.+|++++++++|+|++++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 445666667888888887665332 22467889999987543 33446799999999999999999999998775 568
Q ss_pred EEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++||||+++++|.+++.+.. .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999997654 5899999999999999999999 8999999999999999999999999999998765
Q ss_pred ccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhH--------HhHHHHHHHhh
Q 038905 569 LNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY--------AILTDWAFDCY 639 (709)
Q Consensus 569 ~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~ 639 (709)
..... .......|+..|+| ||++.+..++.++||||||+++|||++++.|......... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~a-pE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYA-PECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccC-HHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 43322 11134556778998 9999988899999999999999999998776532211000 00000011111
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
..+.. .......+..+.+++.+|++.+|.+|||++++++.|+.+
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111 111223567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.04 Aligned_cols=250 Identities=23% Similarity=0.299 Sum_probs=193.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcC-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEG----- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~----- 486 (709)
+..|.....+|.|+++.||.+... ..++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~---~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEc---CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 344554455677777777655544 567899999986543 3557889999999998 699999999998653
Q ss_pred -CeEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 487 -QNRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 487 -~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
...++||||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+||+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 46789999999999999998643 5889999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccccceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
++........ .....|++.|+| ||++. +..++.++|||||||++|||++|..||.......... ..
T Consensus 158 ~~~~~~~~~~--~~~~~g~~~y~a-PE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~ 228 (272)
T cd06637 158 SAQLDRTVGR--RNTFIGTPYWMA-PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LI 228 (272)
T ss_pred ceeccccccc--CCcccccccccC-HhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HH
Confidence 9866433221 145679999998 99986 3458889999999999999999999996443222111 00
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......+. ....+..+.+++.+||+.+|.+|||++++++
T Consensus 229 -~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 -PRNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -hcCCCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111111111 1123457889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.85 Aligned_cols=260 Identities=20% Similarity=0.239 Sum_probs=189.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcC------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG------ 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~------ 486 (709)
..+|.....+|.|+++.||.+... ..+..||||++.... ....+|+.++++++|+|||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICI---DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEEC---CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 456777777888888888766555 467899999875432 2345799999999999999999876432
Q ss_pred --CeEEEEEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEc
Q 038905 487 --QNRLLVYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQIS 559 (709)
Q Consensus 487 --~~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~ 559 (709)
...++||||+++ +|..++.. ...+++.....++.||+.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence 246799999986 67666542 346889999999999999999999 89999999999999999665 69999
Q ss_pred cccccccccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH--
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-- 636 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-- 636 (709)
|||+|+.+...... ....||+.|+| ||++.+. .++.++|||||||++|||++|.+||......+.........
T Consensus 214 DFGla~~~~~~~~~---~~~~~t~~y~a-PE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 214 DFGSAKNLLAGQRS---VSYICSRFYRA-PELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred ccccchhccCCCCc---ccCCCCcCccC-HHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999876543221 34678999999 9998764 68999999999999999999999997654432111110000
Q ss_pred ---Hhhh--cCCcccc-----ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 637 ---DCYR--NGKLDDL-----VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 637 ---~~~~--~g~~~~l-----~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+.+. ......+ ....+....+...+..+.+++..||+.||.+|||+.|+++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000 0000000 0000111111224567899999999999999999999985
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=298.03 Aligned_cols=253 Identities=18% Similarity=0.208 Sum_probs=192.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... .+++.+|+|.+... .....+.+.+|+.++..++|+||+++++++.++.+.++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMK---NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CceEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 4555666777888877666555 56788999998642 22334568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++.+ ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++..+...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999999976 346889999999999999999999 899999999999999999999999999999765433
Q ss_pred ccccceeccccCcccccccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC-Cc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRN-----STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-KL 644 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~-----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g-~~ 644 (709)
.... .....||+.|+| ||++.. ..++.++|||||||++|||++|+.||......+.. ...... ..
T Consensus 156 ~~~~-~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-------~~i~~~~~~ 226 (331)
T cd05597 156 GTVQ-SNVAVGTPDYIS-PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHKEH 226 (331)
T ss_pred CCcc-ccceeccccccC-HHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH-------HHHHcCCCc
Confidence 2211 133579999999 999863 45788999999999999999999999754332211 111111 11
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccC--CCCCCCCHHHHHHH
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQE--DPSLRPTMRKVSQM 688 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~ev~~~ 688 (709)
..+.. .....++.+.+++..|++. ++..||+++++++.
T Consensus 227 ~~~~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQFPP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccCCC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11100 0112455677788776654 34448899998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=287.54 Aligned_cols=253 Identities=28% Similarity=0.390 Sum_probs=200.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+++.||.+. . .....+|||.+.... ...+++.+|+.++++++|+|++++++++.+....++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~-~---~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGT-W---NGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEE-E---cCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 3456666677888888886654 3 245779999887543 3457899999999999999999999999998999999
Q ss_pred EeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++++|.+++.+.. .+++..+..++.+++.||.||| +.+++|+||||+||++++++.+||+|||+++.+...
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999997654 5889999999999999999999 889999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..... ....++..|++ ||.+.+..++.++|+||||++++||++ |+.||......... .....+.
T Consensus 157 ~~~~~-~~~~~~~~y~~-PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-------~~~~~~~------ 221 (261)
T cd05034 157 EYTAR-EGAKFPIKWTA-PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL-------EQVERGY------ 221 (261)
T ss_pred hhhhh-hccCCCccccC-HHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC------
Confidence 21111 23334567998 999999899999999999999999998 89998654322211 1111110
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
....+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ---RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000111235678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.09 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=200.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCC-ceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTR-TTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
...|.....+|.|+++.||.+.....+.. ...+|+|.+..... ....++.+|+.++++++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 34566667788888888866655533221 23578888765432 2345789999999999999999999998754 467
Q ss_pred EEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+++||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999999997654 5889999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
...........++..|++ ||++.+..++.++||||||+++|||++ |..||......+.. .....+... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~--~ 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMA-LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-------DLLEKGERL--P 231 (303)
T ss_pred cccccccCCCccccccCC-HHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHCCCCC--C
Confidence 332222233445678998 999999999999999999999999997 88998654322211 111111110 0
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
........+.+++..|+..+|++||++++++++|..+.
T Consensus 232 -------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 232 -------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01123457889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.94 Aligned_cols=248 Identities=23% Similarity=0.294 Sum_probs=198.5
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEc-CCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE-GQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~-~~~~~lV 492 (709)
|.....+|.|+++.||.+... ..++.+|+|++... .....+.+.+|++++++++|+|++++++.+.. ....++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEc---CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 455666788888888777665 45778999998643 23345678999999999999999999998764 4467899
Q ss_pred EeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++++|.+++... ..+++.++..++.+++.||.+|| +.+++|+||||+||+++.++.++|+|||++..+...
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999999763 35899999999999999999999 889999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... .....|++.|+| ||++.+..++.++||||||++++||++|+.||........ .. ....+....
T Consensus 156 ~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~-~~~~~~~~~---- 221 (257)
T cd08223 156 CDM--ASTLIGTPYYMS-PELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VY-RIIEGKLPP---- 221 (257)
T ss_pred CCc--cccccCCcCccC-hhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HH-HHHhcCCCC----
Confidence 222 245678999998 9999999999999999999999999999999875432221 11 112222211
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.....+..+.+++.+|++.+|++|||+.++++.
T Consensus 222 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 122355678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.00 Aligned_cols=251 Identities=18% Similarity=0.210 Sum_probs=197.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+++.||.+... ..+..+++|.+........+++.+|+.++++++|+|++++++.+..+...++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNK---ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEEC---CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 34555556777777777666554 467899999987766566778999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++++|..++.+. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999999999887653 46899999999999999999999 88999999999999999999999999999875433221
Q ss_pred ccceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 573 KAIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
. .....+++.|+| ||++. ...++.++|||||||++|||++|+.||........ ...........+
T Consensus 166 ~--~~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~ 235 (292)
T cd06644 166 R--RDSFIGTPYWMA-PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-------LLKIAKSEPPTL 235 (292)
T ss_pred c--cceecCCccccC-ceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-------HHHHhcCCCccC
Confidence 1 134568899998 99984 44578899999999999999999999865432211 111111111111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. ........+.+++.+||+.+|++||+++++++
T Consensus 236 ~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 S-------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 12234456889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=286.87 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=195.5
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch---------hHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD---------GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
....+|.|+++.||.+... ..+..+|+|.+...... ..+.+.+|+.++.+++|+||+++++++.+...
T Consensus 4 ~~~~ig~g~~~~v~~a~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNA---SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred ccceeecCCCeEEEEEEec---CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3345666777777655544 45788999977543211 22568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||||+++++|.+++.....+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999988878899999999999999999999 8899999999999999999999999999998775
Q ss_pred cccccc----ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 569 LNQSKA----IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 569 ~~~~~~----~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
.+.... ......|+..|++ ||.+.+..++.++|+||||++++||++|+.||........ +.. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~-pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~~ 229 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMA-PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFK-IGENAS 229 (267)
T ss_pred cccccCCccccccccCCCcCccC-hhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHH-HhccCC
Confidence 322111 1123568899998 9999998999999999999999999999999975432111 000 111111
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. ......++.+.+++.+||+.+|.+||+++++++
T Consensus 230 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 P---------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred C---------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 112234577889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=288.07 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=199.0
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
|.....+|.|+++.||.+... .++..+|+|.+.... ......+.+|+.++++++|+|++++++++.++...++|+|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDK---RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEEC---CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 444455677777777655544 468899999986543 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
|+++++|.+++... ++++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+++.+......
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK- 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc-
Confidence 99999999998765 7899999999999999999999 889999999999999999999999999999877644322
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
.....|++.|++ ||++.+..++.++||||||+++|||++|+.||........ ......+....+.+
T Consensus 155 -~~~~~~~~~y~~-PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~----- 220 (274)
T cd06609 155 -RNTFVGTPFWMA-PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-------LFLIPKNNPPSLEG----- 220 (274)
T ss_pred -cccccCCccccC-hhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-------HHHhhhcCCCCCcc-----
Confidence 145678899998 9999998899999999999999999999999975432211 11111111111111
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...+..+.+++..|++.+|++|||++++++
T Consensus 221 ---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 ---NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 114567889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=289.52 Aligned_cols=246 Identities=19% Similarity=0.235 Sum_probs=193.8
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~g 499 (709)
..+|.|+++.||.+... ..+..+++|.+........+.+.+|+++++.++|+|++++++++..++..++|+||++++
T Consensus 11 ~~lg~g~~g~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 11 GELGDGAFGKVYKAQNK---ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred hhcccCCCeEEEEEEEC---CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 34666777777555443 467889999987655556678999999999999999999999999999999999999999
Q ss_pred CHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceec
Q 038905 500 TLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578 (709)
Q Consensus 500 sL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 578 (709)
+|..++.+ ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......... ...
T Consensus 88 ~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~ 162 (282)
T cd06643 88 AVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDS 162 (282)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccccc--ccc
Confidence 99998865 346899999999999999999999 889999999999999999999999999999765432211 144
Q ss_pred cccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 579 IRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
..|+..|++ ||++. +..++.++|||||||++|||++|++||......+.. .. ...+....+.
T Consensus 163 ~~~~~~y~a-PE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~-~~~~~~~~~~----- 229 (282)
T cd06643 163 FIGTPYWMA-PEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL------LK-IAKSEPPTLA----- 229 (282)
T ss_pred ccccccccC-HhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH------HH-HhhcCCCCCC-----
Confidence 678999999 99984 455788999999999999999999998654322211 01 1111111111
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.+...+..+.+++..||+.+|.+||+++++++.
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 --QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122345678999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=290.20 Aligned_cols=261 Identities=20% Similarity=0.228 Sum_probs=190.4
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhcc---CcCceeEEEeEEEc-----
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQT---YHKNLVRLLGFCDE----- 485 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nlv~l~~~~~~----- 485 (709)
|.....+|.|+++.||.+... .+++.+|+|.+.... ......+.+|+.++..+ +|+||+++++++..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDP---HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred ceEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 455566778888888766665 568899999876432 11234566777777665 69999999998864
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 486 GQNRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
....++||||+.+ +|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCc
Confidence 3457899999985 8888887643 4889999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHH-hHHHHHH----Hh
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDWAF----DC 638 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~----~~ 638 (709)
++........ ....||..|+| ||++.+..++.++|||||||++|||++|++||......+.. ....... ..
T Consensus 155 ~~~~~~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 155 ARIYSCQMAL---TPVVVTLWYRA-PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred cccccCcccC---CCccccccccC-chHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 9876533221 44678999998 99999999999999999999999999999999765432211 1111000 00
Q ss_pred hhcC-Cc-cccccCcc---cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNG-KL-DDLVEGDM---EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g-~~-~~l~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+... .. ........ .........+.+.+++..|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00 00000000 00011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.44 Aligned_cols=248 Identities=22% Similarity=0.320 Sum_probs=210.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchh--HHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDG--EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|.|+.|.++.+. .++..||||.+++..-+. ...+.+|+++|..++|||||+++.+......+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~---~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHI---LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEec---CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 667778888999999999888887 579999999998654332 245899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||+.+|.+.+++.+++++.......++.|+.+|++||| ++.|||||||++||||+.++++||+|||++..+...
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999999999999888999999999999999999 999999999999999999999999999999988744
Q ss_pred ccccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... .+.+|++.|.| ||++.+..| .+++|+||+|++||-|+.|..||+...-.+.. +..+.
T Consensus 209 ~~l---qt~cgsppyAa-PEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl~ 269 (596)
T KOG0586|consen 209 LML---QTFCGSPPYAA-PELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVLR 269 (596)
T ss_pred ccc---cccCCCCCccC-hHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chhee
Confidence 322 78999999998 999999886 57899999999999999999999854321100 01111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..++. +.-....+.++++.+|..+|.+|++++++.+
T Consensus 270 gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 270 GKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeecc--cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11222 3345667889999999999999999999876
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=290.75 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=201.7
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
++|.....+|.|+++.||.+... ..++.+|+|.+.... ....+++.+|++++..++|+||+++++++......++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHI---PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEc---CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 44555556777778877666554 467889999875432 33457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||+++++|..++.+.+.+++.....++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 9999999999999887789999999999999999999993 2589999999999999999999999999987543221
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhh-----HHhHHHHHHHhhhcCCcccc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~g~~~~l 647 (709)
.....|+..|++ ||++.+..++.++|+|||||+++||++|+.||......+ ........... .......
T Consensus 159 ---~~~~~~~~~~~a-PE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~- 232 (284)
T cd06620 159 ---ADTFVGTSTYMS-PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI-VQEPPPR- 232 (284)
T ss_pred ---cCccccCcccCC-HHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH-hhccCCC-
Confidence 134678999998 999988899999999999999999999999997544311 11111111111 1111110
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 689 (709)
......+..+.+++.+|++.||.+|||++|++++.
T Consensus 233 -------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 -------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01112456788999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=284.83 Aligned_cols=249 Identities=21% Similarity=0.251 Sum_probs=199.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
++|.....+|.|+++.||.+... ..++.+++|.+.... ..+++.+|++++++++|+|++++++++.+....++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHK---ETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEc---CCCcEEEEEEeecHH--HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 45665566777777777555444 357889999987543 2678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++++|.+++... ..+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.+||+|||++........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999999764 46899999999999999999999 88999999999999999999999999999987654332
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
. .....|+..|++ ||++.+..++.++||||||++++||++|+.|+.......... ....... .
T Consensus 155 ~--~~~~~~~~~y~~-PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~-----~-- 217 (256)
T cd06612 155 K--RNTVIGTPFWMA-PEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNKPP-----P-- 217 (256)
T ss_pred c--cccccCCccccC-HHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccCCC-----C--
Confidence 1 134568899998 999999999999999999999999999999997543322110 0000000 0
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...........+.+++..|++.+|.+|||++||++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01112234567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=292.26 Aligned_cols=250 Identities=23% Similarity=0.277 Sum_probs=200.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+++.||.+... ..+..||+|.+........+.+.+|+.+++.++|+|++++++++..+...++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDI---ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEEC---CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 45666667788877777655544 568899999987655555677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+++++|.+++.+ ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999999865 45788899999999999999999 889999999999999999999999999999865443221
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
. ....|++.|++ ||.+.+..++.++|+||||+++|+|++|..||.......... .....+ ...
T Consensus 172 ~--~~~~~~~~y~a-PE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~--------~~~ 234 (297)
T cd06656 172 R--STMVGTPYWMA-PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG--------TPE 234 (297)
T ss_pred c--CcccCCccccC-HHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC--------CCC
Confidence 1 34568899998 999999999999999999999999999999996543211100 000001 000
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..........+.+++..||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112234566889999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=284.98 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=196.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.|.....+|.|+++.||.+... .+..+|+|.+.... ....++.+|++++++++|+|++++++++......++|||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe----CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 4555566777777777655433 35678999886432 245679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 495 FLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 495 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
|+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999764 45889999999999999999999 889999999999999999999999999999866433211
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
.. ....++.+|+| ||++.+..++.++||||||+++|||++ |+.||......+.. +....+. ....+
T Consensus 157 ~~-~~~~~~~~~~a-Pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~--~~~~~-- 223 (256)
T cd05112 157 SS-TGTKFPVKWSS-PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV-------ETINAGF--RLYKP-- 223 (256)
T ss_pred cc-CCCccchhhcC-HhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-------HHHhCCC--CCCCC--
Confidence 11 22335668998 999998889999999999999999998 89998754432211 1111111 11111
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
...++.+.+++.+||+.+|++|||+++++++|.
T Consensus 224 -----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 -----RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 113467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=289.77 Aligned_cols=252 Identities=20% Similarity=0.206 Sum_probs=200.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
++|.....+|.|+++.||.+... .++..+|+|..........+.+.+|++++++++|+|++++++.+.++...++||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHK---ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEc---CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 45665566778888888666554 467889999987665556678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++++|..++.+. ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999999998764 36899999999999999999999 88999999999999999999999999999876543322
Q ss_pred ccceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 573 KAIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
. .....|++.|++ ||++. ...++.++|+||||+++|||++|+.||......+.. ..+..+....+
T Consensus 159 ~--~~~~~~~~~y~~-PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~ 228 (280)
T cd06611 159 K--RDTFIGTPYWMA-PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL-------LKILKSEPPTL 228 (280)
T ss_pred c--cceeecchhhcC-HHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH-------HHHhcCCCCCc
Confidence 2 145678999998 99975 345788999999999999999999999754322211 11112211111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
. .....+..+.+++..||+.+|.+||+++++++.
T Consensus 229 ~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 D-------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred C-------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 112345578899999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=287.36 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=195.2
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhH--HHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
....+|.|+++.||.+... ..++.+|+|.+........ ....+|+.++++++|+||+++++++.+....++||||
T Consensus 3 ~~~~lg~G~~g~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNK---KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEESSEEEEEEEET---TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred EeEEEEeCCCEEEEEEEEC---CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 3445666666666555554 5778999999876543322 2345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+++++|.+++.....++...+..++.|+++||.+|| +.+|+|+||||+||++++++.++|+|||.+....... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~ 154 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--EN 154 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SE
T ss_pred cccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc--cc
Confidence 999999999997778999999999999999999999 8899999999999999999999999999998642211 12
Q ss_pred eeccccCccccccccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HHHHHHHhhhcCCccccccCccc
Q 038905 576 KKAIRGTKGYVASPEWFR-NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
.....+++.|.| ||++. +..++.++||||||+++++|++|..|+......+... .......... .. ..
T Consensus 155 ~~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--------~~-~~ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMA-PEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP--------SS-SQ 224 (260)
T ss_dssp BSSSSSSGGGSC-HHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH--------HH-TT
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc--------cc-cc
Confidence 256778999998 99998 8889999999999999999999999998652211111 1111110000 00 00
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. .......+.+++..||+.||++||++.++++
T Consensus 225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c--cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011278999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=283.58 Aligned_cols=243 Identities=22% Similarity=0.224 Sum_probs=201.5
Q ss_pred cccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc---ccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 412 NMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR---VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 412 ~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
..++|...+.+|.|.||+|.++... ..++..|+|++++ +..+....-..|-++|...+||.+..+--.++..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEK---at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREK---ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeec---ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 3678888888999999988888777 5677788887764 344455666789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
+++||||..||.|.-+|.+...+++...+.+..+|+.||.||| +++||.||||.+|+|||.+|++||+|||+++.--
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999999999998888999999999999999999999 9999999999999999999999999999998543
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
... ..+.++||||.|+| ||++.+..|..++|+|.+|||+|||++|+.||...+.+... +++..+++.
T Consensus 320 ~~g--~t~kTFCGTPEYLA-PEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF-------eLIl~ed~k--- 386 (516)
T KOG0690|consen 320 KYG--DTTKTFCGTPEYLA-PEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF-------ELILMEDLK--- 386 (516)
T ss_pred ccc--ceeccccCChhhcC-chhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH-------HHHHhhhcc---
Confidence 332 22378999999999 99999999999999999999999999999999866544322 222222221
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCC
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 680 (709)
.+.....+...++.-.|..||.+|.
T Consensus 387 -------FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 -------FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -------CCccCCHHHHHHHHHHhhcChHhhc
Confidence 1223345566777788999999995
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=286.05 Aligned_cols=251 Identities=20% Similarity=0.254 Sum_probs=193.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-----chhHHHHHHHHHHHhccCcCceeEEEeEEEc--C
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-----QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE--G 486 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~--~ 486 (709)
.+|.....+|.|+++.||.+... ..+..+++|++.... ......+.+|+.++++++|+||+++++++.+ .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDV---DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEc---CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 46777777888888888766655 467889999875331 1234578899999999999999999998865 3
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++++||+++++|.+++.....+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++.
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 567899999999999999988778899999999999999999999 88999999999999999999999999999986
Q ss_pred ccccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 567 LTLNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 567 ~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
+...... .......++..|+| ||++.+..++.++||||||+++|||++|+.||........ +........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~~-- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMS-PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQPT-- 226 (266)
T ss_pred cccccccCCccccCCccccccC-HHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCCC--
Confidence 5432111 11134568899998 9999998999999999999999999999999974432111 111111111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+ ..+....+.+..++ .|+..+|++||+++||++
T Consensus 227 ---~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ---NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01 11122344555665 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=285.08 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=196.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
..|.....+|.|+++.||.+. . .....+++|.+.... ...+.+.+|++++++++|+|++++++++.+ ...+++|
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~-~---~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMAT-Y---NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cceeEEeEecCccceEEEEEE-e---cCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 345555667777777776664 3 245568999876532 345788999999999999999999999887 7789999
Q ss_pred eecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++++|.+++.+. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999764 35788889999999999999999 8899999999999999999999999999998765432
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... .....++..|++ ||++....++.++|+||||+++++|++ |+.||......+.. .....+...
T Consensus 157 ~~~-~~~~~~~~~y~~-PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~~~~----- 222 (260)
T cd05073 157 YTA-REGAKFPIKWTA-PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERGYRM----- 222 (260)
T ss_pred ccc-ccCCcccccccC-HhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCCCCC-----
Confidence 211 133445677998 999998889999999999999999998 88898654332211 111111111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
......+..+.+++.+|++.+|++||++.++.++|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=288.73 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=201.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCC-CceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTST-RTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..|.....+|.|+++.||.+....++. ....+|+|.+.... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 345555667777777776655443322 24468999886543 3345788999999999999999999999987 78899
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++... ..+++..+..++.||+.||+||| +.+++||||||+||++++++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999875 36899999999999999999999 899999999999999999999999999999877643
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..........++..|++ ||.+....++.++|+||||++++||++ |+.||.....++.. .....+...
T Consensus 163 ~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~---- 230 (279)
T cd05057 163 EKEYHAEGGKVPIKWMA-LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-------DLLEKGERL---- 230 (279)
T ss_pred ccceecCCCcccccccC-HHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHhCCCCC----
Confidence 32211112223567998 999988899999999999999999998 99999765433311 111122111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
..+......+.+++..||..+|.+||++.++++.|+.+.
T Consensus 231 -----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 231 -----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111223456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=292.07 Aligned_cols=265 Identities=17% Similarity=0.216 Sum_probs=196.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
...|.....+|.|+++.||.+... ..+..||+|.+.... ......+.+|+.++++++|+||+++++++.+....++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSK---LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEc---CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 445676777888888888666554 467889999876432 2234567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||++ ++|..++.+. ..+++..+..++.||+.||.||| +.+|+|+||||+||++++++.+||+|||+++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 999997 4898888764 35888999999999999999999 899999999999999999999999999999765432
Q ss_pred ccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... .....+++.|++ ||++.+ ..++.++||||||+++|||++|+.||......+...................+..
T Consensus 158 ~~~--~~~~~~~~~y~~-PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 158 TKT--YSNEVVTLWYRP-PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCc--ccccceeecccC-cHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 211 134567889998 998865 4578899999999999999999999976543322111100000000000000000
Q ss_pred C---------ccc----ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 G---------DME----AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~---------~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. ... .......+..+.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 000 0001123557889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=286.40 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=197.6
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc----------hhHHHHHHHHHHHhccCcCceeEEEeEEEc
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ----------DGEKEFKNEVVMIGQTYHKNLVRLLGFCDE 485 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~ 485 (709)
|.....+|.|+++.||.+... .+++.+|+|.+..... ...+.+.+|+.++.+++|+|++++++++..
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 79 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNV---TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT 79 (272)
T ss_pred eeecceecccCceEEEEEeec---CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc
Confidence 444556788888877655544 4678899998753211 123468889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 486 GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
.+..++||||+++++|.+++.+...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999999988888999999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccCCC--CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNST--ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~--~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
...............|+..|++ ||.+.... ++.++|+||||++++||++|..|+......+. .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMA-PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGNKRS 229 (272)
T ss_pred cccccccccccccccCCccccC-HHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhcccc
Confidence 6543322222245678899998 99987654 88999999999999999999999864332111 111111111
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
...+ . .......+..+.+++..|++.+|.+|||+++|++.
T Consensus 230 ~~~~-~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPI-P----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcC-C----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 1 11122346788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.34 Aligned_cols=263 Identities=22% Similarity=0.263 Sum_probs=195.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG---- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~---- 486 (709)
.++|.....+|.|+++.||.+... ..++.+|||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEec---CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 456777778888888888766544 567889999987532 23446788999999999999999999988543
Q ss_pred --CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 487 --QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 487 --~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
...++||||+++ +|...+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999976 66666643 4788888999999999999999 899999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHH-hHHHH---------
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDW--------- 634 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~--------- 634 (709)
+....... .....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.. .....
T Consensus 167 ~~~~~~~~---~~~~~~t~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGTSFM---MTPYVVTRYYRA-PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCCccc---cCCccccCCccC-HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 86543321 145678999999 99999999999999999999999999999999765432111 00000
Q ss_pred -----HHHhhhcC--Cccccc------cCcc--cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 635 -----AFDCYRNG--KLDDLV------EGDM--EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 635 -----~~~~~~~g--~~~~l~------~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....+... ....+. +... ...........+.+++.+|++.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 000000 0000 000112235678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=291.57 Aligned_cols=256 Identities=18% Similarity=0.219 Sum_probs=201.0
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..++.|++|.+.... ....+.+.+|+.+++.++|+||+++++.+..++..++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHK---ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEEC---CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 5666667778888888766555 567889999876542 2334678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|.+++.....+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999999988788999999999999999999999 8899999999999999999999999999987421110
Q ss_pred c-------------ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 572 S-------------KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 572 ~-------------~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
. ........|+..|+| ||.+.+..++.++|+||||+++|||++|..||......+. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-------~~~ 227 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIA-PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-------FGQ 227 (305)
T ss_pred cccccccccccchhhccccCCccCccccC-chhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH
Confidence 0 001123567889998 9999988999999999999999999999999975432221 111
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
...+....... ....+..+.+++.+||+.+|++||++.++.++|+.
T Consensus 228 ~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDIEWPEG-------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcccCCCCc-------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111111000 11345678899999999999999998777777766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=290.84 Aligned_cols=246 Identities=22% Similarity=0.284 Sum_probs=195.0
Q ss_pred ceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 417 TRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 417 ~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
+....+|.|+++.||.+... ..+..||+|.+.... ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDN---RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEc---CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 33344666777767554443 467889999886432 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+++++|.+++.. ..+++..+..++.|+++|+.||| +.+++|+||+|+||++++++.+||+|||++..+......
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-- 157 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-- 157 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchh--
Confidence 999999998854 46888999999999999999999 899999999999999999999999999999876543211
Q ss_pred eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccccc
Q 038905 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 655 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~ 655 (709)
.....|+..|++ ||++.+..++.++||||||++++||++|+.|+......... .....+.. ..
T Consensus 158 ~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~---------~~ 220 (277)
T cd06642 158 RNTFVGTPFWMA-PEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKNSP---------PT 220 (277)
T ss_pred hhcccCcccccC-HHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcCCC---------CC
Confidence 134568899998 99999999999999999999999999999998643322111 00111111 11
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 656 NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 656 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.....+..+.+++..|++.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 122345678899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=301.06 Aligned_cols=263 Identities=22% Similarity=0.254 Sum_probs=194.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--- 487 (709)
..+|.....+|.|+++.||.+... ..+..+|||++... ......++.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDT---VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEc---CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 456777778888888888766554 56889999998643 2334567889999999999999999999986443
Q ss_pred ---eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 488 ---NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 488 ---~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
..++||||+++ +|...+.. .++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999976 56665543 4788888999999999999999 899999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HH-----------
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LT----------- 632 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~----------- 632 (709)
+....... .....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+... ..
T Consensus 171 ~~~~~~~~---~~~~~~t~~y~a-PE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 171 RTACTNFM---MTPYVVTRYYRA-PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred cccccCcc---CCCCcccCCCCC-chhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 76543221 145678999999 999999999999999999999999999999997654321100 00
Q ss_pred HH---HHHhhhcCC--cc-----ccccCc-c--cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 633 DW---AFDCYRNGK--LD-----DLVEGD-M--EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 633 ~~---~~~~~~~g~--~~-----~l~~~~-~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.. ....+...+ .. ++.... . ...........+.+++..||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000000 00 000000 0 000111234678899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=293.81 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=198.0
Q ss_pred ceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeec
Q 038905 417 TRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 417 ~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
.....+|.|+++.||.+... ..+..+|||++........+.+.+|+.++.+++|+||+++++.+..++..++||||+
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEK---HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred hhhhcccCCCCeEEEEEEEC---CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 33455777777777655444 467899999987655556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 497 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
++++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+||++++++.+||+|||++..........
T Consensus 102 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~-- 175 (292)
T cd06658 102 EGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR-- 175 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC--
Confidence 99999998754 46889999999999999999999 8899999999999999999999999999997654333221
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
....|++.|+| ||.+.+..++.++||||||++++||++|+.||.......... ...... ......
T Consensus 176 ~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------~~~~~~-----~~~~~~-- 240 (292)
T cd06658 176 KSLVGTPYWMA-PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------RIRDNL-----PPRVKD-- 240 (292)
T ss_pred ceeecCccccC-HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhcC-----CCcccc--
Confidence 34678999998 999998899999999999999999999999997543322111 111110 011111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.......+.+++..|++.||++|||++++++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11244568889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=297.87 Aligned_cols=191 Identities=21% Similarity=0.268 Sum_probs=162.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+... ..+..||+|..... ....|+.++.+++|+|||++++++.++...++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKP---GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEEC---CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 567888888899999988766554 46778999975432 235699999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
+||+. ++|..++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 99996 5888887654 46899999999999999999999 8899999999999999999999999999997543222
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~ 620 (709)
. .....||+.|+| ||++.+..++.++|||||||++|||+++..++
T Consensus 212 ~---~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 A---FLGLAGTVETNA-PEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c---cccccccccccC-CeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 145679999999 99999999999999999999999999866554
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=288.24 Aligned_cols=265 Identities=19% Similarity=0.239 Sum_probs=197.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+... .+++.+|+|++.... ....+.+.+|+.++++++|+|++++++++......++|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNR---ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred ceeeeeeecccCCeEEEEEEEC---CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 4555566777777777655443 467889999875432 22345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||++++.|..++.....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999999888877667999999999999999999999 89999999999999999999999999999987654332
Q ss_pred ccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh--------hhcCC
Q 038905 573 KAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC--------YRNGK 643 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~g~ 643 (709)
. .....++..|++ ||++.+ ..++.++||||||++++||++|+.||......+........... +....
T Consensus 156 ~--~~~~~~~~~~~a-PE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 D--YTDYVATRWYRA-PELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--ccCcccccccCC-HHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 134557888998 999876 55789999999999999999999999765433221111100000 00000
Q ss_pred c-cccccCccccc-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 644 L-DDLVEGDMEAM-----NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 644 ~-~~l~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
. ..+..+..... .....+..+.+++.+||+.+|++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 00000000000 011235678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.91 Aligned_cols=247 Identities=22% Similarity=0.280 Sum_probs=198.4
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
|.....+|.|+++.||.+... ..+..+|||.+.... ......+.+|+.+++++.|+||+++++++.++...++|||
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEc---cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 344445777777777665554 467889999876432 3455789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
|+++++|.+++.. .++++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+......
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-
Confidence 9999999998864 46888889999999999999999 899999999999999999999999999999876543221
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
.....++..|+| ||++.+..++.++|+||||+++|||++|..|+.......... ....+. ..
T Consensus 158 -~~~~~~~~~y~a-pE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~---------~~ 219 (277)
T cd06640 158 -RNTFVGTPFWMA-PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPKNN---------PP 219 (277)
T ss_pred -cccccCcccccC-HhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhcCC---------CC
Confidence 134568888998 999998889999999999999999999999987543322110 011111 11
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
......+..+.+++..||+.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1233466788999999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=292.71 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=199.1
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
|.....+|.|+++.||.+... .++..+|+|.+........+.+.+|+.++..++|||++++++++..++..++|+||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREK---HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEc---CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 334456778888877665544 46789999998655445567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+++++|..++.. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..+.......
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~- 174 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR- 174 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc-
Confidence 999999987754 46889999999999999999999 8899999999999999999999999999997665433221
Q ss_pred eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccccc
Q 038905 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 655 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~ 655 (709)
....|++.|+| ||++.+..++.++||||||++++||++|+.||......+... .+........ .
T Consensus 175 -~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~~-------~ 238 (297)
T cd06659 175 -KSLVGTPYWMA-PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-------RLRDSPPPKL-------K 238 (297)
T ss_pred -cceecCccccC-HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhccCCCCc-------c
Confidence 44678999998 999999899999999999999999999999997544322111 1111111100 0
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 656 NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 656 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
........+.+++..|++.+|++||+++++++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 011234568899999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=281.42 Aligned_cols=248 Identities=21% Similarity=0.293 Sum_probs=199.6
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|+....+|.|+++.+|.+... .+++.+|+|.+... .....+++.+|+.++++++|+||+++++++.+.++.++|+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSK---EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred ceEEEEeccCCceEEEEEEEc---CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 555667788888877666554 46788999987642 2334568999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999999987643 5788899999999999999999 8899999999999999999999999999998765432
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
... ....|++.|++ ||++.+..++.++|+||||++++||++|+.|+......+. ......+....
T Consensus 156 ~~~--~~~~~~~~~~~-pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~~----- 220 (256)
T cd08218 156 ELA--RTCIGTPYYLS-PEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-------VLKIIRGSYPP----- 220 (256)
T ss_pred hhh--hhccCCccccC-HHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-------HHHHhcCCCCC-----
Confidence 211 34568889998 9999998999999999999999999999999875433221 11112222111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
........+.+++.+|++.+|.+||++++|++.
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 ----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 122345678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=337.10 Aligned_cols=261 Identities=24% Similarity=0.455 Sum_probs=205.7
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.+.....+|.|+++.||.+... .++..||||+++.... ...+|++++++++|||||+++++|.++...++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSI---KNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEEC---CCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3445556777777777555444 4678999999865432 22356889999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
|+++|+|.+++.+ ++|..+.+++.||++||+|||..++.+|+||||||+||+++.++.+++. ||.+......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 9999999999963 8899999999999999999998878899999999999999999988875 6665443221
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
....||+.|+| ||++.+..++.++|||||||++|||++|+.|++..... ......|+............+++.+..
T Consensus 836 --~~~~~t~~y~a-PE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 --TKCFISSAYVA-PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCccccccccC-cccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccC
Confidence 23468899999 99999999999999999999999999999999654322 122334444334344444455554422
Q ss_pred --cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 655 --MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 655 --~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.....+..++.+++.+||+.+|++||||+||+++|+.+..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2344667788999999999999999999999999998754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.12 Aligned_cols=263 Identities=22% Similarity=0.258 Sum_probs=195.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG---- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~---- 486 (709)
.++|.....+|.|+++.||.+... ..++.+|||++.... .....++.+|+.+++.++|+||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEEC---CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 456777778888888888666554 567889999986532 23446788999999999999999999987543
Q ss_pred --CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 487 --QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 487 --~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
...++||||+++ +|...+.. .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999976 67776653 4788888999999999999999 899999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HHH--------H-
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD--------W- 634 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~--------~- 634 (709)
+....... .....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+... ... .
T Consensus 174 ~~~~~~~~---~~~~~~t~~y~a-PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 174 RTAGTSFM---MTPYVVTRYYRA-PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred cccCCCCc---ccCCcccCCcCC-HHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 86543221 145678999999 999999999999999999999999999999997654322110 000 0
Q ss_pred -----HHHhhhcCC--cc-----ccccCcc---cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 635 -----AFDCYRNGK--LD-----DLVEGDM---EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 635 -----~~~~~~~g~--~~-----~l~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....+.... .. .+..... ...........+.+++.+|++.||.+|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00 0000000 000111234578899999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.56 Aligned_cols=245 Identities=21% Similarity=0.259 Sum_probs=203.0
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhH---HHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGE---KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
-|....-+|.|+||.|||+... .+..+||||++.-...+.. .++..|+..|.++.|||+|.+-|+|......+|
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~---~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHhcCCccceeEEeecc---CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 4677778899999999999888 6899999999975544333 578999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||||-| |-.+++.-. .++.+..+..|+.+.+.||+||| +.+.||||||+.||||.+.|.|||+|||.|.+....
T Consensus 104 VMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 104 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9999976 767777643 46889999999999999999999 899999999999999999999999999999876432
Q ss_pred ccccceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
..++|||.||| ||++. .+.|+-|+||||||++..||.-.++|.......... +- +...+.
T Consensus 180 ------nsFvGTPywMA-PEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL------YH-IAQNes--- 242 (948)
T KOG0577|consen 180 ------NSFVGTPYWMA-PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YH-IAQNES--- 242 (948)
T ss_pred ------hcccCCccccc-hhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH------HH-HHhcCC---
Confidence 67899999999 99985 467999999999999999999998887543322211 11 111111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
......++++.++.++..||+.-|++|||.++++..
T Consensus 243 -----PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 -----PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -----CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111245788999999999999999999999998764
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=281.17 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=197.6
Q ss_pred eeeecCeeEEEEEEEEEEecC-CCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeec
Q 038905 419 SVLLGSSVFVNFTLVGVIQTS-TRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
...+|.|+++.||.+.....+ .....+|+|.+...... ..+.+.+|+.++.+++|+||+++++++.+.+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 345667777777655555321 23488999998765433 5678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 497 NNGTLASFLFENLK--PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 497 ~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
++++|.+++..... +++..+..++.|++.||.+|| +.+++|+||||+||++++++.++|+|||+++.........
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 84 EGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred CCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999986554 899999999999999999999 8899999999999999999999999999998765442221
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
. ....+++.|++ ||.+.+..++.++||||||++++||++ |+.|+......... +....+.....
T Consensus 161 ~-~~~~~~~~y~~-Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~------ 225 (258)
T smart00219 161 K-KGGKLPIRWMA-PESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL-------EYLKKGYRLPK------ 225 (258)
T ss_pred c-ccCCCcccccC-hHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCCCCCC------
Confidence 1 12337788998 999988889999999999999999998 77887653322211 11122221111
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 689 (709)
....+..+.+++.+|++.+|++|||+.+++++|
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112456788999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=289.37 Aligned_cols=266 Identities=20% Similarity=0.252 Sum_probs=200.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+... .++..+++|+++.. .....+.+.+|++++++++|+||+++++++.+++..++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNK---ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeC---CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 4555666777777777555444 45789999988643 233457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||++++.+..++.+...+++..+..++.||+.||.||| ..+++|+||||+||++++++.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 999999888777766667899999999999999999999 88999999999999999999999999999987765443
Q ss_pred ccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh---------cC
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---------NG 642 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~g 642 (709)
... ....++..|+| ||++.+. .++.++||||||++++||++|+.||......+............. ..
T Consensus 156 ~~~-~~~~~~~~~~~-PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 SPL-TDYVATRWYRA-PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccc-cCcccccCCcC-CchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 121 45678899998 9999888 889999999999999999999999975543221111111100000 00
Q ss_pred Ccc-----ccccCc-ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 643 KLD-----DLVEGD-MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 643 ~~~-----~l~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
... ...+.. .........+..+.+++..||+.+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 000000 0001112236789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.81 Aligned_cols=260 Identities=20% Similarity=0.207 Sum_probs=196.1
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-----hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-----GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
|.....+|.|+++.||.+... .+++.++||++...... ....+.+|++++++++|+||+++++++.+.+..+
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDK---ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN 78 (298)
T ss_pred ceeeeeeeeccccEEEEEEEC---CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEE
Confidence 444455777777777665554 45789999998654322 3456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+ +++|.+++.... .+++..+..++.||++||.||| +.+|+|+||||+||+++.++.+||+|||+++....
T Consensus 79 lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999999 889999998766 7999999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc-------
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------- 641 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 641 (709)
..... ....+++.|+| ||.+.+ ..++.++||||||++++||++|.++|......+.... ..+....
T Consensus 155 ~~~~~--~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 228 (298)
T cd07841 155 PNRKM--THQVVTRWYRA-PELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK---IFEALGTPTEENWP 228 (298)
T ss_pred CCccc--cccccceeeeC-HHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH---HHHHcCCCchhhhh
Confidence 32211 33456788998 998864 4678999999999999999999887765443221110 1110000
Q ss_pred --CCccccccCccc-----ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 642 --GKLDDLVEGDME-----AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 642 --g~~~~l~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
............ ..........+.+++..||+.+|++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 00112346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=282.29 Aligned_cols=239 Identities=26% Similarity=0.393 Sum_probs=185.4
Q ss_pred ecCeeEEEEEEEEEEecC-------CCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 422 LGSSVFVNFTLVGVIQTS-------TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
+|.|+++.||.+.....+ .....+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|||
T Consensus 3 lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e 80 (259)
T cd05037 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEE 80 (259)
T ss_pred ccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEE
Confidence 566666666544433211 11246778876654332 6789999999999999999999999988 77899999
Q ss_pred ecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-------CeEEcccccccc
Q 038905 495 FLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-------NAQISDFGLAKL 566 (709)
Q Consensus 495 y~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~DFGla~~ 566 (709)
|+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++ .+||+|||+++.
T Consensus 81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 999999999998766 6899999999999999999999 89999999999999999888 799999999986
Q ss_pred ccccccccceeccccCcccccccccccCC--CCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 567 LTLNQSKAIKKAIRGTKGYVASPEWFRNS--TITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 567 ~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~--~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
.... ....++..|+| ||++.+. .++.++||||||++++||++ |..|+......+... .+....
T Consensus 158 ~~~~------~~~~~~~~y~a-PE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~~~~ 223 (259)
T cd05037 158 VLSR------EERVERIPWIA-PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQDQH 223 (259)
T ss_pred cccc------cccccCCCccC-hhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHhcCC
Confidence 5431 33456778998 9999876 78999999999999999999 466775443221111 011000
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
. . . ......+.+++..||+.+|.+|||+.+|++.|+
T Consensus 224 ~--~-----~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 R--L-----P----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C--C-----C----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 0 001167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.25 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=192.4
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.||.+... .+++.+|||++.... ....+.+.+|+.++.+++|+||+++++++.++...++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNK---KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred ceEeeEecccCceEEEEEEEC---CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 455556777777777665544 467889999886432 223467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 494 KFLNNGTLASFLFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||++ ++|.+++... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9997 5888887643 35889999999999999999999 899999999999999999999999999999865433
Q ss_pred ccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC-------
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG------- 642 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g------- 642 (709)
... .....+++.|+| ||++.+. .++.++||||||++++||++|+.||......................
T Consensus 155 ~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 VRV--YTHEVVTLWYRA-PEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ccc--ccCCcccccccC-hHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 211 134467889998 9988754 57899999999999999999999997544321111000000000000
Q ss_pred --C----ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 643 --K----LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 643 --~----~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+ ......... .......+.++.+++.+||+.||++|||+++|++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 000000000 0001124567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=286.38 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=199.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.+.....+|.|+++.||.+... ..+..+++|++........+.+.+|+.+++.++|+|++++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK---STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC---CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3445567777888877665544 4678899998876555556778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
|+++++|.+++.. .++++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++..........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 9999999999877 57889999999999999999999 8899999999999999999999999999987654432211
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
....|++.|++ ||.+.+..++.++||||||++++||++|+.||........ ......+....+.
T Consensus 173 --~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-------~~~~~~~~~~~~~------ 236 (285)
T cd06648 173 --KSLVGTPYWMA-PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-------MKRIRDNLPPKLK------ 236 (285)
T ss_pred --ccccCCccccC-HHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-------HHHHHhcCCCCCc------
Confidence 34568999998 9999988899999999999999999999999865432211 1111111111110
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....+..+.+++.+||+.+|++||++.++++
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 01124567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=286.76 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=193.6
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC------eEEE
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ------NRLL 491 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~------~~~l 491 (709)
..+|.|+++.||.+........+..+|||.+... .....+++.+|++++++++||||+++++++.... ..++
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 3466777777765555544456789999988643 2334567899999999999999999999886432 2478
Q ss_pred EEeecCCCCHHHHHhhC------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 492 VYKFLNNGTLASFLFEN------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
++||+++++|..++... ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccccc
Confidence 99999999999887532 14688889999999999999999 8899999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
...............+++.|++ ||.+.+..++.++||||||+++|||++ |++||......+. ......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~-pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~~~ 233 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLA-LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI-------YNYLIKGNR 233 (273)
T ss_pred cccCCcceecCCCccCchhhcC-HhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH-------HHHHHcCCc
Confidence 7643322111123345677888 999999899999999999999999999 8888864432221 111112111
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.. .....+..+.+++.+|++.+|.+|||+.++++.|+++
T Consensus 234 ~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0123456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.28 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=205.6
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
...+|.|.|+.|+..+....+.+...||||.+...... ...+|.+|+.+|.+|+|+|+|+|+|+..+ ....+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 34566777776655555555567778999999765443 66899999999999999999999999987 78899999999
Q ss_pred CCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 498 NGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 498 ~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
.|||.+.|++.. .+-......++.|||.|+.||. .+++|||||.+.|+||...-.+||+||||.+-++..+....
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 999999998833 4777888899999999999999 99999999999999999999999999999999987776544
Q ss_pred eeccccCc-ccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 576 KKAIRGTK-GYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 576 ~~~~~Gt~-~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
....+--+ .|.| ||.+....++.++|||+|||+||||++ |..||........ .+.+|....
T Consensus 271 m~p~rkvPfAWCa-PEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI----------------L~~iD~~er 333 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCA-PESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI----------------LKNIDAGER 333 (1039)
T ss_pred ecCCCcCcccccC-HhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH----------------HHhcccccc
Confidence 34444444 3555 999999999999999999999999998 6689876654332 223444455
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...+..++++++++++.||..+|++|||+..+++
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 5557789999999999999999999999999974
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.17 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=200.6
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEE--cCCeEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCD--EGQNRLL 491 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~--~~~~~~l 491 (709)
|.....+|.|+++.||.+... .+++.+|+|.+... .....+++.+|++++++++|+|++++++++. .+...++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRK---SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred ceeeeeeccCCCeEEEEeeec---CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 445566788888888766555 46788999987532 3344567899999999999999999999875 3456789
Q ss_pred EEeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcC--CCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 492 VYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNC--SSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
+|||+++++|.+++... .++++.....++.|++.||.|||..+ +.+++|+||||+||+++.++.+||+|||+++
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999999998753 46899999999999999999999655 6789999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
......... ....|++.|++ ||.+.+..++.++|+||||+++++|++|+.||......+ ..+....+...
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~-pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~ 228 (265)
T cd08217 159 ILGHDSSFA--KTYVGTPYYMS-PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKIKEGKFR 228 (265)
T ss_pred cccCCcccc--cccccCCCccC-hhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHHHhcCCCC
Confidence 776543211 44578999998 999999889999999999999999999999997654222 11222222221
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
. .....+..+.+++.+|++.+|.+||++++|+++
T Consensus 229 ~---------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 R---------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C---------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 122345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.22 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=200.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc------chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF------QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
+|.....+|.|+++.||.+... .+++.+|+|.+.... ....+++++|+.++++++|+||+++++++.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV---KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEc---CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe
Confidence 3555666788888888765544 567889999876432 1234678999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQISDFGLAKLL 567 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~ 567 (709)
.++||||+++++|.+++.+..++++..+..++.||+.||.||| +.+++|+||||+||+++.++ .+||+|||++..+
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999999988788999999999999999999999 88999999999999998776 5999999999876
Q ss_pred cccccc--cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 568 TLNQSK--AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 568 ~~~~~~--~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
...... .......|+..|++ ||.+.+..++.++||||+|+++++|++|..||.......... ...+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~-PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~--- 227 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMA-PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIASAT--- 227 (268)
T ss_pred ccccccCCccccccccccceeC-HhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhccC---
Confidence 543211 11134578899998 999998889999999999999999999999986443211111 111111000
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....+......+.+++.+|++.+|.+||++.++++
T Consensus 228 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011123345677889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=280.61 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=204.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+|.....+|.|+++.||.+... .++..++||++..... ...+++.+|+.++.+++|+|++++++++......++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~---~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHK---PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4565666777777777666555 4688999999876543 45678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCC-CCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCS-SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++++|.+++.....++...+..++.|+++|+.||| + .+++|+||+|+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999999988788999999999999999999999 8 9999999999999999999999999999987754433
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
.. ....++..|++ ||.+.+..++.++|+||||+++|||++|+.|+..........+. ..........
T Consensus 156 ~~--~~~~~~~~y~~-pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~------ 222 (264)
T cd06623 156 QC--NTFVGTVTYMS-PERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QAICDGPPPS------ 222 (264)
T ss_pred cc--cceeecccccC-HhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HHHhcCCCCC------
Confidence 22 35678899998 99999999999999999999999999999999755321111111 1111111111
Q ss_pred cccCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 653 EAMNDIK-CVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 653 ~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.... .++.+.+++..|++.+|++||++.++++.
T Consensus 223 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 ---LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1112 56789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=283.27 Aligned_cols=247 Identities=26% Similarity=0.335 Sum_probs=196.5
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-----chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-----QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
|.....+|.|+++.||.+... .++..+++|.+.... .+..+++.+|+.++++++|+|++++++++.++...+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNL---DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLY 78 (258)
T ss_pred ccccceeeecCCceEEEEEEc---CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEE
Confidence 344455667777777554443 467889999875432 234578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+|+||+++++|.+++.+...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999999988777899999999999999999999 889999999999999999999999999999876443
Q ss_pred ccccceeccccCcccccccccccCCC-CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNST-ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~-~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
. ......|++.|++ ||.+.... ++.++|+||||+++++|++|+.||......... ...........
T Consensus 156 ~---~~~~~~~~~~y~~-pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~--- 222 (258)
T cd06632 156 S---FAKSFKGSPYWMA-PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKELPP--- 222 (258)
T ss_pred c---cccccCCCcceeC-HHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhcccCCC---
Confidence 3 1245678999998 99988776 899999999999999999999999654321111 11111011111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........+.+++.+|++.+|.+||+++++++
T Consensus 223 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11234567889999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=281.63 Aligned_cols=252 Identities=19% Similarity=0.229 Sum_probs=194.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-----chhHHHHHHHHHHHhccCcCceeEEEeEEEcC--
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-----QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG-- 486 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~-- 486 (709)
.+|.....+|.|+++.||.+... .++..||||.+.... ....+.+.+|+.++.+++|+||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA---DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc---CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 35666667777777777655444 567899999875321 12346788999999999999999999988763
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++||||+++++|.+++.....+++.....++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+++.
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 467899999999999999987777888999999999999999999 88999999999999999999999999999986
Q ss_pred ccccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 567 LTLNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 567 ~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
+...... .......|+..|+| ||.+.+..++.++||||||+++|||++|+.||........ .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~-- 226 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMS-PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQPT-- 226 (265)
T ss_pred cccccccccccccCCCCccccC-hhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHhcCCC--
Confidence 5432111 11134568899998 9999988899999999999999999999999964322111 011111100
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....+......+.+++..|+. +|++||+++++++.
T Consensus 227 -------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 -------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111133455677888888885 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=289.50 Aligned_cols=264 Identities=22% Similarity=0.260 Sum_probs=197.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+... ..++.+|+|++..... ...+.+.+|+++++.++|+||+++++++.++...++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEEC---CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 4555566777777777655443 4578899998764322 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||+++++|..+......+++..+..++.||+.||.||| +.+++|+||+|+||++++++.+||+|||+++.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999999988776667899999999999999999999 88999999999999999999999999999987644332
Q ss_pred ccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh--------cCC
Q 038905 573 KAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR--------NGK 643 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~g~ 643 (709)
. .....++..|+| ||++.+ ..++.++||||||++++||++|++||......+...........+. ...
T Consensus 156 ~--~~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 V--YTDYVATRWYRA-PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--cCcccceeeccC-cHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 134568889998 999875 4578899999999999999999999865443221111110000000 000
Q ss_pred c-cccccCccc-----ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 L-DDLVEGDME-----AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ~-~~l~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+ .....+... .......+..+.+++..||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 000000000 0011234677999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=285.03 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=199.1
Q ss_pred hhHhhhcccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEE
Q 038905 406 EDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCD 484 (709)
Q Consensus 406 ~~~~~~~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~ 484 (709)
++... +++|.....+|.|+++.||.+... .+++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++.
T Consensus 16 ~~~~~--~~~y~~~~~l~~g~~~~vy~~~~~---~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 16 SLGDP--TDTWEIIETIGKGTYGKVYKVTNK---KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred cCCCC--CCCeEEEEEeecCCCeEEEEEEEC---CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 34444 677888778888888888766655 567889999886532 2346788999999998 7999999999986
Q ss_pred cC-----CeEEEEEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC
Q 038905 485 EG-----QNRLLVYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555 (709)
Q Consensus 485 ~~-----~~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 555 (709)
.. ...++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence 53 358999999999999998863 346889999999999999999999 889999999999999999999
Q ss_pred eEEccccccccccccccccceeccccCcccccccccccCC-----CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh
Q 038905 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-----TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 630 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-----~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~ 630 (709)
+||+|||+++......... ....|+..|++ ||.+... .++.++|||||||++|||++|+.||.........
T Consensus 167 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~- 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRR--NTSVGTPFWMA-PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL- 242 (291)
T ss_pred EEEeecccchhcccccccc--cCccCCccccC-hhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-
Confidence 9999999998765332211 34568899998 9998643 3689999999999999999999998754322111
Q ss_pred HHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 631 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 631 ~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
. .+..+....+.+ .......+.+++.+|++.+|++||++.++++.
T Consensus 243 -----~-~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 -----F-KIPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----H-HHhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 111121111111 12234568999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=317.00 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=195.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEc--CCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE--GQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~--~~~ 488 (709)
..+|.....+|.|+|+.||.+... .....+|+|.+... .......+..|+.++.+++|||||++++++.+ ...
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk---~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHK---RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC---CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 456777778888888888877766 56788889887642 23345678999999999999999999998854 456
Q ss_pred EEEEEeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcC----CCCeEecCCCCCceeecC--------
Q 038905 489 RLLVYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNC----SSQIIHCDIKPQNILLDD-------- 552 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~----~~~iiH~Dlkp~NIll~~-------- 552 (709)
.+|||||+++++|..+|... ..+++..++.|+.||+.||.|||... ..+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999998753 46899999999999999999999432 146999999999999964
Q ss_pred ---------CCCeEEccccccccccccccccceeccccCcccccccccccC--CCCCcccchHHHHHHHHHHHhCCCCCC
Q 038905 553 ---------YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEIISCRKSFD 621 (709)
Q Consensus 553 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~ 621 (709)
...+||+|||+++.+..... .....||+.|+| ||++.+ ..++.++|||||||+||||++|..||.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmA-PEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWS-PELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccC-HHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 34589999999987654321 145679999999 999864 458899999999999999999999997
Q ss_pred ccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 622 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....... ....+..+. .+ . ....+..+.+|+..||+.+|.+||++.|+++
T Consensus 245 ~~~~~~q------li~~lk~~p--~l-----p---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANNFSQ------LISELKRGP--DL-----P---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCcHHH------HHHHHhcCC--CC-----C---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 5432211 111111111 00 0 1123467889999999999999999999984
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=278.49 Aligned_cols=247 Identities=22% Similarity=0.350 Sum_probs=197.8
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.||.+... ..+..+|||.+... .....+.+.+|++++++++|+|++++++.+..+...++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRK---ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred ceEEEEecccCceEEEEEEEc---CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 555667777777777666555 46888999987643 2334578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-CCeEEcccccccccccc
Q 038905 494 KFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-YNAQISDFGLAKLLTLN 570 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~~~~~ 570 (709)
||+++++|.+++.... .+++..+..++.+++.||.||| +.+++|+||||+||+++++ ..+||+|||+++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999997643 4788999999999999999999 8899999999999999865 45899999999876543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... ....|+..|+| ||.+.+..++.++||||||+++++|++|+.||......... .....+....+
T Consensus 156 ~~~---~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~--- 221 (256)
T cd08220 156 SKA---YTVVGTPCYIS-PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV-------LKIMSGTFAPI--- 221 (256)
T ss_pred ccc---cccccCCcccC-chhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH-------HHHHhcCCCCC---
Confidence 321 34568999999 99999988999999999999999999999998754332211 11111111111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.......+.+++..||+.+|.+|||++|+++.
T Consensus 222 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 ------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ------CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11245678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=283.49 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=195.3
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc----------cchhHHHHHHHHHHHhc-cCcCceeEEEeEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV----------FQDGEKEFKNEVVMIGQ-TYHKNLVRLLGFCD 484 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~nlv~l~~~~~ 484 (709)
|.....+|.|+++.||.+.... ...+.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKN--NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcC--CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 4444556777777776655442 24678999976422 22234567788888865 79999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcc
Q 038905 485 EGQNRLLVYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD 560 (709)
Q Consensus 485 ~~~~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 560 (709)
+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||. ..+++|+||||+||+++.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988743 2358889999999999999999992 25799999999999999999999999
Q ss_pred ccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh
Q 038905 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 640 (709)
Q Consensus 561 FGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 640 (709)
||++....... ......|+..|++ ||++.+..++.++||||||+++|||++|+.||......... ....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~-Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~-------~~~~ 226 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSC-PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA-------TKIV 226 (269)
T ss_pred ccceeeccccc---ccccccCcccCcC-hhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH-------HHHh
Confidence 99998765443 2245678999998 99999988999999999999999999999998654322111 1111
Q ss_pred cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 641 NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 641 ~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
.+....+. .......+.+++.+|++.||++||++.||..+|+
T Consensus 227 ~~~~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYEPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCCcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111111 1123467889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.46 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=192.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.|.....+|.|+++.||. +. ..+..+|+|++.... ..+.+.+|+.++.+++|+|++++++++... ..++|||
T Consensus 7 ~~~~~~~lg~g~~g~v~~-~~----~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQ-GE----YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HceeeeeeccCCCCceEe-cc----cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 455556667777777754 33 256779999886532 346789999999999999999999998654 5799999
Q ss_pred ecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 495 FLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 495 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999997654 4788899999999999999999 8999999999999999999999999999997643221
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.....+..|++ ||++.+..++.++|+||||++++||++ |+.||......+.. .....+....
T Consensus 155 ----~~~~~~~~y~~-pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~----- 217 (254)
T cd05083 155 ----DNSKLPVKWTA-PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKGYRME----- 217 (254)
T ss_pred ----CCCCCCceecC-HHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCCCCCC-----
Confidence 22334567998 999998899999999999999999998 89998654432211 1111111111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
.....+..+.+++.+|++.+|.+||+++++++.|+.
T Consensus 218 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 ----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=290.32 Aligned_cols=251 Identities=22% Similarity=0.219 Sum_probs=199.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc---hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ---DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..++.+|+|.+..... ...+.+.+|++++..++|+||+++++.+.++...++
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLK---GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEc---CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 4666667888888888776655 4678999998865432 245678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
||||+.+++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999998764 46889999999999999999999 88999999999999999999999999999875532
Q ss_pred cccc---------------------------cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 038905 570 NQSK---------------------------AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDI 622 (709)
Q Consensus 570 ~~~~---------------------------~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~ 622 (709)
.... .......|+..|++ ||++.+..++.++||||||+++|+|++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a-PE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA-PEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC-HHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 2110 01123578999998 9999998999999999999999999999999975
Q ss_pred cchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 038905 623 EMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT----MRKVSQ 687 (709)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~ev~~ 687 (709)
....... ....... .........+..+.+++.+|++.+|++||+ ++++++
T Consensus 235 ~~~~~~~-------~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRDETF-------SNILKKE--------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchHHHH-------HHHhcCC--------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 5432211 0011111 111111125678999999999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=285.86 Aligned_cols=244 Identities=24% Similarity=0.255 Sum_probs=199.7
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEc---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 4566667777888877766655 467889999876432 2344678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|.+++.....++...+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||+++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence 9999999999999988888999999999999999999999 8999999999999999999999999999998765431
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
....|++.|++ ||.+.+...+.++||||||+++++|++|+.||....... .......+...
T Consensus 156 -----~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------ 216 (290)
T cd05580 156 -----YTLCGTPEYLA-PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IYEKILEGKVR------ 216 (290)
T ss_pred -----CCCCCCccccC-hhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCcc------
Confidence 45678999999 999998889999999999999999999999997554221 11111122211
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
.+...+..+.+++.+||+.+|.+|+ +++++++
T Consensus 217 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 ----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0112356788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.98 Aligned_cols=247 Identities=21% Similarity=0.330 Sum_probs=197.7
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEE--ccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe--EEEEE
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKK--LDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN--RLLVY 493 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~--~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~--~~lV~ 493 (709)
..+|.|.|-+| |++... ..+..||=-. +.... ....++|..|+.+|+.|+|+|||+++.++.+... ..+|+
T Consensus 46 evLGrGafKtV-Yka~De--~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 46 EVLGRGAFKTV-YKAFDE--EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred hhcccccceee-eecccc--ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34555566555 565543 4555554322 12222 2344789999999999999999999999977655 67999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-CCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-YYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~ 572 (709)
|.|..|+|..|+.+.++.+.+....+++||++||.|||++ ..+|||||||.+||+++. .|.|||+|+|||+++.....
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999999999999999999999999999999999975 568999999999999975 58899999999998775442
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
..+.|||.||| ||++. ..|++.+|||||||.++||+|+..|+..... +..+++++..|.-..-+..
T Consensus 202 ----ksvIGTPEFMA-PEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~k-- 267 (632)
T KOG0584|consen 202 ----KSVIGTPEFMA-PEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSK-- 267 (632)
T ss_pred ----ceeccCccccC-hHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhc--
Confidence 45899999999 99999 7899999999999999999999999975432 2336777777765443332
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHcc
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEV 691 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~ 691 (709)
-....+.+||..||.. .++|||+.|+++ +|..
T Consensus 268 ------V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 268 ------VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred ------cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1235688999999999 999999999997 4544
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=281.70 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=194.9
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc------chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF------QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
|.....+|.|+++.||.+ .. .++..+|||.+.... ......+.+|++++++++|+||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~~-~~---~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCG-LT---NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI 77 (265)
T ss_pred ccccceEeccCCeEEEEE-EE---cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence 334455677777777554 33 357789999875321 12335688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++|+||+++++|.+++.+...+++..+..++.|++.||.||| +.+|+|+||||+||++++++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999999988778899999999999999999999 88999999999999999999999999999986532
Q ss_pred ccc----ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 570 NQS----KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 570 ~~~----~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
... ........|+..|++ ||++.+..++.++||||||++++||++|..||.......... ......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~-pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~ 228 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMA-PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGAHRGLMP 228 (265)
T ss_pred ccccccccccccccCCCccccC-hhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----HhhhccCCCC
Confidence 111 111134568999998 999999999999999999999999999999997543221110 0000001111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. ......+.+.+++.+||+.+|.+||++.++++
T Consensus 229 ~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 R---------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C---------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 11234567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=283.23 Aligned_cols=252 Identities=23% Similarity=0.270 Sum_probs=194.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEE-----cC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCD-----EG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~-----~~ 486 (709)
.++|.....+|.|+++.||.+... ..++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++. .+
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~---~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNK---KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEEC---CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 667777777888888877665554 467789999876532 2346788999999999 6999999999874 44
Q ss_pred CeEEEEEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 562 (709)
...++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCC
Confidence 678999999999999998753 235788889999999999999999 8899999999999999999999999999
Q ss_pred ccccccccccccceeccccCcccccccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN-----STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 637 (709)
+++.+...... .....|++.|+| ||++.. ..++.++|||||||++|||++|+.|+......... .
T Consensus 170 ~~~~~~~~~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~------~- 239 (286)
T cd06638 170 VSAQLTSTRLR--RNTSVGTPFWMA-PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL------F- 239 (286)
T ss_pred ceeecccCCCc--cccccCCCcccC-hhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH------h-
Confidence 99876433211 134579999999 999853 45788999999999999999999998754321110 0
Q ss_pred hhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 638 ~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....+....+.+ .......+.+++.+|++.+|++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 KIPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 011111111111 11234568899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=292.20 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=204.1
Q ss_pred eecCeeEEEEEEEEEEecC--CCceEEEEEEccc-ccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 421 LLGSSVFVNFTLVGVIQTS--TRTTVIVVKKLDR-VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~--~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
.+|.|-||.| |+|+.... ...-.||||..+. ...+..+.|..|..+|++++|||||+++|+|.+ ...++|||.++
T Consensus 396 ~iG~GqFGdV-y~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~ 473 (974)
T KOG4257|consen 396 LIGEGQFGDV-YKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAP 473 (974)
T ss_pred hhcCCcccce-eeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEeccc
Confidence 3444444455 77776543 2345588998876 345567889999999999999999999999976 56899999999
Q ss_pred CCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 498 NGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 498 ~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
-|.|..+|..+. .++......++.||+.||+||| +...|||||..+|||+...-.+||+|||+++.+..+.--..
T Consensus 474 ~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka- 549 (974)
T KOG4257|consen 474 LGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA- 549 (974)
T ss_pred chhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc-
Confidence 999999998765 6888999999999999999999 99999999999999999999999999999998876543322
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccccc
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 655 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~ 655 (709)
++..-...||| ||-+.-..++.++|||-|||.+|||++ |.+||..-. +.++.-.++...+..
T Consensus 550 S~~kLPIKWma-PESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----------------NsDVI~~iEnGeRlP 612 (974)
T KOG4257|consen 550 SRGKLPIKWMA-PESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----------------NSDVIGHIENGERLP 612 (974)
T ss_pred cccccceeecC-ccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc----------------ccceEEEecCCCCCC
Confidence 33334567998 999999999999999999999999986 889997543 233334445555566
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 656 NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 656 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.++.++..|..++-+||..+|.+||.+.++...|+.+
T Consensus 613 ~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 613 CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 6778999999999999999999999999998877653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.81 Aligned_cols=195 Identities=18% Similarity=0.303 Sum_probs=156.5
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEc--CCeEEEEEeecCC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE--GQNRLLVYKFLNN 498 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~--~~~~~lV~Ey~~~ 498 (709)
.+|.|+++.||.+.. ..+...+.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+.+
T Consensus 8 ~lG~G~~g~Vy~~~~-~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 8 KVGRGTYGHVYKAKR-KDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccCCCeEEEEEEE-ccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 467777777755543 334567889999986532 34567899999999999999999998854 4567899999865
Q ss_pred CCHHHHHhhC---------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee----cCCCCeEEccccccc
Q 038905 499 GTLASFLFEN---------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL----DDYYNAQISDFGLAK 565 (709)
Q Consensus 499 gsL~~~l~~~---------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla~ 565 (709)
+|..++... ..++...+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 787776532 24788889999999999999999 8899999999999999 466789999999998
Q ss_pred cccccccc-cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 038905 566 LLTLNQSK-AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIE 623 (709)
Q Consensus 566 ~~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~ 623 (709)
.+...... .......||+.|+| ||++.+ ..++.++||||+||+++||++|++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRA-PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccC-CHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 76543221 11245678999999 999876 45899999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=296.50 Aligned_cols=262 Identities=20% Similarity=0.224 Sum_probs=192.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG---- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~---- 486 (709)
.++|.....+|.|+++.||.+... .++..||||++..... ...+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDT---RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEEC---CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 356777777888888888766555 5678999999865322 2345678999999999999999999987543
Q ss_pred --CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 487 --QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 487 --~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
...++++|++ +++|..++. ...+++..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||++
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 4568999988 779988764 456899999999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HHHH-------H
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------A 635 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~~-------~ 635 (709)
+...... ....||+.|+| ||++.+ ..++.++|||||||++|||++|+.||......+... .... .
T Consensus 166 ~~~~~~~-----~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 166 RQADDEM-----TGYVATRWYRA-PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred eecCCCc-----CCccccccccC-chHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 8654322 45678999998 999877 568999999999999999999999997543221110 0000 0
Q ss_pred HHhhhcCCccccccC--cccc----cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 636 FDCYRNGKLDDLVEG--DMEA----MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 636 ~~~~~~g~~~~l~~~--~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
...+........+.. .... .........+.+++..|++.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 0000 0000123457899999999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=279.57 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=198.4
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.||.+... .+++.+++|.+..... ...+++.+|+.++++++|+||+++++++.+.+..++|+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNL---DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred ceeeeEeecCCCcEEEEEEEC---CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 445556677777777555444 4678899998865433 35678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+++++|.+++.+...+++..+..++.+++.||.||| +.+|+|+||||+||++++++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999999988777899999999999999999999 889999999999999999999999999999876543322
Q ss_pred cc--eeccccCcccccccccccCCC---CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 574 AI--KKAIRGTKGYVASPEWFRNST---ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 574 ~~--~~~~~Gt~~y~aaPE~~~~~~---~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.. .....+++.|++ ||++.+.. .+.++||||||++++||++|+.||......... .+. ...+....+
T Consensus 156 ~~~~~~~~~~~~~~~~-PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~~-~~~~~~~~~- 227 (264)
T cd06626 156 MGEEVQSLAGTPAYMA-PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MFH-VGAGHKPPI- 227 (264)
T ss_pred ccccccCCcCCcCccC-hhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HHH-HhcCCCCCC-
Confidence 11 124568889998 99998766 889999999999999999999999654321110 010 011111111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.........+.+++..|++.+|.+|||+.+++.
T Consensus 228 ------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 ------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011123567789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.06 Aligned_cols=247 Identities=26% Similarity=0.263 Sum_probs=204.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.+.|+..+.+|.|||++|+-.... .+++..|.|++++- ...++.-..+|-+||.+++.+.||.+--.++..+.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvr---aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVR---ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred ccceeeeEEEecccccceeEEEEe---cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 567888889999999999777666 57888888888642 344666788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
+||+..|.||+|.-+|...+ .+++.....++.+|+.||.+|| +++||.|||||+|||||+.|+++|+|+|||..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999998776 6999999999999999999999 999999999999999999999999999999988
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
...+.. +..+||.|||| ||++.+..|+...|+|||||+||||+.|+.||.......... .+.+...+
T Consensus 338 ~~g~~~---~~rvGT~GYMA-PEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evdrr~~~------ 404 (591)
T KOG0986|consen 338 PEGKPI---RGRVGTVGYMA-PEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVDRRTLE------ 404 (591)
T ss_pred CCCCcc---ccccCcccccC-HHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHHHHHhc------
Confidence 766544 44589999999 999999999999999999999999999999997543211110 01111110
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 682 (709)
. ...+....++++..+....|+.||++|.-.
T Consensus 405 --~--~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 405 --D--PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred --c--hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 0 112234567788888888999999999643
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=278.03 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=199.6
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+|.....+|.|+++.||.+... .++..+++|++.... ....+.+.+|+++++.++|+|++++++.+..++..++|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICL---PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEc---CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4555566777777777555444 467789999986432 235678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 494 KFLNNGTLASFLFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||+++++|.+++... ..+++.....++.|++.||.||| +.+++|+||||+||++++++.+||+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999999764 35889999999999999999999 899999999999999999999999999999876644
Q ss_pred ccc--cceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 571 QSK--AIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 571 ~~~--~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
... .......|+..|++ ||++... .++.++|+||||++++||++|+.||......+. . .+ ...+....+
T Consensus 156 ~~~~~~~~~~~~~~~~y~~-Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~----~~-~~~~~~~~~ 227 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMA-PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--L----ML-TLQNDPPSL 227 (267)
T ss_pred ccccccccccccCChhhcC-hHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--H----HH-HhcCCCCCc
Confidence 322 12244578999998 9998877 789999999999999999999999975433211 0 11 111111110
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. .......++.+.+++..|++.||++|||++++++
T Consensus 228 -~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 -ET---GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CC---ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0011245677899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.73 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=199.1
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
|.....+|.|+++.||.+... ..++.+++|.+.... ....+++.+|++++++++|+||+++++.+..+...++|+|
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHR---PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEc---CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 444455677777777666554 578889999886543 3455788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCC-CCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 495 FLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCS-SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 495 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|+++++|.+++... ..++......++.|++.||.||| + .+++|+||||+||++++++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999999876 67889999999999999999999 7 8999999999999999999999999999876643221
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
....|+..|++ ||++.+..++.++||||||+++++|++|+.||......... .... .+....+....+
T Consensus 157 ----~~~~~~~~y~~-PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~----- 224 (265)
T cd06605 157 ----KTFVGTSSYMA-PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFEL-LQYIVNEPPPRL----- 224 (265)
T ss_pred ----hcccCChhccC-HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHH-HHHHhcCCCCCC-----
Confidence 22678899998 99999999999999999999999999999999654321110 0111 111111111111
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.....+..+.+++..|++.+|++|||+.++++.
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 ---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011155678899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=284.10 Aligned_cols=249 Identities=19% Similarity=0.269 Sum_probs=193.6
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
|.....+|.|+++.||.+... ..+..+|+|.+... ......++.+|+.++++++|+||+++++.+......++|||
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHR---PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEc---CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 344445667777777655444 46788999987643 23345688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhC---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 495 FLNNGTLASFLFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 495 y~~~gsL~~~l~~~---~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|+++++|..++... ..+++..+..++.+++.||.|||+ +.+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999988763 368999999999999999999993 2489999999999999999999999999997654322
Q ss_pred cccceeccccCcccccccccccCC------CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNS------TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~------~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
. ....|++.|++ ||.+.+. .++.++|+|||||++|||++|+.||.......... .......+...
T Consensus 158 ~----~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~ 228 (286)
T cd06622 158 A----KTNIGCQSYMA-PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA----QLSAIVDGDPP 228 (286)
T ss_pred c----ccCCCccCccC-cchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH----HHHHHhhcCCC
Confidence 1 34568889998 9998544 35889999999999999999999996543221111 01111111111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. ........+.+++.+|++.+|++||++++++.
T Consensus 229 ~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 T---------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred C---------CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1 12235677889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=284.35 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=193.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEc------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDE------ 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~------ 485 (709)
...|.....+|.|+++.||.+... ..++.+|+|...... ....++..|+.++.++ +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEc---CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 455665566788888888766655 567889999876543 3456788999999998 69999999999853
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 486 GQNRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
....++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+|+||||+||++++++.++|+|||+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 467899999999999999997643 4778888999999999999999 88999999999999999999999999999
Q ss_pred cccccccccccceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
+......... .....|++.|+| ||++. ...++.++||||||+++|||++|..||.......... ..
T Consensus 168 ~~~~~~~~~~--~~~~~~~~~y~a-PE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~~ 238 (282)
T cd06636 168 SAQLDRTVGR--RNTFIGTPYWMA-PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------LI 238 (282)
T ss_pred hhhhhccccC--CCcccccccccC-HhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------hH
Confidence 8865432211 145678999998 99986 3467889999999999999999999996543221110 00
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...... .......+..+.+++..||+.||.+|||+.|+++
T Consensus 239 -~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 -PRNPPP--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hhCCCC--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000 0011234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=282.28 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=197.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQ---- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~---- 487 (709)
+++|.....+|.|+++.||.+... ..++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++.+..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHK---KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEEC---CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 677777777888888888766554 4577899998875433 457899999999999 6999999999997644
Q ss_pred --eEEEEEeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccc
Q 038905 488 --NRLLVYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 488 --~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence 489999999999999988652 46889999999999999999999 899999999999999999999999999
Q ss_pred cccccccccccccceeccccCcccccccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH
Q 038905 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN-----STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 636 (709)
Q Consensus 562 Gla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 636 (709)
|++......... .....|+..|+| ||++.. ..++.++||||||++++||++|+.||......... .
T Consensus 158 ~~~~~~~~~~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~ 228 (275)
T cd06608 158 GVSAQLDSTLGR--RNTFIGTPYWMA-PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL------F 228 (275)
T ss_pred ccceecccchhh--hcCccccccccC-HhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH------H
Confidence 999765433222 145678999999 998753 34788999999999999999999999643321111 1
Q ss_pred HhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 637 DCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 637 ~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. ...+.... ........+.+.+++.+||+.||++|||++++++
T Consensus 229 ~-~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 K-IPRNPPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred H-hhccCCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11111111 1112235678899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=280.47 Aligned_cols=255 Identities=25% Similarity=0.313 Sum_probs=197.6
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcC--CeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~~~l 491 (709)
+|.....+|.|+++.||.+... ..+..+|+|.+.... .....++.+|++++++++|+||+++++++.+. ...++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLK---NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEEC---CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 5666677788888888666655 467889999887532 23557799999999999999999999998643 46899
Q ss_pred EEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 492 VYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
||||+++++|.+++.. ...++......++.||+.||.||| ..+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 9999999999988753 235788899999999999999999 889999999999999999999999999998765
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchh--hHHhHHHHHHHhhhcCCcc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~g~~~ 645 (709)
..... ....++..|++ ||.+.+..++.++||||||+++|||++|..||...... .......+ .......
T Consensus 156 ~~~~~----~~~~~~~~y~~-pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~ 226 (287)
T cd06621 156 VNSLA----GTFTGTSFYMA-PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----IVNMPNP 226 (287)
T ss_pred ccccc----ccccCCccccC-HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----HhcCCch
Confidence 43221 34567888998 99999999999999999999999999999999765321 11111111 1111111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+.+. .......++.+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 227 ELKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11111 1111235678899999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=285.27 Aligned_cols=260 Identities=17% Similarity=0.220 Sum_probs=192.0
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.||.+... ..+..+|+|.+.... ......+.+|+.++++++|+|++++++++.+....++|+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~---~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred ceeEEEecccCCeEEEEEEEC---CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 455556777888877666555 467789999886432 223356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++ +|.+++.. ...+++.....++.||++||.||| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 99975 78777765 456899999999999999999999 88999999999999999999999999999986643322
Q ss_pred ccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC------cc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------LD 645 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~------~~ 645 (709)
. .....+++.|+| ||++.+. .++.++||||||+++|||++|..|+......+.. ...+.+...... ..
T Consensus 155 ~--~~~~~~~~~y~a-PE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 155 C--YSAEVVTLWYRP-PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred C--cCCCccccCCcC-hHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhh
Confidence 1 134567889998 9998765 4789999999999999999999886543321110 011111100000 00
Q ss_pred ccccCc----cc-----ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 646 DLVEGD----ME-----AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 646 ~l~~~~----~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+.+.. .. .......+..+.+++..||+.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 00 0011224567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=287.63 Aligned_cols=196 Identities=18% Similarity=0.304 Sum_probs=156.8
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEE--cCCeEEEEEeecC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCD--EGQNRLLVYKFLN 497 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~--~~~~~~lV~Ey~~ 497 (709)
..+|.|+++.||.+. ...+.....+|+|.+.... ....+.+|+.++++++||||+++++++. .+...++|+||+.
T Consensus 7 ~~lG~G~~g~Vy~~~-~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAK-RKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEE-ecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 346777777775554 4344567889999886542 3456789999999999999999999884 4567799999987
Q ss_pred CCCHHHHHhhC---------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee----cCCCCeEEcccccc
Q 038905 498 NGTLASFLFEN---------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL----DDYYNAQISDFGLA 564 (709)
Q Consensus 498 ~gsL~~~l~~~---------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla 564 (709)
+ +|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 777766421 24778889999999999999999 8899999999999999 56778999999999
Q ss_pred ccccccccc-cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 038905 565 KLLTLNQSK-AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIE 623 (709)
Q Consensus 565 ~~~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~ 623 (709)
+........ .......||+.|+| ||++.+ ..++.++|||||||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRA-PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccC-cHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543321 11245678999999 999876 45899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=291.50 Aligned_cols=266 Identities=21% Similarity=0.230 Sum_probs=200.8
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-c-----CceeEEEeEEEcCCe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-H-----KNLVRLLGFCDEGQN 488 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nlv~l~~~~~~~~~ 488 (709)
+|.....+|.|.||.|..+-.. .+++.||||++++.. .-..+...|+.+|..|+ | -|+|++++++...+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~---~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH---KTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEec---CCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 4556778888888866444443 789999999998753 34567788999999997 3 479999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC--CCeEEcccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY--YNAQISDFGLA 564 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~DFGla 564 (709)
.|||+|.++- +|.++|..+. .++...++.++.||+.||..|| ..+|||||||||||||.+. ..+||+|||.+
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999854 9999998775 5889999999999999999999 8999999999999999654 36999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH-----hh
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----CY 639 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~ 639 (709)
....... .+..-++.|.| ||++.+.+|+.+.||||||||+.||++|.+.|......+....+..+.. ++
T Consensus 339 c~~~q~v-----ytYiQSRfYRA-PEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 339 CFESQRV-----YTYIQSRFYRA-PEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccCCcc-----eeeeecccccc-chhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 8765432 35556788888 9999999999999999999999999999888877665443222211110 00
Q ss_pred hcC-CccccccC---------------------------------ccc------ccCCH-HHHHHHHHHHHhcccCCCCC
Q 038905 640 RNG-KLDDLVEG---------------------------------DME------AMNDI-KCVEKLVMVSIWCIQEDPSL 678 (709)
Q Consensus 640 ~~g-~~~~l~~~---------------------------------~~~------~~~~~-~~~~~l~~l~~~Cl~~dP~~ 678 (709)
..+ +.....+. ... ..... .....++++++.|++.||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 000 00000000 000 00011 34456799999999999999
Q ss_pred CCCHHHHHH--HHccccc
Q 038905 679 RPTMRKVSQ--MLEVVVE 694 (709)
Q Consensus 679 RPs~~ev~~--~L~~~~~ 694 (709)
|+|..|+++ .|.+...
T Consensus 493 R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 493 RITPAQALNHPFLTGTSL 510 (586)
T ss_pred cCCHHHHhcCcccccccc
Confidence 999999988 4554443
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=283.78 Aligned_cols=251 Identities=24% Similarity=0.284 Sum_probs=199.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+++.||.+... .++..+++|.+........+.+.+|+.++++++|||++++++++...+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDV---ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEc---CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 45565666777777777555433 457789999987555555678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+++++|.+++.+. .+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999999998653 5788899999999999999999 889999999999999999999999999998766543321
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
. ....|++.|++ ||.+....++.++|+||||+++|||++|+.||......+... .....+. ..
T Consensus 172 ~--~~~~~~~~y~~-PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~--------~~ 234 (293)
T cd06647 172 R--STMVGTPYWMA-PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT--------PE 234 (293)
T ss_pred c--ccccCChhhcC-chhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC--------CC
Confidence 1 34578899998 999988889999999999999999999999997543322110 0000110 01
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..........+.+++..||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122345678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=280.75 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=194.7
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccC---cCceeEEEeEEEcCCeEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTY---HKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~nlv~l~~~~~~~~~~~l 491 (709)
|+....+|.|+++.||.+... .++..+|+|.+... .....+++.+|+.++++++ |+|++++++++.++...++
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHV---PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhheeccCCceEEEEEEc---CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 344445677777777655554 56789999987643 2334567889999999986 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|.+++.. ..+++.....++.|++.||.||| +.+|+|+||+|+||++++++.++|+|||++..+....
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999999999865 47889999999999999999999 8899999999999999999999999999998775443
Q ss_pred cccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... ....|+..|+| ||++.+ ..++.++|+||||+++|+|++|..||......... ..........+
T Consensus 156 ~~~--~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~~~~~--- 222 (277)
T cd06917 156 SKR--STFVGTPYWMA-PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSKPPRL--- 222 (277)
T ss_pred ccc--ccccCCcceeC-HHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCCCCCC---
Confidence 221 44578999999 999875 45789999999999999999999999754322110 00011111111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
. .......+.+++..|++.||++||++.++++.
T Consensus 223 --~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 --E---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --C---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0 11145678899999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=282.83 Aligned_cols=263 Identities=16% Similarity=0.236 Sum_probs=192.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+... .+++.+|||.+...... ....+.+|++++++++|+||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSK---LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEc---CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 345666667777777777655443 46788999998643322 23567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+.+ +|.+++.+.. .+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9999985 8999887643 5788999999999999999999 889999999999999999999999999998754322
Q ss_pred ccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC---Cccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDD 646 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g---~~~~ 646 (709)
... .....++..|+| ||++.+ ..++.++||||||+++|||++|+.||........ ....+++..... ....
T Consensus 157 ~~~--~~~~~~~~~~~a-PE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 157 SKT--YSNEVVTLWYRP-PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred Ccc--ccccccccccCC-cHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhh
Confidence 211 123456888998 999875 4588999999999999999999999965442111 011111111100 0000
Q ss_pred -------------ccc-Cccc-ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 647 -------------LVE-GDME-AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 647 -------------l~~-~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... .... ..........+.+++..|++.+|++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000 0001111267789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-31 Score=272.00 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=201.8
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
|.....+|.|+++.||.+... .+++.+++|++........+++.+|++++++++|+|++++++++......++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHK---RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEEC---CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 344556777777777655544 46788999998776555678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 496 LNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 496 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
+++++|.+++... ..+++..+..++.|++.||.+|| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999999876 57899999999999999999999 89999999999999999999999999999987665432
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
.....|+..|++ ||.+.+..++.++|+||||+++++|++|+.|+........... ........+..
T Consensus 154 -~~~~~~~~~~~~-PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~----- 219 (253)
T cd05122 154 -RNTMVGTPYWMA-PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-------IATNGPPGLRN----- 219 (253)
T ss_pred -ccceecCCcccC-HHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-------HHhcCCCCcCc-----
Confidence 245678899998 9999988899999999999999999999999875532221110 00111111111
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.......+.+++..|++.||++|||+.++++.
T Consensus 220 --~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 --PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11125678999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=280.00 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=201.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+++|.....+|.|+++.||.+... ..+..+++|.+..... ..+.+.+|++++++++|+|++++++++......++|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDR---ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEc---cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 455665566777777777655443 4678899999876543 567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
+||+++++|.+++.... .+++..+..++.+++.||.||| +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999998876 7999999999999999999999 8999999999999999999999999999987654332
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. .....+++.|++ ||++.+..++.++|+||||+++|+|++|+.|+.......... .........+.
T Consensus 171 ~~--~~~~~~~~~y~~-PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~~~--- 237 (286)
T cd06614 171 SK--RNSVVGTPYWMA-PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-------LITTKGIPPLK--- 237 (286)
T ss_pred hh--hccccCCcccCC-HhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhcCCCCCc---
Confidence 21 134568889998 999998889999999999999999999999987543322111 01111111111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....+..+.+++.+|++.+|.+|||+.++++
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 ----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11224567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=279.78 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=194.8
Q ss_pred ceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 417 TRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 417 ~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
.....+|.|+++.||.+... ..+..+|||...... ....+.+.+|+.++.+++|+||+++++++.++...++||||
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDN---RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhheeEeecCCeEEEEEEEC---CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 33445667777777654333 467899999876432 23446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+++++|..++.. ..+++.....++.+++.|+.||| +.+++|+||||+||+++.++.++|+|||++..+......
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-- 157 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-- 157 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh--
Confidence 999999998864 46889999999999999999999 899999999999999999999999999999766433211
Q ss_pred eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccccc
Q 038905 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 655 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~ 655 (709)
.....|+..|++ ||.+.+..++.++|+|||||+++||++|..|+......... .....+....
T Consensus 158 ~~~~~~~~~y~~-PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~--------- 220 (277)
T cd06641 158 RNTFVGTPFWMA-PEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL-------FLIPKNNPPT--------- 220 (277)
T ss_pred hccccCCccccC-hhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH-------HHHhcCCCCC---------
Confidence 134578889998 99999888999999999999999999999998643321111 1111111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 656 NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 656 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.....+..+.+++.+|++.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122345678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-31 Score=272.32 Aligned_cols=251 Identities=25% Similarity=0.307 Sum_probs=202.2
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcC--CeEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QNRLL 491 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~~~l 491 (709)
|.....+|.|+++.||.+... .+++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+.+. ...++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDK---DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred ceeeeEeeecCceEEEEEEEC---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 455556777777777555444 4688899998865432 4567899999999999999999999999988 88999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|+||+++++|.+++.....+++..+..++.++++||.||| +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999999988778999999999999999999999 8899999999999999999999999999998776554
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.........++..|++ ||.+.....+.++||||||+++++|++|..||....... ...+.....+....
T Consensus 156 ~~~~~~~~~~~~~y~~-pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~----- 224 (260)
T cd06606 156 TGEGTGSVRGTPYWMA-PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIGSSGEPPE----- 224 (260)
T ss_pred ccccccCCCCCccccC-HhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhccccCCCcC-----
Confidence 3111245678899998 999998889999999999999999999999997654111 11111111111111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+...+..+.+++.+|++.+|.+||++.++++
T Consensus 225 ----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 ----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 12233678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=285.27 Aligned_cols=250 Identities=21% Similarity=0.257 Sum_probs=194.9
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
|.....+|.|+++.||.+... .++..+|+|++.... .+...++.+|++++++++|+|++++++++.++...++|
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDV---RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhheeccCCCeEEEEEEEc---CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 555566788888877666554 467889999886432 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+.+ +|.+.+.. ...+++..+..++.+++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 999975 77666654 456899999999999999999999 889999999999999999999999999998754321
Q ss_pred cccceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
....|++.|++ ||++. ...++.++|||||||+++||++|+.||......... . .+..+...
T Consensus 179 -----~~~~~~~~y~a-PE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~-~~~~~~~~--- 242 (317)
T cd06635 179 -----NSFVGTPYWMA-PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------Y-HIAQNESP--- 242 (317)
T ss_pred -----ccccCCccccC-hhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH------H-HHHhccCC---
Confidence 34568899998 99974 456889999999999999999999998654322111 1 11111110
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..........+.+++.+|++.+|.+||++.++++.+-....
T Consensus 243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 01122345678999999999999999999999986654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=269.68 Aligned_cols=254 Identities=23% Similarity=0.296 Sum_probs=205.2
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEeecCCC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFLNNG 499 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~Ey~~~g 499 (709)
.+|.|.++.|--...+ .++..+|||++++.......++.+|++++.+.+ |+||++|+++|+++...|||||-|.||
T Consensus 85 ~LGeGAyasVqtcv~i---~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSI---QTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HhcCccceeeeeeeee---ccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 4667777765555555 578889999999888888899999999999986 999999999999999999999999999
Q ss_pred CHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC---eEEccccccccccccccc---
Q 038905 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN---AQISDFGLAKLLTLNQSK--- 573 (709)
Q Consensus 500 sL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFGla~~~~~~~~~--- 573 (709)
+|..+|.++..+++.+..++..+|+.||.+|| .++|.||||||+|||..+-.. +||+||.|+.-+..+...
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 99999999999999999999999999999999 999999999999999965443 899999998655433222
Q ss_pred --cceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhh--------HHhHHHHHHHh
Q 038905 574 --AIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--------YAILTDWAFDC 638 (709)
Q Consensus 574 --~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~--------~~~~~~~~~~~ 638 (709)
....+.+|+..||| ||+.. ...|+.+.|.||||||||-|++|.+||.....++ -..-....++.
T Consensus 239 stP~L~tPvGSAEfMA-PEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMA-PEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCccccCcccchhhcc-hhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 11246889999999 99863 3458999999999999999999999998765422 11122334455
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+.+|+.+. .|.. -...+....+++...+..++.+|.++.+++.
T Consensus 318 IQEGkYeF-Pdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKYEF-PDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCCcC-Chhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 55665542 1111 2246677888888899999999999999877
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-32 Score=284.02 Aligned_cols=245 Identities=21% Similarity=0.252 Sum_probs=192.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.|.....+|.|+++.||.+... ..++.||+|.+... ..+..+++.+|+.+++.++|||++++++++.+....++
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDV---RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEc---CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 4555566777777777666554 46788999987532 22344678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|+||+.+ +|.+++.. ...+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.+||+|||++......
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9999975 66666653 446899999999999999999999 889999999999999999999999999998765322
Q ss_pred ccccceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
....|++.|+| ||++. ...++.++||||||+++|||++|..|+......... ... .......
T Consensus 169 ------~~~~~~~~y~a-PE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~-~~~~~~~- 233 (307)
T cd06607 169 ------NSFVGTPYWMA-PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHI-AQNDSPT- 233 (307)
T ss_pred ------CCccCCccccC-ceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHH-hcCCCCC-
Confidence 34568889998 99874 456889999999999999999999998654322211 110 1111110
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
......+..+.+++..||+.+|++||++.++++.
T Consensus 234 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 -------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1122356679999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=280.57 Aligned_cols=248 Identities=20% Similarity=0.284 Sum_probs=189.8
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHH-HhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVM-IGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+... .++..||+|+++... .+...++..|+.+ ++.++|+|++++++++..+...++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHV---PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CceEEEEecccCCeEEEEEEEc---CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 5666667788888888766655 568999999886542 2344566667665 6667899999999999999999999
Q ss_pred EeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 493 YKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNCSS-QIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
|||++ ++|.+++... ..+++..+..++.||+.||.||| ++ +++||||||+||+++.++.+||+|||++..+
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99997 5888777542 35889999999999999999999 65 8999999999999999999999999999866
Q ss_pred cccccccceeccccCcccccccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRN----STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
..... .....|+..|+| ||.+.+ ..++.++|+||||+++|||++|+.||....... ..+ ... ..+.
T Consensus 155 ~~~~~---~~~~~~~~~y~a-PE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~----~~~-~~~~ 224 (283)
T cd06617 155 VDSVA---KTIDAGCKPYMA-PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQL----KQV-VEEP 224 (283)
T ss_pred ccccc---cccccCCccccC-hhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHH----HHH-HhcC
Confidence 43221 134568899998 998865 456889999999999999999999986432111 111 011 1111
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...+. ....++.+.+++..||+.+|.+||+++++++
T Consensus 225 ~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 SPQLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 1124567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=280.67 Aligned_cols=263 Identities=16% Similarity=0.194 Sum_probs=192.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+.+|.....+|.|+++.||.+... .++..+|+|.+.... ......+.+|+.++..++|+||+++++++.++...++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISR---INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEc---CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 456776677788888877655554 457789999886433 2233567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+. ++|.+++... ..+.+..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++.....
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 999996 5777666543 45778888899999999999999 889999999999999999999999999999765432
Q ss_pred ccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc---C----
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---G---- 642 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---g---- 642 (709)
... .....+++.|+| ||++.+. .++.++||||||++++||++|..||......... +. .++..+.. .
T Consensus 157 ~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~-~~-~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 157 SQT--YSSEVVTLWYRP-PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ-LE-KIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCC--CCCccccccccC-CceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH-HH-HHHHHcCCCChhhhhh
Confidence 211 134457899998 9998754 5788999999999999999999999755432111 10 01110000 0
Q ss_pred --Ccc----cccc---C-cc-cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 643 --KLD----DLVE---G-DM-EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 643 --~~~----~l~~---~-~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... .... + .. ...........+.+++.+|++.||.+|||++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 0000 0 00 00001112457789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=279.94 Aligned_cols=261 Identities=18% Similarity=0.194 Sum_probs=195.9
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.||.+... .++..+|+|++.... ....+.+.+|+.++++++|+||+++++++.++...++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDR---ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred ceEEeecccCCCcEEEEEEEC---CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 344455677777777655554 467889999986543 334568999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+ +++|.+++... ..+++..+..++.||++||.||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999 99999998754 46899999999999999999999 88999999999999999999999999999987754432
Q ss_pred ccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC---------
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG--------- 642 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g--------- 642 (709)
.. .....|+..|+| ||++.+. .++.++||||+|++++||++|.++|......+... .+...+...
T Consensus 155 ~~-~~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 RL-YSHQVATRWYRA-PELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA---IVFRTLGTPNEETWPGLT 229 (286)
T ss_pred Cc-cccccCcccccC-ceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH---HHHHHcCCCChHHHhhcc
Confidence 11 144578999998 9998654 46899999999999999999988776543322111 111110000
Q ss_pred ---CccccccCccc----ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 643 ---KLDDLVEGDME----AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 643 ---~~~~l~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
+...+...... .....+....+.+++.+|++.+|++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00112345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=280.89 Aligned_cols=262 Identities=20% Similarity=0.262 Sum_probs=193.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+... .+++.+|||++.... ......+.+|++++++++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC---CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 3666667788888888665544 467889999886432 22335789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+. ++|.+++... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+++.+...
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99996 5898888653 35889999999999999999999 889999999999999999999999999999866433
Q ss_pred ccccceeccccCcccccccccccCCC-CCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HHHH-------HHHh---
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNST-ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------AFDC--- 638 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~-~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~~-------~~~~--- 638 (709)
... .....+++.|+| ||++.+.. ++.++||||||+++|||++|+.||......+... .... .+..
T Consensus 154 ~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 154 VRT--YTHEVVTLWYRA-PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ccc--cccccccccccC-CeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 211 133457888998 99887644 6889999999999999999999997544321110 0000 0000
Q ss_pred hhc--CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRN--GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~--g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... ............. ........+.+++.+|++.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 0000000000000 01123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=278.93 Aligned_cols=242 Identities=23% Similarity=0.251 Sum_probs=186.5
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHH---hccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMI---GQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
+|.|+++.||.+... .+++.+|+|.+.... ......+.+|..++ ...+|+|++.+++++..++..++||||
T Consensus 2 lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 2 IGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred cccCCCeEEEEEEEC---CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 577777777666554 568899999875432 12223344554433 345799999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+++++|..++.....+++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+|||++........
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 999999999988888999999999999999999999 88999999999999999999999999999975543221
Q ss_pred eeccccCccccccccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 576 KKAIRGTKGYVASPEWFR-NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
....|+..|+| ||.+. +..++.++|||||||+++||++|..||........... ...... . ..
T Consensus 153 -~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~------~----~~ 216 (279)
T cd05633 153 -HASVGTHGYMA-PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------V----NV 216 (279)
T ss_pred -cCcCCCcCccC-HHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhhc------C----Cc
Confidence 34568999999 99986 45689999999999999999999999975432221111 110000 0 01
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 688 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 688 (709)
..+...+..+.+++..|++.||++|| |++++++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11223456788999999999999999 69999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=281.35 Aligned_cols=264 Identities=16% Similarity=0.165 Sum_probs=194.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC--CeE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QNR 489 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~~ 489 (709)
++|.....+|.|+++.||.+... .+++.+++|.++... ......+.+|+.++.+++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK---KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC---CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 45666666777777777665544 467889999886432 22234677899999999999999999998877 889
Q ss_pred EEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++||||+++ +|.+++.... .+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||+++.+.
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999999985 9998887654 5899999999999999999999 8899999999999999999999999999998766
Q ss_pred ccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHH-hHHHH-------HHHhh
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDW-------AFDCY 639 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~-------~~~~~ 639 (709)
...... ....+++.|+| ||.+.+. .++.++|+||||++++||++|..||......+.. ..... .+..+
T Consensus 158 ~~~~~~--~~~~~~~~~~a-PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 158 SPLKPY--TQLVVTLWYRA-PELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred CCcccc--ccccccccccC-chhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 542211 34567888998 9998764 4689999999999999999999999765432211 11000 00000
Q ss_pred hc------CCccccccCcccccCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 640 RN------GKLDDLVEGDMEAMNDIK-CVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 640 ~~------g~~~~l~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. ..........+....... ..+.+.+++..|++.+|++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 000000000111111111 3667889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=286.80 Aligned_cols=263 Identities=22% Similarity=0.249 Sum_probs=196.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG---- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~---- 486 (709)
...|.....+|.|+++.||.+... .+++.+|||.+... ......++.+|+.++++++|+||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDT---VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEEC---CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 356777777888888888766555 56889999998643 223446788899999999999999999988543
Q ss_pred --CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 487 --QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 487 --~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
...++||||+.+ +|...+... ++...+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 357999999965 888877654 888889999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhH-HhHH-----------
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILT----------- 632 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~-~~~~----------- 632 (709)
+....... .....|++.|+| ||.+.+..++.++|||||||++++|++|+.||........ ....
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~a-PE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRA-PEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred eeCCCCCC---CCCCcccccccC-HHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 87654322 134568899998 9999999999999999999999999999999975432111 0000
Q ss_pred ---HHHHHhhhcCC-------ccccccCcc----cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 633 ---DWAFDCYRNGK-------LDDLVEGDM----EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 633 ---~~~~~~~~~g~-------~~~l~~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
......+.... ...+..... ........+..+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 000110000 000012346678899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=277.71 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=197.6
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccccc---hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ---DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
+|.|+++.||.+... ..+..+++|.+..... ...+.+.+|++++.+++|+||+++++.+..+...++||||+++
T Consensus 1 lg~g~~~~vy~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKK---STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEEC---CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 356777777655544 4578899998865432 4557889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc-----
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK----- 573 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----- 573 (709)
++|.+++.+...+++..+..++.||+.||.||| ..+++|+||+|+||++++++.+||+|||++.........
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999999988778999999999999999999999 889999999999999999999999999998765433211
Q ss_pred -cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 574 -AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 574 -~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
.......++..|++ ||+......+.++||||||++++||++|..||......+. ......+....
T Consensus 155 ~~~~~~~~~~~~~~~-Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~------ 220 (265)
T cd05579 155 EKEDKRIVGTPDYIA-PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-------FQNILNGKIEW------ 220 (265)
T ss_pred cccccCcccCccccC-HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCcCC------
Confidence 11245678889998 9999988899999999999999999999999975543221 11111121110
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
......+..+.+++..|++.+|.+|||+.++.+.|+-
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 --PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred --CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0011135778999999999999999999777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-34 Score=277.35 Aligned_cols=248 Identities=19% Similarity=0.221 Sum_probs=207.8
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.|.....+|.|+++.||.+-+. ..++++|||+.... ....++..|+.|+.+...+++|+++|.+.....+++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~---EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHR---ESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHh---ccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3555556778888877666555 68999999998754 467899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 495 FLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 495 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||--||+.+.++-+ ..+.+.++..+++..++||.||| ...-||||||+.||||+-+|++||+|||.|-.+......
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999999999755 46999999999999999999999 778899999999999999999999999999887654433
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
. .++.|||.||| ||++..-.|..++||||||+...||..|++|+...++...... --..+...
T Consensus 186 R--NTVIGTPFWMA-PEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM--------------IPT~PPPT 248 (502)
T KOG0574|consen 186 R--NTVIGTPFWMA-PEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM--------------IPTKPPPT 248 (502)
T ss_pred h--CccccCccccc-HHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe--------------ccCCCCCC
Confidence 3 67899999999 9999999999999999999999999999999975543221100 00111222
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...+...+...-++++.||-.+|++|-|+-++++
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2235678889999999999999999999988876
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=277.87 Aligned_cols=248 Identities=23% Similarity=0.274 Sum_probs=200.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+|.....+|.|+++.||.+... ..+..+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR---DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc---cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEE
Confidence 3556667788888888766554 467889999886432 2346789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|+||+++++|..++.....++...+..++.|+++||.||| ..+++|+||||+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999999988778999999999999999999999 8899999999999999999999999999998765432
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
. .....|+..|++ ||.+.+..++.++|+||||+++|+|++|..||........... ...... .
T Consensus 155 ~---~~~~~~~~~y~~-PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~-~-------- 217 (258)
T cd05578 155 L---TTSTSGTPGYMA-PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET-A-------- 217 (258)
T ss_pred c---ccccCCChhhcC-HHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc-c--------
Confidence 1 145678889998 9999988899999999999999999999999986553211111 111110 0
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM--RKVS 686 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~ev~ 686 (709)
....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 -DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011122345788899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-34 Score=321.27 Aligned_cols=254 Identities=23% Similarity=0.305 Sum_probs=206.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
-++.+...+|+|.||.||.++.. .++...|+|-+... .....+.+.+|..++..++|||+|+++|+-.+.+..+|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~---~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNL---DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeeccccccCCcceeeeEEeecC---CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 44557788999999999888888 56777788766432 23455788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
.||||++|+|.+.+....-.++.....+..|++.|++||| +.|||||||||+||+|+.+|.+|++|||.|+.+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999999988777778888889999999999999 8999999999999999999999999999998876553
Q ss_pred cc--cceeccccCcccccccccccCCC---CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 572 SK--AIKKAIRGTKGYVASPEWFRNST---ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 572 ~~--~~~~~~~Gt~~y~aaPE~~~~~~---~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
.. .......|||-||| ||++.+.. -..++||||||||++||+||++||...+ .++..+. ++-.|....
T Consensus 1389 ~~~~~el~~~~GT~~YMA-PEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-ne~aIMy-----~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMA-PEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-NEWAIMY-----HVAAGHKPQ 1461 (1509)
T ss_pred hcCCHHHHhhcCCchhcC-chhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-chhHHHh-----HHhccCCCC
Confidence 11 11246889999999 99997654 4678999999999999999999996433 3332221 222344333
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 689 (709)
+. ...+..-.+++..|++.||++|.++.|+++.-
T Consensus 1462 ~P---------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1462 IP---------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred Cc---------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 32 23566778999999999999999998887653
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=286.26 Aligned_cols=250 Identities=20% Similarity=0.262 Sum_probs=196.2
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc--ccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR--VFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~ 490 (709)
..|.+...+|.||...||.+.. .+.+.+|+|+... ...+...-|.+|+..|.+|+ |.+||+|++|-..++.+|
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~----s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLN----SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred chhhHHHhhcCCCcceeeeeec----CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3455666788888888865543 4677888887643 23445678999999999996 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCC-CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLK-PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~-l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||=+ .+|.+.|.+... +..-.++.+..|++.|+.+.| ..+|||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 437 mvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 437 MVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9999864 499999987754 332378889999999999999 88999999999999886 47899999999999988
Q ss_pred cccccceeccccCcccccccccccCCC-----------CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNST-----------ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~-----------~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
+...-.....+||+.||+ ||.+.... ++.++|||||||+||+|+.|+.||.... ...
T Consensus 512 DTTsI~kdsQvGT~NYMs-PEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~------ 579 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMS-PEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI------ 579 (677)
T ss_pred cccceeeccccCcccccC-HHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH------
Confidence 877666678999999999 99986432 5689999999999999999999995221 110
Q ss_pred hhcCCccccccCcccccCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNGKLDDLVEGDMEAMNDI-KCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.++..+.++.-+..++. .....++++++.||+.||.+||++.++++
T Consensus 580 ---aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 ---AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12334455533222221 11122999999999999999999999987
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=274.20 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=196.0
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.||.+... .++..+|+|.+.... ....+.+.+|+.++++++|+|++++++.+.+....++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAK---SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred ceEEEEecCCCcceEEEEEEc---CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 555566777777777655554 467788999886431 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEcccccccccccc
Q 038905 494 KFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQISDFGLAKLLTLN 570 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~ 570 (709)
||+++++|.+++.+.. .+++..+..++.|+++||.||| +.+++|+||||+||++++++ .+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999997644 4789999999999999999999 88999999999999999885 4699999999876543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.... ....|++.|+| ||++.+..++.++|+||||++++||++|..||......+. ... ...+....+
T Consensus 156 ~~~~--~~~~~~~~~~a-pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~~--- 222 (257)
T cd08225 156 MELA--YTCVGTPYYLS-PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLK-ICQGYFAPI--- 222 (257)
T ss_pred cccc--cccCCCccccC-HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHH-HhcccCCCC---
Confidence 3221 34568899998 9999988899999999999999999999999865432221 111 111111111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.......+.+++.+|++.+|++|||++++++.
T Consensus 223 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=280.53 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=194.7
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~g 499 (709)
..+|.|+++.||.+... .++..+|||++........+.+.+|+.++++++|+|++++++++..++..++||||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVK---SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEc---CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 45677777766554444 578899999987555556678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceecc
Q 038905 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579 (709)
Q Consensus 500 sL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 579 (709)
+|.+++.. ..+++.....++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++......... ....
T Consensus 103 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 176 (292)
T cd06657 103 ALTDIVTH-TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSL 176 (292)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--cccc
Confidence 99997754 46889999999999999999999 889999999999999999999999999998765433221 1346
Q ss_pred ccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHH
Q 038905 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 659 (709)
Q Consensus 580 ~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~ 659 (709)
.|++.|++ ||++.+..++.++|+||||++++||++|..||......+... ....+... .... ...
T Consensus 177 ~~~~~y~~-pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-------~~~~~~~~-----~~~~--~~~ 241 (292)
T cd06657 177 VGTPYWMA-PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------MIRDNLPP-----KLKN--LHK 241 (292)
T ss_pred ccCccccC-HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhhCCc-----ccCC--ccc
Confidence 78999998 999988889999999999999999999999987543322111 11111000 0000 112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 660 CVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 660 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+..+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 3456788999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=275.74 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=194.9
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
+|.|+++.||.+... ..+..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.++...++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVK---SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEEC---CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 466777777666554 467889999876432 23457799999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceec
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 578 (709)
++|.+++.+...++...+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||+++...... ....
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999999988777899999999999999999999 8999999999999999999999999999998775432 1134
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCH
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~ 658 (709)
..|++.|++ ||.+.+..++.++|+||||+++|||++|..||.....+.... ......+. .....+.
T Consensus 152 ~~~~~~~~~-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~--------~~~~~~~ 217 (262)
T cd05572 152 FCGTPEYVA-PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI-----YNDILKGN--------GKLEFPN 217 (262)
T ss_pred ccCCcCccC-hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH-----HHHHhccC--------CCCCCCc
Confidence 578899998 999988889999999999999999999999997654211111 11111100 0111122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 659 KCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 659 ~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
..+..+.+++..||+.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 23678999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=277.81 Aligned_cols=258 Identities=20% Similarity=0.219 Sum_probs=193.5
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC--CeEEEEE
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QNRLLVY 493 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~~~lV~ 493 (709)
....+|.|+++.||.+... ..+..+|+|++.... ......+.+|+.++++++|+|++++++++.+. ...++|+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNK---KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred eeEEeccCCCeEEEEEEEC---CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 3445677777777655544 457889999987653 33446788999999999999999999999887 8899999
Q ss_pred eecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++ +|.+++... ..+++..+..++.||+.||.||| +.+++|+||||+||++++++.+||+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 99985 898888765 47899999999999999999999 88999999999999999999999999999987655432
Q ss_pred ccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc---C---Ccc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---G---KLD 645 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---g---~~~ 645 (709)
... ....++..|++ ||.+.+ ..++.++||||||++++||++|+.||........... ..+.... . ...
T Consensus 156 ~~~-~~~~~~~~y~~-PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 156 ADY-TNRVITLWYRP-PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK---IFELCGSPTDENWPGVS 230 (287)
T ss_pred ccc-cccccccccCC-ceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCchhhccccc
Confidence 111 34567888998 998765 4678999999999999999999999976543221111 1110000 0 000
Q ss_pred cc-----------ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 646 DL-----------VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 646 ~l-----------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+ ............++..+.+++..|++.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0000000001113678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=277.30 Aligned_cols=261 Identities=19% Similarity=0.270 Sum_probs=194.8
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+|.....+|.|+++.||.+... .++..+|||.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR---TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC---CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 3556666777888877655544 4688999998865432 23467789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 494 KFLNNGTLASFLFENL---KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||+++ +|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 99986 8888886543 5899999999999999999999 889999999999999999999999999999765433
Q ss_pred ccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HHHH-------HHHhhhc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------AFDCYRN 641 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~~-------~~~~~~~ 641 (709)
... .....+++.|++ ||++.+. .++.++||||||++++||++|+.||......+... .... .++.+.
T Consensus 154 ~~~--~~~~~~~~~y~~-PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 229 (284)
T cd07836 154 VNT--FSNEVVTLWYRA-PDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS- 229 (284)
T ss_pred ccc--cccccccccccC-hHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-
Confidence 211 134567889998 9998654 57899999999999999999999997654322111 1000 000011
Q ss_pred CCccccccCc------ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 GKLDDLVEGD------MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 g~~~~l~~~~------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....+.... .........+..+.+++..|++.||.+||+++++++
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 -QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred -cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 000011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=274.03 Aligned_cols=244 Identities=22% Similarity=0.250 Sum_probs=189.9
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHH-HhccCcCceeEEEeEEEcCCeEEEEEeec
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVM-IGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
.+|.|+++.||.+... ..++.+|||.+.... ......+..|..+ ....+|+|++++++++.+++..++|+||+
T Consensus 3 ~l~~g~~~~v~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 3 PISKGAFGSVYLAKKR---STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred cCCcCCCeeEEEEEec---CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 3566777777665554 467889999886432 1222344555544 44568999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 497 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
++++|.+++.....++...+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||+++.....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------ 150 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------ 150 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc------
Confidence 99999999988778899999999999999999999 889999999999999999999999999998765431
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
....|++.|++ ||.+.+..++.++||||||+++|||++|..||........ +.....+.... ....
T Consensus 151 ~~~~~~~~y~~-pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~------~~~~ 216 (260)
T cd05611 151 KKFVGTPDYLA-PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-------FDNILSRRINW------PEEV 216 (260)
T ss_pred ccCCCCcCccC-hhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcccCC------CCcc
Confidence 44568899998 9999988899999999999999999999999975543221 11111221110 0001
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
....+..+.+++.+||+.+|++||++.++.++|.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1134577899999999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=278.94 Aligned_cols=260 Identities=18% Similarity=0.210 Sum_probs=190.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCe---
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQN--- 488 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~--- 488 (709)
+|.....+|.|+++.||.+... .+++.||||+...... .....+.+|+.++++++ |+||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~---~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDK---NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CceEeeEecccCCeEEEEEEEC---CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 4666667788888877655544 5688999998765322 23467889999999995 6999999999987665
Q ss_pred --EEEEEeecCCCCHHHHHhhC-----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-CCCeEEcc
Q 038905 489 --RLLVYKFLNNGTLASFLFEN-----LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-YYNAQISD 560 (709)
Q Consensus 489 --~~lV~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~D 560 (709)
.++||||+++ +|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+||+++. ++.+||+|
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEee
Confidence 8999999986 888887643 24789999999999999999999 889999999999999998 89999999
Q ss_pred ccccccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 561 FGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
||+++.+....... ....+++.|+| ||++.+ ..++.++||||||+++|||++|..||......... .. +....
T Consensus 155 fg~~~~~~~~~~~~--~~~~~~~~~~a-PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~-~~~~~ 228 (295)
T cd07837 155 LGLGRAFSIPVKSY--THEIVTLWYRA-PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LH-IFKLL 228 (295)
T ss_pred cccceecCCCcccc--CCcccccCCCC-hHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH-HHHHh
Confidence 99998654332211 23356888998 998865 45799999999999999999999999754332211 00 11111
Q ss_pred hcCCcc------cccc--------CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 640 RNGKLD------DLVE--------GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 640 ~~g~~~------~l~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...... ...+ +.............+.+++..||+.+|.+||+++|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000 00000001235667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=282.83 Aligned_cols=260 Identities=21% Similarity=0.264 Sum_probs=192.2
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeec
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
.++.|.|+++.||.+... ..++.||+|...... ....+.+++|+.+++.++||||+++++++..++..++|+||+
T Consensus 5 ~ig~g~~~~~~v~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 5 EIGRGFCNLTSVYLARHT---PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HhCCcccCceeEEEEEEc---CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 355666788888777665 578999999976432 234467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 497 NNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 497 ~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
.+++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+|++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999999987643 4788888999999999999999 8899999999999999999999999998654332211110
Q ss_pred -----ceeccccCcccccccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH----------
Q 038905 575 -----IKKAIRGTKGYVASPEWFRNS--TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD---------- 637 (709)
Q Consensus 575 -----~~~~~~Gt~~y~aaPE~~~~~--~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~---------- 637 (709)
......++..|++ ||++.+. .++.++||||||++++||++|+.||.......... .....
T Consensus 159 ~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLS-PELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL--QKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccC-hhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH--HHhcCCCCCCccccc
Confidence 0011234567998 9999764 47899999999999999999999997543221110 00000
Q ss_pred ------hhhc----------------CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 638 ------CYRN----------------GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 638 ------~~~~----------------g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+.. +....+.+..............+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 0000011111111122346678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=286.79 Aligned_cols=269 Identities=20% Similarity=0.237 Sum_probs=200.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcC-----
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG----- 486 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~----- 486 (709)
++|.....+|.|+++.||.+... .+++.||||.+... ......++.+|+.++..++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNS---ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEec---CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45676777888888888766555 57889999988643 233456778899999999999999999988644
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++||||+. ++|.+++.....+++.....++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 35799999996 689999887778999999999999999999999 88999999999999999999999999999987
Q ss_pred ccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH--------
Q 038905 567 LTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-------- 637 (709)
Q Consensus 567 ~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------- 637 (709)
....... .....++..|+| ||.+.+ ..++.++||||||+++++|++|+.||.................
T Consensus 158 ~~~~~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEKGDF--MTEYVVTRWYRA-PELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCCccc--ccccccccCccC-hHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 6543211 134567889998 998865 4689999999999999999999999975432211111000000
Q ss_pred hhhcCCccccc-------cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hcccc
Q 038905 638 CYRNGKLDDLV-------EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEVVV 693 (709)
Q Consensus 638 ~~~~g~~~~l~-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~ 693 (709)
....+.....+ +.... ......+..+.+++.+||+.+|++|||++++++. ++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000000000 00000 0012345678999999999999999999999985 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-31 Score=270.23 Aligned_cols=248 Identities=24% Similarity=0.325 Sum_probs=202.1
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.||.+... .++..+++|++..... ...+++.+|++++++++|+|++++++.+..+...++|+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRK---SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEc---CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 455566778888877666654 4678999999875432 45678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 494 KFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
||+++++|.+++.+. ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 999999999999864 56899999999999999999999 88999999999999999999999999999987655
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ......|++.|++ ||...+..++.++|+||+|+++++|++|+.|+......+ ............+
T Consensus 156 ~~~--~~~~~~~~~~y~~-pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-- 223 (258)
T cd08215 156 TVD--LAKTVVGTPYYLS-PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-------LALKILKGQYPPI-- 223 (258)
T ss_pred Ccc--eecceeeeecccC-hhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-------HHHHHhcCCCCCC--
Confidence 431 1244678999998 999999899999999999999999999999986543222 1111122222111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.......+.+++.+|++.+|++|||+.++++.
T Consensus 224 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=279.20 Aligned_cols=259 Identities=20% Similarity=0.244 Sum_probs=191.8
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
....+|.|+++.||.+... .+++.+|+|++.... ....+.+.+|++++++++|+|++++++++.+++..++||||
T Consensus 3 ~~~~l~~g~~~~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDK---LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred hheEecCCCCeEEEEEEEc---CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 3445677777777655554 468899999886432 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 496 LNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 496 ~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
++ ++|.+++.... .+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.+||+|||+++.+......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 95 68999987765 6899999999999999999999 889999999999999999999999999999765433211
Q ss_pred cceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhH-HhHHHH-------HHHhh---hc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW-------AFDCY---RN 641 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~-------~~~~~---~~ 641 (709)
. ....+++.|+| ||++.+. .++.++||||||+++|||++|+.||........ ...... .+... .+
T Consensus 156 ~--~~~~~~~~~~a-PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 Y--THEVVTLWYRA-PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred c--CccccccCCCC-CceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1 33456888998 9988664 578999999999999999999999975543211 110000 00000 00
Q ss_pred --CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 --GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 --g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......... ........+..+.+++.+|++.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 00111234467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=278.03 Aligned_cols=261 Identities=16% Similarity=0.108 Sum_probs=184.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhH-----------HHHHHHHHHHhccCcCceeEEEeE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGE-----------KEFKNEVVMIGQTYHKNLVRLLGF 482 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nlv~l~~~ 482 (709)
+.|.....+|.|+|+.||.+.....+.....+|+|.......... .....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 456666777888888886665543222255667775433221111 112233445667789999999997
Q ss_pred EEcCC----eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEE
Q 038905 483 CDEGQ----NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558 (709)
Q Consensus 483 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 558 (709)
+.... ..++++|++.. ++.+.+......++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEE
Confidence 65443 34678887644 66666655545678888999999999999999 889999999999999999999999
Q ss_pred ccccccccccccccc-----cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccch-hhHHhHH
Q 038905 559 SDFGLAKLLTLNQSK-----AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMG-EEYAILT 632 (709)
Q Consensus 559 ~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~-~~~~~~~ 632 (709)
+|||+|+.+...... .......||+.|+| ||.+.+..++.++|||||||+++||++|..||..... .......
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~a-pe~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAG-LDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccC-HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999999876432211 11134579999998 9999999999999999999999999999999976532 1111110
Q ss_pred H-HHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 633 D-WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 633 ~-~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
. -.......++.. ....+..+.+++..|++.+|++||+++++++.|+
T Consensus 247 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFIKRLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 011111222110 1123467889999999999999999999999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=276.33 Aligned_cols=241 Identities=24% Similarity=0.282 Sum_probs=196.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~ 489 (709)
-.|.....+|.|+|++|.++... .+....|||++++. ..+..+--+.|-++|+.. +-|.+|+++.+++.-+.+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerk---gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERK---GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred cccceEEEeccCccceeeeeccc---CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34666677788888877776666 56777888887643 233344456777777776 467899999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
|+||||+.||+|.-+|..-+++.+.....++.+||-||-+|| +++||.||||.+|||||.+|++||+|||+++.--.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999999985433
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
+. ..+.+++|||.|+| ||++.-++|+..+|+|||||+||||+.|++||+.+++++.. +.+.+.+
T Consensus 503 ~~--~TTkTFCGTPdYiA-PEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF-------~aI~ehn------ 566 (683)
T KOG0696|consen 503 DG--VTTKTFCGTPDYIA-PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------QAIMEHN------ 566 (683)
T ss_pred CC--cceeeecCCCcccc-cceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHHcc------
Confidence 22 33478999999999 99999999999999999999999999999999988765522 2222211
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCC
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 680 (709)
..++...+.+...+....+...|.+|.
T Consensus 567 ----vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ----VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 223445666777788888999999995
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=276.18 Aligned_cols=243 Identities=27% Similarity=0.288 Sum_probs=190.9
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
+|.|+++.||.+... ..++.+|+|.+.... ......+.+|++++++++|||++++++.+...+..++||||+++
T Consensus 1 lg~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVK---ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEc---CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 467778888766554 467889999875421 22345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 499 GTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 499 gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
++|.+++.+.. .+++..+..++.|++.||.||| +.+++|+||||+||++++++.+||+|||++.........
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--- 151 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--- 151 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---
Confidence 99999998765 6889999999999999999999 889999999999999999999999999999866432211
Q ss_pred eccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 577 KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
....++..|++ ||++.+..++.++||||||+++++|++|+.||.......... .+...... . ....
T Consensus 152 ~~~~~~~~y~~-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~--------~--~~~~ 217 (277)
T cd05577 152 KGRAGTPGYMA-PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTLE--------M--AVEY 217 (277)
T ss_pred ccccCCCCcCC-HHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhcccc--------c--cccC
Confidence 34567889998 999988889999999999999999999999996543211000 00110000 0 0111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
....+..+.+++..||+.+|.+|| ++.++++
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 223466788999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=281.88 Aligned_cols=257 Identities=16% Similarity=0.192 Sum_probs=190.4
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
.+.|+|+++ ++.... .+++.+|||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 8 ~~~~~~~~v---~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 8 KCFEDLMIV---HLAKHK--PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred HhhcCCceE---EEEEec--CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 344556665 332222 36889999998654 34455789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc--
Q 038905 498 NGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK-- 573 (709)
Q Consensus 498 ~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-- 573 (709)
+++|.+++.+. ..+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+..+......
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999864 35788889999999999999999 889999999999999999999999999998755322211
Q ss_pred ---cceeccccCcccccccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh----hh----
Q 038905 574 ---AIKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC----YR---- 640 (709)
Q Consensus 574 ---~~~~~~~Gt~~y~aaPE~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----~~---- 640 (709)
.......++..|+| ||++.. ..++.++|+||||++++||++|..||........ ........ +.
T Consensus 160 ~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 160 VVHDFPKSSVKNLPWLS-PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccccC-HHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCch
Confidence 11134557788998 999876 3588999999999999999999999975432211 00000000 00
Q ss_pred ---cCCccc----cccC----cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 641 ---NGKLDD----LVEG----DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 641 ---~g~~~~----l~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...... ..+. .............+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 0000 0111122345567899999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=273.19 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=199.9
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.||.+... .++..+++|.+... ......++.+|++++++++|+||+++++++.+....++||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRL---SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred ceEeeeecCCCceeEEEEEEC---CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 455556777777777766555 56788999988643 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 494 KFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 494 Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
||+++++|.+++.+ ...+++..+..++.+++.||.||| +.+++|+||||+||++++++.+||+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999999999876 345888999999999999999999 89999999999999999999999999999987755
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ....|++.|++ ||++.+..++.++|+||||++++||++|+.||......+.. .....+....+
T Consensus 156 ~~~----~~~~~~~~~~~-Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~-- 221 (256)
T cd08530 156 NMA----KTQIGTPHYMA-PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------YKVQRGKYPPI-- 221 (256)
T ss_pred CCc----ccccCCccccC-HHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCCCCC--
Confidence 421 34568889998 99999999999999999999999999999999755432211 11122222111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.......+.+++..|++.+|.+||++.++++.
T Consensus 222 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 -------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 22456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=268.64 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=199.7
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.+|.+... ..++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.++...++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNL---ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEc---CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 445566777777777655444 4677899999876543 45578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+++++|.+++.....+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999999988788999999999999999999999 899999999999999999999999999999876544322
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
.....|+..|++ ||...+..++.++||||+|+++++|++|+.|+......... +.. .......
T Consensus 156 --~~~~~~~~~y~~-pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~------~~~-~~~~~~~------- 218 (254)
T cd06627 156 --DASVVGTPYWMA-PEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL------FRI-VQDDHPP------- 218 (254)
T ss_pred --ccccccchhhcC-HhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHH-hccCCCC-------
Confidence 134568899998 99998888999999999999999999999998654321110 111 1111111
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....++.+.+++.+|++.+|++|||+.+++.
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 --LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11223567889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=277.49 Aligned_cols=259 Identities=21% Similarity=0.236 Sum_probs=201.0
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc----chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF----QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~ 490 (709)
|.....+|.|+++.||.+.......++..+|||.+.... ....+.+.+|+.++.++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 455566788888888776655444567889999876432 22345788999999999 5999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||+++++|.+++.....+++.....++.|+++||.||| +.+++||||||+||+++.++.++|+|||+++.+...
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999987777899999999999999999999 889999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccCCC--CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNST--ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~--~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.... .....|+..|++ ||.+.+.. .+.++||||||++++||++|..||....... .......... ...
T Consensus 159 ~~~~-~~~~~~~~~y~a-PE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~-~~~----- 228 (288)
T cd05583 159 EEER-AYSFCGTIEYMA-PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRIL-KSK----- 228 (288)
T ss_pred cccc-cccccCCccccC-HHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHH-ccC-----
Confidence 3221 134568999998 99987655 7889999999999999999999986432111 0001111111 110
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
. ..+......+.+++.+||+.+|++|||+.++.+.|+-.
T Consensus 229 -~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 -P----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -C----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 01122345678999999999999999999998887663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=277.66 Aligned_cols=253 Identities=20% Similarity=0.281 Sum_probs=191.7
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+... ..+..+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHK---PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEEC---CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 3444456778888877665554 567899999886432 235567899999999996 99999999999999999999
Q ss_pred EeecCCCCHHHHH---h--hCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 493 YKFLNNGTLASFL---F--ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 493 ~Ey~~~gsL~~~l---~--~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
|||+.. +|.++. . ....+++.....++.+++.||.|||+ +.+++||||||+||+++.++.+||+|||+++.+
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 999864 554432 2 23468899999999999999999993 248999999999999999999999999999766
Q ss_pred cccccccceeccccCcccccccccccCC---CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNS---TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~---~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
...... ....|+..|+| ||++.+. .++.++||||||++++||++|+.||..... . .....+ ...+..
T Consensus 159 ~~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~----~~~~~~-~~~~~~ 228 (288)
T cd06616 159 VDSIAK---TRDAGCRPYMA-PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-V----FDQLTQ-VVKGDP 228 (288)
T ss_pred ccCCcc---ccccCccCccC-HHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-H----HHHHhh-hcCCCC
Confidence 433222 34568899998 9999876 689999999999999999999999864431 0 011111 111111
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.. +........+..+.+++.+|++.+|++|||+++|++.
T Consensus 229 ~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PI-----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred Cc-----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1111123456789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=280.49 Aligned_cols=266 Identities=19% Similarity=0.230 Sum_probs=191.3
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcC--CeEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QNRL 490 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~~~ 490 (709)
|.....+|.|+++.||.+... ....+..+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRK-NGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEec-CCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 444455777777777555544 21268899999987632 33446788999999999999999999999888 8899
Q ss_pred EEEeecCCCCHHHHHhhC-----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC----CCCeEEccc
Q 038905 491 LVYKFLNNGTLASFLFEN-----LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD----YYNAQISDF 561 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DF 561 (709)
+||||+++ +|.+++... ..++...+..++.||+.||.||| +.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 666666432 25788899999999999999999 889999999999999999 999999999
Q ss_pred cccccccccccc-cceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhh-------HHhHH
Q 038905 562 GLAKLLTLNQSK-AIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEE-------YAILT 632 (709)
Q Consensus 562 Gla~~~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~-------~~~~~ 632 (709)
|+++.+...... .......+++.|+| ||.+.+. .++.++||||||++++||++|+.||....... ...+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRA-PELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred ccccccCCCcccccccCCccccccccC-HHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999876543321 11134578899998 9988764 58899999999999999999999997544321 00000
Q ss_pred HHHHHhhhc------------CCccccccC---------cccccCC--HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 633 DWAFDCYRN------------GKLDDLVEG---------DMEAMND--IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 633 ~~~~~~~~~------------g~~~~l~~~---------~~~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.+...+.. .......+. .+..... ......+.+++.+|++.||++|||+.|+++.
T Consensus 236 -~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 -RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred -HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00110000 000000000 0000000 0234578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=300.08 Aligned_cols=267 Identities=17% Similarity=0.229 Sum_probs=184.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEE------------------EEEEcccccchhHHHHHHHHHHHhccCcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVI------------------VVKKLDRVFQDGEKEFKNEVVMIGQTYHK 474 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~v------------------avK~~~~~~~~~~~~~~~E~~~l~~l~h~ 474 (709)
..+|.....+|.|+|++||.+..... ....+ +.|++.. ......++.+|+.++.+++|+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRAS--TEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEecc--chhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 35677778889999998876543311 11111 1122211 123456789999999999999
Q ss_pred ceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCC-----CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcee
Q 038905 475 NLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENL-----KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549 (709)
Q Consensus 475 nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIl 549 (709)
|||++++++.+.+..++|+|++.+ +|..++.... .........++.||+.||.||| +++||||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 999999999999999999999854 7777765432 2335567789999999999999 889999999999999
Q ss_pred ecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCC-CCccchhhH
Q 038905 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS-FDIEMGEEY 628 (709)
Q Consensus 550 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p-~~~~~~~~~ 628 (709)
++.++.+||+|||+++.+....... .....||+.|+| ||++.+..++.++|||||||++|||++|..+ +........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNS-PEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCC-chhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 9999999999999998775433221 135679999998 9999999999999999999999999998754 432221111
Q ss_pred HhHHHHHH-----------------HhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 629 AILTDWAF-----------------DCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 629 ~~~~~~~~-----------------~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..+...+. ..+....+...................+.+++.+||+.||.+|||+.|+++.
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111110 0000000000000000000001123456778999999999999999999873
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=276.16 Aligned_cols=260 Identities=21% Similarity=0.247 Sum_probs=190.5
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+... .+++.+|+|++.... ....+.+.+|++++++++|+||+++++++.++...++|
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDR---VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEec---CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4666666777777777555443 467889999886432 22346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-CCCeEEccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLK--PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-YYNAQISDFGLAKLLTL 569 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~ 569 (709)
|||+++ +|.+++..... +++.....++.||+.||.||| +++++|+||||+||+++. ++.+||+|||++.....
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 999964 78887765443 577788899999999999999 889999999999999985 55799999999976543
Q ss_pred cccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC-----
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK----- 643 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~----- 643 (709)
.... .....+++.|++ ||++.+ ..++.++||||||+++|+|++|+.||......+.... .........
T Consensus 156 ~~~~--~~~~~~~~~y~~-PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (294)
T PLN00009 156 PVRT--FTHEVVTLWYRA-PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK---IFRILGTPNEETWP 229 (294)
T ss_pred Cccc--cccCceeecccC-HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChhhcc
Confidence 3211 134467889998 998866 4578999999999999999999999975543221110 111110000
Q ss_pred -ccccccC---------cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 -LDDLVEG---------DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 -~~~l~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...+.+. ..........++.+.+++.+|++.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0000011234567889999999999999999999986
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=278.60 Aligned_cols=267 Identities=17% Similarity=0.209 Sum_probs=193.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--- 487 (709)
..+|.....+|.|+++.||.+... .++..+|||++.... ......+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHK---KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEEC---CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 456777777888888888666554 468899999875432 222345678999999999999999999987654
Q ss_pred -----eEEEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccc
Q 038905 488 -----NRLLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 488 -----~~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
..++||||+.+ +|...+.... .+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcC
Confidence 35999999975 7888776543 6899999999999999999999 889999999999999999999999999
Q ss_pred cccccccccccc--cceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 562 GLAKLLTLNQSK--AIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 562 Gla~~~~~~~~~--~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|++..+...... .......++..|+| ||++.+. .++.++||||||+++|||++|+.||..............+...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRP-PELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccC-cHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999866443221 11134567888998 9988664 4788999999999999999999999765433222111111110
Q ss_pred hhcCCccc-----cc------cCc---cc-ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNGKLDD-----LV------EGD---ME-AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g~~~~-----l~------~~~---~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........ .. ... .. ..........+.+++.+||+.||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000 00 000 00 0000112456779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=279.00 Aligned_cols=266 Identities=21% Similarity=0.206 Sum_probs=193.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC--Ce
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~ 488 (709)
..+|.....+|.|+++.||.+... .++..||+|++.... ......+.+|+.++.+++|+|++++++++.+. +.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDT---TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEEC---CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 566777777788888877665544 567889999886432 12234567899999999999999999998755 56
Q ss_pred EEEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
.++||||+.+ +|.+++... ..+++..+..++.||+.||.||| +.+++||||||+||++++++.+||+|||+++..
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 8999999975 788887753 46899999999999999999999 889999999999999999999999999999877
Q ss_pred cccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH--------HHh
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDC 638 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~ 638 (709)
....... ....+++.|+| ||.+.+ ..++.++||||||+++|||++|+.||......+........ +..
T Consensus 159 ~~~~~~~--~~~~~~~~y~a-PE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 159 GLPAKPM--TPKVVTLWYRA-PELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CCccCCC--CcccccccccC-hhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 5432111 33345788998 999865 56899999999999999999999999765443221111000 000
Q ss_pred hhcCCc-ccc-cc-Cccc--ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 639 YRNGKL-DDL-VE-GDME--AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 639 ~~~g~~-~~l-~~-~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
+..... ... +. .... ..........+.+++..|++.||++|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 000 00 0000 00001135667899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=264.66 Aligned_cols=244 Identities=20% Similarity=0.186 Sum_probs=188.1
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEc----CCeEEEEE
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDE----GQNRLLVY 493 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~----~~~~~lV~ 493 (709)
.+|+|-.|.| ....+. .+++..|+|++.. ....++|+++--.. .|+|||.+++++.+ ...+++||
T Consensus 69 vLG~GinGkV--~~C~~k---~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 69 VLGAGINGKV--VQCVHK---RTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred hhccccCCce--EEEEec---cchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 4455555544 333333 5677889998753 23567899876555 59999999998853 45578999
Q ss_pred eecCCCCHHHHHhhCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC---CCCeEEcccccccccc
Q 038905 494 KFLNNGTLASFLFENLK--PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---YYNAQISDFGLAKLLT 568 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~ 568 (709)
|.|+||.|.+.+.+++. +++++...|..||+.|+.||| +.+|.||||||+|+|... +-.+||+|||+|+.-.
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 99999999999998875 999999999999999999999 999999999999999964 5569999999998654
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.... ..+.+-||.|.| ||++....|+...|+||+||++|-|++|.+||......- +.--+.+.++.|....
T Consensus 216 ~~~~---L~TPc~TPyYva-Pevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy~F-- 286 (400)
T KOG0604|consen 216 EPGD---LMTPCFTPYYVA-PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQYEF-- 286 (400)
T ss_pred CCcc---ccCCcccccccC-HHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCccC--
Confidence 3222 267889999998 999999999999999999999999999999998665311 0001122233333221
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....-...++...++++.+|..+|.+|.|++++...
T Consensus 287 ----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 ----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 111123467789999999999999999999999763
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=270.42 Aligned_cols=250 Identities=20% Similarity=0.211 Sum_probs=194.6
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-----cchhHHHHHHHHHHHhccCcCceeEEEeEEEcC--C
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-----FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--Q 487 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~ 487 (709)
+|.....+|.|+++.||.+... .++..+|+|.+... ..+....+.+|++++++++|+||+++++++.+. .
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 79 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDA---DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEK 79 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEc---CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCC
Confidence 5666667777877777665544 56788999986421 223446789999999999999999999998664 4
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
..++|+||+++++|.+++.....+++.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++..
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 57899999999999999988777889999999999999999999 889999999999999999999999999999865
Q ss_pred ccccc-ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 568 TLNQS-KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 568 ~~~~~-~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
..... ........|+..|++ ||++.+..++.++|+||||++++||++|+.||........ +........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~--- 226 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMS-PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIATQPT--- 226 (264)
T ss_pred ccccccCccccccCCcccccC-HhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHHcCCC---
Confidence 43211 111134568999998 9999998899999999999999999999999964322111 111111111
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....+....+.+.+++..|++ +|..||+..+++.
T Consensus 227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111133455778999999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=285.13 Aligned_cols=267 Identities=19% Similarity=0.226 Sum_probs=193.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcC--C
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEG--Q 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~--~ 487 (709)
..+|.....+|.|+++.||.+... ..+..+|+|++... .......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR---RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc---CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 345665556677777777544433 45788999987542 223445678899999999 999999999998643 4
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
..++||||+++ +|..++... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 68999999974 999888765 7888899999999999999999 889999999999999999999999999999876
Q ss_pred cccccc---cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH-------
Q 038905 568 TLNQSK---AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF------- 636 (709)
Q Consensus 568 ~~~~~~---~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~------- 636 (709)
...... .......|++.|++ ||++.+ ..++.++||||||+++|||++|+.||......+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRA-PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccC-ceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543221 12244678999998 998765 467899999999999999999999997554322111000000
Q ss_pred -HhhhcCCcccccc----Ccc--cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 637 -DCYRNGKLDDLVE----GDM--EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 637 -~~~~~g~~~~l~~----~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..+.......+++ ... ........+..+.+++.+|++.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000110 000 000011246678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=272.93 Aligned_cols=242 Identities=21% Similarity=0.227 Sum_probs=186.8
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHH---HHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVV---MIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
+|.|+++.||.+... ..++.||+|.+.... ......+.+|.. ++....|+|++++++++.+.+..++||||
T Consensus 2 ig~g~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 2 IGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred cccCCCeEEEEEEEe---cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 567777777766554 467889999876431 122223444443 44456799999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+++++|..++.....+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 999999999988778999999999999999999999 88999999999999999999999999999976543221
Q ss_pred eeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 576 KKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
....|+..|+| ||.+.+. .++.++||||+|++++||++|+.||........... ....... ..
T Consensus 153 -~~~~~~~~y~a-PE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~------~~---- 216 (278)
T cd05606 153 -HASVGTHGYMA-PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM------AV---- 216 (278)
T ss_pred -cCcCCCcCCcC-cHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhcc------CC----
Confidence 34578999998 9998754 689999999999999999999999976532211111 1111100 00
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQM 688 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~ 688 (709)
......+..+.+++..|++.+|.+|| +++++++.
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 01112356789999999999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=274.28 Aligned_cols=254 Identities=20% Similarity=0.249 Sum_probs=196.7
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc----chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF----QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~ 490 (709)
|.....+|.|+++.||.+.......++..+|+|.+.... ....+++.+|+.++.++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 455667788888888777665433567889999886432 12346788999999999 5999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||+++++|.+++.....+++.....++.|++.||.||| +.+++||||||+|||+++++.+||+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999988878899999999999999999999 899999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNS--TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~--~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.... .....|+..|++ ||++... .++.++||||||+++|+|++|..||....... .......... ...
T Consensus 159 ~~~~-~~~~~~~~~y~a-PE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~-~~~----- 228 (290)
T cd05613 159 EVER-AYSFCGTIEYMA-PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRIL-KSE----- 228 (290)
T ss_pred cccc-cccccCCcccCC-hhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhh-ccC-----
Confidence 2221 134668999998 9998753 46789999999999999999999986432211 0111111111 110
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
...+......+.+++..|++.+|++|| ++++++.
T Consensus 229 -----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001222456788999999999999997 6677765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.89 Aligned_cols=241 Identities=20% Similarity=0.252 Sum_probs=186.2
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
+.+.+.+|.|+++.||.+... .++..+|+|......... . |+.....+ +|+|++++++.+...+..++|||
T Consensus 18 ~~~~~~lg~g~~g~v~~~~~~---~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 18 IVKKLKLIDGKFGKVSVLKHK---PTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred cccceeecCCCceEEEEEEEc---CCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 444555788888888766655 567888999876432111 1 22222212 69999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~ 573 (709)
|+++++|.+++.....+++..+..++.|+++||.||| +.+++||||||+||+++.++ .++|+|||+++.....
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 9999999999988778999999999999999999999 88999999999999999998 9999999999765432
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
....|+..|+| ||++.+..++.++||||||++++||++|+.||.....++. ....+... . ....
T Consensus 164 ---~~~~~~~~y~a-PE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-~-~~~~--------- 227 (267)
T PHA03390 164 ---SCYDGTLDYFS-PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKR-Q-QKKL--------- 227 (267)
T ss_pred ---ccCCCCCcccC-hhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHh-h-cccC---------
Confidence 23468899998 9999998999999999999999999999999974432221 11111110 0 1000
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPT-MRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~ 687 (709)
......+..+.+++..||+.+|.+||+ ++++++
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 -PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111245677899999999999999996 688874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=284.81 Aligned_cols=269 Identities=19% Similarity=0.238 Sum_probs=195.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcC-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG----- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~----- 486 (709)
.++|.....+|.|+++.||.+... .+++.||||.+.... ......+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc---CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 356777777777888777665554 567889999986432 23446788999999999999999999987544
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
.+.++|+||+.+ +|..++. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 357999999975 7877764 346899999999999999999999 88999999999999999999999999999987
Q ss_pred cccccccc-ceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC--
Q 038905 567 LTLNQSKA-IKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-- 642 (709)
Q Consensus 567 ~~~~~~~~-~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g-- 642 (709)
........ ......|++.|+| ||.+.+ ..++.++||||||++++||++|+.||......... ..+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~ 231 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRA-PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQ 231 (336)
T ss_pred ccccccccCCcCCcCcCCCccC-hHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCH
Confidence 64332211 1134578999998 998754 56899999999999999999999999654321111 0011111000
Q ss_pred -CccccccC-------------ccc-ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hcccc
Q 038905 643 -KLDDLVEG-------------DME-AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEVVV 693 (709)
Q Consensus 643 -~~~~l~~~-------------~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~ 693 (709)
+...+.+. ... .......+..+.+++..||+.+|++|||+.++++. ++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000000 000 00011235678899999999999999999999985 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=306.18 Aligned_cols=253 Identities=20% Similarity=0.255 Sum_probs=210.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc---ccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR---VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
...|.....+|.|+||.|.++.+. .+++++|.|++++ .......-|..|-.+|..-+.+-||+++-.|++..++
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k---~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHK---STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEee---ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 678888899999999999999888 6788999999877 3444557799999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
|+|||||+||+|-.++.+..++++...+.++..|+.||..|| +.|+|||||||+|||||..|++||+|||.+-.+..
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 999999999999999999889999999999999999999999 99999999999999999999999999999988876
Q ss_pred cccccceeccccCccccccccccc----C-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFR----N-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~----~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
+..-.. ...+|||-|++ ||++. + +.|+..+|+||+||++|||+.|..||+...-.+ .+..+.+.+
T Consensus 228 dG~V~s-~~aVGTPDYIS-PEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve-------TY~KIm~hk- 297 (1317)
T KOG0612|consen 228 DGTVRS-SVAVGTPDYIS-PEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE-------TYGKIMNHK- 297 (1317)
T ss_pred CCcEEe-ccccCCCCccC-HHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH-------HHHHHhchh-
Confidence 654332 56799999999 99986 3 568999999999999999999999998654322 122222210
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT---MRKVSQ 687 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ev~~ 687 (709)
..+......+.++...++|+..+. +|+.|.. ++++-.
T Consensus 298 -----~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 298 -----ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred -----hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 011111233467788888888776 7788877 888765
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=273.61 Aligned_cols=257 Identities=18% Similarity=0.217 Sum_probs=187.2
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccC-cCceeEEEeEEEcC--CeEEEEEe
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEG--QNRLLVYK 494 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~--~~~~lV~E 494 (709)
...+|.|+++.||.+... .++..+|+|++.... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 4 ~~~lg~g~~~~v~~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSR---KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred EeeccccccceEEEEEEc---CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 344566777766555544 567889999886532 222334567888999885 99999999999887 88999999
Q ss_pred ecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 495 FLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 495 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
|+++ +|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++. +.+||+|||+++.+......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 9975 777777654 46899999999999999999999 889999999999999999 99999999999876543322
Q ss_pred cceeccccCccccccccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HHH-------HHHHhhhcCCc
Q 038905 574 AIKKAIRGTKGYVASPEWFR-NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD-------WAFDCYRNGKL 644 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~-------~~~~~~~~g~~ 644 (709)
....+++.|+| ||++. +..++.++|||||||++|||++|..||......+... ... ...........
T Consensus 156 ---~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 156 ---TEYISTRWYRA-PECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred ---CCCCCCcccCC-hhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 33567889998 99765 4567899999999999999999999997654322110 000 00011111111
Q ss_pred cccccCccc----ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 645 DDLVEGDME----AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 645 ~~l~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....+... .......+..+.+++..||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 111000000 0001234688999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=276.76 Aligned_cols=265 Identities=19% Similarity=0.204 Sum_probs=192.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--- 487 (709)
..+|.....+|.|+++.||.+... .+++.+|+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDK---DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEEC---CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456666666777777777655554 457789999886432 223456788999999999999999999987655
Q ss_pred -------eEEEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEc
Q 038905 488 -------NRLLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 488 -------~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
..++|+||+++ +|...+... ..+++..+..++.|++.||.||| +.+|+|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999987 666666544 36899999999999999999999 8899999999999999999999999
Q ss_pred cccccccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||++..+........ ....++..|++ ||.+.+ ..++.++|||||||+++||++|++||......+...........
T Consensus 159 dfg~~~~~~~~~~~~~-~~~~~~~~y~~-PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEESRPY-TNKVITLWYRP-PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred cccccccccCCccccc-ccceeccCccC-hHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999987654332111 23456778998 998865 45789999999999999999999999755432211111100000
Q ss_pred hhcCCccccc--------cC------cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNGKLDDLV--------EG------DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g~~~~l~--------~~------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........+. +. .... .....+..+.+++..||+.+|.+||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000000 00 0000 01123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=284.80 Aligned_cols=266 Identities=19% Similarity=0.243 Sum_probs=196.0
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEE----cCC
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCD----EGQ 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~----~~~ 487 (709)
.+|.....+|.|+++.||.+... .+++.+|+|++.... ......+.+|+.++++++|+||+++++++. ...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT---RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 45666666777777777655544 568899999886532 234567888999999999999999999875 345
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
..++||||+. ++|..++.....+++..+..++.||+.||.||| +.+|+||||||+||++++++.+||+|||+++..
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 6899999996 589999987777999999999999999999999 889999999999999999999999999999866
Q ss_pred cccccc--cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHH--------HH
Q 038905 568 TLNQSK--AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AF 636 (709)
Q Consensus 568 ~~~~~~--~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~--------~~ 636 (709)
...... .......|+..|++ ||++.+ ..++.++||||||+++|||++|+.||.............. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRA-PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccC-hHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 443221 11134578899998 999865 4689999999999999999999999975543221110000 00
Q ss_pred HhhhcCCccccccCcc-ccc-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 637 DCYRNGKLDDLVEGDM-EAM-----NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 637 ~~~~~g~~~~l~~~~~-~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+......+....+... ... .....+..+.+++..|++.+|++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000100000000 000 01234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=283.43 Aligned_cols=278 Identities=19% Similarity=0.221 Sum_probs=198.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC-----
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG----- 486 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~----- 486 (709)
.+|.....+|.|+++.||.+... .+++.+|||++.... ......+.+|+.++++++|+||+++++++...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDK---RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeC---CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 56776677788888877655544 467899999886432 22345688999999999999999999998654
Q ss_pred -CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 487 -QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 487 -~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
...++|+||+.. +|..++. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 346899999975 7766552 35888999999999999999999 8899999999999999999999999999997
Q ss_pred cccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH--------H
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------F 636 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------~ 636 (709)
...... ....+++.|+| ||++.+ ..++.++|||||||+++||++|+.||............... .
T Consensus 166 ~~~~~~-----~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADAEM-----TGYVVTRWYRA-PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCCC-----CCceeeecccC-hhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 653321 34567889998 999876 46889999999999999999999999765432211100000 0
Q ss_pred HhhhcCCccccccC--ccccc----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHcccccCCCCCCCCCCcc
Q 038905 637 DCYRNGKLDDLVEG--DMEAM----NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVVVEVDVPPNPSTFSC 706 (709)
Q Consensus 637 ~~~~~g~~~~l~~~--~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~~~p~~p~~~~~ 706 (709)
..+........... ..... ........+.+++..||+.||++||+++++++ .++...+.+..+.|..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~~~~ 317 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYDD 317 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCcccc
Confidence 00000000000000 00000 00123456889999999999999999999995 4777665544444444433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=284.99 Aligned_cols=249 Identities=18% Similarity=0.235 Sum_probs=199.5
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
+....-+|-|.||.||.+... .....-|-|.++....+..+++.-|++||+...||+||+|++.|...+.+++++||
T Consensus 34 WeIiGELGDGAFGKVyKA~nk---et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNK---ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcc---cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 334445777788877544433 45666677888777777788999999999999999999999999989999999999
Q ss_pred cCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 496 LNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 496 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
|.||.++..+-+-+ .+.+.++.-+++|++.||.||| +.+|||||||+.|||+.-+|.++|+|||.+........
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q-- 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ-- 185 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHh--
Confidence 99999999887654 5899999999999999999999 99999999999999999999999999999754332211
Q ss_pred ceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 575 IKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
....+.|||+||| ||+.+ +.+|+.++||||||+.|.||..+.+|...-..... +. .+.......++
T Consensus 186 kRDsFIGTPYWMA-PEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------ll-KiaKSePPTLl- 256 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMA-PEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LL-KIAKSEPPTLL- 256 (1187)
T ss_pred hhccccCCccccc-chheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH------HH-HHhhcCCCccc-
Confidence 1257899999999 99875 67899999999999999999999999753332211 11 11112222222
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+..+...+.+++..||..||..||++.++++
T Consensus 257 ------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 ------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 24467788999999999999999999999876
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=269.80 Aligned_cols=257 Identities=22% Similarity=0.273 Sum_probs=190.6
Q ss_pred ceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhcc---CcCceeEEEeEEEcCCe---
Q 038905 417 TRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQT---YHKNLVRLLGFCDEGQN--- 488 (709)
Q Consensus 417 ~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nlv~l~~~~~~~~~--- 488 (709)
.....+|.|+++.||.+... .+++.+|+|++..... .....+.+|+.++.++ .|+|++++++++...+.
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDL---NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred eEEEEecccCceEEEEEEEC---CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 34456677777777666554 3678899999864322 2234567788777665 59999999999987776
Q ss_pred --EEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 489 --RLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 489 --~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
.+++|||+.+ +|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 8988887643 4899999999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh-cCC
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR-NGK 643 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~g~ 643 (709)
..+...... ....++..|++ ||++.+..++.++|+||||++++||++|++||......+... . +.+... .+.
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~-PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~ 227 (287)
T cd07838 155 RIYSFEMAL---TSVVVTLWYRA-PEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--K-IFDVIGLPSE 227 (287)
T ss_pred eeccCCccc---ccccccccccC-hHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--H-HHHHcCCCCh
Confidence 876543321 33457888998 999999999999999999999999999999987654332111 1 111000 000
Q ss_pred c---------cccccCccc---ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 L---------DDLVEGDME---AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ~---------~~l~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. ......... ..........+.+++..||+.||.+||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 1111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=281.96 Aligned_cols=270 Identities=20% Similarity=0.231 Sum_probs=202.4
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC-----e
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ-----N 488 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~-----~ 488 (709)
|.....+|.|+++.||.+... ..+..+|||++.... ....+.+.+|+.++++++|+||+++++++.... .
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDK---RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeC---CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 455566777778777666554 458889999987643 334568999999999999999999999988775 7
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||||+.+ +|.+++.+...+++..+..++.+|+.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 8999999984 89999887778999999999999999999999 8899999999999999999999999999998765
Q ss_pred ccccc-cceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh-------
Q 038905 569 LNQSK-AIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY------- 639 (709)
Q Consensus 569 ~~~~~-~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 639 (709)
..... .......+++.|+| ||++.+. .++.++|+||||+++++|++|+.||......+............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRA-PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccccCcCC-ceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54311 11134567888998 9999888 88999999999999999999999997655432211110000000
Q ss_pred -hcCCccccccCccc------ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hcccc
Q 038905 640 -RNGKLDDLVEGDME------AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEVVV 693 (709)
Q Consensus 640 -~~g~~~~l~~~~~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~ 693 (709)
........+..... .......+..+.+++..||+.+|.+||+++++++. +++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000000000 00011245678999999999999999999999983 55544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=275.49 Aligned_cols=244 Identities=21% Similarity=0.240 Sum_probs=188.9
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
|.....+|.|+++.||.+... ..+..+++|++.... ......+.+|++++++++|+|++++++++.+....++|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS---HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC---CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 333445777777777665443 567889999886432 22345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+.+ +|.+++.. ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 999965 77776654 346899999999999999999999 88999999999999999999999999999864321
Q ss_pred cccceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.....|+..|++ ||++. ...++.++||||||++++||++|..|+.......... ... ........
T Consensus 174 ----~~~~~~~~~y~a-PE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~-~~~~~~~~ 241 (313)
T cd06633 174 ----ANSFVGTPYWMA-PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIA-QNDSPTLQ 241 (313)
T ss_pred ----CCCccccccccC-hhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHH-hcCCCCCC
Confidence 135678899998 99984 4568899999999999999999999986543322111 111 11111111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 242 --------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 --------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11234568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=272.77 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=193.0
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
..+|.|+++.||.+... .+++.+++|.+..... .....+.+|++++++++|+||+++++++..+...++|+||++
T Consensus 5 ~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 5 GKIGEGTYGVVYKARDK---LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred eeeecCCCceEEEEEcC---CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34566666666554443 5688899998865432 245678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 498 NGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 498 ~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
+ +|.+++... ..+++..+..++.|++.||.||| ..+|+|+||||+||+++.++.+||+|||.+......... .
T Consensus 82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~--~ 155 (283)
T cd05118 82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP--Y 155 (283)
T ss_pred C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc--c
Confidence 6 888887764 47899999999999999999999 889999999999999999999999999999877654311 1
Q ss_pred eccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC---Cccccc----
Q 038905 577 KAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDDLV---- 648 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g---~~~~l~---- 648 (709)
....++..|++ ||.+.+. .++.++|+||||+++|+|++|+.||......+.... ..+.+... ....+.
T Consensus 156 ~~~~~~~~~~~-PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 156 THYVVTRWYRA-PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred cCccCcccccC-cHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhh
Confidence 33557888988 9998876 789999999999999999999999865543221111 11110000 000000
Q ss_pred -------cCccc--ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 -------EGDME--AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 -------~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+.... .......+..+.+++..||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 0012235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=263.94 Aligned_cols=249 Identities=21% Similarity=0.275 Sum_probs=201.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
-..|.....+|.|++.+|.++... ++.+.+|+|++++.. .+..+=.+.|-.+..+. +||.+|.++.+++.++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~---~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLK---KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred cccceeeeeecCcchhhhhheehc---ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 456888889999999988777777 567778887776432 23334466777777665 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
+++|+||++||+|.-++.++.++++++.+.+..+|+.||.||| ++|||.||||.+|+|||..|++||+|+|+++.--
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999999998644
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccc-hhhHHhHHHHHHHhhhcCCcccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
.+.. .+.+++|||.|+| ||++.+..|...+|+|+|||+++||+.|+.||+.-- .....+-..+.++.+.+..++
T Consensus 403 ~~gd--~tstfcgtpnyia-peilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-- 477 (593)
T KOG0695|consen 403 GPGD--TTSTFCGTPNYIA-PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-- 477 (593)
T ss_pred CCCc--ccccccCCCcccc-hhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--
Confidence 3332 3378999999999 999999999999999999999999999999998642 122223334445444443332
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCC
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 680 (709)
. +...+.+...+++.-+++||.+|.
T Consensus 478 ------i--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 ------I--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ------c--cceeehhhHHHHHHhhcCCcHHhc
Confidence 1 223445566778888999999985
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=278.35 Aligned_cols=258 Identities=18% Similarity=0.195 Sum_probs=192.0
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchh--------------HHHHHHHHHHHhccCcCceeEEEeEEEc
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDG--------------EKEFKNEVVMIGQTYHKNLVRLLGFCDE 485 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nlv~l~~~~~~ 485 (709)
..+|.|+++.||.+... ..++.+|||++....... ...+.+|++++.+++|+||+++++++..
T Consensus 15 ~~ig~G~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDT---LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hcccCCCceeEEEEEEC---CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 34677777777655544 467889999875432211 1257899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 486 GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
++..++||||+. ++|.+++.....++......++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+++
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcccee
Confidence 999999999997 599999987778999999999999999999999 8899999999999999999999999999998
Q ss_pred cccccc------------cccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHH
Q 038905 566 LLTLNQ------------SKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 632 (709)
Q Consensus 566 ~~~~~~------------~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~ 632 (709)
...... .........+++.|++ ||++.+. .++.++||||||++++||++|..||......+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--- 243 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRA-PELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL--- 243 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCC-ChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 765111 0111123456888998 9998764 4689999999999999999999999765443211
Q ss_pred HHHHHhhhcCCc---cccc--------cC---cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 633 DWAFDCYRNGKL---DDLV--------EG---DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 633 ~~~~~~~~~g~~---~~l~--------~~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..+......... .... .. .............+.+++..|++.+|++|||++|++..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 111111111000 0000 00 00000011235678899999999999999999999873
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.19 Aligned_cols=255 Identities=22% Similarity=0.253 Sum_probs=193.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC-----
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ----- 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~----- 487 (709)
+.+.....+|.|+|+.||..... ..+..||||...... ....+...+|+++|++++|+|||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnk---etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNK---ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred cceeehhhhcCCccceeeeeccc---ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 44555667788888877443334 689999999987643 234567889999999999999999999876544
Q ss_pred -eEEEEEeecCCCCHHHHHhhCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec--C--CCCeEEc
Q 038905 488 -NRLLVYKFLNNGTLASFLFENL---KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD--D--YYNAQIS 559 (709)
Q Consensus 488 -~~~lV~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~--~--~~~~kl~ 559 (709)
...+|||||.+|||+..+.+.. .+++...+.++..++.||.||| ..+|+||||||.||++- + .-..||+
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeee
Confidence 5689999999999999998754 5999999999999999999999 88999999999999993 3 3348999
Q ss_pred cccccccccccccccceeccccCccccccccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFR-NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||.|+.+..+. ..+.+.||+.|++ ||++. ...|+..+|.|||||++||.+||..||.+...... ....++..
T Consensus 167 DfG~Arel~d~s---~~~S~vGT~~YLh-Pel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~--~~~~~~~~ 240 (732)
T KOG4250|consen 167 DFGAARELDDNS---LFTSLVGTEEYLH-PELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN--NKEIMWHI 240 (732)
T ss_pred cccccccCCCCC---eeeeecCchhhcC-hHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc--cchhhhhh
Confidence 999999887665 2378999999999 99999 48899999999999999999999999986544211 11112222
Q ss_pred hhc---CCccccc-------cC----cccccCCHHHHHHHHHHHHhcccCCCCCCC
Q 038905 639 YRN---GKLDDLV-------EG----DMEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680 (709)
Q Consensus 639 ~~~---g~~~~l~-------~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 680 (709)
... +.+.... +. .....-......++-+.+..++..+|++|-
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 211 1111000 00 001111234566777788888888999997
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=257.43 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=195.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV 492 (709)
......-+|.|..|.|+...+. ..+..+|||.+.+. +.+..+++...+.++.+-+ +|.||+.+|+|..+....+.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~r---s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFR---STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEc---ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 3444456788888888777776 67899999998754 3445577888888877765 99999999999999999999
Q ss_pred EeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||.|.- -++.++.+- .++++...-++...++.||.||.+ +++|||||+||+|||+|+.|++|++|||++-.+-...
T Consensus 170 MelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 998843 455555543 468888888999999999999996 6699999999999999999999999999997665433
Q ss_pred cccceeccccCcccccccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRN---STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
. .++-.|-+.||| ||.+.- ..|+.++||||||+.++||.||+.||.....+ +..+.. +.+... ..+
T Consensus 247 A---htrsAGC~~YMa-PERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltk-----vln~eP-P~L 315 (391)
T KOG0983|consen 247 A---HTRSAGCAAYMA-PERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTK-----VLNEEP-PLL 315 (391)
T ss_pred c---cccccCCccccC-ccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHH-----HHhcCC-CCC
Confidence 2 267789999999 999863 46899999999999999999999999865432 222211 111111 111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+. ....+...+++...||+.|+.+||...++++
T Consensus 316 ~~------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 316 PG------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred Cc------ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 2236778899999999999999999999876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=271.91 Aligned_cols=249 Identities=22% Similarity=0.258 Sum_probs=200.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~ 490 (709)
+|.....+|.|+++.||.+... .+++.+|+|.+... .....+.+.+|++++.+++ |+||+++++++.+++..+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEK---ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CceEeeeecCCCceEEEEEEEc---CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 4555666788888888666554 46888999987642 2334567899999999999 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||+++++|.+++.+...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999999998888999999999999999999999 889999999999999999999999999999876543
Q ss_pred ccc------------------cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHH
Q 038905 571 QSK------------------AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 632 (709)
Q Consensus 571 ~~~------------------~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~ 632 (709)
... .......|+..|++ ||+..+..++.++|+||||++++++++|+.||....... .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~- 231 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVS-PELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TF- 231 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccC-HHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HH-
Confidence 321 11134568899998 999998889999999999999999999999997554211 11
Q ss_pred HHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 038905 633 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM----RKVSQ 687 (709)
Q Consensus 633 ~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~ev~~ 687 (709)
+...... .......++.+.+++..||+.+|.+||++ +++++
T Consensus 232 ----~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 ----QKILKLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----HHHHhcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111110 01122336778999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=275.07 Aligned_cols=247 Identities=20% Similarity=0.234 Sum_probs=190.8
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.|.....+|.|+++.||.+... ..+..+|+|.+... ......++.+|+++++.++|+|++++++++......++
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEc---CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3444455667777777666555 46788999987532 22334578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+. ++|.+.+.. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 999997 577776654 446889999999999999999999 889999999999999999999999999998765422
Q ss_pred ccccceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
....|++.|+| ||++. ...++.++|||||||+++||++|..|+......+... ....+....
T Consensus 169 ------~~~~~~~~y~a-PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~~- 233 (308)
T cd06634 169 ------NXFVGTPYWMA-PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNESPA- 233 (308)
T ss_pred ------ccccCCccccC-HHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-------HHhhcCCCC-
Confidence 34568899998 99975 3567889999999999999999999986443221111 111111111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
.........+.+++.+||+.+|++||+++++++..-
T Consensus 234 -------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 012235567889999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=275.77 Aligned_cols=267 Identities=20% Similarity=0.180 Sum_probs=192.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--- 487 (709)
.++|.....+|.|+++.||.+... .+++.+|||++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI---KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC---CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 567887778888888888776655 4678899998754322 22346789999999999999999999875433
Q ss_pred -----eEEEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccc
Q 038905 488 -----NRLLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 488 -----~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
..++|+||+.+ +|...+... ..+++..+..++.|+++||.||| +.+|+|+||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999976 677766543 46999999999999999999999 889999999999999999999999999
Q ss_pred ccccccccccccc---------ceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhH
Q 038905 562 GLAKLLTLNQSKA---------IKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 631 (709)
Q Consensus 562 Gla~~~~~~~~~~---------~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~ 631 (709)
|+++......... ..+...|++.|+| ||.+.+ ..++.++||||||+++|||++|++||...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRP-PELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCC-hHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9998654332111 1133567888998 998765 4589999999999999999999999976544221111
Q ss_pred HHHHHHhhhcC------Cccccc----cCcccc---cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 632 TDWAFDCYRNG------KLDDLV----EGDMEA---MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 632 ~~~~~~~~~~g------~~~~l~----~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........... .+.... ...... .........+.+++.+|++.+|++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11000000000 000000 000000 001123367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=271.46 Aligned_cols=252 Identities=20% Similarity=0.292 Sum_probs=190.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~ 490 (709)
-++|.....+|.|+++.||.+... ..++.+|||.+.... .....++..|+.++.+.+ |+||+++++++.++...+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFK---KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEEC---CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 345666667777777777655544 457889999986532 234456777887777775 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCC-CCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 491 LVYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCS-SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
+||||+.+ +|..++.. ...+++..+..++.|++.||.||| + .+|+||||+|+||++++++.+||+|||++..+.
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999854 77776655 346889999999999999999999 5 589999999999999999999999999997664
Q ss_pred ccccccceeccccCcccccccccccCCC----CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNST----ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~----~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
..... ....++..|+| ||.+.+.. ++.++||||||+++|||++|+.||....... ..+ .. ...+..
T Consensus 167 ~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~----~~-~~~~~~ 236 (296)
T cd06618 167 DSKAK---TRSAGCAAYMA-PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVL----TK-ILQEEP 236 (296)
T ss_pred CCCcc---cCCCCCccccC-HhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHH----HH-HhcCCC
Confidence 33222 33457889998 99987654 7899999999999999999999996432211 111 11 111111
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..+.. .....+.+.+++.+||+.||.+||+++++++.
T Consensus 237 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11100 11245678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=264.90 Aligned_cols=221 Identities=21% Similarity=0.174 Sum_probs=176.1
Q ss_pred eeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCCHHHH
Q 038905 425 SVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504 (709)
Q Consensus 425 g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 504 (709)
|.++.||.+... .+++.+|+|++.... ++.+|...+....|||++++++++.+.+..++||||+++++|.++
T Consensus 4 g~~~~v~~~~~~---~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDT---RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEc---cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 344456666555 578889999986532 334556666667799999999999999999999999999999999
Q ss_pred HhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcc
Q 038905 505 LFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKG 584 (709)
Q Consensus 505 l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~ 584 (709)
+.+...+++.....++.|++.||.||| +++|+||||||+||+++.++.++++|||++..+.... ....++..
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 988778999999999999999999999 8899999999999999999999999999887654322 33456778
Q ss_pred cccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHH
Q 038905 585 YVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL 664 (709)
Q Consensus 585 y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l 664 (709)
|++ ||.+....++.++||||+|+++|||++|+.|+....... .. ......+...+..+
T Consensus 148 y~a-PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~---------~~~~~~~~~~~~~~ 205 (237)
T cd05576 148 YCA-PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT---------HTTLNIPEWVSEEA 205 (237)
T ss_pred ccC-CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc---------ccccCCcccCCHHH
Confidence 998 999988889999999999999999999998865321100 00 00000112245678
Q ss_pred HHHHHhcccCCCCCCCCHH
Q 038905 665 VMVSIWCIQEDPSLRPTMR 683 (709)
Q Consensus 665 ~~l~~~Cl~~dP~~RPs~~ 683 (709)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=277.54 Aligned_cols=261 Identities=21% Similarity=0.220 Sum_probs=192.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG---- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~---- 486 (709)
+++|.....+|.|+++.||.+... .+++.||+|++.... ....+.+.+|+.++.+++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDT---KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEc---CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 677888888888888888666554 567899999987532 22346788899999999999999999988543
Q ss_pred --CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 487 --QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 487 --~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
...+++++++ +++|.+++.. ..+++..+..++.|+++||.||| +.+|+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence 3467888876 7799887754 46899999999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HHH-------HH
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD-------WA 635 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~-------~~ 635 (709)
+...... ....|++.|+| ||.+.+ ..++.++||||||++++||++|+.||.......... ... ..
T Consensus 168 ~~~~~~~-----~~~~~~~~y~a-PE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 168 RHTDDEM-----TGYVATRWYRA-PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred ccccccc-----cccccCCCccC-HHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 7653221 34568889998 999876 568899999999999999999999986543321110 000 00
Q ss_pred HHhhhcCCc-------cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 636 FDCYRNGKL-------DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 636 ~~~~~~g~~-------~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
...+..... ......... .........+.+++..|++.||.+||++.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000 000000000 0001235568899999999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=269.81 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=189.7
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEeec
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
...+|.|+++.||.+... ..++.++||++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 4 ~~~ig~g~~g~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 4 IKQLGDGTFGSVYLARNK---ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred heeeccCCceEEEEEEEC---CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 345666666666544433 4578899999865432 23334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 497 NNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 497 ~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
+++|.+++.... .+++..+..++.|++.+|.||| +.+++|+||||+||++++++.++|+|||+++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 789999887765 6899999999999999999999 889999999999999999999999999999866543221
Q ss_pred ceeccccCccccccccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HHH---------HHHHhhhcCC
Q 038905 575 IKKAIRGTKGYVASPEWFR-NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD---------WAFDCYRNGK 643 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~---------~~~~~~~~g~ 643 (709)
....|+..|+| ||++. ...++.++|+||||++++||++|+.||......+... ... |.........
T Consensus 156 --~~~~~~~~~~a-PE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 156 --TDYVSTRWYRA-PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --CCCCCcccccC-ceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 34568888998 99885 4557899999999999999999999986554322111 000 0000000001
Q ss_pred ccccccCccc---ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 644 LDDLVEGDME---AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 644 ~~~l~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....+..... ..........+.+++..|++.+|++|||++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1100000000 00001124679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=271.85 Aligned_cols=262 Identities=19% Similarity=0.215 Sum_probs=195.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEc-CCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE-GQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~-~~~~ 489 (709)
+++|.....+|.|+++.||.+... .++..+|||++... .....+.+.+|+.++.+++||||+++.+++.. ....
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQ---LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEEC---CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 677888888888988888766655 57889999987542 22345678899999999999999999999865 5678
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++|+||+ +++|..++.. ..++......++.|++.||.||| +.+|+||||||+||++++++.+||+|||++.....
T Consensus 86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 9999998 5689887754 45778888899999999999999 89999999999999999999999999999975432
Q ss_pred cccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHH-hHHHH-------HHHhhh
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDW-------AFDCYR 640 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~-------~~~~~~ 640 (709)
.. ....+++.|++ ||.+.+ ..++.++||||||++++||++|+.||......... ..... ..+.+.
T Consensus 161 ~~-----~~~~~~~~y~a-PE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 161 QM-----TGYVSTRYYRA-PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred Cc-----CCCcccccccC-ceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 21 34567888998 998766 56899999999999999999999999755432111 11000 001111
Q ss_pred cCCccccccCc-cccc-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 641 NGKLDDLVEGD-MEAM-----NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 641 ~g~~~~l~~~~-~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.+....++... .... ........+.+++..|++.+|++||++++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111110000 0000 011235688999999999999999999998775
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=280.18 Aligned_cols=251 Identities=20% Similarity=0.233 Sum_probs=207.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
++.+.-.+|-||||.|-++.........+.+++|+.+.+....++.+..|-.||.+.+.+.||+++-.|.+....|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 44555678888888777777764333345566666667777778889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
-|-||.|-..|.+++.++..+...++..+++|+.||| +++||.|||||+|.+||.+|-+||.|||+|+.++....
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K-- 575 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK-- 575 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc--
Confidence 9999999999999999999999999999999999999 99999999999999999999999999999999876543
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
+.++||||.|+| ||++.++..+.++|.||||+++|||++|.+||...++... +..+..|- +. .
T Consensus 576 -TwTFcGTpEYVA-PEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-------Yn~ILkGi-d~-------i 638 (732)
T KOG0614|consen 576 -TWTFCGTPEYVA-PEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-------YNLILKGI-DK-------I 638 (732)
T ss_pred -eeeecCCccccc-chhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-------HHHHHhhh-hh-------h
Confidence 278999999999 9999999999999999999999999999999987765432 22222221 00 1
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
..+........++++.....+|.+|.- +.++-+
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 112234456778888888999999975 566654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=275.40 Aligned_cols=243 Identities=23% Similarity=0.303 Sum_probs=194.3
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
..+|+|-|+.||-..+. .+++.||||.+++. ....+.++++|+.||.+++||.||.+...|+..+..++|||-+.
T Consensus 570 evLGSGQFG~VYgg~hR---ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHR---KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred hhccCCcceeeecceec---ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 34555656655444444 67888999988754 33466899999999999999999999999999999999999998
Q ss_pred CCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC---CCeEEccccccccccccccc
Q 038905 498 NGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY---YNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 498 ~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~ 573 (709)
|.-|.-.|.. .++++++....+..||+.||.||| -++|+||||||+||||... -.+||+|||+|++++...-+
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 7666666654 457999999999999999999999 9999999999999999654 45999999999999876544
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
..++|||.|+| ||++.++.|...-|+||.||++|--++|..||....+.. +++.+... ...
T Consensus 724 ---rsVVGTPAYLa-PEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn---------dQIQNAaF------MyP 784 (888)
T KOG4236|consen 724 ---RSVVGTPAYLA-PEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN---------DQIQNAAF------MYP 784 (888)
T ss_pred ---hhhcCCccccC-HHHHhhccccccccceeeeEEEEEEecccccCCCccchh---------HHhhcccc------ccC
Confidence 67899999999 999999999999999999999999999999997443211 11111111 111
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...-.+.....+++|...||..-.+|-|.++-+.
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2223456678899999999999999999877643
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=265.68 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=191.1
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
|.....+|.|+++.||.+...........+++|..... ......++..|+.++++++|||++++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 44556677888888876665533233444455544321 2223456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 494 KFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 494 Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
||+++++|..++.+ ...+++..+..++.|++.||.||| +.+++|+||||+||++++ +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998864 235889999999999999999999 889999999999999975 5699999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... .....|++.|++ ||.+.+..++.++|+||||+++++|++|..|+........ ......+....
T Consensus 158 ~~~~--~~~~~~~~~~~~-pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-------~~~~~~~~~~~--- 224 (260)
T cd08222 158 SCDL--ATTFTGTPYYMS-PEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV-------VLRIVEGPTPS--- 224 (260)
T ss_pred Cccc--ccCCCCCcCccC-HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHcCCCCC---
Confidence 3321 145668899998 9999888899999999999999999999999864332111 11111121111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....+..+.+++.+|++.+|++||++.++++
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 ------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 12345668889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=275.66 Aligned_cols=265 Identities=19% Similarity=0.210 Sum_probs=189.6
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhcc-CcCceeEEEeEEEc----CCe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDE----GQN 488 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~----~~~ 488 (709)
|.....+|.|+++.||.+... ....+..+|+|++.... ....+.+.+|+.++.++ +|+||+++++.+.. ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNA-ETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred ceEEEEccccCCeEEEEEEeC-CCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 455556777777777655544 21227789999886432 22346788999999999 59999999987543 245
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++++||+. ++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788899886 589999987778999999999999999999999 8899999999999999999999999999998665
Q ss_pred ccccc--cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHH--------HHH
Q 038905 569 LNQSK--AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AFD 637 (709)
Q Consensus 569 ~~~~~--~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~--------~~~ 637 (709)
..... .......|++.|+| ||++.+ ..++.++|+||||+++++|++|..||.............. ...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~a-PE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRA-PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred cccccccccccCcccCccccC-cHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 32211 11134678999998 998765 5689999999999999999999999875442211100000 000
Q ss_pred hhhcCCccccc-------cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 638 CYRNGKLDDLV-------EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 638 ~~~~g~~~~l~-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+...+..... ..... .........+.+++.+|++.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 00000 001113467889999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=267.30 Aligned_cols=269 Identities=25% Similarity=0.330 Sum_probs=200.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhc--cCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQ--TYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nlv~l~~~~~~~~--- 487 (709)
...+...++.|++|.| +++.+ .++.||||++.. +....|.+|-.|... ++|+||+++++.-..+.
T Consensus 211 pl~l~eli~~Grfg~V---~KaqL----~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCV---WKAQL----DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred chhhHHHhhcCcccee---ehhhc----cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 3444555666666666 77777 469999999875 456678888888765 58999999999876655
Q ss_pred -eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhc------CCCCeEecCCCCCceeecCCCCeEEcc
Q 038905 488 -NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVN------CSSQIIHCDIKPQNILLDDYYNAQISD 560 (709)
Q Consensus 488 -~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~------~~~~iiH~Dlkp~NIll~~~~~~kl~D 560 (709)
+..||+||.+.|+|.++|..+ ..+|....+|+..+++||+|||++ .+..|+|||||.+|||+.+|++..|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 789999999999999999764 589999999999999999999963 345799999999999999999999999
Q ss_pred ccccccccccccccceeccccCcccccccccccCCC-CC-----cccchHHHHHHHHHHHhCCCCCCccchhhHH-----
Q 038905 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST-IT-----ANVDVYSFGVLLLEIISCRKSFDIEMGEEYA----- 629 (709)
Q Consensus 561 FGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~-~s-----~k~DvwSlGvvl~elltg~~p~~~~~~~~~~----- 629 (709)
||+|..+............+||..||| ||++.+.. +. .+.||||+|.|||||++.-.-+++....++.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMA-PEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMA-PEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcC-HHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999998876665554467899999999 99997642 22 4689999999999999865444321111100
Q ss_pred -----hHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCC
Q 038905 630 -----ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVD 696 (709)
Q Consensus 630 -----~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 696 (709)
.-.+.++..+...+.+..+...... ..-...+++.+..||..||+.|.|+.=|.+.+..+....
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 0011122222222222222211111 134567899999999999999999999988887765443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=274.47 Aligned_cols=268 Identities=21% Similarity=0.213 Sum_probs=196.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--- 487 (709)
.++|.....+|.|+++.||.+... .++..||||++.... ....+.+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDR---RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEEC---CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 456777777888888888666554 568899999885432 223457889999999999999999999986543
Q ss_pred ---eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 488 ---NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 488 ---~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
..++||||+ +++|..++.. ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999998 7799887753 56899999999999999999999 899999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhH-HhHHH-------HH
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTD-------WA 635 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~-~~~~~-------~~ 635 (709)
....... ....+++.|++ ||++.+ ..++.++|+||||+++++|++|+.||........ ..... ..
T Consensus 166 ~~~~~~~-----~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 166 RQTDSEM-----TGYVVTRWYRA-PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccCc-----cccccCCcccC-HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8654322 34567889998 999876 4588999999999999999999999975543111 00000 00
Q ss_pred HHhhhcCCccccccC--ccc----ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHccccc
Q 038905 636 FDCYRNGKLDDLVEG--DME----AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVVVE 694 (709)
Q Consensus 636 ~~~~~~g~~~~l~~~--~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~ 694 (709)
...+........+.. ... ..........+.+++.+|++.||++|||+.++++ .++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 000000000000000 000 0001123456889999999999999999999984 5555433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=268.20 Aligned_cols=258 Identities=21% Similarity=0.256 Sum_probs=193.9
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeec
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
...+|.|+++.||.+... ..++.+|+|.+.... ....+.+.+|+.++++++|+|++++++++.+....++||||+
T Consensus 4 ~~~ig~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 4 LEKLGEGTYGVVYKARDK---KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred ehcccccCcceEEEeeec---CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 345677777777665554 468899999887643 333467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 497 NNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 497 ~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
++ +|.+++.+. ..+++..+..++.+++.||.||| ..+|+||||+|+||++++++.+||+|||+++.........
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~- 155 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY- 155 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc-
Confidence 84 899999876 57899999999999999999999 8899999999999999999999999999998765433211
Q ss_pred eeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHH-hHHHH-------HHHhhhc-----
Q 038905 576 KKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDW-------AFDCYRN----- 641 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~-------~~~~~~~----- 641 (709)
....++..|+| ||++.+. .++.++||||||++++||++|+.||......+.. ..... .+..+..
T Consensus 156 -~~~~~~~~~~a-PE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 156 -THEVVTLWYRA-PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred -CccccCcCcCC-hHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 33456778898 9998776 7899999999999999999999998765432211 11000 0000000
Q ss_pred CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........... ..........+.+++..||+.+|++||++++++.
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 0001123567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=286.36 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=207.7
Q ss_pred eeeeecCeeEEEEEEEEEE-ecC-CCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 418 RSVLLGSSVFVNFTLVGVI-QTS-TRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~-~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
+...+|+|.||+| |+|.+ ..+ .-..+||||.+... ..+...++.+|+-+|.++.||||+||+|+|.... ..||++
T Consensus 700 k~kvLGsgAfGtV-~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTV-YKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhceeccccceeE-EeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3445666666666 55544 322 23467999987543 4456689999999999999999999999998765 889999
Q ss_pred ecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 495 FLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 495 y~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+.|.|.++++.+. .+..+..+.+..|||+|+.||| .++++||||-++|||+..-.++||.|||+|+.+..+..+
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 999999999998654 6888999999999999999999 899999999999999999999999999999999877655
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
.......-.+.||| -|.+....++.++|||||||.+||++| |..|++....++ +.++++...
T Consensus 855 y~~~~gK~pikwma-le~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~ge 917 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMA-LESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGE 917 (1177)
T ss_pred ccccccccCcHHHH-HHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhccc
Confidence 43233333567888 899999999999999999999999998 889998765444 233444444
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+...++.+..++..++.+||..|+..||+++++...+.+..
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 45557778899999999999999999999999998887754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=262.04 Aligned_cols=237 Identities=27% Similarity=0.282 Sum_probs=192.1
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
+|.|+++.||.+... ..++.+++|.+.... ....+.+.+|+.++++++|+||+++++.+..+...++||||+++
T Consensus 1 lg~G~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKK---DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEEC---CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 467777777665554 467889999876432 22456889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceec
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 578 (709)
++|.+++.....+++.....++.|++.||.||| ..+++|+||||+||+++.++.++|+|||++......... ...
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~ 152 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNT 152 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc--ccC
Confidence 999999988778899999999999999999999 899999999999999999999999999999876543211 145
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCH
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~ 658 (709)
..|+..|++ ||...+...+.++|+||||++++||++|..||........ .+....+.. ..+.
T Consensus 153 ~~~~~~~~~-Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~----------~~~~ 214 (250)
T cd05123 153 FCGTPEYLA-PEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-------YEKILKDPL----------RFPE 214 (250)
T ss_pred CcCCccccC-hHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHhcCCC----------CCCC
Confidence 678899998 9999988899999999999999999999999965433111 111111110 1112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHH
Q 038905 659 KCVEKLVMVSIWCIQEDPSLRPTMRK 684 (709)
Q Consensus 659 ~~~~~l~~l~~~Cl~~dP~~RPs~~e 684 (709)
..+..+.+++..|++.||++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 23567889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=278.36 Aligned_cols=265 Identities=18% Similarity=0.153 Sum_probs=191.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcC-------
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG------- 486 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~------- 486 (709)
.+|.....+|.|+++.||.+... .+++.||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~---~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDS---DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEEC---CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 46777777888888888665544 56889999998765555667899999999999999999999776543
Q ss_pred -------CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec-CCCCeEE
Q 038905 487 -------QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQI 558 (709)
Q Consensus 487 -------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl 558 (709)
...++||||++ ++|.+++.+ ..+++.....++.||+.||.||| +.+|+||||||+||+++ +++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 488887754 46889999999999999999999 88999999999999997 4567899
Q ss_pred ccccccccccccccc-cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH-
Q 038905 559 SDFGLAKLLTLNQSK-AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA- 635 (709)
Q Consensus 559 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~- 635 (709)
+|||+++.+...... .......|+..|+| ||++.+ ..++.++|||||||++|||++|+.||......+........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRS-PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred CCcccceecCCccccccccccccccccccC-HHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999865432211 11123467888998 998754 56888999999999999999999999755432211100000
Q ss_pred -------HHhhhcCCccccccCcccc-----cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 636 -------FDCYRNGKLDDLVEGDMEA-----MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 636 -------~~~~~~g~~~~l~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
................... .........+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000000000 001124467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=294.81 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=194.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcC-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG----- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~----- 486 (709)
...|.....+|.||||.|+.+... -+++.+|||++... .......+.+|+..+++|+|||+|+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNK---lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNK---LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeec---ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 457888889999999999877766 68999999998754 333456789999999999999999998643110
Q ss_pred --------------------------------------------------------------------------------
Q 038905 487 -------------------------------------------------------------------------------- 486 (709)
Q Consensus 487 -------------------------------------------------------------------------------- 486 (709)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEeecCCCCHHHHHhhCCCC-ChHHHHHHHHHHHHHHHHhh
Q 038905 487 ----------------------------------QNRLLVYKFLNNGTLASFLFENLKP-GWNLRANIAFQIARGLLHLH 531 (709)
Q Consensus 487 ----------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~l-~~~~~~~i~~~i~~al~~LH 531 (709)
..+||-||||+...|..++.++... .....++++++|+.||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1247889999998888888766544 46677899999999999999
Q ss_pred hcCCCCeEecCCCCCceeecCCCCeEEccccccccccc----------------cccccceeccccCcccccccccccCC
Q 038905 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL----------------NQSKAIKKAIRGTKGYVASPEWFRNS 595 (709)
Q Consensus 532 ~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~----------------~~~~~~~~~~~Gt~~y~aaPE~~~~~ 595 (709)
+.+||||||||.||+||++..|||+|||+|+.... .......+...||.-|+| ||.+.+.
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA-PEll~~~ 790 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA-PELLSDT 790 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec-HHHhccc
Confidence 89999999999999999999999999999987320 000112367899999999 9999866
Q ss_pred C---CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcc
Q 038905 596 T---ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCI 672 (709)
Q Consensus 596 ~---~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl 672 (709)
. |+.|+|+|||||||+||+. ||...++ ... +...++.|.+..- ......+...-.+++.|++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RAS----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHH--HHH----HHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 5 9999999999999999975 4544322 111 2234445544432 1112234445668999999
Q ss_pred cCCCCCCCCHHHHHH
Q 038905 673 QEDPSLRPTMRKVSQ 687 (709)
Q Consensus 673 ~~dP~~RPs~~ev~~ 687 (709)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=280.38 Aligned_cols=237 Identities=22% Similarity=0.240 Sum_probs=190.3
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
+.....+|.|+++.|.+.... .+.+..+||++... ..+-.+|+.++... +|+|++++.+.+.++.+.++|||
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~---~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESS---PTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred hccccccCCCCccceeeeecc---ccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 334455777777766666665 56777888887654 22345677665554 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee-cCCCCeEEccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL-DDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
.+.|+.|.+.+.....+. ..+..|+.+|+.|+.||| .++||||||||+|||+ ++.++++|+|||.++.....-
T Consensus 397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~-- 470 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC-- 470 (612)
T ss_pred hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchhh--
Confidence 999999888887765555 778889999999999999 8999999999999999 699999999999999876551
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
.+.+-|..|.| ||++....|++++|+||||++||+|++|+.||....... .+...+..++.
T Consensus 471 ---~tp~~t~~y~A-PEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~~~~~--------- 531 (612)
T KOG0603|consen 471 ---DTPALTLQYVA-PEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQMPKF--------- 531 (612)
T ss_pred ---cccchhhcccC-hhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhcCCcc---------
Confidence 45577899999 999999999999999999999999999999997543331 11122222221
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....++..++++.+|||.||.+||+|+++..
T Consensus 532 ---s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 ---SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 2456778899999999999999999999876
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=290.16 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=197.9
Q ss_pred eecCeeEEEEEEEEEEecCC----CceEEEEEEcccccc-hhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEe
Q 038905 421 LLGSSVFVNFTLVGVIQTST----RTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.+|.|.|+.|+......... ....||||.++.... ...+.+..|+++|+.+ +|+|+|.++|+|.+....++|+|
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~E 382 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVE 382 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEE
Confidence 66677777665444332212 267899999975433 4567899999999998 59999999999999999999999
Q ss_pred ecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEE
Q 038905 495 FLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558 (709)
Q Consensus 495 y~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 558 (709)
|++.|+|.+++++.. .+.......++.|||.|+.||+ +.++|||||-++|||+.++..+||
T Consensus 383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~~~kI 459 (609)
T KOG0200|consen 383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNKVIKI 459 (609)
T ss_pred eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCCEEEE
Confidence 999999999998765 2778889999999999999999 899999999999999999999999
Q ss_pred ccccccccccccccccceecccc--CcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHH
Q 038905 559 SDFGLAKLLTLNQSKAIKKAIRG--TKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 635 (709)
Q Consensus 559 ~DFGla~~~~~~~~~~~~~~~~G--t~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 635 (709)
+|||+|+.......... ..-.| ...||| ||.+....|+.|+|||||||+||||++ |..|+....... .+
T Consensus 460 aDFGlar~~~~~~~y~~-~~~~~~LP~kWmA-pEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~------~l 531 (609)
T KOG0200|consen 460 ADFGLARDHYNKDYYRT-KSSAGTLPVKWMA-PESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE------EL 531 (609)
T ss_pred ccccceeccCCCCceEe-cCCCCccceeecC-HHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH------HH
Confidence 99999986554332221 11122 234888 999999999999999999999999998 666775422111 12
Q ss_pred HHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 636 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 636 ~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
++.++.|...+ .+..+..++.++++.||+.+|++||++.++++.|+.
T Consensus 532 ~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 532 LEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 33444554322 234467889999999999999999999999999987
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=259.02 Aligned_cols=253 Identities=19% Similarity=0.235 Sum_probs=196.4
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHh-ccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIG-QTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.....-+|.|.||.|+.-. +...++..|||++..... ....++..|++... .-++||||+++|.+..+...++.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~---hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKML---HKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred HHHHHHhcCCcchhhhhhh---cCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 3344557788888554333 337899999999975433 45578888887654 457999999999998888999999
Q ss_pred eecCCCCHHHHHh-----hCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 494 KFLNNGTLASFLF-----ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 494 Ey~~~gsL~~~l~-----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
|.|+ .||+.+-. .+..+++...-.|+...+.||.||.+ ..+|||||+||+|||||..|.+||+|||++-.+.
T Consensus 143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 9995 47766543 23468888889999999999999986 5689999999999999999999999999997765
Q ss_pred ccccccceeccccCcccccccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
..... +.-.|-..||| ||.+.. ..|+.++||||||++|+|+.||..|+...++. .. ...++..|+...
T Consensus 220 ~SiAk---T~daGCrpYmA-PERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-fe-----ql~~Vv~gdpp~ 289 (361)
T KOG1006|consen 220 DSIAK---TVDAGCRPYMA-PERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-FE-----QLCQVVIGDPPI 289 (361)
T ss_pred HHHHh---hhccCCccccC-hhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-HH-----HHHHHHcCCCCe
Confidence 43322 56679999999 999863 35899999999999999999999999755431 11 123445566665
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
+..... ..+....++.++..|+.+|..+||..+++.++
T Consensus 290 l~~~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LLFDKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecCccc----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 554322 23456788999999999999999999988763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=271.56 Aligned_cols=205 Identities=22% Similarity=0.346 Sum_probs=178.1
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.-|.+..-+|-|.||+|.++...+ +.+.+|.|.+.+. ........+.|..||+....+-||+|+-.|++++.+|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred cceEEEeeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 357788889999999998888884 5777788877543 4455677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||++||++..+|.+-+-+.+...+.++.++..|+.+.| +.|.|||||||+|||||.+|++||+||||++-+.-.
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999999644210
Q ss_pred cc----------------------------------------ccceeccccCcccccccccccCCCCCcccchHHHHHHH
Q 038905 571 QS----------------------------------------KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610 (709)
Q Consensus 571 ~~----------------------------------------~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl 610 (709)
.. +......+||+.|+| ||++....++..+|+||.||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia-pevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA-PEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC-hHHhcccCccccchhhHhhHHH
Confidence 00 001134789999999 9999999999999999999999
Q ss_pred HHHHhCCCCCCccch
Q 038905 611 LEIISCRKSFDIEMG 625 (709)
Q Consensus 611 ~elltg~~p~~~~~~ 625 (709)
|||+.|+.||.....
T Consensus 862 ~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHhhCCCCccCCCC
Confidence 999999999976554
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=275.59 Aligned_cols=261 Identities=20% Similarity=0.211 Sum_probs=193.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe--
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN-- 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~-- 488 (709)
.++|.....+|.|+++.||.+... .+++.+|||++... .....+++.+|+.++++++|+|++++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDT---KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEEC---CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 456777777888888888666554 46788999988643 22344667889999999999999999988765554
Q ss_pred ----EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 489 ----RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 489 ----~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 5699988865 46899999999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHH-hHHHH-------H
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDW-------A 635 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~-------~ 635 (709)
....... ....++..|++ ||.+.+ ..++.++||||||++++||++|+.||......... ..... .
T Consensus 166 ~~~~~~~-----~~~~~~~~y~a-PE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDEM-----TGYVATRWYRA-PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----cCCcccccccC-HHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 8764331 44567888998 999865 36789999999999999999999999654332111 00000 0
Q ss_pred HHhhhcCCccccccCcc-cc-----cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 636 FDCYRNGKLDDLVEGDM-EA-----MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 636 ~~~~~~g~~~~l~~~~~-~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...+........+.... .. ......+..+.+++..|++.+|++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000000000 00 000123678999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=288.76 Aligned_cols=147 Identities=21% Similarity=0.245 Sum_probs=129.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... ..++.||||++... ......++.+|+.++..++|+||+++++++....+.
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKK---NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence 456777777888888888776665 56788999988643 223346789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
+|||||+.+++|.+++.....+++...+.++.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999988778899999999999999999999 8899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=251.67 Aligned_cols=237 Identities=25% Similarity=0.304 Sum_probs=190.9
Q ss_pred EEEEEEEEEecCCCceEEEEEEcccccchh-HHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHh
Q 038905 428 VNFTLVGVIQTSTRTTVIVVKKLDRVFQDG-EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF 506 (709)
Q Consensus 428 ~~v~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~ 506 (709)
+.||.+... .++..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus 3 g~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 3 GKVYLARDK---KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred eEEEEEEEC---CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 445444333 357889999987654444 6899999999999999999999999999999999999999999999998
Q ss_pred hCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccc
Q 038905 507 ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV 586 (709)
Q Consensus 507 ~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~ 586 (709)
....+++..+..++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 7666899999999999999999999 8899999999999999999999999999998776542 114566888999
Q ss_pred cccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHH
Q 038905 587 ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVM 666 (709)
Q Consensus 587 aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~ 666 (709)
+ ||.+....++.++||||||+++++|++|..||......+. ..+....+...... .....+..+.+
T Consensus 154 ~-pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~ 219 (244)
T smart00220 154 A-PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE------LFKKIGKPKPPFPP-------PEWKISPEAKD 219 (244)
T ss_pred C-HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH------HHHHHhccCCCCcc-------ccccCCHHHHH
Confidence 8 9999988899999999999999999999999875322111 11111111111100 00014567899
Q ss_pred HHHhcccCCCCCCCCHHHHHH
Q 038905 667 VSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 667 l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=271.45 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=199.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEE-----cC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCD-----EG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~-----~~ 486 (709)
++.|.....+|.|..+.||.+... ..++..|+|++.... +..+++..|..|++.+ +|||++.++|++. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~---~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHV---KTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeee---ecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 444554444555555544444444 467888888877653 4678889999999888 5999999999985 45
Q ss_pred CeEEEEEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
+.++||||||.+||..+++..- .++.|..+.-|+..+++|+.+|| +..+||||||-.||||..++.+||.|||++
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeee
Confidence 7899999999999999998754 46899999999999999999999 899999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRN-----STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
..+.....+ ..+..|||.||| ||++.. ..|+.++|+||||++..||--|.+|+...+.......
T Consensus 171 aQldsT~gr--RnT~iGtP~WMA-PEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-------- 239 (953)
T KOG0587|consen 171 AQLDSTVGR--RNTFIGTPYWMA-PEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------- 239 (953)
T ss_pred eeeeccccc--ccCcCCCccccc-ceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc--------
Confidence 877644332 367899999999 999964 3477899999999999999999999876654432211
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
-.-.+......+....+++.+++..|+..|.+.||++.++++
T Consensus 240 ------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 ------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 011222333446788999999999999999999999998876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=246.83 Aligned_cols=281 Identities=19% Similarity=0.214 Sum_probs=196.8
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCC--ceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEc-CCeE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTR--TTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDE-GQNR 489 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~-~~~~ 489 (709)
.|.....+|.|.+|.||.+..... .+ ...+|||+++.... .......+|+.+++.++|+|+|.|..++.+ +...
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~-n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNT-NDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccC-CcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 345555688888888866644432 33 45899999876422 123567899999999999999999999876 7778
Q ss_pred EEEEeecCCCCHHHHHhhC-----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC----CCeEEcc
Q 038905 490 LLVYKFLNNGTLASFLFEN-----LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY----YNAQISD 560 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~D 560 (709)
+|++||.+. +|...|..+ ..++......|+.||+.|+.||| +..|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988 777777643 24788899999999999999999 8899999999999999877 9999999
Q ss_pred cccccccccccccc-ceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhh------HHhHH
Q 038905 561 FGLAKLLTLNQSKA-IKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILT 632 (709)
Q Consensus 561 FGla~~~~~~~~~~-~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~------~~~~~ 632 (709)
||+++++...-... ....++-|..|.| ||.+.+. .|+.+.|||+.||++.||++-.+.|......- .....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRA-PELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRA-PELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecC-hHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999886543221 2245677889998 9998875 69999999999999999999888886543210 00111
Q ss_pred HHHHHhhhc---CCcc---ccccC-----ccc-ccC-C----------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038905 633 DWAFDCYRN---GKLD---DLVEG-----DME-AMN-D----------IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689 (709)
Q Consensus 633 ~~~~~~~~~---g~~~---~l~~~-----~~~-~~~-~----------~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 689 (709)
..+++.+-. .+-. ...+- ..+ ... + ...+....+++..+|+.||.+|.|+++.++..
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 112221110 0000 01110 000 000 0 01223367899999999999999999887642
Q ss_pred cccccCCCCCCCC
Q 038905 690 EVVVEVDVPPNPS 702 (709)
Q Consensus 690 ~~~~~~~~p~~p~ 702 (709)
- ..+-+.||.|.
T Consensus 339 y-F~~d~lpp~pt 350 (438)
T KOG0666|consen 339 Y-FTEDPLPPLPT 350 (438)
T ss_pred c-cccCCCCCCcc
Confidence 1 12344455553
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=255.62 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=196.7
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEccc---ccchh----HHHHHHHHHHHhccCcCceeEEEeEEE-cCCeEEE
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR---VFQDG----EKEFKNEVVMIGQTYHKNLVRLLGFCD-EGQNRLL 491 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~---~~~~~----~~~~~~E~~~l~~l~h~nlv~l~~~~~-~~~~~~l 491 (709)
-.+|.|||.+||.+..+ ...+-||||+-.. +..+. .+...+|..|-+.|.||.||++++++. +.+..+-
T Consensus 469 hLLGrGGFSEVyKAFDl---~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCT 545 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDL---TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCT 545 (775)
T ss_pred HHhccccHHHHHHhccc---chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccccee
Confidence 46899999999888777 5678889987542 21111 145788999999999999999999985 5566789
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec---CCCCeEEcccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD---DYYNAQISDFGLAKLLT 568 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~~~ 568 (709)
|.|||+|.+|+-+|..+..+++++...|+.||+.||.||.+. +.+|||-||||.||||- .-|.+||.||||++++.
T Consensus 546 VLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd 624 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD 624 (775)
T ss_pred eeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence 999999999999999999999999999999999999999865 67899999999999995 35779999999999987
Q ss_pred ccccc-----cceeccccCcccccccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 569 LNQSK-----AIKKAIRGTKGYVASPEWFRN----STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 569 ~~~~~-----~~~~~~~Gt~~y~aaPE~~~~----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
.+... ..+....||+.|++ ||.+.- ..++.|+||||+||++|..+.|++||......... +
T Consensus 625 ddSy~~vdGmeLTSQgAGTYWYLP-PEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI---------L 694 (775)
T KOG1151|consen 625 DDSYNSVDGMELTSQGAGTYWYLP-PECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI---------L 694 (775)
T ss_pred CCccCcccceeeecccCceeeecC-cceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH---------H
Confidence 65432 33456889999998 998853 35789999999999999999999999765432211 1
Q ss_pred hcCCccccccCcc-cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 640 RNGKLDDLVEGDM-EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 640 ~~g~~~~l~~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.... ++.... .....+........+|+.||+..-++|.+..++..
T Consensus 695 qeNT---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 QENT---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhhc---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111 111111 11122345567889999999999999998887754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=253.78 Aligned_cols=261 Identities=21% Similarity=0.257 Sum_probs=196.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCc--C----ceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH--K----NLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----nlv~l~~~~~~~ 486 (709)
+++|.....+|.|.|+.| ..... ......||||+++.+.. -.+..+-|++++.++.+ | -+|++.+++.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV-~ec~D--~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKV-VECWD--RETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccce-EEEee--cCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 344555555566666644 33222 24589999999987743 44567889999999842 2 278898999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC------------
Q 038905 487 QNRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD------------ 552 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~------------ 552 (709)
.+.++|+|.+ |-|+.++|.++. +++..++..++.|+++++++|| +.+++|.||||+|||+-+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999998 569999998765 5889999999999999999999 999999999999999931
Q ss_pred --------CCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 038905 553 --------YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEM 624 (709)
Q Consensus 553 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~ 624 (709)
+..+||+|||.|+.-.... ..++.|..|.| ||++.+..++.++||||+||+|.|+.+|...|....
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRA-PEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRA-PEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCC-chheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 3458999999998655443 67789999999 999999999999999999999999999999998776
Q ss_pred hhhHHhHHHHHHH--------------hhhcCCcc-----------ccccCcc----cccCCHHHHHHHHHHHHhcccCC
Q 038905 625 GEEYAILTDWAFD--------------CYRNGKLD-----------DLVEGDM----EAMNDIKCVEKLVMVSIWCIQED 675 (709)
Q Consensus 625 ~~~~~~~~~~~~~--------------~~~~g~~~-----------~l~~~~~----~~~~~~~~~~~l~~l~~~Cl~~d 675 (709)
..+...+.+.+.. .+..|+++ ...+... .......+...|.+++..||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 5443333332221 11111111 1111100 01123356778999999999999
Q ss_pred CCCCCCHHHHHH
Q 038905 676 PSLRPTMRKVSQ 687 (709)
Q Consensus 676 P~~RPs~~ev~~ 687 (709)
|.+|+|+.|+++
T Consensus 394 P~~RiTl~EAL~ 405 (415)
T KOG0671|consen 394 PARRITLREALS 405 (415)
T ss_pred ccccccHHHHhc
Confidence 999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-29 Score=271.66 Aligned_cols=244 Identities=25% Similarity=0.330 Sum_probs=188.5
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEe
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
|+....+|.|.-+++.|.|.. .++.||||++-. +......+|+..|..- .|||||++++.-.+.+.+|+..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y----e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY----EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee----CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 444455666666666799998 688999999754 2445678999999888 59999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCC----CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC---C--CCeEEccccccc
Q 038905 495 FLNNGTLASFLFENLK----PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---Y--YNAQISDFGLAK 565 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~----l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---~--~~~kl~DFGla~ 565 (709)
.|.. +|.+++..... ......+.+..|+++||++|| +.+||||||||+||||+. + .+++|+|||+++
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9965 99999987411 111345778899999999999 899999999999999975 3 569999999999
Q ss_pred cccccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhC-CCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 566 LLTLNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 566 ~~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
.+..+... .......||.||+| ||++....-+.++||+|+|||+|+.++| ..||......+.. +..|.
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~A-PE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N---------Il~~~ 729 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQA-PEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN---------ILTGN 729 (903)
T ss_pred ccCCCcchhhcccCCCCcccccC-HHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh---------hhcCc
Confidence 98876654 22367889999999 9999998888899999999999999987 7899744322211 11111
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..- .......++ ...++|..|+..+|..||++.+|+.
T Consensus 730 ~~L-----~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 YTL-----VHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cce-----eeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 100 011112222 7889999999999999999999953
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=270.99 Aligned_cols=263 Identities=19% Similarity=0.152 Sum_probs=165.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCC----ceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeE------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTR----TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGF------ 482 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~------ 482 (709)
.++|.....+|.|+|+.||.+... .+ +..+|||++..... .+...+| .+....+.+++.++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~---~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLV---NKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEc---CCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 667888888888888888666554 34 78899998764321 1111111 1111122222211111
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhCCC--------------------CChHHHHHHHHHHHHHHHHhhhcCCCCeEecC
Q 038905 483 CDEGQNRLLVYKFLNNGTLASFLFENLK--------------------PGWNLRANIAFQIARGLLHLHVNCSSQIIHCD 542 (709)
Q Consensus 483 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~D 542 (709)
+.++...++||||+.+++|.+++..... .....+..++.||+.||.||| +++|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCc
Confidence 3456788999999999999999875421 112335678999999999999 88999999
Q ss_pred CCCCceeecC-CCCeEEccccccccccccccccceeccccCcccccccccccCC----------------------CCCc
Q 038905 543 IKPQNILLDD-YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS----------------------TITA 599 (709)
Q Consensus 543 lkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~----------------------~~s~ 599 (709)
|||+|||++. ++.+||+|||+|+.+....... .....|++.|+| ||.+... .+..
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~A-PE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAA-PEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccC-hHHhhccCCCCCCccccccccccchhccccCCC
Confidence 9999999986 5899999999998765433222 256789999999 9965322 2345
Q ss_pred ccchHHHHHHHHHHHhCCCCCCccchhhHHhHHH--HHHHhhhcCCccccccCccc--ccCCHHHHHHHHHHHHhcccCC
Q 038905 600 NVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--WAFDCYRNGKLDDLVEGDME--AMNDIKCVEKLVMVSIWCIQED 675 (709)
Q Consensus 600 k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~g~~~~l~~~~~~--~~~~~~~~~~l~~l~~~Cl~~d 675 (709)
++|||||||+||||+++..+.+.........+.. .-...|....... ...... ............+|+.+||+.|
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-ASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 6799999999999999776654221110000000 0000010000000 000000 0000011234568999999999
Q ss_pred CCCCCCHHHHHHH
Q 038905 676 PSLRPTMRKVSQM 688 (709)
Q Consensus 676 P~~RPs~~ev~~~ 688 (709)
|++|||++++++.
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999883
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=238.75 Aligned_cols=262 Identities=17% Similarity=0.221 Sum_probs=192.7
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc--ccchhHHHHHHHHHHHhccCcCceeEEEeEEEcC--------C
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR--VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--------Q 487 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--------~ 487 (709)
+.-.+|+|.|++||.+... ..++.||+|+.-. ....--....+|+.+|..+.|+|++.+++.|... .
T Consensus 21 k~~kigqGtfgeVFkAr~~---n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 21 KLAKIGQGTFGEVFKARSK---NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHhcCCchHHHHHHHhhc---CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445778888877766555 5677788887532 2222235678999999999999999999988532 3
Q ss_pred eEEEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
..+||+++|+. +|..+|... .+++..++.++..+++.||.|+| +..|+|||+||+|+|++.++.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 47999999987 898888776 57999999999999999999999 99999999999999999999999999999987
Q ss_pred ccccccc--cceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH-----h
Q 038905 567 LTLNQSK--AIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----C 638 (709)
Q Consensus 567 ~~~~~~~--~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----~ 638 (709)
+...... ...+..+-|..|.+ ||.+.+. .|+++.|||.-||++.||.++.+.+..........++...-. .
T Consensus 174 fs~~~n~~kprytnrvvTLwYrp-pEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRP-PELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred eecccccCCCCcccceeeeecCC-HHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 7543322 11234455888998 9988764 699999999999999999999999987766554444333211 1
Q ss_pred hhcCCc---------cccccCccc----ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNGKL---------DDLVEGDME----AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g~~---------~~l~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
|.+-+- +.+...... ...+........+++..++..||.+|+++++++.
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 111110 001111000 0001122346778999999999999999998864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=215.97 Aligned_cols=263 Identities=18% Similarity=0.211 Sum_probs=190.5
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+.+...+|.|.+++||.+... .....||+|+..... +.......+|+.+++.++|.|||+++++...+....||+
T Consensus 4 ydkmekigegtygtvfkarn~---~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred hHHHHhhcCCcceeeEecccC---CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 444556777777777555444 578899999875432 223367889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||+. +|..+... ++.++.+....++.|+++||.++| ++.+.|||+||+|.|++.+|..|++|||+++.++-...
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 99965 78777754 456899999999999999999999 99999999999999999999999999999998875442
Q ss_pred ccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCC---cccc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK---LDDL 647 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~---~~~l 647 (709)
.. ...+-|..|.+ |.++.+. .|+...|+||-||++.|+.. |++.|...+..+.....-+......+.. +..+
T Consensus 157 cy--saevvtlwyrp-pdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 CY--SAEVVTLWYRP-PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ee--eceeeeeeccC-cceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 21 34455777887 9998765 58999999999999999986 5555544443333322222221111111 2223
Q ss_pred ccCcccccCC---------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 648 VEGDMEAMND---------IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 648 ~~~~~~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.|...-..++ +.....=.+++...+.-+|..|.++++.++.
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 3332211111 1122233566777777799999999988763
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=260.02 Aligned_cols=263 Identities=21% Similarity=0.165 Sum_probs=178.7
Q ss_pred cccccceeeeecCeeEEEEEEEEEE-------------ecCCCceEEEEEEcccccchhHHHH--------------HHH
Q 038905 412 NMMNVTRSVLLGSSVFVNFTLVGVI-------------QTSTRTTVIVVKKLDRVFQDGEKEF--------------KNE 464 (709)
Q Consensus 412 ~~~~f~~~~~~G~g~~~~v~~~~~~-------------~~~~~~~~vavK~~~~~~~~~~~~~--------------~~E 464 (709)
..++|.....+|+|+|+.||..... .....++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3778888888888888888554321 1123456899999865433322333 346
Q ss_pred HHHHhccCcCce-----eEEEeEEEc--------CCeEEEEEeecCCCCHHHHHhhCC----------------------
Q 038905 465 VVMIGQTYHKNL-----VRLLGFCDE--------GQNRLLVYKFLNNGTLASFLFENL---------------------- 509 (709)
Q Consensus 465 ~~~l~~l~h~nl-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------- 509 (709)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777776654 677777743 356899999999999999886421
Q ss_pred --CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCccccc
Q 038905 510 --KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA 587 (709)
Q Consensus 510 --~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~a 587 (709)
.+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+........ ....+++.|++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeC
Confidence 1356678889999999999999 88999999999999999999999999999976543322111 22345889999
Q ss_pred ccccccCCCC----------------------CcccchHHHHHHHHHHHhCCC-CCCccch--hhHHh--HHHHHHHhhh
Q 038905 588 SPEWFRNSTI----------------------TANVDVYSFGVLLLEIISCRK-SFDIEMG--EEYAI--LTDWAFDCYR 640 (709)
Q Consensus 588 aPE~~~~~~~----------------------s~k~DvwSlGvvl~elltg~~-p~~~~~~--~~~~~--~~~~~~~~~~ 640 (709)
||.+..... ..+.||||+||++++|+++.. |+..... .+... .....|+.+.
T Consensus 379 -PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 379 -PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred -hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 998753221 134799999999999999875 6643211 01000 0001122222
Q ss_pred cCCccccccCcccccCCHHHHHHHHHHHHhcccCCC---CCCCCHHHHHH
Q 038905 641 NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDP---SLRPTMRKVSQ 687 (709)
Q Consensus 641 ~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~ev~~ 687 (709)
..+.. ........+...+++..+|..+| .+|+|++|+++
T Consensus 458 ~~~~~--------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQKYD--------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccCCC--------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 22211 11122345678899999998766 68999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=221.24 Aligned_cols=194 Identities=23% Similarity=0.340 Sum_probs=158.6
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEccc-ccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR-VFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
.-+|.|+.+ .+....+.+.++..|+|++.. ...+..++..+|+.+..+. .+|.+|.++|........++.||.|+
T Consensus 52 ~elGrGayG---~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 52 EELGRGAYG---VVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhcCCccc---hhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 346777666 333333347899999999864 3445667888999876664 79999999999988899999999995
Q ss_pred CCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 498 NGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 498 ~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
- ||+.+-.+ ....++...-+|+..|..||.|||+ +..+||||+||.|||++.+|++||||||.+-.+...-..
T Consensus 129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 4 88776543 3458888899999999999999996 568999999999999999999999999999877543322
Q ss_pred cceeccccCccccccccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 038905 574 AIKKAIRGTKGYVASPEWFR----NSTITANVDVYSFGVLLLEIISCRKSFDIE 623 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~----~~~~s~k~DvwSlGvvl~elltg~~p~~~~ 623 (709)
+...|-..|+| ||.+. ...|+.|+||||||+.+.||.+++.|++..
T Consensus 206 ---t~daGCkpYma-PEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 206 ---TMDAGCKPYMA-PERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ---HHhcCCCccCC-hhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 44678899999 99985 346899999999999999999999999754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=236.41 Aligned_cols=264 Identities=21% Similarity=0.299 Sum_probs=192.8
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhc--cCcCceeEEEeEEEcCC----eE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQ--TYHKNLVRLLGFCDEGQ----NR 489 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nlv~l~~~~~~~~----~~ 489 (709)
......+|+|-||+| ..|.+ .+..||||++..- +++.+.+|.+|..- |+|+||+.+++.-..+. ++
T Consensus 213 I~L~e~IGkGRyGEV-wrG~w----rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEV-WRGRW----RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred eEEEEEecCccccce-eeccc----cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 334445566666666 56666 5889999998653 45677788777654 69999999998765443 57
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhh-----cCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHV-----NCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~-----~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
+||.+|.++|||.+||.+ ..++.+..++++..+|.||++||. +.+..|.|||||..|||+..++...|+|+|||
T Consensus 285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 899999999999999987 578889999999999999999994 44567999999999999999999999999999
Q ss_pred ccccccccc--cceeccccCcccccccccccCCC----C-C-cccchHHHHHHHHHHHh----------CCCCCCccchh
Q 038905 565 KLLTLNQSK--AIKKAIRGTKGYVASPEWFRNST----I-T-ANVDVYSFGVLLLEIIS----------CRKSFDIEMGE 626 (709)
Q Consensus 565 ~~~~~~~~~--~~~~~~~Gt~~y~aaPE~~~~~~----~-s-~k~DvwSlGvvl~ellt----------g~~p~~~~~~~ 626 (709)
.....+... ...+..+||..||| ||++.... + + ..+||||||.|+||+.. -+.||...-+.
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMA-PEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMA-PEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred EEecccCCcccCCCCCccceeeccC-hHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 766544221 12256789999999 99996542 2 2 35999999999999974 24555433221
Q ss_pred hHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 627 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 627 ~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+... +.+.+.+--.+.+..+.. .....+....+.++++.||..+|.-|.|+-.+-+.|.++.+
T Consensus 443 DPs~--eeMrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DPSF--EEMRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCH--HHHhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1110 001111111111111111 22344678889999999999999999999999998887765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=235.15 Aligned_cols=262 Identities=23% Similarity=0.260 Sum_probs=192.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC--------cCceeEEEeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY--------HKNLVRLLGFCD 484 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nlv~l~~~~~ 484 (709)
..+|...+.+|.|.|.+||++-.. +..+-||+|+.+.. +.-.+....|+++|++++ ..+||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDt---q~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDT---QNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred CceEEEEEeccccccceeEEEeec---cCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 456777888999999999999988 67888999987654 234466789999999883 346999999985
Q ss_pred ----cCCeEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-----
Q 038905 485 ----EGQNRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY----- 553 (709)
Q Consensus 485 ----~~~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~----- 553 (709)
.+.|+++|+|++ |..|..+|.... .++...+.+|++||+.||.|||++| +|||.||||+||||-.+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence 578999999998 668888887654 5899999999999999999999866 99999999999999210
Q ss_pred ------C-------------------------------------------------------------------------
Q 038905 554 ------Y------------------------------------------------------------------------- 554 (709)
Q Consensus 554 ------~------------------------------------------------------------------------- 554 (709)
+
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 038905 555 -------------------------------------------------------------------------------- 554 (709)
Q Consensus 555 -------------------------------------------------------------------------------- 554 (709)
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence
Q ss_pred --CeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhH----
Q 038905 555 --NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY---- 628 (709)
Q Consensus 555 --~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~---- 628 (709)
.+||+|||-|.-..... +.-.-|..|.| ||++.+..|+..+||||++|+++||+||...|++...+.+
T Consensus 390 di~vKIaDlGNACW~~khF-----T~DIQTRQYRa-pEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHKHF-----TEDIQTRQYRA-PEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred ceeEEEeeccchhhhhhhh-----chhhhhhhccC-cceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 02333333333222211 22335678998 9999999999999999999999999999999987654221
Q ss_pred ---HhHHHHH----HHhhhcCCc-cccccCcc-------------------cccCCHHHHHHHHHHHHhcccCCCCCCCC
Q 038905 629 ---AILTDWA----FDCYRNGKL-DDLVEGDM-------------------EAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681 (709)
Q Consensus 629 ---~~~~~~~----~~~~~~g~~-~~l~~~~~-------------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 681 (709)
+.+.+.. +.....|+. +++++.+- .-....+....+.+++.-||+.+|++|||
T Consensus 464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 1111111 122222321 22222210 11123567888999999999999999999
Q ss_pred HHHHHH
Q 038905 682 MRKVSQ 687 (709)
Q Consensus 682 ~~ev~~ 687 (709)
+.+.++
T Consensus 544 A~~cl~ 549 (590)
T KOG1290|consen 544 AAQCLK 549 (590)
T ss_pred HHHHhc
Confidence 999886
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-28 Score=232.13 Aligned_cols=265 Identities=22% Similarity=0.240 Sum_probs=196.5
Q ss_pred ceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch--hHHHHHHHHHHHhccCcCceeEEEeEEEcC-----CeE
Q 038905 417 TRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD--GEKEFKNEVVMIGQTYHKNLVRLLGFCDEG-----QNR 489 (709)
Q Consensus 417 ~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~-----~~~ 489 (709)
.-.+.+|-|.||-||-+... .+++.||+|++....+. ..+.+.+|+++|..++|.|++..++..+-. ++.
T Consensus 56 ~PDRPIGYGAFGVVWsVTDP---RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDP---RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCCcccccceeEEEeccCC---CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 33467888888877777665 68999999999765433 447889999999999999999988877543 346
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
|+|+|.|.. +|.+.|-....++...+.-++.||++||+||| +.+|.||||||.|.|++.+-.+||+|||+|+.-..
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence 788898865 88888877778899999999999999999999 99999999999999999999999999999998776
Q ss_pred cccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHH--------------
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW-------------- 634 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~-------------- 634 (709)
++...+ +..+-|..|.| ||.+++. .|+.++||||.||++.|++..+..|......+...++..
T Consensus 209 d~~~hM-TqEVVTQYYRA-PEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 209 RDRLNM-THEVVTQYYRA-PELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhh-HHHHHHHHhcc-HHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 665544 45566888888 9999875 699999999999999999988888876554322211111
Q ss_pred --HHHhhhcCCccccccCcc-cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 635 --AFDCYRNGKLDDLVEGDM-EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 635 --~~~~~~~g~~~~l~~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
+..++..+-.+.--.+.+ ..........+...+.++++..||.+|.+..+.+..+.
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111111111000111 11111122234556777889999999999988887653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-25 Score=219.76 Aligned_cols=210 Identities=32% Similarity=0.479 Sum_probs=179.8
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+|.|.++.||.+... ..++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++
T Consensus 1 l~~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDK---KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEec---CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 356666766555444 35888999998765432 35789999999999999999999999999999999999999999
Q ss_pred HHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-CCCeEEccccccccccccccccceec
Q 038905 501 LASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-YYNAQISDFGLAKLLTLNQSKAIKKA 578 (709)
Q Consensus 501 L~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 578 (709)
|.+++... ..++...+..++.++++++.+|| +.+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99999876 46889999999999999999999 889999999999999999 89999999999987654321 1144
Q ss_pred cccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 579 IRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
..+...|++ ||.+... ..+.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~-pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMA-PEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred ccCCCCccC-hhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 567888998 9999887 888999999999999999
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 467789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=229.71 Aligned_cols=252 Identities=24% Similarity=0.271 Sum_probs=187.0
Q ss_pred CCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEE------cCCeEEEEEeecCCCCHHHHHhhCCCC
Q 038905 440 TRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCD------EGQNRLLVYKFLNNGTLASFLFENLKP 511 (709)
Q Consensus 440 ~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~------~~~~~~lV~Ey~~~gsL~~~l~~~~~l 511 (709)
-.++.||+|++... .....++..+|...+..++|+|+++++.++. +-...|+|||||.. +|...+. ..+
T Consensus 39 v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~--~el 115 (369)
T KOG0665|consen 39 VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL--MEL 115 (369)
T ss_pred hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH--Hhc
Confidence 57889999998654 2344577899999999999999999999984 23457999999965 8888776 457
Q ss_pred ChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCccccccccc
Q 038905 512 GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEW 591 (709)
Q Consensus 512 ~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~ 591 (709)
+-+....|+.|++.|++||| +.+|+||||||+||++..+..+||.|||+|+.-..+ ...+....|+.|.| ||+
T Consensus 116 DH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyra-pev 188 (369)
T KOG0665|consen 116 DHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRA-PEV 188 (369)
T ss_pred chHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccC-chh
Confidence 78888999999999999999 999999999999999999999999999999865433 22366788899998 999
Q ss_pred ccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhh-HH---------------hHHHHHHHhhhc------CCcc-ccc
Q 038905 592 FRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YA---------------ILTDWAFDCYRN------GKLD-DLV 648 (709)
Q Consensus 592 ~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~-~~---------------~~~~~~~~~~~~------g~~~-~l~ 648 (709)
+.+..+.+.+||||+||++.||++|.--|.+...-+ +. .+...+....+. -... .+.
T Consensus 189 il~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fp 268 (369)
T KOG0665|consen 189 ILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFP 268 (369)
T ss_pred eeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCC
Confidence 999889999999999999999999998876544311 11 111111111110 0000 111
Q ss_pred cCccc--ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc-----ccccCCCCCCC
Q 038905 649 EGDME--AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE-----VVVEVDVPPNP 701 (709)
Q Consensus 649 ~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~-----~~~~~~~p~~p 701 (709)
|.... ..........+.+++..||..+|++|.++++++..-- ...+++.|+.|
T Consensus 269 D~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 269 DSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred cccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence 11111 1112234556889999999999999999999998532 33456666655
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=228.67 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=188.5
Q ss_pred ecCeeEEEEEEEEEEecC---CCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEE-cCCeEEEEEeec
Q 038905 422 LGSSVFVNFTLVGVIQTS---TRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCD-EGQNRLLVYKFL 496 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~-~~~~~~lV~Ey~ 496 (709)
+-.|.||.| |.|.+... .+.+.|-+|.++... +-....+..|.-.+..++|||+..+.+++. +....+.+|.++
T Consensus 292 lqEGtFGri-~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~ 370 (563)
T KOG1024|consen 292 LQEGTFGRI-YRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPAT 370 (563)
T ss_pred hhcCchhhe-eeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEecc
Confidence 334444555 55544221 234556666665432 334467889999999999999999999985 456779999999
Q ss_pred CCCCHHHHHhh-----CC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 497 NNGTLASFLFE-----NL---KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 497 ~~gsL~~~l~~-----~~---~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.-|.|..++.. .. .++..+...++.|++.|+.||| +++|||.||.++|+++|+...+||+|=.+++.+-
T Consensus 371 ~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF 447 (563)
T KOG1024|consen 371 GVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLF 447 (563)
T ss_pred CcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccccC
Confidence 99999999982 21 2566677889999999999999 9999999999999999999999999999998653
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
..+-.......-....||+ ||.+.+..|+.++|||||||+||||+| |+.|+...++.+... .+..
T Consensus 448 P~DYhcLGDnEnRPvkWMs-lEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-------ylkd------ 513 (563)
T KOG1024|consen 448 PGDYHCLGDNENRPVKWMS-LEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-------YLKD------ 513 (563)
T ss_pred cccccccCCCCCCcccccC-HHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-------HHhc------
Confidence 2221111111122356898 999999999999999999999999997 788887655544221 1222
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
..+...+.++++++..++.-||...|++||+++|++.-|.+.
T Consensus 514 ---GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 514 ---GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ---cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 223334667899999999999999999999999999988753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=238.85 Aligned_cols=196 Identities=22% Similarity=0.298 Sum_probs=169.3
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--------chhHHHHHHHHHHHhccC---cCceeEEEeEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--------QDGEKEFKNEVVMIGQTY---HKNLVRLLGFC 483 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~nlv~l~~~~ 483 (709)
.|.....+|.|.+|.|+++.+. .....|+||.+.+.. ....-.+-.|++||+.++ |+||++++.+|
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K---~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHK---ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred cceeeeeccccccceEEEeeec---ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4566778888899988888877 568999999886531 111123567999999997 99999999999
Q ss_pred EcCCeEEEEEeec-CCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccc
Q 038905 484 DEGQNRLLVYKFL-NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562 (709)
Q Consensus 484 ~~~~~~~lV~Ey~-~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 562 (709)
++++..||+||-. ++.+|.++|..+..+++.+...|++||+.|+++|| +.+|||||||-+|+.++.+|-+||+|||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence 9999999999965 56799999999999999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCCC-cccchHHHHHHHHHHHhCCCCCC
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTIT-ANVDVYSFGVLLLEIISCRKSFD 621 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s-~k~DvwSlGvvl~elltg~~p~~ 621 (709)
.|...+...- ..++||.+|.| ||++.+.+|- ..-|||++|++||-++....||.
T Consensus 716 saa~~ksgpf----d~f~gtv~~aa-pevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPF----DVFVGTVDYAA-PEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCc----ceeeeeccccc-hhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987654432 57899999998 9999999884 56899999999999998888875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=210.22 Aligned_cols=259 Identities=17% Similarity=0.240 Sum_probs=184.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCC--eE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQ--NR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~--~~ 489 (709)
.++|.....+|.|-+.+||-...+ .+...++||.++.. ..+.+.+|+.||..|. ||||++++++..+.. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~---~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINI---TNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhccccc---CCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 455665556667766666544444 46788899998865 4578999999999998 999999999987654 45
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~ 568 (709)
.||+||+.+.+...+.. .++...+..+..+++.||.|+| +.||+|||+||.|+++|... .++|+|+|+|....
T Consensus 111 aLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 79999999988766542 4777788899999999999999 99999999999999998654 59999999998776
Q ss_pred ccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchh-hHH-h---------HHHHHH
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGE-EYA-I---------LTDWAF 636 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~-~~~-~---------~~~~~~ 636 (709)
...+- ...+.+..|-- ||.+.+. .|+..-|+|||||+|.+|+..+.||-...+. +.. . +..++.
T Consensus 185 p~~eY---nVRVASRyfKG-PELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEY---NVRVASRYFKG-PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCcee---eeeeehhhcCC-chheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 55432 22233444444 9998765 5789999999999999999999998654431 111 0 111110
Q ss_pred --HhhhcCCccccccCc--------ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 637 --DCYRNGKLDDLVEGD--------MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 637 --~~~~~g~~~~l~~~~--------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......+..+++... +..........+.++++...|..|-++|||++|...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 001111112211111 111111123467889999999999999999999865
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=232.49 Aligned_cols=261 Identities=20% Similarity=0.192 Sum_probs=194.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC------cCceeEEEeEEEcCC
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY------HKNLVRLLGFCDEGQ 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nlv~l~~~~~~~~ 487 (709)
..|......|.|.|++|.-+... ..+..||||++... +-..+.=..|++||++|+ --|.++++..|...+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~---~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQ---ARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred ceeEEEeccccceeeeeeecccc---CCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 45566667788888877555444 55669999998753 223455678999999996 347899999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-CCeEEccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENL---KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-YNAQISDFGL 563 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGl 563 (709)
|+|||+|-+ ...|.+.|.+.+ .+....+..++.|+..||..|. ..+|+|+||||+|||+++. ..+||||||.
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcc
Confidence 999999977 448999998765 4888899999999999999999 8899999999999999865 5689999999
Q ss_pred cccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH-----Hh
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----DC 638 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----~~ 638 (709)
|.....++- +-..-+..|.| ||++.+.+|+...|+||.||.||||.||+..|..........+.-.+. .+
T Consensus 584 A~~~~enei----tPYLVSRFYRa-PEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 584 ASFASENEI----TPYLVSRFYRA-PEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred ccccccccc----cHHHHHHhccC-cceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 987765442 23334566777 999999999999999999999999999999887665443322211111 11
Q ss_pred hhcCCccc---------------------------cccC------cc-----cccCCHHHHHHHHHHHHhcccCCCCCCC
Q 038905 639 YRNGKLDD---------------------------LVEG------DM-----EAMNDIKCVEKLVMVSIWCIQEDPSLRP 680 (709)
Q Consensus 639 ~~~g~~~~---------------------------l~~~------~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 680 (709)
++.|...+ .+.+ .+ ...........+.+|+..|+..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 11111100 0111 00 0011234667788999999999999999
Q ss_pred CHHHHHH
Q 038905 681 TMRKVSQ 687 (709)
Q Consensus 681 s~~ev~~ 687 (709)
|..++++
T Consensus 739 t~nqAL~ 745 (752)
T KOG0670|consen 739 TVNQALK 745 (752)
T ss_pred CHHHHhc
Confidence 9999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-24 Score=212.74 Aligned_cols=196 Identities=28% Similarity=0.402 Sum_probs=167.2
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecC
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
...+|.|+++.||.+... ..+..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 4 ~~~i~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 4 GKKLGEGAFGKVYLARDK---GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred eeEeecCCCeEEEEEEEc---CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 345566666666555444 35788999998765544 57789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCC-CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccce
Q 038905 498 NGTLASFLFENLK-PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576 (709)
Q Consensus 498 ~gsL~~~l~~~~~-l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 576 (709)
+++|.+++..... +++.....++.+++.++.+|| ..+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 9999999987766 899999999999999999999 789999999999999999999999999999877654311 11
Q ss_pred eccccCcccccccccc-cCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 038905 577 KAIRGTKGYVASPEWF-RNSTITANVDVYSFGVLLLEIISCRKSFDI 622 (709)
Q Consensus 577 ~~~~Gt~~y~aaPE~~-~~~~~s~k~DvwSlGvvl~elltg~~p~~~ 622 (709)
....++..|++ ||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~-pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLA-PEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCC-HhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 44567888998 9998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-26 Score=240.46 Aligned_cols=254 Identities=20% Similarity=0.204 Sum_probs=207.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|+|.++.||.+... ..+...|||.++....+...-+.+|+-+++..+|+|||.++|.+...+..++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~---~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDK---RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhccc---ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 456776777899999999777777 56777777777776667778889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||||.+|+|.+.-+-.+++++.++....++.++|++||| +.+-+|||||-.|||+.+.|.+|++|||.+-.++..-.
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence 999999999998888889999999999999999999999 89999999999999999999999999999877765433
Q ss_pred ccceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 573 KAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
+. ..+.||+.||| ||+.. ...|..++|||++|+...|+---++|....+......+. . ....+
T Consensus 168 Kr--ksfiGtpywma-pEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--------T---kS~~q 233 (829)
T KOG0576|consen 168 KR--KSFIGTPYWMA-PEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--------T---KSGFQ 233 (829)
T ss_pred hh--hcccCCccccc-hhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--------h---ccCCC
Confidence 22 67899999999 99874 567999999999999999998877776544433322211 0 01111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+ ..........+.+.++++.|+-.+|.+||+++.+++
T Consensus 234 p-p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 P-PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C-CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 111123456778899999999999999999988765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=262.65 Aligned_cols=195 Identities=18% Similarity=0.211 Sum_probs=139.3
Q ss_pred ccCc-CceeEEEeEE-------EcCCeEEEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 038905 470 QTYH-KNLVRLLGFC-------DEGQNRLLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIH 540 (709)
Q Consensus 470 ~l~h-~nlv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH 540 (709)
.++| .||++++++| .+....++++||+ +++|.++|... ..+++.++..++.||++||.||| +++|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 4455 5777778777 2334567888987 55999999754 35899999999999999999999 899999
Q ss_pred cCCCCCceeecC-------------------CCCeEEccccccccccccccc--------------cceeccccCccccc
Q 038905 541 CDIKPQNILLDD-------------------YYNAQISDFGLAKLLTLNQSK--------------AIKKAIRGTKGYVA 587 (709)
Q Consensus 541 ~Dlkp~NIll~~-------------------~~~~kl~DFGla~~~~~~~~~--------------~~~~~~~Gt~~y~a 587 (709)
|||||+||||+. ++.+||+|||+++........ .......||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 445667777776543210000 00122468999999
Q ss_pred ccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHH
Q 038905 588 SPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMV 667 (709)
Q Consensus 588 aPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l 667 (709)
||++.+..++.++|||||||+||||++|..|+..... .... +.... ..+. ..........+
T Consensus 184 -PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~-----~~~~~----~~~~-----~~~~~~~~~~~ 244 (793)
T PLN00181 184 -PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS-----LRHRV----LPPQ-----ILLNWPKEASF 244 (793)
T ss_pred -hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH-----HHHhh----cChh-----hhhcCHHHHHH
Confidence 9999999999999999999999999998887642211 0000 00000 0000 01122345678
Q ss_pred HHhcccCCCCCCCCHHHHHH
Q 038905 668 SIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 668 ~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+.+||+.+|.+||+|.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 88999999999999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-25 Score=210.97 Aligned_cols=252 Identities=19% Similarity=0.259 Sum_probs=185.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeE-EEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGF-CDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~-~~~~~~~~l 491 (709)
+.|....-+|.|-|+.+-++.+. +..+.+|+|-..... ...++|.+|...--.| .|.||+..+++ |+..+..++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr---~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHR---QSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeecc---CCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 34444444555556644455555 788999999987754 3668899998665455 58999988765 677778889
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec--CCCCeEEccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD--DYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DFGla~~~~~ 569 (709)
++||++-|+|.+-+.. ..+.+....+++.|+++||.|+| ++.+||||||.+|||+- +...+||+|||+.+..+.
T Consensus 100 ~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999998865 34667778899999999999999 99999999999999993 445799999999876543
Q ss_pred cccccceeccccCcccccccccccC---C--CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRN---S--TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~---~--~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
.- ...-.+-.|.+ ||.... . ...+.+|+|.||++++.+++|..||......+ ...|-|..|..++.
T Consensus 176 tV-----~~~~~~~~y~~-pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 176 TV-----KYLEYVNNYHA-PELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKRKN 246 (378)
T ss_pred ee-----hhhhhhcccCC-cHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcccC
Confidence 22 23334566787 776542 2 35778999999999999999999998433222 23456677777776
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..+.+. .....+++.++.++-+..++++|--+-++-++
T Consensus 247 ~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 PALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 655443 22345677888888899999999544444443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=199.48 Aligned_cols=166 Identities=22% Similarity=0.171 Sum_probs=126.2
Q ss_pred CCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccccee
Q 038905 499 GTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577 (709)
Q Consensus 499 gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 577 (709)
|+|.+++.+++ .+++..+..++.||+.||.||| +.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence 68999998744 5999999999999999999999 555 999999999999999 9999876432
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
...||+.|+| ||++.+..++.++|||||||++|||++|+.||........ .+. .+..+........ ....
T Consensus 63 ~~~g~~~y~a-PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~-----~~~~~~~~~~~~~---~~~~ 132 (176)
T smart00750 63 QSRVDPYFMA-PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILE-----ILLNGMPADDPRD---RSNL 132 (176)
T ss_pred cCCCcccccC-hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHH-----HHHHHhccCCccc---cccH
Confidence 2368999999 9999999999999999999999999999999865432111 010 1111111100000 0011
Q ss_pred HHHHH--HHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 658 IKCVE--KLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 658 ~~~~~--~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
..... .+.+++..|++.+|.+||++.++++.+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 22233 689999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-23 Score=209.18 Aligned_cols=264 Identities=22% Similarity=0.280 Sum_probs=188.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.|...-.+|.|.|..||.+...........||+|.+.... ...++.+|+++|..+. +.||+++.+++..++...+|+
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL 114 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence 3444445556666655444333222367889999987653 4567999999999995 999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-CCCeEEccccccccccccc-
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-YYNAQISDFGLAKLLTLNQ- 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~- 571 (709)
||+++.+..++..+ ++...+..+++.+..||.++| ..|||||||||.|+|.+. .+.-.|.|||+|.......
T Consensus 115 p~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred cccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 99999999988875 678889999999999999999 999999999999999974 4668899999997211000
Q ss_pred -----------------------------------------cccceeccccCcccccccccccCC-CCCcccchHHHHHH
Q 038905 572 -----------------------------------------SKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVL 609 (709)
Q Consensus 572 -----------------------------------------~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvv 609 (709)
.........||+||.| ||++... ..++++||||.||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRa-PEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRA-PEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCc-hHHHhhccCcCCccceeeccce
Confidence 0001123569999998 9998755 57899999999999
Q ss_pred HHHHHhCCCCCCccchh-----hHHhHHHH---HHHhhhcCC--c------ccc---------c--cC----c----ccc
Q 038905 610 LLEIISCRKSFDIEMGE-----EYAILTDW---AFDCYRNGK--L------DDL---------V--EG----D----MEA 654 (709)
Q Consensus 610 l~elltg~~p~~~~~~~-----~~~~~~~~---~~~~~~~g~--~------~~l---------~--~~----~----~~~ 654 (709)
++.+++++.||....++ +...+... ..-....|. + ..+ + .. . ...
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999998654331 11111000 000111122 0 000 0 00 0 000
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......+..+.+++.+|+..||.+|.|+++.++
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 111223457899999999999999999999986
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-22 Score=177.55 Aligned_cols=87 Identities=36% Similarity=0.570 Sum_probs=61.8
Q ss_pred CCcEEEEccCCCCCCCCC---CCcEEEEecCccEEEEcCCCcEEEee-c----c---E----------EEeccCCceeee
Q 038905 80 KKIVVWYTDNEDQNPVVP---RGSQVKLTADQGLVLNDPQGKQVWSS-K----L---I----------LVQSFSSSRLWD 138 (709)
Q Consensus 80 ~~t~VW~Anr~~~~~p~~---~~~~L~l~~~G~L~l~~~~g~~vWss-~----~---~----------vl~~~~~~~lWQ 138 (709)
++||||+|||+ .|+. ..++|.|..||+|+|.|+.++++|++ + . . ||+|..+.+|||
T Consensus 1 ~~tvvW~an~~---~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~ 77 (114)
T PF01453_consen 1 PRTVVWVANRN---SPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQ 77 (114)
T ss_dssp ---------TT---EEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEE
T ss_pred Ccccccccccc---cccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEe
Confidence 37999999999 8884 34899999999999999999999999 3 1 1 888988999999
Q ss_pred ecCCCCCccCCCcccCC----C--ceEEecCCCCCCC
Q 038905 139 SFSNPTDTLLPGKMMET----E--QGLFSGKSDTNFS 169 (709)
Q Consensus 139 SFd~PtDtlLpgq~l~~----~--~~L~S~~s~~dps 169 (709)
||||||||+||||+|+. + ..|+||++.+|||
T Consensus 78 Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 78 SFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp STTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred ecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999886 2 4599999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-19 Score=193.07 Aligned_cols=259 Identities=19% Similarity=0.168 Sum_probs=193.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCc----CceeEEEeEE-EcCCeE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH----KNLVRLLGFC-DEGQNR 489 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nlv~l~~~~-~~~~~~ 489 (709)
+|.....+|.|+|+.||.+...... ...+|+|............+..|+.++..+.. +++.+++... ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 7888889999999999888776432 56778887655433333378899999988873 6888999888 577788
Q ss_pred EEEEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-----CCeEEcccc
Q 038905 490 LLVYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-----YNAQISDFG 562 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~DFG 562 (709)
++||+.+ |.+|.++.... ..++..+...|+.|++.+|.+|| +.|++||||||+|+++... ..+.|.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999987 77999988554 46999999999999999999999 9999999999999999865 459999999
Q ss_pred ccc--ccccccc------ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchh-hHHhHHH
Q 038905 563 LAK--LLTLNQS------KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTD 633 (709)
Q Consensus 563 la~--~~~~~~~------~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~-~~~~~~~ 633 (709)
+++ .+..... +.....++||..|.+ +....+...+.+.|+||++.++.|++.|..||...... ....+..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S-~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYAS-INVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCcccccc-HHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 998 3322211 111235779999998 99999999999999999999999999999999654321 1111110
Q ss_pred HHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 634 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 634 ~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
... ...... .....+..+.++...+-..+..++|....+...|....
T Consensus 252 ~~~--------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 252 DPR--------KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred Hhh--------hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 000 000000 11223345566666666689999999999999887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=197.88 Aligned_cols=166 Identities=20% Similarity=0.138 Sum_probs=125.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-----cchhHHHHHHHHHHHhccCcCceeE-EEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-----FQDGEKEFKNEVVMIGQTYHKNLVR-LLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nlv~-l~~~~~~~ 486 (709)
..+|.....+|.|+|+.||.+.... .++..+|||++... .....+.+.+|++++.+++|+|++. ++..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAG--DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcC--CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 4567777778888888887665542 24667899986532 1223567999999999999999985 4432
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCC-CCCceeecCCCCeEEccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDI-KPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~DFGla~ 565 (709)
...+|||||++|++|... . ... ...++.++++||.||| +.+|+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 457999999999999632 1 111 2467889999999999 899999999 9999999999999999999999
Q ss_pred cccccccccc------eeccccCcccccccccccCC
Q 038905 566 LLTLNQSKAI------KKAIRGTKGYVASPEWFRNS 595 (709)
Q Consensus 566 ~~~~~~~~~~------~~~~~Gt~~y~aaPE~~~~~ 595 (709)
.+........ .+...+++.|++ ||++...
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~-pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYA-PDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCC-cccCChh
Confidence 7765432111 146778899998 9998643
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=166.00 Aligned_cols=99 Identities=26% Similarity=0.469 Sum_probs=85.7
Q ss_pred CccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEecCccEEEE
Q 038905 34 STLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLN 113 (709)
Q Consensus 34 ~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~~G~L~l~ 113 (709)
++|.. +++|+|++|.|++|||++.. ...++++|||.+.+ +++||.||++ .|....++|.|+.||+|+|.
T Consensus 2 ~~l~~---~~~l~s~~~~f~~G~~~~~~----q~~dgnlv~~~~~~-~~~vW~snt~---~~~~~~~~l~l~~dGnLvl~ 70 (116)
T cd00028 2 NPLSS---GQTLVSSGSLFELGFFKLIM----QSRDYNLILYKGSS-RTVVWVANRD---NPSGSSCTLTLQSDGNLVIY 70 (116)
T ss_pred cCcCC---CCEEEeCCCcEEEecccCCC----CCCeEEEEEEeCCC-CeEEEECCCC---CCCCCCEEEEEecCCCeEEE
Confidence 34666 79999999999999999865 21389999999877 8899999999 77667889999999999999
Q ss_pred cCCCcEEEeecc--------E--------EEeccCCceeeeecCCC
Q 038905 114 DPQGKQVWSSKL--------I--------LVQSFSSSRLWDSFSNP 143 (709)
Q Consensus 114 ~~~g~~vWss~~--------~--------vl~~~~~~~lWQSFd~P 143 (709)
|.+|.++|+|++ + ||++.++.+||||||||
T Consensus 71 ~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 71 DGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred cCCCcEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 999999999862 1 77888889999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-21 Score=220.39 Aligned_cols=214 Identities=22% Similarity=0.270 Sum_probs=172.8
Q ss_pred HHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 038905 461 FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIH 540 (709)
Q Consensus 461 ~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH 540 (709)
+..|+.+-..++|+|++..+..+.+.....-+|||+++ +|..++.+...+....+..++.|++.|+.|+| ..||.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~Giah 443 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAH 443 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHH---hcCcee
Confidence 66677888889999998888877777777667999999 99999988878999999999999999999999 999999
Q ss_pred cCCCCCceeecCCCCeEEccccccccccccccc--cceeccccCcccccccccccCCCCCcc-cchHHHHHHHHHHHhCC
Q 038905 541 CDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK--AIKKAIRGTKGYVASPEWFRNSTITAN-VDVYSFGVLLLEIISCR 617 (709)
Q Consensus 541 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aaPE~~~~~~~s~k-~DvwSlGvvl~elltg~ 617 (709)
||+|++|+++..++.+||+|||.+..+....+. .....++|+..|+| ||.+.+..|.+. .||||.|+++..|++|+
T Consensus 444 rdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~a-pE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 444 RDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLA-PEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred ccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcC-cccccccccCcchhhhhhccceEEEEecCC
Confidence 999999999999999999999999888766554 44478999999999 999999999764 89999999999999999
Q ss_pred CCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 618 ~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.||......+... ......+. ..+... ........+.+...++..+|+.+|.+|.||++|++
T Consensus 523 ~~Wk~a~~~~~~~-----~~~~~~~~-~~~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 523 FPWKVAKKSDNSF-----KTNNYSDQ-RNIFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred Cccccccccccch-----hhhccccc-cccccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 9997655433211 00000000 011111 11113356778889999999999999999999987
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-20 Score=180.57 Aligned_cols=259 Identities=17% Similarity=0.171 Sum_probs=193.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+|.....+|.|.||..+....+ -++..||||.-..- ....+++.|.+..+.|. .+.|.+++-+-.++-+-.||+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl---~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNL---YNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeeccccc---ccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 5677777888888866555555 57899999986543 35578899999988885 789999999999999999999
Q ss_pred eecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-----CCeEEccccccccc
Q 038905 494 KFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-----YNAQISDFGLAKLL 567 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~DFGla~~~ 567 (709)
|.+ |-||++++.-.+ +++.++...++.|++.-+.|+| .+.+|.|||||+|+||..- ..+.|+|||||+.+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 998 779999886554 6999999999999999999999 8999999999999999653 34889999999988
Q ss_pred cccccc-----cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 568 TLNQSK-----AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 568 ~~~~~~-----~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
.+..+. .......||..||+ ---..+..-+.+.|+-|||-|+++.+-|..||..-.........+-+-+.-+.-
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMS-INTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMS-INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeE-eeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 765543 23356889999998 667778889999999999999999999999998764322111111111111111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.+.++.+ ..++++..-+...-..+-.+-|+.+-+...+..+
T Consensus 259 ~i~~Lc~---------g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 259 PIEVLCE---------GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred CHHHHHh---------cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1222221 1334444444444556777888887776655543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-18 Score=183.68 Aligned_cols=255 Identities=25% Similarity=0.319 Sum_probs=189.1
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch---hHHHHHHHHHHHhccCcC-ceeEEEeEEEcCCeEEEEEe
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD---GEKEFKNEVVMIGQTYHK-NLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nlv~l~~~~~~~~~~~lV~E 494 (709)
...+|.|+++.||.+... ..+++|.+...... ....+.+|+.++..+.|+ +++++...+......++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred EEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 334556666655444333 67788887654332 367899999999999988 79999999987777899999
Q ss_pred ecCCCCHHHHHhhCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEcccccccccccc
Q 038905 495 FLNNGTLASFLFENL---KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQISDFGLAKLLTLN 570 (709)
Q Consensus 495 y~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~ 570 (709)
|+.++++.+++.... .+.......+..|++.++.|+| +.+++|||+||+||+++... .++++|||+++.+...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999997777664 6888999999999999999999 88899999999999999998 7999999999866544
Q ss_pred cccc----ceeccccCcccccccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCccchh-hHHhHHHHHHHhhhcC
Q 038905 571 QSKA----IKKAIRGTKGYVASPEWFRN---STITANVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWAFDCYRNG 642 (709)
Q Consensus 571 ~~~~----~~~~~~Gt~~y~aaPE~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~g 642 (709)
.... ......|+..|++ ||.+.+ .......|+||+|+++++++.|..|+...... .... ....+...
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~-pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~----~~~~~~~~ 230 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMA-PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILEL 230 (384)
T ss_pred CccccccccccccccccccCC-HHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH----HHHHHHhc
Confidence 3321 2367889999999 999988 57889999999999999999999997655421 0111 11111111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..... ...............+.+++..|+..+|..|.++.+....
T Consensus 231 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTPSL-ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCccc-ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11100 0000000002234577889999999999999998887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=170.33 Aligned_cols=260 Identities=17% Similarity=0.122 Sum_probs=192.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCc-CceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH-KNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nlv~l~~~~~~~~~~~l 491 (709)
...+...+.+|+|+|+.+|....+ ..+..||||.-+... .-.++.-|..+...|++ ..|+.+..+..+...-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i---~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISI---TSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeec---cCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 356777888999999999888888 679999999865432 33578889999999975 678888889999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC---CCeEEccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY---YNAQISDFGLAKLL 567 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla~~~ 567 (709)
|||.+ |.||++++.-. ..++..+.+-++-|++.-++|+| .++.|||||||+|+|..-. ..+.++|||+|+.+
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99988 77999988644 46999999999999999999999 8999999999999999643 44889999999977
Q ss_pred cccccc-----cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 568 TLNQSK-----AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 568 ~~~~~~-----~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
....+. .......||..|.+ -....+...+.+.|+-|+|.+|.+.--|..||............ +.+.+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYAS-inAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy----EkI~Ek 239 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYAS-INAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY----EKISEK 239 (341)
T ss_pred ccccccccCccccCCccceeeeehh-hhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH----HHHHHh
Confidence 544332 22256789999987 55556667788999999999999999999999876543322222 222222
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
++.-.+...-. ..+.+..-.+..|-+..-++-|+...+.+++..
T Consensus 240 K~s~~ie~LC~-----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 240 KMSTPIEVLCK-----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred hcCCCHHHHhC-----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 22221111000 123344555666767777777777666665443
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=158.88 Aligned_cols=97 Identities=29% Similarity=0.492 Sum_probs=84.3
Q ss_pred CccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEecCccEEEE
Q 038905 34 STLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLN 113 (709)
Q Consensus 34 ~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~~G~L~l~ 113 (709)
+.|.. ++.|+|+++.|++|||.+.. . .++++|||+..+ +++||.|||+ .|+..++.|.|.+||+|+|.
T Consensus 2 ~~l~~---~~~l~s~~~~f~~G~~~~~~----q-~dgnlV~~~~~~-~~~vW~snt~---~~~~~~~~l~l~~dGnLvl~ 69 (114)
T smart00108 2 NTLSS---GQTLVSGNSLFELGFFTLIM----Q-NDYNLILYKSSS-RTVVWVANRD---NPVSDSCTLTLQSDGNLVLY 69 (114)
T ss_pred cccCC---CCEEecCCCcEeeeccccCC----C-CCEEEEEEECCC-CcEEEECCCC---CCCCCCEEEEEeCCCCEEEE
Confidence 34555 79999999999999999865 3 389999999887 8899999999 88876689999999999999
Q ss_pred cCCCcEEEeecc--------E--------EEeccCCceeeeecCC
Q 038905 114 DPQGKQVWSSKL--------I--------LVQSFSSSRLWDSFSN 142 (709)
Q Consensus 114 ~~~g~~vWss~~--------~--------vl~~~~~~~lWQSFd~ 142 (709)
|.+|.++|+|++ + ||++..+.++||||||
T Consensus 70 ~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 70 DGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred eCCCCEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 999999999862 1 7788888999999997
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-20 Score=178.34 Aligned_cols=233 Identities=21% Similarity=0.339 Sum_probs=175.8
Q ss_pred EEEEEecCCCceEEEEEEcc--cccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCC
Q 038905 432 LVGVIQTSTRTTVIVVKKLD--RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENL 509 (709)
Q Consensus 432 ~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~ 509 (709)
.+|..+ +-.+++|++. .......++|.+|.-.|+-+.||||..++|.|....++.++..||+-|||...+++..
T Consensus 207 wrgrwq----gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t 282 (448)
T KOG0195|consen 207 WRGRWQ----GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQT 282 (448)
T ss_pred cccccc----CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCc
Confidence 566663 3345556553 2334455789999999999999999999999999999999999999999999998875
Q ss_pred C--CChHHHHHHHHHHHHHHHHhhhcCCCCeE-ecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccc
Q 038905 510 K--PGWNLRANIAFQIARGLLHLHVNCSSQII-HCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV 586 (709)
Q Consensus 510 ~--l~~~~~~~i~~~i~~al~~LH~~~~~~ii-H~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~ 586 (709)
. .+..+..+++.+|++|++|||+. ..++ ---|....+++|++.+++|+- +-+++ ... .......|.|+
T Consensus 283 ~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarism-ad~kf-sfq-----e~gr~y~pawm 353 (448)
T KOG0195|consen 283 SVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-SFQ-----EVGRAYSPAWM 353 (448)
T ss_pred cEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheec-cccee-eee-----ccccccCcccC
Confidence 4 67788899999999999999953 2344 446888999999999988751 11110 000 02334578899
Q ss_pred cccccccCCCCC---cccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHH
Q 038905 587 ASPEWFRNSTIT---ANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 663 (709)
Q Consensus 587 aaPE~~~~~~~s---~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~ 663 (709)
+ ||.+...+-+ .++|+|||.+++||+.|...||......+-. .++.-..++...++..+..
T Consensus 354 s-pealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 354 S-PEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRVHIPPGISRH 417 (448)
T ss_pred C-HHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccccccCCCCccHH
Confidence 8 9999876643 4789999999999999999999765443321 1112223334445667788
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 664 LVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 664 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+.+++.-|+.+||.+||.+++++-+||...
T Consensus 418 m~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 999999999999999999999999998753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=186.97 Aligned_cols=215 Identities=25% Similarity=0.434 Sum_probs=162.4
Q ss_pred HhccCcCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCe-EecCCCC
Q 038905 468 IGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQI-IHCDIKP 545 (709)
Q Consensus 468 l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~i-iH~Dlkp 545 (709)
|+++.|.|+.+++|.+.++...+.|.+||..|+|.+.+... .++++.-...+.++|+.||.||| ...| .|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 46789999999999999999999999999999999999874 47899999999999999999999 4444 9999999
Q ss_pred CceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCC-------CCcccchHHHHHHHHHHHhCCC
Q 038905 546 QNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST-------ITANVDVYSFGVLLLEIISCRK 618 (709)
Q Consensus 546 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~-------~s~k~DvwSlGvvl~elltg~~ 618 (709)
.|+++|....+||+|||+.................-..-|.| ||.+.+.. .+.+.||||||++++||++...
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~a-Pellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTA-PELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccC-HHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999887643111111122233445666 99997642 4677999999999999999999
Q ss_pred CCCccchhhH-HhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 619 SFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 619 p~~~~~~~~~-~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
||+....... ..+ +.. +.. .....+.+.+... .+..+.+..++..||..+|++||++++|-..++.+.
T Consensus 157 ~~~~~~~~~~~~ei---i~~-~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEI---ILR-VKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHH---HHH-HHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9986543221 111 111 222 1122222222211 134447999999999999999999999999887654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-18 Score=169.61 Aligned_cols=178 Identities=12% Similarity=0.120 Sum_probs=133.0
Q ss_pred hhhHhhhcccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHH---------HHHHHHHHHhccCcCc
Q 038905 405 PEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEK---------EFKNEVVMIGQTYHKN 475 (709)
Q Consensus 405 ~~~~~~~~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~n 475 (709)
.++....-.++|.....+|.|+++.|+.... ++..+|||.+......... .+.+|+..+.++.|++
T Consensus 22 ~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G 96 (232)
T PRK10359 22 KEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG 96 (232)
T ss_pred HHHHHHHhhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence 3444444467888888899999998876322 3557999998643322222 2689999999999999
Q ss_pred eeEEEeEEEcC--------CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCc
Q 038905 476 LVRLLGFCDEG--------QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQN 547 (709)
Q Consensus 476 lv~l~~~~~~~--------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~N 547 (709)
|+.+..++... ...+|||||++|.+|.++.. ++. ....+++.+|..+| +.+++|||+||.|
T Consensus 97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~N 165 (232)
T PRK10359 97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGN 165 (232)
T ss_pred CCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHH
Confidence 99999886533 35789999999999988632 222 34569999999999 9999999999999
Q ss_pred eeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHH
Q 038905 548 ILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614 (709)
Q Consensus 548 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ell 614 (709)
|+++.++ ++|+|||..+....+... ..+.....+..++|+|+||+.+....
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~---------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAK---------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhH---------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988 999999998765322211 22333445667999999999887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-19 Score=192.68 Aligned_cols=236 Identities=22% Similarity=0.214 Sum_probs=180.2
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccccch--hHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD--GEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
+|.|.++.|+++........+...|.|.+.+.... .....+.|..++...+ ||.+|++.-.++.....+++.+|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 45666666666665544445556666655432111 1125677888888887 99999999999999999999999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceec
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 578 (709)
|.|...+.+...+.......+...++-++.++| +.+|+|||+|++||+++.+|++|+.|||+++..-... .
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~ 152 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------I 152 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh------h
Confidence 999999988888888888899999999999999 9999999999999999999999999999998764332 2
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCH
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~ 658 (709)
.|||..||| ||++. .....+|.||||++++||++|..||..+ .... |+. .+...+.
T Consensus 153 ~cgt~eymA-pEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~---~~~~----------------Il~--~~~~~p~ 208 (612)
T KOG0603|consen 153 ACGTYEYRA-PEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD---TMKR----------------ILK--AELEMPR 208 (612)
T ss_pred cccchhhhh-hHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH---HHHH----------------Hhh--hccCCch
Confidence 289999999 99999 5678899999999999999999999751 1000 111 1122244
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH--HHHHHHHc
Q 038905 659 KCVEKLVMVSIWCIQEDPSLRPTM--RKVSQMLE 690 (709)
Q Consensus 659 ~~~~~l~~l~~~Cl~~dP~~RPs~--~ev~~~L~ 690 (709)
.....+.+++..+...+|.+|.-. ..+.++++
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 556667777777888888888544 34444433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-18 Score=164.85 Aligned_cols=139 Identities=12% Similarity=0.067 Sum_probs=103.8
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccch--h-------H-----------------HHHHHHHHHHhccCcC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD--G-------E-----------------KEFKNEVVMIGQTYHK 474 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ 474 (709)
.+|.|+++.||.+.. .+++.||||++...... . . .....|++++.++.++
T Consensus 4 ~ig~G~~~~Vy~a~~----~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 4 CISTGKEANVYHATT----ANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred ccccccceEEEEEEC----CCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 467788887765543 26889999998643211 1 1 1224599999999877
Q ss_pred ceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHh-hhcCCCCeEecCCCCCceeecCC
Q 038905 475 NLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHL-HVNCSSQIIHCDIKPQNILLDDY 553 (709)
Q Consensus 475 nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~~iiH~Dlkp~NIll~~~ 553 (709)
++.....+.. ...+|||||++++++...+.+...++......++.|++.+|.+| | +.+|+||||||+|||++ +
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-C
Confidence 6643332222 22389999999988776554556788999999999999999999 7 77999999999999998 4
Q ss_pred CCeEEccccccccccc
Q 038905 554 YNAQISDFGLAKLLTL 569 (709)
Q Consensus 554 ~~~kl~DFGla~~~~~ 569 (709)
+.++|+|||+|.....
T Consensus 154 ~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 GKLYIIDVSQSVEHDH 169 (190)
T ss_pred CcEEEEEccccccCCC
Confidence 7899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.8e-18 Score=161.72 Aligned_cols=182 Identities=19% Similarity=0.072 Sum_probs=132.6
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch----hHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEe
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD----GEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~E 494 (709)
..++.++|++|+++.. .+..++.+.++....- ....+.+|+++|++++ |+++++++++ +..+++||
T Consensus 8 ~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred eeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567778887774443 4666776666544321 1125889999999995 5789999886 45699999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCC-CCCceeecCCCCeEEccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDI-KPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
|+.|.+|...+.. ....++.|++++|.++| +.+|+|||| ||+|||++.++.++|+|||+|+........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9999998754321 12357789999999999 899999999 799999999999999999999865543311
Q ss_pred ----c-------ceeccccCcccccccccccCC-CCC-cccchHHHHHHHHHHHhCCCCCC
Q 038905 574 ----A-------IKKAIRGTKGYVASPEWFRNS-TIT-ANVDVYSFGVLLLEIISCRKSFD 621 (709)
Q Consensus 574 ----~-------~~~~~~Gt~~y~aaPE~~~~~-~~s-~k~DvwSlGvvl~elltg~~p~~ 621 (709)
. .+....+++.|++ |+...-. ..+ ...++++.|.-+|.++|++.+..
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~-~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALT-PVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCC-HHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0112336777777 6654322 233 56789999999999999998764
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=147.12 Aligned_cols=100 Identities=27% Similarity=0.480 Sum_probs=75.6
Q ss_pred eecccccCCCCCCCcceEEecccceEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEEeecCCCCCeEEEEec
Q 038905 200 YISGTYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSFYLKNGNGNWSVVWSQ 279 (709)
Q Consensus 200 w~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~~~~~~~~~W~~~~~~ 279 (709)
||+|+|+|.. +.+...+....-+.+.+..+..+..+++. ..+.+.++|++||.+|++++|.|.+. .++|.+.|++
T Consensus 1 wrsG~WnG~~--f~g~p~~~~~~~~~~~fv~~~~e~~~t~~--~~~~s~~~r~~ld~~G~l~~~~w~~~-~~~W~~~~~~ 75 (110)
T PF00954_consen 1 WRSGPWNGQR--FSGIPEMSSNSLYNYSFVSNNEEVYYTYS--LSNSSVLSRLVLDSDGQLQRYIWNES-TQSWSVFWSA 75 (110)
T ss_pred CCccccCCeE--ECCcccccccceeEEEEEECCCeEEEEEe--cCCCceEEEEEEeeeeEEEEEEEecC-CCcEEEEEEe
Confidence 8999999866 33333332222344556666666666665 44667899999999999999999886 8999999999
Q ss_pred cCCCcccCcCCCCcccccCCCC----------CCCCCeeCC
Q 038905 280 PENICVNIGGELGSGAYGFNSI----------CPKGYSLLD 310 (709)
Q Consensus 280 p~~~C~~~~~~~~~~~CG~~~~----------C~~gf~~~~ 310 (709)
|.|+||+ |+.||+||+ |++||+|++
T Consensus 76 p~d~Cd~------y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 76 PKDQCDV------YGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred cccCCCC------ccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999 666666666 788888763
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-17 Score=157.99 Aligned_cols=139 Identities=14% Similarity=0.064 Sum_probs=105.3
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccch--------------------------hHHHHHHHHHHHhccCcC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD--------------------------GEKEFKNEVVMIGQTYHK 474 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ 474 (709)
.+|.|+++.||.+. . .+++.||||.+...... ....+..|.+.+.++.|+
T Consensus 4 ~ig~G~~~~Vy~a~-~---~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 4 CISTGKEANVYHAR-T---GDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred eeecCCCcEEEEEE-c---CCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 46777777776554 3 26889999998643210 012246789999999998
Q ss_pred ceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCC-CCeEecCCCCCceeecCC
Q 038905 475 NLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCS-SQIIHCDIKPQNILLDDY 553 (709)
Q Consensus 475 nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~iiH~Dlkp~NIll~~~ 553 (709)
++.....+... ..+|||||++|+++.........++......++.+++.++.+|| . .+|+||||||+||+++ +
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence 87443333322 34899999999865544334456788889999999999999999 7 8999999999999999 8
Q ss_pred CCeEEccccccccccc
Q 038905 554 YNAQISDFGLAKLLTL 569 (709)
Q Consensus 554 ~~~kl~DFGla~~~~~ 569 (709)
+.++|+|||+++.+..
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=162.93 Aligned_cols=232 Identities=21% Similarity=0.249 Sum_probs=144.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccC----------cCceeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTY----------HKNLVRLL 480 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------h~nlv~l~ 480 (709)
.+..+...+|.|+++.||.+.+. .+++..|||..... .....+++++|.-.+..+. |-.++.-+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~---~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDV---ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred eEEEEccccccCCceEEEEEEEc---cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 34456666777777766665555 67899999986432 3335577888876665532 22232222
Q ss_pred eEEE---------cC---C-----eEEEEEeecCCCCHHHHHh---hCCC----CChHHHHHHHHHHHHHHHHhhhcCCC
Q 038905 481 GFCD---------EG---Q-----NRLLVYKFLNNGTLASFLF---ENLK----PGWNLRANIAFQIARGLLHLHVNCSS 536 (709)
Q Consensus 481 ~~~~---------~~---~-----~~~lV~Ey~~~gsL~~~l~---~~~~----l~~~~~~~i~~~i~~al~~LH~~~~~ 536 (709)
+... .. + ..+++|+-+. ++|..++. .... +....+..+..|+++.+++|| +.
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~ 164 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SY 164 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hc
Confidence 2221 11 1 2367777774 47777654 2222 334455677789999999999 89
Q ss_pred CeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccccccccccC--------CCCCcccchHHHHH
Q 038905 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN--------STITANVDVYSFGV 608 (709)
Q Consensus 537 ~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~--------~~~s~k~DvwSlGv 608 (709)
|++|+||||+|++++.+|.++|+||+.....+.... ....+..|.+ ||.... ..++.+.|.|+||+
T Consensus 165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~P-Pe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTP-PELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS--HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred ceEecccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCC-hhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999999998876554321 1223355555 987643 25788999999999
Q ss_pred HHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCC
Q 038905 609 LLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLR 679 (709)
Q Consensus 609 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 679 (709)
++|.|.+++.||......... +... ..+. +.++.+..++..+|+.+|.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~-------------------~~~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADP-------------------EWDF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTS-------------------GGGG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCccccc-------------------cccc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999999865332100 0011 2234 788999999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-16 Score=154.83 Aligned_cols=136 Identities=18% Similarity=0.146 Sum_probs=103.6
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-----CcCceeEEEeEEEcCC---eE
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-----YHKNLVRLLGFCDEGQ---NR 489 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nlv~l~~~~~~~~---~~ 489 (709)
....+|.|+++.|| + +. .....+||+.........+++.+|+.++.++ .||||++++|+++++. ..
T Consensus 6 ~~~~LG~G~~~~Vy-~-hp----~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCY-A-HP----EDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEE-E-CC----CCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 44567788888775 3 32 3344578887654444567899999999999 5799999999998764 33
Q ss_pred E-EEEee--cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHH-HHhhhcCCCCeEecCCCCCceeecC----CCCeEEccc
Q 038905 490 L-LVYKF--LNNGTLASFLFENLKPGWNLRANIAFQIARGL-LHLHVNCSSQIIHCDIKPQNILLDD----YYNAQISDF 561 (709)
Q Consensus 490 ~-lV~Ey--~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al-~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DF 561 (709)
+ +|+|| +.+++|.+++.+. .+++. ..++.+++.++ .||| +.+|+||||||+|||++. +..++|+||
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 3 78999 5679999999663 45544 35677888777 8999 899999999999999974 347999995
Q ss_pred cccc
Q 038905 562 GLAK 565 (709)
Q Consensus 562 Gla~ 565 (709)
+.+.
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 5443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.3e-17 Score=185.66 Aligned_cols=251 Identities=24% Similarity=0.271 Sum_probs=169.0
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHH--HhccCcCceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVM--IGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+....-+|.+.|-+|. ..+ ...-.|+||++-+.. .-..+.|.++++- ...++|||.+.+.-........|||
T Consensus 25 ~~~~~~LGstRFlKv~---r~k--~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVA---RAK--DREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred eeeecccCchhhhhhh---hcc--CCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHH
Confidence 4444455665555332 222 233448888874432 2233444444433 5556899999888776677777899
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc--ccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL--TLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~--~~~ 570 (709)
-+|..+ +|.+.|..+.-+...+.+-|+.|++.||.-+| +.+|+|+|||.+|||+..=.-+.|+||.--|.. ..+
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 899877 89999988777888888999999999999999 999999999999999999889999999876643 222
Q ss_pred ccccc---eeccccCcccccccccccC----------CC-CCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHH
Q 038905 571 QSKAI---KKAIRGTKGYVASPEWFRN----------ST-ITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA 635 (709)
Q Consensus 571 ~~~~~---~~~~~Gt~~y~aaPE~~~~----------~~-~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 635 (709)
..... ..+-+.-.-|+| ||.+.. .. .+++.||||+||+++||++ |+++|.... +. +
T Consensus 176 NPadf~fFFDTSrRRtCYiA-PERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~--a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIA-PERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LL--A 246 (1431)
T ss_pred CcccceEEEecCCceeeecC-hHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HH--h
Confidence 11111 011112234888 998753 12 5788999999999999987 577775321 11 1
Q ss_pred HHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 636 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 636 ~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
++.|. .......++. -+...+.++++.|+|.||++|.++++.++.-.|.
T Consensus 247 ---Yr~~~-~~~~e~~Le~----Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 ---YRSGN-ADDPEQLLEK----IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ---HhccC-ccCHHHHHHh----CcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 12221 1111111111 1223678899999999999999999999976553
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=154.81 Aligned_cols=193 Identities=23% Similarity=0.291 Sum_probs=134.0
Q ss_pred CcCceeEEEeEEEc---------------------------CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHH
Q 038905 472 YHKNLVRLLGFCDE---------------------------GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIA 524 (709)
Q Consensus 472 ~h~nlv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~ 524 (709)
.|||||+++++|.+ +...|+||.-.+. +|..++..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence 69999999987743 2346899987755 8999997654 45556677889999
Q ss_pred HHHHHhhhcCCCCeEecCCCCCceee--cCCCC--eEEccccccccccccccc----cceeccccCcccccccccccCCC
Q 038905 525 RGLLHLHVNCSSQIIHCDIKPQNILL--DDYYN--AQISDFGLAKLLTLNQSK----AIKKAIRGTKGYVASPEWFRNST 596 (709)
Q Consensus 525 ~al~~LH~~~~~~iiH~Dlkp~NIll--~~~~~--~kl~DFGla~~~~~~~~~----~~~~~~~Gt~~y~aaPE~~~~~~ 596 (709)
+|+.||| +++|.|||+|.+|||+ |+|+. +.|+|||.+-.-....-+ .-....-|...-|| ||+....+
T Consensus 352 Eav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA-PEi~ta~P 427 (598)
T KOG4158|consen 352 EAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA-PEIATAVP 427 (598)
T ss_pred HHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc-hhhhhcCC
Confidence 9999999 9999999999999999 44544 679999987432211000 00123456667787 99986432
Q ss_pred -----C-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHh
Q 038905 597 -----I-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIW 670 (709)
Q Consensus 597 -----~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~ 670 (709)
. -.|+|.|+.|.+.||++....||+..-.. .+.. +.+.+.++..+.+ ..+..+.+++..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~~---r~Yqe~qLPalp~---------~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLDT---RTYQESQLPALPS---------RVPPVARQLVFD 492 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eech---hhhhhhhCCCCcc---------cCChHHHHHHHH
Confidence 1 35899999999999999999999752111 0000 1122223332222 345567788888
Q ss_pred cccCCCCCCCCHHHH
Q 038905 671 CIQEDPSLRPTMRKV 685 (709)
Q Consensus 671 Cl~~dP~~RPs~~ev 685 (709)
.++.||++|++.+=.
T Consensus 493 lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIA 507 (598)
T ss_pred HhcCCccccCCccHH
Confidence 999999999886543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.6e-17 Score=169.67 Aligned_cols=170 Identities=25% Similarity=0.347 Sum_probs=131.2
Q ss_pred eEEEEEeecCCCCHHHHHhhCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENL---KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
..++.|++|.-.+|.++|.++. ..++.....++.|++.|+.| ++.+|+|+||.||....+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 4689999999999999997654 46778889999999999998 68999999999999999999999999999
Q ss_pred ccccccc----cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhh
Q 038905 565 KLLTLNQ----SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 565 ~~~~~~~----~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
....... ....++...||..||+ ||.+.+..|+.|+||||||++|+|++. -...++.. -....+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~Yms-PEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMS-PEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCC-HHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhh
Confidence 8776554 1223367889999999 999999999999999999999999987 22222110 022333
Q ss_pred hcCCcc--ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 038905 640 RNGKLD--DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKV 685 (709)
Q Consensus 640 ~~g~~~--~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 685 (709)
+.|.+. .+.|. ..-..++.+++...|.+||++.++
T Consensus 473 r~g~ip~~~~~d~-----------p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGIIPPEFLQDY-----------PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCChHHhhcC-----------cHHHHHHHHhcCCCcccCchHHHH
Confidence 444444 11111 123468889999999999954443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5e-16 Score=175.01 Aligned_cols=211 Identities=20% Similarity=0.195 Sum_probs=145.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|..++.+-.|.++.||++.+. ...+..|+|+.+.. - -+++ |+.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~---~trqrfa~kiNkq~-l----ilRn---ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHK---ETRQRFAMKINKQN-L----ILRN---ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeecc---ccccchhhcccccc-h----hhhc---cccccCCccee---------------
Confidence 577888888889999999988877 45677777442211 0 0111 33333444443
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc--
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN-- 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~-- 570 (709)
|+=...+...+.++. +++.+++||| +.+|+|||+||+|.++..-|++|+.|||+.+.....
T Consensus 136 ------gDc~tllk~~g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ------chhhhhcccCCCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 333344433333332 2278999999 999999999999999999999999999998753211
Q ss_pred ----------c-cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 571 ----------Q-SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 571 ----------~-~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
+ .+.....++|||.|+| ||++..+.|...+|+|++|+++||.+.|..||.....++......-....|
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyia-PeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w 277 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIA-PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 277 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccC-hhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence 0 1112246799999999 999999999999999999999999999999998876655322111111111
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 681 (709)
.++ +.....++.+++.+.|+.+|.+|--
T Consensus 278 pE~--------------dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 278 PEE--------------DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ccc--------------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 111 2233456778888899999999953
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-15 Score=170.39 Aligned_cols=193 Identities=20% Similarity=0.169 Sum_probs=149.6
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC---cCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY---HKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nlv~l~~~~~~~~~~~l 491 (709)
.|....-+|.|++++||.+... +++.||+|.-+....- +|--=.+++.+|+ -+.|..+...+.-.+.-+|
T Consensus 699 ~~~I~~e~G~g~y~~vy~a~~~----~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 699 KFCISKEIGEGSYGSVYVATHS----NGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eEEEEeeeccccceEEEEeecC----CCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 4566777888888888766655 4999999986543221 1111112222222 1223333444445667789
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec-------CCCCeEEcccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-------DYYNAQISDFGLA 564 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~-------~~~~~kl~DFGla 564 (709)
|+||.+-|+|.+++...+.+++.....++.|+++.+.+|| ..+|||+||||+|.||. ....++|+|||-+
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 9999999999999998888999999999999999999999 89999999999999994 2345999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCC
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK 618 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~ 618 (709)
..+..-.........++|-++-. +|+..+.+++.++|.|.|..+++-|+.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C-~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDC-IEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchh-HHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 87765555544477889999998 999999999999999999999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.1e-15 Score=148.69 Aligned_cols=143 Identities=14% Similarity=0.098 Sum_probs=107.1
Q ss_pred cceeeeecCeeEEEEEEEE-EEecCCCceEEEEEEcccccch------------------------hHHHHHHHHHHHhc
Q 038905 416 VTRSVLLGSSVFVNFTLVG-VIQTSTRTTVIVVKKLDRVFQD------------------------GEKEFKNEVVMIGQ 470 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~-~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 470 (709)
|.....+|.|+++.||.+. .. .+++.||||.+.....+ ....+..|+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFD---GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred HHhCCeeccCcceeEEEEEecC---CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4445567777888776554 23 46889999987643210 11235789999999
Q ss_pred cCcC--ceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCC-eEecCCCCCc
Q 038905 471 TYHK--NLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ-IIHCDIKPQN 547 (709)
Q Consensus 471 l~h~--nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-iiH~Dlkp~N 547 (709)
+.+. .++++++. ...++||||+++.+|.........+.......++.|++.++.+|| ..+ |+||||||+|
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N 179 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN 179 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence 9763 34555543 235899999999888776544445666667889999999999999 888 9999999999
Q ss_pred eeecCCCCeEEccccccccccc
Q 038905 548 ILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 548 Ill~~~~~~kl~DFGla~~~~~ 569 (709)
|+++ ++.++|+|||++...+.
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999876543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.2e-14 Score=142.71 Aligned_cols=133 Identities=20% Similarity=0.224 Sum_probs=106.0
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--------hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--------DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.+|.|+++.||. +.. .+..++||+...... .....+.+|+.++..++|++++....++.+....++|
T Consensus 3 ~l~~G~~~~vy~-~~~----~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 3 LIKRGAEAEIYL-GDF----LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIV 77 (211)
T ss_pred ccccCceEEEEE-Eee----CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEE
Confidence 456777776654 443 356678886542111 1124678899999999999988777777777888999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
|||++|++|.+++..... .+..++.+++.+|.+|| ..+++|+|++|.|||++ ++.++|+|||+++.
T Consensus 78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999865322 78899999999999999 89999999999999999 78899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-14 Score=141.08 Aligned_cols=129 Identities=18% Similarity=0.225 Sum_probs=100.0
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc-c-------hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-Q-------DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+|.|+++.||.. .. .+..+++|...... . ...+++.+|++++..++|+++.....++...+..++||
T Consensus 2 ig~G~~~~vy~~-~~----~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 76 (199)
T TIGR03724 2 IAKGAEAIIYLG-DF----LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVM 76 (199)
T ss_pred CCCCceEEEEEe-ec----CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEE
Confidence 566777766544 43 35678888753211 1 12356789999999999887655555555666779999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
||++|++|.+++..... .++.+++.+|.+|| +.+++|+|++|+||+++ ++.+++.|||+++.
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999988755321 78999999999999 89999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.2e-14 Score=159.06 Aligned_cols=134 Identities=15% Similarity=0.223 Sum_probs=103.8
Q ss_pred ceeeeecCeeEEEEEEEEEEecCCCceEEEEEEc-ccc-c------chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 417 TRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKL-DRV-F------QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 417 ~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
.....+|.|+++.||. +... +..+++|+. ... . ....+++.+|++++.+++|++++....++.+...
T Consensus 336 ~~~~~iG~G~~g~Vy~-~~~~----~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 336 IPDHLIGKGAEADIKK-GEYL----GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred CccceeccCCcEEEEE-Eeec----CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3455677777887765 4442 222333321 111 1 1123568899999999999999988888877778
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
.++||||+++++|.+++. ....++.+++++|.+|| +.+++||||||+|||+ +++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999999875 35678999999999999 8999999999999999 6789999999999764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-13 Score=134.69 Aligned_cols=134 Identities=13% Similarity=0.116 Sum_probs=99.3
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc----------------------hhHHHHHHHHHHHhccCcC--
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ----------------------DGEKEFKNEVVMIGQTYHK-- 474 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~-- 474 (709)
...+|.|+++.|| ++.. .+++.+|||....... .....+..|..++.++.|+
T Consensus 20 ~~~i~~G~~g~Vy-~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 20 GNQIGVGKESDVY-LALD---PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred CCccccCcceEEE-EEEc---CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3446666666664 4444 3688999997643210 0112367889999999887
Q ss_pred ceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC
Q 038905 475 NLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554 (709)
Q Consensus 475 nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~ 554 (709)
.++..++. ...++||||++|++|...... .....++.+++.++.++| ..+|+||||||+||++++++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCC
Confidence 44454442 345899999999998765421 345678899999999999 88999999999999999999
Q ss_pred CeEEccccccccccc
Q 038905 555 NAQISDFGLAKLLTL 569 (709)
Q Consensus 555 ~~kl~DFGla~~~~~ 569 (709)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.1e-13 Score=135.71 Aligned_cols=131 Identities=18% Similarity=0.117 Sum_probs=97.2
Q ss_pred CeeEEEEEEEEEEecCCCceEEEEEEccccc-------------chhHHHHHHHHHHHhccCcCce--eEEEeEEEcCC-
Q 038905 424 SSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-------------QDGEKEFKNEVVMIGQTYHKNL--VRLLGFCDEGQ- 487 (709)
Q Consensus 424 ~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nl--v~l~~~~~~~~- 487 (709)
.||.++||.+... +..++||.+.... ......+.+|+.++.+++|+++ ++.+++.....
T Consensus 42 ~~g~gtv~~v~~~-----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 42 AKGRGTTWFVQTP-----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred CCCCccEEEEEeC-----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4555555555432 5678888764310 1233568889999999998775 77777654322
Q ss_pred ---eEEEEEeecCC-CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 488 ---NRLLVYKFLNN-GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 488 ---~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
..++||||++| .+|.+++.+. .++.. .+.+|+.+|.+|| ..||+||||||+|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 23599999997 6898887543 34433 3678999999999 99999999999999999999999999999
Q ss_pred cccc
Q 038905 564 AKLL 567 (709)
Q Consensus 564 a~~~ 567 (709)
++..
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 8753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1e-14 Score=164.87 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=183.4
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
+|.|.+..|-..... +.....+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++.||..+
T Consensus 28 ig~gs~~~~~~~~~~--~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 28 IGKGSFSSSALASNS--RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccchhhhhhhc--CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 455555533222221 2345556667665543 223355666888877787 99999999999999999999999999
Q ss_pred CCHHHHH-hhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEccccccccccc-ccccc
Q 038905 499 GTLASFL-FENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQISDFGLAKLLTL-NQSKA 574 (709)
Q Consensus 499 gsL~~~l-~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~-~~~~~ 574 (709)
+++...+ .... ..+......++.|+..++.|+|. ..++.|||+||+|.+++..+ ..|++|||+|..+.. +....
T Consensus 106 ~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~ 183 (601)
T KOG0590|consen 106 GSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAER 183 (601)
T ss_pred cccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcce
Confidence 9999888 4443 56677788899999999999995 56899999999999999999 999999999998877 44444
Q ss_pred ceecccc-CcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 575 IKKAIRG-TKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 575 ~~~~~~G-t~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
.....+| ++.|.| ||...+. ...+..|+||.|+++.-+++|..|++......... ..|.+.+. ..
T Consensus 184 ~~~~~~g~s~~y~a-~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------~~~~~~~~------~~ 250 (601)
T KOG0590|consen 184 SLKDRCGSSPPYGA-PEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------SSWKSNKG------RF 250 (601)
T ss_pred eeecccCCCCCCCC-cccccchhhcCCCcccccccccccccccCCCCccccccccccc------eeeccccc------cc
Confidence 4466788 999999 9999885 45778999999999999999999998665433111 01111110 00
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.............++...++..+|..|.+.+++..
T Consensus 251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 01112234456677888889899999999988754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.2e-13 Score=123.21 Aligned_cols=132 Identities=23% Similarity=0.212 Sum_probs=106.9
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCc--CceeEEEeEEEcCCeEEEEEeecCC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH--KNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
.+|.|.+..||.+... +..+++|....... ..++.+|+.++..++| .++++++.+....+..+++|||+++
T Consensus 5 ~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 5 LLKGGLTNRVYLLGTK-----DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ecccccccceEEEEec-----CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3566666666555432 26789998765432 5678999999999987 5899999998888889999999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
+.+..+ +......++.++++++.+||.....+++|+|++|+||+++..+.+++.|||.++.
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 877654 4566778899999999999955446899999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.3e-13 Score=134.39 Aligned_cols=200 Identities=21% Similarity=0.251 Sum_probs=140.0
Q ss_pred HHHHhccCcCceeEEEeEEEc-----CCeEEEEEeecCCCCHHHHHhhCC----CCChHHHHHHHHHHHHHHHHhhhcCC
Q 038905 465 VVMIGQTYHKNLVRLLGFCDE-----GQNRLLVYKFLNNGTLASFLFENL----KPGWNLRANIAFQIARGLLHLHVNCS 535 (709)
Q Consensus 465 ~~~l~~l~h~nlv~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~i~~al~~LH~~~~ 535 (709)
..-|-++-|.|||+++.|..+ ..+..+++|||+.|+|..+|++.. .+......+++-||..||.|||. |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 345666779999999988754 345789999999999999998643 47788889999999999999994 57
Q ss_pred CCeEecCCCCCceeecCCCCeEEcccccccc-cccc-ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHH
Q 038905 536 SQIIHCDIKPQNILLDDYYNAQISDFGLAKL-LTLN-QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613 (709)
Q Consensus 536 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~-~~~~-~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~el 613 (709)
..|+|+++..+.|++..++-+||.----... .... .....+....|-++|.+ ||.-.....+.++|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a-~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSA-PESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCcccc-CCcCcccccccchhhhhhhHHHHHH
Confidence 8999999999999999999999852111100 0000 00111245567888998 9998888889999999999999999
Q ss_pred HhCCCC-CCccchhh-HHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 614 ISCRKS-FDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 614 ltg~~p-~~~~~~~~-~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
--+..- -......+ .... . .....+.. ..-..++..|++.+|..||+|.+++-
T Consensus 276 ailEiq~tnseS~~~~ee~i-----a-----~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENI-----A-----NVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhhhh-----h-----hheeeccC-----------ccccCcCcccccCCCCCCcchhhhhc
Confidence 876643 22211110 0000 0 00000111 11224677899999999999998754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.1e-12 Score=124.61 Aligned_cols=136 Identities=15% Similarity=0.165 Sum_probs=91.7
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccch---hHHH---------------------HHHHHHHHhccCcCc-
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD---GEKE---------------------FKNEVVMIGQTYHKN- 475 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~---------------------~~~E~~~l~~l~h~n- 475 (709)
.+|.|+++.||.+ .. .++..||||.+...... .... ...|...+.++.+..
T Consensus 4 ~lg~G~~g~Vy~a-~~---~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 4 PIGTGKEADVYLA-LD---GDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred ccccccceeEEEE-EC---CCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3677777777654 33 25788999987543211 1111 135666666665432
Q ss_pred -eeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCC-CCeEecCCCCCceeecCC
Q 038905 476 -LVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCS-SQIIHCDIKPQNILLDDY 553 (709)
Q Consensus 476 -lv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~iiH~Dlkp~NIll~~~ 553 (709)
+.+.+++ ...++||||++++.+........... .....++.+++.++.++| . .+|+|+||||+||+++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 4455543 24589999999954321111111111 567789999999999999 7 8999999999999999 8
Q ss_pred CCeEEccccccccccc
Q 038905 554 YNAQISDFGLAKLLTL 569 (709)
Q Consensus 554 ~~~kl~DFGla~~~~~ 569 (709)
+.++|+|||.+.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 9999999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.7e-10 Score=126.90 Aligned_cols=141 Identities=17% Similarity=0.171 Sum_probs=95.4
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhH----------------------------------------
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGE---------------------------------------- 458 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------- 458 (709)
...+|++++++||.+ .+ .+++.||||+.........
T Consensus 122 ~~plasaSigQVh~A-~l---~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 122 EKPLAAASIAQVHRA-RL---VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred CcceeeeehhheEEE-Ee---cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 357888888888555 55 3678999998753211100
Q ss_pred HHHHHHHHHHhccC----cCceeEEEeEE-EcCCeEEEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHH-HHHHhh
Q 038905 459 KEFKNEVVMIGQTY----HKNLVRLLGFC-DEGQNRLLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIAR-GLLHLH 531 (709)
Q Consensus 459 ~~~~~E~~~l~~l~----h~nlv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~-al~~LH 531 (709)
-+|.+|...+.++. |.+-|.+-.++ ......+|||||++|++|.+...... .. .+..++..++. .+..+|
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 02444555554442 33333333333 22445799999999999988765321 12 34456666666 467788
Q ss_pred hcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 532 ~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
..+++|+|+||.||+++.++.+++.|||++..+..
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88999999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.9e-10 Score=105.71 Aligned_cols=125 Identities=22% Similarity=0.155 Sum_probs=88.2
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCce-eEEEeEEEcCCeEEEEEeecCCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNL-VRLLGFCDEGQNRLLVYKFLNNGT 500 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nl-v~l~~~~~~~~~~~lV~Ey~~~gs 500 (709)
+++|....||... . .+..+++|....... ....+..|+.++..+.+.++ ++++.+. ....++||||++|.+
T Consensus 6 l~~G~~~~vy~~~-~----~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 6 LKGGMTNKNYRVE-V----ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred cCCcccCceEEEE-E----CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 4555555554433 2 367799998754321 23456889999998876554 4555543 234589999999988
Q ss_pred HHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCC-----eEecCCCCCceeecCCCCeEEcccccccc
Q 038905 501 LASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ-----IIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 501 L~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-----iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
+... . .....+..+++++|+.|| ..+ ++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~-----~---~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE-----D---FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----c---ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7643 0 112345678999999999 555 59999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.6e-10 Score=123.69 Aligned_cols=240 Identities=23% Similarity=0.208 Sum_probs=170.8
Q ss_pred eeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEeecCCCCH
Q 038905 425 SVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501 (709)
Q Consensus 425 g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 501 (709)
|.++.+|..... .......+|+|+-+.... .....-.+|+...++++ |+|.|+........+..++-.|++. .+|
T Consensus 127 g~~~s~~~~~~~-~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl 204 (524)
T KOG0601|consen 127 GSKGSVFKSRCT-NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESL 204 (524)
T ss_pred CCCceeecccCC-cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chh
Confidence 666666555442 236778889988544332 23334456777666664 9999998888899999999999986 688
Q ss_pred HHHHhhCCC-CChHHHHHHHHHHHH----HHHHhhhcCCCCeEecCCCCCceeecCC-CCeEEcccccccccccccccc-
Q 038905 502 ASFLFENLK-PGWNLRANIAFQIAR----GLLHLHVNCSSQIIHCDIKPQNILLDDY-YNAQISDFGLAKLLTLNQSKA- 574 (709)
Q Consensus 502 ~~~l~~~~~-l~~~~~~~i~~~i~~----al~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~~~~~~~~~- 574 (709)
..+...... ++....+.++.+..+ ||.++| ...++|-|+||+||++..+ ...+++|||+...++...-..
T Consensus 205 ~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~ 281 (524)
T KOG0601|consen 205 QSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSV 281 (524)
T ss_pred HHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcceeEEccCCccccc
Confidence 777766554 777778888888888 999999 9999999999999999999 889999999999887654221
Q ss_pred --ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 575 --IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 575 --~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
...+..|...|++ ||...+ .++.+.|+|++|.++++.+.+........... |...+.+- +.+.
T Consensus 282 ~~~~~r~~~~~~Y~~-ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r~~~---ip~e-- 346 (524)
T KOG0601|consen 282 FKVSKRPEGDCIYAA-KELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLRQGY---IPLE-- 346 (524)
T ss_pred eeeeecCCCCceEeC-hhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC--------cccccccc---Cchh--
Confidence 1123468888998 997765 57889999999999999998876554321111 11111111 1111
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.-..-..++...+.++++.+|..|++.+.+..
T Consensus 347 ---~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 347 ---FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11112334445888999999999999876654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.3e-10 Score=132.05 Aligned_cols=252 Identities=19% Similarity=0.161 Sum_probs=168.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+.|.....+-.+.++.++...-...+......+.++.........+....+-.++-..+||-+++..--+......+||+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 34444334444445443333322222222333344444443334444445544444455676666555555677889999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc----
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL---- 569 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~---- 569 (709)
+|..+++|...++..+..+..........+..++.||| ...+.|+|++|.|++...+++.+++|||+....+.
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999988776666666667778889999999 77799999999999999999999999984432210
Q ss_pred -----------------ccc--------ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccc
Q 038905 570 -----------------NQS--------KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEM 624 (709)
Q Consensus 570 -----------------~~~--------~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~ 624 (709)
... ........||+.|.+ ||...+......+|+|++|++++|.++|..||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~la-Pe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLA-PEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccC-CcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 000 011245789999999 999999999999999999999999999999998665
Q ss_pred hhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 038905 625 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMR 683 (709)
Q Consensus 625 ~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 683 (709)
.+. +++.+..+++.-. ...........+++...+..+|.+|..+.
T Consensus 1040 pq~-------~f~ni~~~~~~~p-------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQ-------IFENILNRDIPWP-------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhh-------hhhccccCCCCCC-------CCccccChhhhhhhhhhhccCchhccCcc
Confidence 443 2233333332211 11223445566677777888999997765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.6e-09 Score=100.18 Aligned_cols=98 Identities=14% Similarity=0.175 Sum_probs=75.1
Q ss_pred HHHHHHhccCc--CceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHh-hhcCCCCeE
Q 038905 463 NEVVMIGQTYH--KNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHL-HVNCSSQII 539 (709)
Q Consensus 463 ~E~~~l~~l~h--~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~~ii 539 (709)
+|...|.++.. .++++++.+ ...+|||||+.+..+....-+...++......+..+++.+|..| | +.+||
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glV 147 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLV 147 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 89999998853 466677764 46789999998754432222223345556677889999999998 8 78999
Q ss_pred ecCCCCCceeecCCCCeEEcccccccccc
Q 038905 540 HCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 540 H~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
|+||++.|||++ ++.+.|+|||.+....
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999997 4679999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=9.1e-10 Score=119.50 Aligned_cols=250 Identities=16% Similarity=0.160 Sum_probs=175.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHH--HHHHHHHHhcc-CcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKE--FKNEVVMIGQT-YHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~ 489 (709)
...|.....+|.+.++.|+.+. . ...++..+++|.+.+.......+ -..|+.+...+ .|.++++....+....+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~-~-r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVS-K-RPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeee-e-cCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 5677888888888888775544 2 22578888888876543333222 24566665555 588899888888777888
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-CCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-YNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~~~ 568 (709)
++=-||++++++...+.-...++...++++..|++.++.++| ++.++|+|+||+||++..+ +.-++.|||.++.+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccc
Confidence 899999999998877744445778888999999999999999 9999999999999999886 788999999987543
Q ss_pred ccccccceeccccCcccc-cccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 569 LNQSKAIKKAIRGTKGYV-ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~-aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
... ....+.-++. .+|+......+..+.|++|||.-+.|.+++..-..... . +..+..|+...
T Consensus 419 ~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--~--------~~~i~~~~~p~- 482 (524)
T KOG0601|consen 419 FSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--Q--------SLTIRSGDTPN- 482 (524)
T ss_pred eec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--c--------ceeeecccccC-
Confidence 222 1222223333 22666777889999999999999999998875432110 0 01111121111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.....+.+..+..-++..++..||.+.++..+.+-+
T Consensus 483 ---------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 483 ---------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111225566677778999999999998887766543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.93 E-value=3e-09 Score=118.35 Aligned_cols=144 Identities=15% Similarity=0.123 Sum_probs=90.4
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch----------------------------------hHH--
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD----------------------------------GEK-- 459 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~-- 459 (709)
|.. ..+|+|++++||.+... .+++.||||+......+ -.+
T Consensus 122 fd~-~PlasaSiaQVh~A~l~---~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLK---DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred cCh-hhhcCCCccEEEEEEEC---CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 444 67899999988666554 24889999998632110 011
Q ss_pred ----HHHHHHHHHhccC----cCceeEEEeEEEc-CCeEEEEEeecCCCCHHHHH--hhCCCCChHHHHHHHHHHHHH-H
Q 038905 460 ----EFKNEVVMIGQTY----HKNLVRLLGFCDE-GQNRLLVYKFLNNGTLASFL--FENLKPGWNLRANIAFQIARG-L 527 (709)
Q Consensus 460 ----~~~~E~~~l~~l~----h~nlv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l--~~~~~l~~~~~~~i~~~i~~a-l 527 (709)
++.+|...+.++. +.+.+.+-.++.+ ....+|||||++|+.+.+.- ... ..+. ..++...+.. +
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~-g~d~---~~la~~~v~~~~ 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA-GTDM---KLLAERGVEVFF 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc-CCCH---HHHHHHHHHHHH
Confidence 2344444444442 4444444444433 45678999999999997742 222 1221 1222222222 2
Q ss_pred HHhhhcCCCCeEecCCCCCceeecCCC----CeEEcccccccccccc
Q 038905 528 LHLHVNCSSQIIHCDIKPQNILLDDYY----NAQISDFGLAKLLTLN 570 (709)
Q Consensus 528 ~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFGla~~~~~~ 570 (709)
.-++ ..|++|+|+||.||+++.++ .+++.|||++..+...
T Consensus 274 ~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 2233 67999999999999999888 9999999999877543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.2e-08 Score=111.98 Aligned_cols=165 Identities=18% Similarity=0.172 Sum_probs=120.1
Q ss_pred CCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHH
Q 038905 440 TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANI 519 (709)
Q Consensus 440 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i 519 (709)
.++..|.|...+..........++-++.|+.++||||++++.......+.|||+|-+. -|..++.+.+ .....-.
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~G 109 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLG 109 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHH
Confidence 4566677777665554445667888899999999999999999999999999999875 4666665532 4445556
Q ss_pred HHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCc
Q 038905 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITA 599 (709)
Q Consensus 520 ~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~ 599 (709)
+.||+.||.+||+ +.+++|++|-.+.|++++.|..||++|-++.......... ....---.|.. |+.+.... -
T Consensus 110 l~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~-P~~~~~s~--~ 182 (690)
T KOG1243|consen 110 LFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDD-PEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccC-hhhcCccc--c
Confidence 7899999999986 4589999999999999999999999999886443222100 11111112333 44332221 2
Q ss_pred ccchHHHHHHHHHHHhC
Q 038905 600 NVDVYSFGVLLLEIISC 616 (709)
Q Consensus 600 k~DvwSlGvvl~elltg 616 (709)
..|.|.||++++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 46999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.9e-08 Score=92.02 Aligned_cols=98 Identities=21% Similarity=0.347 Sum_probs=80.3
Q ss_pred HHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCe
Q 038905 459 KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQI 538 (709)
Q Consensus 459 ~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i 538 (709)
++-.+|..+|.++.-..|.-..-+..+.....|+|||++|..|.+.+... +..++..|-.-+.-|| ..+|
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH---~~gi 113 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLH---KAGI 113 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHH---hcCe
Confidence 45678999999987555444444556777889999999999999888765 3567778888889999 9999
Q ss_pred EecCCCCCceeecCCCCeEEccccccccc
Q 038905 539 IHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 539 iH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
+|+||+++||++.... +.++||||+..-
T Consensus 114 vHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 114 VHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred ecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999999998775 999999999743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.79 E-value=3e-08 Score=99.06 Aligned_cols=141 Identities=16% Similarity=0.166 Sum_probs=102.3
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCc--CceeEEEeEEEcCC---eEEEEEe
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYH--KNLVRLLGFCDEGQ---NRLLVYK 494 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nlv~l~~~~~~~~---~~~lV~E 494 (709)
.+++|....+|.+... ++..+++|....... ....++.+|++++..+.+ .++++++.+..+.. ..++|||
T Consensus 5 ~l~~G~~n~~~~v~~~----~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 5 QLSGGQSNLTYLLTAG----GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ecCCCccceEEEEEec----CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 3455656666554432 257889998754322 135678999999999976 44677887776543 5689999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNC---------------------------------------- 534 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~---------------------------------------- 534 (709)
|++|.++...+.. ..++...+..++.+++++|..||+..
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888775532 34667777788888888888888421
Q ss_pred -------------CCCeEecCCCCCceeecC--CCCeEEcccccccc
Q 038905 535 -------------SSQIIHCDIKPQNILLDD--YYNAQISDFGLAKL 566 (709)
Q Consensus 535 -------------~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~ 566 (709)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66689999999864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.8e-07 Score=96.40 Aligned_cols=158 Identities=20% Similarity=0.268 Sum_probs=122.8
Q ss_pred CCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEE----cCCeEEEEEeecCC-CCHHHHHhhCC-----
Q 038905 440 TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCD----EGQNRLLVYKFLNN-GTLASFLFENL----- 509 (709)
Q Consensus 440 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~----~~~~~~lV~Ey~~~-gsL~~~l~~~~----- 509 (709)
.++..+++|+++....+.......-+++.+++.|.|+|++.+++. .+..++|||+|.++ ++|.++.+...
T Consensus 299 ~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~ 378 (655)
T KOG3741|consen 299 VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKR 378 (655)
T ss_pred cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccc
Confidence 578889999985544333344566789999999999999999886 34567899999986 47777666431
Q ss_pred ----------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceecc
Q 038905 510 ----------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579 (709)
Q Consensus 510 ----------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 579 (709)
+.++...+.++.|+..||.++| +.|+.-+-|.+.+||++.+.+++|+..|...++..+...
T Consensus 379 ~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~------ 449 (655)
T KOG3741|consen 379 TNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTE------ 449 (655)
T ss_pred cccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCCCc------
Confidence 2557888999999999999999 889999999999999999999999988887665543311
Q ss_pred ccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 038905 580 RGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620 (709)
Q Consensus 580 ~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~ 620 (709)
| +.. -.+-|.=.||.+++.|.+|....
T Consensus 450 ---------~--le~---~Qq~D~~~lG~ll~aLAt~~~ns 476 (655)
T KOG3741|consen 450 ---------P--LES---QQQNDLRDLGLLLLALATGTENS 476 (655)
T ss_pred ---------c--hhH---HhhhhHHHHHHHHHHHhhccccc
Confidence 1 111 13568889999999999997653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.2e-07 Score=86.51 Aligned_cols=107 Identities=22% Similarity=0.297 Sum_probs=82.5
Q ss_pred HHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC-CCHHHHHhhCCC--CChHHHHHHHHHHHHHHHHhhhcC
Q 038905 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN-GTLASFLFENLK--PGWNLRANIAFQIARGLLHLHVNC 534 (709)
Q Consensus 458 ~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~--l~~~~~~~i~~~i~~al~~LH~~~ 534 (709)
..+.++|.+++.++.--.|.-..-++.+...-.|+|||++| .++.+++..... ........++..|-+.+.-||
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--- 130 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--- 130 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---
Confidence 46778999999998755554444456667777899999987 478888876542 223333688899999999999
Q ss_pred CCCeEecCCCCCceeecCCCC---eEEccccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDYYN---AQISDFGLAKLL 567 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~---~kl~DFGla~~~ 567 (709)
..+|||+||..+||+|..++. +.+.|||++...
T Consensus 131 ~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 131 DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999999999999999976554 589999998654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.6e-07 Score=96.04 Aligned_cols=104 Identities=15% Similarity=0.164 Sum_probs=81.1
Q ss_pred HHHHHHHHHhccCcC--ceeEEEeEEEc-----CCeEEEEEeecCCC-CHHHHHhh--CCCCChHHHHHHHHHHHHHHHH
Q 038905 460 EFKNEVVMIGQTYHK--NLVRLLGFCDE-----GQNRLLVYKFLNNG-TLASFLFE--NLKPGWNLRANIAFQIARGLLH 529 (709)
Q Consensus 460 ~~~~E~~~l~~l~h~--nlv~l~~~~~~-----~~~~~lV~Ey~~~g-sL~~~l~~--~~~l~~~~~~~i~~~i~~al~~ 529 (709)
.+.+|...+.++... ..++++++... ....+||+|++++. +|.+++.+ ....+...+..++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 478999988888533 33444555432 23568999999986 89998854 2345566778899999999999
Q ss_pred hhhcCCCCeEecCCCCCceeecC-------CCCeEEcccccccc
Q 038905 530 LHVNCSSQIIHCDIKPQNILLDD-------YYNAQISDFGLAKL 566 (709)
Q Consensus 530 LH~~~~~~iiH~Dlkp~NIll~~-------~~~~kl~DFGla~~ 566 (709)
|| ..||+|+|+++.|||++. +..+.++||+.+..
T Consensus 154 LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99 999999999999999975 46799999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.1e-07 Score=87.84 Aligned_cols=100 Identities=21% Similarity=0.283 Sum_probs=68.0
Q ss_pred HHHHHHHHHHhccCcC--ceeEEEeEEEcCCeEEEEEeecC--CCCHHHHHhhCCCCChHHHHHHHHHHHHHHHH-hhhc
Q 038905 459 KEFKNEVVMIGQTYHK--NLVRLLGFCDEGQNRLLVYKFLN--NGTLASFLFENLKPGWNLRANIAFQIARGLLH-LHVN 533 (709)
Q Consensus 459 ~~~~~E~~~l~~l~h~--nlv~l~~~~~~~~~~~lV~Ey~~--~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~-LH~~ 533 (709)
...++|.+.|.++... ++++++.+- ...|||||++ |..+..+.... ++......++.+++..+.. +|
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~-- 124 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLH-- 124 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHH--
Confidence 4567899999999765 567777553 4479999998 65554432211 1244556777788885555 67
Q ss_pred CCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 534 CSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 534 ~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
+.+|+|+||.+.|||++++ .+.|+|||.+....
T Consensus 125 -~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 125 -KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp -CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred -hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 8899999999999999988 99999999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.2e-07 Score=88.24 Aligned_cols=109 Identities=18% Similarity=0.184 Sum_probs=86.9
Q ss_pred hHHHHHHHHHHHhccC--cCceeEEEeEEEcC----CeEEEEEeecCCC-CHHHHHhhCCCCChHHHHHHHHHHHHHHHH
Q 038905 457 GEKEFKNEVVMIGQTY--HKNLVRLLGFCDEG----QNRLLVYKFLNNG-TLASFLFENLKPGWNLRANIAFQIARGLLH 529 (709)
Q Consensus 457 ~~~~~~~E~~~l~~l~--h~nlv~l~~~~~~~----~~~~lV~Ey~~~g-sL~~~l~~~~~l~~~~~~~i~~~i~~al~~ 529 (709)
......+|...+..+. .-..++.+++.... ...+||+|++++. +|.+++......+......++.++++.+.-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 3456788888888775 33345666665542 2358999999984 899999875556777888999999999999
Q ss_pred hhhcCCCCeEecCCCCCceeecCCC---CeEEcccccccccc
Q 038905 530 LHVNCSSQIIHCDIKPQNILLDDYY---NAQISDFGLAKLLT 568 (709)
Q Consensus 530 LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DFGla~~~~ 568 (709)
|| ..+|+|+|+++.|||++.+. .+.++||+.++...
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99 99999999999999999887 79999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=4.6e-08 Score=107.82 Aligned_cols=152 Identities=19% Similarity=0.237 Sum_probs=104.3
Q ss_pred HHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc-------cceeccccCcccccccccc
Q 038905 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK-------AIKKAIRGTKGYVASPEWF 592 (709)
Q Consensus 520 ~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-------~~~~~~~Gt~~y~aaPE~~ 592 (709)
+.+++.|+.++|. +.++||++|.|++|.++..+..||+.|+.+......... ....-..-...|.| ||++
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a-pE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA-PEYL 181 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccccc-chhh
Confidence 4456699999996 568999999999999999999999999998655431111 00012234567888 9999
Q ss_pred cCCCCCcccchHHHHHHHHHHHhCC-CCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhc
Q 038905 593 RNSTITANVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671 (709)
Q Consensus 593 ~~~~~s~k~DvwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~C 671 (709)
.....+.++|+||+|+++|.+..|. ..+.......... .....+......+..+.+.++.+=+.++
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHHHHHH
Confidence 9988999999999999999999544 4443322111110 0001111111112244566777888888
Q ss_pred ccCCCCCCCCHHHHHH
Q 038905 672 IQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 672 l~~dP~~RPs~~ev~~ 687 (709)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998877644
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.1e-07 Score=77.64 Aligned_cols=53 Identities=26% Similarity=0.511 Sum_probs=44.4
Q ss_pred CCCCHHHHHHHhccCCceEEEEEe--CCcccccCCCCCCcccccccccceeeccc
Q 038905 337 RPYDEVQCKNNCLSDCFCVVAIFR--GDSCWSKKLPLSNGRAHSSVNGKAFLKYK 389 (709)
Q Consensus 337 ~~~~~~~C~~~Cl~nC~C~a~~~~--~~~C~~~~~~l~~g~~~~~~~~~~~lkv~ 389 (709)
.++++++|++.|++||+|+||+|. +++|++|..++.+.+.....+..+|+|++
T Consensus 30 ~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 30 TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 567899999999999999999997 58999999988887665444578898863
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=98.31 E-value=4e-07 Score=71.88 Aligned_cols=37 Identities=24% Similarity=0.561 Sum_probs=33.2
Q ss_pred CCCCHHHHHHHhccCCceEEEEEe----CCcccccCCCCCC
Q 038905 337 RPYDEVQCKNNCLSDCFCVVAIFR----GDSCWSKKLPLSN 373 (709)
Q Consensus 337 ~~~~~~~C~~~Cl~nC~C~a~~~~----~~~C~~~~~~l~~ 373 (709)
.+.++++|+.+||+||+|+||+|. +++|++|..+|.+
T Consensus 25 ~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 25 SSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred cCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 568999999999999999999997 3789999988765
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.21 E-value=9.8e-07 Score=72.07 Aligned_cols=50 Identities=18% Similarity=0.240 Sum_probs=42.1
Q ss_pred CCCHHHHHHHhcc---CCceEEEEEe--CCcccccCCCC-CCcccccccccceeec
Q 038905 338 PYDEVQCKNNCLS---DCFCVVAIFR--GDSCWSKKLPL-SNGRAHSSVNGKAFLK 387 (709)
Q Consensus 338 ~~~~~~C~~~Cl~---nC~C~a~~~~--~~~C~~~~~~l-~~g~~~~~~~~~~~lk 387 (709)
..+.++|+++|++ ||+|.||+|. +.+|++|..++ .+.+...+.+..+|+|
T Consensus 24 ~~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 24 ANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred ccCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 3689999999999 9999999996 46899999999 7777665556677776
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=76.62 Aligned_cols=119 Identities=16% Similarity=0.141 Sum_probs=89.1
Q ss_pred EEEEEEcccc-----c-chhHHHHHHHHHHHhccCc--CceeEEEeEEE-c----CCeEEEEEeecCC-CCHHHHHhhCC
Q 038905 444 VIVVKKLDRV-----F-QDGEKEFKNEVVMIGQTYH--KNLVRLLGFCD-E----GQNRLLVYKFLNN-GTLASFLFENL 509 (709)
Q Consensus 444 ~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~h--~nlv~l~~~~~-~----~~~~~lV~Ey~~~-gsL~~~l~~~~ 509 (709)
.+-+|+-... . .-+...|.+|...|.++.. ..++++. ++. . ....+||+|-+.| .+|.+++.+..
T Consensus 43 ~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~ 121 (216)
T PRK09902 43 KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHA 121 (216)
T ss_pred EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCC
Confidence 5667765411 0 3367889999999999863 3345555 332 1 1235799997764 48998886642
Q ss_pred --CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC--eEEcccccccc
Q 038905 510 --KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN--AQISDFGLAKL 566 (709)
Q Consensus 510 --~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DFGla~~ 566 (709)
+.+...+..+..+|+..+.-|| ..++.|+|+.+.||+++.++. ++++||--++.
T Consensus 122 ~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 122 VSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 4677888899999999999999 999999999999999986667 99999987653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.2e-05 Score=80.02 Aligned_cols=138 Identities=14% Similarity=0.128 Sum_probs=95.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc----------------------chhHHHHHHHHHHHhcc
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF----------------------QDGEKEFKNEVVMIGQT 471 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l 471 (709)
..+..++|.|.=+-+ |.+.. +.+..+|||.-.... .-.....++|.++|.+|
T Consensus 93 e~iG~~IGvGKEsdV---Y~~~~---~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L 166 (304)
T COG0478 93 EAIGTKIGVGKESDV---YVAID---PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL 166 (304)
T ss_pred HhhccccccCccceE---EEEEC---CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence 345566777777766 77766 568889998632110 01223467899999998
Q ss_pred CcC--ceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcee
Q 038905 472 YHK--NLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549 (709)
Q Consensus 472 ~h~--nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIl 549 (709)
.-. .+++.+++ +...+||||++|-.|...- ++.+....++..|++-+.-+- +.||||+|+.+-||+
T Consensus 167 ~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIl 234 (304)
T COG0478 167 YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNIL 234 (304)
T ss_pred hhcCCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEE
Confidence 755 66666553 5668999999996665432 233444455555555555554 678999999999999
Q ss_pred ecCCCCeEEccccccccccc
Q 038905 550 LDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 550 l~~~~~~kl~DFGla~~~~~ 569 (709)
++++|.+.++||-.+.....
T Consensus 235 V~~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPISH 254 (304)
T ss_pred EecCCCEEEEeCcccccCCC
Confidence 99999999999998865443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.6e-05 Score=82.99 Aligned_cols=254 Identities=15% Similarity=0.120 Sum_probs=150.4
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeE--------EEeEEEcCCeE
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVR--------LLGFCDEGQNR 489 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~--------l~~~~~~~~~~ 489 (709)
.+.+|+|+-+.+|-.+.. .-.+-|+..........+...| |.+. .||-+-. ++|- ..+...
T Consensus 16 gr~LgqGgea~ly~l~e~------~d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i 85 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV------RDQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGG-RRGKVI 85 (637)
T ss_pred CccccCCccceeeecchh------hchhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence 355778888777666554 1223455554433333333333 3333 3442221 1111 112224
Q ss_pred EEEEeecCCCC-HHHHHh---h---CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccc
Q 038905 490 LLVYKFLNNGT-LASFLF---E---NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562 (709)
Q Consensus 490 ~lV~Ey~~~gs-L~~~l~---~---~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 562 (709)
-++|..+.+.. ...++. + ....+|.-..+.++.++.+.+.|| ..|.+-+|+.++|+|+++++.+.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccc
Confidence 57777776642 222221 1 123789999999999999999999 8899999999999999999999998754
Q ss_pred ccccccccccccceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhC-CCCCCccchh--hHHhHHHH
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISC-RKSFDIEMGE--EYAILTDW 634 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg-~~p~~~~~~~--~~~~~~~~ 634 (709)
--.+-.. .......+|.+.|.. ||.-. +-..+...|-|.|||++++++.| +.||...... ......
T Consensus 163 sfqi~~n---g~~~~cpVg~~eftP-PElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E-- 236 (637)
T COG4248 163 SFQINAN---GTLHLCPVGVSEFTP-PELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE-- 236 (637)
T ss_pred ceeeccC---CceEecccCccccCC-HHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--
Confidence 3322211 112245678999998 99754 34457789999999999999886 8898764320 000000
Q ss_pred HHHhhhcCCccccccCc------ccccCCHHHHHHHHHHHHhcccC--CCCCCCCHHHHHHHHcccc
Q 038905 635 AFDCYRNGKLDDLVEGD------MEAMNDIKCVEKLVMVSIWCIQE--DPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 635 ~~~~~~~g~~~~l~~~~------~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~ev~~~L~~~~ 693 (709)
..+..|......+.. .......-.+..+..+..+|+.+ ++.-|||.+..+..|..+.
T Consensus 237 --~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 237 --TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred --hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 001112111111111 01111122445677788888865 3678999999888887644
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.07 E-value=1e-05 Score=78.40 Aligned_cols=102 Identities=25% Similarity=0.400 Sum_probs=83.6
Q ss_pred HHHHHHHhccCc-CceeEEEeEEEcCCeEEEEEeecCCCCHHHH---HhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCC
Q 038905 462 KNEVVMIGQTYH-KNLVRLLGFCDEGQNRLLVYKFLNNGTLASF---LFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ 537 (709)
Q Consensus 462 ~~E~~~l~~l~h-~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~---l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ 537 (709)
.+|..++..+++ +++++++|+| ..++|.||...+++... +.+-...+|..|.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 6999999999 34789999987765321 222234789999999999999999999765567
Q ss_pred eEecCCCCCceeecCCCCeEEccccccccc
Q 038905 538 IIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 538 iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
+.-+|++++|+-+++++.+|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=8.9e-05 Score=82.44 Aligned_cols=142 Identities=17% Similarity=0.199 Sum_probs=89.1
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch------------------------------hH----H-----
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD------------------------------GE----K----- 459 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~------------------------------~~----~----- 459 (709)
...+++++.++| +++.+ .+++.||||+....-.+ .. +
T Consensus 130 ~~PiAsASIaQV-H~A~L---~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 130 PEPIASASIAQV-HRAVL---KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred CCchhhhhHhhh-eeEEe---cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 367888888888 45555 35999999985431100 00 1
Q ss_pred -HHHHHHHHHhcc----CcCceeEEEeEE-EcCCeEEEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHH-HHHhh
Q 038905 460 -EFKNEVVMIGQT----YHKNLVRLLGFC-DEGQNRLLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARG-LLHLH 531 (709)
Q Consensus 460 -~~~~E~~~l~~l----~h~nlv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~a-l~~LH 531 (709)
++.+|..-+.++ +...-+++=.++ +-.....|+|||++|-.+.+...-. ...+ +..++..++++ +..+-
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQLL 282 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 123344333333 222223333333 3356789999999999988875322 3344 33344444443 22222
Q ss_pred hcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 532 ~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
..|+.|.|..|-||+++.++.+.+.|||+...+...
T Consensus 283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 569999999999999999999999999998876544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00034 Score=70.10 Aligned_cols=137 Identities=12% Similarity=0.106 Sum_probs=81.0
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCc--eeEEEeEEEcCCeEEEEEeecC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKN--LVRLLGFCDEGQNRLLVYKFLN 497 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--lv~l~~~~~~~~~~~lV~Ey~~ 497 (709)
..+|+|....||. . .+...++|...... ......+|.+++..+..-. +++.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~---~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYT---H----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeE---e----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 3456777766653 1 13346677765422 3456789999999986443 4788888888888889999999
Q ss_pred CCC-HHHHHh--------------------hCC---CCChHHH-HHHHH----------HHHHH-HHHhhh-cCCCCeEe
Q 038905 498 NGT-LASFLF--------------------ENL---KPGWNLR-ANIAF----------QIARG-LLHLHV-NCSSQIIH 540 (709)
Q Consensus 498 ~gs-L~~~l~--------------------~~~---~l~~~~~-~~i~~----------~i~~a-l~~LH~-~~~~~iiH 540 (709)
|.. +...+. +.. ....... ..+.. .+... ..+|.. .....++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 211111 000 0111110 00000 01111 122221 11345789
Q ss_pred cCCCCCceeecCCCCeEEcccccccc
Q 038905 541 CDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 541 ~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
+|+.|.||++++++ +.|.||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998853
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00032 Score=71.26 Aligned_cols=121 Identities=13% Similarity=0.034 Sum_probs=74.9
Q ss_pred eEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHh---------------
Q 038905 443 TVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF--------------- 506 (709)
Q Consensus 443 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~--------------- 506 (709)
..++||...... ..++.+|++++..+. +--+++++++....+..++|||+++|.+|.....
T Consensus 23 ~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l 99 (244)
T cd05150 23 PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEAL 99 (244)
T ss_pred CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHH
Confidence 567778765432 346778999888874 4456688888777677899999999988764421
Q ss_pred ---hCC-----CCChH--HHHHHHH--------------------HHHHHHHHhhh----cCCCCeEecCCCCCceeecC
Q 038905 507 ---ENL-----KPGWN--LRANIAF--------------------QIARGLLHLHV----NCSSQIIHCDIKPQNILLDD 552 (709)
Q Consensus 507 ---~~~-----~l~~~--~~~~i~~--------------------~i~~al~~LH~----~~~~~iiH~Dlkp~NIll~~ 552 (709)
+.. ..... .+..... .+...+..|-. .....++|+|+.|.|||+++
T Consensus 100 ~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~ 179 (244)
T cd05150 100 RRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDP 179 (244)
T ss_pred HHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeC
Confidence 000 00000 0000000 01111122211 11345899999999999999
Q ss_pred CCCeEEcccccccc
Q 038905 553 YYNAQISDFGLAKL 566 (709)
Q Consensus 553 ~~~~kl~DFGla~~ 566 (709)
+..+.|+||+.+..
T Consensus 180 ~~~~~iIDwe~a~~ 193 (244)
T cd05150 180 GKFSGFIDLGRLGV 193 (244)
T ss_pred CcEEEEEEcccccc
Confidence 87788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=5.5e-06 Score=90.62 Aligned_cols=151 Identities=22% Similarity=0.201 Sum_probs=113.6
Q ss_pred HHHHHHHHHHhccCcCc-eeEEEeEEEcCCeEEEEEeecCCC-CHHHHHh-hCCCCChHHHHHHHHHHHHHHHHhhhcCC
Q 038905 459 KEFKNEVVMIGQTYHKN-LVRLLGFCDEGQNRLLVYKFLNNG-TLASFLF-ENLKPGWNLRANIAFQIARGLLHLHVNCS 535 (709)
Q Consensus 459 ~~~~~E~~~l~~l~h~n-lv~l~~~~~~~~~~~lV~Ey~~~g-sL~~~l~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~ 535 (709)
....-++++|.+++||| .++.++-++.+....++++++.++ +-..... ....+...+...+.+.-.+++++|| +
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~ 354 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---S 354 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc---c
Confidence 55677899999999999 778888788888889999999887 2111111 1112333444556667778899999 5
Q ss_pred CCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh
Q 038905 536 SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615 (709)
Q Consensus 536 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt 615 (709)
..-+|+| ||+..+ +..|..||+.+..+.+.... +...+++.+++ ||+.....+..+.|+|++|+--.+|--
T Consensus 355 ~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~---~t~~~~~~~~~-pev~~~~~~~~~p~~~~~~~~~~~~ap 425 (829)
T KOG0576|consen 355 SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKP---RTAIGTPEPLA-PEVIQENTIDGCPDSGSLAVSAIQMAP 425 (829)
T ss_pred ccccCcc----cccccc-cccccccccCCcccCccccc---ccCCCCCCCCC-chhhcccccccCCCccCCCcchhhcCC
Confidence 4457888 777766 67899999999877765422 67789999999 999999999999999999987777766
Q ss_pred CCCCCC
Q 038905 616 CRKSFD 621 (709)
Q Consensus 616 g~~p~~ 621 (709)
|-+|-.
T Consensus 426 ~~pPr~ 431 (829)
T KOG0576|consen 426 GLPPRS 431 (829)
T ss_pred CCCCCC
Confidence 666643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00059 Score=66.79 Aligned_cols=68 Identities=19% Similarity=0.258 Sum_probs=53.4
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...+|||||++|..|.+... ++. .+...+.+++.-|| ..|+.|+|..|.|++++.++ +++.||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 44569999999988765432 221 35566778899999 89999999999999999655 99999988654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00055 Score=67.76 Aligned_cols=138 Identities=15% Similarity=0.173 Sum_probs=86.8
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhH---------HH---------------HHHHHHHHhccC--cC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGE---------KE---------------FKNEVVMIGQTY--HK 474 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~---------~~---------------~~~E~~~l~~l~--h~ 474 (709)
.+..|--..||++.. .++..+|||+......... .. ...|+.-|.++. +-
T Consensus 55 ~istGKEA~Vy~a~~----~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 55 CISTGKEANVYLAET----GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eecCCcceEEEeecc----CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 344555556654433 4688899998754322111 11 235666666663 44
Q ss_pred ceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC
Q 038905 475 NLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554 (709)
Q Consensus 475 nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~ 554 (709)
.+++.+++. +..|||||+....+..-.-+..++.......+..++++.+.-|-. ..++||+||..=|||+. ++
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CC
Confidence 555555554 347999998653211111111122333566777788888877762 37999999999999999 88
Q ss_pred CeEEccccccccccc
Q 038905 555 NAQISDFGLAKLLTL 569 (709)
Q Consensus 555 ~~kl~DFGla~~~~~ 569 (709)
.+.|+|||.|.....
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999999986653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0014 Score=63.97 Aligned_cols=131 Identities=16% Similarity=0.150 Sum_probs=85.3
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEccccc----------------chhHHHHHHHHHHHhccC------cCcee
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF----------------QDGEKEFKNEVVMIGQTY------HKNLV 477 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~nlv 477 (709)
..+|.|+.-.||.- +......||+..... ....++..+|+....++. +.+|.
T Consensus 7 ~~i~~G~~R~cy~H------P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 7 DLIAQGGERDCYQH------PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred cccccCCCceEEEC------CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 45666666544322 345556667665443 223466777776665555 88999
Q ss_pred EEEeEEEcCCeEEEEEeecCC------CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec
Q 038905 478 RLLGFCDEGQNRLLVYKFLNN------GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551 (709)
Q Consensus 478 ~l~~~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~ 551 (709)
+++|+.++....-+|+|.+.+ -+|.+++.+. .++. ...+.+.+. ..||- ...|+.+|++|.||++.
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEE
Confidence 999999999999999998744 2688888544 3444 333333333 34454 56799999999999995
Q ss_pred CCC----CeEEcc-cccc
Q 038905 552 DYY----NAQISD-FGLA 564 (709)
Q Consensus 552 ~~~----~~kl~D-FGla 564 (709)
... .+.|+| ||-.
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 432 466666 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00089 Score=80.24 Aligned_cols=80 Identities=10% Similarity=0.187 Sum_probs=50.9
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccC-cCce--eEEEeEEEcC---CeEEEEE
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTY-HKNL--VRLLGFCDEG---QNRLLVY 493 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nl--v~l~~~~~~~---~~~~lV~ 493 (709)
.+++|....+|... ...+.....+++|+..... ......+.+|++++..+. |.++ ++++.+|.+. ...++||
T Consensus 45 ~l~gG~sn~ty~l~-~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 45 QFGHGQSNPTFLLE-VGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EeCCCCcCceEEEE-ECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 34555555555443 2221222467777764322 123457889999999995 6654 8888888764 3578999
Q ss_pred eecCCCCH
Q 038905 494 KFLNNGTL 501 (709)
Q Consensus 494 Ey~~~gsL 501 (709)
||++|..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99998643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0012 Score=66.06 Aligned_cols=121 Identities=21% Similarity=0.193 Sum_probs=68.9
Q ss_pred eEEEEEEcccccchhHHHHHHHHHHHhccCcC--ceeEEEeEEEc---CCeEEEEEeecCCCCHHH--------------
Q 038905 443 TVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHK--NLVRLLGFCDE---GQNRLLVYKFLNNGTLAS-------------- 503 (709)
Q Consensus 443 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nlv~l~~~~~~---~~~~~lV~Ey~~~gsL~~-------------- 503 (709)
..+++|..... .....+.+|..++..+... .+++++.+... ....+++|++++|..+..
T Consensus 21 ~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~ 98 (239)
T PF01636_consen 21 GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQL 98 (239)
T ss_dssp SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHH
T ss_pred cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccc
Confidence 58899986554 4567888999998888533 35677765432 334689999999988777
Q ss_pred --HHh---hC----CCCChHH---------HHHH------------HHHHHH-HHHHhhh----cCCCCeEecCCCCCce
Q 038905 504 --FLF---EN----LKPGWNL---------RANI------------AFQIAR-GLLHLHV----NCSSQIIHCDIKPQNI 548 (709)
Q Consensus 504 --~l~---~~----~~l~~~~---------~~~i------------~~~i~~-al~~LH~----~~~~~iiH~Dlkp~NI 548 (709)
.+. .. ..+.... .... ...+.+ .+..++. .....++|+|+.|.||
T Consensus 99 ~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Ni 178 (239)
T PF01636_consen 99 GRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNI 178 (239)
T ss_dssp HHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGE
T ss_pred hhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccc
Confidence 111 11 0111100 0000 111222 2333332 1356799999999999
Q ss_pred eec-CCCCeEEccccccc
Q 038905 549 LLD-DYYNAQISDFGLAK 565 (709)
Q Consensus 549 ll~-~~~~~kl~DFGla~ 565 (709)
+++ +++.+-|.||+.+.
T Consensus 179 l~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 179 LVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEESSTTEEEE--GTT-E
T ss_pred eeeeccceeEEEecccce
Confidence 999 66666899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00067 Score=79.67 Aligned_cols=198 Identities=19% Similarity=0.128 Sum_probs=135.7
Q ss_pred HHHHHHHHhccCcCceeEEEeEEEcCCeEE----EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCC
Q 038905 461 FKNEVVMIGQTYHKNLVRLLGFCDEGQNRL----LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS 536 (709)
Q Consensus 461 ~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~ 536 (709)
..-|...+.++.|+|++.+++|-.+....- +..|++..-++...+..-...+..+.+.+..+..+||.|+| +.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h---~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH---SL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH---Hh
Confidence 345667788889999999999986654433 44578888899998888888899999999999999999999 44
Q ss_pred CeEecCCCCC---ceeecCCCCeEEc--cccccccccccccccceeccccCcccccccccccCCCCCc--ccchHHHHHH
Q 038905 537 QIIHCDIKPQ---NILLDDYYNAQIS--DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITA--NVDVYSFGVL 609 (709)
Q Consensus 537 ~iiH~Dlkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~--k~DvwSlGvv 609 (709)
...|.-+... +.-.+.++.+.++ ||+..+.+...... ....-...+.+ +|......+.. ..|+|.+|.+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~-~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNA-DEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCcccccc-ccccccccchhhhhhHHHHHHHH
Confidence 4444444333 4444566777777 99988876554332 12223344555 77776665544 4799999999
Q ss_pred HHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 038905 610 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQML 689 (709)
Q Consensus 610 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L 689 (709)
+..+..|..+-..... ...+.+. . .. ..+.+....|+..++++|++..+++...
T Consensus 382 ~~~~~~~~~i~~~~~~------------------~~~~l~~----~-~~---~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------------------PVSLLDV----L-ST---SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCcccccccc------------------hhhhhcc----c-cc---hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999988765431110 0001110 0 00 1455677889999999999999999865
Q ss_pred cc
Q 038905 690 EV 691 (709)
Q Consensus 690 ~~ 691 (709)
-.
T Consensus 436 f~ 437 (1351)
T KOG1035|consen 436 FL 437 (1351)
T ss_pred hc
Confidence 44
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0014 Score=72.91 Aligned_cols=80 Identities=16% Similarity=0.228 Sum_probs=53.8
Q ss_pred CCeEEEEEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC----CCCeEEcc
Q 038905 486 GQNRLLVYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD----YYNAQISD 560 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~D 560 (709)
...+.|+||||+|..+.+.-.- ...++.. .++..+.++... ..-..|.+|+|-.|-||++.. ++.+.+.|
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~~~~--qIf~~GffHaDPHPGNilv~~~~~~~~~ivllD 348 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEAYLE--QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLD 348 (538)
T ss_pred CcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHHHHH--HHHhcCCccCCCCCCcEEEecCCCCCccEEEEc
Confidence 4578999999999877665331 1234444 333333333222 111458999999999999983 67899999
Q ss_pred cccccccccc
Q 038905 561 FGLAKLLTLN 570 (709)
Q Consensus 561 FGla~~~~~~ 570 (709)
||+...+...
T Consensus 349 hGl~~~is~~ 358 (538)
T KOG1235|consen 349 HGLYAVISHK 358 (538)
T ss_pred ccccccccHH
Confidence 9999876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.002 Score=65.11 Aligned_cols=32 Identities=28% Similarity=0.458 Sum_probs=26.9
Q ss_pred CCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++|+|+.+.||+++++...-|.||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 44589999999999998776667999999753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0044 Score=54.83 Aligned_cols=100 Identities=20% Similarity=0.232 Sum_probs=67.6
Q ss_pred cCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccceEEEEEecC
Q 038905 153 METEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRNG 232 (709)
Q Consensus 153 l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (709)
|..++.|+|... ..+.|.|++.++.+|++.++.... ..++|.+...... ..+..+.++.+|.+.+.+.++
T Consensus 4 l~~~~~l~s~~~--~f~~G~~~~~~q~dgnlV~~~~~~-----~~~vW~snt~~~~---~~~~~l~l~~dGnLvl~~~~g 73 (114)
T smart00108 4 LSSGQTLVSGNS--LFELGFFTLIMQNDYNLILYKSSS-----RTVVWVANRDNPV---SDSCTLTLQSDGNLVLYDGDG 73 (114)
T ss_pred cCCCCEEecCCC--cEeeeccccCCCCCEEEEEEECCC-----CcEEEECCCCCCC---CCCEEEEEeCCCCEEEEeCCC
Confidence 445566666432 336899999999999988874221 3579988765321 223567888899888887767
Q ss_pred eeEEEeeeeccCCCCeEEEEEEccCCcEEEEEe
Q 038905 233 RRFDLTTERVVPAADFYHRATLNFDGVFVQSFY 265 (709)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~~ 265 (709)
..+.-+.. . ......+++|..||+|++|.-
T Consensus 74 ~~vW~S~t--~-~~~~~~~~~L~ddGnlvl~~~ 103 (114)
T smart00108 74 RVVWSSNT--T-GANGNYVLVLLDDGNLVIYDS 103 (114)
T ss_pred CEEEEecc--c-CCCCceEEEEeCCCCEEEECC
Confidence 65544322 1 234567899999999998864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0081 Score=62.94 Aligned_cols=79 Identities=6% Similarity=0.005 Sum_probs=53.6
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCc---CceeEEEeEEEcC---CeE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH---KNLVRLLGFCDEG---QNR 489 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nlv~l~~~~~~~---~~~ 489 (709)
......+|+|....||..... ++ .+++|..+.. .....+.+|...|+.+.- ..++++++++..+ +..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~----~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS----QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hheeeecCCccceeEEEEEcC----CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 345567888988877655332 22 3455553321 133588999999988853 4688999888643 568
Q ss_pred EEEEeecCCCCH
Q 038905 490 LLVYKFLNNGTL 501 (709)
Q Consensus 490 ~lV~Ey~~~gsL 501 (709)
+||||++++.++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999998764
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0046 Score=54.90 Aligned_cols=100 Identities=19% Similarity=0.187 Sum_probs=67.5
Q ss_pred cCCCceEEecCCCCCCCCcceEEeecc-CCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccceEEEEEec
Q 038905 153 METEQGLFSGKSDTNFSRGRFQFRLLK-DSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRN 231 (709)
Q Consensus 153 l~~~~~L~S~~s~~dps~G~y~l~~~~-~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (709)
|..++.|+|.. ...+.|+|++.++. +|++.++.... ...+|.+..-.. ......+.++.+|.+++.+.+
T Consensus 4 l~~~~~l~s~~--~~f~~G~~~~~~q~~dgnlv~~~~~~-----~~~vW~snt~~~---~~~~~~l~l~~dGnLvl~~~~ 73 (116)
T cd00028 4 LSSGQTLVSSG--SLFELGFFKLIMQSRDYNLILYKGSS-----RTVVWVANRDNP---SGSSCTLTLQSDGNLVIYDGS 73 (116)
T ss_pred cCCCCEEEeCC--CcEEEecccCCCCCCeEEEEEEeCCC-----CeEEEECCCCCC---CCCCEEEEEecCCCeEEEcCC
Confidence 44556666642 33457999999998 99888774221 357898766431 134456788889988888777
Q ss_pred CeeEEEeeeeccCCCCeEEEEEEccCCcEEEEEe
Q 038905 232 GRRFDLTTERVVPAADFYHRATLNFDGVFVQSFY 265 (709)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~~ 265 (709)
+..+.-+.. .. .....+++|..||+|++|.-
T Consensus 74 g~~vW~S~~--~~-~~~~~~~~L~ddGnlvl~~~ 104 (116)
T cd00028 74 GTVVWSSNT--TR-VNGNYVLVLLDDGNLVLYDS 104 (116)
T ss_pred CcEEEEecc--cC-CCCceEEEEeCCCCEEEECC
Confidence 766544332 11 24568899999999999875
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0038 Score=65.40 Aligned_cols=141 Identities=13% Similarity=0.115 Sum_probs=80.3
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcC--ceeEEEeE------EEcCCeE
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHK--NLVRLLGF------CDEGQNR 489 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nlv~l~~~------~~~~~~~ 489 (709)
....+.+|....+|..... +..+++|+... ...+++..|++++..+++. .+++++.. ....+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~~-----~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD-----SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred heecccCccccceEEEEeC-----CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 3445555554555554332 33578887654 2345677888888887543 24455442 1233456
Q ss_pred EEEEeecCCCCHHH----HHh----------hC-CC----------CChHHHH----------HHHHHHHHHHHHhhh--
Q 038905 490 LLVYKFLNNGTLAS----FLF----------EN-LK----------PGWNLRA----------NIAFQIARGLLHLHV-- 532 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~----~l~----------~~-~~----------l~~~~~~----------~i~~~i~~al~~LH~-- 532 (709)
++|++|++|..+.. .+. .. .. ..|.... .....+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999976532 000 00 00 1111110 011123334444442
Q ss_pred --cCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 533 --NCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 533 --~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
....+++|+|+.|.||+++++..+.|.||+.+..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 1235799999999999999987788999998853
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0013 Score=53.57 Aligned_cols=39 Identities=21% Similarity=0.510 Sum_probs=32.6
Q ss_pred CCCCHHHHHHHhcc-CCceEEEEEe--CCcccccC-CCCCCcc
Q 038905 337 RPYDEVQCKNNCLS-DCFCVVAIFR--GDSCWSKK-LPLSNGR 375 (709)
Q Consensus 337 ~~~~~~~C~~~Cl~-nC~C~a~~~~--~~~C~~~~-~~l~~g~ 375 (709)
...+.++|++.|++ +|.|.++.|. ++.|++|. .++.+..
T Consensus 23 ~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 23 SVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred cCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 45689999999999 9999999997 68999998 5555544
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.023 Score=55.18 Aligned_cols=125 Identities=21% Similarity=0.234 Sum_probs=82.6
Q ss_pred cccceeeeecCeeE-EEEEEEEEEecCCCceEEEEEEccc------------ccc---------hhHHHHHHHHHHHhcc
Q 038905 414 MNVTRSVLLGSSVF-VNFTLVGVIQTSTRTTVIVVKKLDR------------VFQ---------DGEKEFKNEVVMIGQT 471 (709)
Q Consensus 414 ~~f~~~~~~G~g~~-~~v~~~~~~~~~~~~~~vavK~~~~------------~~~---------~~~~~~~~E~~~l~~l 471 (709)
..|.....+|.|.- +.| ++..+ .+...|+|.... ... .-...|..|.+..++|
T Consensus 37 ~~I~flefLg~g~~~~~V-~kv~I----~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYV-FKVEI----DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CcEeeeeecCCCCceeEE-EEEEE----CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 45666666666666 545 44444 477999998211 000 1123588999988887
Q ss_pred C---cCce--eEEEeEEEcC------------------CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHH
Q 038905 472 Y---HKNL--VRLLGFCDEG------------------QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLL 528 (709)
Q Consensus 472 ~---h~nl--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~ 528 (709)
+ +.++ |+.+|+..=. ....||.||++... ....+-+.+|.+-+.
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRDIPQMLRDLK 178 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhHHHHHHHHHH
Confidence 5 4456 9999987211 12357888876533 112234556777888
Q ss_pred HhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 529 HLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 529 ~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
.+| ..+|+-+|+|+.|.. .-||+|||.+
T Consensus 179 ~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 899 999999999999976 5689999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.016 Score=58.41 Aligned_cols=31 Identities=19% Similarity=0.324 Sum_probs=27.3
Q ss_pred CCCeEecCCCCCceeecC-CCCeEEccccccc
Q 038905 535 SSQIIHCDIKPQNILLDD-YYNAQISDFGLAK 565 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~ 565 (709)
...++|+|+.+.|||+++ +..+.|.||..|.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 346999999999999998 5789999999875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.012 Score=51.96 Aligned_cols=88 Identities=30% Similarity=0.528 Sum_probs=51.8
Q ss_pred CcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEecCccEEEEcCCCcEEEe
Q 038905 43 SPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWS 122 (709)
Q Consensus 43 ~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~~G~L~l~~~~g~~vWs 122 (709)
+++.+.+|.+.|-|-.-++ |-| |.. ..++||..+... ......+.|.|.++|||||.|..+.++|+
T Consensus 12 ~p~~~~s~~~~L~l~~dGn---------Lvl-~~~--~~~~iWss~~t~--~~~~~~~~~~L~~~GNlvl~d~~~~~lW~ 77 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN---------LVL-YDS--NGSVIWSSNNTS--GRGNSGCYLVLQDDGNLVLYDSSGNVLWQ 77 (114)
T ss_dssp EEEEECETTEEEEEETTSE---------EEE-EET--TTEEEEE--S-T--TSS-SSEEEEEETTSEEEEEETTSEEEEE
T ss_pred cccccccccccceECCCCe---------EEE-EcC--CCCEEEEecccC--CccccCeEEEEeCCCCEEEEeecceEEEe
Confidence 4455545778887754221 222 232 356799884320 22225789999999999999999999999
Q ss_pred ec-----cE----------EEeccCCceeeeecCCCC
Q 038905 123 SK-----LI----------LVQSFSSSRLWDSFSNPT 144 (709)
Q Consensus 123 s~-----~~----------vl~~~~~~~lWQSFd~Pt 144 (709)
|. +. +++.....+.|.|=+.|+
T Consensus 78 Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 78 SFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp STTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred ecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 84 11 223334468888876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0067 Score=62.12 Aligned_cols=121 Identities=12% Similarity=0.093 Sum_probs=65.8
Q ss_pred CceEEEEEEcccccchhHHHHHHHHHHHhccCcCce-eEEEeEEEcCCeEEEEEeecCCCCHHHH--------------H
Q 038905 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNL-VRLLGFCDEGQNRLLVYKFLNNGTLASF--------------L 505 (709)
Q Consensus 441 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nl-v~l~~~~~~~~~~~lV~Ey~~~gsL~~~--------------l 505 (709)
.+..+++|........-.-...+|..+++.+....+ ++++.... ..+||||++|..+... +
T Consensus 18 ~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l 93 (256)
T TIGR02721 18 PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLELAALL 93 (256)
T ss_pred CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHHHHHH
Confidence 345677777543322111235778888888864333 44454432 3689999998765421 1
Q ss_pred ---hhCC----CCChHHH-HHHHH---------HHHHHHHHhhhc-----CCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 506 ---FENL----KPGWNLR-ANIAF---------QIARGLLHLHVN-----CSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 506 ---~~~~----~l~~~~~-~~i~~---------~i~~al~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
+... +++...+ ..+.. .+.+.+..+... ....++|+|+.|.||++++++ +.|.||..
T Consensus 94 ~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~ 172 (256)
T TIGR02721 94 HQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEY 172 (256)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccc
Confidence 1100 1111111 11111 111112222111 123689999999999999877 78999998
Q ss_pred ccc
Q 038905 564 AKL 566 (709)
Q Consensus 564 a~~ 566 (709)
|..
T Consensus 173 a~~ 175 (256)
T TIGR02721 173 ASD 175 (256)
T ss_pred cCc
Confidence 853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.0015 Score=78.53 Aligned_cols=158 Identities=12% Similarity=-0.030 Sum_probs=112.4
Q ss_pred HHHHHHHHHhccCcCceeEEEeEEE--cCCeEEEEEeecCCCCHHHHHhhCC----CCChHHHHHHHHHHHHHHHHhhhc
Q 038905 460 EFKNEVVMIGQTYHKNLVRLLGFCD--EGQNRLLVYKFLNNGTLASFLFENL----KPGWNLRANIAFQIARGLLHLHVN 533 (709)
Q Consensus 460 ~~~~E~~~l~~l~h~nlv~l~~~~~--~~~~~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~i~~al~~LH~~ 533 (709)
....|...++...|++++....-.. +..+.+.+++|+.+|.+.+.|.+.. .++..-....-.+...+..-.|..
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3445555666778998876655432 3445689999999999999987653 122222222222324455554532
Q ss_pred C--CCCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHH
Q 038905 534 C--SSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611 (709)
Q Consensus 534 ~--~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ 611 (709)
. ..-.+|+++|+-|.++..+..+|++++|+.+...... .......+++.|+. |+....-.++.++|+|..|+.+|
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~-qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVL-QLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHH-HHHHHHHhhhhHHHHHHHHHHHH
Confidence 2 3347899999999999999999999999998433222 22256778888888 99888888999999999999999
Q ss_pred HHHhCCCCC
Q 038905 612 EIISCRKSF 620 (709)
Q Consensus 612 elltg~~p~ 620 (709)
+..-|..++
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 998887766
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.038 Score=57.16 Aligned_cols=31 Identities=29% Similarity=0.557 Sum_probs=26.1
Q ss_pred CCeEecCCCCCceeecCCCC-eEEcccccccc
Q 038905 536 SQIIHCDIKPQNILLDDYYN-AQISDFGLAKL 566 (709)
Q Consensus 536 ~~iiH~Dlkp~NIll~~~~~-~kl~DFGla~~ 566 (709)
..++|+|+.+.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999999864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.094 Score=56.87 Aligned_cols=74 Identities=9% Similarity=-0.014 Sum_probs=45.8
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccc----c---chhHHHHHHHHHHHhccC---cCceeEEEeEEEcCCeEE
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV----F---QDGEKEFKNEVVMIGQTY---HKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~nlv~l~~~~~~~~~~~ 490 (709)
-+|+|....||.+. .. ...+.++||..... . .-..+++..|.+.|..+. -.++++++.+ +.+..+
T Consensus 33 elggGn~N~VyrV~-~~--~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 33 EIGDGNLNLVFRVS-DT--EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred EcCCCceEEEEEEE-eC--CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 45666666554333 31 22257999985311 0 123456777888877753 3467788877 446678
Q ss_pred EEEeecCCC
Q 038905 491 LVYKFLNNG 499 (709)
Q Consensus 491 lV~Ey~~~g 499 (709)
+||||+++.
T Consensus 108 lVME~L~~~ 116 (401)
T PRK09550 108 TVMEDLSDH 116 (401)
T ss_pred EEEecCCCc
Confidence 999999874
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.032 Score=58.33 Aligned_cols=125 Identities=20% Similarity=0.259 Sum_probs=74.3
Q ss_pred ceEEEEEEcc--cccchhHHHHHHHHHHHhccCc--CceeEEEeEEEcCC--eEEEEEeecCCCCHHHHHhhCC------
Q 038905 442 TTVIVVKKLD--RVFQDGEKEFKNEVVMIGQTYH--KNLVRLLGFCDEGQ--NRLLVYKFLNNGTLASFLFENL------ 509 (709)
Q Consensus 442 ~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h--~nlv~l~~~~~~~~--~~~lV~Ey~~~gsL~~~l~~~~------ 509 (709)
++..++. .. ...........+|..+|+.+.- .-..+.+++|.++. ..+.||+|++|..+...+....
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 5566666 32 1222345677888998888753 34567778887776 6699999999943221111000
Q ss_pred -------------------C-------------CChHHHHHH--------HHHHHHHHHHhhhc-----CCCCeEecCCC
Q 038905 510 -------------------K-------------PGWNLRANI--------AFQIARGLLHLHVN-----CSSQIIHCDIK 544 (709)
Q Consensus 510 -------------------~-------------l~~~~~~~i--------~~~i~~al~~LH~~-----~~~~iiH~Dlk 544 (709)
+ ..|....+. .-...+-..+|+.. ....++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 0 001111100 00112223333321 13468999999
Q ss_pred CCceeecCCCCeEEccccccccc
Q 038905 545 PQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 545 p~NIll~~~~~~kl~DFGla~~~ 567 (709)
+.||+++.+.-+-|.||+++.+-
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccC
Confidence 99999999888999999999753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.027 Score=59.15 Aligned_cols=32 Identities=28% Similarity=0.322 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCceeecCC----CCeEEcccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDY----YNAQISDFGLAKL 566 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~----~~~kl~DFGla~~ 566 (709)
...++|+|+.+.||+++++ +.+.++||..|..
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 5578999999999999985 8899999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.054 Score=57.99 Aligned_cols=120 Identities=19% Similarity=0.199 Sum_probs=68.2
Q ss_pred ceEEEEEEcccccchhHHHHHHHHHHHhccCcCce-eEEEeEEEcCCeEEEEEeecCCCCHHHH-------H-------h
Q 038905 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNL-VRLLGFCDEGQNRLLVYKFLNNGTLASF-------L-------F 506 (709)
Q Consensus 442 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nl-v~l~~~~~~~~~~~lV~Ey~~~gsL~~~-------l-------~ 506 (709)
...+++|....... ..-...+|..++..+...++ +++++.+..+ .|+||+++.+|... + .
T Consensus 65 ~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~ 139 (344)
T PLN02236 65 GRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLR 139 (344)
T ss_pred CCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHH
Confidence 46788887755432 22233788888888865444 3556665433 58999988766421 0 0
Q ss_pred --hCCC------CC-hHHHHHHHH-----------------HHHHHHHHhh----h-cCCCCeEecCCCCCceeecC-CC
Q 038905 507 --ENLK------PG-WNLRANIAF-----------------QIARGLLHLH----V-NCSSQIIHCDIKPQNILLDD-YY 554 (709)
Q Consensus 507 --~~~~------l~-~~~~~~i~~-----------------~i~~al~~LH----~-~~~~~iiH~Dlkp~NIll~~-~~ 554 (709)
+... .. +.....+.. .+...+..|. . .....++|+|+++.|||+++ ++
T Consensus 140 ~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~ 219 (344)
T PLN02236 140 EFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETR 219 (344)
T ss_pred HHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCC
Confidence 0101 11 112212211 1111122221 1 12346899999999999986 46
Q ss_pred CeEEcccccccc
Q 038905 555 NAQISDFGLAKL 566 (709)
Q Consensus 555 ~~kl~DFGla~~ 566 (709)
.+.++||..|..
T Consensus 220 ~~~lID~Eya~~ 231 (344)
T PLN02236 220 AITIIDYEYASY 231 (344)
T ss_pred cEEEEeehhccc
Confidence 899999998864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.047 Score=51.48 Aligned_cols=124 Identities=14% Similarity=0.237 Sum_probs=82.4
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCcee-EEEeEEEcCCeEEEEEeecCC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLV-RLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv-~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
++.|..+++ |.+.. .+..+|+|+-... .....+..|+++|..+.-.++- +++.|-.+ ++.|||+.|
T Consensus 30 L~KG~~s~V---yl~~~----~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 30 LAKGTTSVV---YLGEW----RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhcccccEE---EEeec----cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 444455555 66655 3568899986553 3567889999999999866553 55555333 455999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCC-CCceeecCCCCeEEcccccccc
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIK-PQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlk-p~NIll~~~~~~kl~DFGla~~ 566 (709)
-.|.+.-... +. +-...+++.---|. ..||-|..|. |..++|-.+..+-|+||.-|+.
T Consensus 97 ~~L~~~~~~~---~r----k~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG---DR----KHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc---cH----HHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8887765421 22 23334555544455 6789999887 5555665666999999999974
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.089 Score=55.70 Aligned_cols=32 Identities=25% Similarity=0.321 Sum_probs=27.4
Q ss_pred CCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
..++||+|+.|.||+++.+...-|.||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 45899999999999999776668999999853
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.12 Score=55.04 Aligned_cols=30 Identities=20% Similarity=0.311 Sum_probs=26.0
Q ss_pred CeEecCCCCCceeecC-CCCeEEcccccccc
Q 038905 537 QIIHCDIKPQNILLDD-YYNAQISDFGLAKL 566 (709)
Q Consensus 537 ~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~ 566 (709)
-++|.|+-+.|||+++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4789999999999975 57899999999854
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.018 Score=46.34 Aligned_cols=33 Identities=21% Similarity=0.483 Sum_probs=28.4
Q ss_pred CCCCHHHHHHHhccCCceEEEEEe--CCcccccCC
Q 038905 337 RPYDEVQCKNNCLSDCFCVVAIFR--GDSCWSKKL 369 (709)
Q Consensus 337 ~~~~~~~C~~~Cl~nC~C~a~~~~--~~~C~~~~~ 369 (709)
...+.++|++.|+.|+.|.||.|. .+.|++|..
T Consensus 23 ~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 23 FASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred ecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 356889999999999999999997 578998755
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.11 Score=54.67 Aligned_cols=31 Identities=32% Similarity=0.490 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
..+++|+|+.+.||+++.++...|.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4789999999999999998877899999985
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.071 Score=51.96 Aligned_cols=142 Identities=16% Similarity=0.174 Sum_probs=84.7
Q ss_pred eEEEEEEcccccch-hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHH
Q 038905 443 TVIVVKKLDRVFQD-GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAF 521 (709)
Q Consensus 443 ~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~ 521 (709)
-...+|++....-. ...-|.++.+++++++- |+++..- +....-++.|+|.... ....-.|..
T Consensus 86 G~L~lKKi~slp~~~~~~~y~nky~v~ArmhG--ilrL~ND--n~~~yGvIlE~Cy~~~------------i~~~N~i~a 149 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCINDALYFNKYRVFARMHG--ILRLKND--NNYKYGVILERCYKIK------------INFSNFITA 149 (308)
T ss_pred chhhhhhccCCCcccchhhhhhhhhHHHHhhh--eeEeecC--CCceeEEEEeeccCcc------------cchhHHHHH
Confidence 34456666543322 44567889999988763 5555521 3333458888874321 001111211
Q ss_pred HHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCccc
Q 038905 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANV 601 (709)
Q Consensus 522 ~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~ 601 (709)
+ +.+|.-.|++ +.+.+|+|..|+||+-|..|.+||.|=+... .. +..|.- -| -...+.++
T Consensus 150 g-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~------------~V~~vN-~~---Y~~lT~~a 209 (308)
T PF07387_consen 150 G-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN------------QVNMVN-IE---YESLTQEA 209 (308)
T ss_pred h-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--hh------------eeeEEe-ee---ccccChHH
Confidence 1 3567777854 5689999999999999999999999865431 11 001111 11 11246677
Q ss_pred chHHHHHHHHHHHhCCCCC
Q 038905 602 DVYSFGVLLLEIISCRKSF 620 (709)
Q Consensus 602 DvwSlGvvl~elltg~~p~ 620 (709)
.+-+|=.-+++++...+..
T Consensus 210 E~~~fv~s~l~~v~~~~~~ 228 (308)
T PF07387_consen 210 EVKVFVKSCLKLVEKQRSA 228 (308)
T ss_pred HHHHHHHHHHHHHHHHhcC
Confidence 7878877788887655443
|
The function of this family is unknown. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.067 Score=58.31 Aligned_cols=171 Identities=22% Similarity=0.284 Sum_probs=93.9
Q ss_pred HHHHHHHHHHHhccCcCceeEEEeEEEcCC-eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCC
Q 038905 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ-NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS 536 (709)
Q Consensus 458 ~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~ 536 (709)
..++..-.++++.++|+|+-+.+.+..... ...+|+|++ +.||.+.+..+. +. .....+ |
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~------~~s~~~------~----- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LK------DESLLA------H----- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cc------hhhhcc------c-----
Confidence 345666778888899999999999876544 356888987 568888876542 11 000111 1
Q ss_pred CeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhC
Q 038905 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISC 616 (709)
Q Consensus 537 ~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg 616 (709)
++.| .| ..+++| .++. . | + .+..+|+|||++|.++.|+.-|
T Consensus 87 ~~~~-----~~-------~~~~td-~~~t----~--------------~-~-------~~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 87 GVLH-----LN-------IIYITD-HFLT----K--------------Y-P-------SPIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred ccce-----eh-------hhhccc-cccc----c--------------C-C-------CCCCcchhhhhHHHHHHHHHHh
Confidence 1111 11 122233 0100 0 0 0 1122599999999999999998
Q ss_pred CCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC---------HHHHHH
Q 038905 617 RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT---------MRKVSQ 687 (709)
Q Consensus 617 ~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---------~~ev~~ 687 (709)
..-+......+..... .... .-+...++- ..+.....+.++..+++...|+-..|..||. +.||.+
T Consensus 128 ~~l~~~~~~s~~l~~i---~k~~-~~d~~~~~~-a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 128 ISLEAELTESEYLEIL---LKYY-TDDQELLST-AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred hHHHHHHHHHHHHHHH---HHhc-cCchhHHHH-HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 8765433222211110 0000 000000000 0011223356778889999999999998874 455556
Q ss_pred HHcc
Q 038905 688 MLEV 691 (709)
Q Consensus 688 ~L~~ 691 (709)
++..
T Consensus 203 ~~t~ 206 (725)
T KOG1093|consen 203 DLTV 206 (725)
T ss_pred hhhH
Confidence 6554
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.097 Score=51.76 Aligned_cols=31 Identities=29% Similarity=0.448 Sum_probs=21.9
Q ss_pred CCeEecCCCCCceee-cCCCCeEEcccccccc
Q 038905 536 SQIIHCDIKPQNILL-DDYYNAQISDFGLAKL 566 (709)
Q Consensus 536 ~~iiH~Dlkp~NIll-~~~~~~kl~DFGla~~ 566 (709)
..++|+|+.+.|||+ +.++.++++||-.|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 457899999999999 8899999999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.51 E-value=0.43 Score=49.53 Aligned_cols=76 Identities=14% Similarity=0.183 Sum_probs=43.8
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC---cCceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY---HKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nlv~l~~~~~~~~~~~lV 492 (709)
......+++|....+|... ..+..+.||.... .....|..|.+-|+.|. -..+++++++....+..+||
T Consensus 19 i~~~~~v~GG~i~~a~~~~-----~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-----TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-----TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE-----CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3455566666665443322 4677888888662 34457888888877773 55688999988877788999
Q ss_pred EeecCCC
Q 038905 493 YKFLNNG 499 (709)
Q Consensus 493 ~Ey~~~g 499 (709)
+||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.45 E-value=0.91 Score=49.28 Aligned_cols=72 Identities=11% Similarity=0.052 Sum_probs=43.0
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccc----cc---hhHHHHHHHHHHHhccC---cCceeEEEeEEEcCCeE
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV----FQ---DGEKEFKNEVVMIGQTY---HKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~nlv~l~~~~~~~~~~ 489 (709)
.-+|+|..-.||.+.. .+..++||.-... .. ....+-..|...|..+. ..++++++.++. +..
T Consensus 38 ~eiggGn~N~VyrV~~-----~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS-----SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA 110 (418)
T ss_pred EEcCCCceeeEEEEEc-----CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence 3456666665544332 2345888876511 11 13344455566665553 357888998886 456
Q ss_pred EEEEeecCC
Q 038905 490 LLVYKFLNN 498 (709)
Q Consensus 490 ~lV~Ey~~~ 498 (709)
+++|||+++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 788999977
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.24 E-value=0.62 Score=49.07 Aligned_cols=32 Identities=16% Similarity=0.315 Sum_probs=28.9
Q ss_pred CCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
..+++|+|+.++|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 709 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-27 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 4e-95
Identities = 100/255 (39%), Positives = 151/255 (59%), Gaps = 9/255 (3%)
Query: 443 TVIVVKKLDR-VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
T++ VK+L Q GE +F+ EV MI H+NL+RL GFC RLLVY ++ NG++
Sbjct: 55 TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
Query: 502 ASFLFENLKPG----WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
AS L E + W R IA ARGL +LH +C +IIH D+K NILLD+ + A
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
+ DFGLAKL+ + + A+RGT G++A PE+ + DV+ +GV+LLE+I+ +
Sbjct: 175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIA-PEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 618 KSFDI--EMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQED 675
++FD+ ++ +L DW + KL+ LV+ D++ + VE+L+ V++ C Q
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292
Query: 676 PSLRPTMRKVSQMLE 690
P RP M +V +MLE
Sbjct: 293 PMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 8e-83
Identities = 89/256 (34%), Positives = 132/256 (51%), Gaps = 16/256 (6%)
Query: 443 TVIVVKKLDRVFQD----GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498
T + VKKL + +++F E+ ++ + H+NLV LLGF +G + LVY ++ N
Sbjct: 55 TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114
Query: 499 GTLASFLF--ENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
G+L L + P W++R IA A G+ LH N IH DIK NILLD+ +
Sbjct: 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFT 171
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
A+ISDFGLA+ + I GT Y+A PE R IT D+YSFGV+LLEII+
Sbjct: 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMA-PEALRGE-ITPKSDIYSFGVVLLEIIT 229
Query: 616 CRKSFDIEMGEEYAILTDWAFDCYRN-GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQE 674
+ D + L D + ++D ++ M D VE + V+ C+ E
Sbjct: 230 GLPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHE 286
Query: 675 DPSLRPTMRKVSQMLE 690
+ RP ++KV Q+L+
Sbjct: 287 KKNKRPDIKKVQQLLQ 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 5e-82
Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 8/258 (3%)
Query: 443 TVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
+ +K+ G +EF+ E+ + H +LV L+GFCDE +L+YK++ NG L
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 503 SFLFENLKPG----WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
L+ + P W R I ARGL +LH IIH D+K NILLD+ + +I
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK 618
+DFG++K T + ++GT GY+ PE+F +T DVYSFGV+L E++ R
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYID-PEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 619 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSL 678
+ + E L +WA + + NG+L+ +V+ ++ + + K ++ C+
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 679 RPTMRKVSQMLEVVVEVD 696
RP+M V LE + +
Sbjct: 300 RPSMGDVLWKLEYALRLQ 317
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-53
Identities = 63/267 (23%), Positives = 104/267 (38%), Gaps = 27/267 (10%)
Query: 447 VKKLDRVFQDG-EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN----RLLVYKFLNNGTL 501
VK QD + + EV + H+N+++ +G G + L+ F G+L
Sbjct: 52 VKIFPI--QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL 109
Query: 502 ASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ-------IIHCDIKPQNILLDDYY 554
+ FL N WN +IA +ARGL +LH + I H DIK +N+LL +
Sbjct: 110 SDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN-----VDVYSFGVL 609
A I+DFGLA +S GT+ Y+A PE + +D+Y+ G++
Sbjct: 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMA-PEVLEGAINFQRDAFLRIDMYAMGLV 227
Query: 610 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM------EAMNDIKCVEK 663
L E+ S + D + E + + ++V + +
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287
Query: 664 LVMVSIWCIQEDPSLRPTMRKVSQMLE 690
L C D R + V + +
Sbjct: 288 LCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 64/258 (24%), Positives = 122/258 (47%), Gaps = 24/258 (9%)
Query: 447 VKKL--DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
VK L + EF EV ++ + H N+V +G + N +V ++L+ G+L
Sbjct: 65 VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL 124
Query: 505 LFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
L ++ + R ++A+ +A+G+ +LH N + I+H ++K N+L+D Y ++ DF
Sbjct: 125 LHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
GL++L + K+ GT ++A PE R+ DVYSFGV+L E+ + ++ +
Sbjct: 184 GLSRLKA--STFLSSKSAAGTPEWMA-PEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 622 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681
+ ++ F C R +E + ++ + C +P RP+
Sbjct: 241 -NL-NPAQVVAAVGFKCKR-----------LEIPRN--LNPQVAAIIEGCWTNEPWKRPS 285
Query: 682 MRKVSQMLEVVVEVDVPP 699
+ +L +++ VPP
Sbjct: 286 FATIMDLLRPLIKSAVPP 303
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-43
Identities = 62/263 (23%), Positives = 111/263 (42%), Gaps = 33/263 (12%)
Query: 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
V+V+K+L R ++ ++ F EV ++ H N+++ +G + + + +++ GTL
Sbjct: 35 GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94
Query: 502 ASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD 560
+ W+ R + A IA G+ +LH S IIH D+ N L+ + N ++D
Sbjct: 95 RGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVAD 151
Query: 561 FGLAKLLTLNQS------------KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGV 608
FGLA+L+ ++ + + + G ++A PE + VDV+SFG+
Sbjct: 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA-PEMINGRSYDEKVDVFSFGI 210
Query: 609 LLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMV 667
+L EII + D L F + C +
Sbjct: 211 VLCEIIGRVNADPDYLPRTMDFGLNVRGF--LD-----------RYCPPN--CPPSFFPI 255
Query: 668 SIWCIQEDPSLRPTMRKVSQMLE 690
++ C DP RP+ K+ LE
Sbjct: 256 TVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 65/256 (25%), Positives = 100/256 (39%), Gaps = 33/256 (12%)
Query: 447 VKKL----DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
VK D + + E + H N++ L G C + N LV +F G L
Sbjct: 35 VKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLN 94
Query: 503 SFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ----- 557
L + ++ N A QIARG+ +LH IIH D+K NIL+
Sbjct: 95 RVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK 153
Query: 558 ---ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
I+DFGLA+ + K + G ++A PE R S + DV+S+GVLL E++
Sbjct: 154 ILKITDFGLARE----WHRTTKMSAAGAYAWMA-PEVIRASMFSKGSDVWSYGVLLWELL 208
Query: 615 SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQE 674
+ F + + A+ A + + + C E + C
Sbjct: 209 TGEVPFR-GI-DGLAVAYGVAMNKLA-----------LPIPST--CPEPFAKLMEDCWNP 253
Query: 675 DPSLRPTMRKVSQMLE 690
DP RP+ + L
Sbjct: 254 DPHSRPSFTNILDQLT 269
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 58/250 (23%), Positives = 109/250 (43%), Gaps = 32/250 (12%)
Query: 447 VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF 506
+K+++ + K F E+ + + H N+V+L G C LV ++ G+L + L
Sbjct: 36 IKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLH 91
Query: 507 ENLKPG---WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFG 562
+ Q ++G+ +LH +IH D+KP N+LL +I DFG
Sbjct: 92 GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151
Query: 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDI 622
A + + + G+ ++A PE F S + DV+S+G++L E+I+ RK FD
Sbjct: 152 TACDIQTHMTNNK-----GSAAWMA-PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
Query: 623 EMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI--KCVEKLVMVSIWCIQEDPSLRP 680
G + I + + + + + + + C +DPS RP
Sbjct: 206 IGGPAFRI----MWAVHNGTRP------------PLIKNLPKPIESLMTRCWSKDPSQRP 249
Query: 681 TMRKVSQMLE 690
+M ++ +++
Sbjct: 250 SMEEIVKIMT 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 65/309 (21%), Positives = 108/309 (34%), Gaps = 65/309 (21%)
Query: 447 VKKLDRVFQDGEKEFKNE--VVMIGQTYHKNLVRLLGFCDEG-----QNRLLVYKFLNNG 499
VK + F NE + + H N+ R + + LLV ++ NG
Sbjct: 41 VKVFS---FANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNG 97
Query: 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLH------VNCSSQIIHCDIKPQNILLDDY 553
+L +L + W +A + RGL +LH + I H D+ +N+L+ +
Sbjct: 98 SLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156
Query: 554 YNAQISDFGLAKLLTLNQSKAIK------KAIRGTKGYVASPEWFRNS-------TITAN 600
ISDFGL+ LT N+ + GT Y+A PE + +
Sbjct: 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA-PEVLEGAVNLRDXESALKQ 215
Query: 601 VDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--MEAMND 657
VD+Y+ G++ EI C F E EY + AF V E M
Sbjct: 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQM----AF--------QTEVGNHPTFEDMQV 263
Query: 658 IKCVEKL----------------VMVSI--WCIQEDPSLRPTMRKVSQMLE-VVVEVDVP 698
+ EK + C +D R T + + + +++ +
Sbjct: 264 LVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
Query: 699 PNPSTFSCS 707
+ S +
Sbjct: 324 KSVSPTAHH 332
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 59/250 (23%), Positives = 107/250 (42%), Gaps = 22/250 (8%)
Query: 447 VKKL--DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
VK L + FKNEV ++ +T H N++ +G+ +V ++ +L
Sbjct: 51 VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHH 109
Query: 505 L-FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563
L K +IA Q ARG+ +LH + IIH D+K NI L + +I DFGL
Sbjct: 110 LHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166
Query: 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI---TANVDVYSFGVLLLEIISCRKSF 620
A + + + G+ ++A PE R + DVY+FG++L E+++ + +
Sbjct: 167 ATEKSRWSGSHQFEQLSGSILWMA-PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225
Query: 621 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680
+ I+ R DL + C +++ + C+++ RP
Sbjct: 226 S-NINNRDQII--EMVG--RGSLSPDLSKVRSN------CPKRMKRLMAECLKKKRDERP 274
Query: 681 TMRKVSQMLE 690
+ ++ +E
Sbjct: 275 SFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-40
Identities = 58/259 (22%), Positives = 108/259 (41%), Gaps = 35/259 (13%)
Query: 447 VKKL--DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
++ + +R +D K FK EV+ QT H+N+V +G C + ++ TL S
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 505 L-FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563
+ + N IA +I +G+ +LH + I+H D+K +N+ D+ I+DFGL
Sbjct: 120 VRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGL 175
Query: 564 AKLLTLNQSKAIK---KAIRGTKGYVASPEWFRNSTITAN---------VDVYSFGVLLL 611
+ + Q+ + + G ++A PE R + DV++ G +
Sbjct: 176 FSISGVLQAGRREDKLRIQNGWLCHLA-PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 612 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
E+ + F E I + K + ++ I +++ + ++C
Sbjct: 235 ELHAREWPFK-TQPAEAII-----WQMGTGMKPN---------LSQIGMGKEISDILLFC 279
Query: 672 IQEDPSLRPTMRKVSQMLE 690
+ RPT K+ MLE
Sbjct: 280 WAFEQEERPTFTKLMDMLE 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 52/259 (20%), Positives = 93/259 (35%), Gaps = 33/259 (12%)
Query: 441 RTTVIVVKKL--DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE--GQNRLLVYKFL 496
+ IVVK L ++F E + H N++ +LG C + L+ ++
Sbjct: 32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91
Query: 497 NNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
G+L + L E + A +ARG+ LH I + +++++D+
Sbjct: 92 PYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDM 150
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN---VDVYSFGVLLL 611
A+IS + +VA PE + N D++SF VLL
Sbjct: 151 TARISMADVKFSFQ-------SPGRMYAPAWVA-PEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 612 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
E+++ F ++ I A + R + + C
Sbjct: 203 ELVTREVPFA-DL-SNMEIGMKVALEGLR-----------PTIPPG--ISPHVSKLMKIC 247
Query: 672 IQEDPSLRPTMRKVSQMLE 690
+ EDP+ RP + +LE
Sbjct: 248 MNEDPAKRPKFDMIVPILE 266
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 59/266 (22%), Positives = 104/266 (39%), Gaps = 37/266 (13%)
Query: 440 TRTTVIVVKKLDRVFQDGE-------KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492
+V+ +K L +GE +EF+ EV ++ H N+V+L G +V
Sbjct: 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MV 99
Query: 493 YKFLNNGTLASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
+F+ G L L + P W+++ + IA G+ ++ N + I+H D++ NI L
Sbjct: 100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQ 158
Query: 552 DY-----YNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN--VDVY 604
A+++DFGL++ + + G ++A PE + D Y
Sbjct: 159 SLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA-PETIGAEEESYTEKADTY 212
Query: 605 SFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL 664
SF ++L I++ FD + + + R D C +L
Sbjct: 213 SFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR-----------PTIPED--CPPRL 259
Query: 665 VMVSIWCIQEDPSLRPTMRKVSQMLE 690
V C DP RP + + L
Sbjct: 260 RNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 66/283 (23%), Positives = 106/283 (37%), Gaps = 59/283 (20%)
Query: 447 VKKLDRVFQDGEKEFKNEVVMIGQTY---HKNLVRLLGFCDEGQNR----LLVYKFLNNG 499
VK +D EK + E + T H+N++ + ++ L+ + G
Sbjct: 36 VKIFSS--RD-EKSWFRET-ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMG 91
Query: 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ-----IIHCDIKPQNILLDDYY 554
+L +L I IA GL HLH+ I H D+K +NIL+
Sbjct: 92 SLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150
Query: 555 NAQISDFGLAKLL--TLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN------VDVYSF 606
I+D GLA + + NQ GTK Y+A PE + VD+++F
Sbjct: 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA-PEVLDETIQVDCFDSYKRVDIWAF 209
Query: 607 GVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL 664
G++L E+ S I E+Y F D+V D E M + CV++
Sbjct: 210 GLVLWEVARRMVSNGIV--EDYKP----PF--------YDVVPNDPSFEDMRKVVCVDQQ 255
Query: 665 ---------------VMVSI--WCIQEDPSLRPTMRKVSQMLE 690
+ + C ++PS R T ++ + L
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 73/351 (20%), Positives = 119/351 (33%), Gaps = 74/351 (21%)
Query: 395 DPPSVPSPPDPEDKKKRNMMNVTRSVLLGSS--VFVNFTLVGVIQTST------------ 440
+ PS+ P E ++++ + GS + V T+ I
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWR 60
Query: 441 ---RTTVIVVKKLDRVFQDGEKEFKNE--VVMIGQTYHKNLVRLLGFCDEGQNR----LL 491
R + VK E+ + E + H+N++ + ++ L
Sbjct: 61 GKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117
Query: 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ-----IIHCDIKPQ 546
V + +G+L +L +A A GL HLH+ I H D+K +
Sbjct: 118 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176
Query: 547 NILLDDYYNAQISDFGLAKLL--TLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN---- 600
NIL+ I+D GLA + GTK Y+A PE +S +
Sbjct: 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA-PEVLDDSINMKHFESF 235
Query: 601 --VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM--EAMN 656
D+Y+ G++ EI I E+Y + Y DLV D E M
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIH--EDYQL-------PY-----YDLVPSDPSVEEMR 281
Query: 657 DIKCVEKL---------------VMVSI--WCIQEDPSLRPTMRKVSQMLE 690
+ C +KL VM I C + + R T ++ + L
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 64/278 (23%), Positives = 103/278 (37%), Gaps = 49/278 (17%)
Query: 447 VKKLDRVFQDGEKEFKNEVVMIGQTY---HKNLVRLLGFCDEGQNR----LLVYKFLNNG 499
VK + E + E I QT H+N++ + +G L+ + NG
Sbjct: 65 VKVFFT--TE-EASWFRET-EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLH-----VNCSSQIIHCDIKPQNILLDDYY 554
+L +L ++ +A+ GL HLH I H D+K +NIL+
Sbjct: 121 SLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 555 NAQISDFGLAKLL--TLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN------VDVYSF 606
I+D GLA N+ GTK Y+ PE S + D+YSF
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP-PEVLDESLNRNHFQSYIMADMYSF 238
Query: 607 GVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM----------- 655
G++L E+ S I EEY + Y + D DM +
Sbjct: 239 GLILWEVARRCVSGGI--VEEYQL-------PYHDLVPSDPSYEDMREIVCIKKLRPSFP 289
Query: 656 ---NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ +C+ ++ + C +P+ R T +V + L
Sbjct: 290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 60/306 (19%), Positives = 107/306 (34%), Gaps = 37/306 (12%)
Query: 394 PDPPSVPSPPDPEDKKKRNMMNVTRSVLLG----SSVFVNFTLVGVIQTSTRTTVIVVKK 449
P P P D + N +G S V+ V +KK
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYR------AACLLDGVPV-ALKK 64
Query: 450 LDRVFQDGEKE---FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF 506
+ K E+ ++ Q H N+++ E +V + + G L+ +
Sbjct: 65 VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 507 ENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562
K + Q+ L H+H S +++H DIKP N+ + ++ D G
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 181
Query: 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDI 622
L + + + A ++ GT Y SPE + D++S G LL E+ + + F
Sbjct: 182 LGRFFSSKTTAA--HSLVGTPYY-MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238
Query: 623 EMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682
+ Y++ + + D + E+L + CI DP RP +
Sbjct: 239 DKMNLYSLCK-------------KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285
Query: 683 RKVSQM 688
V +
Sbjct: 286 TYVYDV 291
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-28
Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 32/240 (13%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA 517
+EF E ++ + H NLV+LLG C ++ +F+ G L +L E + +
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 319
Query: 518 --NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ---S 572
+A QI+ + +L IH ++ +N L+ + + +++DFGL++L+T +
Sbjct: 320 LLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376
Query: 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 632
K I+ T +PE + + DV++FGVLL EI + S Y +
Sbjct: 377 AGAKFPIKWT-----APESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------PYPGID 424
Query: 633 DWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
++ +L+E D ME C EK+ + C Q +PS RP+ ++ Q E
Sbjct: 425 --------LSQVYELLEKDYRMERPEG--CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 65/265 (24%), Positives = 121/265 (45%), Gaps = 30/265 (11%)
Query: 441 RTTVIV-VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC--DEGQNRLLVYKFLN 497
T +V VK+L D +++F+ E+ ++ + +V+ G Q+ LV ++L
Sbjct: 50 NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 109
Query: 498 NGTLASFLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
+G L FL + + + + QI +G+ +L S + +H D+ +NIL++ +
Sbjct: 110 SGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAH 165
Query: 556 AQISDFGLAKLLTLNQSKAIKKA-----IRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+I+DFGLAKLL L++ + + I +PE ++ + DV+SFGV+L
Sbjct: 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-----APESLSDNIFSRQSDVWSFGVVL 220
Query: 611 LEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--V 665
E+ + C KS E+ + D +L +L+E + A C ++ +
Sbjct: 221 YELFTYCDKSC--SPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPA--CPAEVHEL 276
Query: 666 MVSIWCIQEDPSLRPTMRKVSQMLE 690
M W P RP+ + L+
Sbjct: 277 MKLCW--APSPQDRPSFSALGPQLD 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 60/264 (22%), Positives = 107/264 (40%), Gaps = 39/264 (14%)
Query: 442 TTVIVVKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
T++ VK + + D + +F E ++ Q H N+VRL+G C + Q +V + + G
Sbjct: 139 NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198
Query: 501 LASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
+FL + + A G+ +L S IH D+ +N L+ + +IS
Sbjct: 199 FLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKIS 255
Query: 560 DFGLAKLLTLNQSKAIKKA----IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
DFG+++ A ++ T +PE ++ DV+SFG+LL E S
Sbjct: 256 DFGMSREEADGVYAASGGLRQVPVKWT-----APEALNYGRYSSESDVWSFGILLWETFS 310
Query: 616 CRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIW 670
G Y L+ N + + VE + C + + +M W
Sbjct: 311 L--------GASPYPNLS--------NQQTREFVEKGGRLPCPEL--CPDAVFRLMEQCW 352
Query: 671 CIQEDPSLRPTMRKVSQMLEVVVE 694
+P RP+ + Q L+ + +
Sbjct: 353 --AYEPGQRPSFSTIYQELQSIRK 374
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/264 (22%), Positives = 120/264 (45%), Gaps = 27/264 (10%)
Query: 441 RTTVIV-VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC--DEGQNRLLVYKFLN 497
T +V VKKL ++ ++F+ E+ ++ H N+V+ G C +N L+ ++L
Sbjct: 37 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 96
Query: 498 NGTLASFLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
G+L +L ++ K + QI +G+ +L + + IH D+ +NIL+++
Sbjct: 97 YGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENR 152
Query: 556 AQISDFGLAKLLTLNQSKAIKKA-----IRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+I DFGL K+L ++ K I +PE S + DV+SFGV+L
Sbjct: 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-----APESLTESKFSVASDVWSFGVVL 207
Query: 611 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VM 666
E+ + + E ++ + L +L++ + + + C +++ +M
Sbjct: 208 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDG--CPDEIYMIM 265
Query: 667 VSIWCIQEDPSLRPTMRKVSQMLE 690
W + + RP+ R ++ ++
Sbjct: 266 TECW--NNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 66/316 (20%), Positives = 134/316 (42%), Gaps = 33/316 (10%)
Query: 392 DDPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--GV-IQTSTRTTVIV-V 447
+ ++ S + D + ++ LG NF V T +V V
Sbjct: 19 NLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKG---NFGSVEMCRYDPLQDNTGEVVAV 75
Query: 448 KKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC--DEGQNRLLVYKFLNNGTLASFL 505
KKL ++ ++F+ E+ ++ H N+V+ G C +N L+ ++L G+L +L
Sbjct: 76 KKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
Query: 506 FENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563
++ K + QI +G+ +L + + IH D+ +NIL+++ +I DFGL
Sbjct: 136 QKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 191
Query: 564 AKLLTLNQSKAIKKA-----IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK 618
K+L ++ K I +PE S + DV+SFGV+L E+ + +
Sbjct: 192 TKVLPQDKEYYKVKEPGESPIFWY-----APESLTESKFSVASDVWSFGVVLYELFTYIE 246
Query: 619 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQE 674
E ++ + L +L++ + + + C +++ +M W
Sbjct: 247 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDG--CPDEIYMIMTECW--NN 302
Query: 675 DPSLRPTMRKVSQMLE 690
+ + RP+ R ++ ++
Sbjct: 303 NVNQRPSFRDLALRVD 318
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 60/241 (24%), Positives = 102/241 (42%), Gaps = 37/241 (15%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLR 516
+ F E ++ Q H NLV+LLG E + L +V +++ G+L +L +
Sbjct: 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 289
Query: 517 A--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574
+ + + +L + +H D+ +N+L+ + A++SDFGL K + Q
Sbjct: 290 CLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346
Query: 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTD 633
K ++ T +PE R + DV+SFG+LL EI S G Y +
Sbjct: 347 -KLPVKWT-----APEALREKKFSTKSDVWSFGILLWEIYSF--------GRVPYPRIP- 391
Query: 634 WAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQML 689
+ VE M+A + C + VM + W D + RPT ++ + L
Sbjct: 392 -------LKDVVPRVEKGYKMDAPDG--CPPAVYDVMKNCW--HLDAATRPTFLQLREQL 440
Query: 690 E 690
E
Sbjct: 441 E 441
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-26
Identities = 60/240 (25%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA 517
+ F E ++ + H+ LV+L E + +V ++++ G+L FL L
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 518 --NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ---S 572
++A QIA G+ ++ +H D++ NIL+ + +++DFGLA+L+ N+
Sbjct: 282 LVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338
Query: 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 632
+ K I+ T +PE T DV+SFG+LL E+ + + Y +
Sbjct: 339 QGAKFPIKWT-----APEAALYGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV 386
Query: 633 DWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
N ++ D VE M + C E L + C +++P RPT + LE
Sbjct: 387 --------NREVLDQVERGYRMPCPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-26
Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 46/309 (14%)
Query: 393 DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVG-VIQTSTRTTVIVVKKLD 451
P S P P +D + ++ LG+ F G V + V K
Sbjct: 167 VPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQF------GEVWMATYNKHTKVAVKTM 220
Query: 452 RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKP 511
+ + F E ++ H LV+L + + ++ +F+ G+L FL +
Sbjct: 221 KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGS 279
Query: 512 GWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569
L + + QIA G+ + IH D++ NIL+ +I+DFGLA+++
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336
Query: 570 NQ---SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE 626
N+ + K I+ T +PE + T DV+SFG+LL+EI++ G
Sbjct: 337 NEYTAREGAKFPIKWT-----APEAINFGSFTIKSDVWSFGILLMEIVTY--------GR 383
Query: 627 E-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDPSLRPT 681
Y ++ N ++ +E M + C E+L +M+ W + P RPT
Sbjct: 384 IPYPGMS--------NPEVIRALERGYRMPRPEN--CPEELYNIMMRCW--KNRPEERPT 431
Query: 682 MRKVSQMLE 690
+ +L+
Sbjct: 432 FEYIQSVLD 440
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 64/318 (20%), Positives = 126/318 (39%), Gaps = 54/318 (16%)
Query: 387 KYKKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGS----SVFVNFTLVGVIQTSTRT 442
++ D + + + + + + +G +V+ T T
Sbjct: 5 NQQQDDIEELETKAVGMSNDGRFLK------FDIEIGRGSFKTVYKGL--------DTET 50
Query: 443 TVIV-VK--KLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC---DEGQNRLLVY-KF 495
TV V + ++ + + FK E M+ H N+VR +G+ +++ +
Sbjct: 51 TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110
Query: 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY- 554
+ +GTL ++L + + QI +GL LH + IIH D+K NI +
Sbjct: 111 MTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTG 169
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+ +I D GLA L + +KA+ GT ++A PE + + VDVY+FG+ +LE+
Sbjct: 170 SVKIGDLGLATLKRASFAKAVI----GTPEFMA-PEMYEEKYDES-VDVYAFGMCMLEMA 223
Query: 615 SCRKSF-DIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCI 672
+ + + + + Y +T + D + E I+ CI
Sbjct: 224 TSEYPYSECQNAAQIYRRVTSGV----KPASFDKVA--IPEVKEIIE----------GCI 267
Query: 673 QEDPSLRPTMRKVSQMLE 690
+++ R + + +L
Sbjct: 268 RQNKDERYS---IKDLLN 282
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 72/333 (21%), Positives = 127/333 (38%), Gaps = 47/333 (14%)
Query: 393 DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--GVIQTSTRTTVIVV--K 448
P D + + + LG +F V + T +V K
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEG---HFGKVSLYCYDPTNDGTGEMVAVK 66
Query: 449 KLDRVFQDGE-KEFKNEVVMIGQTYHKNLVRLLGFC--DEGQNRLLVYKFLNNGTLASFL 505
L +K E+ ++ YH+++++ G C + LV +++ G+L +L
Sbjct: 67 ALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL 126
Query: 506 FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
+ G A QI G+ +LH + IH D+ +N+LLD+ +I DFGLAK
Sbjct: 127 PRH-SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182
Query: 566 LLTLNQSKAIKKA-----IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKS 619
+ + + +PE + DV+SFGV L E+++ C S
Sbjct: 183 AVPEGHEYYRVREDGDSPVFWY-----APECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
Query: 620 ------FDIEMGEEYAILTDWAFDCYRNGKLDDLVE--GDMEAMNDIKCVEKL--VMVSI 669
F +G +T +L +L+E + + C ++ +M +
Sbjct: 238 QSPPTKFLELIGIAQGQMT--------VLRLTELLERGERLPRPDK--CPAEVYHLMKNC 287
Query: 670 WCIQEDPSLRPTMRKVSQMLEVVVEVDVPPNPS 702
W + + S RPT + +L+ V E PS
Sbjct: 288 W--ETEASFRPTFENLIPILKTVHEKYQGQAPS 318
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 65/272 (23%), Positives = 118/272 (43%), Gaps = 43/272 (15%)
Query: 441 RTTVIV-VKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC--DEGQNRLLVYKFL 496
T V VK L + + K E+ ++ YH+N+V+ G C D G L+ +FL
Sbjct: 48 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 107
Query: 497 NNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
+G+L +L +N K NL+ A QI +G+ +L S Q +H D+ +N+L++ +
Sbjct: 108 PSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEH 163
Query: 555 NAQISDFGLAKLLTLNQSKAIKKA-----IRGTKGYVASPEWFRNSTITANVDVYSFGVL 609
+I DFGL K + ++ K + +PE S DV+SFGV
Sbjct: 164 QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-----APECLMQSKFYIASDVWSFGVT 218
Query: 610 LLEIIS-------CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKC 660
L E+++ F +G + +T +L + ++ + + C
Sbjct: 219 LHELLTYCDSDSSPMALFLKMIGPTHGQMT--------VTRLVNTLKEGKRLPCPPN--C 268
Query: 661 VEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+++ +M W + PS R + + + + E
Sbjct: 269 PDEVYQLMRKCW--EFQPSNRTSFQNLIEGFE 298
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 60/240 (25%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA 517
+ F E ++ + H+ LV+L E + +V ++++ G+L FL L
Sbjct: 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 364
Query: 518 --NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ---S 572
++A QIA G+ ++ +H D++ NIL+ + +++DFGLA+L+ N+
Sbjct: 365 LVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421
Query: 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 632
+ K I+ T +PE T DV+SFG+LL E+ + + Y +
Sbjct: 422 QGAKFPIKWT-----APEAALYGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV 469
Query: 633 DWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
N ++ D VE M + C E L + C +++P RPT + LE
Sbjct: 470 --------NREVLDQVERGYRMPCPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 63/252 (25%), Positives = 99/252 (39%), Gaps = 36/252 (14%)
Query: 447 VKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
VK++ EV ++ H N++R + Q + + + L TL ++
Sbjct: 53 VKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE-LCAATLQEYV 108
Query: 506 FENLKPGWNLRA-NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL-----DDYYNAQIS 559
+ L + Q GL HLH S I+H D+KP NIL+ A IS
Sbjct: 109 EQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMIS 165
Query: 560 DFGLAKLLTLNQ-SKAIKKAIRGTKGYVASPEWFRNSTI---TANVDVYSFGVLLLEIIS 615
DFGL K L + + S + + + GT+G++A PE T VD++S G + +IS
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIA-PEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
Query: 616 CRKSF--DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQ 673
+ +L + DC L D+ A I+ I
Sbjct: 225 EGSHPFGKSLQRQANILLGACSLDC-----LHPEKHEDVIARELIE----------KMIA 269
Query: 674 EDPSLRPTMRKV 685
DP RP+ + V
Sbjct: 270 MDPQKRPSAKHV 281
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 81/352 (23%), Positives = 137/352 (38%), Gaps = 74/352 (21%)
Query: 372 SNGRAHSSVNGKAFLKYKKGDDPDPPSVPSPPDPEDKK---KRNMMNVTRSVLLGSSVF- 427
S+ H S + P V PED K R+ +T LG F
Sbjct: 4 SHHHHHHSQD------------PMLAGVSEYELPEDPKWEFPRD--KLTLGKPLGEGAFG 49
Query: 428 --VNFTLVGVIQTSTRTTVIV-VKKLDRVFQDGEK-EFKNEV-VMIGQTYHKNLVRLLGF 482
V VG+ + + V V VK L + + + +E+ +M HKN++ LLG
Sbjct: 50 QVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109
Query: 483 CDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN----------------IAFQIARG 526
C + ++ ++ + G L +L PG + +Q+ARG
Sbjct: 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 527 LLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS-KAIKKA---IRGT 582
+ +L S + IH D+ +N+L+ + +I+DFGLA+ + K ++
Sbjct: 170 MEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM 226
Query: 583 KGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYR 640
+PE + T DV+SFGVL+ EI + +G I + F +
Sbjct: 227 -----APEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGIPVEELFKLLK 273
Query: 641 NGKLDDLVEGDMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
G M+ + C +L +M W PS RPT +++ + L+
Sbjct: 274 EGHR-------MDKPAN--CTNELYMMMRDCW--HAVPSQRPTFKQLVEDLD 314
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 55/288 (19%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDRVFQDGEK-EFKNEV-VMIGQTYHKNLVRLLGFCDEGQN 488
T G+I++ TV VK L E+ +E+ V+ H N+V LLG C G
Sbjct: 43 TAYGLIKSDAAMTV-AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101
Query: 489 RLLVYKFLNNGTLASFLFENLKPGWNLRAN------------------IAFQIARGLLHL 530
L++ ++ G L +FL + + ++Q+A+G+ L
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 531 HVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS-KAIKKA---IRGTKGYV 586
S IH D+ +NILL +I DFGLA+ + + + A ++
Sbjct: 162 A---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM---- 214
Query: 587 ASPEWFRNSTITANVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKL 644
+PE N T DV+S+G+ L E+ S S + + + + + G
Sbjct: 215 -APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-------FYKMIKEGFR 266
Query: 645 DDLVEGDMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
M + ++ +M + W DP RPT +++ Q++E
Sbjct: 267 -------MLSPEH--APAEMYDIMKTCW--DADPLKRPTFKQIVQLIE 303
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 66/287 (22%), Positives = 118/287 (41%), Gaps = 54/287 (18%)
Query: 431 TLVGVIQTSTRTTVIV-VKKLDRVFQDGEK-EFKNEV-VMIGQTYHKNLVRLLGFCDEGQ 487
VG+ + + V V VK L + + + +E+ +M HKN++ LLG C +
Sbjct: 101 EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160
Query: 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRAN----------------IAFQIARGLLHLH 531
++ ++ + G L +L PG + +Q+ARG+ +L
Sbjct: 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 220
Query: 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS-KAIKKA---IRGTKGYVA 587
S + IH D+ +N+L+ + +I+DFGLA+ + K ++
Sbjct: 221 ---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM----- 272
Query: 588 SPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLD 645
+PE + T DV+SFGVL+ EI + +G I + F + G
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGIPVEELFKLLKEGHR- 323
Query: 646 DLVEGDMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
M+ + C +L +M W PS RPT +++ + L+
Sbjct: 324 ------MDKPAN--CTNELYMMMRDCW--HAVPSQRPTFKQLVEDLD 360
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 52/271 (19%), Positives = 97/271 (35%), Gaps = 51/271 (18%)
Query: 446 VVKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLG-FCDE----GQNRLLVYKFL--- 496
+K++ ++ +E EV + + H +VR + ++ +L
Sbjct: 34 AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQ 93
Query: 497 ----NNGTLASFLFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
L ++ + ++ +I QIA + LH S ++H D+KP NI
Sbjct: 94 MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIF 150
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKA----------IKKAIRGTKGYVASPEWFRNSTITA 599
++ DFGL + ++ + GTK Y SPE ++ +
Sbjct: 151 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLY-MSPEQIHGNSYSH 209
Query: 600 NVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 659
VD++S G++L E++ F +M R L D+ + K
Sbjct: 210 KVDIFSLGLILFELLY---PFSTQME--------------RVRTLTDVRNLKFPPLFTQK 252
Query: 660 CVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ VMV + P RP ++E
Sbjct: 253 YPCEYVMVQ-DMLSPSPMERPE---AINIIE 279
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 37/241 (15%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLR 516
+ F E ++ Q H NLV+LLG E + L +V +++ G+L +L +
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 517 A--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574
+ + + +L + +H D+ +N+L+ + A++SDFGL K + Q
Sbjct: 118 CLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174
Query: 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTD 633
K ++ T +PE R + DV+SFG+LL EI S G Y +
Sbjct: 175 -KLPVKWT-----APEALREKKFSTKSDVWSFGILLWEIYS--------FGRVPYPRIP- 219
Query: 634 WAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQML 689
+ VE M+A + C + VM + W D ++RP+ ++ + L
Sbjct: 220 -------LKDVVPRVEKGYKMDAPDG--CPPAVYEVMKNCW--HLDAAMRPSFLQLREQL 268
Query: 690 E 690
E
Sbjct: 269 E 269
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 38/243 (15%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA 517
+EF E ++ + H NLV+LLG C ++ +F+ G L +L E + +
Sbjct: 53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 518 --NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575
+A QI+ + +L IH D+ +N L+ + + +++DFGL++L+T + A
Sbjct: 113 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 576 KKA---IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAIL 631
A I+ T +PE + + DV++FGVLL EI + G Y +
Sbjct: 170 AGAKFPIKWT-----APESLAYNKFSIKSDVWAFGVLLWEIAT--------YGMSPYPGI 216
Query: 632 TDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQ 687
++ +L+E D ME C EK+ +M + W Q +PS RP+ ++ Q
Sbjct: 217 D--------LSQVYELLEKDYRMERPEG--CPEKVYELMRACW--QWNPSDRPSFAEIHQ 264
Query: 688 MLE 690
E
Sbjct: 265 AFE 267
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 60/250 (24%), Positives = 112/250 (44%), Gaps = 41/250 (16%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN---LKPGWN 514
E EF E + + H LV+ G C + +V ++++NG L ++L + L+P
Sbjct: 47 EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL 106
Query: 515 LRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ--- 571
L + + + G+ L S Q IH D+ +N L+D ++SDFG+ + + +Q
Sbjct: 107 L--EMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161
Query: 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAI 630
S K ++ + +PE F ++ DV++FG+L+ E+ S +G+ Y +
Sbjct: 162 SVGTKFPVKWS-----APEVFHYFKYSSKSDVWAFGILMWEVFS--------LGKMPYDL 208
Query: 631 LTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVS 686
T N ++ V + + + + +M S W E P RPT +++
Sbjct: 209 YT--------NSEVVLKVSQGHRLYRPHL--ASDTIYQIMYSCW--HELPEKRPTFQQLL 256
Query: 687 QMLEVVVEVD 696
+E + E D
Sbjct: 257 SSIEPLREKD 266
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 71/287 (24%), Positives = 117/287 (40%), Gaps = 54/287 (18%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDRVFQDGEK-EFKNEV-VMIGQTYHKNLVRLLGFC-DEGQ 487
G+ +T+T TV VK L E +E+ ++I +H N+V LLG C G
Sbjct: 47 DAFGIDKTATCRTV-AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105
Query: 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRAN----------------IAFQIARGLLHLH 531
+++ +F G L+++L + +FQ+A+G+ L
Sbjct: 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165
Query: 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS-KAIKKA---IRGTKGYVA 587
S + IH D+ +NILL + +I DFGLA+ + + A ++
Sbjct: 166 ---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM----- 217
Query: 588 SPEWFRNSTITANVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLD 645
+PE + T DV+SFGVLL EI S S +++ EE + G
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRLKEG--- 267
Query: 646 DLVEGDMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
M A + ++ M+ W +PS RPT ++ + L
Sbjct: 268 ----TRMRAPDY--TTPEMYQTMLDCW--HGEPSQRPTFSELVEHLG 306
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 64/266 (24%), Positives = 109/266 (40%), Gaps = 35/266 (13%)
Query: 434 GVIQTSTRTTVIVVK--KLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
G Q + VK K + + E E ++ Q + +VR++G C E ++ +L
Sbjct: 36 GYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94
Query: 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
V + G L +L +N + Q++ G+ +L S +H D+ +N+LL
Sbjct: 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLV 151
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV--ASPEWFRNSTITANVDVYSFGVL 609
+ A+ISDFGL+K L +++ KA K V +PE ++ DV+SFGVL
Sbjct: 152 TQHYAKISDFGLSKALRADENYY--KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 209
Query: 610 LLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL-- 664
+ E S G++ Y + ++ ++E M C ++
Sbjct: 210 MWEAFSY--------GQKPYRGMK--------GSEVTAMLEKGERMGCPAG--CPREMYD 251
Query: 665 VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+M W D RP V L
Sbjct: 252 LMNLCW--TYDVENRPGFAAVELRLR 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 68/311 (21%), Positives = 136/311 (43%), Gaps = 42/311 (13%)
Query: 393 DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--GVIQTSTRTTVIV-VKK 449
+P P ++ + ++GS + V G ++ + V V +K
Sbjct: 28 EPHTYEEPGRAGRSFTREIEASRIHIEKIIGS---GDSGEVCYGRLRVPGQRDVPVAIKA 84
Query: 450 LDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN 508
L + + ++ +F +E ++GQ H N++RL G G+ ++V +++ NG+L +FL +
Sbjct: 85 LKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH 144
Query: 509 LKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566
+ + + + G+ +L +H D+ +N+L+D ++SDFGL+++
Sbjct: 145 -DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 567 LTLNQSKAIKKAIRGTKGYV--ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEM 624
L + A G K + +PE T ++ DV+SFGV++ E+++
Sbjct: 201 LEDDPDAAYTT--TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY-------- 250
Query: 625 GEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDPSLR 679
GE Y +T N + VE + A C L +M+ W +D + R
Sbjct: 251 GERPYWNMT--------NRDVISSVEEGYRLPAPMG--CPHALHQLMLDCW--HKDRAQR 298
Query: 680 PTMRKVSQMLE 690
P ++ +L+
Sbjct: 299 PRFSQIVSVLD 309
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 65/287 (22%), Positives = 120/287 (41%), Gaps = 54/287 (18%)
Query: 431 TLVGVIQTSTRTTVIV-VKKLDRVFQDGEK-EFKNEV-VMIGQTYHKNLVRLLGFCDEGQ 487
+G+ + V VK L + + + +E+ +M HKN++ LLG C +
Sbjct: 89 EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148
Query: 488 NRLLVYKFLNNGTLASFL------------FENLKPGWNLRA----NIAFQIARGLLHLH 531
++ ++ + G L +L + P L + + A+Q+ARG+ +L
Sbjct: 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 208
Query: 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS-KAIKKA---IRGTKGYVA 587
S + IH D+ +N+L+ + +I+DFGLA+ + K ++
Sbjct: 209 ---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM----- 260
Query: 588 SPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLD 645
+PE + T DV+SFGVLL EI + +G + + F + G
Sbjct: 261 APEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGSPYPGVPVEELFKLLKEGHR- 311
Query: 646 DLVEGDMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
M+ ++ C +L +M W PS RPT +++ + L+
Sbjct: 312 ------MDKPSN--CTNELYMMMRDCW--HAVPSQRPTFKQLVEDLD 348
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 70/271 (25%), Positives = 102/271 (37%), Gaps = 53/271 (19%)
Query: 447 VKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
VK++ F D E+ ++ H N++R + + + L N L +
Sbjct: 44 VKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE-LCNLNLQDLV 99
Query: 506 FENLKPGWNLR-------ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD------- 551
NL+ ++ QIA G+ HLH S +IIH D+KPQNIL+
Sbjct: 100 ESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTA 156
Query: 552 ------DYYNAQISDFGLAKLLTLNQSKAIK--KAIRGTKGYVASPEWFRNSTITAN--- 600
+ ISDFGL K L QS GT G+ A PE S
Sbjct: 157 DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRA-PELLEESNNLQTKRR 215
Query: 601 ----VDVYSFGVLLLEIISCRKS-FDIEMGEEYAILT-DWAFDCYRNGKLDDLVEGDMEA 654
+D++S G + I+S K F + E I+ ++ D + L+ EA
Sbjct: 216 LTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIA---EA 272
Query: 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKV 685
+ I I DP RPT KV
Sbjct: 273 TDLIS----------QMIDHDPLKRPTAMKV 293
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 74/311 (23%), Positives = 143/311 (45%), Gaps = 42/311 (13%)
Query: 393 DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--GVIQTSTRTTVIV-VKK 449
DP P+ E K+ + N++ ++G+ F V G ++ ++ + V +K
Sbjct: 24 DPHTFEDPTQTVHEFAKELDATNISIDKVVGAG---EFGEVCSGRLKLPSKKEISVAIKT 80
Query: 450 LDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN 508
L + + ++ +F E ++GQ H N++RL G + + ++V +++ NG+L SFL ++
Sbjct: 81 LKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140
Query: 509 LKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566
+ + + IA G+ +L +H D+ +NIL++ ++SDFGL ++
Sbjct: 141 -DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
Query: 567 LTLNQSKAIKKAIRGTKGYV--ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEM 624
L + A RG K + SPE T+ DV+S+G++L E++S
Sbjct: 197 LEDDPEAAYTT--RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------Y 246
Query: 625 GEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDPSLR 679
GE Y ++ N + V+ + D C L +M+ W Q+D + R
Sbjct: 247 GERPYWEMS--------NQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW--QKDRNNR 294
Query: 680 PTMRKVSQMLE 690
P ++ +L+
Sbjct: 295 PKFEQIVSILD 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 63/255 (24%), Positives = 102/255 (40%), Gaps = 32/255 (12%)
Query: 446 VVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLG-FCDEGQNRL-LVYKFLNNGTL 501
V K+LD + +EV ++ + H N+VR D L +V ++ G L
Sbjct: 35 VWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL 94
Query: 502 ASFLFENLKPGWNLR----ANIAFQIARGLLHLH--VNCSSQIIHCDIKPQNILLDDYYN 555
AS + + K L + Q+ L H + ++H D+KP N+ LD N
Sbjct: 95 ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 154
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
++ DFGLA++L + S A K GT Y SPE + D++S G LL E+ +
Sbjct: 155 VKLGDFGLARILNHDTSFA--KTFVGTPYY-MSPEQMNRMSYNEKSDIWSLGCLLYELCA 211
Query: 616 CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQED 675
F L R GK + + +N+I ++ +
Sbjct: 212 LMPPFT---AFSQKEL----AGKIREGKFRRIPYRYSDELNEI--------IT-RMLNLK 255
Query: 676 PSLRPTMRKVSQMLE 690
RP+ V ++LE
Sbjct: 256 DYHRPS---VEEILE 267
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 67/286 (23%), Positives = 115/286 (40%), Gaps = 55/286 (19%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDRVFQDGEK-EFKNEV-VMIGQTYHKNLVRLLGFCDEGQN 488
T G+ + V VK L EK +E+ +M H+N+V LLG C G
Sbjct: 66 TAFGLGKEDAVLKV-AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 489 RLLVYKFLNNGTLASFL----------FENLKPGWNLRAN----IAFQIARGLLHLHVNC 534
L++ ++ G L +FL + Q+A+G+ L
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA--- 181
Query: 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN-----QSKAIKKAIRGTKGYVASP 589
S IH D+ +N+LL + + A+I DFGLA+ + + + A + ++ +P
Sbjct: 182 SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA-RLPVKWM-----AP 235
Query: 590 EWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDL 647
E + T DV+S+G+LL EI S +G IL + F +
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEIFS--------LGLNPYPGILVNSKF-------YKLV 280
Query: 648 VEGD-MEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+G M + + +M + W +P+ RPT +++ L+
Sbjct: 281 KDGYQMAQPAF--APKNIYSIMQACW--ALEPTHRPTFQQICSFLQ 322
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 14/181 (7%)
Query: 447 VKKLDRVFQDGE---KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
+K + ++ E K F+ EV Q H+N+V ++ +E LV +++ TL+
Sbjct: 41 IKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE 100
Query: 504 FLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563
++ + + N QI G+ H H +I+H DIKPQNIL+D +I DFG+
Sbjct: 101 YIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGI 157
Query: 564 AKLL---TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
AK L +L Q+ + GT Y SPE + D+YS G++L E++ F
Sbjct: 158 AKALSETSLTQT----NHVLGTVQYF-SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212
Query: 621 D 621
+
Sbjct: 213 N 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 55/260 (21%), Positives = 104/260 (40%), Gaps = 54/260 (20%)
Query: 446 VVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLG-FCDEGQNRLLVYK---------- 494
V+K++ ++ + EV + + H N+V G + + K
Sbjct: 40 VIKRVKY----NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCL 95
Query: 495 -----FLNNGTLASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKP 545
F + GTL ++ + G L + QI +G+ ++H S ++I+ D+KP
Sbjct: 96 FIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKP 150
Query: 546 QNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYS 605
NI L D +I DFGL L + + +GT Y+ SPE + VD+Y+
Sbjct: 151 SNIFLVDTKQVKIGDFGLVTSLK---NDGKRTRSKGTLRYM-SPEQISSQDYGKEVDLYA 206
Query: 606 FGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLV 665
G++L E++ + E + + L R+G + D+ D + ++
Sbjct: 207 LGLILAELLHVCDTAF-ETSKFFTDL--------RDGIISDIF--DKKEKTLLQ------ 249
Query: 666 MVSIWCIQEDPSLRPTMRKV 685
+ + P RP ++
Sbjct: 250 ----KLLSKKPEDRPNTSEI 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 59/283 (20%), Positives = 109/283 (38%), Gaps = 47/283 (16%)
Query: 439 STRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498
T +++K LD+ ++ + F M+ + HK+LV G C G +LV +F+
Sbjct: 37 QLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKF 96
Query: 499 GTLASFLFEN---LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
G+L ++L +N + W L +A Q+A + L + +IH ++ +NILL +
Sbjct: 97 GSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREED 151
Query: 556 AQ--------ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSF 606
+ +SD G++ + ++ I PE N D +SF
Sbjct: 152 RKTGNPPFIKLSDPGISITVLPKDIL--QERIPWV-----PPECIENPKNLNLATDKWSF 204
Query: 607 GVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEK 663
G L EI S G++ + L + + E + A
Sbjct: 205 GTTLWEICS--------GGDKPLSALD--------SQRKLQFYEDRHQLPAPKA--AELA 246
Query: 664 LVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDVPPNPSTFSC 706
++ + +P RP+ R + + L + D+ P S
Sbjct: 247 NLINNCM--DYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHH 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 55/263 (20%), Positives = 108/263 (41%), Gaps = 43/263 (16%)
Query: 441 RTTVIV-VKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498
+ + V +K+L + KE +E ++ + ++ RLLG C L+ + +
Sbjct: 42 KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPF 100
Query: 499 GTLASFLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
G L ++ E+ K + N QIA+G+ +L +++H D+ +N+L+ +
Sbjct: 101 GCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 156
Query: 557 QISDFGLAKLLTLN----QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
+I+DFGLAKLL ++ K I+ + E + T DV+S+GV + E
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWM-----ALESILHRIYTHQSDVWSYGVTVWE 211
Query: 613 IISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMV 667
+++ G + Y + ++ ++E + C + +M
Sbjct: 212 LMT--------FGSKPYDGIP--------ASEISSILEKGERLPQPPI--CTIDVYMIMR 253
Query: 668 SIWCIQEDPSLRPTMRKVSQMLE 690
W D RP R++
Sbjct: 254 KCW--MIDADSRPKFRELIIEFS 274
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 53/244 (21%), Positives = 101/244 (41%), Gaps = 41/244 (16%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN---LKPGWN 514
E++F E ++ + H LV+L G C E LV +F+ +G L+ +L
Sbjct: 47 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL 106
Query: 515 LRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574
L + + G+ +L + +IH D+ +N L+ + ++SDFG+ + + +Q +
Sbjct: 107 L--GMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161
Query: 575 IKKA---IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAI 630
++ SPE F S ++ DV+SFGVL+ E+ S G+ Y
Sbjct: 162 STGTKFPVKWA-----SPEVFSFSRYSSKSDVWSFGVLMWEVFS--------EGKIPYEN 208
Query: 631 LTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVS 686
+ N ++ + + + + +M W +E P RP ++
Sbjct: 209 RS--------NSEVVEDISTGFRLYKPRL--ASTHVYQIMNHCW--RERPEDRPAFSRLL 256
Query: 687 QMLE 690
+ L
Sbjct: 257 RQLA 260
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 70/310 (22%), Positives = 110/310 (35%), Gaps = 50/310 (16%)
Query: 400 PSPPDPEDKKKR--NMMNVTRSVLLGSSVF--VNFTLVGVIQTSTRTTVIV-VKKL---D 451
+ P ++ LG F V G + TV V VK L
Sbjct: 2 SAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDV 58
Query: 452 RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN--- 508
+ +F EV + H+NL+RL G +V + G+L L ++
Sbjct: 59 LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH 117
Query: 509 LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568
G A Q+A G+ +L S + IH D+ +N+LL +I DFGL + L
Sbjct: 118 FLLGTLS--RYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
Query: 569 LNQSKAIKKAIRGTKGYVA--SPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE 626
N K A +PE + T + D + FGV L E+ + G+
Sbjct: 173 QNDDHY--VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY--------GQ 222
Query: 627 E-YAILTDWAFDCYRNGKLDDLVEGD---MEAMNDIKCVEKL--VMVSIWCIQEDPSLRP 680
E + L ++ ++ + + D C + + VMV W P RP
Sbjct: 223 EPWIGLN--------GSQILHKIDKEGERLPRPED--CPQDIYNVMVQCW--AHKPEDRP 270
Query: 681 TMRKVSQMLE 690
T + L
Sbjct: 271 TFVALRDFLL 280
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 72/338 (21%), Positives = 122/338 (36%), Gaps = 68/338 (20%)
Query: 392 DDPDPPSVPSPPDPEDKK---KRNMMNVTRSVLLGSSVF---VNFTLVGVIQTSTRTTVI 445
D + V D K R N+ +LGS F +N T G+ +T V
Sbjct: 22 SDNEYFYVDFREYEYDLKWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV- 78
Query: 446 VVKKLDRVFQDGEK-EFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
VK L E+ +E+ +M H+N+V LLG C L++++ G L +
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 504 FLFENLKPGWNLRAN-----------------------IAFQIARGLLHLHVNCSSQIIH 540
+L + A+Q+A+G+ L +H
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH 195
Query: 541 CDIKPQNILLDDYYNAQISDFGLAKLLTLNQS-KAIKKA---IRGTKGYVASPEWFRNST 596
D+ +N+L+ +I DFGLA+ + + + A ++ +PE
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM-----APESLFEGI 250
Query: 597 ITANVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654
T DV+S+G+LL EI S + I + + +NG M+
Sbjct: 251 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-------FYKLIQNGFK-------MDQ 296
Query: 655 MNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
E++ +M S W D RP+ ++ L
Sbjct: 297 PFY--ATEEIYIIMQSCW--AFDSRKRPSFPNLTSFLG 330
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 60/293 (20%), Positives = 101/293 (34%), Gaps = 50/293 (17%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR----L 490
V +K++ Q +E + E M H N++RL+ +C +
Sbjct: 48 VEGLHDGHFY-ALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQ 546
L+ F GTL + + G L + I RGL +H + H D+KP
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPT 163
Query: 547 NILLDDYYNAQISDFGLAKLLTLNQSKAIK-------KAIRGTKGYVASPEWF---RNST 596
NILL D + D G ++ + + A R T Y +PE F +
Sbjct: 164 NILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY-RAPELFSVQSHCV 222
Query: 597 ITANVDVYSFGVLLLEIISCRKSFD--IEMGEEY--AILTDWAF--DCYRNGKLDDLVEG 650
I DV+S G +L ++ +D + G+ A+ + + L L+
Sbjct: 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLN- 281
Query: 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDVPPNPST 703
+ DP RP + + LE ++ P +T
Sbjct: 282 -------------------SMMTVDPHQRPHIPLLLSQLE-ALQPPAPGQHTT 314
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 67/243 (27%), Positives = 110/243 (45%), Gaps = 39/243 (16%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA 517
F E ++ Q H+ LVRL + + ++ +++ NG+L FL +
Sbjct: 52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINK 110
Query: 518 --NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ---S 572
++A QIA G+ + IH D++ NIL+ D + +I+DFGLA+L+ N+
Sbjct: 111 LLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167
Query: 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAIL 631
+ K I+ T +PE T T DV+SFG+LL EI++ G Y +
Sbjct: 168 EGAKFPIKWT-----APEAINYGTFTIKSDVWSFGILLTEIVT--------HGRIPYPGM 214
Query: 632 TDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQ 687
T N ++ +E M ++ C E+L +M W +E P RPT +
Sbjct: 215 T--------NPEVIQNLERGYRMVRPDN--CPEELYQLMRLCW--KERPEDRPTFDYLRS 262
Query: 688 MLE 690
+LE
Sbjct: 263 VLE 265
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 54/249 (21%), Positives = 110/249 (44%), Gaps = 39/249 (15%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA 517
E EF E ++ H+ LV+L G C + + ++ +++ NG L ++L E + + +
Sbjct: 63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQ 121
Query: 518 --NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575
+ + + +L S Q +H D+ +N L++D ++SDFGL++ + ++ +
Sbjct: 122 LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178
Query: 576 KKA---IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAIL 631
+ +R + PE S ++ D+++FGVL+ EI S G+ Y
Sbjct: 179 VGSKFPVRWS-----PPEVLMYSKFSSKSDIWAFGVLMWEIYSL--------GKMPYERF 225
Query: 632 TDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQ 687
T N + + + + + EK+ +M S W E RPT + +
Sbjct: 226 T--------NSETAEHIAQGLRLYRPHL--ASEKVYTIMYSCW--HEKADERPTFKILLS 273
Query: 688 MLEVVVEVD 696
+ V++ +
Sbjct: 274 NILDVMDEE 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-22
Identities = 44/208 (21%), Positives = 77/208 (37%), Gaps = 37/208 (17%)
Query: 495 FLNNGTLASFLFENLK---PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
L ++ + +I QIA + LH S ++H D+KP NI
Sbjct: 142 LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFT 198
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIR----------GTKGYVASPEWFRNSTITANV 601
++ DFGL + ++ + GTK Y++ PE + + V
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS-PEQIHGNNYSHKV 257
Query: 602 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCV 661
D++S G++L E++ SF +M E I+TD RN K L + +
Sbjct: 258 DIFSLGLILFELLY---SFSTQM-ERVRIITD-----VRNLKFPLLFTQKYPQEHMM--- 305
Query: 662 EKLVMVSI-WCIQEDPSLRPTMRKVSQM 688
+ + P+ RP + +
Sbjct: 306 -------VQDMLSPSPTERPEATDIIEN 326
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 66/280 (23%), Positives = 110/280 (39%), Gaps = 49/280 (17%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489
+ G+ + V VK L V + ++ +F E ++I + H+N+VR +G + R
Sbjct: 50 QVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108
Query: 490 LLVYKFLNNGTLASFLFENLKPGWNLRA-------NIAFQIARGLLHLHVNCSSQIIHCD 542
++ + + G L SFL E + ++A IA G +L + IH D
Sbjct: 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRD 165
Query: 543 IKPQNILLDDY---YNAQISDFGLAKLLTLN-----QSKAIKKAIRGTKGYVASPEWFRN 594
I +N LL A+I DFG+A+ + A ++ PE F
Sbjct: 166 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA-MLPVKWM-----PPEAFME 219
Query: 595 STITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEGDM 652
T+ D +SFGVLL EI S +G Y ++ + +G M
Sbjct: 220 GIFTSKTDTWSFGVLLWEIFS--------LGYMPYPSKSNQEVLEFVTSGGR-------M 264
Query: 653 EAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ + C + +M W Q P RP + + +E
Sbjct: 265 DPPKN--CPGPVYRIMTQCW--QHQPEDRPNFAIILERIE 300
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 62/284 (21%), Positives = 117/284 (41%), Gaps = 52/284 (18%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490
+ T + V VK L K+F+ E ++ H+++V+ G C +G +
Sbjct: 35 ECYNLSPTKDKMLV-AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 93
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRAN----------------IAFQIARGLLHLHVNC 534
+V++++ +G L FL + L IA QIA G+++L
Sbjct: 94 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--- 150
Query: 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS-KAIKKA---IRGTKGYVASPE 590
S +H D+ +N L+ +I DFG+++ + + IR PE
Sbjct: 151 SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-----PPE 205
Query: 591 WFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLV 648
T DV+SFGV+L EI + G++ + L++ +C G++
Sbjct: 206 SIMYRKFTTESDVWSFGVILWEIFTY--------GKQPWFQLSNTEVIECITQGRV---- 253
Query: 649 EGDMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+E C +++ VM+ W Q +P R ++++ ++L
Sbjct: 254 ---LERPRV--CPKEVYDVMLGCW--QREPQQRLNIKEIYKILH 290
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 71/333 (21%), Positives = 124/333 (37%), Gaps = 75/333 (22%)
Query: 393 DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--GVIQTSTRTTVIVVKKL 450
+ PDP + ++ ++G NF V I+ +K++
Sbjct: 4 HHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEG---NFGQVLKARIKKDGLRMDAAIKRM 60
Query: 451 DRVFQDGEK-EFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN 508
+ +F E+ V+ +H N++ LLG C+ L ++ +G L FL ++
Sbjct: 61 KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 120
Query: 509 LKPGWNLRAN----------------IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD 552
+ A +ARG+ +L Q IH D+ +NIL+ +
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGE 177
Query: 553 YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA-----------SPEWFRNSTITANV 601
Y A+I+DFGL+ RG + YV + E S T N
Sbjct: 178 NYVAKIADFGLS---------------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 222
Query: 602 DVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 659
DV+S+GVLL EI+S +G + ++ G +E +
Sbjct: 223 DVWSYGVLLWEIVS--------LGGTPYCGMTCAELYEKLPQGYR-------LEKPLN-- 265
Query: 660 CVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
C +++ +M W +E P RP+ ++ L
Sbjct: 266 CDDEVYDLMRQCW--REKPYERPSFAQILVSLN 296
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 69/327 (21%), Positives = 139/327 (42%), Gaps = 41/327 (12%)
Query: 377 HSSVNGKAFLKYKKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--G 434
H + S P+ + + + VTR ++G+ F V G
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAG---EFGEVYKG 63
Query: 435 VIQTSTRTTVIVV--KKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
+++TS+ + V K L + + ++ +F E ++GQ H N++RL G + + ++
Sbjct: 64 MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123
Query: 492 VYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
+ +++ NG L FL E + + IA G+ +L + +H D+ +NIL+
Sbjct: 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILV 180
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV--ASPEWFRNSTITANVDVYSFGV 608
+ ++SDFGL+++L + G K + +PE T+ DV+SFG+
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKIPIRWTAPEAISYRKFTSASDVWSFGI 238
Query: 609 LLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL- 664
++ E+++ GE Y L+ N ++ + + D C +
Sbjct: 239 VMWEVMT--------YGERPYWELS--------NHEVMKAINDGFRLPTPMD--CPSAIY 280
Query: 665 -VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+M+ W Q++ + RP + +L+
Sbjct: 281 QLMMQCW--QQERARRPKFADIVSILD 305
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 65/279 (23%), Positives = 127/279 (45%), Gaps = 47/279 (16%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489
GV++ T V +K ++ E+ EF NE ++ + ++VRLLG +GQ
Sbjct: 45 VAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103
Query: 490 LLVYKFLNNGTLASFLFENLKPGWNLRA----------NIAFQIARGLLHLHVNCSSQII 539
L++ + + G L S+L N +A +IA G+ +L+ +++ +
Sbjct: 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFV 160
Query: 540 HCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV----ASPEWFRNS 595
H D+ +N ++ + + +I DFG+ + + ++ +K G KG + SPE ++
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRK---GGKGLLPVRWMSPESLKDG 215
Query: 596 TITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEGDME 653
T DV+SFGV+L EI + + E+ Y L++ G L ++
Sbjct: 216 VFTTYSDVWSFGVVLWEIAT--------LAEQPYQGLSNEQVLRFVMEGGL-------LD 260
Query: 654 AMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
++ C + L +M W Q +P +RP+ ++ ++
Sbjct: 261 KPDN--CPDMLFELMRMCW--QYNPKMRPSFLEIISSIK 295
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 63/316 (19%), Positives = 130/316 (41%), Gaps = 52/316 (16%)
Query: 393 DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--GVIQTSTRTTVIV-VKK 449
D D + D +R + + R ++G +F +V G + + +K
Sbjct: 2 DLDSALLAEVKDVLIPHERVVTHSDR--VIGKG---HFGVVYHGEYIDQAQNRIQCAIKS 56
Query: 450 LDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL-VYKFLNNGTLASFLFE 507
L R+ + + F E +++ H N++ L+G + + ++ +G L F+
Sbjct: 57 LSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS 116
Query: 508 NLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
+ ++ + Q+ARG+ +L + +H D+ +N +LD+ + +++DFGLA+
Sbjct: 117 P-QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
Query: 566 LLTLNQSKAIKKA------IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
+ + ++++ ++ T + E + T DV+SFGVLL E+++
Sbjct: 173 DILDREYYSVQQHRHARLPVKWT-----ALESLQTYRFTTKSDVWSFGVLLWELLT---- 223
Query: 620 FDIEMGEE-YAILTDWAFDCYRNGKLDDLVE--GDMEAMNDIKCVEKL--VMVSIWCIQE 674
G Y + L + + C + L VM W +
Sbjct: 224 ----RGAPPYRHID--------PFDLTHFLAQGRRLPQPEY--CPDSLYQVMQQCW--EA 267
Query: 675 DPSLRPTMRKVSQMLE 690
DP++RPT R + +E
Sbjct: 268 DPAVRPTFRVLVGEVE 283
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 68/342 (19%), Positives = 131/342 (38%), Gaps = 63/342 (18%)
Query: 381 NGKAFLKYKKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSVL-----LGSSVF---VNFTL 432
+G + + + +P+ + ++ R + LG F
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIE--NPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC 62
Query: 433 VGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492
++ + V VK L + ++F+ E ++ H+++VR G C EG+ L+V
Sbjct: 63 HNLLPEQDKMLV-AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121
Query: 493 YKFLNNGTLASFLFENLKPGWNLRAN---------------IAFQIARGLLHLHVNCSSQ 537
++++ +G L FL + L +A Q+A G+++L
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLH 178
Query: 538 IIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN-----QSKAIKKAIRGTKGYVASPEWF 592
+H D+ +N L+ +I DFG+++ + + IR PE
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT-MLPIRWM-----PPESI 232
Query: 593 RNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEG 650
T DV+SFGV+L EI + G++ + L++ A DC G+
Sbjct: 233 LYRKFTTESDVWSFGVVLWEIFT--------YGKQPWYQLSNTEAIDCITQGRE------ 278
Query: 651 DMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+E C ++ +M W Q +P R +++ V L+
Sbjct: 279 -LERPRA--CPPEVYAIMRGCW--QREPQQRHSIKDVHARLQ 315
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 59/245 (24%), Positives = 85/245 (34%), Gaps = 41/245 (16%)
Query: 446 VVKKLDRVFQD--GEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
VK+ F+ EV H VRL +EG L + L +L
Sbjct: 86 AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYLQTELCGPSLQ 144
Query: 503 SFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
G +L L HLH S ++H D+KP NI L ++
Sbjct: 145 QHC---EAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKL 198
Query: 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK 618
DFGL L + + G Y+A PE + S TA DV+S G+ +LE+ +
Sbjct: 199 GDFGLLVELG---TAGAGEVQEGDPRYMA-PELLQGSYGTA-ADVFSLGLTILEVACNME 253
Query: 619 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM--EAMNDIKCVEKLVMVSIWCIQEDP 676
GE + L R G L + E + + ++ DP
Sbjct: 254 LPH--GGEGWQQL--------RQGYLPPEFTAGLSSELRSVLV----------MMLEPDP 293
Query: 677 SLRPT 681
LR T
Sbjct: 294 KLRAT 298
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-22
Identities = 61/335 (18%), Positives = 132/335 (39%), Gaps = 53/335 (15%)
Query: 381 NGKAFLKYKKGDDPDPPSVPSPPDPEDK---KKRNMMNVTRSVLLGSSVFVNFTLV--GV 435
+ + + D ++ + + + V + ++G +F V G
Sbjct: 53 SENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRG---HFGCVYHGT 109
Query: 436 IQTSTRTTVIV-VKKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQN-RLLV 492
+ + + VK L+R+ GE +F E +++ H N++ LLG C + L+V
Sbjct: 110 LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169
Query: 493 YKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQ-IIHCDIKPQNIL 549
++ +G L +F+ ++ Q+A+G+ L +S+ +H D+ +N +
Sbjct: 170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCM 224
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKA------IRGTKGYVASPEWFRNSTITANVDV 603
LD+ + +++DFGLA+ + + ++ ++ + E + T DV
Sbjct: 225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-----ALESLQTQKFTTKSDV 279
Query: 604 YSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEGDMEAMNDIKCV 661
+SFGVLL E+++ G Y + + G+ + C
Sbjct: 280 WSFGVLLWELMT--------RGAPPYPDVNTFDITVYLLQGRR-------LLQPEY--CP 322
Query: 662 EKL--VMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694
+ L VM+ W +RP+ ++ + +
Sbjct: 323 DPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 355
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 8e-22
Identities = 74/321 (23%), Positives = 122/321 (38%), Gaps = 52/321 (16%)
Query: 393 DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVF---VNFTLVGVIQTSTRTTVIVVKK 449
+P+ D K+ N+T LG F + G+ + V VK
Sbjct: 50 NPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV-AVKT 108
Query: 450 LDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN 508
L V + ++ +F E ++I + H+N+VR +G + R ++ + + G L SFL E
Sbjct: 109 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 168
Query: 509 LKPGWNLRA-------NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY---YNAQI 558
+ ++A IA G +L + IH DI +N LL A+I
Sbjct: 169 RPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 225
Query: 559 SDFGLAKLLTLN-----QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
DFG+A+ + A ++ PE F T+ D +SFGVLL EI
Sbjct: 226 GDFGMARDIYRAGYYRKGGCA-MLPVKWM-----PPEAFMEGIFTSKTDTWSFGVLLWEI 279
Query: 614 ISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--VMVSI 669
S +G Y ++ + +G M+ + C + +M
Sbjct: 280 FS--------LGYMPYPSKSNQEVLEFVTSGGR-------MDPPKN--CPGPVYRIMTQC 322
Query: 670 WCIQEDPSLRPTMRKVSQMLE 690
W Q P RP + + +E
Sbjct: 323 W--QHQPEDRPNFAIILERIE 341
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 59/254 (23%), Positives = 110/254 (43%), Gaps = 38/254 (14%)
Query: 447 VKKLDRVFQDGE-KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
+K ++ + + ++ IG H ++VRLLG C G + LV ++L G+L +
Sbjct: 47 IKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHV 105
Query: 506 FENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563
++ + + N QIA+G+ +L ++H ++ +N+LL Q++DFG+
Sbjct: 106 RQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGV 161
Query: 564 AKLLTLNQSKAIKKAIRGTKGYV--ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
A LL + + K + + E T DV+S+GV + E+++
Sbjct: 162 ADLLPPDDK---QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF----- 213
Query: 622 IEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDP 676
G E YA L ++ DL+E + C + VMV W D
Sbjct: 214 ---GAEPYAGLR--------LAEVPDLLEKGERLAQPQI--CTIDVYMVMVKCW--MIDE 258
Query: 677 SLRPTMRKVSQMLE 690
++RPT ++++
Sbjct: 259 NIRPTFKELANEFT 272
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 61/248 (24%), Positives = 99/248 (39%), Gaps = 34/248 (13%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
I +K++ + E+ + HKN+V+ LG E + + + G+L++
Sbjct: 49 RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 108
Query: 504 FL---FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQIS 559
L + LK QI GL +LH +QI+H DIK N+L++ Y +IS
Sbjct: 109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKIS 165
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI--TANVDVYSFGVLLLEIISCR 617
DFG +K L + GT Y+A PE D++S G ++E+ + +
Sbjct: 166 DFGTSKRLAGINPC--TETFTGTLQYMA-PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
Query: 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDL--VEGDM--EAMNDIKCVEKLVMVSIWCIQ 673
F E+GE A + ++ G + M EA I C +
Sbjct: 223 PPF-YELGEPQAAM-------FKVGMFKVHPEIPESMSAEAKAFILK----------CFE 264
Query: 674 EDPSLRPT 681
DP R
Sbjct: 265 PDPDKRAC 272
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-21
Identities = 82/425 (19%), Positives = 155/425 (36%), Gaps = 75/425 (17%)
Query: 298 FNSICPKGYSLLDENEKYGSCKADFELSCNGGRQDYELSRPYDEVQCKNNC--LSDCFCV 355
FN + YS ++ ++ K +L G + L+ + N L D +C
Sbjct: 266 FNQVQTIQYSNSEDKDR----KGMLQLKIAGAPEP--LTVTAPSLTIAENMADLIDGYCR 319
Query: 356 VAIFRGDSCWSKKL-----------PLSNGRAHSSVNGKAFLKYKKG-----DDPDPPSV 399
+ S + L+N + + D+ D ++
Sbjct: 320 LVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTM 379
Query: 400 PSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--GVIQTSTRTTVIV-VKKLDRVFQD 456
PS D E +++ + +G F V G+ + + V +K D
Sbjct: 380 PSTRDYEIQRE----RIELGRCIGEG---QFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432
Query: 457 GEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNL 515
+ +F E + + Q H ++V+L+G E ++ + G L SFL K +L
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDL 490
Query: 516 RA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN--- 570
+ A+Q++ L +L S + +H DI +N+L+ ++ DFGL++ + +
Sbjct: 491 ASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547
Query: 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YA 629
++ K I+ +PE T+ DV+ FGV + EI+ G + +
Sbjct: 548 KASKGKLPIKWM-----APESINFRRFTSASDVWMFGVCMWEILMH--------GVKPFQ 594
Query: 630 ILTDWAFDCYRNGKLDDLVE--GDMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKV 685
+ N + +E + + C L +M W DPS RP ++
Sbjct: 595 GVK--------NNDVIGRIENGERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTEL 642
Query: 686 SQMLE 690
L
Sbjct: 643 KAQLS 647
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 56/262 (21%), Positives = 108/262 (41%), Gaps = 41/262 (15%)
Query: 441 RTTVIV-VKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498
+ + V +K+L + KE +E ++ + ++ RLLG C L+ + +
Sbjct: 42 KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPF 100
Query: 499 GTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
G L ++ E+ G N QIA+G+ +L +++H D+ +N+L+ + +
Sbjct: 101 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVK 157
Query: 558 ISDFGLAKLLTLN----QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
I+DFGLAKLL ++ K I+ + E + T DV+S+GV + E+
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWM-----ALESILHRIYTHQSDVWSYGVTVWEL 212
Query: 614 ISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVS 668
++ G + Y + ++ ++E + C + +MV
Sbjct: 213 MT--------FGSKPYDGIP--------ASEISSILEKGERLPQPPI--CTIDVYMIMVK 254
Query: 669 IWCIQEDPSLRPTMRKVSQMLE 690
W D RP R++
Sbjct: 255 CW--MIDADSRPKFRELIIEFS 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 56/299 (18%), Positives = 101/299 (33%), Gaps = 54/299 (18%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFC-------DEG 486
+ +K+L ++ + EV M + H N+V+ D G
Sbjct: 47 AQDVGSGREY-ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105
Query: 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRA----NIAFQIARGLLHLHVNCSSQIIHCD 542
Q L+ L G L FL + ++ L I +Q R + H+H IIH D
Sbjct: 106 QAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRD 163
Query: 543 IKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIR----------GTKGYVASPE-- 590
+K +N+LL + ++ DFG A ++ + R T Y +PE
Sbjct: 164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMY-RTPEII 222
Query: 591 -WFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT---DWAFDCYRNGKLDD 646
+ N I D+++ G +L + + F E G + I+ +
Sbjct: 223 DLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKLRIVNGKYSIPPHDTQYTVFHS 280
Query: 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDVPPNPSTFS 705
L+ +Q +P R ++ +V L+ + S +
Sbjct: 281 LIR--------------------AMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 59/254 (23%), Positives = 104/254 (40%), Gaps = 39/254 (15%)
Query: 446 VVKKLDRVFQDGEKEFK---NEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
V+K+++ KE + EV ++ H N+V+ +E + +V + G L
Sbjct: 53 VIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLF 111
Query: 503 SFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
+ N + G + + QI L H+H +I+H DIK QNI L Q+
Sbjct: 112 KRI--NAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQL 166
Query: 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK 618
DFG+A++L A +A GT Y SPE N D+++ G +L E+ + +
Sbjct: 167 GDFGIARVLNSTVELA--RACIGTPYY-LSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 619 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI--KCVEKLVMVSIWCIQEDP 676
+F+ L + ++ G ++ + LV + +P
Sbjct: 224 AFE---AGSMKNL------------VLKIISGSFPPVSLHYSYDLRSLVS---QLFKRNP 265
Query: 677 SLRPTMRKVSQMLE 690
RP+ V+ +LE
Sbjct: 266 RDRPS---VNSILE 276
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 57/276 (20%), Positives = 116/276 (42%), Gaps = 43/276 (15%)
Query: 434 GVIQTSTRTTVIV-VKKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQN-RL 490
G + + + VK L+R+ GE +F E +++ H N++ LLG C + L
Sbjct: 44 GTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548
+V ++ +G L +F+ ++ Q+A+G+ +L S + +H D+ +N
Sbjct: 104 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNC 159
Query: 549 LLDDYYNAQISDFGLAKLL------TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVD 602
+LD+ + +++DFGLA+ + +++ K ++ + E + T D
Sbjct: 160 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-----ALESLQTQKFTTKSD 214
Query: 603 VYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEGDMEAMNDIKC 660
V+SFGVLL E+++ G Y + + G+ + C
Sbjct: 215 VWSFGVLLWELMT--------RGAPPYPDVNTFDITVYLLQGRR-------LLQPEY--C 257
Query: 661 VEKL--VMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694
+ L VM+ W +RP+ ++ + +
Sbjct: 258 PDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 291
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 63/267 (23%), Positives = 103/267 (38%), Gaps = 47/267 (17%)
Query: 446 VVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK----------- 494
+KK+ ++ +EV+++ H+ +VR E +N +
Sbjct: 35 AIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQ 93
Query: 495 --FLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
+ NGTL + NL + + QI L ++H S IIH D+KP NI +D
Sbjct: 94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFID 150
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIR------------GTKGYVASPEWFRNS-TIT 598
+ N +I DFGLAK + + + GT YVA E +
Sbjct: 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA-TEVLDGTGHYN 209
Query: 599 ANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658
+D+YS G++ E+I S +E L R+ ++ + D M
Sbjct: 210 EKIDMYSLGIIFFEMI-YPFSTGMERVNILKKL--------RSVSIEFPPDFDDNKMKVE 260
Query: 659 KCVEKLVMVSIWCIQEDPSLRPTMRKV 685
K K++ I DP+ RP R +
Sbjct: 261 K---KIIR---LLIDHDPNKRPGARTL 281
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 4e-21
Identities = 70/314 (22%), Positives = 124/314 (39%), Gaps = 42/314 (13%)
Query: 389 KKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLV--GVIQTSTRTTVIV 446
P S P + + + + LG NF V GV + + +
Sbjct: 311 DTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCG---NFGSVRQGVYRMRKKQIDVA 367
Query: 447 VKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
+K L + +E E ++ Q + +VRL+G C + + +LV + G L FL
Sbjct: 368 IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL 426
Query: 506 FENLK--PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563
+ P N+ A + Q++ G+ +L +H ++ +N+LL + + A+ISDFGL
Sbjct: 427 VGKREEIPVSNV-AELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 564 AKLLTLNQSKAIKKAIRGTKGYVA--SPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
+K L + S A K + +PE ++ DV+S+GV + E +S
Sbjct: 483 SKALGADDS--YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY----- 535
Query: 622 IEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL--VMVSIWCIQEDP 676
G++ Y + ++ +E ME + C +L +M W
Sbjct: 536 ---GQKPYKKMK--------GPEVMAFIEQGKRMECPPE--CPPELYALMSDCW--IYKW 580
Query: 677 SLRPTMRKVSQMLE 690
RP V Q +
Sbjct: 581 EDRPDFLTVEQRMR 594
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 63/267 (23%), Positives = 112/267 (41%), Gaps = 37/267 (13%)
Query: 434 GVIQTSTRTTVIVVKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492
GV + + + +K L + +E E ++ Q + +VRL+G C + + +LV
Sbjct: 29 GVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87
Query: 493 YKFLNNGTLASFLFENLK--PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
+ G L FL + P N+ A + Q++ G+ +L +H D+ +N+LL
Sbjct: 88 MEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL---EEKNFVHRDLAARNVLL 143
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA--SPEWFRNSTITANVDVYSFGV 608
+ + A+ISDFGL+K L + S A K + +PE ++ DV+S+GV
Sbjct: 144 VNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 201
Query: 609 LLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL- 664
+ E +S G++ Y + ++ +E ME + C +L
Sbjct: 202 TMWEALS--------YGQKPYKKMK--------GPEVMAFIEQGKRMECPPE--CPPELY 243
Query: 665 -VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+M W RP V Q +
Sbjct: 244 ALMSDCW--IYKWEDRPDFLTVEQRMR 268
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 57/287 (19%)
Query: 431 TLVGVIQTSTRTTVIVVKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489
L G V +K L D+ +EF++E ++ + H N+V LLG + Q
Sbjct: 29 HLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 87
Query: 490 LLVYKFLNNGTLASFLFENLKPGWNLRAN----------------IAFQIARGLLHLHVN 533
+++ + ++G L FL + + QIA G+ +L
Sbjct: 88 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL--- 144
Query: 534 CSSQ-IIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN-----QSKAIKKAIRGTKGYVA 587
SS ++H D+ +N+L+ D N +ISD GL + + + IR
Sbjct: 145 -SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS-LLPIRWM----- 197
Query: 588 SPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLD 645
+PE + + D++S+GV+L E+ S G + Y ++ + RN ++
Sbjct: 198 APEAIMYGKFSIDSDIWSYGVVLWEVFS--------YGLQPYCGYSNQDVVEMIRNRQV- 248
Query: 646 DLVEGDMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ +D C + +M+ W E PS RP + + L
Sbjct: 249 ------LPCPDD--CPAWVYALMIECW--NEFPSRRPRFKDIHSRLR 285
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 48/264 (18%), Positives = 94/264 (35%), Gaps = 58/264 (21%)
Query: 446 VVKKLDRVFQD--GEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
+K+ + E+ EV H ++VR E + L+ ++ N G+LA
Sbjct: 40 AIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 99
Query: 503 SFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD------- 551
+ EN + + ++ Q+ RGL ++H S ++H DIKP NI +
Sbjct: 100 DAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNA 156
Query: 552 ------------DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPE-WFRNSTIT 598
+ +I D G ++ Q + G ++A E N T
Sbjct: 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE------EGDSRFLA-NEVLQENYTHL 209
Query: 599 ANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND- 657
D+++ + ++ G+++ + R G+L + + + +
Sbjct: 210 PKADIFALALTVVCAAGAEPLPR--NGDQWHEI--------RQGRLPRIPQVLSQEFTEL 259
Query: 658 IKCVEKLVMVSIWCIQEDPSLRPT 681
+K I DP RP+
Sbjct: 260 LK----------VMIHPDPERRPS 273
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 68/294 (23%), Positives = 126/294 (42%), Gaps = 63/294 (21%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489
T + + TTV VK L E + +E ++ Q H ++++L G C +
Sbjct: 43 TAFHLKGRAGYTTV-AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101
Query: 490 LLVYKFLNNGTLASFLFENLKPGWNLRAN------------------------IAFQIAR 525
LL+ ++ G+L FL E+ K G + A+QI++
Sbjct: 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQ 161
Query: 526 GLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS-KAIKKA---IRG 581
G+ +L +++H D+ +NIL+ + +ISDFGL++ + S + ++
Sbjct: 162 GMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKW 218
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYR 640
+ E + T DV+SFGVLL EI++ +G Y +
Sbjct: 219 M-----AIESLFDHIYTTQSDVWSFGVLLWEIVT--------LGGNPYPGIP-------- 257
Query: 641 NGKLDDLVE--GDMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+L +L++ ME ++ C E++ +M+ W +++P RP +S+ LE
Sbjct: 258 PERLFNLLKTGHRMERPDN--CSEEMYRLMLQCW--KQEPDKRPVFADISKDLE 307
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 11/167 (6%)
Query: 461 FKNEVVMIGQTYHKNLVRLL--GFCDEGQNRLLVY---KFLNNGTLASFLFENLKPGWNL 515
F+ E H +V + G E L Y ++++ TL +
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 516 RANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK-A 574
+ + L H N IIH D+KP NI++ ++ DFG+A+ + + +
Sbjct: 118 AIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
A+ GT Y+ SPE R ++ A DVYS G +L E+++ F
Sbjct: 175 QTAAVIGTAQYL-SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 31/192 (16%), Positives = 59/192 (30%), Gaps = 23/192 (11%)
Query: 458 EKEF---KNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGW- 513
EF + + + ++ +LV + + GTL + +
Sbjct: 108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK 167
Query: 514 ----NLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA-----------QI 558
L + A ++ + +H +IIH DIKP N +L + + +
Sbjct: 168 VMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224
Query: 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK 618
D G + + L I A T G+ E N +D + + ++
Sbjct: 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQC-VEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
Query: 619 SFDIEMGEEYAI 630
G E
Sbjct: 284 MKVKNEGGECKP 295
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 67/336 (19%), Positives = 127/336 (37%), Gaps = 69/336 (20%)
Query: 394 PDPPSVPSPPDPEDKK---KRNMMNVTRSVLLGSSVF---VNFTLVGVIQTSTRTTVIVV 447
P +P +P+ RN N+ +G F G++ T V V
Sbjct: 26 PMYQRMPLLLNPKLLSLEYPRN--NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMV-AV 82
Query: 448 KKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF 506
K L + +F+ E ++ + + N+V+LLG C G+ L+++++ G L FL
Sbjct: 83 KMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 142
Query: 507 ENLKPGWNLRAN------------------------IAFQIARGLLHLHVNCSSQIIHCD 542
++ IA Q+A G+ +L + +H D
Sbjct: 143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 199
Query: 543 IKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV----ASPEWFRNSTIT 598
+ +N L+ + +I+DFGL++ + + K + PE + T
Sbjct: 200 LATRNCLVGENMVVKIADFGLSR--NIYSADYYKA---DGNDAIPIRWMPPESIFYNRYT 254
Query: 599 ANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEGDMEAMN 656
DV+++GV+L EI S G + Y + R+G + +
Sbjct: 255 TESDVWAYGVVLWEIFS--------YGLQPYYGMAHEEVIYYVRDGNI-------LACPE 299
Query: 657 DIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ C +L +M W + P+ RP+ + ++L+
Sbjct: 300 N--CPLELYNLMRLCW--SKLPADRPSFCSIHRILQ 331
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 59/269 (21%), Positives = 104/269 (38%), Gaps = 42/269 (15%)
Query: 434 GVIQTSTRTTVIV-VKKL-DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
GV + V VK D +++F +E V++ H ++V+L+G +E + +
Sbjct: 31 GVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89
Query: 492 VYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
+ + G L +L N K + + QI + + +L S +H DI +NIL
Sbjct: 90 IMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNIL 145
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKA---IRGTKGYVASPEWFRNSTITANVDVYSF 606
+ ++ DFGL++ + I+ SPE T DV+ F
Sbjct: 146 VASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-----SPESINFRRFTTASDVWMF 200
Query: 607 GVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE--GDMEAMNDIKCVEK 663
V + EI+S G++ + L N + ++E + + C
Sbjct: 201 AVCMWEILS--------FGKQPFFWLE--------NKDVIGVLEKGDRLPKPDL--CPPV 242
Query: 664 L--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
L +M W DPS RP ++ L
Sbjct: 243 LYTLMTRCW--DYDPSDRPRFTELVCSLS 269
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 58/269 (21%), Positives = 106/269 (39%), Gaps = 42/269 (15%)
Query: 434 GVIQTSTRTTVIV-VKKLDRVFQDGEK-EFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
G+ + + V +K D + +F E + + Q H ++V+L+G E +
Sbjct: 34 GIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 92
Query: 492 VYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
+ + G L SFL K +L + A+Q++ L +L S + +H DI +N+L
Sbjct: 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 148
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKA---IRGTKGYVASPEWFRNSTITANVDVYSF 606
+ ++ DFGL++ + + K I+ +PE T+ DV+ F
Sbjct: 149 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-----APESINFRRFTSASDVWMF 203
Query: 607 GVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE--GDMEAMNDIKCVEK 663
GV + EI+ G + + + N + +E + + C
Sbjct: 204 GVCMWEILM--------HGVKPFQGVK--------NNDVIGRIENGERLPMPPN--CPPT 245
Query: 664 L--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
L +M W DPS RP ++ L
Sbjct: 246 LYSLMTKCW--AYDPSRRPRFTELKAQLS 272
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 74/334 (22%), Positives = 137/334 (41%), Gaps = 59/334 (17%)
Query: 388 YKKGDDPDPPSVPSPPDPEDKK---KRNMMNVTRSVLLGSSVFVNFTLV--GVIQTSTRT 442
+ P + + RN++ + + +LG F V G ++ T
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEG---EFGSVMEGNLKQEDGT 61
Query: 443 TVIV-VK--KLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR-----LLVYK 494
++ V VK KLD Q +EF +E + H N++RLLG C E ++ +++
Sbjct: 62 SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 495 FLNNGTLASFLFEN--LKPGWNLRAN----IAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548
F+ G L ++L + ++ IA G+ +L + +H D+ +N
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNC 178
Query: 549 LLDDYYNAQISDFGLAKLLTLN----QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVY 604
+L D ++DFGL+K + Q + K ++ + E + T+ DV+
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-----AIESLADRVYTSKSDVW 233
Query: 605 SFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEGDMEAMNDIKCVE 662
+FGV + EI + G Y + + +D +G ++ D C++
Sbjct: 234 AFGVTMWEIAT--------RGMTPYPGVQNHEMYDYLLHGHR-------LKQPED--CLD 276
Query: 663 KL--VMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694
+L +M S W + DP RPT + LE ++E
Sbjct: 277 ELYEIMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 10/170 (5%)
Query: 446 VVKKLDRVFQDG-EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
V+ K ++ + G E + + EV + H N++RL G+ + L+ ++ GT+
Sbjct: 41 VLFK-AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRE 99
Query: 505 LFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
L + K A ++A L + H S ++IH DIKP+N+LL +I+DFG +
Sbjct: 100 LQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 156
Query: 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
++ + + GT Y+ PE VD++S GVL E +
Sbjct: 157 VHAPSSR----RTDLCGTLDYLP-PEMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 18/176 (10%)
Query: 451 DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFEN-- 508
D VF+ + E G+ ++V + F + + + +N LA+ L
Sbjct: 74 DPVFR---TRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP 130
Query: 509 LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL- 567
L P + I QI L H ++ H D+KP+NIL+ A + DFG+A
Sbjct: 131 LAPPRAVA--IVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT 185
Query: 568 --TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
L Q GT Y +PE F S T D+Y+ +L E ++ +
Sbjct: 186 DEKLTQLGNTV----GTLYY-MAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 59/280 (21%), Positives = 116/280 (41%), Gaps = 50/280 (17%)
Query: 434 GVIQTSTRTTVIV-VK--KLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR- 489
++ + V V VK K D + +EF E + + H ++ +L+G + +
Sbjct: 42 AQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101
Query: 490 -----LLVYKFLNNGTLASFLFENLKP--GWNLRA----NIAFQIARGLLHLHVNCSSQI 538
+++ F+ +G L +FL + +NL IA G+ +L S
Sbjct: 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNF 158
Query: 539 IHCDIKPQNILLDDYYNAQISDFGLAKLLTLN----QSKAIKKAIRGTKGYVASPEWFRN 594
IH D+ +N +L + ++DFGL++ + Q A K ++ + E +
Sbjct: 159 IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL-----ALESLAD 213
Query: 595 STITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGKLDDLVEGDM 652
+ T + DV++FGV + EI++ G+ YA + + ++ G +
Sbjct: 214 NLYTVHSDVWAFGVTMWEIMT--------RGQTPYAGIENAEIYNYLIGGNR-------L 258
Query: 653 EAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ + C+E++ +M W DP RP+ + LE
Sbjct: 259 KQPPE--CMEEVYDLMYQCW--SADPKQRPSFTCLRMELE 294
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 41/199 (20%), Positives = 78/199 (39%), Gaps = 26/199 (13%)
Query: 441 RTTVIV-VKKLDRVFQDGE--KEFKNEVVMIGQTYHKNL--VRLLGFCDEGQNRLLVYKF 495
I +K ++ D + ++NE+ + + + +RL + Q +Y
Sbjct: 50 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMV 106
Query: 496 L--NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY 553
+ N L S+L + R + + + +H I+H D+KP N L+ D
Sbjct: 107 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD- 162
Query: 554 YNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPE-----------WFRNSTITANVD 602
++ DFG+A + + + +K + GT Y+ PE S I+ D
Sbjct: 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP-PEAIKDMSSSRENGKSKSKISPKSD 221
Query: 603 VYSFGVLLLEIISCRKSFD 621
V+S G +L + + F
Sbjct: 222 VWSLGCILYYMTYGKTPFQ 240
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 33/234 (14%), Positives = 71/234 (30%), Gaps = 54/234 (23%)
Query: 473 HKNLVRLLGFCDEGQ--NRLLVYKFLNN------GTLASFLFENLKPGWNLRANIAFQIA 524
K ++R+ + +R +Y + + L S + + R + Q+
Sbjct: 157 KKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI 216
Query: 525 RGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKG 584
R L LH ++H ++P +I+LD ++ F ++G
Sbjct: 217 RLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV------SSVSRG 267
Query: 585 YVASPEWF-----------RNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT- 632
+ PE R + +T + D ++ G+++ Y I
Sbjct: 268 FEP-PELEARRATISYHRDRRTLMTFSFDAWALGLVI-----------------YWIWCA 309
Query: 633 DWAFDCYRNGKLDDLVEGDMEAMNDI-KCVEKLVMVSIWCIQEDPSLRPTMRKV 685
D E + +I + V L+ ++ R +
Sbjct: 310 DLPIT---KDAALGGSEWIFRSCKNIPQPVRALLE---GFLRYPKEDRLLPLQA 357
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 58/333 (17%), Positives = 122/333 (36%), Gaps = 54/333 (16%)
Query: 378 SSVNGKAFLKYKKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSV-----LLG----SSVFV 428
S + A K+++ P D ++V + +G S VF
Sbjct: 15 SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVF- 73
Query: 429 NFTLVGVIQTSTRTTVIV-VKKLDRVFQDGE--KEFKNEVVMIGQTYHKNL--VRLLGFC 483
Q I +K ++ D + ++NE+ + + + +RL +
Sbjct: 74 --------QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY- 124
Query: 484 DEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDI 543
+ + + N L S+L + R + + + +H I+H D+
Sbjct: 125 EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDL 181
Query: 544 KPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST------- 596
KP N L+ D ++ DFG+A + + + +K + G Y+ PE ++ +
Sbjct: 182 KPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP-PEAIKDMSSSRENGK 239
Query: 597 ----ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652
I+ DV+S G +L + + F ++ + + L + + D+ E D
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEI-EFPDIPEKD- 296
Query: 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKV 685
+ +KC C++ DP R ++ ++
Sbjct: 297 -LQDVLKC----------CLKRDPKQRISIPEL 318
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 38/155 (24%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA 517
E + + E+ + H N++R+ + + + L+ +F G L L ++ + A
Sbjct: 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKK 577
++A L + H ++IH DIKP+N+L+ +I+DFG + + ++
Sbjct: 118 TFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RR 170
Query: 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
+ GT Y+ PE T VD++ GVL E
Sbjct: 171 TMCGTLDYLP-PEMIEGKTHDEKVDLWCAGVLCYE 204
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 45/258 (17%), Positives = 100/258 (38%), Gaps = 43/258 (16%)
Query: 447 VKKLDRVFQDGE--KEFKNEVVMIGQTYHKNL--VRLLGFCDEGQNRLLVYKFLNNGTLA 502
+K ++ D + ++NE+ + + + +RL + + + + N L
Sbjct: 38 IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECGNIDLN 96
Query: 503 SFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562
S+L + R + + + +H I+H D+KP N L+ D ++ DFG
Sbjct: 97 SWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFG 152
Query: 563 LAKLLTLNQSKAIKKAIRGTKGYVASPE-----------WFRNSTITANVDVYSFGVLLL 611
+A + + + +K + GT Y+ PE S I+ DV+S G +L
Sbjct: 153 IANQMQPDTTSVVKDSQVGTVNYMP-PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211
Query: 612 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG----DMEAMNDIKCVEKLVMV 667
+ + F ++ + + L + + +E + + + +K
Sbjct: 212 YMTYGKTPFQ-QIINQISKL-------HAIIDPNHEIEFPDIPEKDLQDVLK-------- 255
Query: 668 SIWCIQEDPSLRPTMRKV 685
C++ DP R ++ ++
Sbjct: 256 --CCLKRDPKQRISIPEL 271
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 18/174 (10%), Positives = 40/174 (22%), Gaps = 23/174 (13%)
Query: 516 RANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575
+ Q+ R +L S ++H P N+ + + D +
Sbjct: 196 LHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP--- 249
Query: 576 KKAIRGTKGYVASPEWF--RNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 633
A E+ +T T ++ + G+ + + F +
Sbjct: 250 ---ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306
Query: 634 WAFDCYRNGKLDDLVEGDM--EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKV 685
+ L + I + D R +
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGR----------FLNFDRRRRLLPLEA 350
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 8/159 (5%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA 517
E E+V +V L G EG + + L G+L + + +
Sbjct: 94 EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL 153
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-YNAQISDFGLAKLLT---LNQSK 573
Q GL +LH + +I+H D+K N+LL A + DFG A L L +S
Sbjct: 154 YYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210
Query: 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
I GT+ ++A PE A VD++S ++L
Sbjct: 211 LTGDYIPGTETHMA-PEVVMGKPCDAKVDIWSSCCMMLH 248
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 20/176 (11%)
Query: 444 VIVVKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
I ++ + +E + EV ++ Q H N++ L + + +L+ + ++ G L
Sbjct: 44 FIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL- 102
Query: 503 SFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL----DDYY 554
F+ L +L + QI G+ +LH + +I H D+KP+NI+L
Sbjct: 103 ---FDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIP 156
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+ ++ DFGLA + K GT +VA PE + D++S GV+
Sbjct: 157 HIKLIDFGLAHE--IEDGVEFKNIF-GTPEFVA-PEIVNYEPLGLEADMWSIGVIT 208
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 42/188 (22%), Positives = 81/188 (43%), Gaps = 27/188 (14%)
Query: 447 VKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLGFCDEGQNRL--LVYKFLNNGTLAS 503
+K + + + E ++ + HKN+V+L +E R L+ +F G+L +
Sbjct: 39 IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT 98
Query: 504 FLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL----DDYYN 555
L E + L + + G+ HL + I+H +IKP NI+ D
Sbjct: 99 VLEEP-SNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSV 154
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI--------TANVDVYSFG 607
+++DFG A+ L ++ ++ GT+ Y+ P+ + + + A VD++S G
Sbjct: 155 YKLTDFGAARELEDDE---QFVSLYGTEEYLH-PDMYERAVLRKDHQKKYGATVDLWSIG 210
Query: 608 VLLLEIIS 615
V +
Sbjct: 211 VTFYHAAT 218
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 37/174 (21%), Positives = 73/174 (41%), Gaps = 24/174 (13%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
+ VK D+ K E+ ++ H+N++ L + + +++++F++ +
Sbjct: 37 FVKVKGTDQ------VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI-- 88
Query: 504 FLFEN-LKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ- 557
FE + L + Q+ L LH S I H DI+P+NI+ ++
Sbjct: 89 --FERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTI 143
Query: 558 -ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
I +FG A+ L + Y A PE ++ ++ D++S G L+
Sbjct: 144 KIIEFGQARQ--LKPGDNFRLLF-TAPEYYA-PEVHQHDVVSTATDMWSLGTLV 193
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 7/139 (5%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA-NIAFQIARGLLHLH 531
H +++ L + ++ LV + +NG + +L +KP A + QI G+L+LH
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEW 591
S I+H D+ N+LL N +I+DFGLA L + K + GT Y++ PE
Sbjct: 130 ---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYIS-PEI 183
Query: 592 FRNSTITANVDVYSFGVLL 610
S DV+S G +
Sbjct: 184 ATRSAHGLESDVWSLGCMF 202
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 10/176 (5%)
Query: 441 RTTVIV-VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
+ V VK +D Q + NEVV++ H N+V + G+ ++ +FL G
Sbjct: 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 500 TLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
L + + L A + + + L +LH + +IH DIK +ILL ++
Sbjct: 128 ALTDIVSQVRLNEEQI--ATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKL 182
Query: 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
SDFG ++ + K +K++ GT Y +PE S VD++S G++++E++
Sbjct: 183 SDFGFCAQISKDVPK--RKSLVGTP-YWMAPEVISRSLYATEVDIWSLGIMVIEMV 235
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 36/185 (19%), Positives = 71/185 (38%), Gaps = 26/185 (14%)
Query: 446 VVKKL----DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL-----LVYKFL 496
V+K L D Q E + + H ++V++ F + +V +++
Sbjct: 110 VLKGLVHSGDAEAQ---AMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166
Query: 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
+L + L + +I L +LH S +++ D+KP+NI+L +
Sbjct: 167 GGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLH---SIGLVYNDLKPENIMLTE-EQL 220
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISC 616
++ D G + + GT G+ +PE R A D+Y+ G L +
Sbjct: 221 KLIDLGAVSRIN--SFGYLY----GTPGFQ-APEIVRTGPTVAT-DIYTVGRTLAALTLD 272
Query: 617 RKSFD 621
+ +
Sbjct: 273 LPTRN 277
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 20/176 (11%)
Query: 444 VIVVKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
I ++ + +E + EV ++ Q H N++ L + + +L+ + ++ G L
Sbjct: 44 FIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL- 102
Query: 503 SFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL----DDYY 554
F+ L +L + QI G+ +LH + +I H D+KP+NI+L
Sbjct: 103 ---FDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIP 156
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+ ++ DFGLA + K GT +VA PE + D++S GV+
Sbjct: 157 HIKLIDFGLAHE--IEDGVEFKNIF-GTPEFVA-PEIVNYEPLGLEADMWSIGVIT 208
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 440 TRTTVIV-VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498
T V +++++ Q ++ NE++++ + + N+V L G +V ++L
Sbjct: 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 499 GTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
G+L + E + G A + + + L LH S+Q+IH DIK NILL + +
Sbjct: 102 GSLTDVVTETCMDEGQI--AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
++DFG +T QSK + + GT ++A PE VD++S G++ +E+I
Sbjct: 157 LTDFGFCAQITPEQSK--RSTMVGTPYWMA-PEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 40/242 (16%)
Query: 387 KYKKGDDPDPPSVPSPPDPEDKKKRNMM---NVTRSVLLGSSVFVNFTLVGV----IQTS 439
D P P K+ + V+++ +LG F G +T+
Sbjct: 59 TSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRF------GQVHKCEETA 112
Query: 440 TRTT----VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495
T +I + + ++E KNE+ ++ Q H NL++L + + +LV ++
Sbjct: 113 TGLKLAAKIIKTRGMK-----DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167
Query: 496 LNNGTLASFLFEN-LKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
++ G L F+ + +NL QI G+ H+H I+H D+KP+NIL
Sbjct: 168 VDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILC 220
Query: 551 DDYYNAQI--SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGV 608
+ QI DFGLA+ + +K GT ++A PE ++ D++S GV
Sbjct: 221 VNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFLA-PEVVNYDFVSFPTDMWSVGV 276
Query: 609 LL 610
+
Sbjct: 277 IA 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 40/174 (22%), Positives = 73/174 (41%), Gaps = 13/174 (7%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
++ V K ++ K E + H ++V LL +V++F++ L
Sbjct: 56 IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115
Query: 504 FLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNA 556
+ + G+ ++ QI L + H + IIH D+KP +LL ++
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPV 172
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
++ FG+A L + A + GT ++A PE + VDV+ GV+L
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRV--GTPHFMA-PEVVKREPYGKPVDVWGCGVIL 223
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 18/171 (10%)
Query: 447 VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF 506
K ++ + + KNE+ ++ Q +H L+ L ++ +L+ +FL+ G L F
Sbjct: 81 AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL----F 136
Query: 507 ENL-KPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ--IS 559
+ + + + N Q GL H+H I+H DIKP+NI+ + + I
Sbjct: 137 DRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
DFGLA LN + +K T + A PE + D+++ GVL
Sbjct: 194 DFGLATK--LNPDEIVKVTT-ATAEFAA-PEIVDREPVGFYTDMWAIGVLG 240
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 25/182 (13%)
Query: 447 VKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLGFCDEGQNRL--LVYKFLNNGTLAS 503
+K + + + E ++ + HKN+V+L +E R L+ +F G+L +
Sbjct: 39 IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT 98
Query: 504 FLFENLKPGW---NLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL----DDYYNA 556
L E + + + G+ HL + I+H +IKP NI+ D
Sbjct: 99 VLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI--------TANVDVYSFGV 608
+++DFG A+ L + GT+ Y+ P+ + + + A VD++S GV
Sbjct: 156 KLTDFGAARELE--DDEQFVSLY-GTEEYLH-PDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 609 LL 610
Sbjct: 212 TF 213
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 22/167 (13%)
Query: 455 QDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGW 513
Q+ + EV ++ + H N+++L + LV+ + G LF+ L
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKV 119
Query: 514 NLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569
L I + + LH I+H D+KP+NILLDD N +++DFG + L
Sbjct: 120 TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITAN------VDVYSFGVLL 610
+ + + GT Y+A PE S + VD++S GV++
Sbjct: 177 GE---KLREVCGTPSYLA-PEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 40/166 (24%), Positives = 72/166 (43%), Gaps = 17/166 (10%)
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWN 514
+ +FKNE+ +I ++ + G ++Y+++ N ++ F N
Sbjct: 84 KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 515 LR--------ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566
I + ++H I H D+KP NIL+D ++SDFG ++
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 567 LTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN--VDVYSFGVLL 610
+ K IK + RGT ++ PE+F N + VD++S G+ L
Sbjct: 202 M---VDKKIKGS-RGTYEFMP-PEFFSNESSYNGAKVDIWSLGICL 242
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 6e-17
Identities = 48/183 (26%), Positives = 75/183 (40%), Gaps = 22/183 (12%)
Query: 447 VKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLGFCDEGQN------RLLVYKFLNNG 499
+K+ + +E + E+ ++ + H N+V D Q LL ++ G
Sbjct: 44 IKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGG 103
Query: 500 TLASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
L +L + + L+ + I+ L +LH ++IIH D+KP+NI+L
Sbjct: 104 DLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQ 159
Query: 556 AQ---ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
I D G AK L GT Y+A PE T VD +SFG L E
Sbjct: 160 RLIHKIIDLGYAKELD-QGELC--TEFVGTLQYLA-PELLEQKKYTVTVDYWSFGTLAFE 215
Query: 613 IIS 615
I+
Sbjct: 216 CIT 218
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 446 VVKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+KK R QD E +E+ V+ ++ L + +L+ ++ G + S
Sbjct: 61 FLKK-RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119
Query: 505 LFENLKPGWNLR--ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQIS 559
L + + QI G+ +LH + I+H D+KPQNILL + +I
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV 176
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
DFG+++ + + +++ + GT Y+A PE IT D+++ G++
Sbjct: 177 DFGMSRK--IGHACELREIM-GTPEYLA-PEILNYDPITTATDMWNIGIIA 223
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 35/228 (15%), Positives = 64/228 (28%), Gaps = 38/228 (16%)
Query: 396 PPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ 455
P PP K+ + + R + + + I KK+ RV
Sbjct: 111 PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 170
Query: 456 DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNL 515
D + + NL L S + +
Sbjct: 171 DERDMWVLSRFFLYPRMQSNLQTFGE------------------VLLSHSSTHKSLVHHA 212
Query: 516 RANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575
R + Q+ R L LH ++H ++P +I+LD ++ F +
Sbjct: 213 RLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-------RDG 262
Query: 576 KKAIRGTKGYVASPEWF----------RNSTITANVDVYSFGVLLLEI 613
A+ A PE + +T D ++ G+ + I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 20/176 (11%)
Query: 444 VIVVKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
I ++L + +E + EV ++ + H N++ L + + +L+ + ++ G L
Sbjct: 37 FIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL- 95
Query: 503 SFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD--DYYNA 556
F+ L +L QI G+ +LH S +I H D+KP+NI+L + N
Sbjct: 96 ---FDFLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNP 149
Query: 557 QI--SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+I DFG+A + K GT +VA PE + D++S GV+
Sbjct: 150 RIKLIDFGIAHK--IEAGNEFKNIF-GTPEFVA-PEIVNYEPLGLEADMWSIGVIT 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 20/176 (11%)
Query: 444 VIVVKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
I ++ + +E + EV ++ + H N++ L + + +L+ + + G L
Sbjct: 43 FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL- 101
Query: 503 SFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL--DDYYNA 556
F+ L +L QI G+ +LH S QI H D+KP+NI+L +
Sbjct: 102 ---FDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKP 155
Query: 557 QI--SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+I DFGLA ++ K GT +VA PE + D++S GV+
Sbjct: 156 RIKIIDFGLAHK--IDFGNEFKNIF-GTPEFVA-PEIVNYEPLGLEADMWSIGVIT 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 8e-16
Identities = 51/257 (19%), Positives = 99/257 (38%), Gaps = 30/257 (11%)
Query: 366 SKKLPLSNGRAHSSVNGKAFLKYKKGDDPDPPSVPSPPDPEDKKKRNMMNV-TRSVLLGS 424
++ V GK + + P P + K ++++ LG+
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167
Query: 425 SVFVNFTLVGV----IQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLL 480
F GV + +T K + + ++ + E+ + H LV L
Sbjct: 168 GAF------GVVHRVTERATGNNF-AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 481 GFCDEGQNRLLVYKFLNNGTLASFLFENL-KPGWNLR----ANIAFQIARGLLHLHVNCS 535
++ +++Y+F++ G L FE + + Q+ +GL H+H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 273
Query: 536 SQIIHCDIKPQNILLDDYYNAQI--SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFR 593
+ +H D+KP+NI+ + ++ DFGL L+ +++K GT + A PE
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTT-GTAEFAA-PEVAE 329
Query: 594 NSTITANVDVYSFGVLL 610
+ D++S GVL
Sbjct: 330 GKPVGYYTDMWSVGVLS 346
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 36/138 (26%), Positives = 62/138 (44%), Gaps = 6/138 (4%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHV 532
H+++V GF ++ +V + +L QI G +LH
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH- 132
Query: 533 NCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWF 592
+++IH D+K N+ L++ +I DFGLA + + + KK + GT Y+A PE
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIA-PEVL 187
Query: 593 RNSTITANVDVYSFGVLL 610
+ VDV+S G ++
Sbjct: 188 SKKGHSFEVDVWSIGCIM 205
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 49/271 (18%), Positives = 93/271 (34%), Gaps = 51/271 (18%)
Query: 370 PLSNGRAHSSVNGKAFLKYKKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSVLLG------ 423
+ A+ K + + P+ E +
Sbjct: 46 DDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRG 105
Query: 424 --SSVFVNFTLVGVIQTSTRTTV----IVVKKL---DRVFQDGEKEFKNEV-VMIGQTYH 473
S V + +T + V ++ + + E ++ H
Sbjct: 106 VSSVVRR------CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 474 KNLVRLLGFCDEGQNRLLVYKFLNNGTL------ASFLFENLKPGWNLR--ANIAFQIAR 525
+++ L+ + LV+ + G L L E + +I +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE--------KETRSIMRSLLE 211
Query: 526 GLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGY 585
+ LH ++ I+H D+KP+NILLDD ++SDFG + L + + + GT GY
Sbjct: 212 AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGY 265
Query: 586 VASPEWFRNSTITAN------VDVYSFGVLL 610
+A PE + S + VD+++ GV+L
Sbjct: 266 LA-PEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 36/138 (26%), Positives = 62/138 (44%), Gaps = 6/138 (4%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHV 532
H+++V GF ++ +V + +L QI G +LH
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH- 158
Query: 533 NCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWF 592
+++IH D+K N+ L++ +I DFGLA + + + KK + GT Y+A PE
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIA-PEVL 213
Query: 593 RNSTITANVDVYSFGVLL 610
+ VDV+S G ++
Sbjct: 214 SKKGHSFEVDVWSIGCIM 231
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 45/180 (25%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 440 TRTTVIV-VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498
T IV +K++ + +E E+ ++ Q ++V+ G + + +V ++
Sbjct: 51 KETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA 108
Query: 499 GTLASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
G+++ + K L A I +GL +LH + IH DIK NILL+
Sbjct: 109 GSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEG 162
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+A+++DFG+A LT +K + + GT ++A PE + D++S G+ +E+
Sbjct: 163 HAKLADFGVAGQLTDTMAK--RNTVIGTPFWMA-PEVIQEIGYNCVADIWSLGITAIEMA 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-15
Identities = 56/172 (32%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 446 VVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL-LVYKFLNNGTLASF 504
++K + GE NE ++ + + +V L + E ++ L LV +N G L
Sbjct: 216 KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFH 274
Query: 505 LFENLKPGWNL-RANI-AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562
++ + G+ RA A +I GL LH +I++ D+KP+NILLDD+ + +ISD G
Sbjct: 275 IYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLG 331
Query: 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
LA + Q+ K GT GY+A PE +N T + D ++ G LL E+I
Sbjct: 332 LAVHVPEGQT---IKGRVGTVGYMA-PEVVKNERYTFSPDWWALGCLLYEMI 379
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 31/190 (16%), Positives = 60/190 (31%), Gaps = 16/190 (8%)
Query: 436 IQTSTRTTVIVVKK--LDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493
T V V++ L+ + + E+ + H N+V +V
Sbjct: 47 RYKPTGEYV-TVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105
Query: 494 KFLNNGTLASFLFENLKPGWN--LRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
F+ G+ + + G N A I + + L ++H +H +K +IL+
Sbjct: 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILIS 162
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWF-------RNSTITANVDVY 604
+S + + + + K V W A D+Y
Sbjct: 163 VDGKVYLSGLRSNLSMISHGQRQ-RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221
Query: 605 SFGVLLLEII 614
S G+ E+
Sbjct: 222 SVGITACELA 231
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 54/174 (31%), Positives = 82/174 (47%), Gaps = 12/174 (6%)
Query: 446 VVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL-LVYKFLNNGTLASF 504
+ K + G + E ++ + + + +V L + E + L LV +N G +
Sbjct: 217 KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYH 275
Query: 505 LFENLKPGWNL---RANI-AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD 560
++ + RA QI GL HLH II+ D+KP+N+LLDD N +ISD
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISD 332
Query: 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
GLA L Q+K K GT G++A PE +VD ++ GV L E+I
Sbjct: 333 LGLAVELKAGQTKT--KGYAGTPGFMA-PELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 63/280 (22%), Positives = 114/280 (40%), Gaps = 44/280 (15%)
Query: 446 VVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
V+ K + ++ EV ++ Q H N+++L F ++ LV + G L
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---- 113
Query: 506 FENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQI 558
F+ + A I Q+ G+ ++H ++I+H D+KP+N+LL N +I
Sbjct: 114 FDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRI 170
Query: 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK 618
DFGL+ SK +K I GT Y+A PE + DV+S GV+L ++S
Sbjct: 171 IDFGLSTH--FEASKKMKDKI-GTAYYIA-PEVLHGT-YDEKCDVWSTGVILYILLSGCP 225
Query: 619 SFDIEMGEE--YAILT-DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQED 675
F+ + + + F+ + K+ + A + I+ +
Sbjct: 226 PFNGANEYDILKKVEKGKYTFELPQWKKVSE------SAKDLIRK----------MLTYV 269
Query: 676 PSLRPTMRKV------SQMLEVVVEVDVPPNPSTFSCSKR 709
PS+R + R + + VDVP + ++
Sbjct: 270 PSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQ 309
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 43/180 (23%), Positives = 75/180 (41%), Gaps = 37/180 (20%)
Query: 447 VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF 506
VK +D+ +D +E +++ H N++ L D+G+ +V + + G L
Sbjct: 52 VKIIDKSKRDPTEE---IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----L 104
Query: 507 ENLKPGWNLR------------ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---- 550
+ + + + F I + + +LH + ++H D+KP NIL
Sbjct: 105 D--------KILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDES 153
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+ + +I DFG AK L + T +VA PE A D++S GVLL
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMTPC--YTANFVA-PEVLERQGYDAACDIWSLGVLL 210
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 42/285 (14%), Positives = 111/285 (38%), Gaps = 51/285 (17%)
Query: 441 RTTVIVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLG-FCDEGQNRLLVY---K 494
+ +++ +KL + + E+ ++ + +V G F +G+ + +
Sbjct: 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISICME 111
Query: 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
++ G+L L + + + ++ + +GL +L +I+H D+KP NIL++
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRG 169
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
++ DFG++ L ++ + GT+ Y++ PE + + + D++S G+ L+E+
Sbjct: 170 EIKLCDFGVSGQLI----DSMANSFVGTRSYMS-PERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 615 SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIW---- 670
R + I + + + + + ++ ++I+
Sbjct: 225 VGR--YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD 282
Query: 671 -------------------------CIQEDPSLRPTMRKVSQMLE 690
C+ ++P+ R ++ Q++
Sbjct: 283 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK---QLMV 324
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 20/183 (10%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494
VI+ S + + E+ NE+ ++ H N+++L ++ + LV +
Sbjct: 68 VIKKSQFDKGRYSDDNKNIEKFHEE-IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126
Query: 495 FLNNGTLASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
F G L FE + ANI QI G+ +LH I+H DIKP+NILL
Sbjct: 127 FYEGGEL----FEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILL 179
Query: 551 ---DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFG 607
+ N +I DFGL+ ++ ++ + GT Y+A PE + DV+S G
Sbjct: 180 ENKNSLLNIKIVDFGLSSF--FSKDYKLRDRL-GTAYYIA-PEVLKKK-YNEKCDVWSCG 234
Query: 608 VLL 610
V++
Sbjct: 235 VIM 237
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 21/174 (12%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
+I KKL +D +K + E + + H N+VRL E LV+ + G L
Sbjct: 38 IINTKKLSA--RDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-- 92
Query: 504 FLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ-- 557
FE++ ++ QI + + H S+ I+H ++KP+N+LL
Sbjct: 93 --FEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV 147
Query: 558 -ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
++DFGLA +N S+A GT GY++ PE + + VD+++ GV+L
Sbjct: 148 KLADFGLAIE--VNDSEAWHGFA-GTPGYLS-PEVLKKDPYSKPVDIWACGVIL 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 46/213 (21%), Positives = 74/213 (34%), Gaps = 50/213 (23%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
++ K+ ++ + K EV ++ + +H N+ RL ++ Q LV + + G L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117
Query: 504 FLFENLKPGWNLR----------------------------------------ANIAFQI 523
L + +NI QI
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 524 ARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ--ISDFGLAKLLTLNQSKAIK--KAI 579
L +LH + I H DIKP+N L + + + DFGL+K +
Sbjct: 178 FSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 580 RGTKGYVASPEWFRNST--ITANVDVYSFGVLL 610
GT +VA PE + D +S GVLL
Sbjct: 235 AGTPYFVA-PEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 52/233 (22%), Positives = 92/233 (39%), Gaps = 35/233 (15%)
Query: 401 SPPDPEDKKKRNMMNVTRSVLLGSS---VFVNFTLVGVI-QTSTRTTVIVVKK------- 449
E+ + + T + + S + + V + + ++ K
Sbjct: 7 HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66
Query: 450 -----LDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
V + EV ++ H N+++L F ++ +N LV + G L
Sbjct: 67 IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL--- 123
Query: 505 LFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQ 557
F+ + A I Q+ G+ +LH I+H D+KP+N+LL + +
Sbjct: 124 -FDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIK 179
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
I DFGL+ + K +K+ + GT Y+A PE R DV+S GV+L
Sbjct: 180 IVDFGLSAV--FENQKKMKERL-GTAYYIA-PEVLRKK-YDEKCDVWSIGVIL 227
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 36/190 (18%), Positives = 80/190 (42%), Gaps = 29/190 (15%)
Query: 440 TRTTVIV-VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498
T + K ++ ++ +++ E+ ++ H +V+LLG ++ +F
Sbjct: 41 KETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100
Query: 499 GTLASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
G + + + E + L + Q+ L LH S +IIH D+K N+L+
Sbjct: 101 GAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEG 154
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEW----------FRNSTITANVDVY 604
+ +++DFG++ K R + ++ +P W +++ D++
Sbjct: 155 DIRLADFGVSAKNLKTLQK------RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIW 206
Query: 605 SFGVLLLEII 614
S G+ L+E+
Sbjct: 207 SLGITLIEMA 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 446 VVKKLD-RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
V+K ++ Q ++ + E+ ++ H N++++ ++ N +V + G L
Sbjct: 51 VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER 110
Query: 505 LFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQ 557
+ G L A + Q+ L + H S ++H D+KP+NIL + +
Sbjct: 111 IVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIK 167
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
I DFGLA+L + A GT Y+A PE F+ +T D++S GV++
Sbjct: 168 IIDFGLAELFK--SDEHSTNAA-GTALYMA-PEVFKRD-VTFKCDIWSAGVVM 215
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 49/182 (26%), Positives = 77/182 (42%), Gaps = 36/182 (19%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
+I KKL +D +K + E + H N+VRL E + L++ + G L
Sbjct: 43 IINTKKLSA--RDHQK-LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL-- 97
Query: 504 FLFENLKPGWNLR------------ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
FE ++ QI +LH H ++H ++KP+N+LL
Sbjct: 98 --FE--------DIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLA 144
Query: 552 DYY-NAQ--ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGV 608
A ++DFGLA + Q A GT GY++ PE R VD+++ GV
Sbjct: 145 SKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLS-PEVLRKDPYGKPVDLWACGV 201
Query: 609 LL 610
+L
Sbjct: 202 IL 203
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 35/179 (19%)
Query: 447 VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF 506
+K + + + +NE+ ++ + H+N+V L + + LV + ++ G L F
Sbjct: 39 LKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL----F 94
Query: 507 ENLKPGWNLR------------ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---D 551
+ R + + Q+ + +LH + I+H D+KP+N+L +
Sbjct: 95 D--------RILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPE 143
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+ I+DFGL+K+ Q+ + A GT GYVA PE + VD +S GV+
Sbjct: 144 ENSKIMITDFGLSKME---QNGIMSTAC-GTPGYVA-PEVLAQKPYSKAVDCWSIGVIT 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 43/255 (16%)
Query: 388 YKKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVG------VIQTSTR 441
+ + P +P D +K + + + ++ + N ++G V Q
Sbjct: 3 FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62
Query: 442 TTVIV-VKKLDRVFQDGEKEFKN-EVVMIGQTYHKNLVRLLGF-----CDEGQNRL-LVY 493
+ V +KK V QD K FKN E+ ++ H N+V L F + + L LV
Sbjct: 63 ESDEVAIKK---VLQD--KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 494 KFLNNGTLASFLFENLKPGWNLRAN----IAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
+++ T+ K + +Q+ R L ++H S I H DIKPQN+L
Sbjct: 118 EYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLL 173
Query: 550 LD-DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVAS-----PEW-FRNSTITANVD 602
LD ++ DFG AK+L + Y+ S PE F + T N+D
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGEP---------NVSYICSRYYRAPELIFGATNYTTNID 224
Query: 603 VYSFGVLLLEIISCR 617
++S G ++ E++ +
Sbjct: 225 IWSTGCVMAELMQGQ 239
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 462 KNEVVMIGQTYHKNLVRLLG-FCDEGQNRL-LVYKFLNNGTLASFL-----FENLKPGWN 514
E ++ + H V+L F D+ +L + NG L ++ F+
Sbjct: 78 TRERDVMSRLDHPFFVKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDET----- 130
Query: 515 LRANI-AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573
+I L +LH IIH D+KP+NILL++ + QI+DFG AK+L+ +
Sbjct: 131 -CTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS 615
A + GT YV+ PE + + D+++ G ++ ++++
Sbjct: 187 ARANSFVGTAQYVS-PELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 39/162 (24%), Positives = 76/162 (46%), Gaps = 14/162 (8%)
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWN 514
D + E+ ++ + H ++++ F D ++ +V + + G L + N +
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEA 239
Query: 515 LRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFGLAKLLTLNQ 571
+Q+ + +LH + IIH D+KP+N+LL ++ +I+DFG +K+L
Sbjct: 240 TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
Query: 572 SKAIKKAIRGTKGYVASPEWFRNSTI---TANVDVYSFGVLL 610
+ + + GT Y+A PE + VD +S GV+L
Sbjct: 297 ---LMRTLCGTPTYLA-PEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 34/169 (20%)
Query: 458 EKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR 516
E + E+ + H N+V+L + + LV + LN G L FE R
Sbjct: 49 EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----FE--------R 96
Query: 517 ------------ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDF 561
+ I ++ + H+H ++H D+KP+N+L +D +I DF
Sbjct: 97 IKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDF 153
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
G A+L + T Y A PE + + D++S GV+L
Sbjct: 154 GFARLKPPDNQPLKTPC--FTLHYAA-PELLNQNGYDESCDLWSLGVIL 199
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 45/172 (26%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 447 VKKLD-RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
+K +D +D ++ + E+ ++ Q + + G + ++ ++L G+ L
Sbjct: 52 IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL 111
Query: 506 FENLKPGWNLRANIAF---QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562
+PG IA +I +GL +LH S + IH DIK N+LL ++ +++DFG
Sbjct: 112 ----EPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFG 164
Query: 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+A LT Q K + GT ++A PE + S + D++S G+ +E+
Sbjct: 165 VAGQLTDTQIK--RNTFVGTPFWMA-PEVIKQSAYDSKADIWSLGITAIELA 213
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 56/189 (29%), Positives = 86/189 (45%), Gaps = 36/189 (19%)
Query: 447 VKKLDRVFQDGEKEFKN-EVVMIGQTYHKNLVRLLG-FCDEGQNRL-----LVYKFLNNG 499
+KK V QD K FKN E+ ++ + H N+VRL F G+ + LV ++
Sbjct: 84 IKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE- 137
Query: 500 TLASFLFENLKPGWNLRAN----IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYY 554
T+ + L +Q+ R L ++H S I H DIKPQN+LLD D
Sbjct: 138 TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTA 194
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVAS-----PEWFRNSTI-TANVDVYSFGV 608
++ DFG AK L + Y+ S PE +T T+++DV+S G
Sbjct: 195 VLKLCDFGSAKQLVRGEP---------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245
Query: 609 LLLEIISCR 617
+L E++ +
Sbjct: 246 VLAELLLGQ 254
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 21/174 (12%)
Query: 444 VIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
+I KKL +D +K + E + + H N+VRL E LV+ + G L
Sbjct: 61 IINTKKLSA--RDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-- 115
Query: 504 FLFENL--KPGWNLR--ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ-- 557
FE++ + ++ ++ QI + + H S+ I+H ++KP+N+LL
Sbjct: 116 --FEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV 170
Query: 558 -ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
++DFGLA +N S+A GT GY++ PE + + VD+++ GV+L
Sbjct: 171 KLADFGLAIE--VNDSEAWHGFA-GTPGYLS-PEVLKKDPYSKPVDIWACGVIL 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 41/171 (23%), Positives = 70/171 (40%), Gaps = 19/171 (11%)
Query: 447 VKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLF 506
KK+ + F + FK E+ ++ H N++RL ++ + LV + G L F
Sbjct: 39 AKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----F 94
Query: 507 ENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQIS 559
E + R A I + + + H + H D+KP+N L ++
Sbjct: 95 ERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLI 151
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
DFGLA K ++ + GT YV+ P+ D +S GV++
Sbjct: 152 DFGLAAR--FKPGKMMRTKV-GTPYYVS-PQVLEGL-YGPECDEWSAGVMM 197
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 48/181 (26%), Positives = 77/181 (42%), Gaps = 34/181 (18%)
Query: 518 NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS-KAIK 576
+FQ+A+G+ L S + IH D+ +NILL + +I DFGLA+ + +
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 577 KA---IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS--FDIEMGEEYAIL 631
A ++ +PE + T DV+SFGVLL EI S S +++ EE
Sbjct: 254 DARLPLKWM-----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F 305
Query: 632 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--VMVSIWCIQEDPSLRPTMRKVSQML 689
+ R M A + ++ M+ W +PS RPT ++ + L
Sbjct: 306 CRRLKEGTR-----------MRAPDY--TTPEMYQTMLDCW--HGEPSQRPTFSELVEHL 350
Query: 690 E 690
Sbjct: 351 G 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 24/118 (20%), Positives = 45/118 (38%), Gaps = 10/118 (8%)
Query: 436 IQTSTRTTVIVVKKLDRVFQDGE-KEFKNEV-VMIGQTYHKNLVRLLGFC-DEGQNRLLV 492
I + + VK L E + +E+ ++I +H N+V LLG C G +++
Sbjct: 46 IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 105
Query: 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
+F G L+++L + R +G I D+K + +
Sbjct: 106 VEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSI 156
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 34/168 (20%)
Query: 458 EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR- 516
+K + E+ ++ + H N+++L + LV + + G L F+ R
Sbjct: 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL----FD--------RI 139
Query: 517 -----------ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFG 562
A+ QI + +LH + I+H D+KP+N+L +I+DFG
Sbjct: 140 VEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFG 196
Query: 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
L+K+ + +K GT GY A PE R VD++S G++
Sbjct: 197 LSKI--VEHQVLMKTVC-GTPGYCA-PEILRGCAYGPEVDMWSVGIIT 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 26/182 (14%)
Query: 447 VKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
VK +++ EV ++ H+N++ L+ F +E LV++ + G+ +
Sbjct: 43 VKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS----I 98
Query: 506 FENL--KPGWNLR--ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQI 558
++ + +N + + +A L LH + I H D+KP+NIL + +I
Sbjct: 99 LSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKI 155
Query: 559 SDFGLAKLLTLNQSKAIKKAIR-----GTKGYVASPEWFRNSTITAN-----VDVYSFGV 608
DF L + LN + G+ Y+A PE + A+ D++S GV
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA-PEVVEAFSEEASIYDKRCDLWSLGV 214
Query: 609 LL 610
+L
Sbjct: 215 IL 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 520 AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAI 579
A +I GL H+H + +++ D+KP NILLD++ + +ISD GLA + + A
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 580 RGTKGYVASPE-WFRNSTITANVDVYSFGVLLLEII 614
GT GY+A PE + ++ D +S G +L +++
Sbjct: 352 -GTHGYMA-PEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 20/172 (11%)
Query: 446 VVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
V+ K EV ++ + H N+++L ++ + +V + G L
Sbjct: 54 VINK-ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---- 108
Query: 506 FENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQI 558
F+ + A I Q+ G+ ++H I+H D+KP+NILL + + +I
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKI 165
Query: 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
DFGL+ Q+ +K I GT Y+A PE R + DV+S GV+L
Sbjct: 166 IDFGLSTC--FQQNTKMKDRI-GTAYYIA-PEVLRGT-YDEKCDVWSAGVIL 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
++ K EV ++ + H N+++L ++ + +V + G L
Sbjct: 54 VINKA--SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL--- 108
Query: 505 LFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQ 557
F+ + A I Q+ G+ ++H I+H D+KP+NILL + + +
Sbjct: 109 -FDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIK 164
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
I DFGL+ Q+ +K I GT Y+A PE R + DV+S GV+L
Sbjct: 165 IIDFGLSTC--FQQNTKMKDRI-GTAYYIA-PEVLRGT-YDEKCDVWSAGVIL 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 40/166 (24%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 455 QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWN 514
D + E+ ++ + H ++++ F D ++ +V + + G L F+ +
Sbjct: 56 ADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGEL----FDKVVGNKR 110
Query: 515 LR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFGLAKLL 567
L+ +Q+ + +LH + IIH D+KP+N+LL ++ +I+DFG +K+L
Sbjct: 111 LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTI---TANVDVYSFGVLL 610
++ ++ GT Y+A PE + VD +S GV+L
Sbjct: 168 G--ETSLMRTLC-GTPTYLA-PEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 33/188 (17%)
Query: 447 VKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLG-----FCDEGQNRL-LVYKFLNNG 499
+K +D V D E+E K E+ M+ + +H+N+ G ++L LV +F G
Sbjct: 54 IKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 112
Query: 500 TLASFLFENLKPGWNLRANIAF---QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
++ L +N K IA+ +I RGL HLH ++IH DIK QN+LL +
Sbjct: 113 SVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV 168
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEW----------FRNSTITANVDVYSF 606
++ DFG++ L + R T ++ +P W ++T D++S
Sbjct: 169 KLVDFGVSAQLDRTVGR------RNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220
Query: 607 GVLLLEII 614
G+ +E+
Sbjct: 221 GITAIEMA 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 36/112 (32%), Positives = 57/112 (50%), Gaps = 16/112 (14%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL---TLNQSKAIKKA 578
++ L +L + +IIH D+KP NILLD++ + I+DF +A +L T + A
Sbjct: 123 ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---- 175
Query: 579 IRGTKGYVASPEWFRNSTI---TANVDVYSFGVLLLEIISCRKSFDIEMGEE 627
GTK Y+A PE F + + VD +S GV E++ R+ + I
Sbjct: 176 --GTKPYMA-PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 29/196 (14%)
Query: 438 TSTRTTVIVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLL------GFCDEGQNR 489
V +KKL R FQ+ K E+V++ HKN++ LL +E Q+
Sbjct: 47 AILERNV-AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105
Query: 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
+V + ++ L + L + + +Q+ G+ HLH S+ IIH D+KP NI+
Sbjct: 106 YIVMELMDA-NLCQVIQMELDH--ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 159
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA-----SPEWFRNSTITANVDVY 604
+ +I DFGLA+ + YV +PE NVD++
Sbjct: 160 VKSDCTLKILDFGLARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIW 210
Query: 605 SFGVLLLEIISCRKSF 620
S G ++ E+I F
Sbjct: 211 SVGCIMGEMIKGGVLF 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 21/183 (11%)
Query: 447 VKKLD-RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
+K+++ Q E E+ + Q +H N+V LV K L+ G++ +
Sbjct: 45 IKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDII 104
Query: 506 FENLKPGWNLR--------ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
+ G + A I ++ GL +LH + IH D+K NILL + + Q
Sbjct: 105 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQ 161
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEW------FRNSTITANVDVYSFGVLLL 611
I+DFG++ L K R T +V +P W + D++SFG+ +
Sbjct: 162 IADFGVSAFLATGGDITRNKV-RKT--FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 612 EII 614
E+
Sbjct: 219 ELA 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 10/101 (9%)
Query: 517 ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
IA I + L HLH +IH D+KP N+L++ ++ DFG++ L A
Sbjct: 112 GKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKD 167
Query: 577 KAIRGTKGYVASPE----WFRNSTITANVDVYSFGVLLLEI 613
G K Y+A PE + D++S G+ ++E+
Sbjct: 168 IDA-GCKPYMA-PERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 40/194 (20%)
Query: 447 VKKLDRVFQDGEKEFKN----EVVMIGQTYHKNLVRLL------GFCDEGQNRL-LVYKF 495
+KK V QD F+N + + +H N+V+L G D L +V ++
Sbjct: 53 IKK---VIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107
Query: 496 LNNGTLASFLFENLKPGWNLRAN----IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
+ + TL + FQ+ R + LH+ S + H DIKP N+L++
Sbjct: 108 VPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVN 165
Query: 552 DYYNAQ--ISDFGLAKLLTLNQSKAIKKAIRGTKGYVAS-----PEWFRNSTI-TANVDV 603
+ + + DFG AK L+ ++ Y+ S PE + T VD+
Sbjct: 166 E-ADGTLKLCDFGSAKKLSPSEPNV---------AYICSRYYRAPELIFGNQHYTTAVDI 215
Query: 604 YSFGVLLLEIISCR 617
+S G + E++
Sbjct: 216 WSVGCIFAEMMLGE 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 35/101 (34%), Positives = 47/101 (46%), Gaps = 10/101 (9%)
Query: 517 ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
I + L HL N +IIH DIKP NILLD N ++ DFG++ L S A
Sbjct: 128 GKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKT 183
Query: 577 KAIRGTKGYVASPE----WFRNSTITANVDVYSFGVLLLEI 613
+ G + Y+A PE DV+S G+ L E+
Sbjct: 184 RDA-GCRPYMA-PERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 30/110 (27%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+Q R + LH S +IH D+KP N+L++ + ++ DFGLA+++ + + +
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 579 IRGTK--GYVA-----SPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSF 620
+ + +VA +PE S + +DV+S G +L E+ R F
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 15/174 (8%)
Query: 445 IVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLG-FCDEGQNRL-LVYKFLNNGTLA 502
I+ KK R +GE K E+ ++ + HKN+++L+ +E + ++ +V ++ G
Sbjct: 37 ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE 96
Query: 503 SFLFENLKPGWNLRANIA---F-QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
+ +++ A F Q+ GL +LH S I+H DIKP N+LL +I
Sbjct: 97 --MLDSVPEK-RFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKI 150
Query: 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI--TANVDVYSFGVLL 610
S G+A+ L + + +G+ + PE VD++S GV L
Sbjct: 151 SALGVAEALHPFAADDTCRTSQGSPAFQP-PEIANGLDTFSGFKVDIWSAGVTL 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 29/101 (28%), Positives = 46/101 (45%), Gaps = 9/101 (8%)
Query: 517 ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIK 576
+ I + L +L +IH D+KP NILLD+ ++ DFG++ L KA
Sbjct: 127 GKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKD 182
Query: 577 KAIRGTKGYVA----SPEWFRNSTITANVDVYSFGVLLLEI 613
++ G Y+A P DV+S G+ L+E+
Sbjct: 183 RSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 473 HKNLVRLLG-FCDEGQNRL---LVYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARG 526
++++LL F +G N + +V++ L L + + + G L I+ Q+ G
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 527 LLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ------ISDFGLAKLLTLNQSKAIKKAIR 580
L ++H C IIH DIKP+N+L++ + + I+D G A + + +I+
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ---- 197
Query: 581 GTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
T+ Y + PE + D++S L+ E+I+ F+
Sbjct: 198 -TREYRS-PEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ G+++LH I H DIKP+N+LLD+ N +ISDFGLA + N + + + G
Sbjct: 113 QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 582 TKGYVASPEWFRNSTIT-ANVDVYSFGVLL 610
T YVA PE + VDV+S G++L
Sbjct: 170 TLPYVA-PELLKRREFHAEPVDVWSCGIVL 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 26/92 (28%), Positives = 47/92 (51%), Gaps = 9/92 (9%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+ +G+ +LH +IIH DIKP N+L+ + + +I+DFG++ + + G
Sbjct: 145 DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV--G 199
Query: 582 TKGYVASPEWFRNSTIT---ANVDVYSFGVLL 610
T ++A PE + +DV++ GV L
Sbjct: 200 TPAFMA-PESLSETRKIFSGKALDVWAMGVTL 230
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 23/174 (13%)
Query: 447 VKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNR----LLVYKFLNNGTL 501
+K L + + EV + ++V +L + + L++ + + G L
Sbjct: 59 LKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113
Query: 502 ASFLFENLKPGWNLR--ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNA 556
S + E + R A I I + LH S I H D+KP+N+L +
Sbjct: 114 FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVL 170
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+++DFG AK T N ++ T YVA PE + D++S GV++
Sbjct: 171 KLTDFGFAKETTQNA---LQTPC-YTPYYVA-PEVLGPEKYDKSCDMWSLGVIM 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 19/107 (17%)
Query: 521 FQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFGLAKLLTLNQSKAIKKAI 579
+Q+ R + +H S I H DIKPQN+L++ ++ DFG AK L ++
Sbjct: 148 YQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP------- 197
Query: 580 RGTKGYVAS-----PEWFRNSTI-TANVDVYSFGVLLLEIISCRKSF 620
+ Y+ S PE +T T ++D++S G + E+I + F
Sbjct: 198 --SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 44/207 (21%), Positives = 72/207 (34%), Gaps = 70/207 (33%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFGLAKLLTLNQSKAIKKAIR 580
Q+ + H H + ++H DIK +NIL+D + ++ DFG LL +
Sbjct: 157 QVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD- 209
Query: 581 GTKGYVASPEWFRNSTITAN-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639
GT+ Y PEW R V+S G+LL Y ++
Sbjct: 210 GTRVYSP-PEWIRYHRYHGRSAAVWSLGILL-----------------YDMVC------- 244
Query: 640 RNGKL-----DDLVEGD--------MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKV- 685
G + ++++ G E + I+ WC+ PS RPT ++
Sbjct: 245 --GDIPFEHDEEIIRGQVFFRQRVSSECQHLIR----------WCLALRPSDRPTFEEIQ 292
Query: 686 ----------SQMLEVVVEVDVPPNPS 702
Q + + P PS
Sbjct: 293 NHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ G+++LH I H DIKP+N+LLD+ N +ISDFGLA + N + + + G
Sbjct: 113 QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 582 TKGYVASPEWFRNSTIT-ANVDVYSFGVLL 610
T YVA PE + VDV+S G++L
Sbjct: 170 TLPYVA-PELLKRREFHAEPVDVWSCGIVL 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 44/197 (22%), Positives = 83/197 (42%), Gaps = 32/197 (16%)
Query: 438 TSTRTTVIVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLL------GFCDEGQNR 489
+ V +KKL R FQ K E++++ H+N++ LL +
Sbjct: 46 KRSGEKV-AIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104
Query: 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549
LV F+ L + + +Q+ +GL ++H S+ ++H D+KP N+
Sbjct: 105 YLVMPFMQT-DLQKIMGLKFSE--EKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLA 158
Query: 550 LDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA-----SPEWFRNSTI-TANVDV 603
+++ +I DFGLA+ + GYV +PE + VD+
Sbjct: 159 VNEDCELKILDFGLARHADAEMT-----------GYVVTRWYRAPEVILSWMHYNQTVDI 207
Query: 604 YSFGVLLLEIISCRKSF 620
+S G ++ E+++ + F
Sbjct: 208 WSVGCIMAEMLTGKTLF 224
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 56/235 (23%), Positives = 88/235 (37%), Gaps = 30/235 (12%)
Query: 392 DDPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGV-IQTSTRTTV---IVV 447
P PP P+PP ++ LLG F V + + R V ++
Sbjct: 9 GPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKG---GFGTVFAGHRLTDRLQVAIKVIP 65
Query: 448 KK--LDRVFQDGEKEFKNEV-VMI---GQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
+ L EV ++ H ++RLL + + + +LV +
Sbjct: 66 RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQD 125
Query: 502 ASFLFENLKPGWNLRANIA---F-QIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNA 556
LF+ + L + F Q+ + H H S ++H DIK +NIL+D A
Sbjct: 126 ---LFDYITEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA 179
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITAN-VDVYSFGVLL 610
++ DFG LL + GT+ Y PEW A V+S G+LL
Sbjct: 180 KLIDFGSGALL---HDEPYTDFD-GTRVYSP-PEWISRHQYHALPATVWSLGILL 229
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHL 530
H NLV LL + LV+++ ++ T+ L + + G +I +Q + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 531 HVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568
H + IH D+KP+NIL+ + ++ DFG A+LLT
Sbjct: 119 HKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 13/101 (12%)
Query: 473 HKNLVRLL----GFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANI---AFQIA 524
H N+VRL + + +L LV++ ++ L ++L + + I FQ+
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLL 130
Query: 525 RGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
RGL LH + ++H D+KPQNIL+ +++DFGLA+
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 29/195 (14%)
Query: 440 TRTTVIV-VKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLL------GFCDEGQNRL 490
V +KKL R FQ+ K E+V++ HKN++ LL +E Q+
Sbjct: 84 AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
LV + ++ L + L + + +Q+ G+ HLH S+ IIH D+KP NI++
Sbjct: 144 LVMELMDA-NLCQVIQMELDH--ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVV 197
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVA-----SPEWFRNSTITANVDVYS 605
+I DFGLA+ + YV +PE NVD++S
Sbjct: 198 KSDCTLKILDFGLARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWS 248
Query: 606 FGVLLLEIISCRKSF 620
G ++ E++ + F
Sbjct: 249 VGCIMGEMVRHKILF 263
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 20/108 (18%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+ +QI RGL ++H S+ IIH D+KP N+ +++ +I DFGLA+ +
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT------ 187
Query: 579 IRGTKGYVA-----SPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSF 620
GYVA +PE N VD++S G ++ E+++ R F
Sbjct: 188 -----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 7/107 (6%)
Query: 464 EVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA--NIAF 521
E+ ++ Q H+NLV LL C + + LV++F+++ T+ L E G + + F
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLF 131
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568
QI G+ H + IIH DIKP+NIL+ ++ DFG A+ L
Sbjct: 132 QIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 22/174 (12%)
Query: 447 VKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNR----LLVYKFLNNGTL 501
+K L + + EV + + ++VR++ + L+V + L+ G L
Sbjct: 92 LKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 146
Query: 502 ASFLFENLKPGWNLR--ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNA 556
S + + + R + I I + +LH S I H D+KP+N+L
Sbjct: 147 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 203
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+++DFG AK T + S + T YVA PE + D++S GV++
Sbjct: 204 KLTDFGFAKETTSHNS--LTTPC-YTPYYVA-PEVLGPEKYDKSCDMWSLGVIM 253
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 16/109 (14%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+QI RGL ++H S+ ++H D+KP N+LL+ + +I DFGLA++ +
Sbjct: 133 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL- 188
Query: 579 IRGTKGYVASPEWFR-------NSTITANVDVYSFGVLLLEIISCRKSF 620
YVA+ W+R + T ++D++S G +L E++S R F
Sbjct: 189 ----TEYVAT-RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 18/108 (16%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+ I GL LH + ++H D+ P NILL D + I DF LA+ T + +
Sbjct: 139 FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN------ 189
Query: 579 IRGTKGYVA-----SPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSF 620
YV +PE T VD++S G ++ E+ + + F
Sbjct: 190 ---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
QI + + H I+H D+K +N+LLD N +I+DFG + T+ A G
Sbjct: 122 QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCG 175
Query: 582 TKGYVASPEWFRNSTIT-ANVDVYSFGVLL 610
Y A PE F+ VDV+S GV+L
Sbjct: 176 APPYAA-PELFQGKKYDGPEVDVWSLGVIL 204
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 26/95 (27%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHL 530
HKN+VRL + LV++F + L + ++ + + FQ+ +GL
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 531 HVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
H ++H D+KPQN+L++ ++++FGLA+
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.1 bits (152), Expect = 1e-10
Identities = 26/95 (27%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHL 530
H N+V+L + +LV++ L+ L L + + G + Q+ G+ +
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL-DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 531 HVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
H +++H D+KPQN+L++ +I+DFGLA+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANI---AFQIARGLLH 529
H N+V+LL LV++FL+ L F+ + I FQ+ +GL
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 530 LHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
H + +++H D+KPQN+L++ +++DFGLA+
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 20/108 (18%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+ +Q+ +GL ++H ++ IIH D+KP N+ +++ +I DFGLA+ +
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT------ 183
Query: 579 IRGTKGYVA-----SPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSF 620
GYV +PE N T VD++S G ++ E+I+ + F
Sbjct: 184 -----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 26/113 (23%), Positives = 52/113 (46%), Gaps = 23/113 (20%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ-----ISDFGLAKLLTLNQSK 573
+Q+ RGL ++H S+ ++H D+KP N+ + N + I DFGLA+++ + S
Sbjct: 125 FMYQLLRGLKYIH---SANVLHRDLKPANLFI----NTEDLVLKIGDFGLARIMDPHYSH 177
Query: 574 AIKKAIRGTKGYVA-----SPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSF 620
+ SP + T +D+++ G + E+++ + F
Sbjct: 178 KGHL-----SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 470 QTYHKNLVRLL----GFCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANI---AF 521
H N+VRL+ + + ++ LV++ ++ L ++L + P I
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMR 127
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
Q RGL LH N I+H D+KP+NIL+ +++DFGLA+
Sbjct: 128 QFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA--NIAFQIARGLLHL 530
H N+V L+ + LV++F+ L L + K G +Q+ RG+ H
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL-DENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 531 HVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
H + +I+H D+KPQN+L++ +++DFGLA+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 30/118 (25%), Positives = 56/118 (47%), Gaps = 22/118 (18%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+ +Q+ + + +LH S ++H D+KP NILL+ + +++DFGL++ +
Sbjct: 114 VVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 579 IRGTK-------------GYVA-----SPEWFRNSTI-TANVDVYSFGVLLLEIISCR 617
+ + YVA +PE ST T +D++S G +L EI+ +
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 37/91 (40%), Positives = 55/91 (60%), Gaps = 6/91 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
++A L HLH S II+ D+KP+NILLD+ + +++DFGL+K ++ KA + G
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YSFCG 188
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
T Y+A PE T + D +SFGVL+ E
Sbjct: 189 TVEYMA-PEVVNRRGHTQSADWWSFGVLMFE 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 29/260 (11%), Positives = 64/260 (24%), Gaps = 52/260 (20%)
Query: 447 VKKLDRVFQDGE---KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLAS 503
+ +D + +E + + + + + R+L L+V +++ G+L
Sbjct: 61 LTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQE 120
Query: 504 FLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563
+ P +R +A H + + P + +S G
Sbjct: 121 VADTSPSPVGAIR--AMQSLAAAADAAH---RAGVALSIDHPSRVR--------VSIDGD 167
Query: 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIE 623
L + D+ G L ++ R
Sbjct: 168 VVL--------------AYPATMP--------DANPQDDIRGIGASLYALLVNRWPLPEA 205
Query: 624 MGEE--YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681
D A +D + + A + +Q D +R
Sbjct: 206 GVRSGLAPAERDTAGQPIEPADIDRDIPFQISA---------VAA---RSVQGDGGIRSA 253
Query: 682 MRKVSQMLEVVVEVDVPPNP 701
++ M + D
Sbjct: 254 STLLNLMQQATAVADRTEVL 273
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 50/247 (20%), Positives = 88/247 (35%), Gaps = 52/247 (21%)
Query: 387 KYKKGDDPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGS----SVFVNFTLVGVIQTSTRT 442
+ DPD + DPE + +G +V+
Sbjct: 34 RAGSLKDPDVAELFFKDDPEKL-------FSDLREIGHGSFGAVYF------ARDVRNSE 80
Query: 443 TVIVVKKLDRVFQDGE---KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
V +KK+ + ++ EV + + H N ++ G LV ++ G
Sbjct: 81 VV-AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LG 138
Query: 500 TLASFLFENLKPGWNLR----ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
+ + L + KP L+ A + +GL +LH S +IH D+K NILL +
Sbjct: 139 SASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 192
Query: 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEW--------FRNSTITANVDVYSFG 607
++ DFG A ++ + +V +P W VDV+S G
Sbjct: 193 VKLGDFGSASIMA----P------ANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 240
Query: 608 VLLLEII 614
+ +E+
Sbjct: 241 ITCIELA 247
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I L +LH + +++ D+K +N++LD + +I+DFGL K + + K G
Sbjct: 256 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCG 311
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
T Y+A PE ++ VD + GV++ E++ R F
Sbjct: 312 TPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 39/198 (19%)
Query: 438 TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQ--TYHKNLVRLLG-FCDEGQNRL-LVY 493
+ V VVK L V +K+ K E+ I + N++ L D LV+
Sbjct: 58 ITNNEKV-VVKILKPVK---KKKIKREI-KILENLRGGPNIITLADIVKDPVSRTPALVF 112
Query: 494 KFLNNGTLASFLFENLKPGWNLRANIAF---QIARGLLHLHVNCSSQIIHCDIKPQNILL 550
+ +NN L++ L +I F +I + L + H S I+H D+KP N+++
Sbjct: 113 EHVNNTDFKQ-LYQTLTD-----YDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMI 163
Query: 551 D-DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFR------NSTI-TANVD 602
D ++ ++ D+GLA+ Q VAS +F+ + + ++D
Sbjct: 164 DHEHRKLRLIDWGLAEFYHPGQE---------YNVRVAS-RYFKGPELLVDYQMYDYSLD 213
Query: 603 VYSFGVLLLEIISCRKSF 620
++S G +L +I ++ F
Sbjct: 214 MWSLGCMLASMIFRKEPF 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 21/157 (13%)
Query: 462 KNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL-----FENLKPGWNLR 516
NE ++ LV+L + N +V +++ G + S L F
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP------H 142
Query: 517 ANI-AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575
A A QI +LH S +I+ D+KP+N+L+D Q++DFG AK + K
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGR 194
Query: 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
+ GT +A PE + VD ++ GVL+ E
Sbjct: 195 TWTLCGTPEALA-PEIILSKGYNKAVDWWALGVLIYE 230
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 8/101 (7%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
Q+ + +L IIH DIK +NI++ + + ++ DFG A L + + G
Sbjct: 138 QLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCG 191
Query: 582 TKGYVASPEWFRNST-ITANVDVYSFGVLLLEIISCRKSFD 621
T Y A PE + ++++S GV L ++ F
Sbjct: 192 TIEYCA-PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 29/96 (30%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANI---AFQIARGLLH 529
H N+V L ++ LV+++L+ L +L ++ N+ N+ FQ+ RGL +
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINM-HNVKLFLFQLLRGLAY 115
Query: 530 LHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
H +++H D+KPQN+L+++ +++DFGLA+
Sbjct: 116 CHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 28/121 (23%), Positives = 52/121 (42%), Gaps = 23/121 (19%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
I + + G +H S IIH D+KP N LL+ + ++ DFGLA+ + + I
Sbjct: 134 ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 579 IRGTK--------------GYVA-----SPEWFRNSTI-TANVDVYSFGVLLLEIISCRK 618
+ + +V +PE T ++D++S G + E+++ +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 619 S 619
S
Sbjct: 251 S 251
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I L +LH S +++ DIK +N++LD + +I+DFGL K + + K G
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCG 167
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
T Y+A PE ++ VD + GV++ E++ R F
Sbjct: 168 TPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 10/98 (10%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL---FENLKPGWNLRANIA---FQIARG 526
H+N+VRL LV++F++N L ++ P + +Q+ +G
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 527 LLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
L H N +I+H D+KPQN+L++ ++ DFGLA
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 24/110 (21%), Positives = 46/110 (41%), Gaps = 21/110 (19%)
Query: 473 HKNLVRLLG-FCDEGQNRL-LVYKFLNNGTLASFLFENLKPGWNLRANIAF--------- 521
H N++ L F ++ L++ + + L + + + + +
Sbjct: 77 HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII-KFHRASKANKKPVQLPRGMVKSLL 134
Query: 522 -QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ----ISDFGLAKL 566
QI G+ +LH N ++H D+KP NIL+ + I+D G A+L
Sbjct: 135 YQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 8/114 (7%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I L+ LH II+ D+K N+LLD + +++DFG+ K N G
Sbjct: 132 EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCG 186
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 633
T Y+A PE + VD ++ GVLL E++ F+ E ++ AIL D
Sbjct: 187 TPDYIA-PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 24/98 (24%), Positives = 46/98 (46%), Gaps = 9/98 (9%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHV 532
H+N++ L L++++ N L ++ +N + + +Q+ G+ H
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 533 NCSSQIIHCDIKPQNILLDDYYNAQ-----ISDFGLAK 565
+ +H D+KPQN+LL ++ I DFGLA+
Sbjct: 151 R---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 6e-10
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I+ L HLH II+ D+KP+NI+L+ + +++DFGL K + + G
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--HTFCG 183
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
T Y+A PE S VD +S G L+ +
Sbjct: 184 TIEYMA-PEILMRSGHNRAVDWWSLGALMYD 213
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 9/96 (9%)
Query: 473 HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANI---AFQIARGLLH 529
H N++ LL N LV+ F+ L + ++ ++I +GL +
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMETD-LEVII-KDNSLVLTP-SHIKAYMLMTLQGLEY 127
Query: 530 LHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
LH + I+H D+KP N+LLD+ +++DFGLAK
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 6/100 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+IA L +LH S I++ D+KP+NILLD + ++DFGL K + S G
Sbjct: 147 EIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCG 201
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
T Y+A PE VD + G +L E++ F
Sbjct: 202 TPEYLA-PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 37/114 (32%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+IA GL L S II+ D+K N++LD + +I+DFG+ K + K G
Sbjct: 129 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTFCG 183
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 633
T Y+A PE +VD ++FGVLL E+++ + F+ E +E +I+
Sbjct: 184 TPDYIA-PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 37/114 (32%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+IA GL L S II+ D+K N++LD + +I+DFG+ K + K G
Sbjct: 450 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTFCG 504
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 633
T Y+A PE +VD ++FGVLL E+++ + F+ E +E +I+
Sbjct: 505 TPDYIA-PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 41/114 (35%), Positives = 59/114 (51%), Gaps = 8/114 (7%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I GL LH S I++ D+K NILLD + +I+DFG+ K L +K G
Sbjct: 126 EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCG 180
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 633
T Y+A PE +VD +SFGVLL E++ + F + EE ++I D
Sbjct: 181 TPDYIA-PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 32/106 (30%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I+ L +LH II+ D+K N+LLD + +++D+G+ K G
Sbjct: 118 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCG 172
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627
T Y+A PE R +VD ++ GVL+ E+++ R FDI +
Sbjct: 173 TPNYIA-PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 27/126 (21%), Positives = 55/126 (43%), Gaps = 28/126 (22%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578
+ + + G+ ++H S+ I+H D+KP N L++ + ++ DFGLA+ + ++ +
Sbjct: 161 LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 579 IRGTK-------------------GYVA-----SPEWFRNSTI-TANVDVYSFGVLLLEI 613
I + G+V +PE T +DV+S G + E+
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 614 ISCRKS 619
++ K
Sbjct: 278 LNMIKE 283
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 27/176 (15%)
Query: 446 VVKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLG-FCDEGQNRL-LVYKFLNNGTLA 502
V+KK + V + + E +E +M+ H ++R+ G F D ++ ++ ++ G L
Sbjct: 38 VLKK-EIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMIMDYIEGGELF 94
Query: 503 SFL-----FENLKPGWNLRANI-AFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
S L F N A A ++ L +LH S II+ D+KP+NILLD +
Sbjct: 95 SLLRKSQRFPNP------VAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHI 145
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
+I+DFG AK + + GT Y+A PE ++D +SFG+L+ E
Sbjct: 146 KITDFGFAK-----YVPDVTYTLCGTPDYIA-PEVVSTKPYNKSIDWWSFGILIYE 195
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
QI + + H ++H D+KP+N+LLD + NA+I+DFGL+ +++ + + G
Sbjct: 119 QILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCG 172
Query: 582 TKGYVASPEWFRNSTIT-ANVDVYSFGVLL 610
+ Y A PE VD++S GV+L
Sbjct: 173 SPNYAA-PEVISGRLYAGPEVDIWSCGVIL 201
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 32/106 (30%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I+ L +LH II+ D+K N+LLD + +++D+G+ K G
Sbjct: 161 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCG 215
Query: 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627
T Y+A PE R +VD ++ GVL+ E+++ R FDI +
Sbjct: 216 TPNYIA-PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 28/102 (27%), Positives = 48/102 (47%), Gaps = 15/102 (14%)
Query: 473 HKNLVRLLGFCDEGQNRL--------LVYKFLNNGTLASFLFENLKPGWNLR--ANIAFQ 522
H+N+V L+ C + LV+ F + LA L N+ + L +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTLSEIKRVMQM 132
Query: 523 IARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
+ GL ++H N +I+H D+K N+L+ +++DFGLA
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
QI + + H +I+H D+KP+N+LLDD N +I+DFGL+ ++T K G
Sbjct: 116 QIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCG 169
Query: 582 TKGYVASPEWFRNSTIT-ANVDVYSFGVLLLEIISCRKSFD 621
+ Y A PE VDV+S G++L ++ R FD
Sbjct: 170 SPNYAA-PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 34/122 (27%), Positives = 52/122 (42%), Gaps = 27/122 (22%)
Query: 505 LFENLK----PGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
L+E +K G++L A I + L LH ++IIHCD+KP+NILL + I
Sbjct: 185 LYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGI 241
Query: 559 S--DFGLAKLLTLNQSKAIKKAIRGTKGYVAS-----PEWFRNSTITANVDVYSFGVLLL 611
DFG + Y+ S PE + +D++S G +L
Sbjct: 242 KVIDFGSSCYEHQRVYT-----------YIQSRFYRAPEVILGARYGMPIDMWSLGCILA 290
Query: 612 EI 613
E+
Sbjct: 291 EL 292
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 10/96 (10%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
++ + +H +H DIKP NIL+D + +++DFG L + + A+ G
Sbjct: 183 EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-G 238
Query: 582 TKGYVASPEWFRNSTITAN-----VDVYSFGVLLLE 612
T Y++ PE + D +S GV + E
Sbjct: 239 TPDYIS-PEILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 27/95 (28%), Positives = 43/95 (45%), Gaps = 9/95 (9%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
++ L +H S IH D+KP N+LLD + +++DFG + A+ G
Sbjct: 176 EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 231
Query: 582 TKGYVASPEWFRNSTITAN----VDVYSFGVLLLE 612
T Y++ PE ++ D +S GV L E
Sbjct: 232 TPDYIS-PEVLKSQGGDGYYGRECDWWSVGVFLYE 265
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
+I L HLH II+ DIK +NILLD + ++DFGL+K ++++ G
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCG 222
Query: 582 TKGYVASPEWFRNSTI--TANVDVYSFGVLLLEIISCRKSFDIE 623
T Y+A P+ R VD +S GVL+ E+++ F ++
Sbjct: 223 TIEYMA-PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 24/68 (35%), Positives = 34/68 (50%), Gaps = 9/68 (13%)
Query: 505 LFENLK----PGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
L++ L+ G +L A Q+ LL L IIHCD+KP+NILL + + I
Sbjct: 142 LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200
Query: 559 S--DFGLA 564
DFG +
Sbjct: 201 KIVDFGSS 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 36/133 (27%), Positives = 56/133 (42%), Gaps = 19/133 (14%)
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRANIA-F---QIARGLLHLHVNCSSQIIHCDIKPQ 546
LV ++ G L + L K G + A +A F +I + +H +H DIKP
Sbjct: 138 LVMEYYVGGDLLTLL---SKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPD 191
Query: 547 NILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVY-- 604
NILLD + +++DFG L + + A+ GT Y++ PE + Y
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLS-PEILQAVGGGPGTGSYGP 249
Query: 605 -----SFGVLLLE 612
+ GV E
Sbjct: 250 ECDWWALGVFAYE 262
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 19/75 (25%), Positives = 36/75 (48%), Gaps = 5/75 (6%)
Query: 504 FLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
FL EN + L ++A+Q+ L LH +Q+ H D+KP+NIL + + +
Sbjct: 111 FLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNE 167
Query: 562 GLAKLLTLNQSKAIK 576
+ ++ +I+
Sbjct: 168 HKSCEEKSVKNTSIR 182
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 17/78 (21%), Positives = 34/78 (43%), Gaps = 9/78 (11%)
Query: 505 LFENLK----PGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
++ +K + L +A+QI + + LH N ++ H D+KP+NIL +
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA 159
Query: 559 SDFGLAKLLTLNQSKAIK 576
+ + + + IK
Sbjct: 160 YNPKIKRDERTLINPDIK 177
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 8/90 (8%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581
QI G+ + H ++H D+KP+N+LLD + NA+I+DFGL+ +++ + + G
Sbjct: 124 QILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCG 177
Query: 582 TKGYVASPEWFRNSTIT-ANVDVYSFGVLL 610
+ Y A PE VD++S GV+L
Sbjct: 178 SPNYAA-PEVISGRLYAGPEVDIWSSGVIL 206
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 33/103 (32%), Positives = 47/103 (45%), Gaps = 10/103 (9%)
Query: 522 QIARGLLHLHVNCSSQIIHCDIKPQNILLDD--YYNAQISDFGLAKLLTLNQSKAIKKAI 579
Q+ G+ + H S QI H D+K +N LLD +I DFG +K L+ K+
Sbjct: 124 QLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKST 177
Query: 580 RGTKGYVASPEWFRNSTIT-ANVDVYSFGVLLLEIISCRKSFD 621
GT Y+A PE DV+S GV L ++ F+
Sbjct: 178 VGTPAYIA-PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 29/133 (21%), Positives = 54/133 (40%), Gaps = 26/133 (19%)
Query: 447 VKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNR----LLVYKFLNNGTL 501
+K L + + EV + + ++VR++ + L+V + L+ G L
Sbjct: 48 LKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 102
Query: 502 ASFLFENLKPGWNLR------ANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DD 552
F ++ + + I I + +LH S I H D+KP+N+L
Sbjct: 103 ----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRP 155
Query: 553 YYNAQISDFGLAK 565
+++DFG AK
Sbjct: 156 NAILKLTDFGFAK 168
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 17/81 (20%), Positives = 34/81 (41%), Gaps = 7/81 (8%)
Query: 504 FLFENLKPGWNLRA--NIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD--YYNAQIS 559
+ N G+++ +I + L +L + H D+KP+NILLDD + + I+
Sbjct: 125 IITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181
Query: 560 DFGLAKLLTLNQSKAIKKAIR 580
+ + + I+
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIK 202
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 5e-07
Identities = 18/114 (15%), Positives = 34/114 (29%), Gaps = 14/114 (12%)
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
+V +F G + L +I Q+ L + + H D+ N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTKL-SSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLL 195
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVY 604
++ K T+ + G S + S + + V
Sbjct: 196 KKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDGIVV 238
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 36/159 (22%), Positives = 58/159 (36%), Gaps = 57/159 (35%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILL--DDYY---------------------- 554
I Q+ +GL +LH C +IIH DIKP+NILL ++ Y
Sbjct: 151 IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 555 -------------------------NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASP 589
+I+D G A + + ++ I+ T+ Y +
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRS-L 262
Query: 590 EWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY 628
E S D++S + E+ + F+ GEEY
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.8 bits (120), Expect = 6e-07
Identities = 35/272 (12%), Positives = 62/272 (22%), Gaps = 55/272 (20%)
Query: 24 AQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIV 83
+P TL+AG LSP+ F G L I N +
Sbjct: 11 GVGTSVLPAYQTLSAG---QYLLSPNQRFKLLLQGDGN---------LVIQDNGATVWVA 58
Query: 84 VWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWSSKLILVQSFSSSRL------- 136
P+ + + + G L+D ++VW + S
Sbjct: 59 NEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQD 118
Query: 137 --------------WDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSN 182
+ ++ L G G + D N
Sbjct: 119 DGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---GASKLVFQGDGN 175
Query: 183 LVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERV 242
LV A + +GT + +F G + + +
Sbjct: 176 LVAY------GPNGAATWNAGT-----QGKGAVRAVFQGDGNLVVYGAGNAVLWHSH--- 221
Query: 243 VPAADFYHRATLNFDGVFVQSFYLKNGNGNWS 274
L +G + + W+
Sbjct: 222 -TGGHASAVLRLQANGSIA----ILDEKPVWA 248
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 66/454 (14%), Positives = 128/454 (28%), Gaps = 118/454 (25%)
Query: 290 ELGSGAYGFNSICPKGYSLLDENEKYGSCK--ADFELSCNGGRQ-DYELSRPYDEVQCKN 346
E G Y + I D CK D S + D+ +
Sbjct: 10 ETGEHQYQYKDILS---VFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66
Query: 347 NCLSDCFC-----VVAIFRGDSC-----WSKKLPLSNGRAHSSVNGKAFLKYKKGDDPDP 396
L +V F + + P+ + S+ + +++ + D
Sbjct: 67 --LFWTLLSKQEEMVQKFVEEVLRINYKFLMS-PIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 397 PSVP----SPPDPEDKKKRNMMNVTRS--VLL------GSSVFVNFTLVGVIQTSTRTTV 444
S P K ++ ++ + + VL+ G + +
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC--------LSYK 175
Query: 445 IVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
+ K ++F V+ + Q L+Y+ N T
Sbjct: 176 VQCKMDFKIFWLNLKNCNSPETVLEMLQK-------------------LLYQIDPNWTSR 216
Query: 503 SFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD-F 561
S N+K LR + R LL + ++ L + NA+ + F
Sbjct: 217 SDHSSNIK----LRIHSIQAELRRLLKSKPYENCLLV----------LLNVQNAKAWNAF 262
Query: 562 GL-AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS- 619
L K+L + K + + S + + T+T + LLL+ + CR
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLD-HHSMTLTPD---EVKS-LLLKYLDCRPQD 317
Query: 620 ----------FDIEM-GEEYAILTDWA--FDCYRNGKLDDLVEGDMEAMNDIKCVEKLVM 666
+ + E + D +D +++ D L + + L
Sbjct: 318 LPREVLTTNPRRLSIIAES---IRDGLATWDNWKHVNCDKL----TTIIE--SSLNVL-- 366
Query: 667 VSIWCIQEDPSLRPTMRKVSQMLEVVVE-VDVPP 699
+P+ RK+ L V +P
Sbjct: 367 --------EPAE---YRKMFDRLSVFPPSAHIPT 389
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 1e-04
Identities = 29/135 (21%), Positives = 45/135 (33%), Gaps = 30/135 (22%)
Query: 144 TDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISG 203
+D L G L +G S G + F + D NLVL N A + SG
Sbjct: 1 SDRLNSG------HQLDTGGSLAE---GGYLFIIQNDCNLVLYDNN-------RAVWASG 44
Query: 204 TYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQS 263
T SG + G + I + + T R + + L D V
Sbjct: 45 TN----GKASGCVLKMQNDGNLVIYSGSRAIWASNTNR----QNGNYYLILQRDRNVV-- 94
Query: 264 FYLKNGNGNWSVVWS 278
+ + + N +W+
Sbjct: 95 --IYDNSNN--AIWA 105
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 32/121 (26%), Positives = 49/121 (40%), Gaps = 16/121 (13%)
Query: 478 RLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR--ANIAFQIARGLLHLHVNCS 535
+ EG ++V + L G LF ++L+ +A Q+ + ++H S
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 123
Query: 536 SQIIHCDIKPQNILLDDYYNAQ---ISDFGLAKLLTLNQSKAI-----KKAIRGTKGYVA 587
IH D+KP N L+ I DFGLAK ++ K + GT Y A
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 588 S 588
S
Sbjct: 183 S 183
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 11/49 (22%), Positives = 25/49 (51%), Gaps = 5/49 (10%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI--SDFGLAK 565
+A ++ L LH ++ +H ++ +NI +D +Q+ + +G A
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 18/71 (25%), Positives = 33/71 (46%), Gaps = 10/71 (14%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI--SDFGLAKLLTLNQS-KAI 575
+ ++ L ++H ++ +H DIK N+LL Q+ +D+GL+ N + K
Sbjct: 156 LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
Query: 576 ----KKAIRGT 582
+K GT
Sbjct: 213 QENPRKGHNGT 223
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 15/49 (30%), Positives = 26/49 (53%), Gaps = 5/49 (10%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI--SDFGLAK 565
++ +I L ++H + +H DIK N+LL+ Q+ D+GLA
Sbjct: 157 LSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 18/52 (34%), Positives = 27/52 (51%), Gaps = 8/52 (15%)
Query: 519 IAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ-----ISDFGLAK 565
IA Q+ + ++H S +I+ D+KP+N L+ N I DF LAK
Sbjct: 110 IAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 22/95 (23%), Positives = 40/95 (42%), Gaps = 12/95 (12%)
Query: 478 RLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLR--ANIAFQIARGLLHLHVNCS 535
+ F EG + +LV L G L + ++++ A A Q+ + +H
Sbjct: 70 NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 124
Query: 536 SQIIHCDIKPQNILLDDYYNAQ-----ISDFGLAK 565
+++ DIKP N L+ + + DFG+ K
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 709 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.79 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.77 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.68 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.65 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.64 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.62 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.45 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.35 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.35 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.21 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.12 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.03 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.93 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.85 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.85 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.79 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.75 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.7 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.65 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.61 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.51 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.5 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 98.41 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.36 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 98.36 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.22 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.2 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.1 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.99 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 97.98 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.95 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 97.95 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.86 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.79 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.23 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.81 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.33 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.31 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.23 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.15 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.09 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.07 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.76 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.15 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.62 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 86.78 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.62 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.36 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=423.27 Aligned_cols=262 Identities=22% Similarity=0.415 Sum_probs=214.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+|+.||.+.... ...++..||||+++....+..++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 3456666677788888776554431 22467899999998777677789999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhC-------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeE
Q 038905 491 LVYKFLNNGTLASFLFEN-------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 557 (709)
||||||++|+|.++|.+. ..+++..+..++.||++||.||| +++||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence 999999999999999764 25899999999999999999999 88999999999999999999999
Q ss_pred EccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHH
Q 038905 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF 636 (709)
Q Consensus 558 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 636 (709)
|+|||+|+...............||+.|+| ||++.+..++.++|||||||+||||+| |+.||......+ +.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymA-PE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~ 240 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMP-PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VI 240 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HH
T ss_pred ECCcccceecCCCCceeecCceecChhhcC-HHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 999999987755443333345679999999 999999999999999999999999998 899997654333 22
Q ss_pred HhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 637 DCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 637 ~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..+..|..... +...++.+.+++..||+.||++|||++||+++|+.+..
T Consensus 241 ~~i~~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 241 ECITQGRVLQR---------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 23333432211 22356788999999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=425.29 Aligned_cols=261 Identities=22% Similarity=0.408 Sum_probs=203.7
Q ss_pred cccceeeeecCeeEEEEEEEEEEe---cCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQ---TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.+|.....+|.|+|+.| |++... ...+++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 41 ~d~~l~~~LG~G~fG~V-y~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKV-FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEE-EEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEE-EEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34554455566666666 555432 22467899999998777777789999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhC---------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC
Q 038905 491 LVYKFLNNGTLASFLFEN---------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 555 (709)
||||||++|+|.+++.+. .++++.++..++.||++||.||| +++||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence 999999999999999754 24899999999999999999999 889999999999999999999
Q ss_pred eEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHH
Q 038905 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW 634 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 634 (709)
+||+|||+|+.+.............||+.||| ||++.+..++.++|||||||+||||+| |+.||......+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymA-PE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~------ 269 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP-PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA------ 269 (329)
T ss_dssp EEECCCC----------------CCCCGGGCC-HHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH------
T ss_pred EEEcccccceeccCCCcceecCcccccccccC-hhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 99999999997765444333356789999999 999999999999999999999999999 8999976544331
Q ss_pred HHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccC
Q 038905 635 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEV 695 (709)
Q Consensus 635 ~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 695 (709)
...+..+.... .+...++.+.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 270 -~~~i~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 -IDCITQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -HHHHHHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHHHHcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 12223332111 1223557889999999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=417.88 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=210.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe---cCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ---TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~---~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
+..|.+++|.|++|.| |++.+. ....++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++.
T Consensus 27 ~~~~~~~lG~G~fG~V---ykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKV---YKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GEEEEEEEEECSSCEE---EEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HCeEeeEeccCCCcEE---EEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 5566677666666666 777652 23467899999996543 3456789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC
Q 038905 489 RLLVYKFLNNGTLASFLFEN----------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD 552 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~ 552 (709)
.+||||||++|+|.++|..+ ..+++..+..++.|||+||.||| +++||||||||+||||++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECC
Confidence 99999999999999999653 24889999999999999999999 889999999999999999
Q ss_pred CCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhH
Q 038905 553 YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL 631 (709)
Q Consensus 553 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 631 (709)
++.+||+|||+|+.+............+||+.|+| ||++.+..++.++|||||||+||||+| |+.||......+
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymA-PE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---- 255 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA-PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---- 255 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH----
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccC-HHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999997765443333366789999999 999999999999999999999999998 899997654433
Q ss_pred HHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 632 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 632 ~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+...+..+.... .+..++..+.+++..||+.||++||||.||++.|+....
T Consensus 256 ---~~~~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 256 ---VVEMIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp ---HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred ---HHHHHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 222333333221 123456789999999999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=407.84 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=195.7
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
++.....+|.|+|+.| |++.. ...||||+++.. ..+..++|.+|+.++++++|||||+++|++.+ +..+||
T Consensus 37 ~l~l~~~iG~G~fG~V-y~~~~-----~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTV-YKGKW-----HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp SCCEEEECCCCSSSEE-EEEES-----SSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HeEEeeEEeeCCCcEE-EEEEE-----CCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 3444445566666666 55554 225899988643 33456789999999999999999999999865 568999
Q ss_pred EeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+||+|.++|... .++++..+..|+.|||+||.||| +++||||||||+||||++++.+||+|||+|+......
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999999765 47999999999999999999999 8899999999999999999999999999998776544
Q ss_pred cccceeccccCcccccccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRN---STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
........+||+.||| ||++.+ ..|+.++|||||||+||||++|+.||......... ...+..+...
T Consensus 187 ~~~~~~~~~GT~~ymA-PE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~~~~--- 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMA-PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRGYAS--- 256 (307)
T ss_dssp -------CCCCTTSCC-HHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTTCCC---
T ss_pred cceeecccccCCCccC-HHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCCCC---
Confidence 3333366799999999 999964 46899999999999999999999999754432211 1112222111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+.. .......++.+.+++..||+.||++||||.||++.|+.+.
T Consensus 257 -p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 257 -PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp -CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred -CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 100 1112345678899999999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=409.48 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=213.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+|+.||.+... .+++.||||++++. .....+.+.+|+++|++++|||||++++++++++..
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~---~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEecccCeEEEEEEEC---CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 456888888888888888777766 67889999998643 234567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
||||||++||+|.+++.+.+.+++.....++.||+.||.||| +++|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999999998889999999999999999999999 89999999999999999999999999999998865
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..........+||+.|+| ||++.+..|+.++|||||||++|||++|+.||......+ +...+..++.. +
T Consensus 185 ~~~~~~~~~~~GTp~YmA-PEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~-~-- 253 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVS-PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------IFAKIIKLEYD-F-- 253 (311)
T ss_dssp TTTCCCBCCCCSCGGGCC-HHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC-C--
T ss_pred CCCcccccCcccCcccCC-HHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC-C--
Confidence 544444467899999999 999999999999999999999999999999997654332 12222333321 1
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVS 686 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~ 686 (709)
+...+..+.+++.+||+.||++|||++|++
T Consensus 254 -------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 -------PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 122356788999999999999999999863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=412.63 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=208.3
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.|.....+|.|+|+.||.+... .+++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVR---SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hcEEeEEeecCcCeEEEEEEEC---CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4666666777777777666555 5789999999976655566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA 574 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 574 (709)
||+||+|.+++.+ .++++..+..++.||+.||.||| +++||||||||+||||+.++.+||+|||+|+.+......
T Consensus 152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~- 226 (346)
T 4fih_A 152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 226 (346)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-
Confidence 9999999999875 57999999999999999999999 889999999999999999999999999999987654332
Q ss_pred ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccc
Q 038905 575 IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 654 (709)
Q Consensus 575 ~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~ 654 (709)
....+||+.|+| ||++.+..|+.++|||||||++|||++|+.||......+.. ..+..+....+
T Consensus 227 -~~~~~GTp~YmA-PEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------~~i~~~~~~~~------- 290 (346)
T 4fih_A 227 -RKSLVGTPYWMA-PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------KMIRDNLPPRL------- 290 (346)
T ss_dssp -BCCCCSCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSSCCCC-------
T ss_pred -ccccccCcCcCC-HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------HHHHcCCCCCC-------
Confidence 267899999999 99999999999999999999999999999999765433311 12222211111
Q ss_pred cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 655 MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 655 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......+..+.+|+.+||+.||++|||++|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112234577899999999999999999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=412.57 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=205.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+|+.||.+... .+++.||||++... .....+++.+|++++++++|||||++++++.+++..|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKST---EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp CCCEEEEEEC------CEEEEEET---TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEEC---CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 457888888999999999877766 57899999998643 3344578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
||||||+||+|.++|.... .+++.....++.||+.||.||| +++||||||||+||||++++.+||+|||+|+.+.
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 9999999999999997654 4788899999999999999999 8999999999999999999999999999999775
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.... ..+..+||+.|+| ||++.+..|+.++|||||||++|||++|+.||......+. ...+..+....+
T Consensus 177 ~~~~--~~~~~~GT~~YmA-PE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i~~~~~~~~- 245 (350)
T 4b9d_A 177 STVE--LARACIGTPYYLS-PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL-------VLKIISGSFPPV- 245 (350)
T ss_dssp HHHH--HHHHHHSCCTTCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCCCCC-
T ss_pred CCcc--cccccCCCccccC-HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHcCCCCCC-
Confidence 4322 2256789999999 9999999999999999999999999999999986543331 122223332211
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....+..+.+|+.+||+.||++|||++|+++
T Consensus 246 --------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 --------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2234567899999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=402.94 Aligned_cols=262 Identities=19% Similarity=0.168 Sum_probs=208.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
...|.....+|.|+|+.||.+... .+++.||||+++.... ..+|+.++++++|||||++++++.+++..|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~---~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDK---QTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEEC---CCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 445666667888888888766655 5789999999875322 25799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~~ 571 (709)
||||+||+|.++|.+.+.+++..+..++.||+.||.||| +++||||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999999998889999999999999999999999 89999999999999999998 59999999999876443
Q ss_pred cc---cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 572 SK---AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 572 ~~---~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.. .....++||+.||| ||++.+..|+.++|||||||++|||++|+.||......+... .+..+...
T Consensus 206 ~~~~~~~~~~~~GT~~YmA-PE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-------~i~~~~~~--- 274 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMA-PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-------KIASEPPP--- 274 (336)
T ss_dssp --------CCCCCCGGGCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-------HHHHSCCG---
T ss_pred cccceecCCccccCccccC-HHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------HHHcCCCC---
Confidence 21 11245789999999 999999999999999999999999999999997654322111 11111110
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc----ccCCCCCC
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV----VEVDVPPN 700 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~----~~~~~p~~ 700 (709)
....+...+..+.+++.+||+.||.+|||+.|+++.|... ..+..|..
T Consensus 275 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~ 326 (336)
T 4g3f_A 275 ----IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK 326 (336)
T ss_dssp ----GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred ----chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence 0111334567889999999999999999999999877653 23555543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=413.47 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=208.7
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
..|.....+|.|+|+.||.+... .+++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVR---SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEEC---CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 34666667777777777766655 578999999997665566678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
|||+||+|.+++.. .++++..+..++.||+.||.||| +++||||||||+||||+.++.+||+|||+|+.+......
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999999865 56999999999999999999999 889999999999999999999999999999987654332
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
....+||+.||| ||++.+..|+.++|||||||++|||++|+.||......+.. ..+..+....+
T Consensus 304 --~~~~~GTp~YmA-PEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------~~i~~~~~~~~------ 367 (423)
T 4fie_A 304 --RKSLVGTPYWMA-PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------KMIRDNLPPRL------ 367 (423)
T ss_dssp --BCCCEECTTTCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSCCCCC------
T ss_pred --ccccccCcCcCC-HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-------HHHHcCCCCCC------
Confidence 267899999999 99999999999999999999999999999999765433311 12222211111
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......+..+.+|+..||+.||++|||++|+++
T Consensus 368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112234567899999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=394.43 Aligned_cols=242 Identities=24% Similarity=0.343 Sum_probs=193.1
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEc----CCeEEEEE
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE----GQNRLLVY 493 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~----~~~~~lV~ 493 (709)
..+|.|+|+.||.+... .++..||||++... .....++|.+|++++++++|||||++++++.+ +...+|||
T Consensus 32 ~~iG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eEEecCcCcEEEEEEEC---CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34566666666554443 57889999998643 33445789999999999999999999999864 35579999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCC--eEecCCCCCceeec-CCCCeEEcccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ--IIHCDIKPQNILLD-DYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~~ 570 (709)
|||+||+|.+++.+...+++..+..++.||+.||.||| +++ ||||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999999998889999999999999999999999 777 99999999999997 4799999999999864432
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.....+||+.||| ||++.+ .|+.++|||||||++|||++|+.||........ +...+..+.....+
T Consensus 186 ----~~~~~~GTp~YmA-PE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~~~~i~~~~~~~~~-- 251 (290)
T 3fpq_A 186 ----FAKAVIGTPEFMA-PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASF-- 251 (290)
T ss_dssp ----SBEESCSSCCCCC-GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGGG--
T ss_pred ----ccCCcccCccccC-HHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------HHHHHHcCCCCCCC--
Confidence 2256799999999 999875 699999999999999999999999965432221 22233333221111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+...+..+.+++..||+.||++|||++|+++
T Consensus 252 ------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 ------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123356889999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=389.96 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=193.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+|+.||.+... .+++.||||+++.. ..+..+.+.+|+.++++++|||||++++++.+.+..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHT---TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECT---TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 467888888899999988776655 57899999998643 223456799999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+ +|+|.+++.++.++++.....++.||+.||.||| +++|+||||||+|||+++++++||+|||+|+....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999999 6799999999899999999999999999999999 89999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
... ....+||+.|+| ||++.+..+ +.++||||+||++|||++|+.||......+ ..+.+..+...
T Consensus 165 ~~~---~~~~~GT~~Y~A-PE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-------~~~~i~~~~~~--- 230 (275)
T 3hyh_A 165 GNF---LKTSCGSPNYAA-PEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-------LFKNISNGVYT--- 230 (275)
T ss_dssp -------------CTTSC-HHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC---
T ss_pred CCc---cCCeeECcccCC-hhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC---
Confidence 332 256789999999 999998886 579999999999999999999997654322 12222333221
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+...+..+.+++.+||+.||++|||++|+++
T Consensus 231 -------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 -------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01224567889999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=401.00 Aligned_cols=252 Identities=25% Similarity=0.264 Sum_probs=203.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+|+.||.+.....+..++.||||+++... .....++.+|++++++++|||||++++++.+++..|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 456888888888888888877776555678999999986432 223457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||||+||+|.+++.+.+.+++..+..++.||+.||.||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999999889999999999999999999999 899999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... ....+||+.|+| ||++.+..|+.++|||||||++|||++|+.||......+. ...+..+...
T Consensus 180 ~~~--~~~~~GT~~YmA-PE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i~~~~~~----- 244 (304)
T 3ubd_A 180 EKK--AYSFCGTVEYMA-PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-------MTMILKAKLG----- 244 (304)
T ss_dssp -CC--CCSCCCCGGGCC-HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC-----
T ss_pred Ccc--ccccccCcccCC-HHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-------HHHHHcCCCC-----
Confidence 322 256899999999 9999999999999999999999999999999986544331 1222222221
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
.+...+..+.+++..||+.||++||| ++|+++
T Consensus 245 -----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 -----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11234567899999999999999998 467765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=406.62 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=210.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecC--CCceEEEEEEcccccc-hhHHHHHHHHHHHhccCc-CceeEEEeEEEc-CC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTS--TRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYH-KNLVRLLGFCDE-GQ 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~nlv~l~~~~~~-~~ 487 (709)
.++|.....+|.|+||.||.+.....+ ...+.||||++..... ...++|.+|+++|.+++| ||||+++|+|.+ ++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 345666666777777777655544322 3457899999975433 345679999999999965 899999999966 46
Q ss_pred eEEEEEeecCCCCHHHHHhhC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec
Q 038905 488 NRLLVYKFLNNGTLASFLFEN----------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~ 551 (709)
..+||||||++|+|.++|... ..+++..+..++.|||+||.||| +++||||||||+||||+
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeC
Confidence 789999999999999999753 23789999999999999999999 88999999999999999
Q ss_pred CCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHh
Q 038905 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI 630 (709)
Q Consensus 552 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 630 (709)
+++.+||+|||+|+.+..+.........+||+.||| ||++.+..|+.++|||||||+||||+| |+.||......+.
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymA-PE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-- 296 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA-PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 296 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccC-HHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999998766554444467889999999 999999999999999999999999998 8999976543221
Q ss_pred HHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 631 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 631 ~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+...+..|..... +...+..+.+++..||+.||++|||+.||++.|+.+.+
T Consensus 297 ----~~~~i~~g~~~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 ----FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp ----HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 1222333322111 22345678999999999999999999999999987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=386.43 Aligned_cols=263 Identities=20% Similarity=0.239 Sum_probs=191.8
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC----eEEEEEee
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ----NRLLVYKF 495 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~----~~~lV~Ey 495 (709)
..+|.|+||.| |++.. .++.||||+++... .....+..|+.++.+++|||||+++++|.+.+ ..+|||||
T Consensus 9 ~~iG~G~fG~V-y~~~~----~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 9 ESIGKGRFGEV-WRGKW----RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEECSSSEE-EEEEE----TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEeeCCCeEE-EEEEE----CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 33444444455 56665 47899999987542 22233455677778899999999999997653 57999999
Q ss_pred cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcC-----CCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNC-----SSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|++|+|.+++.+. ++++..+.+++.|+++||.|||+.+ ..+||||||||+||||+.++++||+|||+|+.....
T Consensus 83 ~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 83 HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 9999999999764 6899999999999999999999431 239999999999999999999999999999877544
Q ss_pred ccc--cceeccccCcccccccccccCC------CCCcccchHHHHHHHHHHHhCCCCCCccchhhHH--------hHHHH
Q 038905 571 QSK--AIKKAIRGTKGYVASPEWFRNS------TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTDW 634 (709)
Q Consensus 571 ~~~--~~~~~~~Gt~~y~aaPE~~~~~------~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~ 634 (709)
... ......+||+.|+| ||++.+. .++.++|||||||+||||++|.+|+......+.. .....
T Consensus 162 ~~~~~~~~~~~~GT~~ymA-PE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMA-PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTEESCC-----CCGGGCC-HHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCceeeecccccccccccC-HHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 322 12245689999999 9999764 4678999999999999999998877543221000 00011
Q ss_pred HHHhhhcCCccccccCccc-ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 635 AFDCYRNGKLDDLVEGDME-AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 635 ~~~~~~~g~~~~l~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.......+.. ++.+. .....+.++.+.+++.+||+.||++||||.||+++|+.+.+
T Consensus 241 ~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 241 MRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1111212111 12111 11233567789999999999999999999999999988754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=377.70 Aligned_cols=249 Identities=20% Similarity=0.264 Sum_probs=186.2
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCC-----
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ----- 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~----- 487 (709)
.+|.....+|.|+|+.||.+... .+++.||||+++.... ...+++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET---TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEEC---CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 35777778888888888776655 5788999999865433 34467999999999999999999999986543
Q ss_pred -------eEEEEEeecCCCCHHHHHhhCCC---CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeE
Q 038905 488 -------NRLLVYKFLNNGTLASFLFENLK---PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557 (709)
Q Consensus 488 -------~~~lV~Ey~~~gsL~~~l~~~~~---l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 557 (709)
..|+|||||++|+|.+++..... .++..+..++.||++||.||| +++||||||||+||||+.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEE
Confidence 36899999999999999987654 345667889999999999999 88999999999999999999999
Q ss_pred Ecccccccccccccccc----------ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhh
Q 038905 558 ISDFGLAKLLTLNQSKA----------IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627 (709)
Q Consensus 558 l~DFGla~~~~~~~~~~----------~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~ 627 (709)
|+|||+|+.+....... ..+..+||+.||| ||++.+..|+.++|||||||++|||++ ||..... .
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmA-PE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-~ 233 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS-PEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-R 233 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSC-HHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-H
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccC-HHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-H
Confidence 99999999876543211 1245689999999 999999999999999999999999996 6653221 1
Q ss_pred HHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 628 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 628 ~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. ........+.... .......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~-----~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VR-----TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-----HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-----HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1111222222111 1123345678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=377.11 Aligned_cols=270 Identities=17% Similarity=0.227 Sum_probs=203.0
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEc------
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE------ 485 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~------ 485 (709)
++|.....+|.|+||.||.+... .+++.||||++.... ....+.+.+|+++|++++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~---~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRR---LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCeEEEEEEecccCeEEEEEEEC---CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 35777777788888877766655 678999999986542 2345678899999999999999999998753
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 486 GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
..+.|||||||+ |+|.+++.+...+++..+..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 467899999996 689999998889999999999999999999999 8999999999999999999999999999998
Q ss_pred ccccccc--ccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 566 LLTLNQS--KAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 566 ~~~~~~~--~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
.+..... .......+||+.|+| ||++.+. .++.++||||+||++|||++|++||......+...............
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~A-PEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRA-PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCC-HHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecccCccccccccccceeChHhcC-HHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 7654321 122357899999999 9998875 56999999999999999999999998765433222111100000000
Q ss_pred Cccc--------cccCcc-cccC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHcc
Q 038905 643 KLDD--------LVEGDM-EAMN-----DIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEV 691 (709)
Q Consensus 643 ~~~~--------l~~~~~-~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~ 691 (709)
.... .+.... .... ....+..+.+|+.+||+.||++|||++|+++ .+..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 0000 000000 0000 1123567889999999999999999999987 3444
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=388.56 Aligned_cols=250 Identities=21% Similarity=0.229 Sum_probs=203.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHH---HHHHHhccCcCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKN---EVVMIGQTYHKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~---E~~~l~~l~h~nlv~l~~~~~~~ 486 (709)
.++|.....+|.|+||.||.+... .+++.+|||++++. ..+....+.+ ++.+++.++|||||++++++++.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~---~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred hHHeEEEEEEecccCeEEEEEEEC---CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 567888888999999988877766 67899999998642 1223333444 46677788999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
+..||||||++||+|..+|.+.+.+++.....++.||+.||.||| +++||||||||+||||+.+|++||+|||+|+.
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999999999889999999999999999999999 99999999999999999999999999999987
Q ss_pred ccccccccceeccccCccccccccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 567 LTLNQSKAIKKAIRGTKGYVASPEWFR-NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 567 ~~~~~~~~~~~~~~Gt~~y~aaPE~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
+.... ..+.+||+.||| ||++. +..|+.++|||||||++|||++|+.||......+... +..........
T Consensus 342 ~~~~~----~~t~~GTp~YmA-PEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~----i~~~i~~~~~~ 412 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMA-PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMAVE 412 (689)
T ss_dssp CSSCC----CCSCCSCGGGCC-HHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH----HHHHHHHCCCC
T ss_pred cCCCC----CCCccCCcCccC-HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhhcCCCCC
Confidence 75433 256799999999 99996 4679999999999999999999999997644322111 11112222111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
.+...+..+.+|+..||+.||.+|++ ++||.+
T Consensus 413 ----------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 ----------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 12234567899999999999999998 577765
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=365.04 Aligned_cols=204 Identities=19% Similarity=0.261 Sum_probs=170.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~l 491 (709)
.+.|.....+|.|+|+.||.+........++.||||++... ....++.+|+++|.++ +|||||++++++.+.++.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 45677777788888888877765544456789999998654 3456788999999998 69999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-CCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-YNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~~~~~ 570 (709)
||||+++|+|.+++. .+++.++..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999984 4899999999999999999999 8999999999999999877 79999999999865432
Q ss_pred ccc--------------------------cceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCcc
Q 038905 571 QSK--------------------------AIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIE 623 (709)
Q Consensus 571 ~~~--------------------------~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~ 623 (709)
... ...+..+||+.|+| ||++.+. .++.++||||+||++|||++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A-PE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRA-PEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCC-HHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccccCccccC-HHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 110 11234689999999 9999875 5899999999999999999999999655
Q ss_pred ch
Q 038905 624 MG 625 (709)
Q Consensus 624 ~~ 625 (709)
.+
T Consensus 251 ~~ 252 (361)
T 4f9c_A 251 SD 252 (361)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=362.68 Aligned_cols=283 Identities=30% Similarity=0.540 Sum_probs=238.3
Q ss_pred ChhhHhhhcccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEE
Q 038905 404 DPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC 483 (709)
Q Consensus 404 ~~~~~~~~~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~ 483 (709)
..++... +++|.....+|.|+++.||.+ .. .+++.||||++........+++.+|+.++++++||||+++++++
T Consensus 31 ~~~~~~~--~~~y~~~~~lg~G~~g~Vy~~-~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 31 LVDLEEA--TNNFDHKFLIGHGVFGKVYKG-VL---RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp CSCCCCC--CCCCSCCCCSCBCSSSEEEEE-EC---TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred HHHHHHH--HhccCccceeecCCCeeEEEE-EE---CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3344445 778887777777777777554 44 45789999998876666778899999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhCC----CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEc
Q 038905 484 DEGQNRLLVYKFLNNGTLASFLFENL----KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 484 ~~~~~~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
.+.+..++||||+++++|.+++.... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEEC
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999997653 4889999999999999999999 8899999999999999999999999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
|||+++...............||+.|+| ||++.+..++.++||||||+++|||++|+.||......+......+.....
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYID-PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCC-HHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred ecccccccccccccccccccCCCccccC-HHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 9999987654333322255679999999 999999999999999999999999999999998665544444455555566
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCC
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVD 696 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 696 (709)
..+.+..++++..........+..+.+++.+||+.||++|||+.||++.|+.+..+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 667777777777766667889999999999999999999999999999999876543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=387.89 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=208.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+|+.||.+... .+++.||||++........+.+.+|+.+|++++|||||++++++.+....+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~---~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTER---ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEEC---CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 356777777778888877766655 67889999998776656677899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC--CCeEEccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY--YNAQISDFGLAKLLTL 569 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~DFGla~~~~~ 569 (709)
||||+||+|.++|.+. ..+++..+..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999999654 57999999999999999999999 8999999999999999854 8999999999998765
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... ...+||+.|+| ||++.+..|+.++|||||||++|||++|+.||......+. ...+..++...
T Consensus 310 ~~~~---~~~~GT~~y~A-PEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-------~~~i~~~~~~~--- 375 (573)
T 3uto_A 310 KQSV---KVTTGTAEFAA-PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDWNM--- 375 (573)
T ss_dssp TSEE---EEECSSGGGCC-HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCCCC---
T ss_pred CCce---eeeEECccccC-HHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHhCCCCC---
Confidence 4322 56789999999 9999999999999999999999999999999986654332 12222222110
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........++.+.+|+..||+.||.+|||++|+++
T Consensus 376 ---~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 ---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ---CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111234567889999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=355.88 Aligned_cols=285 Identities=36% Similarity=0.590 Sum_probs=233.8
Q ss_pred CCCChhhHhhhcccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEE
Q 038905 401 SPPDPEDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRL 479 (709)
Q Consensus 401 ~~~~~~~~~~~~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l 479 (709)
.++..++... .++|.....+|.|+++.||.+ .. .+++.||||++..... ....++.+|+.++.+++||||+++
T Consensus 19 ~~~~~~~~~~--~~~y~~~~~lg~G~~g~V~~~-~~---~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 19 RFSLRELQVA--SDNFSNKNILGRGGFGKVYKG-RL---ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp ECCTHHHHTT--TTSSCSTTEEECCSSSEEEEE-CC---SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred eecHHHHHHH--hhccccceeEecCCCcEEEEE-Ee---cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 4567777777 777877767777777777544 33 4688999999875432 233478999999999999999999
Q ss_pred EeEEEcCCeEEEEEeecCCCCHHHHHhhCC----CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC
Q 038905 480 LGFCDEGQNRLLVYKFLNNGTLASFLFENL----KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555 (709)
Q Consensus 480 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 555 (709)
++++.+....++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999998654 3899999999999999999999544449999999999999999999
Q ss_pred eEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccch--hhHHhHHH
Q 038905 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMG--EEYAILTD 633 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~--~~~~~~~~ 633 (709)
+||+|||+++......... .....||+.|+| ||++.+..++.++||||||+++|||++|+.||..... ........
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIA-PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp EEECCCSSCEECCSSSSCE-ECCCCSCGGGCC-HHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred EEeccCccccccCcccccc-cccccCCcCccC-HHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 9999999998775443332 255679999999 9999998999999999999999999999999964321 22233444
Q ss_pred HHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 634 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 634 ~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+............+.+...........+..+.+++.+||+.||.+|||+.||+++|++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 555556666777777777777778889999999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=347.73 Aligned_cols=264 Identities=23% Similarity=0.365 Sum_probs=198.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||.+ .. .++.||||++.... ....+++.+|+.++++++||||+++++++.+....+
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~-~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRA-EW----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEE-EE----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred hhHceeeeEeecCCCeEEEEE-EE----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 456666666777777777554 33 47789999986543 334568999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCC---CChHHHHHHHHHHHHHHHHhhhcCCCC--eEecCCCCCceeecCCCCeEEccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLK---PGWNLRANIAFQIARGLLHLHVNCSSQ--IIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~---l~~~~~~~i~~~i~~al~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
+||||+++++|.+++.+... +++..+..++.||+.||.||| +.+ |+||||||+|||++.++.+||+|||+++
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999987653 899999999999999999999 888 9999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
........ .....||+.|+| ||.+.+..++.++||||||+++|||++|+.||......+.... ........
T Consensus 188 ~~~~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~------~~~~~~~~ 258 (309)
T 3p86_A 188 LKASTFLS--SKSAAGTPEWMA-PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA------VGFKCKRL 258 (309)
T ss_dssp ----------------CCTTSC-HHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH------HHHSCCCC
T ss_pred cccccccc--cccCCCCccccC-hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhcCCCC
Confidence 65443221 245789999999 9999999999999999999999999999999976544332111 00011111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCCCCCCCC
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVDVPPNPS 702 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~p~~p~ 702 (709)
......+..+.+++..||+.||.+|||+.+++++|+.+..-..||.++
T Consensus 259 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 259 ---------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred ---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 112234567889999999999999999999999999988766655544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=344.60 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=210.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+... .+++.||+|++........+.+.+|+.++.+++||||+++++++.++...++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHR---ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET---TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEEC---CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 456777777888888888666554 57889999998776666778999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++++|.+++.. ...+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999987 457999999999999999999999 8899999999999999999999999999998765433
Q ss_pred ccc------------ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 572 SKA------------IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 572 ~~~------------~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
... ......||+.|+| ||.+.+..++.++||||||+++|||++|..|+..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--------- 232 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMA-PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--------- 232 (310)
T ss_dssp -----------------CCCCSCGGGCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS---------
T ss_pred ccccccccccccccccccccCCCcceeC-HHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH---------
Confidence 211 0125689999999 999999999999999999999999999999886433211000
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
................+..+.+++..||+.||++|||+.++++.|+.+..
T Consensus 233 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 233 -----GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -----SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000000011122334568899999999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=348.53 Aligned_cols=264 Identities=20% Similarity=0.344 Sum_probs=212.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+.....+..+..||||++... .....+++.+|+.++.+++||||+++++++.++...++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 44566667777788888877766666667788999998754 33455789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999765 47999999999999999999999 889999999999999999999999999999887654
Q ss_pred cccc-ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 571 QSKA-IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 571 ~~~~-~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.... ......+|+.|+| ||++.+..++.++||||||+++|||++ |+.||......+.. ..+..+..
T Consensus 205 ~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~~~---- 272 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTA-PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-------SSVEEGYR---- 272 (325)
T ss_dssp --CCEECC---CCGGGSC-HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-------HHHHTTCC----
T ss_pred ccceeeccCCCCcccccC-HhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHHcCCC----
Confidence 3221 1134456788998 999999999999999999999999999 99999765433311 11122211
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCC
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVD 696 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 696 (709)
.......+..+.+++..||+.||.+|||+.+|+++|+.+...+
T Consensus 273 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 273 -----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 1112245578899999999999999999999999999976543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.30 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=207.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+... .+++.||||++........+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBT---TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 345666667777777777665544 57889999998766666678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||+++++|.+++.+. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999999765 6899999999999999999999 88999999999999999999999999999987765433
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
.. ....||+.|+| ||++.+..++.++||||||+++|||++|+.||.......... .....+...
T Consensus 172 ~~--~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~~~~~~------- 235 (297)
T 3fxz_A 172 KR--STMVGTPYWMA-PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTPE------- 235 (297)
T ss_dssp CB--CCCCSCGGGCC-HHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCSCC-------
T ss_pred cc--CCccCCcCccC-hhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCCCC-------
Confidence 22 56789999999 999999999999999999999999999999997654332211 111111110
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......+..+.+++..||+.||++|||++|+++
T Consensus 236 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1112234567889999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.54 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=208.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||.+... .+++.||||++... .....+++.+|+.++++++||||+++++++.+.+..+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHI---LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 567787778888888888777665 57889999998654 2344567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||+++++|.+++....++++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999999988888999999999999999999999 889999999999999999999999999999876544
Q ss_pred ccccceeccccCcccccccccccCCCCC-cccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTIT-ANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s-~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ...+||+.|+| ||++.+..+. .++|||||||++|||++|+.||......+.. .....+...
T Consensus 168 ~~~---~~~~gt~~y~a-PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~~~---- 232 (328)
T 3fe3_A 168 GKL---DAFCGAPPYAA-PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR-------ERVLRGKYR---- 232 (328)
T ss_dssp CGG---GTTSSSGGGCC-HHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCC----
T ss_pred Ccc---ccccCCcceeC-cccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC----
Confidence 322 56789999999 9999988875 7999999999999999999999865533311 122222221
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.+...+..+.+++..||+.||.+|||++|+++.
T Consensus 233 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 ------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 112245678899999999999999999999873
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.54 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=213.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe----cCCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ----TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~ 486 (709)
.++|.....+|.|+++.||.+.... ....+..||||++.... ....+++.+|+.+++++ +|||||++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 4567777778888888887776542 22456789999997543 33457899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee
Q 038905 487 QNRLLVYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll 550 (709)
+..++||||+++|+|.+++.... .+++..+..++.||++||.||| +++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 99999999999999999998653 3788999999999999999999 8899999999999999
Q ss_pred cCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHH
Q 038905 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 629 (709)
Q Consensus 551 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~ 629 (709)
+.++.+||+|||+++.+.............||+.|+| ||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA-PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCC-HHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceEC-HhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999987665433322245677899999 999999999999999999999999999 99999765433311
Q ss_pred hHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 630 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 630 ~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..+..+.... .+...+..+.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 316 -------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 316 -------KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -------HHHHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1222222111 122345678999999999999999999999999988653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=342.89 Aligned_cols=249 Identities=23% Similarity=0.242 Sum_probs=207.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.+|||.+... .....+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 467777778888888888766654 57889999998653 234567889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++|+|..++.+...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999999988888999999999999999999999 88999999999999999999999999999986443
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ...+..+...
T Consensus 158 ~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~---- 223 (337)
T 1o6l_A 158 DGAT--MKTFCGTPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEEIR---- 223 (337)
T ss_dssp TTCC--BCCCEECGGGCC-GGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC----
T ss_pred CCCc--ccccccChhhCC-hhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCC----
Confidence 3222 256789999999 9999999999999999999999999999999976543321 1112222211
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
.+...+..+.+++..||+.||++|| +++|+++
T Consensus 224 ------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1123456789999999999999999 8999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=335.08 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=207.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... ..++.||+|.+... .....+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDT---ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET---TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hccEEEEEEEccCCCEEEEEEEEC---CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 345777777778888877666554 57889999987432 233457899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++++|.+++.....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999999998888999999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..... .....||+.|+| ||.+.+..++.++||||||+++|||++|+.||......... ...... .....
T Consensus 164 ~~~~~-~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~-~~~~~-- 232 (294)
T 4eqm_A 164 TSLTQ-TNHVLGTVQYFS-PEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD-SVPNV-- 232 (294)
T ss_dssp ------------CCSSCC-HHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS-CCCCH--
T ss_pred ccccc-cCccccCccccC-HhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc-cCCCc--
Confidence 33221 245679999999 99999999999999999999999999999999765432211 111111 11111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHcccccCC
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEVVVEVD 696 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~~~~~ 696 (709)
........+..+.+++.+|++.||++|| +++++.+.|+......
T Consensus 233 ---~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 233 ---TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp ---HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ---chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 1111233557889999999999999998 9999999998876433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.66 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=204.3
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
|.....+|.|+++.||.+... .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~---~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREK---HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhccEEeccCCCeEEEEEEEC---CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 455556777777777655544 57889999998766666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccc
Q 038905 496 LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 575 (709)
+++++|.+++.+ ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~- 198 (321)
T 2c30_A 124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR- 198 (321)
T ss_dssp CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB-
T ss_pred CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc-
Confidence 999999998864 46899999999999999999999 8899999999999999999999999999998776543221
Q ss_pred eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccccc
Q 038905 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 655 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~ 655 (709)
....||+.|+| ||++.+..++.++||||||+++|||++|+.||......+.. ..+.......+.
T Consensus 199 -~~~~gt~~y~a-PE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~-------~~~~~~~~~~~~------- 262 (321)
T 2c30_A 199 -KSLVGTPYWMA-PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-------KRLRDSPPPKLK------- 262 (321)
T ss_dssp -CCCCSCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSSCCCCT-------
T ss_pred -ccccCCccccC-HhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCCCCcC-------
Confidence 56789999999 99999999999999999999999999999999765432211 111111111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 656 NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 656 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.....+..+.+++.+||+.||++|||++++++.
T Consensus 263 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 263 NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112345678899999999999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=346.46 Aligned_cols=268 Identities=24% Similarity=0.283 Sum_probs=205.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC----e
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ----N 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~----~ 488 (709)
.++|.....+|.|+++.||.+ .. .++.||||++.... .....+..|+.++.+++|||||++++++.+.. .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~-~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKA-QL----LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEE-EE----TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEE-EE----CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 456666666777777777554 43 36899999987543 34456677999999999999999999997743 4
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCC----------CeEecCCCCCceeecCCCCeEE
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS----------QIIHCDIKPQNILLDDYYNAQI 558 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~----------~iiH~Dlkp~NIll~~~~~~kl 558 (709)
.++||||+++|+|.+++... .+++..+..++.||++||.||| +. +|+||||||+|||++.++.+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 69999999999999999764 5899999999999999999999 77 9999999999999999999999
Q ss_pred ccccccccccccccccceeccccCcccccccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhH--
Q 038905 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN-----STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL-- 631 (709)
Q Consensus 559 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~-- 631 (709)
+|||+++.+.............||+.|+| ||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMA-PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCC-HHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred ccCCcccccccccCccccccCccCccccC-HhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 99999987765544333345789999999 999987 3567789999999999999999999975432111000
Q ss_pred -------HHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 632 -------TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 632 -------~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
................+.. .......+..+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0011111111111111111 11123466789999999999999999999999999988754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=352.95 Aligned_cols=264 Identities=22% Similarity=0.367 Sum_probs=198.2
Q ss_pred hhcccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 410 KRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 410 ~~~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
.....+|.....+|.|+++.||.+.....+..+..||||+++.. .....+++.+|+.++++++|||||++++++.+...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 33355677666666777776655444433456788999998754 33455789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
.++||||+++++|.+++.+.. .+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999998764 6999999999999999999999 889999999999999999999999999999877
Q ss_pred cccccccc-eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 568 TLNQSKAI-KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 568 ~~~~~~~~-~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
........ .....+++.|+| ||++.+..++.++||||||+++|||++ |+.||......+.. ..+..+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~-------~~i~~~~-- 267 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTS-PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-------KAVDEGY-- 267 (373)
T ss_dssp ----------------CTTSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH-------HHHHTTE--
T ss_pred ccCCccceeccCCCcCCCccC-hhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC--
Confidence 65432211 123345778998 999999999999999999999999998 99999755433211 1111111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
........+..+.+++..||+.||.+||++.+|+++|+.+.
T Consensus 268 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 268 -------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp -------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 11112345677899999999999999999999999998864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.37 Aligned_cols=252 Identities=22% Similarity=0.248 Sum_probs=205.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch------hHHHHHHHHHHHhccCcCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD------GEKEFKNEVVMIGQTYHKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~ 486 (709)
.+.|.....+|.|+++.||.+... .+++.+|+|.+...... ..+++.+|+.++.+++|||||++++++.+.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREK---STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred hhceEEeeEEeeCcCEEEEEEEEC---CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 345666677777877877666554 57889999988653221 357899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC----CeEEcccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY----NAQISDFG 562 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFG 562 (709)
...++||||+++|+|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999999988888999999999999999999999 88999999999999998877 79999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
+++.+..... .....||+.|+| ||++.+..++.++|||||||++|||++|..||......+. ...+..+
T Consensus 165 ~a~~~~~~~~---~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-------~~~i~~~ 233 (361)
T 2yab_A 165 LAHEIEDGVE---FKNIFGTPEFVA-PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITAV 233 (361)
T ss_dssp SCEECCTTCC---CCCCCSCGGGCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTT
T ss_pred CceEcCCCCc---cccCCCCccEEC-chHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc
Confidence 9987754332 156789999999 9999999999999999999999999999999976544331 1122222
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.... +.. .....++.+.+++..||+.||.+|||+.|+++
T Consensus 234 ~~~~--~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SYDF--DEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCC--CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCC--Cch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2110 000 01123567889999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.68 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=210.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
.++|.....+|.|+++.||.+.... ....++.||||++.... ....+.+.+|++++.++ +|||||++++++.+.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 5677777778888888887665443 33577899999997643 33456799999999999 79999999999987554
Q ss_pred -EEEEEeecCCCCHHHHHhhCCC---------------------------------------------------------
Q 038905 489 -RLLVYKFLNNGTLASFLFENLK--------------------------------------------------------- 510 (709)
Q Consensus 489 -~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 510 (709)
.++||||+++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 8999999999999999986532
Q ss_pred ---------CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceecccc
Q 038905 511 ---------PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG 581 (709)
Q Consensus 511 ---------l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 581 (709)
+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+.............|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 788899999999999999999 88999999999999999999999999999987755444333356789
Q ss_pred CcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHH
Q 038905 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 660 (709)
Q Consensus 582 t~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~ 660 (709)
|+.|+| ||++.+..++.++||||||+++|||++ |+.||......+.. ......+..... ....
T Consensus 258 t~~y~a-PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~~~~~~---------~~~~ 321 (359)
T 3vhe_A 258 PLKWMA-PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMRA---------PDYT 321 (359)
T ss_dssp CGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHTCCCCC---------CTTC
T ss_pred CceeEC-hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcCCCCCC---------CCCC
Confidence 999999 999999999999999999999999998 99999765432211 111122211111 1224
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 661 VEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 661 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+..+.+++..||+.||++|||+.|++++|+.+.
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 467889999999999999999999999998765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=345.57 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=202.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
.++|.....+|.|+++.||.+... .+++.+|||++... .....+.+.+|..++..+ +|||||++++++.+.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVK---ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEc---CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 567887778888888888766655 57889999998653 233556788999999988 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||||+++|+|..++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999999998888999999999999999999999 8899999999999999999999999999998644
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ...+..+...
T Consensus 176 ~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~~~~--- 242 (353)
T 3txo_A 176 CNGVT--TATFCGTPDYIA-PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEAILNDEVV--- 242 (353)
T ss_dssp C-----------CCGGGCC-HHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC---
T ss_pred cCCcc--ccccCCCcCeEC-hhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCCC---
Confidence 33222 256789999999 9999999999999999999999999999999986654331 1222222211
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM------RKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~ev~~ 687 (709)
.+...+..+.+++..||+.||++||++ +++++
T Consensus 243 -------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 -------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 112245678899999999999999998 67765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.40 Aligned_cols=251 Identities=21% Similarity=0.283 Sum_probs=201.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+++.||.+... .+++.+|||++.... ....+.+.+|..++.++ +|||||++++++.+.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLK---KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 567787778888888888766655 578899999987542 22335688999999887 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||||+++|+|..++.+...+++..+..++.||+.||.||| +++|+||||||+|||++.++++||+|||+++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999999998888999999999999999999999 8899999999999999999999999999998643
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhh--HHhHHHHHHHhhhcCCccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~g~~~~ 646 (709)
..... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ .........+....+...
T Consensus 205 ~~~~~--~~~~~gt~~Y~a-PE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 280 (396)
T 4dc2_A 205 RPGDT--TSTFCGTPNYIA-PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 280 (396)
T ss_dssp CTTCC--BCCCCBCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-
T ss_pred cCCCc--cccccCCcccCC-chhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-
Confidence 32222 267899999999 999999999999999999999999999999996432211 111111222222222221
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 682 (709)
.+...+..+.+++..||+.||.+||++
T Consensus 281 ---------~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 ---------IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 122345678899999999999999995
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=341.67 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=202.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCC-ceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTR-TTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||.+.....+.. ...||+|.+... .....+++.+|+.++++++|||||++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 56788777888888888876665533222 234688887543 2345678999999999999999999999998754 78
Q ss_pred EEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+|+||+.+|+|.+++.+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999999875 46999999999999999999999 88999999999999999999999999999998765
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
...........||+.|+| ||++.+..++.++||||||+++|||++ |+.||......+.. .....+..
T Consensus 170 ~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~~---- 237 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGER---- 237 (327)
T ss_dssp TCC-------CCCGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCC----
T ss_pred CcccccccCCCccccccC-hHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------HHHHcCCC----
Confidence 544433345667889999 999999999999999999999999999 99999765443321 11111111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.......+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 238 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1112234567889999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.29 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=205.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSR---HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 456777777777778877766554 578899999986532 23456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++|+|.+++.+...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999999998888999999999999999999999 89999999999999999999999999999987643
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.. ...+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ...+..+...
T Consensus 159 ~~-----~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~~~---- 221 (318)
T 1fot_A 159 VT-----YTLCGTPDYIA-PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKILNAELR---- 221 (318)
T ss_dssp CB-----CCCCSCTTTCC-HHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHCCCC----
T ss_pred cc-----ccccCCccccC-HhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC----
Confidence 22 56789999999 9999999999999999999999999999999976543221 1122222211
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
.+...+..+.+++..||+.||++|| +++++++
T Consensus 222 ------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 ------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1122456788999999999999999 8899875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.35 Aligned_cols=261 Identities=26% Similarity=0.322 Sum_probs=208.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+.... ....+..||||++... ......++.+|+.++.+++|||||++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4567767777888888776655332 2246788999998654 344556799999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC-------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC---CeEEc
Q 038905 490 LLVYKFLNNGTLASFLFENL-------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY---NAQIS 559 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~-------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 559 (709)
++||||+++|+|.+++.... .+++..+..++.||++||.||| +++|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999998643 4889999999999999999999 88999999999999999555 59999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||+++.+.............||+.|+| ||++.+..++.++|||||||++|||++ |..||......+. ...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~-------~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMP-PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------LEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHH
T ss_pred CCccccccccccccccCCCcCCcccEEC-HHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH
Confidence 9999986644333222255678999999 999999999999999999999999998 9999976543331 122
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+..+.... .....+..+.+++..||+.||++|||+.+|++.|+.+.
T Consensus 299 i~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 299 VTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 22222111 12234567889999999999999999999999998865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=347.08 Aligned_cols=264 Identities=27% Similarity=0.381 Sum_probs=213.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEec----CCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQT----STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~ 486 (709)
.++|.....+|.|+++.||.+..... ......||||++.... ....+++.+|+++++++ +|||||++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 45677777777778888876665432 1345789999987543 33457899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee
Q 038905 487 QNRLLVYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll 550 (709)
+..++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 99999999999999999998753 4899999999999999999999 8899999999999999
Q ss_pred cCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHH
Q 038905 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 629 (709)
Q Consensus 551 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~ 629 (709)
+.++.+||+|||+++...............||+.|+| ||++.+..++.++||||||++++||++ |..||......+.
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA-PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSC-HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeC-HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 9999999999999987765433333355678899998 999999999999999999999999999 9999975543321
Q ss_pred hHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCC
Q 038905 630 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVD 696 (709)
Q Consensus 630 ~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 696 (709)
...+..+..... ....+..+.+++..||+.||++|||++||++.|+.+....
T Consensus 303 ------~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 303 ------FKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp ------HHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ------HHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 122222221111 1234567899999999999999999999999999876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=341.65 Aligned_cols=268 Identities=22% Similarity=0.357 Sum_probs=204.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe-cCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEc--CCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ-TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE--GQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~--~~~~ 489 (709)
..+|.....+|.|+++.||.+.... ....++.||||++........+++.+|+.++.+++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4556666666777777775554221 235789999999987766667889999999999999999999999854 3558
Q ss_pred EEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999998765 4999999999999999999999 8899999999999999999999999999998775
Q ss_pred ccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhH---------HhHHHHHHHh
Q 038905 569 LNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY---------AILTDWAFDC 638 (709)
Q Consensus 569 ~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~ 638 (709)
..... .......|+..|+| ||.+.+..++.++||||||+++|||++|..|+........ ........+.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp ----------CTTCGGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeC-cHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 44322 11234557778998 9999999999999999999999999999999864322110 0000111111
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
...+. ....+...+..+.+++..||+.||++|||+.|+++.|+.+.
T Consensus 245 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 245 LKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111 11113345678999999999999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=351.18 Aligned_cols=258 Identities=22% Similarity=0.292 Sum_probs=205.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+... .+++.||||.+.... .+..+++.+|++++++++|||||++++++.+.+..++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLR---ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEe---cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 445666666777777777554443 468899999987542 2344678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999998654 5899999999999999999999 889999999999999999999999999999865433
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..........+++.|+| ||.+.+..++.++||||||+++|||++ |..||......+.. ..+..+...
T Consensus 267 ~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~---- 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTA-PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEKGGRL---- 334 (377)
T ss_dssp EEECCSSCCEEEGGGSC-HHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHTTCCC----
T ss_pred ceeecCCCCCCCcCcCC-HhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCCC----
Confidence 22111123346778998 999998899999999999999999998 99999765433211 112222111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
..+...+..+.+++..||+.||++|||++++++.|+.+.
T Consensus 335 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 -----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 112234567889999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.78 Aligned_cols=253 Identities=20% Similarity=0.218 Sum_probs=206.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+++.||.+... .+++.+|+|++.... ....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~---~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKV---LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEET---TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEEC---CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 456777777888888888666555 578899999886432 334567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec---CCCCeEEccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD---DYYNAQISDFGLAKLL 567 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~~ 567 (709)
+||||+++|+|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+++..
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999999999889999999999999999999999 88999999999999998 5678999999999877
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
...... .....||+.|+| ||++.+..++.++|||||||++|+|++|..||......+ ....+..+.....
T Consensus 164 ~~~~~~--~~~~~gt~~Y~A-PE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~ 233 (444)
T 3soa_A 164 EGEQQA--WFGFAGTPGYLS-PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAYDFP 233 (444)
T ss_dssp CTTCCB--CCCSCSCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCCC
T ss_pred cCCCce--eecccCCcccCC-HHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCCCCC
Confidence 644322 145789999999 999999999999999999999999999999997654333 1222233322111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......+..+.+++..||+.||.+|||+.|+++
T Consensus 234 ------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 ------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0011234567889999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.42 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=211.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecC--CCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTS--TRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+...... ..++.||||.+.... ....+++.+|+.++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 567777777777777777666554211 355899999987543 33457899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhC------------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCC
Q 038905 490 LLVYKFLNNGTLASFLFEN------------------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKP 545 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp 545 (709)
++||||+++++|.+++... ..+++..+..++.||++||.||| +++|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCc
Confidence 9999999999999999864 45889999999999999999999 88999999999
Q ss_pred CceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccc
Q 038905 546 QNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEM 624 (709)
Q Consensus 546 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~ 624 (709)
+|||++.++.+||+|||+++.+.............||+.|+| ||++.+..++.++||||||+++|||++ |..||....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP-PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecC-hhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999987654433222245678999999 999999999999999999999999999 999997654
Q ss_pred hhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 625 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 625 ~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..+. ......+....+ +...+..+.+++..||+.||++|||+.+++++|+.+.+
T Consensus 282 ~~~~-------~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 HEEV-------IYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HHHH-------HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hHHH-------HHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 3321 122233332211 12345678999999999999999999999999998765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.63 Aligned_cols=257 Identities=23% Similarity=0.321 Sum_probs=208.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+ .. ..+..||||++.... ...+++.+|+.++.+++||||+++++++.+....++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~-~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLG-KW---KGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEE-EE---TTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEE-Ee---cCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 456666666777777777554 44 356789999987643 3457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999998754 4999999999999999999999 8899999999999999999999999999998765543
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.... ....+|+.|+| ||.+.+..++.++||||||++++||++ |+.||......+.. .....+....
T Consensus 159 ~~~~-~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~~~---- 225 (268)
T 3sxs_A 159 YVSS-VGTKFPVKWSA-PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-------LKVSQGHRLY---- 225 (268)
T ss_dssp EEEC-CSCCCCGGGCC-HHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHHHTTCCCC----
T ss_pred hhcc-cCCCcCcccCC-HHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-------HHHHcCCCCC----
Confidence 2221 44567788998 999999999999999999999999999 99999765443321 1111211110
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccC
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEV 695 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 695 (709)
.+...+..+.+++..||+.||++|||+.++++.|+.+.+.
T Consensus 226 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 226 -----RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -----CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -----CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0112345788999999999999999999999999998654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=330.60 Aligned_cols=278 Identities=33% Similarity=0.497 Sum_probs=218.2
Q ss_pred CCCCChhhHhhhccccccee------eeecCeeEEEEEEEEEEecCCCceEEEEEEcccc----cchhHHHHHHHHHHHh
Q 038905 400 PSPPDPEDKKKRNMMNVTRS------VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV----FQDGEKEFKNEVVMIG 469 (709)
Q Consensus 400 ~~~~~~~~~~~~~~~~f~~~------~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~ 469 (709)
..++..++... +++|... ..+|.|+++.|| .+.. .++.||||++... .....+.+.+|+.+++
T Consensus 13 ~~~~~~~l~~~--~~~f~~~~~~~~~~~lg~G~~g~Vy-~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~ 85 (307)
T 2nru_A 13 HSFSFYELKNV--TNNFDERPISVGGNKMGEGGFGVVY-KGYV----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85 (307)
T ss_dssp EECCHHHHHHH--TTTTCCSBTTTTCCEEEECSSEEEE-EEES----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH
T ss_pred CcccHHHHHHH--HcccccccccccCCccccCCCeEEE-EEEE----CCceEEEEEEecccCcchHHHHHHHHHHHHHHH
Confidence 35667788888 7777755 556666666665 4443 4778999988642 2334678999999999
Q ss_pred ccCcCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhh---CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCC
Q 038905 470 QTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFE---NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQ 546 (709)
Q Consensus 470 ~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~---~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~ 546 (709)
+++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+
T Consensus 86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~ 162 (307)
T 2nru_A 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSA 162 (307)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHH
Confidence 99999999999999999999999999999999999874 245899999999999999999999 889999999999
Q ss_pred ceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchh
Q 038905 547 NILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE 626 (709)
Q Consensus 547 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~ 626 (709)
||+++.++.+||+|||+++...............||+.|+| ||.+.+ .++.++||||||+++|||++|+.||......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a-PE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA-PEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCC-HHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCC-hHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 99999999999999999987665433333345689999999 998876 4889999999999999999999999765432
Q ss_pred hHHhHHHHHHHhhh--cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 627 EYAILTDWAFDCYR--NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 627 ~~~~~~~~~~~~~~--~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
..... +.+... ...+...++... .......++.+.+++..||+.||.+|||+.+|+++|+.+.
T Consensus 241 ~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 241 QLLLD---IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SBTTH---HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHH---HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 21110 011111 112222333322 2235677889999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=330.04 Aligned_cols=256 Identities=22% Similarity=0.340 Sum_probs=206.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+ .. ..+..||||++.... ...+++.+|+.++.+++||||+++++++.+....++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~-~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLG-YW---LNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEE-EE---TTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEE-Ee---cCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 345665566666666666544 44 356779999987643 3457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 99999999999997644 5899999999999999999999 8899999999999999999999999999998765433
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.... ....||+.|+| ||.+.+..++.++||||||++++||++ |+.||......+.. .....+..
T Consensus 161 ~~~~-~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~-------~~~~~~~~------ 225 (269)
T 4hcu_A 161 YTSS-TGTKFPVKWAS-PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------EDISTGFR------ 225 (269)
T ss_dssp HHST-TSTTCCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTTCC------
T ss_pred cccc-cCcccccccCC-HHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHhcCcc------
Confidence 2221 45567888998 999999999999999999999999999 99999765433211 11112111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
...+...+..+.+++..||+.||++|||+.++++.|+.+.+
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 226 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 01122235678999999999999999999999999988754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=339.19 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=204.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEEC---CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 356777777788888877666554 578899999986432 2234678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999999999988878999999999999999999999 8899999999999999999999999999998775444
Q ss_pred cccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.........||+.|+| ||++.+..+ +.++||||||+++|||++|+.||.......... ..+......
T Consensus 160 ~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~----- 227 (323)
T 3tki_A 160 RERLLNKMCGTLPYVA-PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTY----- 227 (323)
T ss_dssp EECCBCSCCSCGGGSC-HHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH------HHHHTTCTT-----
T ss_pred cccccCCCccCcCccC-cHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHhccccc-----
Confidence 3333356789999999 999988775 789999999999999999999997654322111 111111110
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.......+..+.+++..||+.||++|||++|+++.
T Consensus 228 ---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00112345678899999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.01 Aligned_cols=250 Identities=17% Similarity=0.199 Sum_probs=203.7
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+++.||.+... .++..+|+|.+... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVET---SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEEC---CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 45666666777777777655544 57889999998754 345567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC--CCCeEEcccccccccccc
Q 038905 494 KFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD--YYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~~ 570 (709)
||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++.+...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999997654 6999999999999999999999 889999999999999987 789999999999877543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.. .....||+.|+| ||++.+..++.++||||||+++|||++|..||......+. ...+..+.....
T Consensus 158 ~~---~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~~--- 223 (321)
T 1tki_A 158 DN---FRLLFTAPEYYA-PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-------IENIMNAEYTFD--- 223 (321)
T ss_dssp CE---EEEEESCGGGSC-HHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCCCC---
T ss_pred Cc---cccccCChhhcC-cHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-------HHHHHcCCCCCC---
Confidence 32 255789999999 9999998899999999999999999999999976544321 112222221110
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......+..+.+++..||+.||.+|||+.|+++
T Consensus 224 ---~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 ---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001123567899999999999999999999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=338.08 Aligned_cols=246 Identities=23% Similarity=0.222 Sum_probs=207.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.||||.+... .....+.+.+|+.++.+++||||+++++++.+....
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEEC---CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 456777777888888888766655 57889999998643 223457889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++|+|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999999998888999999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.. ...+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ ..+.+..+...
T Consensus 194 ~~-----~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~---- 256 (350)
T 1rdq_E 194 RT-----WTLCGTPEALA-PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVR---- 256 (350)
T ss_dssp CB-----CCCEECGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC----
T ss_pred Cc-----ccccCCccccC-HHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCCCC----
Confidence 32 46789999999 999999999999999999999999999999997654322 12222333221
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
.+...+..+.+++..||+.||.+||+ ++++++
T Consensus 257 ------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 ------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11234567899999999999999998 888876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.95 Aligned_cols=251 Identities=24% Similarity=0.265 Sum_probs=204.1
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc------hhHHHHHHHHHHHhccCcCceeEEEeEEEcCC
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ------DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~ 487 (709)
+.|.....+|.|+++.||.+... .++..+|||.+..... ...+++.+|+.++.+++||||+++++++.+..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREK---STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEET---TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cceEeceEEeeCCCeEEEEEEEC---CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45666667777888877666554 5688999998865322 13678999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC----CeEEccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY----NAQISDFGL 563 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFGl 563 (709)
..++||||+++++|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999999988888999999999999999999999 88999999999999999887 799999999
Q ss_pred cccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
++.+...... ....||+.|+| ||++.+..++.++||||||+++|||++|+.||......+... ......
T Consensus 165 a~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~~~~~~ 233 (326)
T 2y0a_A 165 AHKIDFGNEF---KNIFGTPEFVA-PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NVSAVN 233 (326)
T ss_dssp CEECCTTSCC---CCCCSCTTTCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHHTC
T ss_pred CeECCCCCcc---ccccCCcCcCC-ceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------HHHhcC
Confidence 9877543322 45679999999 999999999999999999999999999999997654332111 111111
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... ........+..+.+++..||+.||.+|||+.|+++
T Consensus 234 ~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YEF------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCC------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCc------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110 00001123467889999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.58 Aligned_cols=248 Identities=25% Similarity=0.307 Sum_probs=205.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+.+..|..++.++ +||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFK---KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 667887777788888877666554 578999999986532 34556788999999887 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||||+++|+|..++.+...+++..+..++.||+.||.||| +++|+||||||+|||++.++++||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999999998888999999999999999999999 8899999999999999999999999999998654
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ...+..+...
T Consensus 170 ~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~--- 236 (345)
T 1xjd_A 170 LGDAK--TNTFCGTPDYIA-PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-------FHSIRMDNPF--- 236 (345)
T ss_dssp CTTCC--BCCCCSCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC---
T ss_pred cCCCc--ccCCCCCcccCC-hhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHhCCCC---
Confidence 32222 256789999999 9999999999999999999999999999999976543321 1222222211
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMR-KVS 686 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~ 686 (709)
.+...+..+.+++..||+.||++||++. ++.
T Consensus 237 -------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 -------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1122456788999999999999999997 665
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.99 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=211.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+..... ...+..||||++.... ....+++.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45666666677777777766655422 2456899999987543 34457899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCC------------------------CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCC
Q 038905 490 LLVYKFLNNGTLASFLFENLK------------------------PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKP 545 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp 545 (709)
++||||+++++|.+++..... +++..+..++.||++||.||| +.+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 999999999999999987543 788899999999999999999 88999999999
Q ss_pred CceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccc
Q 038905 546 QNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEM 624 (709)
Q Consensus 546 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~ 624 (709)
+||+++.++.+||+|||+++...............+++.|+| ||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMA-IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCC-HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccC-hhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987765443333345667889999 999999999999999999999999999 999997654
Q ss_pred hhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 625 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 625 ~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..... .....+.... .....++.+.+++..||+.||++|||+.++++.|+.+.+
T Consensus 258 ~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PERLF-------NLLKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGGHH-------HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH-------HHhhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 43321 1222222111 122345678999999999999999999999999988653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=337.77 Aligned_cols=249 Identities=23% Similarity=0.278 Sum_probs=206.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+++.||.+... .+++.+|||++... .....+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET---TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 567887788888888888776655 56889999998653 234557789999999988 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||||+++|+|..++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999999998888999999999999999999999 8899999999999999999999999999998643
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ ..+.+..+...
T Consensus 173 ~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~--- 239 (353)
T 2i0e_A 173 WDGVT--TKTFCGTPDYIA-PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNVA--- 239 (353)
T ss_dssp CTTCC--BCCCCSCGGGCC-HHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC---
T ss_pred cCCcc--cccccCCccccC-hhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCCC---
Confidence 32222 256789999999 999999999999999999999999999999997654332 11222222211
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
.+...+..+.+++..||+.||.+||+ ++++++
T Consensus 240 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 -------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11234567899999999999999996 466654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=339.30 Aligned_cols=253 Identities=20% Similarity=0.227 Sum_probs=204.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+++.||.+... .+++.+|+|++... .....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEEC---CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 345666666777777777655544 57889999998643 2334567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC---CCeEEccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY---YNAQISDFGLAKLL 567 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla~~~ 567 (709)
+||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+++..
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999999988888999999999999999999999 8899999999999999865 45999999999877
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
..... .....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ ....+..+.....
T Consensus 182 ~~~~~---~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~~~ 250 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLS-PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDYP 250 (362)
T ss_dssp TTCCS---CCCSCSCTTTCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCCC
T ss_pred cCCcc---cccCCCCccccC-HHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCCC
Confidence 64332 145789999999 999999999999999999999999999999997654322 1122223322110
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
. ......+..+.+++..||+.||++|||+.++++.
T Consensus 251 -~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 -S-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -T-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -c-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0012345678899999999999999999998763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.05 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=201.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+++.||.+... .+++.+|||++... .....+.+.+|..++.++ +|||||++++++.+...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLK---KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 456777777888888888766554 57889999998654 233456788999999988 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||||+++|+|..++.+...+++..+..++.||+.||.||| +++|+||||||+|||++.++++||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999999988888999999999999999999999 8899999999999999999999999999998643
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhh--HHhHHHHHHHhhhcCCccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~g~~~~ 646 (709)
..... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||....... .........+....+...
T Consensus 162 ~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 237 (345)
T 3a8x_A 162 RPGDT--TSTFCGTPNYIA-PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 237 (345)
T ss_dssp CTTCC--BCCCCSCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-
T ss_pred CCCCc--ccccCCCccccC-ccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-
Confidence 32222 256789999999 999999999999999999999999999999996532111 001111122222222211
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 682 (709)
.+...+..+.+++..||+.||.+||++
T Consensus 238 ---------~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 ---------IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 112345678899999999999999995
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=340.14 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=205.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.+|+|.+... .....+.+.+|+.++.+++|||||++++++.+.+..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKN---DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 466777778888888888766555 57889999988643 233557889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+.+|+|..++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999999998888999999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRN---STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
... ....+||+.|+| ||++.+ ..++.++|||||||++|||++|+.||............ ........
T Consensus 168 ~~~---~~~~~gt~~Y~a-PE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~~-- 237 (384)
T 4fr4_A 168 ETQ---ITTMAGTKPYMA-PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETTVV-- 237 (384)
T ss_dssp TCC---BCCCCSCGGGCC-GGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHCCC--
T ss_pred CCc---eeccCCCccccC-CeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhccc--
Confidence 332 256789999999 999974 45899999999999999999999999755432221111 11111111
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-MRKVSQ 687 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~ 687 (709)
..+...+..+.+++..||+.||.+||+ ++++.+
T Consensus 238 --------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 --------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 112234567899999999999999998 777664
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.39 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=206.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+++.||.+ .. ..+..||||++.... ...+++.+|++++.+++|+||+++++++.+....++|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~-~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYG-KW---RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp GGGEEEEEECC---CEEEEEE-EE---TTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEE-EE---cCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 456777778888888888655 44 357789999987653 2457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++++|.+++.. ...+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999976 457999999999999999999999 8899999999999999999999999999998765433
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.... ....+|+.|+| ||.+.+..++.++||||||+++|||++ |+.||......+.. .....+...
T Consensus 175 ~~~~-~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~~~~----- 240 (283)
T 3gen_A 175 YTSS-VGSKFPVRWSP-PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-------EHIAQGLRL----- 240 (283)
T ss_dssp HHST-TSTTSCGGGCC-HHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHHHTTCCC-----
T ss_pred cccc-cCCccCcccCC-HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-------HHHhcccCC-----
Confidence 2211 34567888998 999999999999999999999999998 99999765433211 111121110
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..+...++.+.+++..||+.||.+|||++++++.|+.+.+
T Consensus 241 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 241 ----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 0112234678899999999999999999999999987654
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=329.05 Aligned_cols=214 Identities=18% Similarity=0.262 Sum_probs=173.6
Q ss_pred hhccccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCC-----
Q 038905 24 AQTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPR----- 98 (709)
Q Consensus 24 ~~~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~----- 98 (709)
+++.|+|++|++|++ +++|||++|+|+||||..+ ++|| |+ +.+ |||+|||+ .|+..
T Consensus 11 ~~~~~~l~~g~~l~~---~~~l~S~~g~F~lgf~~~~-------~~~l---y~--~~~-vvW~Anr~---~p~~~~~~~~ 71 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSA---GQYLLSPNQRFKLLLQGDG-------NLVI---QD--NGA-TVWVANEQ---QPFSSTIPLR 71 (276)
T ss_dssp CTTSSEECTTEEBCT---TCEEECTTSSEEEEECTTS-------CEEE---EE--TTE-EEEECSTT---STTEEEEECC
T ss_pred cccCCEecCCCEecC---CCEEEcCCCcEEEEEECCC-------CeEE---EC--CCC-eEEECCCC---CCcCCccccc
Confidence 456799999999999 7999999999999999321 2677 77 777 99999999 89874
Q ss_pred CcEEEEecCccEEE--EcCCCcEEEeecc-------------E--------EEeccCCceeeeecCCCCCccCCCcc---
Q 038905 99 GSQVKLTADQGLVL--NDPQGKQVWSSKL-------------I--------LVQSFSSSRLWDSFSNPTDTLLPGKM--- 152 (709)
Q Consensus 99 ~~~L~l~~~G~L~l--~~~~g~~vWss~~-------------~--------vl~~~~~~~lWQSFd~PtDtlLpgq~--- 152 (709)
+++|+|+.||+|+| .|++|++||||++ + ||+| +.+|||| ||||||||||+
T Consensus 72 ~~~l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~ 147 (276)
T 3m7h_A 72 NKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSL 147 (276)
T ss_dssp CTTCCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCE
T ss_pred ceEEEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--cccccccccccccc
Confidence 78999999999999 8888999999851 1 6666 7899999 99999999999
Q ss_pred -cCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccceEEEEEec
Q 038905 153 -METEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRN 231 (709)
Q Consensus 153 -l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (709)
|..+++| ++.+||++|.|+++|+++|++.++ +++ ..+||++++|+. .. ..+.++.+|.+.+.+.+
T Consensus 148 ~l~~g~~L---~S~~dps~G~fsl~l~~dGnlvLy-~~~-----~~~yW~Sgt~~~----~~-~~l~l~~dGnLvl~d~~ 213 (276)
T 3m7h_A 148 LLAPGSEL---VQGVVYGAGASKLVFQGDGNLVAY-GPN-----GAATWNAGTQGK----GA-VRAVFQGDGNLVVYGAG 213 (276)
T ss_dssp EECSSEEE---CTTCEEEETTEEEEECTTSCEEEE-CTT-----SSEEEECCCTTT----TC-CEEEECTTSCEEEECTT
T ss_pred ccccCccc---ccCCCCCCceEEEeecCCceEEEE-eCC-----CeEEEECCCCCC----cc-EEEEEcCCCeEEEEeCC
Confidence 7778888 567899999999999999987664 222 579999999974 22 56788888988887766
Q ss_pred CeeEEEeeeeccCCCCeEEEEEEccCCcEEEEEeecCCCCCeEEEEeccCC
Q 038905 232 GRRFDLTTERVVPAADFYHRATLNFDGVFVQSFYLKNGNGNWSVVWSQPEN 282 (709)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~~~~~~~~~W~~~~~~p~~ 282 (709)
+..+..+... ....+|++|+.||++++|.| ...|+.++.+|..
T Consensus 214 ~~~vWsS~t~----~~~~~rl~Ld~dGnLvly~~----~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 214 NAVLWHSHTG----GHASAVLRLQANGSIAILDE----KPVWARFGFQPTY 256 (276)
T ss_dssp SCEEEECSCT----TCTTCEEEECTTSCEEEEEE----EEEEESSSCCTTS
T ss_pred CcEEEEecCC----CCCCEEEEEcCCccEEEEcC----CCeEEccCccCCc
Confidence 6555554431 11238999999999999998 2468888777763
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.32 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=211.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEcccccc-hhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
.++|.....+|.|+++.||.+.... ....++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 4566766677777777776665432 335678999999875432 3457899999999999 99999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee
Q 038905 489 RLLVYKFLNNGTLASFLFENL------------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll 550 (709)
.++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 999999999999999998654 3889999999999999999999 8899999999999999
Q ss_pred cCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHH
Q 038905 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 629 (709)
Q Consensus 551 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~ 629 (709)
+.++.+||+|||+++...............||+.|+| ||.+.+..++.++||||||++++||++ |+.||.........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA-PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeC-hHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 9999999999999988766544333355678899999 999999999999999999999999999 99999765432211
Q ss_pred hHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 630 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 630 ~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
......+.. .......+..+.+++..||+.||.+|||+.+++++|+.+.
T Consensus 258 ------~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 ------YKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ------HHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHhccCCC---------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111111110 0112234567899999999999999999999999998865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.50 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=194.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+.....+.....||||+..... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 445666666677777777665555444567789999987543 334567999999999999999999999984 567899
Q ss_pred EEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 999999999999998665 6899999999999999999999 889999999999999999999999999999877543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... .....+++.|+| ||.+.+..++.++||||||+++|||++ |..||......+.. ..+..+....
T Consensus 170 ~~~~-~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~-------~~i~~~~~~~--- 237 (281)
T 1mp8_A 170 TYYK-ASKGKLPIKWMA-PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------GRIENGERLP--- 237 (281)
T ss_dssp ----------CCGGGCC-HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCCCC---
T ss_pred cccc-cccCCCcccccC-hhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH-------HHHHcCCCCC---
Confidence 3221 134567889998 999999999999999999999999996 99999765443311 1112221111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.....+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 238 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 238 ------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 12234567889999999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.04 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=193.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE-
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR- 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~- 489 (709)
..+|.....+|.|+++.||.+.....+.....||||++... .....+++.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 45677777788888888876665543333458999998654 344567899999999999999999999999877665
Q ss_pred -----EEEEeecCCCCHHHHHhhCC------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEE
Q 038905 490 -----LLVYKFLNNGTLASFLFENL------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558 (709)
Q Consensus 490 -----~lV~Ey~~~gsL~~~l~~~~------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 558 (709)
++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence 99999999999999996532 5899999999999999999999 889999999999999999999999
Q ss_pred ccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHH
Q 038905 559 SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD 637 (709)
Q Consensus 559 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 637 (709)
+|||+++...............+++.|+| ||.+.+..++.++||||||+++|||++ |+.||......+.. .
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~ 250 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLA-LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-------N 250 (323)
T ss_dssp CCCCC-----------------CCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------H
T ss_pred eeccccccccccccccccccccCcccccC-chhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-------H
Confidence 99999987654433322245567889998 999999999999999999999999999 89999765443311 1
Q ss_pred hhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 638 ~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
....+... ......+..+.+++..||+.||++|||+.++++.|+.+..
T Consensus 251 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 251 YLIGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11122111 1122345678999999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=338.62 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=200.2
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.+.....+|.|+++.||.+... .++..||+|++........+++.+|+.++.+++|||||++++++.+.+..+||||
T Consensus 90 ~~~~~~~lG~G~~g~Vy~a~~~---~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 90 TVSKTEILGGGRFGQVHKCEET---ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp EEEEEEECC-----CEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eeecceEEecCcCEEEEEEEEc---CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3444567889999988766555 5688999999887655667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee--cCCCCeEEccccccccccccc
Q 038905 495 FLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL--DDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 495 y~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll--~~~~~~kl~DFGla~~~~~~~ 571 (709)
|+++++|.+++.... .+++..+..++.||++||.||| +.+|+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 999999999887654 6899999999999999999999 8899999999999999 567889999999998775443
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. ....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.. ..+...... +..
T Consensus 244 ~~---~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~i~~~~~~-~~~-- 309 (373)
T 2x4f_A 244 KL---KVNFGTPEFLA-PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL-------NNILACRWD-LED-- 309 (373)
T ss_dssp BC---CCCCSSCTTCC-HHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHTCCC-SCS--
T ss_pred cc---ccccCCCcEeC-hhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhccCC-CCh--
Confidence 22 45679999999 99999999999999999999999999999999765443211 111111111 000
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......++.+.+++..||+.||.+|||++|+++
T Consensus 310 ---~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 ---EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 001224567899999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.92 Aligned_cols=272 Identities=18% Similarity=0.195 Sum_probs=209.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC--eE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--NR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHK---KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEEC---CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 345666667777777777665554 568899999987543 334677889999999999999999999998665 77
Q ss_pred EEEEeecCCCCHHHHHhhCCC---CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee----cCCCCeEEcccc
Q 038905 490 LLVYKFLNNGTLASFLFENLK---PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL----DDYYNAQISDFG 562 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~---l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFG 562 (709)
++||||+++++|.+++..... +++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 999999999999999986543 899999999999999999999 8899999999999999 788889999999
Q ss_pred ccccccccccccceeccccCccccccccccc--------CCCCCcccchHHHHHHHHHHHhCCCCCCccchhh-HHhHHH
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFR--------NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTD 633 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~--------~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~-~~~~~~ 633 (709)
+++.+...... ....||+.|+| ||++. +..++.++|||||||++|||++|+.||....... ......
T Consensus 162 ~a~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 162 AARELEDDEQF---VSLYGTEEYLH-PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TCEECCTTCCB---CCCCSCGGGCC-HHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CceecCCCCce---eecccCCCccC-HHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 99877654322 45679999999 99986 5788999999999999999999999997543211 111111
Q ss_pred HHHHhhhcCCccccc-----------cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 634 WAFDCYRNGKLDDLV-----------EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 634 ~~~~~~~~g~~~~l~-----------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.+...........+. +-.............+.+++..||+.||++|||++|+++.......
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 111111111111000 0011122345778889999999999999999999999998876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.94 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=209.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+++.||.+..... ...+..||||.+.... ....+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 45677667777777777766665422 2467789999987532 23447899999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC-----------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCC
Q 038905 489 RLLVYKFLNNGTLASFLFENL-----------------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKP 545 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp 545 (709)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence 999999999999999998653 2788999999999999999999 88999999999
Q ss_pred CceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccc
Q 038905 546 QNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEM 624 (709)
Q Consensus 546 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~ 624 (709)
+|||++.++.+||+|||+++.+.............||+.|+| ||.+.+..++.++||||||+++|||++ |..||....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA-PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccC-HHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999987765544333356678899999 999999999999999999999999998 999997654
Q ss_pred hhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 625 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 625 ~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..... ......+.. ...+...++.+.+++..||+.||.+|||+.++++.|+.+..
T Consensus 280 ~~~~~------~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDANF------YKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSHHH------HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHHHH------HHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 32211 111112111 11122345678999999999999999999999999988654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=338.47 Aligned_cols=253 Identities=23% Similarity=0.253 Sum_probs=205.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+++.||.+... .+++.+|+|.+..........+.+|+.++.+++|||||++++++.+....++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEK---ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEEC---CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 345676667777777777665554 57889999998766555667899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC--CCCeEEccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD--YYNAQISDFGLAKLLTL 569 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~ 569 (709)
|||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999997654 6899999999999999999999 889999999999999974 57799999999987754
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... ....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.. ..+..+...
T Consensus 204 ~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------~~i~~~~~~---- 268 (387)
T 1kob_A 204 DEIV---KVTTATAEFAA-PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------QNVKRCDWE---- 268 (387)
T ss_dssp TSCE---EEECSSGGGCC-HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHHCCCC----
T ss_pred Ccce---eeeccCCCccC-chhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC----
Confidence 4322 45679999999 99999999999999999999999999999999865432211 111111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.........+..+.+++..||+.||.+|||+.|+++.
T Consensus 269 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 --FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0011112345678999999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=356.18 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=207.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+... ..+..||||.+.... ...++|.+|+.++++++|||||++++++.+....++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEG---GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEc---CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 345665666677777767544433 457899999997643 3567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++|+|.+++.+.. .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999998643 5889999999999999999999 889999999999999999999999999999877543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ......+++.|+| ||++.+..++.++|||||||++|||++ |+.||......+.. +.+..+.
T Consensus 372 ~~~-~~~~~~~~~~y~a-PE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~------ 436 (495)
T 1opk_A 372 TYT-AHAGAKFPIKWTA-PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKDY------ 436 (495)
T ss_dssp CEE-CCTTCCCCGGGCC-HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTC------
T ss_pred cee-ecCCCcCCcceeC-HhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC------
Confidence 322 1134556788998 999999999999999999999999999 89999765433211 1111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
....+...++.+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus 437 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 437 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 111123455788999999999999999999999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=332.32 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=197.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc----chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF----QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+++.||.+........++.+|||++.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 456777777888888888776665444678999999987542 2234568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||||+++++|.+++.....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999999999988888999999999999999999999 8899999999999999999999999999998654
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... ....+||+.|+| ||++.+..++.++||||||+++|||++|+.||......+.. ..+..+...
T Consensus 173 ~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-------~~i~~~~~~--- 239 (327)
T 3a62_A 173 HDGTV--THTFCGTIEYMA-PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI-------DKILKCKLN--- 239 (327)
T ss_dssp --------CTTSSCCTTSC-HHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHTCCC---
T ss_pred cCCcc--ccccCCCcCccC-HhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhCCCC---
Confidence 33221 256789999999 99999999999999999999999999999999765433211 111111111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
.+...+..+.+++..||+.||++|| +++|+++
T Consensus 240 -------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 -------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1123456788999999999999999 7778876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=326.36 Aligned_cols=263 Identities=16% Similarity=0.136 Sum_probs=207.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... ..+++.+|+.++.++ +|+|++++++++.++...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNL---LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET---TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEEC---CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 345666666777777777655544 578999999886432 345688999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC-----eEEccccccc
Q 038905 492 VYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN-----AQISDFGLAK 565 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~DFGla~ 565 (709)
||||+ +++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+|||+++
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999 999999998755 5999999999999999999999 899999999999999987776 9999999998
Q ss_pred cccccccc-----cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh
Q 038905 566 LLTLNQSK-----AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 640 (709)
Q Consensus 566 ~~~~~~~~-----~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 640 (709)
........ .......||+.|+| ||.+.+..++.++||||||+++|||++|+.||..............+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMS-INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCC-chhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 77654322 11256789999999 9999999999999999999999999999999986543221111111111111
Q ss_pred cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 641 NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 641 ~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
......+ ....++.+.+++..||+.||++|||+++|++.|+.+.+
T Consensus 239 ~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 239 STPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0010000 11245678999999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.91 Aligned_cols=271 Identities=20% Similarity=0.257 Sum_probs=201.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe-
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN- 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~- 488 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... ......+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDL---RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEEEccCCCEEEEEEEEC---CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 456777777777888877766655 578999999987542 2334678999999999999999999999876543
Q ss_pred ---EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 489 ---RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 489 ---~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
.++||||+++++|.+++.....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 4999999999999999988888999999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 566 LLTLNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 566 ~~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
.+...... .......||+.|+| ||++.+..++.++||||||+++|||++|+.||......+.. .........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~ 237 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLS-PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI 237 (311)
T ss_dssp -----------------CCTTCC-HHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC
T ss_pred cccccccccccccccCcCcccCC-HHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCC
Confidence 76544322 22245679999999 99999999999999999999999999999999765443211 111111111
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHcccccCCCCCCCCC
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVS-QMLEVVVEVDVPPNPST 703 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~-~~L~~~~~~~~p~~p~~ 703 (709)
.. .......+..+.+++..||+.||++||++.+++ ..|........|..|..
T Consensus 238 ~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~ 290 (311)
T 3ork_A 238 PP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290 (311)
T ss_dssp CH-------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCC
T ss_pred Cc-------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 00 000122456788999999999999999665554 55555544444444443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.88 Aligned_cols=247 Identities=22% Similarity=0.308 Sum_probs=203.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... .+....+.+|+.+++.++||||+++++++.+....
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHY---KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 466777777888888888766655 578899999986432 22346789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+ +|+|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999999 7899999988888999999999999999999999 78999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.... ...+||+.|+| ||++.+..+ +.++||||||+++|||++|+.||........ ...+.
T Consensus 161 ~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~ 221 (336)
T 3h4j_B 161 GNFL---KTSCGSPNYAA-PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVN 221 (336)
T ss_dssp SBTT---CCCTTSTTTSC-GGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCC
T ss_pred Cccc---ccccCCcCcCC-HHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHH
Confidence 4322 56789999999 999998876 7899999999999999999999975432110 00111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... ...+...+..+.+++..||+.||.+|||++|+++
T Consensus 222 ~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 110 1112234567889999999999999999999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=346.54 Aligned_cols=255 Identities=18% Similarity=0.193 Sum_probs=204.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... ..++.+|||++.... ....+.+.+|+.++.+++|||||++++++.+.+..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLK---NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEc---CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 577888788888888888666554 568899999986532 12233489999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
+|||||+++|+|.+++.+ ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 999999999999999987 467999999999999999999999 8899999999999999999999999999998765
Q ss_pred ccccccceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
...... ....+||+.|+| ||++. ...++.++|||||||++|||++|+.||......+... .+....
T Consensus 227 ~~~~~~-~~~~~GT~~Y~A-PE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-------~i~~~~ 297 (437)
T 4aw2_A 227 EDGTVQ-SSVAVGTPDYIS-PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-------KIMNHK 297 (437)
T ss_dssp TTSCEE-CCSCCSCGGGCC-HHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTHH
T ss_pred cCCCcc-cccccCCcCeeC-hHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH-------hhhhcc
Confidence 443322 245789999999 99997 5678999999999999999999999998655433111 111100
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSL--RPTMRKVSQ 687 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~ 687 (709)
. .+..+. .....+..+.+++..||+.+|++ ||+++|+++
T Consensus 298 ~-~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 E-RFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp H-HCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred c-cccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0 000000 01124567889999999888888 999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=332.35 Aligned_cols=261 Identities=16% Similarity=0.132 Sum_probs=207.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+... .+++.||||.+.... ..+++.+|+.+++++ +|+||+++++++.++...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNL---YTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEET---TTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEEC---CCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 356777778888888888766654 578999999986532 334688999999999 99999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC-----eEEccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN-----AQISDFGLAK 565 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~DFGla~ 565 (709)
||||+ +++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+|||+++
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999 99999999874 57999999999999999999999 889999999999999998887 9999999998
Q ss_pred ccccccccc-----ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh
Q 038905 566 LLTLNQSKA-----IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 640 (709)
Q Consensus 566 ~~~~~~~~~-----~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 640 (709)
.+....... ......||+.|+| ||++.+..++.++||||||+++|||++|+.||......+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~--- 234 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMS-INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD--- 234 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH---
T ss_pred eeecCCCCccccccccCCcCCCccccC-hHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh---
Confidence 765443221 1246789999999 9999999999999999999999999999999986543222111111111
Q ss_pred cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 641 NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 641 ~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.+.....+. . ....+ .+.+++..|++.||.+||++++|++.|+.+.
T Consensus 235 -~~~~~~~~~-~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 235 -TKRATPIEV-L----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp -HHHHSCHHH-H----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -hhccCCHHH-H----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000000000 0 00123 8899999999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=350.03 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=204.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.|| .+.. ..+..||||++.... ...++|.+|+.++++++|||||++++++. .+..++|
T Consensus 187 ~~~~~~~~~lG~G~fg~V~-~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVW-MATY---NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp GGGEEEEEEEECCSSEEEE-EEEE---TTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred hHHeEEEEEcccCCceEEE-EEEE---CCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 4456656666667777665 4554 357789999997643 35788999999999999999999999986 5678999
Q ss_pred EeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999997543 6888999999999999999999 889999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... .....+++.|+| ||++....++.++||||||+++|||++ |+.||......+.. ..+..+..
T Consensus 338 ~~~~-~~~~~~~~~y~a-PE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~~----- 403 (454)
T 1qcf_A 338 EYTA-REGAKFPIKWTA-PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERGYR----- 403 (454)
T ss_dssp HHHT-TCSSSSCGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHHHHTCC-----
T ss_pred ceec-cCCCcccccccC-HHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC-----
Confidence 2211 134557788998 999999999999999999999999999 99999765433211 11122211
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
...+...++.+.+++..||+.||++|||+++|+++|+.+..
T Consensus 404 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11122356788999999999999999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=345.91 Aligned_cols=253 Identities=18% Similarity=0.223 Sum_probs=203.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.+|+|++.... ....+.+.+|+.++..++|||||++++++.+....
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEEC---CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 567887788888888888766655 568899999986421 22334588999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||++||+|.+++.+ ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++.+..
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 999999999999999875 46899999999999999999999 88999999999999999999999999999987754
Q ss_pred cccccceeccccCcccccccccccCCC----CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNST----ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~----~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
..... ....+||+.|+| ||++.+.. ++.++|||||||++|||++|+.||......+.. ..+..+...
T Consensus 221 ~~~~~-~~~~~gt~~Y~A-PE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~~ 291 (410)
T 3v8s_A 221 EGMVR-CDTAVGTPDYIS-PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------SKIMNHKNS 291 (410)
T ss_dssp TSEEE-CCSCCSCGGGCC-HHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTHHHH
T ss_pred CCccc-ccCCcCCccccC-HHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH-------HHHHhcccc
Confidence 43221 246789999999 99998765 889999999999999999999999865443211 111111000
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSL--RPTMRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~ 687 (709)
.........+..+.+++..||+.+|.+ ||+++||++
T Consensus 292 ------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 292 ------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 000001124567889999999999988 999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=325.58 Aligned_cols=262 Identities=17% Similarity=0.190 Sum_probs=196.9
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEEC---CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4666666677777777655544 578899999986432 33447889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||++++.+..+......+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 999987444444444567999999999999999999999 88999999999999999999999999999987754332
Q ss_pred ccceeccccCcccccccccccCCC-CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc---CCccc--
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNST-ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLDD-- 646 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~-~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---g~~~~-- 646 (709)
. .....||+.|+| ||++.+.. ++.++||||||+++|||++|..|+......... ...+.+.... .....
T Consensus 157 ~--~~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 157 C--YSAEVVTLWYRP-PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp C--CCSCCSCGGGCC-HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGG
T ss_pred c--ccCCccccCCcC-hHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChhhhhhhc
Confidence 2 255688999999 99998765 899999999999999999988886443322111 1111111111 00000
Q ss_pred -cccC---------cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 647 -LVEG---------DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 647 -l~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+.+. ..........+..+.+++..||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 0001112235677889999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.90 Aligned_cols=251 Identities=18% Similarity=0.224 Sum_probs=205.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+++.||.+... ..+..+|+|++........+.+.+|++++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQK---GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeC---CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 345666667777777777655544 56788999998876666778999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee---cCCCCeEEccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~~~ 569 (709)
|||+++++|.+++.....+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++..+..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999999988888999999999999999999999 8899999999999999 8889999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... ....||+.|+| ||++.+. ++.++||||||++++||++|+.||......+.. ..+..+.......
T Consensus 162 ~~~~---~~~~~t~~y~a-PE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~ 229 (277)
T 3f3z_A 162 GKMM---RTKVGTPYYVS-PQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-------LKIREGTFTFPEK 229 (277)
T ss_dssp TSCB---CCCCSCTTTCC-HHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCCCHH
T ss_pred ccch---hccCCCCCccC-hHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhCCCCCCch
Confidence 3322 45679999999 9998765 899999999999999999999999765433211 1122222111000
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....+..+.+++..||+.||++|||+.++++
T Consensus 230 ------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 ------DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00123567889999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.35 Aligned_cols=250 Identities=21% Similarity=0.256 Sum_probs=179.9
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
..+|.|+++.||.+... .+++.||||++.. .....+.+|+.++.++. |||||++++++.+....++||||+++
T Consensus 17 ~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK---KSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEET---TTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEEC---CCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 45666677767655544 5788999999864 34567889999999997 99999999999999999999999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC---CeEEccccccccccccccccc
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY---NAQISDFGLAKLLTLNQSKAI 575 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~ 575 (709)
++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+++........
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 999999999888999999999999999999999 88999999999999997765 7999999999876543322
Q ss_pred eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccccc
Q 038905 576 KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 655 (709)
Q Consensus 576 ~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~ 655 (709)
....+||+.|+| ||++.+..++.++||||||+++|||++|+.||..................+..+.... ...
T Consensus 166 ~~~~~~t~~y~a-PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAA-PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSH
T ss_pred ccccCCCcCccC-HHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Ccc
Confidence 256678999999 9999999999999999999999999999999976433211111111223333333211 000
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 656 NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 656 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....++.+.+++..||+.||.+|||++|+++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 01234567899999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.78 Aligned_cols=262 Identities=14% Similarity=0.146 Sum_probs=201.4
Q ss_pred ccccceeeeecCe--eEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSS--VFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g--~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.| +++.||.+... .+++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYK---PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEc---CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 4567766667777 88888766655 578899999986543 3345778899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
.++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999999876 56899999999999999999999 88999999999999999999999999999875
Q ss_pred ccccccc-----cceeccccCcccccccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 567 LTLNQSK-----AIKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 567 ~~~~~~~-----~~~~~~~Gt~~y~aaPE~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
....... .......||+.|+| ||++.+ ..++.++|||||||++|||++|+.||......+.... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-------~ 249 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLS-PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-------K 249 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSC-HHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-------C
T ss_pred eccccccccccccccccccccccccC-HHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------H
Confidence 5332211 11133579999999 999987 6799999999999999999999999976443221100 0
Q ss_pred hcCCccccccC------------------------------------cccccCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 038905 640 RNGKLDDLVEG------------------------------------DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMR 683 (709)
Q Consensus 640 ~~g~~~~l~~~------------------------------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 683 (709)
..+....+.+. ..........+..+.+++.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 00000000000 000011223456789999999999999999999
Q ss_pred HHHHH
Q 038905 684 KVSQM 688 (709)
Q Consensus 684 ev~~~ 688 (709)
|+++.
T Consensus 330 ell~h 334 (389)
T 3gni_B 330 TLLNH 334 (389)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=347.20 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=201.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC-eEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ-NRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~-~~~l 491 (709)
..+|.....+|.|+++.|| .+.. .++.||||.++... ..+.|.+|+.++++++|||||++++++.+.. ..++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~-~~~~----~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVM-LGDY----RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEE-EEEE----TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred hHHeEEEeeecCcCCeeEE-EEEe----cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 4456656666667777665 4444 36789999987643 5578999999999999999999999987665 7899
Q ss_pred EEeecCCCCHHHHHhhCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLK--PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
||||+++|+|.+++.+... +++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999987653 789999999999999999999 88999999999999999999999999999985543
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.. ....+++.|+| ||.+.+..++.++||||||+++|||++ |+.||......+.. ..+..+...
T Consensus 342 ~~-----~~~~~~~~y~a-PE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~~~--- 405 (450)
T 1k9a_A 342 TQ-----DTGKLPVKWTA-PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGYKM--- 405 (450)
T ss_dssp ----------CCCTTTSC-HHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH-------HHHHTTCCC---
T ss_pred cc-----cCCCCCcceeC-HHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCCC---
Confidence 22 23467889998 999999999999999999999999998 99999765433311 122222111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..+...+..+.+++..||+.||.+|||+.++++.|+.+..
T Consensus 406 ------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 406 ------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1123456788999999999999999999999999988653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.86 Aligned_cols=251 Identities=22% Similarity=0.240 Sum_probs=188.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.+.|.....+|.|+++.||.+... ..++.||||++.... ..+.+.+|+.++.+++||||+++++++.+....++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQK---GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEEC---CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 455776667777777777665544 567899999987542 456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC---CCCeEEccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---YYNAQISDFGLAKLLTL 569 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~~ 569 (709)
|||+++++|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++....
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999988888999999999999999999999 889999999999999975 89999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... .....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ....+..+.... .
T Consensus 204 ~~~---~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~~~-~- 271 (349)
T 2w4o_A 204 QVL---MKTVCGTPGYCA-PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEYYF-I- 271 (349)
T ss_dssp ------------CGGGSC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCCCC-C-
T ss_pred ccc---cccccCCCCccC-HHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCCcc-C-
Confidence 321 245789999999 9999999999999999999999999999999975543321 112222222111 0
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......+..+.+++.+||+.||++|||+.|+++
T Consensus 272 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 ----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111234567889999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=335.53 Aligned_cols=251 Identities=21% Similarity=0.207 Sum_probs=199.1
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-----chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-----QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
+.|.....+|.|+++.||.+... .+++.||||++.... ....+++.+|+.++++++|||||++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINR---ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cceEEeeEEeeCCCEEEEEEEEC---CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34565666677777777655444 578899999985421 1246789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC---eEEccc
Q 038905 489 RLLVYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN---AQISDF 561 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DF 561 (709)
.++||||+++++|.+++.+. ..+++..+..++.||+.||.||| +++|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998888643 24899999999999999999999 889999999999999986655 999999
Q ss_pred cccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc
Q 038905 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641 (709)
Q Consensus 562 Gla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 641 (709)
|+++.+...... .....||+.|+| ||++.+..++.++|||||||++|||++|+.||...... ....+..
T Consensus 178 g~a~~~~~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~i~~ 246 (351)
T 3c0i_A 178 GVAIQLGESGLV--AGGRVGTPHFMA-PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--------LFEGIIK 246 (351)
T ss_dssp TTCEECCTTSCB--CCCCCSCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--------HHHHHHH
T ss_pred cceeEecCCCee--ecCCcCCcCccC-HHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--------HHHHHHc
Confidence 999877653321 245689999999 99999999999999999999999999999999764321 1122222
Q ss_pred CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+...... .. ....++.+.+++..||+.||++|||+.|+++
T Consensus 247 ~~~~~~~--~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKYKMNP--RQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCCCCCH--HH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCc--cc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2221100 00 0123567899999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.62 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=203.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCC-ceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTR-TTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||.+.....+.. ...||+|.+.... .....++.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 45677777888888888877666543332 2347888775432 233456789999999999999999999986 46689
Q ss_pred EEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999875 46899999999999999999999 88999999999999999999999999999998765
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
...........|++.|+| ||.+.+..++.++||||||+++|||++ |+.||......+.. ..+..+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~- 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMA-LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DLLEKGERLAQ- 238 (325)
T ss_dssp CTTCCC-----CCTTTSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HHHHTTCBCCC-
T ss_pred ccccccccCCCCcccccC-hHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCCCCCC-
Confidence 544433356778889998 999999999999999999999999999 99999765433321 11222211111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
....+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 239 --------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 --------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp --------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred --------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1123345778999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.95 Aligned_cols=253 Identities=23% Similarity=0.393 Sum_probs=200.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchh-------HHHHHHHHHHHhccCcCceeEEEeEEEc
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDG-------EKEFKNEVVMIGQTYHKNLVRLLGFCDE 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nlv~l~~~~~~ 485 (709)
.++|.....+|.|+++.||.+... .+++.||||++....... .+++.+|+.++.+++||||+++++++.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLV---KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEET---TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hccceehhccccCCceeEEEEEEc---CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 456777777888888877666554 578899999985432211 1678999999999999999999999976
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCC--eEecCCCCCceeecCCCC-----eE
Q 038905 486 GQNRLLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQ--IIHCDIKPQNILLDDYYN-----AQ 557 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~--iiH~Dlkp~NIll~~~~~-----~k 557 (709)
.. ++||||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+ |+||||||+||+++.++. +|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 55 79999999999998887654 6899999999999999999999 888 999999999999988776 99
Q ss_pred EccccccccccccccccceeccccCcccccccccc--cCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH
Q 038905 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWF--RNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 635 (709)
Q Consensus 558 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~--~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 635 (709)
|+|||+++...... ....||+.|+| ||++ ....++.++||||||+++|||++|+.||............
T Consensus 170 l~Dfg~~~~~~~~~-----~~~~g~~~y~a-PE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--- 240 (287)
T 4f0f_A 170 VADFGLSQQSVHSV-----SGLLGNFQWMA-PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN--- 240 (287)
T ss_dssp ECCCTTCBCCSSCE-----ECCCCCCTTSC-GGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH---
T ss_pred eCCCCccccccccc-----cccCCCccccC-chhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH---
Confidence 99999998544322 56789999999 9998 4556789999999999999999999999765433221111
Q ss_pred HHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 636 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 636 ~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
....... ........+..+.+++..||+.||++|||++++++.|+.+
T Consensus 241 --~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 --MIREEGL--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --HHHHSCC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --HHhccCC--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111111 1111223456789999999999999999999999999763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.40 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=210.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+... ..+..||||.+.... ...+++.+|+.++++++||||+++++++.+....++|
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEG---GGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEec---CCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 566777777888888877665554 468899999987543 3567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++++|.+++.+.. .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999998744 4899999999999999999999 789999999999999999999999999999877644
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ......+|+.|+| ||.+.+..++.++||||||+++|+|++ |..||.......... ....+.
T Consensus 165 ~~~-~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-------~~~~~~------ 229 (288)
T 3kfa_A 165 TYT-AHAGAKFPIKWTA-PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------LLEKDY------ 229 (288)
T ss_dssp SSE-EETTEEECGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------HHHTTC------
T ss_pred ccc-cccCCccccCcCC-hhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHhccC------
Confidence 322 2245667889998 999999999999999999999999999 999987654333111 111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
........++.+.+++..|++.||.+|||+++++++|+.+.
T Consensus 230 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 230 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 11112234577899999999999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=326.12 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=203.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCC----CceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTST----RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+++.||.+.....+. ....||+|.+........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4566666677777777776666554322 136799999987766777899999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCC-CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC--------eEEc
Q 038905 489 RLLVYKFLNNGTLASFLFENLK-PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN--------AQIS 559 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~-l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~ 559 (709)
.++||||+++++|.+++..... +++..+..++.||+.||.||| +++|+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999987664 899999999999999999999 889999999999999998887 9999
Q ss_pred cccccccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||+++..... ....||+.|+| ||++.+ ..++.++||||||+++|||++|..|+.......... ..
T Consensus 164 Dfg~~~~~~~~------~~~~~~~~y~a-PE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~------~~ 230 (289)
T 4fvq_A 164 DPGISITVLPK------DILQERIPWVP-PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL------QF 230 (289)
T ss_dssp CCCSCTTTSCH------HHHHHTTTTSC-HHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HH
T ss_pred cCcccccccCc------cccCCcCcccC-HHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH------HH
Confidence 99999765432 34568999998 999987 679999999999999999999655443332211110 00
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.... ..+ ....+..+.+++..||+.||.+|||+.++++.|+.+..
T Consensus 231 ~~~~--~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDR--HQL---------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTT--CCC---------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhcc--CCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1110 000 01123457899999999999999999999999998765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=347.73 Aligned_cols=249 Identities=22% Similarity=0.223 Sum_probs=197.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.||||++... .......+.+|+.++.+++||||+++++++.+.+..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEK---ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEc---CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 467887788888888888766655 67889999998643 233446788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCC-CCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCS-SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++||||+++++|..++.....+++..+..++.||+.||.||| + .+|+||||||+|||++.++.+||+|||+++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999999988888999999999999999999999 6 799999999999999999999999999998654
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||......... .....+...
T Consensus 301 ~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~~~~--- 367 (446)
T 4ejn_A 301 KDGAT--MKTFCGTPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEEIR--- 367 (446)
T ss_dssp C-------CCSSSCGGGCC-HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCC---
T ss_pred CCCcc--cccccCCccccC-HhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-------HHHHhCCCC---
Confidence 33222 256789999999 99999999999999999999999999999999765443211 111111111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
.+...+..+.+++..||+.||.+|| +++|+++
T Consensus 368 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 -------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1122446788999999999999999 9999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=338.55 Aligned_cols=246 Identities=24% Similarity=0.239 Sum_probs=194.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHH-HhccCcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVM-IGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+++.||.+... .+++.+|||++.... ....+.+.+|..+ ++.++|||||++++++.+.+.
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHK---AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEET---TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEc---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 567887778888888888766654 578899999986542 2334567777776 577899999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||||+++|+|..++.+...+++..+..++.||+.||.||| +++|+||||||+|||++.++++||+|||+++...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999999998888999999999999999999999 8899999999999999999999999999998643
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ++.+..+...
T Consensus 191 ~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~~~~--- 257 (373)
T 2r5t_A 191 EHNST--TSTFCGTPEYLA-PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------YDNILNKPLQ--- 257 (373)
T ss_dssp CCCCC--CCSBSCCCCCCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-------HHHHHHSCCC---
T ss_pred cCCCc--cccccCCccccC-HHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHhcccC---
Confidence 32222 257889999999 9999999999999999999999999999999976543321 1222222111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRK 684 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 684 (709)
.....+..+.+++..||+.||.+||++.+
T Consensus 258 -------~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 -------LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -------CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -------CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11224567889999999999999999853
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=327.12 Aligned_cols=250 Identities=19% Similarity=0.243 Sum_probs=196.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--------------------------hhHHHHHHHHH
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--------------------------DGEKEFKNEVV 466 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~ 466 (709)
.++|.....+|.|+++.||.+... .+++.||||++..... ...+++.+|++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNE---NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEET---TTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEEC---CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 466777778888888888766554 5789999999864321 12356899999
Q ss_pred HHhccCcCceeEEEeEEEc--CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCC
Q 038905 467 MIGQTYHKNLVRLLGFCDE--GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIK 544 (709)
Q Consensus 467 ~l~~l~h~nlv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlk 544 (709)
++++++||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||+.||.||| +.+|+|||||
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk 164 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIK 164 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 9999999999999999986 678899999999999988653 457899999999999999999999 8899999999
Q ss_pred CCceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCC---CCcccchHHHHHHHHHHHhCCCCCC
Q 038905 545 PQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST---ITANVDVYSFGVLLLEIISCRKSFD 621 (709)
Q Consensus 545 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~---~s~k~DvwSlGvvl~elltg~~p~~ 621 (709)
|+|||++.++.+||+|||+++.+...... .....||+.|+| ||.+.+.. ++.++||||||+++|||++|+.||.
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMA-PESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCC-GGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccC-hhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999877543322 245689999999 99998765 4788999999999999999999997
Q ss_pred ccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 622 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....... ......+.... ......++.+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~-------~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMCL-------HSKIKSQALEF--------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHHH-------HHHHHHCCCCC--------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHH-------HHHHhcccCCC--------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 6543221 11111111110 011234567899999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.69 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=198.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe--
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN-- 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~-- 488 (709)
.++|.....+|.|+++.||.+........+..||||.+... .....+++.+|+.++++++||||+++++++.+...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 45677777788888888877766655557789999998644 23345779999999999999999999999977553
Q ss_pred ---EEEEEeecCCCCHHHHHhh------CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEc
Q 038905 489 ---RLLVYKFLNNGTLASFLFE------NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 489 ---~~lV~Ey~~~gsL~~~l~~------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
.++||||+++++|.+++.. ...+++..+..++.||++||.||| +.+|+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEe
Confidence 4999999999999999953 245899999999999999999999 8999999999999999999999999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||+++.+.............+++.|+| ||.+.+..++.++||||||+++|||++ |..||......+.. ..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~ 261 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIA-IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY-------DY 261 (313)
T ss_dssp SCSCC----------------CCGGGSC-HHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HH
T ss_pred ecCcceecccccccCcccccCCCccccC-chhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-------HH
Confidence 9999987654432222245567889998 999999999999999999999999999 88898765433311 11
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
...+.... .....+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 262 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 262 LLHGHRLK---------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HHTTCCCC---------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCC---------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12221111 11234567899999999999999999999999998865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.07 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=206.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE-EE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR-LL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~-~l 491 (709)
..|.....+|.|+++.||.+.....+.....+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 344455667788888887776665556677899999875433 3457899999999999999999999999876665 99
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+.+++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999999874 46889999999999999999999 889999999999999999999999999999876543
Q ss_pred ccc--cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCcc-chhhHHhHHHHHHHhhhcCCcccc
Q 038905 571 QSK--AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 571 ~~~--~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
... .......|++.|+| ||.+.+..++.++||||||+++|||++|..|+... ...+.. .....+...
T Consensus 178 ~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~-------~~~~~~~~~-- 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTA-LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT-------HFLAQGRRL-- 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSC-HHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH-------HHHHTTCCC--
T ss_pred cccccccCcCCCCCccccC-hhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH-------HHhhcCCCC--
Confidence 311 12245678899998 99999999999999999999999999966554333 222211 111111111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
......++.+.+++..||+.||.+|||+++++++|+.+.+
T Consensus 248 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 248 -------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1122345678999999999999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=341.82 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=205.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... .+..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHE---LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEET---TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456777777788888877666554 578899999986432 23456899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++++|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999999988888999999999999999999999 89999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
... ....+||+.|+| ||++.+..+ +.++|||||||++|||++|+.||........ ...+..+...
T Consensus 169 ~~~---~~~~~gt~~y~a-PE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~~--- 234 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAA-PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-------FKKICDGIFY--- 234 (476)
T ss_dssp TCC---BCCCCSCSTTCC-HHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-------HHHHHTTCCC---
T ss_pred ccc---ccccCCCcCeEC-hhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCcC---
Confidence 332 256789999999 999998775 7899999999999999999999976543221 1222222211
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+...+..+.+++..||+.||.+|||++|+++
T Consensus 235 -------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 -------TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01123457889999999999999999999997
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.19 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=193.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+++.||. +.. .++.||||++... ...+.+.+|+.++++++||||+++++++.+ ..++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~-~~~----~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCK-AKW----RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEE-EEE----TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred HhHeeeeeEeecCCCceEEE-EEE----CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 34566556666676666654 443 3678999998653 356789999999999999999999998864 47999
Q ss_pred EeecCCCCHHHHHhhCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC-eEEcccccccccc
Q 038905 493 YKFLNNGTLASFLFENL---KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN-AQISDFGLAKLLT 568 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~DFGla~~~~ 568 (709)
|||+++++|.+++.... .++...+..++.|+++||.|||+...++|+||||||+||+++.++. +||+|||+++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999999998765 3678899999999999999999433389999999999999998887 7999999998654
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
... ....||+.|+| ||++.+..++.++||||||+++|||++|+.||.......... .+ ....+....+
T Consensus 158 ~~~-----~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~- 225 (307)
T 2eva_A 158 THM-----TNNKGSAAWMA-PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MW-AVHNGTRPPL- 225 (307)
T ss_dssp ------------CCTTSSC-HHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH----HH-HHHTTCCCCC-
T ss_pred ccc-----ccCCCCCceEC-hhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH----HH-HHhcCCCCCc-
Confidence 332 34569999999 999999999999999999999999999999997543222111 11 1112221111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
....+..+.+++.+||+.||++|||+++++++|+.+..
T Consensus 226 --------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 226 --------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp --------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred --------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11234678899999999999999999999999988653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=331.76 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=201.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCc-eEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRT-TVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~-~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||.+.....+... ..||+|.+... .....+++.+|+.++.+++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 567887778888888888777665443322 34678877533 3446688999999999999999999999998755 78
Q ss_pred EEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+|+||+.+++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999875 46899999999999999999999 88999999999999999999999999999988765
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
...........||+.|+| ||.+.+..++.++||||||+++|||++ |+.||......+... ....+..
T Consensus 170 ~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~~~~---- 237 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGER---- 237 (327)
T ss_dssp ----------CCCGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTCC----
T ss_pred ccccccccCCCccccccC-HHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCCC----
Confidence 443333345567889999 999999999999999999999999999 999997655433211 1111111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.......+..+.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 238 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 -----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11122345678899999999999999999999999988653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=324.16 Aligned_cols=259 Identities=22% Similarity=0.283 Sum_probs=203.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+...........||||.+... .....+++.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 45666666677777777766555544456678999998754 33456789999999999999999999999865 45689
Q ss_pred EEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++.+.. .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 999999999999997654 5899999999999999999999 889999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... .....+++.|+| ||.+.+..++.++||||||+++|||++ |+.||......+... ....+....
T Consensus 167 ~~~~-~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-------~~~~~~~~~--- 234 (281)
T 3cc6_A 167 DYYK-ASVTRLPIKWMS-PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-------VLEKGDRLP--- 234 (281)
T ss_dssp -------CCCCCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-------HHHHTCCCC---
T ss_pred cccc-cccCCCCcceeC-chhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-------HHhcCCCCC---
Confidence 3222 145567889998 999999999999999999999999998 999997554333211 111111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.....++.+.+++..||+.||++|||+.++++.|+.+.
T Consensus 235 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 235 ------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11224567899999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.39 Aligned_cols=261 Identities=19% Similarity=0.239 Sum_probs=197.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+++.||.+. . ..++.||||++.... ....+.+.+|++++++++|||||++++++.++...+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~-~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAK-D---SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEE-E---TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEE-E---CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 4566666667777777775554 3 358899999986432 223467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+++ +|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99999986 7877776654 5899999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc---
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD--- 645 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~--- 645 (709)
..... ....||+.|+| ||++.+ ..++.++|||||||++|||++|+.||......+.... +..........
T Consensus 172 ~~~~~--~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 172 PVRSY--THEVVTLWYRA-PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWP 245 (311)
T ss_dssp CCC-----CCCCCCTTCC-HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSG
T ss_pred Ccccc--cCCcccCCcCC-HHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhh
Confidence 33221 45678999999 999876 5689999999999999999999999976554332211 11111110000
Q ss_pred c-------------cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 646 D-------------LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 646 ~-------------l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. ..+..............+.+++..||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 00000000011123467889999999999999999999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=318.71 Aligned_cols=252 Identities=20% Similarity=0.221 Sum_probs=204.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+++.||.+... .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc---CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 456777777777777777655444 56889999998643 2334577899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC---eEEccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN---AQISDFGLAKLL 567 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFGla~~~ 567 (709)
+||||+++++|.+++.....+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++...
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999999999988888999999999999999999999 889999999999999986655 999999999876
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
...... ....||+.|+| ||.+.+..++.++||||||++++||++|+.||......+.. .....+.....
T Consensus 159 ~~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~ 227 (284)
T 3kk8_A 159 NDSEAW---HGFAGTPGYLS-PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-------AQIKAGAYDYP 227 (284)
T ss_dssp CSSCBC---CCSCSCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCCC
T ss_pred ccCccc---cCCCCCcCCcC-chhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH-------HHHHhccccCC
Confidence 543322 45679999999 99999999999999999999999999999999765433211 11222221110
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......+..+.+++..||+.||++|||++|+++
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 ------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0011234567889999999999999999999988
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.78 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=190.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+... .+++.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK---TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECS---SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEEC---CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 456777777888888888665444 5688999999865432 234678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhC------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 492 VYKFLNNGTLASFLFEN------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
||||++ ++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999998 5999988753 24889999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC--
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-- 642 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g-- 642 (709)
........ .....||+.|+| ||++.+ ..++.++|||||||++|||++|+.||......+.... +.......
T Consensus 157 ~~~~~~~~--~~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~ 230 (317)
T 2pmi_A 157 AFGIPVNT--FSSEVVTLWYRA-PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL---IFDIMGTPNE 230 (317)
T ss_dssp ETTSCCCC--CCCCCSCCTTCC-HHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCT
T ss_pred ecCCCccc--CCCCcccccccC-chHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCh
Confidence 76543222 145679999999 999976 4689999999999999999999999986654332211 11111000
Q ss_pred -Ccc---ccc--cCc------------ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 643 -KLD---DLV--EGD------------MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 643 -~~~---~l~--~~~------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... .+. ... .........+..+.+++..||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 000 000 000011124567899999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.43 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=189.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc----hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ----DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+++.||.+ .. .+..+|||++..... ...+.+.+|+.++++++||||+++++++.+++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~-~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRA-FW----IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEE-EE----TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred hhheeeeeeeccCCCeEEEEE-EE----cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 456666666777777777544 43 377899999865322 234678999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCC---eEecCCCCCceeecC--------CCCeE
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ---IIHCDIKPQNILLDD--------YYNAQ 557 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~---iiH~Dlkp~NIll~~--------~~~~k 557 (709)
.++||||+++++|.+++. ...+++..+..++.|++.||.||| +++ |+||||||+||+++. ++.+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 999999999999999885 457899999999999999999999 666 999999999999986 77899
Q ss_pred EccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH
Q 038905 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637 (709)
Q Consensus 558 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 637 (709)
|+|||+++....... ....||+.|+| ||.+.+..++.++||||||++++||++|+.||......... ..
T Consensus 157 l~Dfg~~~~~~~~~~----~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~ 225 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK----MSAAGAYAWMA-PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YG 225 (271)
T ss_dssp ECCCCC-----------------CCGGGSC-HHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HH
T ss_pred EccCCcccccccccc----cCCCCccceeC-HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hh
Confidence 999999986654322 35679999998 99999999999999999999999999999999765432211 11
Q ss_pred hhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 638 ~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.. .+... .......++.+.+++..||+.||.+|||+.|+++.|+.+
T Consensus 226 ~~-~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 VA-MNKLA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HH-TSCCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hh-cCCCC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 11111 111223456789999999999999999999999999763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=336.82 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=193.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... ...+.+.+|+.++++++|||||++++++.+....++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDK---LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEET---TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEEC---CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 566777777888888888766655 578899999987543 2346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC--eEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN--AQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DFGla~~~~~~ 570 (709)
|||+++++|.+++....++++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+|||+++.....
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999988888999999999999999999999 889999999999999987766 999999999754332
Q ss_pred ccccceeccccCcccccccccccCCCCCcc-cchHHHHHHHHHHHhCCCCCCccchhh-HHhHHHHHHHhhhcCCccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITAN-VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k-~DvwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.. .....||+.|+| ||++.+..++.+ +|||||||++|||++|+.||....... .... . ........
T Consensus 172 ~~---~~~~~gt~~y~a-PE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~-~~~~~~~~---- 239 (361)
T 3uc3_A 172 SQ---PKSTVGTPAYIA-PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT---I-QRILSVKY---- 239 (361)
T ss_dssp ------------CTTSC-HHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH---H-HHHHTTCC----
T ss_pred CC---CCCCcCCCCcCC-hhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH---H-HHHhcCCC----
Confidence 21 145679999999 999988887665 899999999999999999997644321 1111 1 11111111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 240 ----SIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp ----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 11111123467889999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.21 Aligned_cols=254 Identities=18% Similarity=0.181 Sum_probs=202.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.||||++.+.. ....+.+.+|..++.+++|||||++++++.+.+..
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~---~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMK---QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 677887778888888888766655 578899999986532 22334588999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
+|||||+++|+|.+++.+.. .+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++.+.
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 99999999999999998754 7999999999999999999999 8899999999999999999999999999998776
Q ss_pred ccccccceeccccCccccccccccc-------CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFR-------NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~-------~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 641 (709)
...... ....+||+.|+| ||++. ...++.++|||||||++|||++|+.||......+... .+..
T Consensus 214 ~~~~~~-~~~~~Gt~~Y~A-PE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-------~i~~ 284 (412)
T 2vd5_A 214 ADGTVR-SLVAVGTPDYLS-PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG-------KIVH 284 (412)
T ss_dssp TTSCEE-CSSCCSCGGGCC-HHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHT
T ss_pred CCCccc-cceeccccCcCC-HHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH-------HHHh
Confidence 543221 145789999999 99997 4578999999999999999999999998655433111 1111
Q ss_pred CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHH
Q 038905 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLR---PTMRKVSQ 687 (709)
Q Consensus 642 g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~ev~~ 687 (709)
.+. .+..+. .....+..+.+++..||+ +|.+| |+++|+++
T Consensus 285 ~~~-~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 YKE-HLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHH-HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ccc-CcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000 000000 012345678999999999 99998 58999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=334.30 Aligned_cols=268 Identities=22% Similarity=0.320 Sum_probs=211.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe-cCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEE--cCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ-TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCD--EGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~--~~~~~ 489 (709)
.++|.....+|.|+++.||.+.... ....++.||||++........+.+.+|++++++++|+||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4567777777777777776654321 23578999999998776666788999999999999999999999986 55668
Q ss_pred EEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999999864 46999999999999999999999 8899999999999999999999999999998775
Q ss_pred ccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHH--------hHHHHHHHhh
Q 038905 569 LNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTDWAFDCY 639 (709)
Q Consensus 569 ~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~ 639 (709)
..... .......||+.|+| ||++.+..++.++||||||+++|||++|+.||......... ..........
T Consensus 179 ~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYA-PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSC-HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccC-HHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 44322 12234568888998 99999999999999999999999999999998644321100 0001111111
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
..+ .........++.+.+++..||+.||++|||++++++.|+.+.
T Consensus 258 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 258 EEG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hcc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 111223345678999999999999999999999999999865
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=324.13 Aligned_cols=265 Identities=19% Similarity=0.220 Sum_probs=198.2
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
++|.....+|.|+++.||.+... .+++.||||++..... ...+.+.+|+.++.+++||||+++++++.+....++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNR---DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeC---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 35666666777777777655544 5688999998854432 234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|..++.....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999999999988888999999999999999999999 8899999999999999999999999999998765433
Q ss_pred cccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH--------HhhhcC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCYRNG 642 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~g 642 (709)
.. .....||+.|+| ||++.+ ..++.++||||||+++|||++|+.||......+......... ..+...
T Consensus 157 ~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 157 DY--YDDEVATRWYRS-PELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCC-HHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred cc--cCCCcCCccccC-hHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 22 145679999999 999976 678999999999999999999999998765433222111110 000000
Q ss_pred Cc---cccccCcc---cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 643 KL---DDLVEGDM---EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 643 ~~---~~l~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. ..+.++.. ........+..+.+++..||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00000000 00001234567899999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=320.77 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=206.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+. . ..+..||+|++..... ..+++.+|+.++.+++||||+++++++.+.+..++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~-~---~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGY-W---LNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEE-E---TTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEE-e---cCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 3456666666777777665544 3 3567899999876533 457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999999875 46899999999999999999999 8899999999999999999999999999998765432
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... .....|++.|+| ||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+...
T Consensus 159 ~~~-~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~i~~~~~~----- 224 (267)
T 3t9t_A 159 YTS-STGTKFPVKWAS-PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFRL----- 224 (267)
T ss_dssp HHS-TTSTTCCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTCCC-----
T ss_pred ccc-cccccccccccC-hhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-------HHHHhcCCcC-----
Confidence 211 134567888998 999998899999999999999999999 8999976543321 1112222111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 225 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 ----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0112235678899999999999999999999999988754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=326.15 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=207.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+.... ....++.||||.+.... .....++.+|+.++++++|+||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 4566666666666666665554431 12357889999987543 23456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhC----------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEc
Q 038905 490 LLVYKFLNNGTLASFLFEN----------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
++||||+++++|.+++... ..+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEEC
Confidence 9999999999999999753 34688999999999999999999 8899999999999999999999999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||+++...............||+.|+| ||++.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~ 252 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMS-PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------LRF 252 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-------HHH
T ss_pred cCccccccccccccccccCCCCCCCccC-hhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH-------HHH
Confidence 9999987654433222245567899999 999999999999999999999999999 8889875543221 122
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
...+..... ....+..+.+++..||+.||.+|||+.++++.|+...+
T Consensus 253 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 222222111 22345678899999999999999999999999988644
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=333.26 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=208.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe----cCCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ----TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~ 486 (709)
.++|.....+|.|+++.||.+.... ....+..||||++.... ....+++.+|+.++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 4566666667777777776555432 11356789999987543 33457899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee
Q 038905 487 QNRLLVYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll 550 (709)
+..++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 99999999999999999998653 3788999999999999999999 8899999999999999
Q ss_pred cCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHH
Q 038905 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 629 (709)
Q Consensus 551 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~ 629 (709)
+.++.+||+|||+++...............+|+.|+| ||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA-PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCC-HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeC-hHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999987765433322245567889999 999999899999999999999999999 99999765433211
Q ss_pred hHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccC
Q 038905 630 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEV 695 (709)
Q Consensus 630 ~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 695 (709)
..+..+.... .....+..+.+++..||+.||.+|||+.++++.|+.+...
T Consensus 270 -------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 270 -------KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp -------HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHhcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1222222111 1223456788999999999999999999999999987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=333.22 Aligned_cols=265 Identities=23% Similarity=0.351 Sum_probs=205.3
Q ss_pred cceeeeecCeeEEEEEEEEEE-ecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEc--CCeEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVI-QTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE--GQNRLL 491 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~--~~~~~l 491 (709)
|.....+|.|+++.||.+... .....++.||||++.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 366666777777777654332 223578999999987643 2345779999999999999999999999987 467899
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|.+++.+. .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 113 v~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp EECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 99999999999999765 4899999999999999999999 8899999999999999999999999999998876543
Q ss_pred cc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhH--------HhHHHHHHHhhhcC
Q 038905 572 SK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY--------AILTDWAFDCYRNG 642 (709)
Q Consensus 572 ~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~g 642 (709)
.. .......||+.|+| ||.+.+..++.++||||||+++|||++|+.||........ ........+....+
T Consensus 189 ~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYA-PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp SEEEC---CCCCGGGCC-HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred cccccccCCCCCceeeC-hHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 22 12245668888998 9999999999999999999999999999999865322110 00000111111111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.........+..+.+++.+||+.||++|||+++++++|+.+.+
T Consensus 268 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 268 ---------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111233456789999999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=317.85 Aligned_cols=247 Identities=24% Similarity=0.311 Sum_probs=201.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... ..+..||||.+.... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREK---QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 567777777888888877666554 578899999985432 22356799999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999999988888999999999999999999999 89999999999999999999999999999865543
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ....||+.|+| ||.+.+..++.++||||||+++|||++|+.||......+... .......
T Consensus 162 ~~~----~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~----- 224 (279)
T 3fdn_A 162 SRR----TDLCGTLDYLP-PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------RISRVEF----- 224 (279)
T ss_dssp ----------CCCCTTCC-HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTCC-----
T ss_pred ccc----cccCCCCCccC-HhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH-------HHHhCCC-----
Confidence 321 45679999998 999999999999999999999999999999997654332211 1111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+...+..+.+++..||+.||.+|||++|+++
T Consensus 225 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 225 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011224467889999999999999999999997
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.70 Aligned_cols=265 Identities=21% Similarity=0.282 Sum_probs=197.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhc--cCcCceeEEEeEEEc----C
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQ--TYHKNLVRLLGFCDE----G 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nlv~l~~~~~~----~ 486 (709)
.++|.....+|.|+++.||. +.. .++.||||++... ..+.+..|.+++.. ++||||+++++++.+ .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~-~~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWR-GSW----QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEE-EEE----TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEE-EEE----CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 45677666777777777754 443 4788999998653 44556667766666 799999999998654 3
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcC-----CCCeEecCCCCCceeecCCCCeEEccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNC-----SSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||... +.+|+||||||+|||++.++.+||+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 557899999999999999954 57899999999999999999999432 578999999999999999999999999
Q ss_pred ccccccccccccc--ceeccccCcccccccccccCC------CCCcccchHHHHHHHHHHHhC----------CCCCCcc
Q 038905 562 GLAKLLTLNQSKA--IKKAIRGTKGYVASPEWFRNS------TITANVDVYSFGVLLLEIISC----------RKSFDIE 623 (709)
Q Consensus 562 Gla~~~~~~~~~~--~~~~~~Gt~~y~aaPE~~~~~------~~s~k~DvwSlGvvl~elltg----------~~p~~~~ 623 (709)
|+++......... ......||+.|+| ||++.+. .++.++||||||+++|||++| +.||...
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMA-PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCC-HHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCeeecccccccccccccccccccceeC-hhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9998765443221 1134589999999 9999876 556799999999999999999 7787543
Q ss_pred chhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 624 MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
....... ..........+....+. ........+..+.+++..||+.||++|||+.+|+++|+.+
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSF-EDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCH-HHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcch-hhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3211100 00011111111111111 1111235778899999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=325.09 Aligned_cols=252 Identities=22% Similarity=0.260 Sum_probs=203.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch------hHHHHHHHHHHHhccCcCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD------GEKEFKNEVVMIGQTYHKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~ 486 (709)
.++|.....+|.|+++.||.+... .+++.+|||.+...... ..+++.+|+.++.+++||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK---STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccEEEeeEeeecCCEEEEEEEEC---CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 345666666777777777655544 56889999988643221 367899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC----CeEEcccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY----NAQISDFG 562 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFG 562 (709)
...++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999999988888999999999999999999999 88999999999999999888 79999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
+++........ ....||+.|+| ||++.+..++.++||||||+++|||++|+.||......+.. ..+..+
T Consensus 165 ~~~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~ 233 (321)
T 2a2a_A 165 LAHEIEDGVEF---KNIFGTPEFVA-PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------ANITSV 233 (321)
T ss_dssp TCEECCTTCCC---CCCCSCGGGCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHTT
T ss_pred cceecCccccc---cccCCCCCccC-cccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhc
Confidence 99876543321 45679999999 99999999999999999999999999999999765433211 111111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... ..... ....++.+.+++..||+.||++|||+.|+++
T Consensus 234 ~~~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SYD--FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCC--CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccc--cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111 00000 1123467889999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.60 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=209.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEcccccc-hhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCC-
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQ- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~- 487 (709)
.++|.....+|.|+++.||.+.... ....++.||||.+..... ...+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 5677777777788888776665543 235678999999875432 3456799999999999 7999999999987654
Q ss_pred eEEEEEeecCCCCHHHHHhhCCC----------------CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec
Q 038905 488 NRLLVYKFLNNGTLASFLFENLK----------------PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~ 551 (709)
..++||||+++++|.+++..... +++..+..++.||+.||.||| +.+|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEEC
Confidence 58999999999999999987543 788999999999999999999 88999999999999999
Q ss_pred CCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHh
Q 038905 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI 630 (709)
Q Consensus 552 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 630 (709)
.++.+||+|||+++.+.............||+.|+| ||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-- 259 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA-PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 259 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecC-chhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH--
Confidence 999999999999987765443333355678999999 999999999999999999999999998 9999976543221
Q ss_pred HHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 631 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 631 ~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.......+..... ....+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 260 ----~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 260 ----FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp ----HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111222211111 1223567889999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=323.27 Aligned_cols=264 Identities=18% Similarity=0.170 Sum_probs=198.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc---hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ---DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.||||++..... ...+++.+|+.++.+++||||+++++++.+.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDT---VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEET---TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEc---CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 456666666777777777655444 5788999999875432 2347799999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++++|.+++.....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999999998888999999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..... .....|++.|+| ||.+.+..++.++||||||+++|||++|+.||....... ....... ....
T Consensus 187 ~~~~~-~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~-~~~~--- 253 (309)
T 2h34_A 187 EKLTQ-LGNTVGTLYYMA-PERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQ-AIPR--- 253 (309)
T ss_dssp -----------CCGGGCC-GGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHS-CCCC---
T ss_pred ccccc-ccccCCCcCccC-HHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhcc-CCCC---
Confidence 33221 145679999999 999999999999999999999999999999997553321 1111111 1110
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHcccccCCCC
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEVVVEVDVP 698 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~~~~~~p 698 (709)
........+..+.+++..||+.||++|| +++++++.|+...+...+
T Consensus 254 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 254 ---PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp ---GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred ---ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0111223456788999999999999999 999999999987654433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.18 Aligned_cols=262 Identities=19% Similarity=0.293 Sum_probs=198.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.||||++... .....+++.+|+.++++++||||+++++++.+.+..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACL---LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEET---TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ccceEEEEeecCCCCceEEEEEEc---CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 456777778888888888666554 56889999998642 234557899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 490 LLVYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
++||||+++++|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 999999999999999874 346899999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
........ .....|++.|+| ||.+.+..++.++||||||+++|||++|+.||......... .......+...
T Consensus 185 ~~~~~~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~ 256 (310)
T 2wqm_A 185 FFSSKTTA--AHSLVGTPYYMS-PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEQCDYP 256 (310)
T ss_dssp ----------------CCSSCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-----HHHHHHTTCSC
T ss_pred eecCCCcc--ccccCCCeeEeC-hHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-----HHHHhhcccCC
Confidence 76543322 145679999999 99999999999999999999999999999999754322111 11122222222
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCC
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVD 696 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 696 (709)
.+. ....+..+.+++..||+.||.+|||+.+|+++|+.+.+..
T Consensus 257 ~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 257 PLP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CCC--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCc--------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 111 1234567899999999999999999999999999986543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=328.48 Aligned_cols=261 Identities=21% Similarity=0.360 Sum_probs=199.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEec-CCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQT-STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
...|.....+|.|+++.||.+..... +.....||||.+.... .....++.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 34556566667777777765554432 2335679999987543 334567999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999875 46999999999999999999999 88999999999999999999999999999987764
Q ss_pred ccccc-ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 570 NQSKA-IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 570 ~~~~~-~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
..... ......+|+.|+| ||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~~~~-- 269 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTA-PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------MKAINDGFRL-- 269 (333)
T ss_dssp -----------CCCGGGSC-HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTCCC--
T ss_pred ccccccccCCCCccccccC-chhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHCCCcC--
Confidence 43221 1133456788998 999999999999999999999999999 9999975543221 1122222111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
......+..+.+++.+||+.||++||++.+++++|+.+.
T Consensus 270 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 270 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112234567899999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=319.59 Aligned_cols=259 Identities=18% Similarity=0.211 Sum_probs=194.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+++.||.+.. ..++.+|||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN----NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE----TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred cchhhhhcccCCCEEEEEEEc----CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 456566677777777765543 3578899999864432 2346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++ +|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 999986 899988764 56899999999999999999999 8899999999999999999999999999998765432
Q ss_pred cccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc---cc-
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL---DD- 646 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~---~~- 646 (709)
.. .....||+.|+| ||++.+. .++.++||||||+++|||++|+.||......+.... +.+....... ..
T Consensus 155 ~~--~~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 155 RK--YTHEIVTLWYRA-PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNV 228 (288)
T ss_dssp ---------CCCTTCC-HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTG
T ss_pred cc--cccccccccccC-chheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHHCCCChhhchhh
Confidence 22 145678999999 9999764 589999999999999999999999976544322111 1111111000 00
Q ss_pred --c--ccCcc-------cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 647 --L--VEGDM-------EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 647 --l--~~~~~-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+ .++.. ........++.+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000 00111234577899999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.26 Aligned_cols=270 Identities=15% Similarity=0.106 Sum_probs=203.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-----------hHHHHHHHHHHHhccCcCceeEEEe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-----------GEKEFKNEVVMIGQTYHKNLVRLLG 481 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nlv~l~~ 481 (709)
.++|.....+|.|+++.||.+.....+..++.+|||+....... ..+.+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 45688888889999999977766643447889999998654321 1134667888999999999999999
Q ss_pred EEEc----CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC--C
Q 038905 482 FCDE----GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY--N 555 (709)
Q Consensus 482 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~--~ 555 (709)
++.+ ....++||||+ +++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence 9987 78899999999 9999999988778999999999999999999999 88999999999999999887 9
Q ss_pred eEEccccccccccccccc-----cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh
Q 038905 556 AQISDFGLAKLLTLNQSK-----AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 630 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~ 630 (709)
+||+|||+++.+...... .......||+.|+| ||++.+..++.++||||||+++|||++|+.||..........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS-LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCC-HHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccC-HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999877543221 11145689999999 999999999999999999999999999999996432211111
Q ss_pred HHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 631 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 631 ~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
. ........ .+...+. ........++.+.+++..||+.||++|||+++|+++|+...
T Consensus 271 ~--~~~~~~~~-~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 Q--TAKTNLLD-ELPQSVL---KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp H--HHHHHHHH-TTTHHHH---HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred H--HHHHhhcc-cccHHHH---hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 0 01111111 0111000 00001134568999999999999999999999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=355.62 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=199.2
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
.+|.|+|+.| |++.......++.||||+++... ....+++.+|++++.+++|||||++++++.+ +..++||||+++
T Consensus 376 ~LG~G~fG~V-y~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 376 ELGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEECSSEEE-EEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EeccCCCEEE-EEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 3555555555 55555444677899999987543 2346789999999999999999999999965 568899999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc-ccee
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK-AIKK 577 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~ 577 (709)
|+|.+++.....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 999999998888999999999999999999999 889999999999999999999999999999877654322 1123
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
...||+.|+| ||++.+..++.++|||||||++|||++ |+.||......+. ...+..+.... .
T Consensus 531 ~~~~t~~y~A-PE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~~~~---------~ 593 (635)
T 4fl3_A 531 HGKWPVKWYA-PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGERMG---------C 593 (635)
T ss_dssp ----CGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCCCC---------C
T ss_pred CCCCceeeeC-hhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCCC---------C
Confidence 4567889999 999999999999999999999999998 9999976554331 22222332211 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
+...+..+.+++..||+.||++|||+++|+++|+.+
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 223557889999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=332.65 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=208.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecC--CCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTS--TRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
.++|.....+|.|+++.||.+.....+ .....||+|.+.... ....+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 556776677777777777666554322 133589999987543 33457799999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhC--------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC
Q 038905 489 RLLVYKFLNNGTLASFLFEN--------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~ 554 (709)
.++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCC
Confidence 99999999999999999753 34789999999999999999999 88999999999999999999
Q ss_pred CeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHH
Q 038905 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD 633 (709)
Q Consensus 555 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 633 (709)
.+||+|||+++...............||+.|+| ||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---- 276 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA-PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF---- 276 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH----
T ss_pred eEEECccccccccccccceeecCCCCCCccccC-HHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH----
Confidence 999999999987755443333345678889999 999999999999999999999999998 88998755432211
Q ss_pred HHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 634 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 634 ~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
......+... ..+...+..+.+++..||+.||.+|||+.+|+++|+.+.
T Consensus 277 --~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 277 --YKLVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp --HHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1111111110 011223567889999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=342.75 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=197.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.| |.+.. .....||||++.... ...++|.+|+.++++++|||||++++++.+ +..++|
T Consensus 183 ~~~~~~~~~lG~G~fg~V-y~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEV-WMGTW---NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEE-EEEEE---TTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhHceeeeeecCCCCeEE-EEEEE---CCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 344555455555555555 55555 345779999997643 346789999999999999999999999876 678999
Q ss_pred EeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999999753 45899999999999999999999 889999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ......+++.|+| ||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+..
T Consensus 334 ~~~-~~~~~~~~~~y~a-PE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~----- 399 (452)
T 1fmk_A 334 EYT-ARQGAKFPIKWTA-PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGYR----- 399 (452)
T ss_dssp ----------CCGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCC-----
T ss_pred cee-cccCCcccccccC-HhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC-----
Confidence 221 1134567888998 999999999999999999999999999 8999976543321 112222211
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccC
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEV 695 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 695 (709)
...+...++.+.+++..||+.||++|||+++++++|+.+...
T Consensus 400 ----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 400 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 111234567889999999999999999999999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.83 Aligned_cols=258 Identities=21% Similarity=0.257 Sum_probs=209.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .++..||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREK---QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhceeeheecCCCCeEEEEEEEc---CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 466777777777777777665544 578899999986432 23457899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999999988888999999999999999999999 89999999999999999999999999999976543
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ....|++.|+| ||++.+..++.++||||||+++|||++|+.||......+.. ......+..
T Consensus 167 ~~~----~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~---- 230 (284)
T 2vgo_A 167 LRR----RTMCGTLDYLP-PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-------RRIVNVDLK---- 230 (284)
T ss_dssp SCB----CCCCSCGGGCC-HHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTCCC----
T ss_pred ccc----ccccCCCCcCC-HHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-------HHHhccccC----
Confidence 221 45679999999 99999999999999999999999999999999765433211 111111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHcccccCCCC
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVVVEVDVP 698 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~~~p 698 (709)
.+...+..+.+++..|++.||.+|||++++++ .+........|
T Consensus 231 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p 275 (284)
T 2vgo_A 231 ------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275 (284)
T ss_dssp ------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCC
T ss_pred ------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCC
Confidence 11224567889999999999999999999987 45444333333
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=324.28 Aligned_cols=261 Identities=23% Similarity=0.266 Sum_probs=204.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEE----cCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCD----EGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~----~~~~ 488 (709)
.++|.....+|.|+++.||.+... .+++.||||++........+.+.+|+.++++++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGL---HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEET---TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEec---CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 456777778888888888766654 578899999987655566788999999999999999999999986 3457
Q ss_pred EEEEEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 489 RLLVYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
.++||||+++++|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999999976 356899999999999999999999 889999999999999999999999999998
Q ss_pred cccccccccc-------ceeccccCcccccccccccCCC---CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHH
Q 038905 565 KLLTLNQSKA-------IKKAIRGTKGYVASPEWFRNST---ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 634 (709)
Q Consensus 565 ~~~~~~~~~~-------~~~~~~Gt~~y~aaPE~~~~~~---~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 634 (709)
+......... ......||+.|+| ||++.+.. ++.++||||||+++|||++|+.||......... ..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~-- 257 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRA-PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VA-- 257 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCC-GGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HH--
T ss_pred hhcccccccccccccccccccccCCcccCC-HhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hh--
Confidence 7654322110 0124568999999 99997654 689999999999999999999999532211100 00
Q ss_pred HHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 635 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 635 ~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..... ..........+..+.+++..||+.||.+|||++++++.|+.+..
T Consensus 258 --~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 258 --LAVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --HHHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --HHhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00011 00111122345679999999999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=331.27 Aligned_cols=252 Identities=19% Similarity=0.245 Sum_probs=193.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCc--CceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYH--KNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~nlv~l~~~~~~~~~ 488 (709)
.+.|.....+|.|+++.||.+ .. ..++.||||++... .....+.+.+|+.++.+++| +||+++++++.++..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~-~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQV-LN---EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEE-EC---TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred cCEEEEEEEEecCCCeEEEEE-Ee---CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 456777777888888877654 33 45888999988643 33345789999999999986 999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||| +.+++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++.+.
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999999 567899999999888999999999999999999999 88999999999999997 5789999999998876
Q ss_pred ccccccceeccccCcccccccccccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRN-----------STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~-----------~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 637 (709)
............||+.|+| ||++.+ ..++.++|||||||++|||++|+.||........ . ...
T Consensus 159 ~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~----~~~ 232 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMP-PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K----LHA 232 (343)
T ss_dssp -----------CCCCSSCC-HHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H----HHH
T ss_pred cccccccCCCCcCCcCcCC-HHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-H----HHH
Confidence 5544333356789999999 999865 6789999999999999999999999975432111 0 111
Q ss_pred hhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 638 ~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.. +.......+......+.+++..||+.||.+|||+.|+++.
T Consensus 233 ~~---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 II---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hh---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11 1111111122234578899999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.14 Aligned_cols=243 Identities=21% Similarity=0.252 Sum_probs=202.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--------chhHHHHHHHHHHHhccCcCceeEEEeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--------QDGEKEFKNEVVMIGQTYHKNLVRLLGFCD 484 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~ 484 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDK---EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEET---TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccceEEEeEEEecCCEEEEEEEEC---CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456777788888888888766655 578999999986532 113346788999999999999999999999
Q ss_pred cCCeEEEEEeecCCC-CHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 485 EGQNRLLVYKFLNNG-TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 485 ~~~~~~lV~Ey~~~g-sL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
+....++||||+.+| +|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999999777 99999998888999999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
++.+...... ....||+.|+| ||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 177 a~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 177 AAYLERGKLF---YTFCGTIEYCA-PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp CEECCTTCCB---CEECSCGGGCC-HHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ceECCCCCce---eccCCCccccC-hhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 9877544322 45779999999 999998877 88999999999999999999999642110
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....... +...+..+.+++..||+.||++|||++++++.
T Consensus 237 -----~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----HhhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000100 11245678999999999999999999999984
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.32 Aligned_cols=244 Identities=23% Similarity=0.239 Sum_probs=190.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~ 490 (709)
++|.....+|.|+++.||.+... .+++.||||++.... .....++..|+..+.++ +|+|||++++++.++...+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK---EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET---TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeheeccCCCeEEEEEEEC---CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 46777777788888877665554 578999999876432 22334555666666555 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+ +++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999999 668988887654 6999999999999999999999 78999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... ....||+.|+| ||++.+ .++.++|||||||++|||++|..++..... +..+..+....
T Consensus 210 ~~~~---~~~~gt~~y~a-PE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~--- 271 (311)
T 3p1a_A 210 AGAG---EVQEGDPRYMA-PELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPP--- 271 (311)
T ss_dssp --------CCCCCGGGCC-GGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCH---
T ss_pred CCCC---cccCCCccccC-HhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCc---
Confidence 3322 45679999999 999886 789999999999999999999776643221 11122221111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. .....++.+.+++..||+.||++|||++|+++
T Consensus 272 -~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 -E----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -H----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -c----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 01124567899999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.45 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=192.7
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEc-CCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE-GQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~-~~~~~lV 492 (709)
.|.....+|.|+++.||.+...........||||.+.... ....+++.+|+.++++++|||||++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3444455666666667655555444456779999987543 3456789999999999999999999998754 4578999
Q ss_pred EeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++++|.+++.... .+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999998654 5889999999999999999999 8899999999999999999999999999998764432
Q ss_pred cc--cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 572 SK--AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 572 ~~--~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.. .......+++.|+| ||.+.+..++.++||||||+++|||++ |.+||......+.. .....+....
T Consensus 247 ~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~-------~~~~~~~~~~-- 316 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------VYLLQGRRLL-- 316 (373)
T ss_dssp -----------CCGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH-------HHHHTTCCCC--
T ss_pred cccccccCCCCCcccccC-hHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH-------HHHHcCCCCC--
Confidence 21 11134567889999 999999999999999999999999999 66777654332211 1112222110
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.+...+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 317 -------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 317 -------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12234567899999999999999999999999998865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=320.81 Aligned_cols=258 Identities=25% Similarity=0.320 Sum_probs=203.1
Q ss_pred cccceee-eecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSV-LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~-~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.+|.... .+|.|+++.|| .+.......+..||||++.... ....+++.+|+.++++++||||+++++++ +.+..+
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy-~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVK-KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGEEEEEEEEEECSSEEEE-EEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred hhhhhccCccccccCeeeE-eeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 3444333 55666666664 4444344678899999987543 23357899999999999999999999999 567789
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 99999999999999998888999999999999999999999 889999999999999999999999999999877544
Q ss_pred cccc-ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 571 QSKA-IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 571 ~~~~-~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.... ......|++.|+| ||.+.+..++.++||||||+++|||++ |+.||......+. ......+....
T Consensus 171 ~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~~-- 240 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYA-PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGERMG-- 240 (291)
T ss_dssp CSEEEC----CCCGGGCC-HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCCCC--
T ss_pred CCcccccccCCCCceeeC-hHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCCC--
Confidence 3321 1133456788998 999999889999999999999999999 9999976544321 12222222111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.+...+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 241 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 241 -------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12234577999999999999999999999999998864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=332.12 Aligned_cols=271 Identities=13% Similarity=0.110 Sum_probs=203.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecC--CCceEEEEEEcccccchhH-----------HHHHHHHHHHhccCcCceeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTS--TRTTVIVVKKLDRVFQDGE-----------KEFKNEVVMIGQTYHKNLVRL 479 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~--~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nlv~l 479 (709)
..+|.....+|.|+++.||.+...... ..++.||||.+........ ..+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 557888888888888888766544221 1357899999765432111 223456667788899999999
Q ss_pred EeEEEcC----CeEEEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec--C
Q 038905 480 LGFCDEG----QNRLLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD--D 552 (709)
Q Consensus 480 ~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~--~ 552 (709)
++++... ...+|||||+ +++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence 9998764 4589999999 99999999876 57999999999999999999999 88999999999999999 8
Q ss_pred CCCeEEcccccccccccccccc-----ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhh
Q 038905 553 YYNAQISDFGLAKLLTLNQSKA-----IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627 (709)
Q Consensus 553 ~~~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~ 627 (709)
++.+||+|||+++.+....... ......||+.|+| ||++.+..++.++|||||||++|||++|+.||.......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS-IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccC-HHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8999999999998775433221 1134569999999 999999999999999999999999999999997543221
Q ss_pred HHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 628 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 628 ~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
... ........ ..+..+++..+. ....+..+.+++..||+.+|.+||++++|+++|+.+.+
T Consensus 269 ~~~--~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 269 KYV--RDSKIRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHH--HHHHHHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHH--HHHHHHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 110 00111111 112222222111 12235678899999999999999999999999988653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=327.11 Aligned_cols=267 Identities=24% Similarity=0.355 Sum_probs=204.9
Q ss_pred cccceeeeecCeeEEEEEEEEEE-ecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcC--CeE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVI-QTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QNR 489 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~-~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~~ 489 (709)
..|.....+|.|+++.||.+... .....++.||||++... .....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 44666666777777777655422 12357899999998743 233557899999999999999999999999876 668
Q ss_pred EEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999544 56999999999999999999999 8899999999999999999999999999998776
Q ss_pred ccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhh--------HHhHHHHHHHhh
Q 038905 569 LNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEE--------YAILTDWAFDCY 639 (709)
Q Consensus 569 ~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~--------~~~~~~~~~~~~ 639 (709)
..... .......||..|+| ||.+.+..++.++||||||+++|||++|..|+....... ............
T Consensus 178 ~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYA-PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCC-HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccC-CeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 54332 22245678889998 999999999999999999999999999999864322100 000011111111
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
..+. ........++.+.+++..||+.||.+|||+.+++++|+.+.
T Consensus 257 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2211 11112345578999999999999999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=346.34 Aligned_cols=252 Identities=25% Similarity=0.268 Sum_probs=205.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.||||++... .......+.+|+.++.+++|||||++++++.+.+..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 566887778888888888776655 57889999998643 233456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
++||||++||+|..++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++.+
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999999998754 3899999999999999999999 889999999999999999999999999999877
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
...... ...+||+.|+| ||++.+..++.++|||||||++|||++|+.||.......... .+.+.......
T Consensus 337 ~~~~~~---~~~~GT~~Y~A-PEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~~i~~~~~--- 406 (576)
T 2acx_A 337 PEGQTI---KGRVGTVGYMA-PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEVPE--- 406 (576)
T ss_dssp CTTCCE---ECCCSCGGGCC-HHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHHHHHHCCC---
T ss_pred ccCccc---cccCCCccccC-HHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHHHhhcccc---
Confidence 543321 45689999999 999999999999999999999999999999997653211000 01111111111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
......+..+.+++..||+.||.+|| +++||++
T Consensus 407 -------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 -------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11223456789999999999999999 7788875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.49 Aligned_cols=251 Identities=21% Similarity=0.285 Sum_probs=200.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcC--Ce
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG--QN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~--~~ 488 (709)
..+|.....+|.|+++.|| .+.. .+..+|||++... .....+++.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~-~~~~----~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELW-KGRW----QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEE-EEEE----TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred HHHhHHHHHhcCCCcceEE-EEEE----CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 3456666666666666665 4444 3788999998654 234457899999999999999999999999877 78
Q ss_pred EEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCC--eEecCCCCCceeecCCCCeEEcccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQ--IIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
.++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+ |+||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 899999999999999998765 4899999999999999999999 778 999999999999999999999999987
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCc---ccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITA---NVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~---k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 641 (709)
..... ....||+.|+| ||.+.+..++. ++||||||+++|||++|+.||......+.. ......
T Consensus 161 ~~~~~-------~~~~~t~~y~a-PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~ 226 (271)
T 3kmu_A 161 FSFQS-------PGRMYAPAWVA-PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALE 226 (271)
T ss_dssp CTTSC-------TTCBSCGGGSC-HHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHS
T ss_pred eeecc-------cCccCCccccC-hhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhc
Confidence 64322 34568999999 99998766554 799999999999999999999765433211 111111
Q ss_pred CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 642 g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+... ..+...+..+.+++..||+.||++|||++++++.|+.+.+
T Consensus 227 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 GLRP---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111 1122345678999999999999999999999999988654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=324.15 Aligned_cols=250 Identities=19% Similarity=0.237 Sum_probs=194.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ---- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~---- 487 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|+.++++++|||||++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEET---TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEc---CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 356777777888888888666554 578899999986433 335578999999999999999999999986543
Q ss_pred -----------------------------------------------------eEEEEEeecCCCCHHHHHhhCCC---C
Q 038905 488 -----------------------------------------------------NRLLVYKFLNNGTLASFLFENLK---P 511 (709)
Q Consensus 488 -----------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~---l 511 (709)
..++||||+++++|.+++.+... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 37999999999999999987653 4
Q ss_pred ChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc----------cceecccc
Q 038905 512 GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK----------AIKKAIRG 581 (709)
Q Consensus 512 ~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~G 581 (709)
++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++........ .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 55668899999999999999 889999999999999999999999999999887654321 11244679
Q ss_pred CcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHH
Q 038905 582 TKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCV 661 (709)
Q Consensus 582 t~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~ 661 (709)
|+.|+| ||++.+..++.++||||||+++|||++|..|+... .. .......+.... ......
T Consensus 239 t~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~----~~~~~~~~~~~~---------~~~~~~ 299 (332)
T 3qd2_B 239 TKLYMS-PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VR----IITDVRNLKFPL---------LFTQKY 299 (332)
T ss_dssp CGGGSC-HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HH----HHHHHHTTCCCH---------HHHHHC
T ss_pred CcCccC-hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HH----HHHHhhccCCCc---------ccccCC
Confidence 999999 99999999999999999999999999987764211 00 111111221111 012344
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 662 EKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 662 ~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+.+++..||+.||++|||++|+++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 56789999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=321.65 Aligned_cols=264 Identities=19% Similarity=0.202 Sum_probs=198.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-----hhHHHHHHHHHHHhccC---cCceeEEEeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-----DGEKEFKNEVVMIGQTY---HKNLVRLLGFCD 484 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~nlv~l~~~~~ 484 (709)
..+|.....+|.|+++.||.+... .+++.||||++..... .....+.+|+.++++++ ||||+++++++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDP---HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECT---TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 567887778888888888766544 5788999999864321 12346677887777765 999999999997
Q ss_pred cCC-----eEEEEEeecCCCCHHHHHhhCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeE
Q 038905 485 EGQ-----NRLLVYKFLNNGTLASFLFENLK--PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557 (709)
Q Consensus 485 ~~~-----~~~lV~Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 557 (709)
... ..++||||+. ++|.+++..... +++..+..++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEE
Confidence 655 5799999997 599999987654 899999999999999999999 88999999999999999999999
Q ss_pred EccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH
Q 038905 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637 (709)
Q Consensus 558 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 637 (709)
|+|||+++........ ....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+..........
T Consensus 161 l~Dfg~a~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 161 LADFGLARIYSYQMAL---TPVVVTLWYRA-PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp ECSCSCTTTSTTCCCS---GGGGCCCSSCC-HHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EeeCccccccCCCccc---CCccccccccC-chHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999876543322 56789999999 9999999999999999999999999999999986654332211111110
Q ss_pred hhhcCCcccc---ccCccc-------ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 638 CYRNGKLDDL---VEGDME-------AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 638 ~~~~g~~~~l---~~~~~~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......... ...... .......++.+.+++..||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000000 000000 0001234577899999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.57 Aligned_cols=254 Identities=28% Similarity=0.394 Sum_probs=203.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+++.||.+ .. ..+..||||.+.... ...+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~-~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMG-YY---NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEE-EE---TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHhhhheeeecCCCCeEEEEE-EE---cCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 345666666677777777544 44 356789999987543 356789999999999999999999999864 568999
Q ss_pred EeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999997543 6899999999999999999999 889999999999999999999999999999877543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... .....+++.|+| ||.+.+..++.++||||||++++||++ |+.||......+. ......+...
T Consensus 163 ~~~~-~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~---- 229 (279)
T 1qpc_A 163 EYTA-REGAKFPIKWTA-PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-------IQNLERGYRM---- 229 (279)
T ss_dssp CEEC-CTTCCCCTTTSC-HHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCCC----
T ss_pred cccc-ccCCCCccCccC-hhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH-------HHHHhcccCC----
Confidence 3221 134567888998 999998899999999999999999999 8999975543321 1111222111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
......++.+.+++..|++.||++|||+++++++|+.+.
T Consensus 230 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 230 -----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 112234567899999999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=327.55 Aligned_cols=265 Identities=17% Similarity=0.217 Sum_probs=193.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+++.||.+... .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDT---VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEEC---CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 567777777777777777666544 5789999999865432 23456789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec-----CCCCeEEccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-----DYYNAQISDFGLAK 565 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~-----~~~~~kl~DFGla~ 565 (709)
+||||+++ +|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++ +++.+||+|||+++
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99999985 99999998888999999999999999999999 88999999999999994 55569999999998
Q ss_pred cccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
.+...... .....||+.|+| ||++.+. .++.++|||||||++|||++|+.||......+.................
T Consensus 186 ~~~~~~~~--~~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 186 AFGIPIRQ--FTHEIITLWYRP-PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHC-------------CCTTCC-HHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccCCcccc--cCCCcCCccccC-HHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 76543322 145678999999 9999875 5899999999999999999999999766543322111100000000000
Q ss_pred c-------------ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 645 D-------------DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 645 ~-------------~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. ..................+.+++..||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 000000000001124567889999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.80 Aligned_cols=261 Identities=21% Similarity=0.235 Sum_probs=201.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-----cCceeEEEeEEEcCC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-----HKNLVRLLGFCDEGQ 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nlv~l~~~~~~~~ 487 (709)
.++|.....+|.|+++.||.+... .+++.||||++... ....+.+..|+.++.+++ |||||++++++...+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHI---DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred cCEEEEEEEEcccCCeEEEEEEEC---CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 467777777888888888766554 56889999998753 235567888999999986 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-------------
Q 038905 488 NRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD------------- 552 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~------------- 552 (709)
..++||||+ +++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999 899999998765 4899999999999999999999 889999999999999975
Q ss_pred ------------CCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 038905 553 ------------YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620 (709)
Q Consensus 553 ------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~ 620 (709)
++.+||+|||+++...... ....||+.|+| ||++.+..++.++|||||||++|||++|+.||
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRA-PEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCC-HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccC-cHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 7899999999998654332 45679999999 99999999999999999999999999999999
Q ss_pred CccchhhHHhHHHHHHH--------hhhcCCccccccC-ccc----c-cCC---------------HHHHHHHHHHHHhc
Q 038905 621 DIEMGEEYAILTDWAFD--------CYRNGKLDDLVEG-DME----A-MND---------------IKCVEKLVMVSIWC 671 (709)
Q Consensus 621 ~~~~~~~~~~~~~~~~~--------~~~~g~~~~l~~~-~~~----~-~~~---------------~~~~~~l~~l~~~C 671 (709)
......+.......... ..........++. ... . ... ....+.+.+++..|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 86654332211111100 0000000000000 000 0 000 01125688999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 038905 672 IQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 672 l~~dP~~RPs~~ev~~ 687 (709)
|+.||++|||++|+++
T Consensus 340 L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 340 LQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCSSGGGSCCHHHHTT
T ss_pred hcCChhhCCCHHHHhc
Confidence 9999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=325.27 Aligned_cols=261 Identities=22% Similarity=0.262 Sum_probs=196.7
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeecCC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFLNN 498 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~~~ 498 (709)
..+|.|+++.||.+... .+++.||||++........+.+.+|++++.++ +||||+++++++.+++..++||||+++
T Consensus 19 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINL---ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95 (316)
T ss_dssp CCCCCCSSEEEEEEECS---SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ceecCCceEEEEEEEEc---CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCC
Confidence 45777777877665544 57889999999766556678899999999985 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC---eEEccccccccccccccc--
Q 038905 499 GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN---AQISDFGLAKLLTLNQSK-- 573 (709)
Q Consensus 499 gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFGla~~~~~~~~~-- 573 (709)
++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+|||+++........
T Consensus 96 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 96 GSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred CcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 999999998888999999999999999999999 889999999999999998776 999999999866432211
Q ss_pred ---cceeccccCcccccccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCccchhh--------HHhHHHHHHH
Q 038905 574 ---AIKKAIRGTKGYVASPEWFRN-----STITANVDVYSFGVLLLEIISCRKSFDIEMGEE--------YAILTDWAFD 637 (709)
Q Consensus 574 ---~~~~~~~Gt~~y~aaPE~~~~-----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~--------~~~~~~~~~~ 637 (709)
.......||+.|+| ||++.+ ..++.++||||||+++|||++|+.||......+ .........+
T Consensus 173 ~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMA-PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251 (316)
T ss_dssp ---------CCSGGGCC-HHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred ccccccccccCCcCccC-hHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence 11134569999999 999975 568899999999999999999999997653211 0000111222
Q ss_pred hhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHcccc
Q 038905 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVVV 693 (709)
Q Consensus 638 ~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~ 693 (709)
.+..+.... .... ....+..+.+++.+||+.||.+|||+.|+++ .+.+..
T Consensus 252 ~i~~~~~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 252 SIQEGKYEF-PDKD-----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHCCCCC-CHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHhccCccc-Cchh-----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 223332211 0000 0123567899999999999999999999998 344433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=320.77 Aligned_cols=254 Identities=23% Similarity=0.296 Sum_probs=203.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
++|.....+|.|+++.||.+... .+++.||||.+........+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQR---LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEEC---CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45666666777777777666554 578899999987655445577999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee---cCCCCeEEcccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~~~~ 570 (709)
||+++++|.+++.+...+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999999988888999999999999999999999 8899999999999999 78899999999999765432
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
. .....||+.|+| ||++.+..++.++||||||+++|||++|+.||......+. ...+..+....
T Consensus 163 ~----~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~~~---- 226 (304)
T 2jam_A 163 I----MSTACGTPGYVA-PEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-------FEKIKEGYYEF---- 226 (304)
T ss_dssp T----THHHHSCCCBCC-TTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHCCCCC----
T ss_pred c----cccccCCCCccC-hHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCCCC----
Confidence 1 145679999999 9999999999999999999999999999999976543221 12222222110
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHcc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEV 691 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~ 691 (709)
........+..+.+++..||+.||.+|||++|+++ .+.+
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 227 --ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp --CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred --CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 01111234567899999999999999999999987 4444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.04 Aligned_cols=274 Identities=26% Similarity=0.316 Sum_probs=207.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+.... ....+..||||.+... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4567777778888888776655321 2256788999998643 334557899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC-------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC---CCCeEEc
Q 038905 490 LLVYKFLNNGTLASFLFENL-------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---YYNAQIS 559 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~-------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~ 559 (709)
++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999998753 3888999999999999999999 889999999999999984 4569999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||+++...............||+.|+| ||++.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~ 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMP-PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------LEF 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHH
T ss_pred ccccccccccccccccCCCcCCCcceeC-HhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH-------HHH
Confidence 9999986644333222245678999999 999999999999999999999999998 8899975543321 112
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc---CCCCCCCCCCcc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE---VDVPPNPSTFSC 706 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~---~~~p~~p~~~~~ 706 (709)
...+.... .....+..+.+++..||+.||.+|||+.++++.|+.+.. +..+..|..+..
T Consensus 258 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~~ 319 (327)
T 2yfx_A 258 VTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGP 319 (327)
T ss_dssp HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCCCC---
T ss_pred HhcCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhccccccccCC
Confidence 22222111 122345678899999999999999999999999987653 333444444443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.52 Aligned_cols=262 Identities=21% Similarity=0.355 Sum_probs=200.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEE-cCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCD-EGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~-~~~~~~ 490 (709)
..+|.....+|.|+++.||.+.....+.....+|+|.+.... ....+++.+|+.++++++||||+++++++. .+...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 345555666777777777666555444556679999987543 334578999999999999999999999864 556789
Q ss_pred EEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999997643 5889999999999999999999 88999999999999999999999999999987654
Q ss_pred cccc--cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhC-CCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 570 NQSK--AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 570 ~~~~--~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
.... .......||+.|+| ||.+.+..++.++||||||++++||++| .+||......+.. .....+....
T Consensus 181 ~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 252 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------VYLLQGRRLL 252 (298)
T ss_dssp GGGCBC-----CCBCGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH-------HHHHTTCCCC
T ss_pred cchhccccccCCCCCccccC-hHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhcCCCCC
Confidence 3321 12245678889998 9999999999999999999999999994 5565543332211 1111111111
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.+...+..+.+++..||+.||++|||+.+++++|+.+..
T Consensus 253 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 253 ---------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 112234678999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=317.78 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=202.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.+|.....+|.|+++.||.+... .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEEC---CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 45665556666666666555443 568899999986432 33457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||+++++|.+++.....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999999987778999999999999999999999 88999999999999999999999999999987654433
Q ss_pred ccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
........||+.|+| ||++.+..+ +.++||||||++++||++|+.||......... ...+......
T Consensus 161 ~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~------ 227 (276)
T 2yex_A 161 ERLLNKMCGTLPYVA-PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY------ 227 (276)
T ss_dssp ECCBCCCCSCGGGCC-GGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTTCTT------
T ss_pred hhcccCCccccCccC-hHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhcccc------
Confidence 322356789999999 999988775 78999999999999999999999765432211 1111111110
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......+..+.+++..||+.||.+|||++|+++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0011234567889999999999999999999976
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=334.12 Aligned_cols=251 Identities=19% Similarity=0.242 Sum_probs=193.2
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccC--cCceeEEEeEEEcCCeE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTY--HKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nlv~l~~~~~~~~~~ 489 (709)
..|.....+|.|+++.||.+ .. ..++.||||++... .....+.+.+|+.++.+++ |+|||++++++...+..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~-~~---~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQV-LN---EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEE-EC---TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CceEEEEEEccCCCeEEEEE-Ec---CCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 44776677777777777554 33 34888999988643 3345578999999999996 59999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||| +.+++|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99999 568899999998888999999999999999999999 89999999999999995 58999999999988765
Q ss_pred cccccceeccccCcccccccccccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRN-----------STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~-----------~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
..........+||+.|+| ||++.+ ..++.++|||||||++|||++|+.||........ . ...
T Consensus 207 ~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~----~~~- 279 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMP-PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K----LHA- 279 (390)
T ss_dssp -------CCSCCCGGGCC-HHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-H----HHH-
T ss_pred CCccccCCCCCcCCCccC-hHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-H----HHH-
Confidence 443333356789999999 999875 4688999999999999999999999975432211 1 111
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
...+. .....+...+..+.+++..||+.||.+|||+.|+++.
T Consensus 280 ~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 IIDPN--------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHCTT--------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCcc--------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111 1111111224578899999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=317.19 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=181.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESI---HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred cccceeeeeecCCCceEEEEEEEc---cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 456776677777777777666554 568899999986432 22347899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++||||+++++|.+++... ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999999875 46899999999999999999999 8899999999999999999999999999998765
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
...... ....||+.|+| ||.+.+..++.++||||||++++||++|+.||......+.. ..+.
T Consensus 164 ~~~~~~--~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~ 225 (278)
T 3cok_A 164 MPHEKH--YTLCGTPNYIS-PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVV 225 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CC
T ss_pred CCCCcc--eeccCCCCcCC-cchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHh
Confidence 433221 35679999999 99999999999999999999999999999999754332210 0001
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..... .+...+..+.+++.+||+.||++|||++++++
T Consensus 226 ~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LADYE--MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccC--CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01111 12234567889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=318.18 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=205.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... ..++.+|+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDA---DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEeecCCEEEEEEEEC---CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 456777777888888877666554 56788999987643 233557789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999999999988788999999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..... ....||+.|+| ||.+.+..++.++||||||++++||++|+.||......+.. .....+...
T Consensus 168 ~~~~~--~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~---- 233 (294)
T 2rku_A 168 DGERK--KVLCGTPNYIA-PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------LRIKKNEYS---- 233 (294)
T ss_dssp TTCCB--CCCCSCCSSCC-HHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTCCC----
T ss_pred Ccccc--ccccCCCCcCC-cchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhhccCC----
Confidence 33221 45679999999 99999999999999999999999999999999765433211 111121110
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 234 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 234 ------IPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------CccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 01123457889999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=326.73 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=201.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+++.||.+....+ .....+|||.+... .....+++.+|+.++.++ +||||+++++++.+.+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEET-TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccC-CcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 45666666777777777766655532 22224588887643 233456799999999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC
Q 038905 491 LVYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~ 554 (709)
+||||+++++|.+++.+.. .+++..+..++.||+.||.||| +.+|+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCC
Confidence 9999999999999998654 6899999999999999999999 88999999999999999999
Q ss_pred CeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHH
Q 038905 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD 633 (709)
Q Consensus 555 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 633 (709)
.+||+|||+++........ ....+++.|+| ||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------ 249 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKK---TMGRLPVRWMA-IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------ 249 (327)
T ss_dssp CEEECCTTCEESSCEECCC-------CCTTTCC-HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------
T ss_pred eEEEcccCcCccccccccc---cCCCCCccccC-hhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------
Confidence 9999999999754322211 34567889998 999999899999999999999999998 999997654322
Q ss_pred HHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 634 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 634 ~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
....+..+... ......+..+.+++..||+.||.+|||++++++.|+.+.+
T Consensus 250 -~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 250 -LYEKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp -HHHHGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHhhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11222222111 1122345678999999999999999999999999988654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.24 Aligned_cols=258 Identities=22% Similarity=0.256 Sum_probs=204.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc----chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF----QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQ 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~ 487 (709)
..+|.....+|.|+++.||.+........++.||||++.... ....+.+.+|++++.++ +|+||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 467777777777888888776665444578999999986432 23345678899999999 6999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
..++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999998888999999999999999999999 889999999999999999999999999999876
Q ss_pred cccccccceeccccCcccccccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCccchhh-HHhHHHHHHHhhhcCCc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKL 644 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~g~~ 644 (709)
........ ....||+.|+| ||++.+ ..++.++|||||||++|||++|+.||....... ...+ ........
T Consensus 210 ~~~~~~~~-~~~~gt~~y~a-PE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~~~~~~- 282 (355)
T 1vzo_A 210 VADETERA-YDFCGTIEYMA-PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI----SRRILKSE- 282 (355)
T ss_dssp CGGGGGGG-CGGGSCCTTCC-HHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH----HHHHHHCC-
T ss_pred ccCCCCcc-cCcccCcCccC-hhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH----HHHHhccC-
Confidence 54433222 45789999999 999986 357899999999999999999999997543211 1111 11111111
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHH
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQML 689 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~L 689 (709)
.......+..+.+++..||+.||.+|| +++|+++..
T Consensus 283 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011223456788999999999999999 999998743
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=327.52 Aligned_cols=252 Identities=21% Similarity=0.238 Sum_probs=200.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+... .+++.+|||.++.... ...+|++++.++ +||||+++++++.++...++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK---ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 345666667777777777666554 5789999999875432 345788888887 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC----CCeEEccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY----YNAQISDFGLAKLL 567 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~DFGla~~~ 567 (709)
||||+++|+|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+|||+.++ +.+||+|||+++.+
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999999998888999999999999999999999 8899999999999998433 34999999999876
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
...... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||.......... +...+..++...
T Consensus 171 ~~~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~~~~- 242 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVA-PEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILARIGSGKFSL- 242 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCC-HHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH----HHHHHHHCCCCC-
T ss_pred cCCCCc--eeccCCCccccC-HHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH----HHHHHccCCccc-
Confidence 544322 256789999999 999998889999999999999999999999997543221111 122223333221
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........+..+.+++..||+.||++|||+.++++
T Consensus 243 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 -----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11112234567899999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=330.31 Aligned_cols=246 Identities=21% Similarity=0.249 Sum_probs=197.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..|.....+|.|+++.||.+... .+++.||||++.... ....+++.+|+.++++++|||||++++++.+++..+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEc---cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 34666677788888877666554 578999999986432 233467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHh-hCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLF-ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+. |+|.+++. ....+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9999998 57777775 3457999999999999999999999 88999999999999999999999999999987643
Q ss_pred cccccceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
. ....||+.|+| ||++. ...++.++|||||||++|||++|+.||......... .... .+....
T Consensus 207 ~------~~~~gt~~y~a-PE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~-~~~~~~ 272 (348)
T 1u5q_A 207 A------NSFVGTPYWMA-PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA-QNESPA 272 (348)
T ss_dssp B------CCCCSCGGGCC-HHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHH-HSCCCC
T ss_pred C------CcccCCcceeC-HhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHH-hcCCCC
Confidence 2 45679999999 99984 567899999999999999999999999755432211 1111 111111
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
+. ....++.+.+++..||+.||++|||++++++.
T Consensus 273 ~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 LQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC--------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11 12345678899999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=354.99 Aligned_cols=249 Identities=23% Similarity=0.279 Sum_probs=208.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
..+|.....+|.|+|+.||.+... .+++.||||++... .....+.+..|..++..+ +|+||+++++++.+.+.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEES---SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred ccceEEEEEEccCCCEEEEEEEEC---CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 567888888888888888776665 57889999998743 233456788999999987 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.+|||||+++|+|..++.....+++..+..++.||+.||.||| +++|+||||||+||||+.++++||+|||+++...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999999998888999999999999999999999 8899999999999999999999999999998654
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ +.+.+..+...
T Consensus 494 ~~~~~--~~~~~GT~~Y~A-PE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~~--- 560 (674)
T 3pfq_A 494 WDGVT--TKTFCGTPDYIA-PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNVA--- 560 (674)
T ss_dssp CTTCC--BCCCCSCSSSCC-HHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHSSCCC---
T ss_pred cCCcc--cccccCCCcccC-HhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCCC---
Confidence 33222 267889999999 999999999999999999999999999999998654433 12222222211
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM-----RKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~ev~~ 687 (709)
.+...+..+.+|+..||+.||++||++ +||++
T Consensus 561 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 -------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 122355678999999999999999998 66654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=319.18 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=200.7
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~g 499 (709)
.+|.|+++.||. +.......+..||||.+.... ....+++.+|+.++.+++||||+++++++ +.+..++||||++++
T Consensus 17 ~lg~G~~g~Vy~-~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 17 ELGCGNFGSVRQ-GVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEECCTTEEEEE-EEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred cccccCceeEEE-eEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 566666666654 443333567889999997643 34567899999999999999999999999 456789999999999
Q ss_pred CHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc-ccee
Q 038905 500 TLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK-AIKK 577 (709)
Q Consensus 500 sL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~ 577 (709)
+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++........ ....
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 999999754 45899999999999999999999 889999999999999999999999999999877544322 1123
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
...||+.|+| ||++.+..++.++||||||+++|||++ |+.||......+.. .....+.... .
T Consensus 172 ~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~i~~~~~~~---------~ 234 (287)
T 1u59_A 172 AGKWPLKWYA-PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGKRME---------C 234 (287)
T ss_dssp SSCCCGGGCC-HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTCCCC---------C
T ss_pred cccccccccC-HHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHhcCCcCC---------C
Confidence 4567899999 999998899999999999999999998 99999765443311 1222222111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+...+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2235578999999999999999999999999998865
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=325.00 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=206.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... ..++.+|+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDA---DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 456777777888888877666554 56789999987643 234557789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999999999988788999999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... .....||+.|+| ||++.+..++.++||||||+++|||++|+.||......+.. .....+...
T Consensus 194 ~~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~---- 259 (335)
T 2owb_A 194 DGER--KKVLCGTPNYIA-PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------LRIKKNEYS---- 259 (335)
T ss_dssp TTCC--BCCCCSCCSSCC-HHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHTCCC----
T ss_pred Cccc--ccccCCCccccC-HHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-------HHHhcCCCC----
Confidence 3322 145679999999 99999999999999999999999999999999765433211 111111111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. .......+.+++.+||+.||++|||++|+++
T Consensus 260 --~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 --I----PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --C----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --C----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1123456889999999999999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.98 Aligned_cols=249 Identities=23% Similarity=0.292 Sum_probs=193.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
++|.....+|.|+++.||.+... ..+..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER---SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEc---cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 45666666777777777655544 568899999986543 33567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee---cCCCCeEEccccccc
Q 038905 493 YKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFGLAK 565 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~ 565 (709)
|||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999998643 56999999999999999999999 8899999999999999 556889999999998
Q ss_pred cccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
.+...... ....||+.|+| ||.+. ..++.++||||||++++||++|+.||......+... ........
T Consensus 176 ~~~~~~~~---~~~~~t~~y~a-PE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~-------~~~~~~~~ 243 (285)
T 3is5_A 176 LFKSDEHS---TNAAGTALYMA-PEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ-------KATYKEPN 243 (285)
T ss_dssp C-------------CTTGGGCC-HHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCCCC
T ss_pred ecCCcccC---cCcccccCcCC-hHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh-------hhccCCcc
Confidence 76543322 55679999999 99986 468999999999999999999999997654333211 11111111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.... ....+..+.+++..||+.||++|||+.|+++
T Consensus 244 ~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YAVE-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccc-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0113467889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.98 Aligned_cols=270 Identities=17% Similarity=0.224 Sum_probs=195.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchh-HHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDG-EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+|.....+|.|+++.||.+... .+++.||||++....... ...+.+|+.++++++||||+++++++.+....++||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSK---LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEEC---CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 4666666777777777655544 578899999986543222 124568999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++ +|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 99985 8988887754 5899999999999999999999 88999999999999999999999999999986653322
Q ss_pred ccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
. .....||+.|+| ||++.+ ..++.++||||||+++|||++|+.||......+........................
T Consensus 156 ~--~~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 156 T--YDNEVVTLWYRP-PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ---------CGGGCC-HHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred c--cccccCcccccC-hhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2 145678999999 999876 568999999999999999999999998765443222111111100011111111000
Q ss_pred ---------c----cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHccccc
Q 038905 652 ---------M----EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVVVE 694 (709)
Q Consensus 652 ---------~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~ 694 (709)
. ........+..+.+++..||+.||++|||++|+++ .+.+..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0 00001234567889999999999999999999998 4555543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.47 Aligned_cols=256 Identities=23% Similarity=0.266 Sum_probs=200.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc------hhHHHHHHHHHHHhccCcCceeEEEeEEEcCC
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ------DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~ 487 (709)
++|.....+|.|+++.||.+... .+++.+|+|.+..... ...+++.+|+.++++++||||+++++++.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK---GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhHHhhcccCceEEEEEEEc---CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 34565666677777777655544 4688999998764321 13678999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC----CeEEccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY----NAQISDFGL 563 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFGl 563 (709)
..++||||+++++|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+||+++.++ .+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999999988788999999999999999999999 88999999999999998877 799999999
Q ss_pred cccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
++........ ....|++.|+| ||++.+..++.++||||||++++||++|+.||......+.. ..+....
T Consensus 159 ~~~~~~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~ 227 (283)
T 3bhy_A 159 AHKIEAGNEF---KNIFGTPEFVA-PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-------TNISAVN 227 (283)
T ss_dssp CEECC-----------CCCGGGCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTC
T ss_pred ceeccCCCcc---cccCCCcCccC-cceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH-------HHhHhcc
Confidence 9876543321 45679999999 99999999999999999999999999999999765433211 1111111
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHccc
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVV 692 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~ 692 (709)
... . .......++.+.+++.+||+.||++|||+.++++ .++.+
T Consensus 228 ~~~--~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 228 YDF--D----EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCC--C----HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cCC--c----chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 110 0 0001123567889999999999999999999997 44443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=350.57 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=197.5
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~g 499 (709)
.+|.|+|+.| |.+.......+..||||+++... ....+++.+|++++++++|||||++++++.+ +..++||||+++|
T Consensus 343 ~LG~G~fG~V-y~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSV-RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEE-EEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEE-EEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 3455555555 55555444567889999997643 3456889999999999999999999999976 5689999999999
Q ss_pred CHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccccc-cee
Q 038905 500 TLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKA-IKK 577 (709)
Q Consensus 500 sL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~ 577 (709)
+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus 421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 9999997654 5899999999999999999999 8899999999999999999999999999998775443221 112
Q ss_pred ccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccC
Q 038905 578 AIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 656 (709)
Q Consensus 578 ~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~ 656 (709)
...+++.|+| ||++.+..++.++|||||||++|||++ |+.||......+. ...+..+.... .
T Consensus 498 ~~~~~~~y~A-PE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~~~~---------~ 560 (613)
T 2ozo_A 498 AGKWPLKWYA-PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKRME---------C 560 (613)
T ss_dssp ----CCTTSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH-------HHHHHTTCCCC---------C
T ss_pred CCCCccceeC-HhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCCCC---------C
Confidence 3446788999 999999999999999999999999998 9999976554331 12222332111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 657 DIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 657 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+...+..+.+++..||+.||++||++.+|++.|+.+.
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2345678999999999999999999999999998854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.65 Aligned_cols=264 Identities=16% Similarity=0.239 Sum_probs=202.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+... .++..||+|++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHK---PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEEC---CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 456777777777777777665544 57889999998754 33445789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS-QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++++|.+++.+...+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999998888999999999999999999999 64 8999999999999999999999999999765432
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH---------hhhc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD---------CYRN 641 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~~ 641 (709)
. .....||+.|+| ||++.+..++.++||||||+++|||++|+.||......+.......... ....
T Consensus 186 ~----~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 M----ANSFVGTRSYMS-PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp C--------CCCCTTCC-HHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred c----ccCCCCCCCeEC-HHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 2 145689999999 9999999999999999999999999999999976554332111000000 0000
Q ss_pred C--------------Cccc----cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 G--------------KLDD----LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 g--------------~~~~----l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+ .... +.............+..+.+++..||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0 0000 00000001111224567899999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.62 Aligned_cols=268 Identities=22% Similarity=0.357 Sum_probs=207.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe-cCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC--eE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ-TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--NR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--~~ 489 (709)
..+|.....+|.|+++.||.+.... ....++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4456666677777777776554321 23578999999998766667788999999999999999999999986544 68
Q ss_pred EEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 99999999999999998764 5899999999999999999999 8899999999999999999999999999998876
Q ss_pred ccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhH---------HhHHHHHHHh
Q 038905 569 LNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY---------AILTDWAFDC 638 (709)
Q Consensus 569 ~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~ 638 (709)
..... .......++..|+| ||.+.+..++.++||||||++++||++|..|+........ ........+.
T Consensus 197 ~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCC-HHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEEC-chhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 54322 11134567788998 9999998999999999999999999999998764311100 0000011111
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
...+. ........+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 276 ~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 276 LKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 11112335578999999999999999999999999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.41 Aligned_cols=254 Identities=17% Similarity=0.157 Sum_probs=202.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEcccccchhHHHHHHHHHHHhccC---cCceeEEEeEEEcCC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY---HKNLVRLLGFCDEGQ 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nlv~l~~~~~~~~ 487 (709)
...|.....+|.|+++.||.+.... ....++.||||++... ...++..|++++.+++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 5567777777777777776663111 1257889999998754 4457778888877776 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhh-----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC----------
Q 038905 488 NRLLVYKFLNNGTLASFLFE-----NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---------- 552 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~-----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---------- 552 (709)
..++||||+++|+|.+++.. ...+++..+..++.||++||.||| +.+|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999974 346999999999999999999999 899999999999999998
Q ss_pred -CCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhH
Q 038905 553 -YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 631 (709)
Q Consensus 553 -~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~ 631 (709)
++.+||+|||+|+.+............+||+.|+| ||++.+..++.++|||||||++|||++|+.||........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC-VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCC-HHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCC-hHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 89999999999987654333333366789999999 9999999999999999999999999999999864332110
Q ss_pred HHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHHccccc
Q 038905 632 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLR-PTMRKVSQMLEVVVE 694 (709)
Q Consensus 632 ~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~ev~~~L~~~~~ 694 (709)
.+....... ...+.+.+++..|++.+|.+| |+++++.+.|+...+
T Consensus 294 ---------------~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 ---------------KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ---------------EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---------------eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 011111111 235667889999999999998 788888888877543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=326.31 Aligned_cols=255 Identities=22% Similarity=0.183 Sum_probs=194.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-----cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-----FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~ 487 (709)
.++|.....+|.|+++.||.+... .+++.||||++... .....+.+.+|+.++++++|||||++++++.+.+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIEN---QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhheeecceeeecCCeEEEEEEEC---CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 455666666666666666555443 67889999987643 2345678999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhC----------------------------------------CCCChHHHHHHHHHHHHHH
Q 038905 488 NRLLVYKFLNNGTLASFLFEN----------------------------------------LKPGWNLRANIAFQIARGL 527 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~~i~~al 527 (709)
..++||||+++++|.+++... ..+++..+..++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998521 0134667788999999999
Q ss_pred HHhhhcCCCCeEecCCCCCceeecCCC--CeEEccccccccccccccc--cceeccccCcccccccccccC--CCCCccc
Q 038905 528 LHLHVNCSSQIIHCDIKPQNILLDDYY--NAQISDFGLAKLLTLNQSK--AIKKAIRGTKGYVASPEWFRN--STITANV 601 (709)
Q Consensus 528 ~~LH~~~~~~iiH~Dlkp~NIll~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aaPE~~~~--~~~s~k~ 601 (709)
.||| +.+|+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+| ||++.+ ..++.++
T Consensus 182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA-PEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC-HHHHTCSSSCCCTHH
T ss_pred HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC-chhhccCCCCCCcHH
Confidence 9999 88999999999999998776 8999999999876432221 11246789999999 999975 6789999
Q ss_pred chHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC
Q 038905 602 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681 (709)
Q Consensus 602 DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 681 (709)
||||||+++|||++|+.||......+.. .....+.... ........+..+.+++..||+.||.+|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTI-------SQVLNKKLCF------ENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCT------TSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHH-------HHHHhccccc------CCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999765443211 1111111110 00011224567889999999999999999
Q ss_pred HHHHHH
Q 038905 682 MRKVSQ 687 (709)
Q Consensus 682 ~~ev~~ 687 (709)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=326.10 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=201.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNK---DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEET---TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEEC---CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 456777778888888888666554 568899999875432 233466889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||+++++|..++.....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999999999998887778999999999999999999999 889999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH--------HHhhhc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRN 641 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~ 641 (709)
... .....||+.|+| ||++.+. .++.++||||||+++|||++|+.||......+........ ...+..
T Consensus 178 ~~~--~~~~~~t~~y~a-PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 GEV--YDDEVATRWYRA-PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp --------CCCCCTTCC-HHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccc--cCCCcCCccccC-cccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 322 145679999999 9999875 7899999999999999999999999876543322111000 000000
Q ss_pred ------CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 ------GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 ------g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....+.............++.+.+++..||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111111111111111234678999999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=332.59 Aligned_cols=268 Identities=19% Similarity=0.212 Sum_probs=208.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC--eE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--NR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|++++++++|||||++++++.+.. ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHK---KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEEC---CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 345666667777777777666554 568899999987543 334577889999999999999999999998755 77
Q ss_pred EEEEeecCCCCHHHHHhhCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee----cCCCCeEEcccc
Q 038905 490 LLVYKFLNNGTLASFLFENL---KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL----DDYYNAQISDFG 562 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFG 562 (709)
++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999999997654 3899999999999999999999 8899999999999999 778889999999
Q ss_pred ccccccccccccceeccccCcccccccccccC--------CCCCcccchHHHHHHHHHHHhCCCCCCccchhh-HHhHHH
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN--------STITANVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTD 633 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~--------~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~-~~~~~~ 633 (709)
+++........ ....||+.|+| ||++.+ ..++.++|||||||++|||++|+.||....... ....
T Consensus 162 ~a~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~-- 235 (396)
T 4eut_A 162 AARELEDDEQF---VSLYGTEEYLH-PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV-- 235 (396)
T ss_dssp GCEECCCGGGS---SCSSSCCTTCC-HHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH--
T ss_pred CceEccCCCcc---ccccCCccccC-HHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH--
Confidence 99877544322 45679999999 999875 567889999999999999999999997543211 1111
Q ss_pred HHHHhhhcCCccccc---------------cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 634 WAFDCYRNGKLDDLV---------------EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 634 ~~~~~~~~g~~~~l~---------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+.. ...+.....+ +..............+.+++..||+.||++||+++++++.++.+.+
T Consensus 236 -~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 236 -MYK-IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp -HHH-HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred -HHH-HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 111 1122211110 0011112235678889999999999999999999999998877654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=338.83 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=200.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..|.....+|.|+++.||.+... ..+..+|||++.... ......+.+|+.++++++|||||++++++.+....++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDK---VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEET---TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEEC---CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45777778888888888766654 578889999886532 3345788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC---CCCeEEcccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---YYNAQISDFGLAKLLT 568 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~ 568 (709)
||||+++|+|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++.+.
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999999988888999999999999999999999 889999999999999976 4559999999998776
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... ....||+.|+| ||++. ..++.++|||||||++|+|++|+.||......+. ...+..+.....
T Consensus 191 ~~~~~---~~~~gt~~y~a-PE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~~- 257 (494)
T 3lij_A 191 NQKKM---KERLGTAYYIA-PEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-------LRKVEKGKYTFD- 257 (494)
T ss_dssp TTBCB---CCCCSCTTTCC-HHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCCC-
T ss_pred CCccc---cccCCCcCeeC-HHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCCC-
Confidence 44322 55689999999 99986 4699999999999999999999999986554332 122222222110
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. .....+..+.+++..||+.||.+|||+.|+++
T Consensus 258 -~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 -SP----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -SG----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -ch----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00 01124567889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=319.39 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=200.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+...........||||.+... .....+++.+|+.++.+++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 45677777888888888876665544345567999988643 2345678999999999999999999999998755 8
Q ss_pred EEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999999864 46899999999999999999999 8899999999999999999999999999998775
Q ss_pred ccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 569 LNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 569 ~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
..... .......+|+.|+| ||.+.+..++.++||||||+++|||++ |+.||......+.. ......+..
T Consensus 173 ~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~~~-- 243 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCA-PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEGER-- 243 (291)
T ss_dssp C-CCEEEC-----CCGGGCC-HHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSCCC--
T ss_pred ccccchhhhccCCCCceeeC-chhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH------HHHHccCCC--
Confidence 54332 12234567888998 999999899999999999999999999 99999765433211 111111110
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.......+..+.+++..||+.||++|||+.++++.|+.+..
T Consensus 244 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 244 -------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 01122345779999999999999999999999999987653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=324.73 Aligned_cols=255 Identities=20% Similarity=0.247 Sum_probs=186.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEE-------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCD------- 484 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~------- 484 (709)
..+|.....+|.|+++.||.+... .+++.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDV---GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEET---TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEEC---CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 456777777788888877666554 578899999986665566778999999999996 999999999994
Q ss_pred -cCCeEEEEEeecCCCCHHHHHhh---CCCCChHHHHHHHHHHHHHHHHhhhcCCCC--eEecCCCCCceeecCCCCeEE
Q 038905 485 -EGQNRLLVYKFLNNGTLASFLFE---NLKPGWNLRANIAFQIARGLLHLHVNCSSQ--IIHCDIKPQNILLDDYYNAQI 558 (709)
Q Consensus 485 -~~~~~~lV~Ey~~~gsL~~~l~~---~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl 558 (709)
.....++||||+. |+|.+++.. ...+++..+..++.||+.||.||| +.+ |+||||||+|||++.++.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEE
Confidence 3455789999996 689888865 456999999999999999999999 788 999999999999999999999
Q ss_pred cccccccccccccccc----------ceeccccCcccccccccc---cCCCCCcccchHHHHHHHHHHHhCCCCCCccch
Q 038905 559 SDFGLAKLLTLNQSKA----------IKKAIRGTKGYVASPEWF---RNSTITANVDVYSFGVLLLEIISCRKSFDIEMG 625 (709)
Q Consensus 559 ~DFGla~~~~~~~~~~----------~~~~~~Gt~~y~aaPE~~---~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~ 625 (709)
+|||+++......... ......||+.|+| ||++ .+..++.++||||||+++|||++|+.||.....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRT-PEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp CCCTTCBCCSSCC--------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCC-hhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999998775433211 1124569999999 9998 567789999999999999999999999964322
Q ss_pred hhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 626 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 626 ~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
... ..+... ..........+.+++..||+.||.+|||+.|+++.|+.+..
T Consensus 259 ~~~-----------~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 259 LRI-----------VNGKYS--------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------------------CC--------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHh-----------hcCccc--------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 110 011110 11111223457889999999999999999999999988764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.92 Aligned_cols=245 Identities=21% Similarity=0.228 Sum_probs=185.7
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHh-ccCcCceeEEEeEEEc----CCeEEEEEe
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIG-QTYHKNLVRLLGFCDE----GQNRLLVYK 494 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~nlv~l~~~~~~----~~~~~lV~E 494 (709)
..+|.|+++.||.+... .+++.||||++... ..+.+|+.++. ..+||||+++++++.. ....+||||
T Consensus 68 ~~LG~G~~g~V~~~~~~---~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNK---RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp EEEEEETTEEEEEEEET---TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ceeeeccCeEEEEEEEC---CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 45677777777665544 57889999998632 45678888874 4589999999999865 567899999
Q ss_pred ecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC---CCCeEEccccccccccc
Q 038905 495 FLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---YYNAQISDFGLAKLLTL 569 (709)
Q Consensus 495 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~~ 569 (709)
|+++|+|.+++.+.. .+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++....
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999999998754 5899999999999999999999 889999999999999997 78999999999987653
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||........... ....+..+....
T Consensus 217 ~~~---~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~~~--- 286 (400)
T 1nxk_A 217 HNS---LTTPCYTPYYVA-PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEF--- 286 (400)
T ss_dssp -------------CTTCC-GGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCCCC---
T ss_pred CCc---cccCCCCCCccC-HhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCcccC---
Confidence 322 256789999999 9999999999999999999999999999999976543210000 011111222111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
........+..+.+++..||+.||++|||++|+++.
T Consensus 287 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 ---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000112345678999999999999999999999873
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=313.57 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=194.6
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEc----CCeE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE----GQNR 489 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~----~~~~ 489 (709)
|.....+|.|+++.||.+... ..+..||+|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~---~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred EEeeeeccCCCCeEEEEeEec---CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 444455666667766555443 57888999988643 33455789999999999999999999999865 4568
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCC--eEecCCCCCceeec-CCCCeEEcccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ--IIHCDIKPQNILLD-DYYNAQISDFGLAKL 566 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~DFGla~~ 566 (709)
++||||+++++|.+++.....+++..+..++.||+.||.||| +.+ |+||||||+||+++ .++.+||+|||+++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999988788999999999999999999999 777 99999999999997 889999999999976
Q ss_pred ccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 567 LTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 567 ~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
...... ....||+.|+| ||.+.+ .++.++||||||+++|||++|+.||........ .......+....
T Consensus 182 ~~~~~~----~~~~~t~~y~a-PE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~ 249 (290)
T 1t4h_A 182 KRASFA----KAVIGTPEFMA-PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA 249 (290)
T ss_dssp CCTTSB----EESCSSCCCCC-GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG
T ss_pred cccccc----ccccCCcCcCC-HHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCcc
Confidence 543321 45679999999 998875 589999999999999999999999975433221 112222221111
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. ....+..+.+++..||+.||.+|||+.++++
T Consensus 250 ~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 SF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 1122356889999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=335.57 Aligned_cols=263 Identities=22% Similarity=0.231 Sum_probs=193.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG---- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~---- 486 (709)
..+|.....+|.|+++.||.+... .+++.||||++... .....+++.+|+.++++++|||||++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEET---TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEEC---CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 456777777788888877666554 57899999998754 334557889999999999999999999999654
Q ss_pred --CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 487 --QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 487 --~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
.+.++||||++++ |...+.. .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 138 ~~~~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 138 EFQDVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp TCCEEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred cCCeEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 4679999999874 6666643 4889999999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH---------
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------- 635 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------- 635 (709)
+....... .+..+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+........
T Consensus 212 ~~~~~~~~---~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 212 RTAGTSFM---MTPYVVTRYYRA-PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp -----CCC---C----CCCTTCC-HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eecCCCcc---cCCCcccccccC-HHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 87654322 256789999999 99999999999999999999999999999999876543221111000
Q ss_pred ------HHhhhcCC--ccc-----cccCcc-c--ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 636 ------FDCYRNGK--LDD-----LVEGDM-E--AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 636 ------~~~~~~g~--~~~-----l~~~~~-~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
...+.... ... ...... . ..........+.+++.+||+.||++|||++|+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000 000000 0 00011236779999999999999999999999883
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.64 Aligned_cols=250 Identities=24% Similarity=0.281 Sum_probs=204.7
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
++|.....+|.|+++.||.+... .+++.||||++... .....+.+.+|+.++++++|||||++++++.+....+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDK---ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CceEEeeEEecCCCEEEEEEEEC---CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45666667777777777666544 57889999998543 2345678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee---cCCCCeEEccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFGLAKLL 567 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 567 (709)
+||||+.+++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.+
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999998888999999999999999999999 8899999999999999 56789999999999877
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
...... ....||+.|+| ||++.+ .++.++|||||||++|+|++|+.||......+. ...+..+.....
T Consensus 180 ~~~~~~---~~~~gt~~y~a-PE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~~ 247 (484)
T 3nyv_A 180 EASKKM---KDKIGTAYYIA-PEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-------LKKVEKGKYTFE 247 (484)
T ss_dssp CCCCSH---HHHTTGGGTCC-HHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCCC
T ss_pred cccccc---ccCCCCccccC-ceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCCCCC
Confidence 544322 45679999999 999876 689999999999999999999999986544331 122223322211
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
. ......++.+.+++..||+.||.+|||+.|+++
T Consensus 248 ~------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 L------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp S------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 011234567899999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=318.56 Aligned_cols=266 Identities=21% Similarity=0.293 Sum_probs=196.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhc--cCcCceeEEEeEEEcC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQ--TYHKNLVRLLGFCDEG---- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nlv~l~~~~~~~---- 486 (709)
.++|.....+|.|+++.||.+ .. .++.||||++... ....+..|.+++.. ++||||+++++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~-~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMG-KW----RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEE-EE----TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEE-EE----CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 356776677777777777544 43 3789999998543 33455556666555 4899999999999877
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCC--------CeEecCCCCCceeecCCCCeEE
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS--------QIIHCDIKPQNILLDDYYNAQI 558 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~--------~iiH~Dlkp~NIll~~~~~~kl 558 (709)
...++||||+++++|.+++... .+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7889999999999999999654 6899999999999999999999 66 9999999999999999999999
Q ss_pred cccccccccccccccc--ceeccccCcccccccccccCCCCCcc------cchHHHHHHHHHHHhC----------CCCC
Q 038905 559 SDFGLAKLLTLNQSKA--IKKAIRGTKGYVASPEWFRNSTITAN------VDVYSFGVLLLEIISC----------RKSF 620 (709)
Q Consensus 559 ~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aaPE~~~~~~~s~k------~DvwSlGvvl~elltg----------~~p~ 620 (709)
+|||+++.+....... ......||+.|+| ||++.+.....+ +|||||||++|||++| +.||
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMP-PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCC-HHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeC-hhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999998765443221 1135689999999 999988776665 9999999999999999 5555
Q ss_pred CccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCC
Q 038905 621 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVD 696 (709)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 696 (709)
.......... ................. ........++.+.+++.+||+.||++|||+.+|++.|+.+.+..
T Consensus 263 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 263 HDLVPSDPSY--EDMREIVCIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTSCSSCCH--HHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhcCCCCch--hhhHHHHhhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 4332211000 00111111111111010 11112367888999999999999999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=331.88 Aligned_cols=264 Identities=19% Similarity=0.245 Sum_probs=192.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCC--
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQ-- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~-- 487 (709)
..+|.....+|.|+++.||.+... .+++.||||++... ......++.+|+.++.++. |||||++++++...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDR---RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEET---TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEEC---CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 456787888899999988766555 57889999998543 2344567889999999997 999999999997544
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
..++||||++ ++|..++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 7899999998 589998876 47889999999999999999999 889999999999999999999999999999876
Q ss_pred cccc-------------------cccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhh
Q 038905 568 TLNQ-------------------SKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627 (709)
Q Consensus 568 ~~~~-------------------~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~ 627 (709)
.... .....+..+||+.|+| ||++.+ ..++.++|||||||+++||++|+.||......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRA-PEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCC-HHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCC-HHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4311 1111245689999999 999986 678999999999999999999999998665433
Q ss_pred HHhHHHHHHHhhhcCC-----------------------------ccccccC----cccccCCHHHHHHHHHHHHhcccC
Q 038905 628 YAILTDWAFDCYRNGK-----------------------------LDDLVEG----DMEAMNDIKCVEKLVMVSIWCIQE 674 (709)
Q Consensus 628 ~~~~~~~~~~~~~~g~-----------------------------~~~l~~~----~~~~~~~~~~~~~l~~l~~~Cl~~ 674 (709)
..... ........ ...+... ..........+..+.+++.+||+.
T Consensus 239 ~~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 239 QLERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 21111 11100000 0000000 000000112356789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 038905 675 DPSLRPTMRKVSQM 688 (709)
Q Consensus 675 dP~~RPs~~ev~~~ 688 (709)
||++|||++|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=345.97 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=203.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+|+.| |.+.. .....||||++.... ...++|.+|+++|++++|+|||++++++.+ +..+||
T Consensus 266 ~~~~~~~~~lG~G~fg~V-y~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEV-WMGTW---NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp GGGEEEEEEEEECSSEEE-EEEEE---TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhhhhhheecccCCCeEE-EEEEE---CCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 344555555666666666 45554 345779999987643 346789999999999999999999999876 678999
Q ss_pred EeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||+++++.+||+|||+++.+...
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999999753 45899999999999999999999 889999999999999999999999999999876543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... .....++..|+| ||.+.+..++.++|||||||+||||++ |+.||......+. ...+..+...
T Consensus 417 ~~~~-~~~~~~~~~y~a-PE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~~---- 483 (535)
T 2h8h_A 417 EYTA-RQGAKFPIKWTA-PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGYRM---- 483 (535)
T ss_dssp HHHT-TCSTTSCGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH-------HHHHHTTCCC----
T ss_pred ceec-ccCCcCcccccC-HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCC----
Confidence 2111 134557788998 999999999999999999999999999 8999976543321 1122222111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccC
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEV 695 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 695 (709)
......++.+.+|+..||+.||++|||+++|+++|+.+...
T Consensus 484 -----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11223557789999999999999999999999999987643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=318.34 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=200.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEE--cCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCD--EGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~--~~~~ 488 (709)
.++|.....+|.|+++.||.+... .+++.+|+|.+... .....+.+.+|+.++++++||||+++++++. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRK---SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEEC---CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 456776666777777777655444 57889999998643 2345578999999999999999999999874 4678
Q ss_pred EEEEEeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcCCCC-----eEecCCCCCceeecCCCCeEEc
Q 038905 489 RLLVYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNCSSQ-----IIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~~-----iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
.++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+ |+||||||+||+++.++.+||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 89999999999999999753 24899999999999999999999 556 9999999999999999999999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
|||+++........ .....|++.|+| ||.+.+..++.++||||||+++|||++|+.||......+ ....+
T Consensus 159 dfg~~~~~~~~~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i 228 (279)
T 2w5a_A 159 DFGLARILNHDTSF--AKTFVGTPYYMS-PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKI 228 (279)
T ss_dssp CCCHHHHC---CHH--HHHHHSCCTTCC-HHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred cCchheeecccccc--ccccCCCccccC-hHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHH
Confidence 99999876543321 135679999999 999999999999999999999999999999997654322 11222
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
..+....+ ....+..+.+++.+||+.||++|||++||++.+..
T Consensus 229 ~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 229 REGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred hhcccccC---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 33332221 12345678999999999999999999999987754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=338.42 Aligned_cols=251 Identities=23% Similarity=0.275 Sum_probs=201.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.+|.....+|.|+++.||.+... .+++.||||++... .......+.+|+.++++++|||||++++++.+....++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDR---ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEET---TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEEC---CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 44666666777777777655544 57889999998543 23356789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec---CCCCeEEcccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD---DYYNAQISDFGLAKLLT 568 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~~~ 568 (709)
||||+.+++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+++.+.
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999999988888999999999999999999999 88999999999999995 56679999999998765
Q ss_pred ccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... ....||+.|+| ||++.+ .++.++|||||||++|+|++|+.||......+. ...+..+......
T Consensus 176 ~~~~~---~~~~gt~~y~a-PE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 176 QNTKM---KDRIGTAYYIA-PEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-------LKRVETGKYAFDL 243 (486)
T ss_dssp CC-------CCTTGGGGCC-GGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCSCS
T ss_pred CCCcc---CCCcCCCCCCC-HHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCCCC
Confidence 43322 45679999999 999986 589999999999999999999999976544331 1222223221111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
......+..+.+++..||+.||.+|||+.++++.
T Consensus 244 ------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 ------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0112345678999999999999999999999883
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.85 Aligned_cols=267 Identities=22% Similarity=0.242 Sum_probs=198.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--- 487 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+++.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG---RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET---TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cceEEEeEEeeecCCeEEEEEEEC---CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 456777788899999988766554 578899999986432 234567899999999999999999999997653
Q ss_pred ---eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 488 ---NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 488 ---~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
..++||||+ +++|.+++.. ..+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7899999876 57899999999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH--------
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA-------- 635 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~-------- 635 (709)
+...... ....||+.|+| ||++.+ ..++.++|||||||+++||++|+.||......+........
T Consensus 176 ~~~~~~~-----~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 176 RQADSEM-----TGYVVTRWYRA-PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp EECCSSC-----CSSCSCGGGCC-THHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----CcCcCCCCcCC-HHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8765332 55679999999 999887 67999999999999999999999999866543221111000
Q ss_pred HHhhhcCC-------ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHccccc
Q 038905 636 FDCYRNGK-------LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVVVE 694 (709)
Q Consensus 636 ~~~~~~g~-------~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~ 694 (709)
...+.... ......... .......+..+.+++.+||+.||.+|||++|+++ .++...+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 00000000 000000000 0111234567899999999999999999999998 4555443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=314.41 Aligned_cols=264 Identities=16% Similarity=0.133 Sum_probs=203.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEE-EcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC-DEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~-~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... ..+++.+|+.++.+++|++++..+..+ .++...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEc---CCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 456777777788888877666554 578999999876543 334689999999999988866555554 67788899
Q ss_pred EEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee---cCCCCeEEccccccccc
Q 038905 492 VYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFGLAKLL 567 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 567 (709)
||||+ +++|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999 8999999974 446999999999999999999999 8899999999999999 58899999999999877
Q ss_pred ccccccc-----ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 568 TLNQSKA-----IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 568 ~~~~~~~-----~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
....... ......||+.|+| ||.+.+..++.++||||||+++|||++|+.||..............+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYAS-INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cccccccccccccccccccccccCC-hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 6543211 1245689999999 999999999999999999999999999999997643211111111111100000
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccC
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEV 695 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 695 (709)
.... . ....+..+.+++..||+.||.+|||+++|++.|+.+...
T Consensus 238 ~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 238 PIEV-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp CHHH-----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred chHH-----H----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0000 0 112346789999999999999999999999999987643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.63 Aligned_cols=268 Identities=22% Similarity=0.285 Sum_probs=193.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHH--HhccCcCceeEEEeEEE-----c
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVM--IGQTYHKNLVRLLGFCD-----E 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nlv~l~~~~~-----~ 485 (709)
.++|.....+|.|+++.||.+ .. .++.||||++... ....+..|.++ +..++|+||+++++.+. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~-~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKG-SL----DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEE-EE----TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred hHHhheeeecccCCCeEEEEE-EE----CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 556776667777777777544 33 5789999998653 23344444444 55689999999998653 2
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCC---------CeEecCCCCCceeecCCCCe
Q 038905 486 GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS---------QIIHCDIKPQNILLDDYYNA 556 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~---------~iiH~Dlkp~NIll~~~~~~ 556 (709)
....++||||+++|+|.+++... ..++..+..++.||++||.||| +. +|+||||||+|||++.++.+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcE
Confidence 33568999999999999999765 4588899999999999999999 77 99999999999999999999
Q ss_pred EEcccccccccccccc------ccceeccccCcccccccccccC-------CCCCcccchHHHHHHHHHHHhCCCCCCcc
Q 038905 557 QISDFGLAKLLTLNQS------KAIKKAIRGTKGYVASPEWFRN-------STITANVDVYSFGVLLLEIISCRKSFDIE 623 (709)
Q Consensus 557 kl~DFGla~~~~~~~~------~~~~~~~~Gt~~y~aaPE~~~~-------~~~s~k~DvwSlGvvl~elltg~~p~~~~ 623 (709)
||+|||+++.+..... ........||+.|+| ||++.+ ..++.++|||||||++|||++|..|+...
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA-PEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCC-HHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeC-chhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999987654321 111235679999999 999987 45678999999999999999998776443
Q ss_pred chh-hHHh----------HHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 624 MGE-EYAI----------LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 624 ~~~-~~~~----------~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
... +... .................+.. ........+..+.+++..||+.||++|||++|+++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 221 0000 00000111111111111111 1111335777899999999999999999999999999997
Q ss_pred ccC
Q 038905 693 VEV 695 (709)
Q Consensus 693 ~~~ 695 (709)
.+.
T Consensus 317 l~~ 319 (336)
T 3g2f_A 317 MMI 319 (336)
T ss_dssp HHC
T ss_pred HHH
Confidence 643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=324.55 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=201.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--------chhHHHHHHHHHHHhcc-CcCceeEEEeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--------QDGEKEFKNEVVMIGQT-YHKNLVRLLGFC 483 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~ 483 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHR---ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhcccceEEecCCCEEEEEEEEC---CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 345666667777777777655543 468899999875432 11245688999999999 799999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 484 DEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 484 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
......++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 999999999999999999999988888999999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccccceeccccCcccccccccccC------CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRN------STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~------~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 637 (709)
+..+...... ....||+.|+| ||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 247 ~~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-------~~ 315 (365)
T 2y7j_A 247 SCHLEPGEKL---RELCGTPGYLA-PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-------LR 315 (365)
T ss_dssp CEECCTTCCB---CCCCSCGGGCC-HHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HH
T ss_pred ccccCCCccc---ccCCCCCCccC-hhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH-------HH
Confidence 9877643322 55789999999 999863 3588999999999999999999999976443221 11
Q ss_pred hhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 638 ~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+..+...... +. ....+..+.+++..||+.||++|||++++++
T Consensus 316 ~i~~~~~~~~~-~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIMEGQYQFSS-PE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHTCCCCCH-HH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCCCCCC-cc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12222211100 00 0123456889999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=338.16 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=202.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-------------hhHHHHHHHHHHHhccCcCceeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-------------DGEKEFKNEVVMIGQTYHKNLVRL 479 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nlv~l 479 (709)
...|.....+|.|+++.||.+... ..++.+|||++..... ...+++.+|+.++++++|||||++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEK---NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEET---TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccceEEEeEecccCCeEEEEEEEC---CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 456777788888888888776655 5678899998864321 235679999999999999999999
Q ss_pred EeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC---Ce
Q 038905 480 LGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY---NA 556 (709)
Q Consensus 480 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~ 556 (709)
++++.+....++||||+++|+|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999999988888999999999999999999999 88999999999999998776 69
Q ss_pred EEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH
Q 038905 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 636 (709)
Q Consensus 557 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 636 (709)
||+|||+++.+...... ....||+.|+| ||++.+ .++.++|||||||++|+|++|..||......+. .
T Consensus 189 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~a-PE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~ 256 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYKL---RDRLGTAYYIA-PEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-------I 256 (504)
T ss_dssp EECCCTTCEECCTTSCB---CCCCSCTTTCC-HHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H
T ss_pred EEEECCCCEEcCCCCcc---ccccCCcCCCC-HHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------H
Confidence 99999999877654322 45679999999 999874 689999999999999999999999986554331 1
Q ss_pred HhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 637 DCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 637 ~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+..+....... .....+..+.+++..||+.||.+|||++|+++
T Consensus 257 ~~i~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYYFDFN------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCCCCHH------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCCCcc------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2222232211000 00123567899999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.70 Aligned_cols=248 Identities=24% Similarity=0.317 Sum_probs=200.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEc--------
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE-------- 485 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~-------- 485 (709)
.+|.....+|.|+++.||.+... .+++.||||++.... +.+.+|++++.+++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHR---IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEET---TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEc---CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 45666667777777777665544 568899999986543 356789999999999999999998854
Q ss_pred --------CCeEEEEEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC
Q 038905 486 --------GQNRLLVYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555 (709)
Q Consensus 486 --------~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 555 (709)
....++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence 45579999999999999999754 46899999999999999999999 889999999999999999999
Q ss_pred eEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH
Q 038905 556 AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 635 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 635 (709)
+||+|||+++........ ....||+.|+| ||++.+..++.++||||||+++|||++|..|+.... ..
T Consensus 161 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~ 227 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKR---TRSKGTLRYMS-PEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KF 227 (284)
T ss_dssp EEECCCTTCEESSCCSCC---CCCCSCCTTSC-HHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HH
T ss_pred EEECcchhheeccccccc---cccCCcccccC-hhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HH
Confidence 999999999877654322 45679999999 999999999999999999999999999998864211 01
Q ss_pred HHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccCC
Q 038905 636 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEVD 696 (709)
Q Consensus 636 ~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 696 (709)
......+... ...+..+.+++.+||+.||.+|||+.|+++.|+.+..-+
T Consensus 228 ~~~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 228 FTDLRDGIIS------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHHTTCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred HHHhhccccc------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1122222211 123456789999999999999999999999998876433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=339.39 Aligned_cols=252 Identities=25% Similarity=0.267 Sum_probs=203.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.+|||++.... ....+.+.+|+.++.+++|||||++++++.+....
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~---~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMK---ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEC---CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 466777777888888888766554 578899999986432 23456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC----CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENL----KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
++||||++||+|..++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++++||+|||+++
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 99999999999999997643 5899999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchh-hHHhHHHHHHHhhhcCCc
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~g~~ 644 (709)
.+...... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||...... .... +.+....+..
T Consensus 338 ~~~~~~~~--~~~~~GT~~Y~A-PE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~----~~~~i~~~~~ 410 (543)
T 3c4z_A 338 ELKAGQTK--TKGYAGTPGFMA-PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE----LKQRVLEQAV 410 (543)
T ss_dssp ECCTTCCC--BCCCCSCTTTSC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH----HHHHHHHCCC
T ss_pred eccCCCcc--cccccCCccccC-hhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH----HHHHHhhccc
Confidence 77544322 245689999999 99999999999999999999999999999999765321 1111 1111112111
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM-----RKVSQ 687 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~ev~~ 687 (709)
. .+...+..+.+++..||+.||++||++ +++.+
T Consensus 411 ~----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 T----------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp C----------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred C----------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1 122345678899999999999999975 56654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.13 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=194.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.||||.+.... .+..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQ---LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred eccEEEEeeecCCCCeEEEEEEEC---CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 456666667777777777655544 468899999986432 23456899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999999988888999999999999999999999 78999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.... ....|++.|+| ||.+.+..+ +.++||||||++++||++|+.||........ ......+...
T Consensus 164 ~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~--- 229 (276)
T 2h6d_A 164 GEFL---RTSCGSPNYAA-PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-------FKKIRGGVFY--- 229 (276)
T ss_dssp ----------------CC-TGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC---
T ss_pred Ccce---ecccCCccccC-HHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHHhhcCccc---
Confidence 3221 45679999999 999988765 6899999999999999999999976543221 1112222111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.+...+..+.+++..||+.||.+|||++++++.
T Consensus 230 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 -------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011234678899999999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=314.12 Aligned_cols=249 Identities=22% Similarity=0.256 Sum_probs=193.4
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEee
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
+.....+|.|+++.||.+... .+++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDL---SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEET---TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEEC---CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 333445666666666555444 56889999998766555678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-CCCeEEccccccccccccc
Q 038905 496 LNNGTLASFLFENL---KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-YYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 496 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~ 571 (709)
+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++. ++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999998653 4668888999999999999999 889999999999999987 8999999999998765432
Q ss_pred cccceeccccCcccccccccccCCC--CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNST--ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~--~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.. .....|++.|+| ||++.+.. ++.++||||||+++|||++|+.||........... .........
T Consensus 178 ~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~~~~~---- 245 (295)
T 2clq_A 178 PC--TETFTGTLQYMA-PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-----KVGMFKVHP---- 245 (295)
T ss_dssp -----CCCCCCGGGCC-HHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-----HHHHHCCCC----
T ss_pred Cc--ccccCCCccccC-hhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-----hhccccccc----
Confidence 21 145679999999 99997654 88999999999999999999999964432221110 000001000
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......+..+.+++..||+.||++|||++++++
T Consensus 246 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 -----EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112234567889999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=317.14 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=193.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcC-CeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG-QNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~-~~~~l 491 (709)
..+|.....+|.|+++.||.+ .. .+..||||.+... ...+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~-~~----~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLG-DY----RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEE-EE----TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred hhhceEEeEEecCCCceEEEE-EE----cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 455666666666666666544 33 3788999998754 3567899999999999999999999997554 47899
Q ss_pred EEeecCCCCHHHHHhhCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLK--PGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
||||+++++|.+++.+... +++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999999986543 889999999999999999999 88999999999999999999999999999986543
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.. ....+++.|+| ||.+.+..++.++||||||++++||++ |+.||......+.. .....+...
T Consensus 170 ~~-----~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-------~~~~~~~~~--- 233 (278)
T 1byg_A 170 TQ-----DTGKLPVKWTA-PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGYKM--- 233 (278)
T ss_dssp -----------CCTTTSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-------HHHTTTCCC---
T ss_pred cc-----cCCCccccccC-HHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCCCC---
Confidence 32 34467889998 999999999999999999999999998 99999765433211 111222111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
......+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 234 ------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 112234567899999999999999999999999998865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.63 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=190.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||. +.. ...+|||++... .....+.+.+|+.++++++|+||+++++++ .....+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~-~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYK-GKW-----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEE-EES-----SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred ccceeeeeEecCCCCeEEEE-EEE-----cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 34566666666667776654 433 234899988643 234457899999999999999999999965 556789
Q ss_pred EEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999999654 46899999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
...........||+.|+| ||.+. +..++.++||||||+++|||++|+.||......+. .......+....
T Consensus 173 ~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~ 245 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMA-PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSP 245 (289)
T ss_dssp -----------CCCTTCC-HHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSCCC
T ss_pred ccccccccccCCCccccC-chhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcccccCc
Confidence 333323356789999999 99987 66788999999999999999999999976543221 111222222211
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.+.. .....+..+.+++..||+.||.+|||+.+++++|+.+.
T Consensus 246 ~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DLSK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chhh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1110 12234578999999999999999999999999998865
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=327.87 Aligned_cols=266 Identities=14% Similarity=0.102 Sum_probs=202.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCC-----CceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeE---------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTST-----RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVR--------- 478 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~--------- 478 (709)
.++|.....+|.|+++.||.+....+.. .++.||||.+... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3567777777778788776665542111 4788999998643 46889999999999999887
Q ss_pred ------EEeEEEc-CCeEEEEEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcee
Q 038905 479 ------LLGFCDE-GQNRLLVYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL 549 (709)
Q Consensus 479 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIl 549 (709)
+++++.. +...++||||+ +++|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence 6777765 78889999999 99999999876 67999999999999999999999 889999999999999
Q ss_pred ecCCC--CeEEcccccccccccccccc-----ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCc
Q 038905 550 LDDYY--NAQISDFGLAKLLTLNQSKA-----IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDI 622 (709)
Q Consensus 550 l~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~ 622 (709)
++.++ .+||+|||+++.+....... ......||+.|+| ||.+.+..++.++||||||+++|||++|+.||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFIS-MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccC-HHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99998 89999999998775433211 1134589999999 9999999999999999999999999999999976
Q ss_pred cchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 623 EMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
....... ... ....+. .....+.+.... ....+..+.+++..||+.||++|||+++|+++|+.+.+
T Consensus 271 ~~~~~~~-~~~-~~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 271 CLPNTED-IMK-QKQKFV-DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GTTCHHH-HHH-HHHHHH-HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcCHHH-HHH-HHHhcc-CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 5421111 111 111111 111222211110 11234678999999999999999999999999998763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=313.15 Aligned_cols=252 Identities=21% Similarity=0.262 Sum_probs=203.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---------chhHHHHHHHHHHHhccC-cCceeEEEeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---------QDGEKEFKNEVVMIGQTY-HKNLVRLLGF 482 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nlv~l~~~ 482 (709)
..+|.....+|.|+++.||.+... .+++.||||.+.... ....+.+.+|+.++.++. ||||++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHK---PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhccceeeeecCCCceEEEEEEEc---CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 456776677777777777665544 578899999986432 123467889999999996 9999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccc
Q 038905 483 CDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562 (709)
Q Consensus 483 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 562 (709)
+.+....++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999999998888999999999999999999999 8899999999999999999999999999
Q ss_pred ccccccccccccceeccccCccccccccccc------CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFR------NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 636 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~------~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 636 (709)
+++.+...... ....|++.|+| ||++. ...++.++||||||++++||++|+.||......+. .
T Consensus 170 ~~~~~~~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~ 238 (298)
T 1phk_A 170 FSCQLDPGEKL---REVCGTPSYLA-PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------L 238 (298)
T ss_dssp TCEECCTTCCB---CCCCSCGGGCC-HHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H
T ss_pred chhhcCCCccc---ccccCCccccC-HHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-------H
Confidence 99876543322 45679999999 99985 45688999999999999999999999976543221 1
Q ss_pred HhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 637 DCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 637 ~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.....+..... .......+..+.+++..||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGNYQFG------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTCCCCC------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCCcccC------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 12222221110 0111234567899999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=335.69 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=188.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--------chhHHHHHHHHHHHhccCcCceeEEEeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--------QDGEKEFKNEVVMIGQTYHKNLVRLLGFCD 484 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~ 484 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... .+....+.+|+.++++++|||||++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFER---KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEEC---CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 445666666777777777655544 578899999986431 112235889999999999999999999985
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC---CCeEEccc
Q 038905 485 EGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY---YNAQISDF 561 (709)
Q Consensus 485 ~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DF 561 (709)
. +..++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.+ ..+||+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence 4 568999999999999999988888999999999999999999999 8899999999999999654 45999999
Q ss_pred cccccccccccccceeccccCcccccccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN---STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 562 Gla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|+++....... ....+||+.|+| ||++.+ ..++.++|||||||++|||++|+.||......... ...
T Consensus 287 G~a~~~~~~~~---~~~~~gt~~y~a-PE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~------~~~ 356 (419)
T 3i6u_A 287 GHSKILGETSL---MRTLCGTPTYLA-PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQ 356 (419)
T ss_dssp STTTSCC--------------CTTCC-TTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH------HHH
T ss_pred ccceecCCCcc---ccccCCCCCccC-ceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH------HHH
Confidence 99987754322 256789999999 999864 57889999999999999999999999754332111 111
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...+....... .....++.+.+++..||+.||++|||++|+++
T Consensus 357 i~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNFIPE------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCch------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 22222211100 01124567899999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=334.61 Aligned_cols=196 Identities=20% Similarity=0.306 Sum_probs=155.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEE-----c
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCD-----E 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~-----~ 485 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... ....+++.+|+.++.+++|+|||++++++. .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK---LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC---C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC---CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 456788888899999988777665 578899999986532 334578899999999999999999999984 3
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 486 GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
....++||||+. ++|..++.....+++..+..++.||+.||.||| +.+|+||||||+||||+.++.+||+|||+|+
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred CceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 357899999985 699999988888999999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccc-------------------------cceeccccCcccccccccc-cCCCCCcccchHHHHHHHHHHHhC
Q 038905 566 LLTLNQSK-------------------------AIKKAIRGTKGYVASPEWF-RNSTITANVDVYSFGVLLLEIISC 616 (709)
Q Consensus 566 ~~~~~~~~-------------------------~~~~~~~Gt~~y~aaPE~~-~~~~~s~k~DvwSlGvvl~elltg 616 (709)
.+...... ...+..+||+.|+| ||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a-PE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA-PELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCC-HHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccC-hHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76532211 11245688999999 9976 566799999999999999999993
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=319.38 Aligned_cols=261 Identities=21% Similarity=0.271 Sum_probs=185.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+... .+++.||||.+.... ....+++.+|+.++.+++||||+++++++...+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCA---PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC-------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred hhhhhhhheeccccceEEEEEEEC---CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 567787788888888888766554 467899999986532 2345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh--------CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 492 VYKFLNNGTLASFLFE--------NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~--------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
||||+++++|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999974 345899999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccc---cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 564 AKLLTLNQSK---AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 564 a~~~~~~~~~---~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
++.+...... .......||+.|+| ||.+.+ ..++.++||||||+++|||++|+.||.......... . .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~-~ 239 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMA-PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------L-T 239 (303)
T ss_dssp HHHCC---------------CCCTTCC-HHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------H-H
T ss_pred hheeccCCCccchhhhcccCCCccccC-HHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------H-H
Confidence 9876543211 11245679999999 999876 568999999999999999999999997654332111 1 1
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+....+.............+..+.+++..||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111111111111111234567889999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=315.86 Aligned_cols=263 Identities=16% Similarity=0.128 Sum_probs=199.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEE-EcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC-DEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~-~~~~~~~l 491 (709)
.++|.....+|.|+++.||.+... ..++.||||+..... ..+++.+|+.++.+++|++++..++.+ .++...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEc---CCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 456776677777777777665544 578899999865432 234688999999999988876666555 67788899
Q ss_pred EEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee---cCCCCeEEccccccccc
Q 038905 492 VYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFGLAKLL 567 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 567 (709)
||||+ +++|.+++.. ...+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999 9999999985 346999999999999999999999 8899999999999999 78999999999999877
Q ss_pred cccccc-----cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 568 TLNQSK-----AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 568 ~~~~~~-----~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
...... .......||+.|+| ||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYAS-INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccc-hHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 654321 11245789999999 999999999999999999999999999999997643321111111111100000
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.... .....+..+.+++..||+.||++|||+++|+++|+.+.+
T Consensus 238 ~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 238 PIEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp CHHH---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhh---------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0000 011234678999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=311.68 Aligned_cols=243 Identities=19% Similarity=0.247 Sum_probs=196.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.||||++... ......++.+|+.++.++ +||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR---LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEc---CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 456776677777777777666554 57889999998653 234557889999999999 999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-------------
Q 038905 490 LLVYKFLNNGTLASFLFEN----LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD------------- 552 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~------------- 552 (709)
++||||+++++|.+++.+. ..+++..+..++.||+.||.||| +++|+||||||+||+++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999999865 56899999999999999999999 889999999999999984
Q ss_pred ------CCCeEEccccccccccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccch
Q 038905 553 ------YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMG 625 (709)
Q Consensus 553 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~ 625 (709)
...+||+|||+++..... ....||+.|+| ||++.+. .++.++||||||++++||++|.+++.....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~a-PE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLA-NEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp ------CCCEEECCCTTCEETTCS------CCCCCCGGGCC-HHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred ccccCCceEEEEcccccccccCCc------cccCCCccccC-hhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 447999999999876543 23459999999 9999876 667899999999999999999987643321
Q ss_pred hhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 626 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 626 ~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+..+..+....+ +...+..+.+++..||+.||++|||+.++++
T Consensus 237 ----------~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ----------WHEIRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----------HHHHHTTCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------HHHHHcCCCCCC---------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 112223332221 1124567889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.83 Aligned_cols=240 Identities=14% Similarity=0.140 Sum_probs=186.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccc---ccchhHHHHHHHH---HHHhccCcCceeEEE------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDR---VFQDGEKEFKNEV---VMIGQTYHKNLVRLL------ 480 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~nlv~l~------ 480 (709)
.++|.....+|.|+++.||.+... .+++.||||++.. ......+.+.+|+ +++++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQ---ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC----CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CceEEEcceeecCCCEEEEEEEEC---CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 355666777888888877666554 5688999999863 2334567899999 556666899999998
Q ss_pred -eEEEcCC-----------------eEEEEEeecCCCCHHHHHhhCCCCCh-------HHHHHHHHHHHHHHHHhhhcCC
Q 038905 481 -GFCDEGQ-----------------NRLLVYKFLNNGTLASFLFENLKPGW-------NLRANIAFQIARGLLHLHVNCS 535 (709)
Q Consensus 481 -~~~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~l~~-------~~~~~i~~~i~~al~~LH~~~~ 535 (709)
+++.+.+ ..++||||+ +|+|.+++.....++. ..+..++.||+.||.||| +
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 224 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---H 224 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---h
Confidence 6666553 278999999 6799999987554444 778889999999999999 8
Q ss_pred CCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCC-----------CCCcccchH
Q 038905 536 SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-----------TITANVDVY 604 (709)
Q Consensus 536 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-----------~~s~k~Dvw 604 (709)
.+|+||||||+|||++.++.+||+|||+++..... .....| +.|+| ||++.+. .++.++|||
T Consensus 225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~a-PE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEP-PELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCC-HHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccC-hhhhcccccccccccccccCChhhhHH
Confidence 89999999999999999999999999999864331 256678 99998 9999887 899999999
Q ss_pred HHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 038905 605 SFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRK 684 (709)
Q Consensus 605 SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 684 (709)
||||++|||++|+.||....... ....+... ....+..+.+++..||+.||++|||+.|
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~---------------~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALG---------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHHHHHSSCCC------C---------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred HHHHHHHHHHHCCCCCccccccc---------------chhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 99999999999999996433211 01111110 1123567889999999999999999999
Q ss_pred HHH
Q 038905 685 VSQ 687 (709)
Q Consensus 685 v~~ 687 (709)
+++
T Consensus 357 ~l~ 359 (377)
T 3byv_A 357 AME 359 (377)
T ss_dssp HHT
T ss_pred Hhh
Confidence 986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=320.94 Aligned_cols=267 Identities=16% Similarity=0.172 Sum_probs=199.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEc-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE----- 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~----- 485 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ......+.+|+.++.+++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHR---KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEET---TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccceeEEEEEecCCCcEEEEEEEC---CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 456777778888888888766654 578899999885432 2234678899999999999999999999976
Q ss_pred ---CCeEEEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccc
Q 038905 486 ---GQNRLLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 486 ---~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
....++||||+++ +|...+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4568999999986 676666554 57999999999999999999999 889999999999999999999999999
Q ss_pred cccccccccccc--cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 562 GLAKLLTLNQSK--AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 562 Gla~~~~~~~~~--~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|+++.+...... .......||+.|+| ||++.+ ..++.++|||||||++|||++|+.||......+...........
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRP-PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCC-HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhcccccccccccccccCCcccccCccC-chhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999876533221 12245678999999 999876 46899999999999999999999999876544332222111111
Q ss_pred hhcCCccccccC--------cccccCCH-H------HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNGKLDDLVEG--------DMEAMNDI-K------CVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g~~~~l~~~--------~~~~~~~~-~------~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
............ ........ . ....+.+++..||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111000000000 00000000 0 1345889999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.12 Aligned_cols=263 Identities=20% Similarity=0.224 Sum_probs=196.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-----hHHHHHHHHHHHhccCcCceeEEEeEEEcCC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-----GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~ 487 (709)
.++|.....+|.|+++.||.+... .+++.||||++...... ..+.+.+|+.++.+++||||+++++++.+..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDK---NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECS---SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hcccEEEeEEeecCCEEEEEEEEC---CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 456777777777877777655544 56889999998643221 1246889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
..++||||+++ +|..++.... .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 99999999987 8888887654 5899999999999999999999 88999999999999999999999999999987
Q ss_pred ccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC---
Q 038905 567 LTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG--- 642 (709)
Q Consensus 567 ~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g--- 642 (709)
+...... .....||+.|+| ||++.+. .++.++|||||||++|||++|.+||......+... .+.+.....
T Consensus 162 ~~~~~~~--~~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~---~i~~~~~~~~~~ 235 (346)
T 1ua2_A 162 FGSPNRA--YTHQVVTRWYRA-PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEE 235 (346)
T ss_dssp TTSCCCC--CCCSCCCCTTCC-HHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTT
T ss_pred ccCCccc--CCcccccccccC-chHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHcCCCChh
Confidence 7543322 245689999999 9999764 58999999999999999999999997655432211 111111110
Q ss_pred Cccc---cccC---ccccc-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 643 KLDD---LVEG---DMEAM-----NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 643 ~~~~---l~~~---~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.... +.+. ..... .....+..+.+++..||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 0000 00000 012345789999999999999999999999984
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.67 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=202.0
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..|.....+|.|+++.||.+... ..++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDN---RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEEC---CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 45666666677777766554443 578899999986442 34567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
|||+++++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 999999999999864 57899999999999999999999 88999999999999999999999999999987654332
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 652 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~ 652 (709)
. .....||+.|+| ||++.+..++.++||||||++++||++|+.||.......... ....+....+
T Consensus 175 ~--~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~~----- 239 (303)
T 3a7i_A 175 K--RNTFVGTPFWMA-PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-------LIPKNNPPTL----- 239 (303)
T ss_dssp C--BCCCCSCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSCCCCC-----
T ss_pred c--cCccCCCcCccC-HHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-------HhhcCCCCCC-----
Confidence 2 145679999999 999999999999999999999999999999997554322111 1111111111
Q ss_pred cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 653 EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 653 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
....+..+.+++..||+.||.+|||+.++++.
T Consensus 240 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 12234678899999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.60 Aligned_cols=252 Identities=17% Similarity=0.226 Sum_probs=196.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+... .+++.+|+|.+........+++.+|+.++.+++||||+++++++.+.+..++|
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNK---ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEET---TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEc---CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 345666667777777777665544 56889999998776666778899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++++|..++.. ...+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999876 456999999999999999999999 8899999999999999999999999999986443221
Q ss_pred cccceeccccCcccccccccc-----cCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 572 SKAIKKAIRGTKGYVASPEWF-----RNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~-----~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
.. .....||+.|+| ||++ .+..++.++||||||+++|||++|..||......... .....+....
T Consensus 172 ~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~ 241 (302)
T 2j7t_A 172 QK--RDSFIGTPYWMA-PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-------LKIAKSDPPT 241 (302)
T ss_dssp HC-------CCGGGCC-HHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSCCCC
T ss_pred cc--cccccCChhhcC-CeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-------HHHhccCCcc
Confidence 11 145679999999 9998 4677899999999999999999999999765432211 1111111111
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. .....+..+.+++..||+.||.+|||+.++++
T Consensus 242 ~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11 12234567899999999999999999999876
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=313.68 Aligned_cols=259 Identities=19% Similarity=0.220 Sum_probs=199.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEc--CCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDE--GQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~--~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.||||++... ..+.+.+|+.++.+++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINI---TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEEC---CCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 456777777888888888666554 57889999998743 4578999999999997 9999999999987 6778
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~ 568 (709)
++||||+++++|.+++.. ++...+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 109 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999999998853 889999999999999999999 88999999999999999777 89999999998765
Q ss_pred ccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHH--hHHH-----HHHHhhh
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA--ILTD-----WAFDCYR 640 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--~~~~-----~~~~~~~ 640 (709)
..... ....|++.|+| ||.+.+ ..++.++||||||+++|||++|+.||......... .... .....+.
T Consensus 183 ~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQEY---NVRVASRYFKG-PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCCC---CSCCSCGGGCC-HHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCCcc---ccccccccccC-hhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 44322 45679999998 999987 67899999999999999999999999654321110 0000 0001111
Q ss_pred cCCc--------------cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 641 NGKL--------------DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 641 ~g~~--------------~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.... ................+..+.+++..||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1100 0000001111112235678999999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=318.13 Aligned_cols=246 Identities=21% Similarity=0.277 Sum_probs=194.4
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEeec
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFL 496 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~Ey~ 496 (709)
..+|.|+++.||.+... .+++.||||++.... .....++.+|+.++.++. ||||+++++++.+....++||||+
T Consensus 35 ~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~ 111 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISK---STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYA 111 (327)
T ss_dssp EEEEEETTEEEEEEEET---TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceeCCCCCeEEEEEEEC---CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEec
Confidence 45667777777655444 568899999886532 334678999999999994 699999999999999999999999
Q ss_pred CCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC---CCCeEEccccccccccccc
Q 038905 497 NNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---YYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 497 ~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~~~~ 571 (709)
++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||+++......
T Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 188 (327)
T 3lm5_A 112 AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188 (327)
T ss_dssp TTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence 999999998654 46899999999999999999999 889999999999999988 7899999999998775433
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
.. ....||+.|+| ||++.+..++.++||||||+++|||++|+.||......+... ........
T Consensus 189 ~~---~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~~~------ 251 (327)
T 3lm5_A 189 EL---REIMGTPEYLA-PEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL-------NISQVNVD------ 251 (327)
T ss_dssp --------CCCGGGCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCCC------
T ss_pred cc---ccccCCcCccC-CeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH-------HHHhcccc------
Confidence 22 45689999999 999999999999999999999999999999997655433211 11111111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.........+..+.+++..||+.||++|||++++++.
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0111122345678899999999999999999999873
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.88 Aligned_cols=250 Identities=19% Similarity=0.226 Sum_probs=200.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
..+|.....+|.|+++.||.+... .+++.||||.+... ...+++.+|+.++.+++||||+++++++.+....++|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHK---ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEET---TTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEEC---CCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 456777778888888888766554 56889999998753 2456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++++|.+++.. ...+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999999973 457999999999999999999999 8899999999999999999999999999998765433
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
... ....|++.|+| ||.+.+..++.++||||||+++|||++|+.||.......... .........+
T Consensus 180 ~~~--~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~~---- 245 (314)
T 3com_A 180 AKR--NTVIGTPFWMA-PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-------MIPTNPPPTF---- 245 (314)
T ss_dssp SCB--CCCCSCGGGCC-HHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSCCCCC----
T ss_pred ccc--CccCCCCCccC-hhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHhcCCCccc----
Confidence 221 45679999999 999999999999999999999999999999997554322111 1111111111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......+..+.+++..||+.||.+|||+.++++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 012234567889999999999999999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=313.62 Aligned_cols=250 Identities=19% Similarity=0.302 Sum_probs=183.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+++.||.+... .+++.||||++..... ...+.+.++...++.++||||+++++++.+++..+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHV---PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEec---CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 566777777888888877666554 5789999999865422 22234555556688899999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCceeecCCCCeEEccccccc
Q 038905 491 LVYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNCSS-QIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
+||||+++ +|.+++.. ...+++..+..++.||+.||.||| ++ +|+||||||+||+++.++.+||+|||+++
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 99999985 88777653 457999999999999999999999 66 99999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccc----cCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWF----RNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~----~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 641 (709)
........ ....||+.|+| ||++ .+..++.++||||||++++||++|+.||......... .......
T Consensus 159 ~~~~~~~~---~~~~~t~~y~a-PE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~ 229 (290)
T 3fme_A 159 YLVDDVAK---DIDAGCKPYMA-PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-----LKQVVEE 229 (290)
T ss_dssp --------------CCCCCCSC-HHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-----HHHHHHS
T ss_pred cccccccc---cccCCCccccC-hhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-----HHHHhcc
Confidence 76544322 44579999999 9996 5667899999999999999999999999753322111 1111111
Q ss_pred CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. ... .....+..+.+++..||+.||++|||+.|+++
T Consensus 230 ~~-~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PS-PQL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CC-CCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-CCc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11 111 11234567899999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=329.69 Aligned_cols=200 Identities=22% Similarity=0.312 Sum_probs=165.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG---- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~---- 486 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... ....+++.+|+.++++++|+|||++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDK---NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEEC---CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 456777777888888877666554 578999999987532 33457889999999999999999999999766
Q ss_pred -CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 487 -QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 487 -~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
...++||||+. ++|.+++.....+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 57899999987 599999988888999999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccc--------------------cceeccccCcccccccccc-cCCCCCcccchHHHHHHHHHHHhCCCCC
Q 038905 566 LLTLNQSK--------------------AIKKAIRGTKGYVASPEWF-RNSTITANVDVYSFGVLLLEIISCRKSF 620 (709)
Q Consensus 566 ~~~~~~~~--------------------~~~~~~~Gt~~y~aaPE~~-~~~~~s~k~DvwSlGvvl~elltg~~p~ 620 (709)
........ ...+..+||+.|+| ||++ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A-PE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRA-PELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCC-HHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccC-HHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 77543221 11256789999999 9986 5667999999999999999999854444
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.14 Aligned_cols=254 Identities=11% Similarity=0.018 Sum_probs=180.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhcc--CcCceeEEE-------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQT--YHKNLVRLL------- 480 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~nlv~l~------- 480 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|+.++..+ +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDV---ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEEC---CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 345666677777777777666554 578899999987643 23446778885554444 699988855
Q ss_pred eEEEcC-----------------CeEEEEEeecCCCCHHHHHhhCC-CCChHHH------HHHHHHHHHHHHHhhhcCCC
Q 038905 481 GFCDEG-----------------QNRLLVYKFLNNGTLASFLFENL-KPGWNLR------ANIAFQIARGLLHLHVNCSS 536 (709)
Q Consensus 481 ~~~~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~------~~i~~~i~~al~~LH~~~~~ 536 (709)
+++... ...++||||++ ++|.+++.... .+.+..+ ..++.||+.||.||| ++
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~ 213 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SK 213 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HC
Confidence 344322 34799999999 89999998643 4556666 788899999999999 88
Q ss_pred CeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccccccccccC--CCCCcccchHHHHHHHHHHH
Q 038905 537 QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEII 614 (709)
Q Consensus 537 ~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~--~~~s~k~DvwSlGvvl~ell 614 (709)
+|+||||||+|||++.++.+||+|||+++...... ....||+.|+| ||++.+ ..++.++|||||||++|||+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~a-PE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAP-REFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCC-HHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcC-hhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 99999999999999999999999999998765322 25567799998 999987 78999999999999999999
Q ss_pred hCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 615 SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 615 tg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+|+.||......... .+.....................+..+.+++..||+.||++|||+.++++
T Consensus 288 tg~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIKG--------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCTT--------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCccccc--------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999765332110 00000001111111111112245678999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.41 Aligned_cols=249 Identities=24% Similarity=0.275 Sum_probs=193.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc----chhHHHHHHHHHHHhccCcCceeEEEeEE--EcCC
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF----QDGEKEFKNEVVMIGQTYHKNLVRLLGFC--DEGQ 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nlv~l~~~~--~~~~ 487 (709)
++|.....+|.|+++.||.+... .+++.+|||.+.... ....+.+.+|+.++++++|+||+++++++ .+..
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDS---ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBT---TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred cceeEeeEEecCCCeEEEEEEEC---CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 45555556666666666544433 578899999986532 23457899999999999999999999998 4456
Q ss_pred eEEEEEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
..++||||++++ |.+++... ..+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 789999999987 77777653 46899999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccCCC--CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNST--ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~--~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
...............||+.|+| ||++.+.. ++.++||||||+++|||++|+.||......+. ...+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~~ 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQP-PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-------FENIGKGS 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCC-HHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCC
T ss_pred ccCccccccccccCCCCCCCcC-hhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-------HHHHhcCC
Confidence 7654333333356679999999 99998654 47899999999999999999999986543221 12222222
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. .....+..+.+++.+||+.||.+|||++|+++
T Consensus 230 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 230 YA----------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CC----------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC----------CCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 11224567889999999999999999999997
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=331.14 Aligned_cols=261 Identities=17% Similarity=0.154 Sum_probs=202.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCc-CceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH-KNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nlv~l~~~~~~~~~~~lV 492 (709)
++|.....+|.|+++.||.+... .+++.||||++.... ...++.+|++++..++| ++++.+..++.+.+..+||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEET---TTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEEC---CCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 45666666677777777655544 568899999876432 23468899999999986 5666777777888899999
Q ss_pred EeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee---cCCCCeEEcccccccccc
Q 038905 493 YKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL---DDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~~ 568 (709)
|||+ +++|.+++.. ...+++..+..++.||+.||.||| +++|+||||||+|||| +.++.+||+|||+++.+.
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999 9999999985 457999999999999999999999 8899999999999999 688999999999998776
Q ss_pred cccccc-----ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 569 LNQSKA-----IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 569 ~~~~~~-----~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
...... ......||+.|+| ||++.+..++.++|||||||+||||++|+.||..............+........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~a-PE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYAS-VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccC-HHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 543221 1136789999999 9999999999999999999999999999999986543222111111111111111
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+..+. ...+..+.+++..||+.+|++||++++|+++|+.+.
T Consensus 237 ~~~l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 237 IEALC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHHH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11111 123467899999999999999999999999998863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.11 Aligned_cols=260 Identities=21% Similarity=0.225 Sum_probs=195.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEc-------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE------- 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~------- 485 (709)
.++|.....+|.|+++.||.+... .+++.||||++..... ...+|+.++++++|||||++++++..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDI---ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEET---TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cceEEEEEEEEeccCEEEEEEEEC---CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 567888888888888888766655 5788999998864322 23579999999999999999999843
Q ss_pred -------------------------------CCeEEEEEeecCCCCHHHHHh----hCCCCChHHHHHHHHHHHHHHHHh
Q 038905 486 -------------------------------GQNRLLVYKFLNNGTLASFLF----ENLKPGWNLRANIAFQIARGLLHL 530 (709)
Q Consensus 486 -------------------------------~~~~~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~al~~L 530 (709)
....++||||+++ +|.+.+. ....+++..+..++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3347899999985 7766665 345799999999999999999999
Q ss_pred hhcCCCCeEecCCCCCceeec-CCCCeEEccccccccccccccccceeccccCcccccccccccCC-CCCcccchHHHHH
Q 038905 531 HVNCSSQIIHCDIKPQNILLD-DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGV 608 (709)
Q Consensus 531 H~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGv 608 (709)
| +.+|+||||||+|||++ .++.+||+|||+++.+...... ....||+.|+| ||.+.+. .++.++|||||||
T Consensus 158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRA-PELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCC-HHHHTTCSSCCTHHHHHHHHH
T ss_pred H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccC-HHHhcCCCCCCcchhhhhHHH
Confidence 9 89999999999999998 6889999999999876544322 45678999999 9998775 5899999999999
Q ss_pred HHHHHHhCCCCCCccchhhHHhHHHHH---------HHh---hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCC
Q 038905 609 LLLEIISCRKSFDIEMGEEYAILTDWA---------FDC---YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDP 676 (709)
Q Consensus 609 vl~elltg~~p~~~~~~~~~~~~~~~~---------~~~---~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP 676 (709)
++|||++|+.||......+........ ... +..-....+.............+..+.+++..||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999999876543321111000 000 00001111111111111223356678999999999999
Q ss_pred CCCCCHHHHHH
Q 038905 677 SLRPTMRKVSQ 687 (709)
Q Consensus 677 ~~RPs~~ev~~ 687 (709)
++|||+.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=346.86 Aligned_cols=259 Identities=20% Similarity=0.287 Sum_probs=204.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.||.+.....+.....||||++.... ....+++.+|+.++++++|||||++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 445666667777777777666555444567889999987543 334478999999999999999999999985 456899
Q ss_pred EEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 999999999999998654 6899999999999999999999 889999999999999999999999999999877543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... .....||+.|+| ||++.+..++.++||||||+++|||++ |..||......+.. ..+..+....
T Consensus 545 ~~~~-~~~~~~t~~y~a-PE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~-------~~i~~~~~~~--- 612 (656)
T 2j0j_A 545 TYYK-ASKGKLPIKWMA-PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------GRIENGERLP--- 612 (656)
T ss_dssp ----------CCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHHTCCCC---
T ss_pred ccee-ccCCCCCcceeC-HHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHcCCCCC---
Confidence 3221 134567889999 999999999999999999999999997 99999765433311 1122222111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.+...+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 613 ------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 613 ------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 12234567899999999999999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=316.40 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=193.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--------chhHHHHHHHHHHHhccCcCceeEEEeEEEc
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--------QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE 485 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~ 485 (709)
++|.....+|.|+++.||.+... .+++.||||.+.... ......+.+|+.++++++||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFER---KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hceeEeeEEecCCCEEEEEEEEc---CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 45666666777777777655544 578899999986432 1223458899999999999999999999876
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC---eEEcccc
Q 038905 486 GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN---AQISDFG 562 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFG 562 (709)
+. .++||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+|||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 55 8999999999999999988888999999999999999999999 889999999999999987654 9999999
Q ss_pred ccccccccccccceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
+++....... .....||+.|+| ||++. ...++.++||||||+++|||++|+.||......... ...+
T Consensus 163 ~~~~~~~~~~---~~~~~gt~~y~a-PE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~ 232 (322)
T 2ycf_A 163 HSKILGETSL---MRTLCGTPTYLA-PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQI 232 (322)
T ss_dssp TCEECCCCHH---HHHHHSCCTTCC-HHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH------HHHH
T ss_pred cceecccccc---cccccCCcCccC-chhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH------HHHH
Confidence 9987654321 145679999999 99974 567899999999999999999999999754332110 1111
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+....... . ....++.+.+++..||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~--~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYNFIPE--V----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCCCCHH--H----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccccCch--h----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 2222111100 0 1123567899999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=317.52 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=193.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEc------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDE------ 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~------ 485 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... ...+++.+|+.++.++ +||||+++++++..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCcEEEEEEeccCCCEEEEEEEEC---CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 567777777788888877666554 568899999986543 3457899999999999 79999999999976
Q ss_pred CCeEEEEEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 486 GQNRLLVYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
....++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 56789999999999999999865 46889999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccccceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 638 (709)
+..+...... .....||+.|+| ||++. +..++.++||||||+++|||++|+.||.......... .
T Consensus 176 ~~~~~~~~~~--~~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~- 245 (326)
T 2x7f_A 176 SAQLDRTVGR--RNTFIGTPYWMA-PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------L- 245 (326)
T ss_dssp TC---------------CCGGGCC-HHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------H-
T ss_pred ceecCcCccc--cccccCCccccC-hhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH------H-
Confidence 9876543221 145679999999 99987 5678999999999999999999999997554322111 1
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........+. ....+..+.+++..||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPRNPAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHSCCCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhcCccccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111111 1223567889999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.11 Aligned_cols=261 Identities=20% Similarity=0.227 Sum_probs=200.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCc------eeEEEeEEEcCC
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKN------LVRLLGFCDEGQ 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------lv~l~~~~~~~~ 487 (709)
.+|.....+|.|+++.||.+.... ..++.||||++.... ...+.+.+|+.++.+++|++ ++++++++.+.+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEecC--CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 456666667777777776554422 467899999987542 35577899999999987665 999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-------------
Q 038905 488 NRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD------------- 552 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~------------- 552 (709)
..++||||+ +++|.+++.+.. .+++..+..++.||+.||.||| +.+|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889999998765 5889999999999999999999 889999999999999987
Q ss_pred ------CCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchh
Q 038905 553 ------YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE 626 (709)
Q Consensus 553 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~ 626 (709)
++.+||+|||+++...... ....||+.|+| ||++.+..++.++||||||+++|||++|+.||......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRA-PEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCC-HHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccC-hHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 6789999999998654332 45679999999 99999999999999999999999999999999876543
Q ss_pred hHHhHHHHHHH--------hhhcCCcc------------------ccccCc-ccccCCHHHHHHHHHHHHhcccCCCCCC
Q 038905 627 EYAILTDWAFD--------CYRNGKLD------------------DLVEGD-MEAMNDIKCVEKLVMVSIWCIQEDPSLR 679 (709)
Q Consensus 627 ~~~~~~~~~~~--------~~~~g~~~------------------~l~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 679 (709)
+.......... ........ ....+. .........++.+.+++..||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 32221111110 00000000 000000 0011233567889999999999999999
Q ss_pred CCHHHHHH
Q 038905 680 PTMRKVSQ 687 (709)
Q Consensus 680 Ps~~ev~~ 687 (709)
||+.|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.36 Aligned_cols=260 Identities=20% Similarity=0.217 Sum_probs=198.0
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC--------cCceeEEEeEEE-
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY--------HKNLVRLLGFCD- 484 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nlv~l~~~~~- 484 (709)
.+|.....+|.|+++.||.+... .+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDI---QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEec---CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 45776667777777777666554 57899999998754 345678899999999986 788999999987
Q ss_pred ---cCCeEEEEEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCceeecCCC----
Q 038905 485 ---EGQNRLLVYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSS-QIIHCDIKPQNILLDDYY---- 554 (709)
Q Consensus 485 ---~~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~-~iiH~Dlkp~NIll~~~~---- 554 (709)
++...++||||+ +++|.+++... ..+++..+..++.||+.||.||| ++ +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhh
Confidence 667889999999 55666666544 46999999999999999999999 76 999999999999999775
Q ss_pred ---------------------------------------------CeEEccccccccccccccccceeccccCccccccc
Q 038905 555 ---------------------------------------------NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASP 589 (709)
Q Consensus 555 ---------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaP 589 (709)
.+||+|||+++...... ....||+.|+| |
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~a-P 262 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRS-L 262 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCC-H
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccC-C
Confidence 79999999998765432 45679999999 9
Q ss_pred ccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHH---hHHHHHHHh--------hhcCC-----------cccc
Q 038905 590 EWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA---ILTDWAFDC--------YRNGK-----------LDDL 647 (709)
Q Consensus 590 E~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~--------~~~g~-----------~~~l 647 (709)
|++.+..++.++|||||||++|||++|+.||......+.. .....+.+. +..++ ...+
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 9999999999999999999999999999999765432110 001111110 00011 0000
Q ss_pred ccCc---------ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 648 VEGD---------MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 648 ~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+.. ............+.+|+.+||+.||++|||++|+++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000 001124567788999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=314.43 Aligned_cols=267 Identities=20% Similarity=0.267 Sum_probs=201.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhc--cCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQ--TYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nlv~l~~~~~~~~--- 487 (709)
.++|.....+|.|+++.||. +.. .++.||||.+... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~-~~~----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWR-GKW----RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEE-EEE----TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEE-EEE----cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 35666666667777776654 443 4789999998643 45678889888887 78999999999998776
Q ss_pred -eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcC-----CCCeEecCCCCCceeecCCCCeEEccc
Q 038905 488 -NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNC-----SSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 488 -~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||... +.+|+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 78999999999999999976 46899999999999999999999421 468999999999999999999999999
Q ss_pred ccccccccccccc--ceeccccCcccccccccccCC------CCCcccchHHHHHHHHHHHhC----------CCCCCcc
Q 038905 562 GLAKLLTLNQSKA--IKKAIRGTKGYVASPEWFRNS------TITANVDVYSFGVLLLEIISC----------RKSFDIE 623 (709)
Q Consensus 562 Gla~~~~~~~~~~--~~~~~~Gt~~y~aaPE~~~~~------~~s~k~DvwSlGvvl~elltg----------~~p~~~~ 623 (709)
|+++......... ......||+.|+| ||++.+. .++.++||||||+++|||++| ..||...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMA-PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCC-HHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeccccccccccccccCCcCcccCC-HhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9998765443221 1245679999999 9999876 334789999999999999999 6777543
Q ss_pred chhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 624 MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
...... . ......+........+. ...........+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 271 ~~~~~~-~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 271 VPSDPS-V-EEMRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp SCSSCC-H-HHHHHHHTTSCCCCCCC---GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCccc-H-HHHHHHHHHHHhCCCCc---ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 221100 0 01111121211111111 011234677889999999999999999999999999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.55 Aligned_cols=200 Identities=20% Similarity=0.245 Sum_probs=170.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc------CcCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT------YHKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nlv~l~~~~~~~ 486 (709)
.++|.....+|.|+++.||.+... ..++.||||++... ....+++.+|+.++..+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~---~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDH---KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEET---TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEEC---CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 456777777777778877665544 57899999998754 23456788888888877 577999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC--eEEcccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN--AQISDFG 562 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DFG 562 (709)
.+.++||||+. ++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+|||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999996 58999988764 4899999999999999999999 789999999999999999987 9999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchh
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGE 626 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~ 626 (709)
+++...... ....||+.|+| ||++.+..++.++|||||||++|||++|++||......
T Consensus 248 ~a~~~~~~~-----~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 248 SSCYEHQRV-----YTYIQSRFYRA-PEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp TCEETTCCC-----CSSCSCGGGCC-HHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceecCCcc-----cccCCCCCccC-hHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 997654322 45689999999 99999999999999999999999999999999876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=317.79 Aligned_cols=259 Identities=22% Similarity=0.231 Sum_probs=189.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--- 487 (709)
.++|.....+|.|+++.||.+... ..++.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhheeEeeeeEecCCEEEEEEEEC---CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 356777777778888877665544 57889999998653 2334567899999999999999999999997654
Q ss_pred ---eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 488 ---NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 488 ---~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred cccceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999985 78888753 5889999999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHh------
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC------ 638 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------ 638 (709)
+....... .....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.... +.+.
T Consensus 175 ~~~~~~~~---~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~ 247 (371)
T 2xrw_A 175 RTAGTSFM---MTPYVVTRYYRA-PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---VIEQLGTPCP 247 (371)
T ss_dssp ------------------CTTCC-HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHC-CCCCCH
T ss_pred cccccccc---cCCceecCCccC-HHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCH
Confidence 87653321 145689999999 9999999999999999999999999999999976544221110 0000
Q ss_pred ------------hhcCCc-------cccccCccc---ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 639 ------------YRNGKL-------DDLVEGDME---AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 639 ------------~~~g~~-------~~l~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+..... ..+...... ..........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000 000000000 0001234678999999999999999999999988
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.32 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=201.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDR---ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEc---CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345666667777777777665544 568899999986432 335678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC---CCeEEccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY---YNAQISDFGLAKLL 567 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla~~~ 567 (709)
+||||+++++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+||+++.+ +.+||+|||+++..
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999999988788999999999999999999999 8899999999999999754 46999999999876
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
...... ....||+.|+| ||.+.+. ++.++||||||+++++|++|+.||......+. ...+..+.....
T Consensus 175 ~~~~~~---~~~~~~~~y~a-PE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~ 242 (287)
T 2wei_A 175 QQNTKM---KDRIGTAYYIA-PEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-------LKRVETGKYAFD 242 (287)
T ss_dssp CCCSSC---SCHHHHHTTCC-HHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCCC
T ss_pred cCCCcc---ccccCcccccC-hHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCCCCC
Confidence 543322 34568999998 9998764 89999999999999999999999976543321 122222322111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. .....+..+.+++.+||+.||++|||+.++++
T Consensus 243 ~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 LP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SG------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 01123567889999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=321.53 Aligned_cols=262 Identities=22% Similarity=0.223 Sum_probs=183.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG---- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~---- 486 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+++.+|+.++++++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDT---KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEET---TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCceEEeeEEeecCCeEEEEEEEC---CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 356777888899999988766554 678999999986532 23456788999999999999999999998654
Q ss_pred --CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 487 --QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 487 --~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
...++|+||+ +++|.+++.. ..+++..+..++.||++||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 5679999999 6899988865 57999999999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH-------
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF------- 636 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~------- 636 (709)
+...... ....||+.|+| ||++.+ ..++.++|||||||+++||++|+.||......+.........
T Consensus 180 ~~~~~~~-----~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 180 RHTADEM-----TGYVATRWYRA-PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp ----------------CCCTTCC-HHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccC-----CCcCcCcCccC-hHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 8754322 45689999999 999887 678999999999999999999999997665433221110000
Q ss_pred -HhhhcCCccccccCc--ccc----cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 637 -DCYRNGKLDDLVEGD--MEA----MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 637 -~~~~~g~~~~l~~~~--~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
..+........+... ... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000000000 000 0011234678999999999999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.92 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=190.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccC--cCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTY--HKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nlv~l~~~~~~~~~ 488 (709)
.++|.....+|.|+++.||.+. . ..++.||||++... .....+.+.+|+.++.+++ |+||+++++++.+.+.
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~-~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVL-N---EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEE-C---TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred cceEEEEEEecCCCCEEEEEEE-c---CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 5567777777777777775543 3 35788999998643 3345578999999999997 5999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.++||| +.+++|.+++.....+++..+..++.||++||.||| +.+|+||||||+|||+++ +.+||+|||+++.+.
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999999 568899999998888999999999999999999999 889999999999999975 899999999998776
Q ss_pred ccccccceeccccCcccccccccccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRN-----------STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~-----------~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 637 (709)
............||+.|+| ||.+.+ ..++.++||||||+++|||++|+.||......... ...
T Consensus 178 ~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~ 251 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMP-PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHA 251 (313)
T ss_dssp ------------CCGGGCC-HHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHH
T ss_pred CccccccccCCCCCCCcCC-HHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-----HHH
Confidence 5443322345679999999 999876 46888999999999999999999999754322111 111
Q ss_pred hhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 638 ~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. ... .........+..+.+++..||+.||.+|||+.|+++
T Consensus 252 ~~-~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 252 II-DPN--------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HH-CTT--------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH-hcc--------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11 111 111111122467889999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=323.34 Aligned_cols=260 Identities=21% Similarity=0.236 Sum_probs=190.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcC------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG------ 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~------ 486 (709)
...|.....+|.|+++.||.+... .+++.||||++.... +.+.+|++++++++|+|||++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLC---DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEEC---CCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 345666667777777777655554 568899999986432 2345799999999999999999988432
Q ss_pred CeEEEEEeecCCCCHHHHHh----hCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-CCeEEccc
Q 038905 487 QNRLLVYKFLNNGTLASFLF----ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-YNAQISDF 561 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DF 561 (709)
...++||||+++ +|...+. ....+++..+..++.||++||.||| +.+|+||||||+|||++.+ +.+||+||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccc
Confidence 236799999986 5555554 2457999999999999999999999 8999999999999999965 56899999
Q ss_pred cccccccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHh-HHHHH----
Q 038905 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWA---- 635 (709)
Q Consensus 562 Gla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~~~---- 635 (709)
|+++.+...... ....||+.|+| ||++.+. .++.++|||||||++|||++|+.||......+... .....
T Consensus 202 G~a~~~~~~~~~---~~~~~t~~y~a-PE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 202 GSAKQLVRGEPN---VSYICSRYYRA-PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp TTCEECCTTCCC---CSCCSCTTSCC-HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred hhhhhcccCCCc---eeeeeCCCcCC-HHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999876543322 45679999999 9998765 79999999999999999999999998765432111 11000
Q ss_pred HHhhh--cCCccccccCcc-----cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 636 FDCYR--NGKLDDLVEGDM-----EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 636 ~~~~~--~g~~~~l~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+.+. .........+.+ ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000 011111111111 01112234578999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=315.00 Aligned_cols=256 Identities=19% Similarity=0.312 Sum_probs=201.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchh-----------------HHHHHHHHHHHhccCcCc
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDG-----------------EKEFKNEVVMIGQTYHKN 475 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~n 475 (709)
.++|.....+|.|+++.||.+.. +++.||||.+....... .+.+.+|+.++.+++|||
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 45677777778888887766544 58999999986432211 178999999999999999
Q ss_pred eeEEEeEEEcCCeEEEEEeecCCCCHHHH------Hhh--CCCCChHHHHHHHHHHHHHHHHhhhcCC-CCeEecCCCCC
Q 038905 476 LVRLLGFCDEGQNRLLVYKFLNNGTLASF------LFE--NLKPGWNLRANIAFQIARGLLHLHVNCS-SQIIHCDIKPQ 546 (709)
Q Consensus 476 lv~l~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~--~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~iiH~Dlkp~ 546 (709)
|+++++++.+.+..++||||+++++|.++ +.. ...+++..+..++.||+.||.||| + .+|+||||||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~ 181 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPS 181 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGG
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChH
Confidence 99999999999999999999999999998 665 457999999999999999999999 6 89999999999
Q ss_pred ceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCC-CCCc-ccchHHHHHHHHHHHhCCCCCCccc
Q 038905 547 NILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITA-NVDVYSFGVLLLEIISCRKSFDIEM 624 (709)
Q Consensus 547 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~-k~DvwSlGvvl~elltg~~p~~~~~ 624 (709)
||+++.++.+||+|||+++..... ......|++.|+| ||.+.+. .++. ++||||||++++||++|+.||....
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~a-PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMP-PEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCC-GGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccC-chhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999876543 1256779999999 9999887 6666 9999999999999999999998654
Q ss_pred hhhHHhHHHHHHHhhhcCCccccccCc---------ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 625 GEEYAILTDWAFDCYRNGKLDDLVEGD---------MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 625 ~~~~~~~~~~~~~~~~~g~~~~l~~~~---------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.... ....+..+......+.. .........+..+.+++..||+.||.+|||+.|+++
T Consensus 257 ~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SLVE------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSHH------HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHHH------HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4111 11222233221111000 000011335678899999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.94 Aligned_cols=263 Identities=19% Similarity=0.188 Sum_probs=194.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEE--------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCD-------- 484 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~-------- 484 (709)
..+|.....+|.|+++.||.+... .+++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN---DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET---TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEEC---CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 356777788899999988766554 568999999987666666788999999999999999999999873
Q ss_pred ------cCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec-CCCCeE
Q 038905 485 ------EGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQ 557 (709)
Q Consensus 485 ------~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~k 557 (709)
+....++||||++ ++|.+++.. .++++..+..++.||+.||.||| +.+|+||||||+||+++ +++.+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 599998864 56889999999999999999999 88999999999999997 567999
Q ss_pred Eccccccccccccccc-cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH
Q 038905 558 ISDFGLAKLLTLNQSK-AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 635 (709)
Q Consensus 558 l~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 635 (709)
|+|||+++........ .......||+.|+| ||.+.+ ..++.++||||||+++|||++|+.||......+.... +
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---~ 237 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRS-PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL---I 237 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCC-HHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H
T ss_pred EccCccccccCCCcccccccccccccccccC-cHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH---H
Confidence 9999999876533221 11244568999999 998865 6789999999999999999999999986654221111 0
Q ss_pred HHhhhc----------CCccccccCccc------ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 636 FDCYRN----------GKLDDLVEGDME------AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 636 ~~~~~~----------g~~~~l~~~~~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...... ..+...+..... .......+..+.+++..||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000 000000000000 0001124577999999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=310.54 Aligned_cols=201 Identities=23% Similarity=0.273 Sum_probs=169.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cC-----ceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HK-----NLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nlv~l~~~~~~~ 486 (709)
.++|.....+|.|+++.||.+... .+++.||||++... ....+++..|+.++..++ |+ +++++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDR---VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEc---CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 466777777788888877666544 57889999998753 234567888999988885 44 499999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec--CCCCeEEcccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD--DYYNAQISDFG 562 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DFG 562 (709)
++.++||||+.+ +|.+++.... .+++..+..++.||+.||.|||.. +.+|+||||||+|||++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999999965 9999998763 589999999999999999999932 46899999999999994 57889999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccch
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMG 625 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~ 625 (709)
+++...... ....||+.|+| ||++.+..++.++|||||||++|||++|+.||.....
T Consensus 207 ~a~~~~~~~-----~~~~~t~~y~a-PE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 207 SSCQLGQRI-----YQYIQSRFYRS-PEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TCEETTCCC-----CSSCSCGGGCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Cceeccccc-----ccccCCccccC-hHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 998775432 45679999999 9999999999999999999999999999999986654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.92 Aligned_cols=263 Identities=19% Similarity=0.224 Sum_probs=199.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcC-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG----- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~----- 486 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ....+.+.+|++++.+++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDN---LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEEC---CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 346777777788888877666544 578899999987533 33447889999999999999999999999654
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++||||+.+ +|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 103 KDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 468999999985 89998865 46899999999999999999999 88999999999999999999999999999987
Q ss_pred cccccccc-ceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC-
Q 038905 567 LTLNQSKA-IKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK- 643 (709)
Q Consensus 567 ~~~~~~~~-~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~- 643 (709)
........ ......||+.|+| ||++.+ ..++.++||||||+++|||++|+.||......+..... ........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~ 253 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRA-PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQ 253 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCC-HHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCH
T ss_pred cCCCCCccccccccccccCCCC-CHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCH
Confidence 76443221 1245689999999 998754 45899999999999999999999999766543322111 00000000
Q ss_pred --cc------------ccccCcc--cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 --LD------------DLVEGDM--EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 --~~------------~l~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. .+..... ........+..+.+++..||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000000 00001123567899999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.83 Aligned_cols=267 Identities=18% Similarity=0.153 Sum_probs=190.6
Q ss_pred hhHhhhcccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-----------hhHHHHHHHHHHHhccCcC
Q 038905 406 EDKKKRNMMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-----------DGEKEFKNEVVMIGQTYHK 474 (709)
Q Consensus 406 ~~~~~~~~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ 474 (709)
++... ..+|.....+|.|+++.||.+. . ..+..||||++..... ...+.+.+|+.++++++||
T Consensus 16 ~~~~~--~~~y~~~~~lg~G~~g~V~~~~-~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 89 (362)
T 3pg1_A 16 ELHAM--QSPYTVQRFISSGSYGAVCAGV-D---SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89 (362)
T ss_dssp HHHHT--TCSCEEEEEEEEETTEEEEEEE-C---TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred HHHHh--ccceEEeEEeccCCCEEEEEEE-C---CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence 34444 6778877777888887775443 3 3588999998854321 1237899999999999999
Q ss_pred ceeEEEeEEEc-----CCeEEEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCce
Q 038905 475 NLVRLLGFCDE-----GQNRLLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548 (709)
Q Consensus 475 nlv~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NI 548 (709)
||+++++++.. ....++||||++ ++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||
T Consensus 90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNI 165 (362)
T ss_dssp TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHE
Confidence 99999999843 346899999998 58888776554 6899999999999999999999 88999999999999
Q ss_pred eecCCCCeEEccccccccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhh
Q 038905 549 LLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEE 627 (709)
Q Consensus 549 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~ 627 (709)
|++.++.+||+|||+++........ ....||+.|+| ||.+.+ ..++.++||||||+++|||++|+.||......+
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADANK---THYVTHRWYRA-PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCC-HHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEcCCCCEEEEecCccccccccccc---ceecccceecC-cHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999865443322 45679999999 999887 678999999999999999999999998655332
Q ss_pred HHhHHHHHH----------------HhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 628 YAILTDWAF----------------DCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 628 ~~~~~~~~~----------------~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
......... ..+............ ........+..+.+++..||+.||++|||+.|+++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARA-WTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC-HHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhh-HHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 211110000 000000000000000 00011233567899999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=314.99 Aligned_cols=265 Identities=19% Similarity=0.245 Sum_probs=198.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-----------cCceeEEEe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-----------HKNLVRLLG 481 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nlv~l~~ 481 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... ...+.+.+|+.++.+++ |+||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDM---VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEec---CCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 456776777777777777666554 578999999987532 34567889999999886 899999999
Q ss_pred EEEcCC----eEEEEEeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCceeec---
Q 038905 482 FCDEGQ----NRLLVYKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSS-QIIHCDIKPQNILLD--- 551 (709)
Q Consensus 482 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~-~iiH~Dlkp~NIll~--- 551 (709)
++.... ..++||||+ +++|.+++... ..+++..+..++.||+.||.||| ++ +|+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccC
Confidence 987544 789999999 88999999864 35899999999999999999999 76 999999999999994
Q ss_pred ---CCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhH
Q 038905 552 ---DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY 628 (709)
Q Consensus 552 ---~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~ 628 (709)
..+.+||+|||+++...... ....||+.|+| ||++.+..++.++||||||+++|||++|+.||........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRS-PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCC-HHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCcCcceEEEcccccccccCCCC-----CCCCCCccccC-cHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 44579999999998765432 45679999999 9999999999999999999999999999999976542111
Q ss_pred ----HhHHHHHHHhh--------hcC-----------CccccccC---------cccccCCHHHHHHHHHHHHhcccCCC
Q 038905 629 ----AILTDWAFDCY--------RNG-----------KLDDLVEG---------DMEAMNDIKCVEKLVMVSIWCIQEDP 676 (709)
Q Consensus 629 ----~~~~~~~~~~~--------~~g-----------~~~~l~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP 676 (709)
..+.. +.+.. ..+ ....+... .............+.+++..||+.||
T Consensus 244 ~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 244 TKDDDHIAQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp -CHHHHHHH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred CChHHHHHH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 11111 11100 000 00000000 00112345678899999999999999
Q ss_pred CCCCCHHHHHH--HHccc
Q 038905 677 SLRPTMRKVSQ--MLEVV 692 (709)
Q Consensus 677 ~~RPs~~ev~~--~L~~~ 692 (709)
++|||++|+++ .+...
T Consensus 323 ~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp TTCBCHHHHHTCGGGTTC
T ss_pred cccCCHHHHhhChhhhcc
Confidence 99999999998 45544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=314.78 Aligned_cols=261 Identities=18% Similarity=0.198 Sum_probs=193.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE-
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR- 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~- 489 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDK---RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccEEEEeEEecCCCeEEEEEEEC---CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 356666677778888877666554 578999999987542 23357889999999999999999999999877665
Q ss_pred -----EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 490 -----LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 490 -----~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
++||||+. ++|.+++.. .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred cceeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 588887743 4899999999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH------
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD------ 637 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------ 637 (709)
+...... ....||+.|+| ||++.+ ..++.++||||||+++|||++|+.||......+..........
T Consensus 192 ~~~~~~~-----~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 192 RHADAEM-----TGYVVTRWYRA-PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp -------------CTTCCCTTSC-HHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccCc-----CCcccCccccC-HHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 8664332 45678999999 999987 6899999999999999999999999986554322111100000
Q ss_pred --hhhcCCc----cccccCcc--cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 638 --CYRNGKL----DDLVEGDM--EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 638 --~~~~g~~----~~l~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.+..... ..+..... ........+..+.+++..||+.||++|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 00000000 000011235788999999999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=311.40 Aligned_cols=268 Identities=18% Similarity=0.221 Sum_probs=199.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcC-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG----- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~----- 486 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... .....++.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK---PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC---CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 456777777777777777665544 578899999986433 23456788999999999999999999988654
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++||||+. ++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67899999997 589998876 46899999999999999999999 88999999999999999999999999999987
Q ss_pred cccccccc--------ceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH
Q 038905 567 LTLNQSKA--------IKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637 (709)
Q Consensus 567 ~~~~~~~~--------~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 637 (709)
+....... ......||+.|+| ||++.+ ..++.++||||||+++|||++|+.||......+.... +..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~ 237 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRA-PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL---IFG 237 (353)
T ss_dssp CC----------------CCCCCCGGGCC-HHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHH
T ss_pred cccccccccCccccccchhhccccccccC-CeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHH
Confidence 65432211 1134578999999 998764 6789999999999999999999999986654322111 111
Q ss_pred hhhcCC----ccccc--------cCc------ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHccc
Q 038905 638 CYRNGK----LDDLV--------EGD------MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVV 692 (709)
Q Consensus 638 ~~~~g~----~~~l~--------~~~------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~ 692 (709)
...... ...+. ... .........+..+.+++..||+.||++|||++|+++ .+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 110000 00000 000 000001234567889999999999999999999988 45443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.29 Aligned_cols=262 Identities=19% Similarity=0.225 Sum_probs=197.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCc------eeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKN------LVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------lv~l~~~~~~~ 486 (709)
..+|.....+|.|+++.||.+.... ..++.||||.+... ....+.+.+|+.++.+++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHA--RGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecC--CCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 3466666667777777776554432 23478999998754 235577889999999998766 99999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee--------------
Q 038905 487 QNRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL-------------- 550 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll-------------- 550 (709)
.+.++||||+ +++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 567777776553 6899999999999999999999 8999999999999999
Q ss_pred -----cCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccch
Q 038905 551 -----DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMG 625 (709)
Q Consensus 551 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~ 625 (709)
+.++.+||+|||+++...... ....||+.|+| ||++.+..++.++||||||+++|||++|+.||.....
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRP-PEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccCCCcEEEeecCccccccccc-----cCCcCCCcccC-CeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 678899999999998654332 45679999999 9999999999999999999999999999999986654
Q ss_pred hhHHhHHHHHHHh-----hhcCCcccc-ccC---------------------cccccCCHHHHHHHHHHHHhcccCCCCC
Q 038905 626 EEYAILTDWAFDC-----YRNGKLDDL-VEG---------------------DMEAMNDIKCVEKLVMVSIWCIQEDPSL 678 (709)
Q Consensus 626 ~~~~~~~~~~~~~-----~~~g~~~~l-~~~---------------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 678 (709)
.+........... +........ ... .............+.+++..||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 3322111111100 000000000 000 0001122345678999999999999999
Q ss_pred CCCHHHHHH
Q 038905 679 RPTMRKVSQ 687 (709)
Q Consensus 679 RPs~~ev~~ 687 (709)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=317.30 Aligned_cols=265 Identities=21% Similarity=0.224 Sum_probs=192.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ----- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~----- 487 (709)
..+|.....+|.|+++.||.+... ....+|+|++..... ...+|++++++++|||||++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~----~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLV----ESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEET----TTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEEC----CCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 345777777777877877666543 344588888754322 2347999999999999999999985433
Q ss_pred -eEEEEEeecCCCCHHHHHh---hCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec-CCCCeEEcccc
Q 038905 488 -NRLLVYKFLNNGTLASFLF---ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFG 562 (709)
Q Consensus 488 -~~~lV~Ey~~~gsL~~~l~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFG 562 (709)
..++||||++++.+..... ....+++..+..++.||++||.||| +.+|+||||||+|||++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 3789999998854443332 2457899999999999999999999 88999999999999999 79999999999
Q ss_pred ccccccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHH------
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA------ 635 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~------ 635 (709)
+++.+...... ....||+.|+| ||++.+. .++.++|||||||++|||++|+.||......+........
T Consensus 188 ~a~~~~~~~~~---~~~~~t~~y~a-PE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 188 SAKILIAGEPN---VSYICSRYYRA-PELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp TCEECCTTCCC---CSSCSCGGGCC-HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CcccccCCCCC---cccccCcCccC-HHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99876544322 45678999999 9998765 5899999999999999999999999876543321111000
Q ss_pred ------HHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--Hccc
Q 038905 636 ------FDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEVV 692 (709)
Q Consensus 636 ------~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~ 692 (709)
...+.......+.............+..+.+++..||+.||.+|||+.|+++. ++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00011111111111111111122355689999999999999999999999873 5544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.89 Aligned_cols=262 Identities=20% Similarity=0.251 Sum_probs=198.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhcc---CcCceeEEEeEEE---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQT---YHKNLVRLLGFCD--- 484 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nlv~l~~~~~--- 484 (709)
.++|.....+|.|+++.||.+.... ..++.||||++..... .....+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecC--CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4667777777777777776665432 4578899998864322 1223567788777766 8999999999987
Q ss_pred --cCCeEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcc
Q 038905 485 --EGQNRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD 560 (709)
Q Consensus 485 --~~~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 560 (709)
.....++||||++ ++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence 5677899999998 59999998754 4899999999999999999999 88999999999999999999999999
Q ss_pred ccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh
Q 038905 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 640 (709)
Q Consensus 561 FGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 640 (709)
||+++....... .....||+.|+| ||++.+..++.++||||||+++|||++|+.||......+.... +.....
T Consensus 164 fg~~~~~~~~~~---~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQMA---LTSVVVTLWYRA-PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIG 236 (326)
T ss_dssp CCSCCCCCGGGG---GCCCCCCCTTCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHC
T ss_pred CcccccccCCCC---ccccccccceeC-HHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcC
Confidence 999987654332 255779999999 9999999999999999999999999999999986654322111 111110
Q ss_pred cC---Cccc-------cccC---cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 641 NG---KLDD-------LVEG---DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 641 ~g---~~~~-------l~~~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. .... .... ..........+..+.+++..||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0000 0000 0001112235677899999999999999999999995
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=312.61 Aligned_cols=270 Identities=19% Similarity=0.181 Sum_probs=190.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN---- 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~---- 488 (709)
.++|.....+|.|+++.||.+... .+++.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEK---STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEET---TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 678888888899999988766554 568899999885432 233466788888999999999999999865333
Q ss_pred ---EEEEEeecCCCCHHHHH----hhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-CCCeEEcc
Q 038905 489 ---RLLVYKFLNNGTLASFL----FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-YYNAQISD 560 (709)
Q Consensus 489 ---~~lV~Ey~~~gsL~~~l----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~D 560 (709)
.++||||++++ |...+ .....+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 98 DIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp CEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred ceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 78999999875 43333 3455788999999999999999999943 678999999999999997 89999999
Q ss_pred ccccccccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHH-----
Q 038905 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW----- 634 (709)
Q Consensus 561 FGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~----- 634 (709)
||+++.+...... ....||+.|+| ||++.+. .++.++|||||||++|||++|+.||......+.......
T Consensus 176 fg~a~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 176 FGSAKKLSPSEPN---VAYICSRYYRA-PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CTTCBCCCTTSCC---CSTTSCGGGCC-HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CCCceecCCCCCc---ccccCCcceeC-HHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 9999877644322 45678999999 9998765 489999999999999999999999987654332111100
Q ss_pred ---HHHhhhcCCc-cccccC------cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHccc
Q 038905 635 ---AFDCYRNGKL-DDLVEG------DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVV 692 (709)
Q Consensus 635 ---~~~~~~~g~~-~~l~~~------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~ 692 (709)
.+..+..... ....+. ..........+..+.+++..||+.||.+|||+.|+++ .+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 0011100000 000000 0001112235678999999999999999999999987 34444
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=320.40 Aligned_cols=247 Identities=26% Similarity=0.328 Sum_probs=183.4
Q ss_pred ceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEee
Q 038905 417 TRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 417 ~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey 495 (709)
.....+|.|++++||+++. .+++.||||++... ..+.+.+|+.++.++ +|||||++++++.++...++||||
T Consensus 18 ~~~~~LG~G~~g~V~~~~~----~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQGS----FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp EEEEEEEECSTTCEEEEEE----SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eccCeEeeCCCeEEEEEEE----ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 3345567777777766544 36889999998643 345778999999886 899999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCC-------ChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCC-------------CC
Q 038905 496 LNNGTLASFLFENLKP-------GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY-------------YN 555 (709)
Q Consensus 496 ~~~gsL~~~l~~~~~l-------~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~-------------~~ 555 (709)
+. |+|.+++...... .+..+..++.||+.||.||| +.+|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 5999999865432 23345789999999999999 8899999999999999754 48
Q ss_pred eEEcccccccccccccccc--ceeccccCcccccccccccC-------CCCCcccchHHHHHHHHHHHh-CCCCCCccch
Q 038905 556 AQISDFGLAKLLTLNQSKA--IKKAIRGTKGYVASPEWFRN-------STITANVDVYSFGVLLLEIIS-CRKSFDIEMG 625 (709)
Q Consensus 556 ~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aaPE~~~~-------~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~ 625 (709)
+||+|||+++.+....... ......||+.|+| ||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRA-PELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSC-HHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccC-HHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 9999999999876543221 1245689999999 999976 678999999999999999999 8999975433
Q ss_pred hhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 626 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 626 ~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+.. +..+... . ...........+..+.+++.+||+.||.+|||+.+|++
T Consensus 246 ~~~~---------i~~~~~~-~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RESN---------IIRGIFS-L--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHH---------HHHTCCC-C--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHH---------HhcCCCC-c--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 2211 0111110 0 01111224467788999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.36 Aligned_cols=241 Identities=23% Similarity=0.320 Sum_probs=189.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc------hhHHHHHHHHHHHhcc----CcCceeEEEeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ------DGEKEFKNEVVMIGQT----YHKNLVRLLGF 482 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~nlv~l~~~ 482 (709)
.++|.....+|.|+++.||.+... .+++.||||++..... .....+.+|+.++.++ +|+||++++++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRL---TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECT---TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhceEEeeEEEcCCCEEEEEEEEc---cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 456777777778888877655443 5788999999865432 1223466799999988 89999999999
Q ss_pred EEcCCeEEEEEee-cCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec-CCCCeEEcc
Q 038905 483 CDEGQNRLLVYKF-LNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISD 560 (709)
Q Consensus 483 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~D 560 (709)
+.+.+..++|||| +.+++|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+||+++ .++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 789999999998888999999999999999999999 78999999999999999 889999999
Q ss_pred ccccccccccccccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 561 FGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
||+++....... ....|++.|+| ||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 184 fg~~~~~~~~~~----~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------- 245 (312)
T 2iwi_A 184 FGSGALLHDEPY----TDFDGTRVYSP-PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------------- 245 (312)
T ss_dssp CSSCEECCSSCB----CCCCSCTTTSC-HHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------------
T ss_pred cchhhhcccCcc----cccCCcccccC-ceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-------------
Confidence 999987754321 45679999999 999987766 45899999999999999999999643110
Q ss_pred hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 640 RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 640 ~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..... ......+..+.+++..||+.||++|||++|+++
T Consensus 246 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 LEAEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHTCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhhcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00110 011234567889999999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=309.09 Aligned_cols=253 Identities=19% Similarity=0.287 Sum_probs=174.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHH-HHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVV-MIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||.+... .+++.||||++.... .....++..|+. +++.++||||+++++++.+.+..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHK---PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEET---TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEc---CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 355666666777777777655443 578999999986542 233455666665 778889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh-----CCCCChHHHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCceeecCCCCeEEcccccc
Q 038905 491 LVYKFLNNGTLASFLFE-----NLKPGWNLRANIAFQIARGLLHLHVNCSS-QIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~-----~~~l~~~~~~~i~~~i~~al~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
+||||+++ +|.+++.. ...+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999986 88777763 457899999999999999999999 77 9999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccc----cCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhh
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWF----RNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 640 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~----~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 640 (709)
+.+...... ....||+.|+| ||++ .+..++.++||||||+++|||++|+.||........ ......
T Consensus 174 ~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~ 243 (327)
T 3aln_A 174 GQLVDSIAK---TRDAGCRPYMA-PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVV 243 (327)
T ss_dssp CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCC
T ss_pred eeccccccc---ccCCCCccccC-ceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHHHh
Confidence 876543322 34579999999 9998 466789999999999999999999999975322110 001111
Q ss_pred cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 641 NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 641 ~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+....+ ........+..+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQL-----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCC-----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCC-----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1111111 11111234568999999999999999999999966
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.78 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=189.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEc-------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE------- 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~------- 485 (709)
..+|.....+|.|+++.||.+... .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNA---LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEc---CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 345666667777777777655544 57889999998653 3456789999999999999999999998865
Q ss_pred ------CCeEEEEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEE
Q 038905 486 ------GQNRLLVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558 (709)
Q Consensus 486 ------~~~~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 558 (709)
....++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEE
Confidence 456799999999999999998654 5788899999999999999999 889999999999999999999999
Q ss_pred cccccccccccccc------------ccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccch
Q 038905 559 SDFGLAKLLTLNQS------------KAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMG 625 (709)
Q Consensus 559 ~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~ 625 (709)
+|||+++....... ........||+.|+| ||++.+. .++.++||||||+++|||++ |+.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA-TEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSC-HHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccC-cccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 99999987653211 111245679999999 9999865 68999999999999999998 4432211
Q ss_pred hhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 626 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 626 ~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.. . ....+...... .........+..+.+++..||+.||.+|||+.++++
T Consensus 234 ~~--~----~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RV--N----ILKKLRSVSIE------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH--H----HHHHHHSTTCC------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH--H----HHHhccccccc------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 1 11112221111 111123344567889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.20 Aligned_cols=258 Identities=19% Similarity=0.220 Sum_probs=192.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe---
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN--- 488 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~--- 488 (709)
.+|.....+|.|+++.||.+... .+++.||||++.... ....+++.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDK---RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred ceEEEeeeEecCCCeEEEEEEEC---CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 45666677777777777665544 578999999986532 2345678999999999999999999999987654
Q ss_pred ---EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 489 ---RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 489 ---~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
.++||||+. ++|.+++.. .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred ceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 588887743 4899999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHH--------
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-------- 636 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-------- 636 (709)
...... ....||+.|+| ||.+.+ ..++.++||||||+++|||++|+.||......+.........
T Consensus 175 ~~~~~~-----~~~~~t~~y~a-PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 175 HADAEM-----TGYVVTRWYRA-PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp C-------------CCSBCCSC-HHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred CCCCCc-----cccccCcCcCC-HHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 654322 45678999999 999887 678999999999999999999999997654322111100000
Q ss_pred HhhhcC-------CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 637 DCYRNG-------KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 637 ~~~~~g-------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+... .......... .......+..+.+++..||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000000000 0112245678999999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.37 Aligned_cols=241 Identities=22% Similarity=0.357 Sum_probs=198.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch------hHHHHHHHHHHHhccC--cCceeEEEeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD------GEKEFKNEVVMIGQTY--HKNLVRLLGFCD 484 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nlv~l~~~~~ 484 (709)
..+|.....+|.|+++.||.+... .+++.||||.+...... ..+.+.+|+.++.+++ |+||+++++++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRV---SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEET---TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred cCceEEEEEEeeCCCeEEEEEEEC---CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 456777777888888888666554 57899999998654221 2346778999999996 599999999999
Q ss_pred cCCeEEEEEeecCC-CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec-CCCCeEEcccc
Q 038905 485 EGQNRLLVYKFLNN-GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFG 562 (709)
Q Consensus 485 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFG 562 (709)
+.+..++||||+.+ ++|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++ +++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999986 899999998888999999999999999999999 88999999999999999 78999999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 641 (709)
+++....... ....||+.|+| ||++.+..+ +.++||||||+++|||++|+.||...... ..
T Consensus 196 ~~~~~~~~~~----~~~~gt~~y~a-PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------------~~ 257 (320)
T 3a99_A 196 SGALLKDTVY----TDFDGTRVYSP-PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------------IR 257 (320)
T ss_dssp TCEECCSSCB----CCCCSCGGGSC-HHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------------HH
T ss_pred cccccccccc----cCCCCCccCCC-hHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------------hc
Confidence 9987654321 45679999999 999987765 78899999999999999999999643210 01
Q ss_pred CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+... .....++.+.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 GQVF----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCCC----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccc----------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 01123467889999999999999999999988
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=317.02 Aligned_cols=249 Identities=24% Similarity=0.302 Sum_probs=186.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.....+|.|+++.|++++.. +++.||||++..... ..+.+|+.++.++ +|||||++++++.+....++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~----~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMF----DNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEES----SSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEe----CCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 455776677777777777666554 678999999865322 2457899999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-----CCCeEEccccccc
Q 038905 492 VYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-----YYNAQISDFGLAK 565 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DFGla~ 565 (709)
||||+. |+|.+++.... ......+..++.||+.||.||| +.+|+||||||+|||++. ...+||+|||+++
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 999997 59999998664 4556677899999999999999 889999999999999943 3458899999998
Q ss_pred cccccccc-cceeccccCccccccccccc---CCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhh
Q 038905 566 LLTLNQSK-AIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR 640 (709)
Q Consensus 566 ~~~~~~~~-~~~~~~~Gt~~y~aaPE~~~---~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 640 (709)
.+...... .......||+.|+| ||++. ...++.++|||||||++|||++ |..||.......... ..
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~A-PE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--------~~ 242 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIA-PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--------LL 242 (432)
T ss_dssp CC------------CCSCTTSCC-GGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--------HT
T ss_pred eccCCCcceeeccccCCCcCccC-hhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--------Hh
Confidence 77643321 22255789999999 99998 4567889999999999999999 888985433222110 11
Q ss_pred cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 641 NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 641 ~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....... ..........+.+++.+||+.||.+|||+++|++
T Consensus 243 ~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 GACSLDC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCCCCTT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCccc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111111 1112345667889999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.39 Aligned_cols=256 Identities=20% Similarity=0.176 Sum_probs=170.6
Q ss_pred ccccce-eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEc----CC
Q 038905 413 MMNVTR-SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE----GQ 487 (709)
Q Consensus 413 ~~~f~~-~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~----~~ 487 (709)
.++|.. ...+|.|+++.||.+... .+++.||||++.... ....+....+..++|+||+++++++.. +.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHR---RTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEEC---CCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 455665 334677777777655554 568899999986431 222223344667799999999999876 45
Q ss_pred eEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC---CCCeEEcccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---YYNAQISDFG 562 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFG 562 (709)
..++||||+++|+|.+++.+.. .+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 5899999999999999998764 5899999999999999999999 889999999999999976 4559999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
+++...... .....||+.|+| ||++.+..++.++||||||+++|||++|+.||........... .......+
T Consensus 177 ~~~~~~~~~----~~~~~~t~~y~a-PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~ 248 (336)
T 3fhr_A 177 FAKETTQNA----LQTPCYTPYYVA-PEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLG 248 (336)
T ss_dssp TCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred cceeccccc----cccCCCCcCccC-hhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcc
Confidence 998665332 145678999999 9999998999999999999999999999999975433221000 00000111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHccc
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVV 692 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~ 692 (709)
.. ..........+..+.+++..||+.||.+|||++|+++ .+...
T Consensus 249 ~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 249 QY------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cc------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 10 0011111235677899999999999999999999998 44443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.29 Aligned_cols=260 Identities=18% Similarity=0.247 Sum_probs=178.4
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEE--cCCeEEEEEeecC
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCD--EGQNRLLVYKFLN 497 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~--~~~~~~lV~Ey~~ 497 (709)
..+|.|+++.||.+.. .....++.||||++.... ....+.+|+.++++++|||||++++++. .....++||||+.
T Consensus 27 ~~lG~G~~g~Vy~~~~-~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKR-KDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp CCCC-----EEEEEEE-SSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred cEeeecCCeEEEEEEE-ccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 3577888887765543 333567899999987542 3357889999999999999999999994 4778999999997
Q ss_pred CCCHHHHHhhC---------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee----cCCCCeEEcccccc
Q 038905 498 NGTLASFLFEN---------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL----DDYYNAQISDFGLA 564 (709)
Q Consensus 498 ~gsL~~~l~~~---------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla 564 (709)
+ +|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5 777777532 14889999999999999999999 8899999999999999 77899999999999
Q ss_pred ccccccccc-cceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhh------HHhHHHHHH
Q 038905 565 KLLTLNQSK-AIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTDWAF 636 (709)
Q Consensus 565 ~~~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~------~~~~~~~~~ 636 (709)
+.+...... ......+||+.|+| ||++.+. .++.++|||||||++|||++|+.||....... .......+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRA-PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp C----------------CCCTTCC-HHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccC-chhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 877543221 22245789999999 9999874 58999999999999999999999997543210 000111111
Q ss_pred HhhhcC---Ccccccc-------------Ccccc--------cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 637 DCYRNG---KLDDLVE-------------GDMEA--------MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 637 ~~~~~g---~~~~l~~-------------~~~~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+... ....+.. ..... .........+.+|+..||+.||++|||++|+++
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111000 0000000 00000 000011457889999999999999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.99 Aligned_cols=257 Identities=24% Similarity=0.330 Sum_probs=194.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
..+|.....+|.|+++.||. +... ..+|+|++.... ....+.+.+|+.++++++|+||+++++++.+....+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~-~~~~-----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYH-GRWH-----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEE-EEES-----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred HHHeEEeeEeccCCceEEEE-EEEc-----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 45566666677777776654 4431 238888876432 233456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+++++|.+++.+.. .+++..+..++.||+.||.||| +.+|+||||||+||+++ ++.+||+|||+++....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999998765 6899999999999999999999 88999999999999998 67999999999876542
Q ss_pred ccc---ccceeccccCcccccccccccC---------CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH
Q 038905 570 NQS---KAIKKAIRGTKGYVASPEWFRN---------STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637 (709)
Q Consensus 570 ~~~---~~~~~~~~Gt~~y~aaPE~~~~---------~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 637 (709)
... ........||+.|+| ||.+.. ..++.++||||||+++|||++|+.||......... .
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~a-PE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~ 253 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLA-PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-------W 253 (319)
T ss_dssp ------CCSCBCCSGGGGTSC-HHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-------H
T ss_pred ccccccccccccCCCcccccC-hHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------H
Confidence 211 111234569999999 999874 45788999999999999999999999765433211 1
Q ss_pred hhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccC
Q 038905 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEV 695 (709)
Q Consensus 638 ~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 695 (709)
....+....+.. ...+..+.+++..||+.||++|||+.+++++|+.+...
T Consensus 254 ~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 254 QMGTGMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHTTCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HhccCCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 122222211111 12335688999999999999999999999999998753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.42 Aligned_cols=251 Identities=18% Similarity=0.243 Sum_probs=179.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
.++|.....+|.|+++.||.+... .+++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFR---KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp GGGEEEEEEC------CEEEEEET---TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccceeeecCCeeEEEEEEe---cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 566777788899999988766654 5688999999865432 22234455556788889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 491 LVYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSS-QIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
+||||+ ++.+..+... ...+++..+..++.||++||.||| ++ +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999 5556555543 457899999999999999999999 64 99999999999999999999999999998765
Q ss_pred ccccccceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
..... ....||+.|+| ||++. ...++.++||||||+++|||++|+.||........ .......+.
T Consensus 177 ~~~~~---~~~~~~~~y~a-PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~ 246 (318)
T 2dyl_A 177 DDKAK---DRSAGCAAYMA-PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE------VLTKVLQEE 246 (318)
T ss_dssp -------------CCTTCC-HHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH------HHHHHHHSC
T ss_pred CCccc---cccCCCccccC-hhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH------HHHHHhccC
Confidence 43322 45679999999 99994 55688999999999999999999999975332211 111111121
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...+.. ....+..+.+++..||+.||.+|||++++++
T Consensus 247 ~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 PPLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111111 1124567889999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=324.59 Aligned_cols=261 Identities=21% Similarity=0.152 Sum_probs=193.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEc------C
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE------G 486 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~------~ 486 (709)
++|.....+|.|+++.||.+... .+++.||||++... .....+.+.+|+.++.+++|||||++++++.. +
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~---~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQ---DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCT---TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEEC---CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 45666666777777766554433 56888999998653 33455779999999999999999999999765 6
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC---eEEcc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENL---KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN---AQISD 560 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~D 560 (709)
...++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 77899999999999999998754 5889999999999999999999 889999999999999997765 99999
Q ss_pred ccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHH-h-HHH-HHHH
Q 038905 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA-I-LTD-WAFD 637 (709)
Q Consensus 561 FGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~-~-~~~-~~~~ 637 (709)
||+++........ ....||+.|+| ||.+.+..++.++||||||+++|||++|+.||......... . ... ....
T Consensus 168 FG~a~~~~~~~~~---~~~~gt~~Y~A-PE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 168 LGYAKELDQGELC---TEFVGTLQYLA-PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCCCCBTTSCCCC---CCCCSCCTTCS-SCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred ccccccccccccc---ccccCCcccCC-hHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 9999877544322 45789999999 99999999999999999999999999999999754321100 0 000 0000
Q ss_pred hh----hcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 038905 638 CY----RNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRK 684 (709)
Q Consensus 638 ~~----~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 684 (709)
.. ..+.....-............+..+.+++..||+.||++|||+.+
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00 000000000001111223457889999999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=326.03 Aligned_cols=240 Identities=20% Similarity=0.209 Sum_probs=188.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCe----
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQN---- 488 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~---- 488 (709)
++|.....+|.|+++.||.+.... .+++.||||++... .....+.+.+|+.++.+++|||||++++++.+.+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRN--VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGG--GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcC--CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 567777777777777776554432 25789999998643 23445678999999999999999999999987655
Q ss_pred -EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 489 -RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 489 -~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
.+|||||+++++|.+++.. .+++..+..++.||+.||.||| +++|+||||||+|||++.+ .+||+|||+++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999988755 6899999999999999999999 8899999999999999986 8999999999876
Q ss_pred cccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
... ....||+.|+| ||++.+.. +.++|||||||+++||++|..|+...... .+
T Consensus 232 ~~~------~~~~gt~~y~a-PE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------~~ 284 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQA-PEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------GL 284 (681)
T ss_dssp TCC------SCCCCCTTTSC-TTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------SC
T ss_pred ccC------CccCCCccccC-HHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-------------------cc
Confidence 532 45679999999 99987654 88999999999999999998887532110 00
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHccc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-MRKVSQMLEVV 692 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~~L~~~ 692 (709)
.. ..........+.+++.+||+.||.+||+ ++++.+.|.++
T Consensus 285 ~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 PE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 0011223467889999999999999995 66666666553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=286.24 Aligned_cols=230 Identities=11% Similarity=0.060 Sum_probs=179.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
++|.....+|.|+++.||.+... ..++.||||.+.... .+..+++.+|+.++.+++||||+++++++.+.+..+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDT---ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEET---TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEec---CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 45776677777777777655543 568999999997543 233478999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||++|++|.+++.+. ........++.||+.||.||| +.+|+||||||+|||++.++.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999999543 455678889999999999999 8899999999999999999999997433
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
|++ .++.++||||||+++|||++|+.||......+... .....+..
T Consensus 175 --------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~ 220 (286)
T 3uqc_A 175 --------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAG 220 (286)
T ss_dssp --------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTS
T ss_pred --------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhcc
Confidence 333 36889999999999999999999997643311000 00000000
Q ss_pred cc--cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 651 DM--EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 651 ~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.. ........+..+.+++.+||+.||.+| |+.|+++.|+.+..
T Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 00 001122355678999999999999999 99999999988653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=282.49 Aligned_cols=235 Identities=20% Similarity=0.242 Sum_probs=176.3
Q ss_pred ccccee-eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHH-hccCcCceeEEEeEEEc----CC
Q 038905 414 MNVTRS-VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMI-GQTYHKNLVRLLGFCDE----GQ 487 (709)
Q Consensus 414 ~~f~~~-~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nlv~l~~~~~~----~~ 487 (709)
.+|... ..+|.|+++.||.+... .+++.||||+++. ...+.+|+.++ +.++||||+++++++.. ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNK---RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEc---CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 445443 45677777777655544 5788999999854 24567888887 66689999999999876 67
Q ss_pred eEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC---CCCeEEcccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---YYNAQISDFG 562 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFG 562 (709)
..++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 7899999999999999998764 5899999999999999999999 889999999999999998 7889999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
+++... +..++.++||||||+++|||++|+.||........ ...
T Consensus 166 ~a~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~ 209 (299)
T 3m2w_A 166 FAKETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPG 209 (299)
T ss_dssp TCEECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CC
T ss_pred cccccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHH
Confidence 986432 12456789999999999999999999965432110 000
Q ss_pred CccccccCccccc--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHcccccC
Q 038905 643 KLDDLVEGDMEAM--NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVVVEV 695 (709)
Q Consensus 643 ~~~~l~~~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~~ 695 (709)
....+........ .....+..+.+++..||+.||.+|||+.|+++ .+......
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 210 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 0011111110000 00234678999999999999999999999998 44444333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=300.81 Aligned_cols=239 Identities=15% Similarity=0.132 Sum_probs=176.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc---hhHHHHHHHHHHHhccCc-Cc-------------
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ---DGEKEFKNEVVMIGQTYH-KN------------- 475 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~n------------- 475 (709)
..+|.....+|.|+|+.||.+... .+++.||||++..... ...+.+++|+.++..++| +|
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQ---ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred ceeEEEecccccCCCEEEEEEEec---CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 455777777888888888666555 5688999999873322 235789999999999987 21
Q ss_pred --eeE------EEeEEEc-----CCeEEEEEeecCCCCHHHHHhh-------CCCCChHHHHHHHHHHHHHHHHhhhcCC
Q 038905 476 --LVR------LLGFCDE-----GQNRLLVYKFLNNGTLASFLFE-------NLKPGWNLRANIAFQIARGLLHLHVNCS 535 (709)
Q Consensus 476 --lv~------l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~-------~~~l~~~~~~~i~~~i~~al~~LH~~~~ 535 (709)
++. ++.+... ....+++|+++ +++|.+++.. ...+++..+..++.||++||.||| +
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 229 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---H 229 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 111 1111111 22356777765 5799988841 124778889999999999999999 8
Q ss_pred CCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCcccccccccc----------cCCCCCcccchHH
Q 038905 536 SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWF----------RNSTITANVDVYS 605 (709)
Q Consensus 536 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~----------~~~~~s~k~DvwS 605 (709)
++|+||||||+|||++.++.+||+|||+++..... ....+| +.|+| ||++ .+..++.++||||
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~a-PE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAP-PETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCC-HHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeC-chhhhccccccccccCcCCCchhhHHH
Confidence 89999999999999999999999999999876543 256678 99998 9999 5666889999999
Q ss_pred HHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 038905 606 FGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKV 685 (709)
Q Consensus 606 lGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 685 (709)
|||++|||++|+.||......+. ...++.. ....++.+.+++..||+.||++|||+.++
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999999975432210 1111111 11234679999999999999999997666
Q ss_pred H
Q 038905 686 S 686 (709)
Q Consensus 686 ~ 686 (709)
+
T Consensus 362 l 362 (413)
T 3dzo_A 362 M 362 (413)
T ss_dssp T
T ss_pred H
Confidence 4
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=264.74 Aligned_cols=197 Identities=18% Similarity=0.240 Sum_probs=147.4
Q ss_pred hccccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEE
Q 038905 25 QTNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKL 104 (709)
Q Consensus 25 ~~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l 104 (709)
++.|+|++|++|++ +++| ++|.|+|||+.+++ . ++|.. +|+||+|||+ .| .+++|+|
T Consensus 6 ~~~~~i~~g~~L~~---g~~l--~~g~f~l~f~~~gn-------l---~ly~~---~~~vW~an~~---~~--~~~~l~l 62 (236)
T 1dlp_A 6 GLSHEGSHPQTLHA---AQSL--ELSSFRFTMQSDCN-------L---VLFDS---DVRVWASNTA---GA--TGCRAVL 62 (236)
T ss_dssp CSSSSSCSCSCCCT---TCEE--CSTTEEEEECTTSC-------E---EEEES---SSEEECCCCC---SC--SCCBCCB
T ss_pred eccceeCCCCEECC---CCEE--EcCCEEEEECCCCc-------E---EEEEC---CEEEEECCCC---CC--CCeEEEE
Confidence 45699999999999 6888 59999999985433 2 23443 7999999999 66 6789999
Q ss_pred ecCccEEEEcCCCcEEEeecc--------E--------EEeccCCceeeeecCCCCCcc----------CCCcccCC-Cc
Q 038905 105 TADQGLVLNDPQGKQVWSSKL--------I--------LVQSFSSSRLWDSFSNPTDTL----------LPGKMMET-EQ 157 (709)
Q Consensus 105 ~~~G~L~l~~~~g~~vWss~~--------~--------vl~~~~~~~lWQSFd~PtDtl----------Lpgq~l~~-~~ 157 (709)
+.||||||.|++|++||+|++ + ||++ .++||||||||||+ +|||+++. ++
T Consensus 63 ~~dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~---~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~ 139 (236)
T 1dlp_A 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQ 139 (236)
T ss_dssp CSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---SEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCC
T ss_pred cCCCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEec---CCEEECCCCCCcccccCCccceEEecCCcCCCccc
Confidence 999999999999999999851 2 4443 38999999998665 67776654 35
Q ss_pred eEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccceEEEEEecCeeEEE
Q 038905 158 GLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDL 237 (709)
Q Consensus 158 ~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (709)
+|+| .+||++|.|+|+|+++|++.+ +++ ...||++++|++. ......++.+|.+++.+.++..+..
T Consensus 140 ~L~s---~~d~s~G~~~l~l~~dG~LvL--~~~-----~~~~W~s~~~~~~----~~~~~~L~~~Gnl~ly~~~~~~vw~ 205 (236)
T 1dlp_A 140 TLHA---TQSLQLSPYRLSMETDCNLVL--FDR-----DDRVWSTNTAGKG----TGCRAVLQPNGRMDVLTNQNIAVWT 205 (236)
T ss_dssp EECS---SCCCBCSSCEEEEETTTEEEE--EBT-----TBCCSCCCCCSSC----SSCEEEEETTTEEEEEETTTEEEEE
T ss_pred eEEc---CcEeecCcEEEEECCCCcEEE--EcC-----CEeEEeCCCcCCC----CceEEEECCCCcEEEEeCCCcEEEE
Confidence 7774 689999999999999996544 444 3589999999642 2234566777877666666665555
Q ss_pred eeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 238 TTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 238 ~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
++... . ...+|++||+||++++|.
T Consensus 206 s~~~~--~-~~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 206 SGNSR--S-AGRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp CCCCC--S-SSCCEEEECSSSCEEEEC
T ss_pred eCCCC--C-CCCEEEEEcCCCcEEEeC
Confidence 44311 1 235899999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=282.66 Aligned_cols=242 Identities=13% Similarity=0.063 Sum_probs=178.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--------chhHHHHHHHHHHHhccC---------cCc
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--------QDGEKEFKNEVVMIGQTY---------HKN 475 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~n 475 (709)
..+|.....+|.|+++.||.+.. +++.||||++.... ....+.+.+|+.++++++ |+|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred cccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 45566666677777777765543 46899999986542 223478899999998886 888
Q ss_pred eeEEEeEEE------------------------------cCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHH
Q 038905 476 LVRLLGFCD------------------------------EGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIAR 525 (709)
Q Consensus 476 lv~l~~~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~ 525 (709)
||++.+++. +....++||||+++|++.+.+.+ ..+++..+..++.||+.
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA 172 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence 888877642 26789999999999976666644 56899999999999999
Q ss_pred HHHHhhhcCCCCeEecCCCCCceeecCCC--------------------CeEEccccccccccccccccceeccccCccc
Q 038905 526 GLLHLHVNCSSQIIHCDIKPQNILLDDYY--------------------NAQISDFGLAKLLTLNQSKAIKKAIRGTKGY 585 (709)
Q Consensus 526 al~~LH~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y 585 (709)
||.|||. +.+|+||||||+|||++.++ .+||+|||+|+.... ....||+.|
T Consensus 173 aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 9999992 25899999999999999887 899999999987653 245799999
Q ss_pred ccccccccCCCCCcccchHHHHHH-HHHHHhCCCCCCccchhhHHhHHHHHHHhhh-cCCccccccCcccccCCHHHHHH
Q 038905 586 VASPEWFRNSTITANVDVYSFGVL-LLEIISCRKSFDIEMGEEYAILTDWAFDCYR-NGKLDDLVEGDMEAMNDIKCVEK 663 (709)
Q Consensus 586 ~aaPE~~~~~~~s~k~DvwSlGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~g~~~~l~~~~~~~~~~~~~~~~ 663 (709)
+| ||++.+.. +.++|||||+++ .+++++|..||...... .. ..+... ...... ..........+..
T Consensus 244 ~a-PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~----~~~~~~~~~~~~~----~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 244 MD-EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HY----LTDKMLKQMTFKT----KCNTPAMKQIKRK 311 (336)
T ss_dssp TC-SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HH----HHHHHHHTCCCSS----CCCSHHHHHHHHH
T ss_pred cC-hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hH----HHHhhhhhhccCc----ccchhhhhhcCHH
Confidence 99 99999777 899999998777 77788899887421000 00 111111 111110 0111113357788
Q ss_pred HHHHHHhcccCCCCCCCCHHHHH
Q 038905 664 LVMVSIWCIQEDPSLRPTMRKVS 686 (709)
Q Consensus 664 l~~l~~~Cl~~dP~~RPs~~ev~ 686 (709)
+.+++..||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=285.29 Aligned_cols=169 Identities=20% Similarity=0.129 Sum_probs=127.8
Q ss_pred CceEEEEEEcccc----------cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCC
Q 038905 441 RTTVIVVKKLDRV----------FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENL 509 (709)
Q Consensus 441 ~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~ 509 (709)
.+..+++|.+... .+...++|.+|+++|+++ +|+||++++++++++...||||||++|++|.++|.+.+
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~ 337 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE 337 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC
Confidence 4566788877432 122336799999999999 79999999999999999999999999999999999888
Q ss_pred CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceeccccCccccccc
Q 038905 510 KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASP 589 (709)
Q Consensus 510 ~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaP 589 (709)
+++.. +|+.||+.||.||| +++||||||||+||||++++.+||+|||+|+....+.... ...+||++|+| |
T Consensus 338 ~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~--~t~vGTp~YmA-P 408 (569)
T 4azs_A 338 EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP--TNLVQSFFVFV-N 408 (569)
T ss_dssp CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS--HHHHHHHHHHH-H
T ss_pred CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc--cCceechhhcc-H
Confidence 87754 58899999999999 8999999999999999999999999999999776544322 56889999999 9
Q ss_pred ccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 038905 590 EWFRNSTITANVDVYSFGVLLLEIISCRKS 619 (709)
Q Consensus 590 E~~~~~~~s~k~DvwSlGvvl~elltg~~p 619 (709)
|++.+. +..++|+||+|+++++|.++..+
T Consensus 409 E~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 409 ELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHC------------------CCCCTTHHH
T ss_pred HHhCCC-CCCcccccccccchhhhccccch
Confidence 999864 56789999999998887655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.9e-24 Score=238.22 Aligned_cols=183 Identities=19% Similarity=0.239 Sum_probs=144.2
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--------chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--------QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..+|.|+++.||.. . ..+..+++|+..... ....+++.+|++++++++||||+++..++...++.+|
T Consensus 342 ~~LG~G~fg~Vy~~-~----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 342 HLIGKGAEADIKRD-S----YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ------CCEEEEEE-E----CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CEEeeCCCEEEEEE-E----ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 35677777777555 3 346778888753211 1123568999999999999999966666667778899
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++++|.+++.+ +..++.|+++||.||| +++|+||||||+|||++. .+||+|||+++......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999999875 5689999999999999 889999999999999999 99999999999876543
Q ss_pred ccc-----ceeccccCcccccccccccC--CCCCcccchHHHHHHHHHHHhCCCCCC
Q 038905 572 SKA-----IKKAIRGTKGYVASPEWFRN--STITANVDVYSFGVLLLEIISCRKSFD 621 (709)
Q Consensus 572 ~~~-----~~~~~~Gt~~y~aaPE~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~ 621 (709)
... ......||+.|+| ||++.. ..|+..+|+|+..+-.++.+.++.++.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~A-PEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKF-DEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGH-HHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCC-HHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 321 1246789999999 999987 668888999999999999888877663
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-18 Score=154.70 Aligned_cols=110 Identities=19% Similarity=0.289 Sum_probs=90.5
Q ss_pred hccccccCCCccccCCCCCcEE--cCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEE
Q 038905 25 QTNGTVPVGSTLTAGTDSSPWL--SPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQV 102 (709)
Q Consensus 25 ~~~~~i~~g~~l~~~~~~~~lv--S~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L 102 (709)
++.++|.+|++|.+ +++|+ |++|.|+|+|+..++ + +||++ .++||+||++ .| ..++.|
T Consensus 6 ~~~~~l~~g~~L~~---g~~l~~~S~~g~~~L~~~~dgn-------l---vly~~---~~~vW~sn~~---~~-~~~~~l 65 (119)
T 1b2p_A 6 SKQPDDNHPQILHA---TESLEILFGTHVYRFIMQTDCN-------L---VLYDN---NNPIWATNTG---GL-GNGCRA 65 (119)
T ss_dssp CSCSSSCCCCEEET---TCEEEEEETTEEEEEEECTTSC-------E---EEEET---TEEEEECCCT---TS-CSSCEE
T ss_pred ecCcccCCCCEEcC---CCEEEEeCCCCCEEEEEecCCC-------E---EEEEC---CEEEEeCCCc---cC-CCceEE
Confidence 35689999999999 78999 999999999997543 3 57875 7999999998 55 346899
Q ss_pred EEecCccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCc
Q 038905 103 KLTADQGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSN 182 (709)
Q Consensus 103 ~l~~~G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~ 182 (709)
+|.+||||||.|.++ .++|||| +||++|.|+++|+++|+
T Consensus 66 ~l~~dGNLVl~d~~~----------------~~lW~S~-------------------------~~~~~g~~~l~l~~~Gn 104 (119)
T 1b2p_A 66 VLQPDGVLVVITNEN----------------VTVWQSP-------------------------VAGKAGHYVLVLQPDRN 104 (119)
T ss_dssp EECTTSCEEEECTTC----------------CEEEECS-------------------------CCCCSSCEEEEECTTSC
T ss_pred EEccCCEEEEEeCCC----------------cEEEcCC-------------------------CCCCCCCEEEEEECCCc
Confidence 999999999988654 4678888 45678999999999999
Q ss_pred eEEEEecCCCCCCccceeeccc
Q 038905 183 LVLNIANLPTDLAYDAYYISGT 204 (709)
Q Consensus 183 ~~~~~~~~~~~~~~~~yw~s~~ 204 (709)
++++ + ..||++|+
T Consensus 105 lvl~--~-------~~~W~Sg~ 117 (119)
T 1b2p_A 105 VVIY--G-------DALWATQT 117 (119)
T ss_dssp EEEE--E-------SEEEECCC
T ss_pred EEEE--C-------ccEeCCCC
Confidence 7665 2 27999886
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.6e-19 Score=183.90 Aligned_cols=130 Identities=13% Similarity=0.055 Sum_probs=99.9
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc------------------hhHHHHHHHHHHHhccCcCceeEE
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ------------------DGEKEFKNEVVMIGQTYHKNLVRL 479 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nlv~l 479 (709)
....+|.|+++.||.+ .. .+++.||||.+..... .....+.+|+.++.+++| +++
T Consensus 94 ~~~~iG~G~~g~Vy~~-~~---~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 94 IGKLMGEGKESAVFNC-YS---EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp EEEEEEECSSEEEEEE-EE---TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred ecCEeccCCCceEEEE-Ee---CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 3345566666666544 44 4688999999864221 134678999999999994 555
Q ss_pred EeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEc
Q 038905 480 LGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 480 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
.+++.. +..++||||++|++|.+ +. ......++.||+.||.||| +.+|+||||||+|||++ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 554433 55699999999999988 42 1234579999999999999 88999999999999999 9999999
Q ss_pred ccccccc
Q 038905 560 DFGLAKL 566 (709)
Q Consensus 560 DFGla~~ 566 (709)
|||+|+.
T Consensus 235 DFG~a~~ 241 (282)
T 1zar_A 235 DFPQSVE 241 (282)
T ss_dssp CCTTCEE
T ss_pred ECCCCeE
Confidence 9999974
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.3e-16 Score=139.14 Aligned_cols=109 Identities=20% Similarity=0.378 Sum_probs=88.1
Q ss_pred cccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEec
Q 038905 27 NGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTA 106 (709)
Q Consensus 27 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~ 106 (709)
.|+|.+||+|.+ +++|+ +|.|+|+|+..++ +. +|+ ..++||.||++ .|. .+++|+|.+
T Consensus 2 ~dtl~~gq~L~~---g~~L~--~g~~~L~~~~dgn-------lv---ly~---~~~~vW~sn~~---~~~-~~~~l~l~~ 59 (115)
T 2dpf_A 2 DNVLLSGQTLHA---DHSLQ--AGAYTLTIQNKCN-------LV---KYQ---NGRQIWASNTD---RRG-SGCRLTLLS 59 (115)
T ss_dssp CCEEETTCEEET---TEEEE--ETTEEEEECTTSC-------EE---EEE---TTEEEEECSCT---TSC-SSCEEEECT
T ss_pred CCEeCCCCEECC---CCEEE--CCCEEEEEcCCCc-------EE---EEe---CCEEEEeCCCC---CCC-CceEEEECC
Confidence 489999999999 78998 8999999976443 43 365 47899999998 663 568999999
Q ss_pred CccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEE
Q 038905 107 DQGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLN 186 (709)
Q Consensus 107 ~G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~ 186 (709)
+|||||.|.++ .++||||++ +++|.|++.++++|++.++
T Consensus 60 ~GnLvl~d~~~----------------~~vW~S~~~-------------------------~~~g~~~l~l~~dGnlvl~ 98 (115)
T 2dpf_A 60 DGNLVIYDHNN----------------NDVWGSACW-------------------------GDNGKYALVLQKDGRFVIY 98 (115)
T ss_dssp TSCEEEECTTC----------------CEEEECCCC-------------------------CSSSCCEEEECTTSCEEEE
T ss_pred CCcEEEECCCc----------------eEEEEcCCC-------------------------CCCCCEEEEEeCCCeEEEE
Confidence 99999988554 467899987 3578899999999997665
Q ss_pred EecCCCCCCccceeecccccC
Q 038905 187 IANLPTDLAYDAYYISGTYDS 207 (709)
Q Consensus 187 ~~~~~~~~~~~~yw~s~~~~~ 207 (709)
+ . .||++++|..
T Consensus 99 --~------~-~~W~S~~~~~ 110 (115)
T 2dpf_A 99 --G------P-VLWSLGPNGC 110 (115)
T ss_dssp --C------S-EEECSSTTCB
T ss_pred --C------C-CEEECCCCCC
Confidence 2 1 7999999964
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-15 Score=133.15 Aligned_cols=108 Identities=17% Similarity=0.333 Sum_probs=87.4
Q ss_pred cccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEec
Q 038905 27 NGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTA 106 (709)
Q Consensus 27 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~ 106 (709)
+|+|.+|+.|.+ +++|+ ++|.|+|+|+..++ . |+|+ ..++||.||++ .+ ..++.|+|..
T Consensus 1 ~d~l~~g~~L~~---g~~l~-~~~~~~l~~~~dGn-------l---vl~~---~~~~vW~sn~~---~~-~~~~~l~l~~ 59 (110)
T 3a0c_A 1 VNSLSSPNSLFT---GHSLE-VGPSYRLIMQGDCN-------F---VLYD---SGKPVWASNTG---GL-GSGCRLTLHN 59 (110)
T ss_dssp CCEEETTCEECT---TCEEE-ETTTEEEEECTTSC-------E---EEEE---TTEEEEECCCT---TS-CSSCEEEECT
T ss_pred CCEeCCCCEECC---CCEEE-ECCCEEEEEcCCCc-------E---EEEE---CCEEEEECCCC---CC-CCcEEEEEeC
Confidence 378999999999 79999 99999999976443 3 6776 37899999998 54 3467999999
Q ss_pred CccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEE
Q 038905 107 DQGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLN 186 (709)
Q Consensus 107 ~G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~ 186 (709)
||||||.|.+| .++|||| +++++|.|+++|+++|+++++
T Consensus 60 dGNLVl~~~~~----------------~~~W~S~-------------------------t~~~~g~~~l~l~~dGnlvl~ 98 (110)
T 3a0c_A 60 NGNLVIYDQSN----------------RVIWQTK-------------------------TNGKEDHYVLVLQQDRNVVIY 98 (110)
T ss_dssp TSCEEEECTTC----------------CEEEECC-------------------------CCCSSSCCEEEECTTSCEEEE
T ss_pred CCCEEEECCCC----------------cEEEecC-------------------------CCCCCCCEEEEEeCCccEEEE
Confidence 99999987654 4678888 356789999999999997665
Q ss_pred EecCCCCCCccceeecccc
Q 038905 187 IANLPTDLAYDAYYISGTY 205 (709)
Q Consensus 187 ~~~~~~~~~~~~yw~s~~~ 205 (709)
+ ..||+++++
T Consensus 99 --~-------~~~W~S~~~ 108 (110)
T 3a0c_A 99 --G-------PVVWATGSG 108 (110)
T ss_dssp --C-------SEEEECSCC
T ss_pred --C-------CCEecCCCc
Confidence 2 269998875
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.64 E-value=8.3e-16 Score=134.91 Aligned_cols=111 Identities=21% Similarity=0.393 Sum_probs=88.0
Q ss_pred cccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEec
Q 038905 27 NGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTA 106 (709)
Q Consensus 27 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~ 106 (709)
+|+|.+||+|.+ +++| ++|.|+|+|+..++ . ++|.. .++||.||++ .+ ..+++|+|..
T Consensus 1 tdtl~~gq~L~~---g~~L--~~~~~~L~~~~dgn-------l---vl~~~---~~~vW~sn~~---~~-~~~~~l~l~~ 58 (112)
T 1xd5_A 1 SDRLNSGHQLDT---GGSL--AEGGYLFIIQNDCN-------L---VLYDN---NRAVWASGTN---GK-ASGCVLKMQN 58 (112)
T ss_dssp CCEEETTEEECT---TCEE--EETTEEEEECTTSC-------E---EEEET---TEEEEECCCT---TS-CSSEEEEECT
T ss_pred CCCCCCCCEECC---CCEE--eCCCEEEEEcCCCc-------E---EEEEC---CEEEEeCCCc---CC-CCCEEEEEeC
Confidence 489999999999 6888 58999999987554 3 35764 6899999997 43 3567999999
Q ss_pred CccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEE
Q 038905 107 DQGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLN 186 (709)
Q Consensus 107 ~G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~ 186 (709)
+|||||.| ++ .++||||+ +|++|.|+++|+++|++.++
T Consensus 59 ~GNLvl~d-~~----------------~~~W~S~~-------------------------~~~~g~~~l~l~~dGnlvl~ 96 (112)
T 1xd5_A 59 DGNLVIYS-GS----------------RAIWASNT-------------------------NRQNGNYYLILQRDRNVVIY 96 (112)
T ss_dssp TSCEEEEE-TT----------------EEEEECCC-------------------------CCSCCCCEEEECTTSCEEEE
T ss_pred CCCEEEEc-CC----------------EEEEECCc-------------------------cCCCCCEEEEEeCCCcEEEE
Confidence 99999987 44 35788883 45678999999999997665
Q ss_pred EecCCCCCCccceeecccccC
Q 038905 187 IANLPTDLAYDAYYISGTYDS 207 (709)
Q Consensus 187 ~~~~~~~~~~~~yw~s~~~~~ 207 (709)
. .. ..+||++++|+|
T Consensus 97 ~-~~-----~~~~W~S~~~~g 111 (112)
T 1xd5_A 97 D-NS-----NNAIWATHTNVG 111 (112)
T ss_dssp C-TT-----SCEEEECCCCCC
T ss_pred C-CC-----CceEEECCCccC
Confidence 2 21 468999999975
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=8.4e-16 Score=156.57 Aligned_cols=137 Identities=15% Similarity=0.105 Sum_probs=99.9
Q ss_pred eeeeecCeeEEEEEEEEEEecCCCceE--EEEEEcccccc------------------------hhHHHHHHHHHHHhcc
Q 038905 418 RSVLLGSSVFVNFTLVGVIQTSTRTTV--IVVKKLDRVFQ------------------------DGEKEFKNEVVMIGQT 471 (709)
Q Consensus 418 ~~~~~G~g~~~~v~~~~~~~~~~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l 471 (709)
....+|.|+++.||.+... .+++. ||||.+..... .....+.+|+.++.++
T Consensus 51 i~~~ig~G~~g~Vy~a~~~---~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGV---FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEECSSEEEEEEEEE---ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hCCEEeecceEEEEEEEEc---CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 3445677777777666553 35677 99998643211 1123688999999999
Q ss_pred CcCc--eeEEEeEEEcCCeEEEEEeecCC-C----CHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCC
Q 038905 472 YHKN--LVRLLGFCDEGQNRLLVYKFLNN-G----TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIK 544 (709)
Q Consensus 472 ~h~n--lv~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlk 544 (709)
+|++ ++.++.+ ...+|||||+.+ | +|.+.... .++.....++.|++.||.|||. +.+|+|||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence 8875 3445443 356899999942 4 67666533 2345678899999999999994 4589999999
Q ss_pred CCceeecCCCCeEEcccccccccc
Q 038905 545 PQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 545 p~NIll~~~~~~kl~DFGla~~~~ 568 (709)
|+|||++. .++|+|||+|....
T Consensus 199 p~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEETT
T ss_pred HHHEEEcC--cEEEEECcccccCC
Confidence 99999998 99999999997653
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.45 E-value=3.8e-13 Score=115.98 Aligned_cols=76 Identities=18% Similarity=0.328 Sum_probs=64.5
Q ss_pred ccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEecC
Q 038905 28 GTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTAD 107 (709)
Q Consensus 28 ~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~~ 107 (709)
++|.+||.|.+ +++|+| |.|.|.|...+ .|.++. ..++||+|||+ .|....+.|+|+.|
T Consensus 2 n~L~~g~~L~~---g~~L~s--g~y~l~~q~Dg---------NLvly~----~~~~vW~ant~---~~~~~~~~L~l~~d 60 (105)
T 4h3o_A 2 NILDNNEGLYA---GQSLDV--EPYHFIMQDDC---------NLVLYD----HSTSTWASNTE---IGGKSGCSAVLQSD 60 (105)
T ss_dssp CEECTTEEECT---TCEEEE--TTEEEEECTTS---------CEEEEE----TTEEEEECCCC---CTTCCSCEEEECTT
T ss_pred CCcCCCCEEcC---CCEEEE--CCEEEEECCCC---------eEEEEE----CCEEEEEecCC---CCCCccEEEEEeCC
Confidence 68999999998 799988 78999986432 244543 36899999999 88888889999999
Q ss_pred ccEEEEcCCCcEEEeec
Q 038905 108 QGLVLNDPQGKQVWSSK 124 (709)
Q Consensus 108 G~L~l~~~~g~~vWss~ 124 (709)
|||||.|+++++||+|+
T Consensus 61 GnLvL~d~~~~~vWss~ 77 (105)
T 4h3o_A 61 GNFVVYDSSGRSLWASH 77 (105)
T ss_dssp SCEEEECTTCCEEEECC
T ss_pred ccEEEECCCcEEEEEec
Confidence 99999999999999986
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=5.6e-12 Score=109.72 Aligned_cols=105 Identities=24% Similarity=0.442 Sum_probs=80.3
Q ss_pred ccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEecC
Q 038905 28 GTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTAD 107 (709)
Q Consensus 28 ~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~~ 107 (709)
+||.+||.|.+ +++|+ +|.|+|+|...++ ..| |.. .++||.+|++ .+ ..++.|+|..|
T Consensus 2 ntL~~gq~L~~---g~~L~--~g~~~L~~q~dGn-------Lvl---y~~---~~~vW~snt~---~~-~~~~~l~l~~d 59 (109)
T 3dzw_A 2 NILYSGETLSP---GEFLN--NGRYVFIMQEDCN-------LVL---YDV---DKPIWATNTG---GL-DRRCHLSMQSD 59 (109)
T ss_dssp CEEETTEEECT---TCEEE--ETTEEEEECTTSC-------EEE---EET---TEEEEECCCT---TS-SSSCEEEECTT
T ss_pred CCcCCCCEeCC---CCEEE--CCCEEEEEcCCCc-------EEE---EeC---CEEEEECCcc---cC-CCCEEEEEeCC
Confidence 58999999998 68886 7999999976443 544 654 5899999998 54 34679999999
Q ss_pred ccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEE
Q 038905 108 QGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNI 187 (709)
Q Consensus 108 G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~ 187 (709)
|||||.|.++.++|+|+ .. ...+.|.+.++.+|+++++-
T Consensus 60 GNLvl~~~~~~~~W~S~----------------t~-------------------------~~~~~~~~~L~ddGNlvly~ 98 (109)
T 3dzw_A 60 GNLVVYSPRNNPIWASN----------------TG-------------------------GENGNYVCVLQKDRNVVIYG 98 (109)
T ss_dssp SCEEEECTTSCEEEECC----------------CC-------------------------CSSSCEEEEECTTSCEEEEE
T ss_pred CCEEEECCCCCEEEECC----------------CC-------------------------CCCCCEEEEEeCCCEEEEEC
Confidence 99999998777777652 10 02356899999999999882
Q ss_pred ecCCCCCCccceeeccc
Q 038905 188 ANLPTDLAYDAYYISGT 204 (709)
Q Consensus 188 ~~~~~~~~~~~yw~s~~ 204 (709)
.+.|.+++
T Consensus 99 ---------~~~W~s~t 106 (109)
T 3dzw_A 99 ---------TARWATGT 106 (109)
T ss_dssp ---------SCCCCCCC
T ss_pred ---------CCEEeCCC
Confidence 26787765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.35 E-value=3.9e-13 Score=142.69 Aligned_cols=136 Identities=13% Similarity=0.099 Sum_probs=92.1
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--------------hhHH--------HHHHHHHHHhccCc
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--------------DGEK--------EFKNEVVMIGQTYH 473 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h 473 (709)
+.....+|.|+++.||.+ .. .+++.||||++..... .... ....|...|.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a-~d---~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIV-AD---EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp SEEEEEEEECSSEEEEEE-EC---TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEE-EC---CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 344556666666666554 33 4688999998643110 0001 12356677777755
Q ss_pred Cce--eEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec
Q 038905 474 KNL--VRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551 (709)
Q Consensus 474 ~nl--v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~ 551 (709)
..+ ...+.. ...+|||||++|+.|..+.. ......++.||+.+|.+|| +.+||||||||.|||++
T Consensus 173 ~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 173 EGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIR 239 (397)
T ss_dssp TTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred cCCCCCeeeec----cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEe
Confidence 443 223322 12379999999988765432 2334678899999999999 78999999999999998
Q ss_pred CCC----------CeEEcccccccccc
Q 038905 552 DYY----------NAQISDFGLAKLLT 568 (709)
Q Consensus 552 ~~~----------~~kl~DFGla~~~~ 568 (709)
+++ .+.|+||+.+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 776 38899999887543
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.21 E-value=7.9e-11 Score=102.41 Aligned_cols=106 Identities=19% Similarity=0.262 Sum_probs=77.7
Q ss_pred ccccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEe
Q 038905 26 TNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLT 105 (709)
Q Consensus 26 ~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~ 105 (709)
++|+|.+||.|.. +++|+| |.|.|-| +..+ +.. + |.. ++||.+|+. . ...++.|+|.
T Consensus 5 ~~dtL~~gq~L~~---g~~L~s--g~~~L~~-q~dG------nLv--l-~~~----~~vW~snt~---~-~~~~~~l~l~ 61 (110)
T 3r0e_B 5 TNNLLFSGQVLYG---DGRLTA--KNHQLVM-QGDC------NLV--L-YGG----KYGWQSNTH---G-NGEHCFLRLN 61 (110)
T ss_dssp BTTEEETTCEEET---TEEEEC--SSCEEEE-CTTS------CEE--E-ECS----SSCEECCCT---T-SSSSCEEEEC
T ss_pred ccCEECCCCEecC---CCEEEe--CCEEEEE-cCCC------eEE--E-ECC----eEEEECCCc---C-CCcCEEEEEe
Confidence 5699999999999 789998 4588855 3222 233 3 554 489999997 4 2245799999
Q ss_pred cCccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEE
Q 038905 106 ADQGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVL 185 (709)
Q Consensus 106 ~~G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~ 185 (709)
++|||||.|.++.++|+|++ +. ..|.|.+.++.+|++++
T Consensus 62 ~dGNLvl~d~~~~~iW~S~t-----------------------------------~~------~~~~~~~~L~~dGNlvl 100 (110)
T 3r0e_B 62 HKGELIIKDDDFKTIWSSRS-----------------------------------SS------KQGEYVLILQDDGFGVI 100 (110)
T ss_dssp TTSCEEEECTTCCEEEECCC-----------------------------------CC------SSSCCEEEECTTSCEEE
T ss_pred CCCcEEEEeCCCCEEEEcCC-----------------------------------cC------CCCCEEEEEcCCccEEE
Confidence 99999999988877777631 00 23568999999999998
Q ss_pred EEecCCCCCCccceeeccc
Q 038905 186 NIANLPTDLAYDAYYISGT 204 (709)
Q Consensus 186 ~~~~~~~~~~~~~yw~s~~ 204 (709)
+ ..+.|.+++
T Consensus 101 y---------~~~~W~t~~ 110 (110)
T 3r0e_B 101 Y---------GPAIFETSS 110 (110)
T ss_dssp E---------CSEEEESCC
T ss_pred e---------cCCEecCCC
Confidence 8 236788763
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.12 E-value=7.9e-10 Score=96.59 Aligned_cols=109 Identities=14% Similarity=0.206 Sum_probs=80.6
Q ss_pred ccccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEe
Q 038905 26 TNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLT 105 (709)
Q Consensus 26 ~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~ 105 (709)
+.|+|.+||.|.. ++.|.+ |.|.|-|...++ |.++ .. ...++||.+|+. .+ ..++.|.|.
T Consensus 5 ~~~tL~~gq~L~~---g~~L~~--g~~~L~~q~dGN---------LvL~-~~-~~~~~vWssnt~---~~-~~~~~l~l~ 64 (113)
T 3mez_B 5 VRNVLFSSQVMYD---NAQLAT--RDYSLVMRDDCN---------LVLT-KG-SKTNIVWESGTS---GR-GQHCFMRLG 64 (113)
T ss_dssp CSSEEETTCEEET---TCEEEE--TTEEEEECTTSC---------EEEE-ET-TTTEEEEECCCT---TS-CSSCEEEEC
T ss_pred cCCEeCCCCEECC---CCEeEc--CCEEEEEcCCCE---------EEEE-EC-CCCEEEEECCcc---cC-CcCEEEEEe
Confidence 5689999999999 688874 889888854222 3443 32 136899999997 44 245799999
Q ss_pred cCccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEE
Q 038905 106 ADQGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVL 185 (709)
Q Consensus 106 ~~G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~ 185 (709)
.+|||||.|.+++++|+|++ +. ..|.|.+.++.+|++++
T Consensus 65 ~dGNLVl~d~~~~~iW~S~t-----------------------------------~~------~~~~~~~~L~~dGnlvl 103 (113)
T 3mez_B 65 HSGELDITDDRLNTVFVSNT-----------------------------------VG------QEGDYVLILQINGQAVV 103 (113)
T ss_dssp TTSCEEEECTTSCEEEECSC-----------------------------------CC------SSSCCEEEECTTSCEEE
T ss_pred CCCcEEEECCCCCEEEECCC-----------------------------------cC------CCCCEEEEEcCCceEEE
Confidence 99999999988877777631 00 13568999999999998
Q ss_pred EEecCCCCCCccceeeccc
Q 038905 186 NIANLPTDLAYDAYYISGT 204 (709)
Q Consensus 186 ~~~~~~~~~~~~~yw~s~~ 204 (709)
+ ..+.|.+++
T Consensus 104 y---------~~~~W~s~~ 113 (113)
T 3mez_B 104 Y---------GPAVWSTAA 113 (113)
T ss_dssp E---------CSEEEESCC
T ss_pred e---------cCCEecCCC
Confidence 8 247888764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=2.1e-10 Score=116.65 Aligned_cols=143 Identities=13% Similarity=-0.016 Sum_probs=104.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV 492 (709)
.++......++++...||.. .. .+..+++|............+.+|+.+++.+. +..++++++++.+....++|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~-~~----~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKL-VG----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEE-EC----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEE-EC----CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 44544444444444444433 22 35789999986532223456899999999885 67788999999988899999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNC-------------------------------------- 534 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~-------------------------------------- 534 (709)
|||++|.+|.+.+. +......++.+++++|..||...
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999887631 22334578889999999999610
Q ss_pred ------------------CCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 535 ------------------SSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 535 ------------------~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14589999999999998766677999998753
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.3e-09 Score=94.43 Aligned_cols=106 Identities=22% Similarity=0.354 Sum_probs=80.7
Q ss_pred ccccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEe
Q 038905 26 TNGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLT 105 (709)
Q Consensus 26 ~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~ 105 (709)
++|||.+||.|.. +++| .+|.|.|.|...++ .-| |.. +|.+|+. .+ ..++.|+|.
T Consensus 2 ~~dtL~~gq~L~~---g~~L--~~g~~~L~~q~dGN-------Lvl---~~~------~Wssnt~---~~-~~~~~l~l~ 56 (109)
T 3r0e_A 2 GTNYLLSGQTLDT---EGHL--KNGDFDLVMQDDCN-------LVL---YNG------NWQSNTA---NN-GRDCKLTLT 56 (109)
T ss_dssp CCSEEETTCEECT---TCEE--EETTEEEEECTTSC-------EEE---ETT------TEECCCT---TS-CSSCEEEEC
T ss_pred ccCCcCCCCCcCC---CCEe--ECCCEEEEEecCCe-------EEE---EeC------eEEcCCC---CC-CCcEEEEEc
Confidence 4689999999998 6888 57999999854332 322 431 6999987 43 346899999
Q ss_pred cCccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEE
Q 038905 106 ADQGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVL 185 (709)
Q Consensus 106 ~~G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~ 185 (709)
.||||||.|.++.++|++++ + ...+.|.+.++++|++++
T Consensus 57 ~dGnLvl~d~~~~~vWss~t-----------------------------------~------~~~~~~~~~L~~dGNlvl 95 (109)
T 3r0e_A 57 DYGELVIKNGDGSTVWKSGA-----------------------------------Q------SVKGNYAAVVHPDGRLVV 95 (109)
T ss_dssp TTSCEEEECTTSCEEEECCC-----------------------------------C------CSSSCCEEEEETTTEEEE
T ss_pred CCCeEEEEeCCCCEEEcCCC-----------------------------------c------CCCcCEEEEEcCCCeEEE
Confidence 99999999988888887631 0 023568999999999998
Q ss_pred EEecCCCCCCccceeeccccc
Q 038905 186 NIANLPTDLAYDAYYISGTYD 206 (709)
Q Consensus 186 ~~~~~~~~~~~~~yw~s~~~~ 206 (709)
+ ..+.|.+++|-
T Consensus 96 y---------~~~~W~s~t~~ 107 (109)
T 3r0e_A 96 F---------GPSVFKIDPWV 107 (109)
T ss_dssp E---------CSEEEEECTTS
T ss_pred E---------ecCEECCCCcc
Confidence 8 34789998873
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.93 E-value=6.9e-09 Score=90.24 Aligned_cols=108 Identities=14% Similarity=0.204 Sum_probs=77.6
Q ss_pred cccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEec
Q 038905 27 NGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTA 106 (709)
Q Consensus 27 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~ 106 (709)
+++|.+||.|.+ ++.| .+|.|.|-|...++ .-| |.. .. ||.+|+. .+ ..++.|+|..
T Consensus 2 ~~~l~~gq~L~~---g~~L--~~g~~~L~~q~dGn-------Lvl---~~~---~~-vW~snt~---~~-~~~~~l~l~~ 58 (111)
T 3mez_A 2 NNVLLTGDVIHT---DNQL--SYESAAFVMQGDCN-------LVL---YNE---AG-GFQSNTH---GR-GVDCTLRLNN 58 (111)
T ss_dssp TTEEETTCEECT---TCEE--EETTEEEEECTTSC-------EEE---ECS---SC-CEECCCT---TS-CSSCEEEECT
T ss_pred cCEeCCCCEeCC---CCEE--ecCCEEEEEccCCe-------EEE---ECC---CC-EEECCcc---cC-CcCEEEEEcC
Confidence 478999999998 6888 47889999854332 433 543 23 9999987 44 3457999999
Q ss_pred CccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEE
Q 038905 107 DQGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLN 186 (709)
Q Consensus 107 ~G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~ 186 (709)
+|||||.|.++.. ++|||.-+ .....|.|.+.++.||+++++
T Consensus 59 dGNLVl~~~~~~~---------------~vW~S~t~-----------------------~~~~~~~~~l~Lq~dGNlvly 100 (111)
T 3mez_A 59 RGQLEIHSANSNT---------------PVWVYPRS-----------------------VNTVRGNYAATLGPDQHVTIY 100 (111)
T ss_dssp TSCEEEECSSCSS---------------CSEEESSS-----------------------CCCCSSCCEEEECTTSCEEEE
T ss_pred CCcEEEEeCCCCE---------------EEEEeccc-----------------------cCCCCcCEEEEECCCCeEEEe
Confidence 9999999876542 24554410 111357899999999999988
Q ss_pred EecCCCCCCccceeeccc
Q 038905 187 IANLPTDLAYDAYYISGT 204 (709)
Q Consensus 187 ~~~~~~~~~~~~yw~s~~ 204 (709)
..++|.+++
T Consensus 101 ---------~~~~W~s~t 109 (111)
T 3mez_A 101 ---------GPAIWSTPA 109 (111)
T ss_dssp ---------CSEEEECCC
T ss_pred ---------ccCEEccCC
Confidence 257898764
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.85 E-value=7.4e-09 Score=89.72 Aligned_cols=95 Identities=24% Similarity=0.298 Sum_probs=72.3
Q ss_pred CCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccc
Q 038905 144 TDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESG 223 (709)
Q Consensus 144 tDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~ 223 (709)
+|||+|||.|..+..| +.|.|.|.|+.||+++++. .||.++.... ..+..+.+..+|
T Consensus 3 ~dtL~~gq~L~~g~~L---------~~g~~~L~~q~dGNLvl~~----------~~Wssnt~~~----~~~~~l~l~~dG 59 (109)
T 3r0e_A 3 TNYLLSGQTLDTEGHL---------KNGDFDLVMQDDCNLVLYN----------GNWQSNTANN----GRDCKLTLTDYG 59 (109)
T ss_dssp CSEEETTCEECTTCEE---------EETTEEEEECTTSCEEEET----------TTEECCCTTS----CSSCEEEECTTS
T ss_pred cCCcCCCCCcCCCCEe---------ECCCEEEEEecCCeEEEEe----------CeEEcCCCCC----CCcEEEEEcCCC
Confidence 6999999999999999 4699999999999999861 3798876532 234577888899
Q ss_pred eEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 224 YMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
.+.+.+.++..+..+.. .......+++|+.||+|++|.
T Consensus 60 nLvl~d~~~~~vWss~t---~~~~~~~~~~L~~dGNlvly~ 97 (109)
T 3r0e_A 60 ELVIKNGDGSTVWKSGA---QSVKGNYAAVVHPDGRLVVFG 97 (109)
T ss_dssp CEEEECTTSCEEEECCC---CCSSSCCEEEEETTTEEEEEC
T ss_pred eEEEEeCCCCEEEcCCC---cCCCcCEEEEEcCCCeEEEEe
Confidence 88887766655543221 122335789999999999985
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.85 E-value=4.4e-09 Score=106.30 Aligned_cols=116 Identities=16% Similarity=0.098 Sum_probs=86.7
Q ss_pred CCceEEEEEEcccccchhHHHHHHHHHHHhccCcCc--eeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHH
Q 038905 440 TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKN--LVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRA 517 (709)
Q Consensus 440 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--lv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~ 517 (709)
.++..+++|..... ....+.+|+.+++.+.+.+ +++++++..+++..++||||++|.+|. .. .. ...
T Consensus 42 ~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~---~~~ 110 (264)
T 1nd4_A 42 QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HL---APA 110 (264)
T ss_dssp TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CC---CHH
T ss_pred CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cC---CHh
Confidence 34567899986543 2346789999999886544 567899888888899999999998874 21 11 233
Q ss_pred HHHHHHHHHHHHhhhcC-------------------------------------------------------CCCeEecC
Q 038905 518 NIAFQIARGLLHLHVNC-------------------------------------------------------SSQIIHCD 542 (709)
Q Consensus 518 ~i~~~i~~al~~LH~~~-------------------------------------------------------~~~iiH~D 542 (709)
.++.++++.|..||... ...++|+|
T Consensus 111 ~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD 190 (264)
T 1nd4_A 111 EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGD 190 (264)
T ss_dssp HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSS
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCC
Confidence 67778888888888421 11299999
Q ss_pred CCCCceeecCCCCeEEcccccccc
Q 038905 543 IKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 543 lkp~NIll~~~~~~kl~DFGla~~ 566 (709)
++|.||+++++..++|+||+.+..
T Consensus 191 l~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 191 ACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCcEEEECCcEEEEEcchhccc
Confidence 999999998876677999999753
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.79 E-value=2e-08 Score=87.09 Aligned_cols=97 Identities=19% Similarity=0.106 Sum_probs=72.2
Q ss_pred CCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccc
Q 038905 144 TDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESG 223 (709)
Q Consensus 144 tDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~ 223 (709)
+|||+|||.|..++.|+| |.|.|.|+.+|+++++ + ..+||.+..... ..+..+.+..+|
T Consensus 6 ~dtL~~gq~L~~g~~L~s---------g~~~L~~q~dGnLvl~--~------~~~vW~snt~~~----~~~~~l~l~~dG 64 (110)
T 3r0e_B 6 NNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNLVLY--G------GKYGWQSNTHGN----GEHCFLRLNHKG 64 (110)
T ss_dssp TTEEETTCEEETTEEEEC---------SSCEEEECTTSCEEEE--C------SSSCEECCCTTS----SSSCEEEECTTS
T ss_pred cCEECCCCEecCCCEEEe---------CCEEEEEcCCCeEEEE--C------CeEEEECCCcCC----CcCEEEEEeCCC
Confidence 799999999999999985 6799999999998886 2 147998776531 234567888899
Q ss_pred eEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 224 YMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
.+.+.+.++..+..+... ....-.+++|+.||+|++|.
T Consensus 65 NLvl~d~~~~~iW~S~t~---~~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 65 ELIIKDDDFKTIWSSRSS---SKQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp CEEEECTTCCEEEECCCC---CSSSCCEEEECTTSCEEEEC
T ss_pred cEEEEeCCCCEEEEcCCc---CCCCCEEEEEcCCccEEEec
Confidence 888877666655443221 11122789999999999985
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.75 E-value=1.3e-08 Score=108.53 Aligned_cols=141 Identities=11% Similarity=0.134 Sum_probs=100.0
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcc--ccc-chhHHHHHHHHHHHhccC--cCceeEEEeEEEcC---CeEE
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLD--RVF-QDGEKEFKNEVVMIGQTY--HKNLVRLLGFCDEG---QNRL 490 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nlv~l~~~~~~~---~~~~ 490 (709)
...+++|....+|... . .+..+++|+.. ... ......+.+|+.++..+. +..+++++.++.+. ...+
T Consensus 43 ~~~l~~G~sn~~y~v~-~----~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLV-T----PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEE-C----SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred EEEcCCcccceEEEEE-E----CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3445556555555433 2 24578888765 321 123457889999999987 45688999998776 3489
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNC------------------------------------ 534 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~------------------------------------ 534 (709)
+||||++|..+.+... ..++...+..++.++++.|..||...
T Consensus 118 ~vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999999988744221 23677888899999999999999621
Q ss_pred -------------------CCCeEecCCCCCceeecCCCC--eEEcccccccc
Q 038905 535 -------------------SSQIIHCDIKPQNILLDDYYN--AQISDFGLAKL 566 (709)
Q Consensus 535 -------------------~~~iiH~Dlkp~NIll~~~~~--~kl~DFGla~~ 566 (709)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999999874
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.70 E-value=7e-08 Score=84.16 Aligned_cols=100 Identities=17% Similarity=0.146 Sum_probs=73.8
Q ss_pred CCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccc
Q 038905 144 TDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESG 223 (709)
Q Consensus 144 tDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~ 223 (709)
.|||+|||.|..+..|+ .|.|.|.|+.||+++++..+ ...+||.+..... ..+..+.+..+|
T Consensus 6 ~~tL~~gq~L~~g~~L~---------~g~~~L~~q~dGNLvL~~~~-----~~~~vWssnt~~~----~~~~~l~l~~dG 67 (113)
T 3mez_B 6 RNVLFSSQVMYDNAQLA---------TRDYSLVMRDDCNLVLTKGS-----KTNIVWESGTSGR----GQHCFMRLGHSG 67 (113)
T ss_dssp SSEEETTCEEETTCEEE---------ETTEEEEECTTSCEEEEETT-----TTEEEEECCCTTS----CSSCEEEECTTS
T ss_pred CCEeCCCCEECCCCEeE---------cCCEEEEEcCCCEEEEEECC-----CCEEEEECCcccC----CcCEEEEEeCCC
Confidence 69999999999999995 48899999999999987421 1468999876532 234567888899
Q ss_pred eEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 224 YMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
.+.+.+.++..+..+... ......+++|+.||+|++|.
T Consensus 68 NLVl~d~~~~~iW~S~t~---~~~~~~~~~L~~dGnlvly~ 105 (113)
T 3mez_B 68 ELDITDDRLNTVFVSNTV---GQEGDYVLILQINGQAVVYG 105 (113)
T ss_dssp CEEEECTTSCEEEECSCC---CSSSCCEEEECTTSCEEEEC
T ss_pred cEEEECCCCCEEEECCCc---CCCCCEEEEEcCCceEEEec
Confidence 888877666554433221 11123789999999999984
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.65 E-value=7.1e-08 Score=83.78 Aligned_cols=99 Identities=23% Similarity=0.180 Sum_probs=71.8
Q ss_pred CCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccc
Q 038905 144 TDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESG 223 (709)
Q Consensus 144 tDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~ 223 (709)
+|||+|||.|..+..| +.|.|.|.|+.||+++++. . .. ||.+..... ..+..+.+..+|
T Consensus 2 ~~~l~~gq~L~~g~~L---------~~g~~~L~~q~dGnLvl~~-~------~~-vW~snt~~~----~~~~~l~l~~dG 60 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL---------SYESAAFVMQGDCNLVLYN-E------AG-GFQSNTHGR----GVDCTLRLNNRG 60 (111)
T ss_dssp TTEEETTCEECTTCEE---------EETTEEEEECTTSCEEEEC-S------SC-CEECCCTTS----CSSCEEEECTTS
T ss_pred cCEeCCCCEeCCCCEE---------ecCCEEEEEccCCeEEEEC-C------CC-EEECCcccC----CcCEEEEEcCCC
Confidence 6999999999999999 3689999999999998862 1 23 999876532 234567888889
Q ss_pred eEEEEEecCee-EEEeeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 224 YMYILRRNGRR-FDLTTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 224 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
.+.+.+.++.. +..+... ........+++|+.||++++|.
T Consensus 61 NLVl~~~~~~~~vW~S~t~-~~~~~~~~~l~Lq~dGNlvly~ 101 (111)
T 3mez_A 61 QLEIHSANSNTPVWVYPRS-VNTVRGNYAATLGPDQHVTIYG 101 (111)
T ss_dssp CEEEECSSCSSCSEEESSS-CCCCSSCCEEEECTTSCEEEEC
T ss_pred cEEEEeCCCCEEEEEeccc-cCCCCcCEEEEECCCCeEEEec
Confidence 88887765543 4432210 1122345789999999999995
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=1.5e-07 Score=81.55 Aligned_cols=97 Identities=16% Similarity=0.158 Sum_probs=72.6
Q ss_pred CccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccce
Q 038905 145 DTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGY 224 (709)
Q Consensus 145 DtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~~ 224 (709)
+||+|||.|..+..|+ .|.|.|.|+.+|++.++. . ..+||.+..... ..+..+.+..+|.
T Consensus 2 ntL~~gq~L~~g~~L~---------~g~~~L~~q~dGnLvly~-~------~~~vW~snt~~~----~~~~~l~l~~dGN 61 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN---------NGRYVFIMQEDCNLVLYD-V------DKPIWATNTGGL----DRRCHLSMQSDGN 61 (109)
T ss_dssp CEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEE-T------TEEEEECCCTTS----SSSCEEEECTTSC
T ss_pred CCcCCCCEeCCCCEEE---------CCCEEEEEcCCCcEEEEe-C------CEEEEECCcccC----CCCEEEEEeCCCC
Confidence 6999999999999994 589999999999998863 1 368999876532 2345678888998
Q ss_pred EEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 225 MYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
+.+.+.++..+..+.. .......+++|+.||+|++|.
T Consensus 62 Lvl~~~~~~~~W~S~t---~~~~~~~~~~L~ddGNlvly~ 98 (109)
T 3dzw_A 62 LVVYSPRNNPIWASNT---GGENGNYVCVLQKDRNVVIYG 98 (109)
T ss_dssp EEEECTTSCEEEECCC---CCSSSCEEEEECTTSCEEEEE
T ss_pred EEEECCCCCEEEECCC---CCCCCCEEEEEeCCCEEEEEC
Confidence 8887766655543322 112234789999999999985
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.51 E-value=6.5e-07 Score=76.77 Aligned_cols=98 Identities=19% Similarity=0.167 Sum_probs=73.4
Q ss_pred CccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccce
Q 038905 145 DTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGY 224 (709)
Q Consensus 145 DtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~~ 224 (709)
|||+|||.|..++.|+| |.|+|.|+.||+++++. . ..++|.+...+.. ..+..+.+..+|.
T Consensus 2 n~L~~g~~L~~g~~L~s---------g~y~l~~q~DgNLvly~-~------~~~vW~ant~~~~---~~~~~L~l~~dGn 62 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV---------EPYHFIMQDDCNLVLYD-H------STSTWASNTEIGG---KSGCSAVLQSDGN 62 (105)
T ss_dssp CEECTTEEECTTCEEEE---------TTEEEEECTTSCEEEEE-T------TEEEEECCCCCTT---CCSCEEEECTTSC
T ss_pred CCcCCCCEEcCCCEEEE---------CCEEEEECCCCeEEEEE-C------CEEEEEecCCCCC---CccEEEEEeCCcc
Confidence 89999999999999975 78999999999999873 2 4578987665321 2345678888998
Q ss_pred EEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 225 MYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
+.+.+.++..+.-+.. .....-.+++|..||+|.+|.
T Consensus 63 LvL~d~~~~~vWss~t---~~~~~~~~l~L~ddGNlVly~ 99 (105)
T 4h3o_A 63 FVVYDSSGRSLWASHS---TRGSGNYILILQDDGNVIIYG 99 (105)
T ss_dssp EEEECTTCCEEEECCC---CCCSSCEEEEECTTSCEEEEE
T ss_pred EEEECCCcEEEEEecC---CCCCCCEEEEEeCCCeEEEEC
Confidence 8888777766554322 122233678999999999883
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.50 E-value=7.8e-08 Score=99.82 Aligned_cols=170 Identities=16% Similarity=0.125 Sum_probs=108.9
Q ss_pred eEEEEEEcccccchhHHHHHHHHHHHhccC-cCc--eeEEEeEEEcCC---eEEEEEeecCCCCHHHHHhhCCCCChHHH
Q 038905 443 TVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKN--LVRLLGFCDEGQ---NRLLVYKFLNNGTLASFLFENLKPGWNLR 516 (709)
Q Consensus 443 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--lv~l~~~~~~~~---~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~ 516 (709)
..+++|+.... .....+.+|..++..+. +.. +++++....... ..++|||+++|..|...... .++..++
T Consensus 41 ~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~--~l~~~~~ 116 (304)
T 3sg8_A 41 RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN--NLPKQSQ 116 (304)
T ss_dssp TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH--TSCHHHH
T ss_pred CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc--cCCHHHH
Confidence 35788875432 34578899999998873 332 455655544333 34799999999888754432 3667777
Q ss_pred HHHHHHHHHHHHHhhhcC-------------------------------------------------------CCCeEec
Q 038905 517 ANIAFQIARGLLHLHVNC-------------------------------------------------------SSQIIHC 541 (709)
Q Consensus 517 ~~i~~~i~~al~~LH~~~-------------------------------------------------------~~~iiH~ 541 (709)
..++.++++.+..||... ...++|+
T Consensus 117 ~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~Hg 196 (304)
T 3sg8_A 117 NQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHN 196 (304)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECS
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeC
Confidence 888888888888888511 1358999
Q ss_pred CCCCCceeecC--CCCeEEccccccccccccccccceeccccCccccccccccc----CC-C---------CCcccchHH
Q 038905 542 DIKPQNILLDD--YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFR----NS-T---------ITANVDVYS 605 (709)
Q Consensus 542 Dlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~----~~-~---------~s~k~DvwS 605 (709)
|++|.||++++ ...+.|.||+.+..-............. .. .. |+... .. . .....+.|+
T Consensus 197 D~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~--~~-~~-~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~ 272 (304)
T 3sg8_A 197 DFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD--EE-YG-MEFVSKILNHYKHKDIPTVLEKYRMKEKYWS 272 (304)
T ss_dssp CCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT--TS-CC-HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHH
T ss_pred CCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc--cc-cC-HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHH
Confidence 99999999998 4568899999986532211110000000 00 11 22111 00 0 011258999
Q ss_pred HHHHHHHHHhCCCCC
Q 038905 606 FGVLLLEIISCRKSF 620 (709)
Q Consensus 606 lGvvl~elltg~~p~ 620 (709)
++.+++++.+|..++
T Consensus 273 l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 273 FEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHcCCHHH
Confidence 999999999998876
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=9.7e-07 Score=77.19 Aligned_cols=97 Identities=21% Similarity=0.236 Sum_probs=72.3
Q ss_pred CCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccc
Q 038905 144 TDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESG 223 (709)
Q Consensus 144 tDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~ 223 (709)
.|||+|||.|..++.|+ .|.|.|.|+.+|++.++. . ..++|.+..... ..+..+.+..+|
T Consensus 2 ~dtl~~gq~L~~g~~L~---------~g~~~L~~~~dgnlvly~--~-----~~~vW~sn~~~~----~~~~~l~l~~~G 61 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ---------AGAYTLTIQNKCNLVKYQ--N-----GRQIWASNTDRR----GSGCRLTLLSDG 61 (115)
T ss_dssp CCEEETTCEEETTEEEE---------ETTEEEEECTTSCEEEEE--T-----TEEEEECSCTTS----CSSCEEEECTTS
T ss_pred CCEeCCCCEECCCCEEE---------CCCEEEEEcCCCcEEEEe--C-----CEEEEeCCCCCC----CCceEEEECCCC
Confidence 59999999999999996 589999999999998763 2 468999876532 234567788899
Q ss_pred eEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEE
Q 038905 224 YMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQS 263 (709)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~ 263 (709)
.+.+.+.++..+.-++.. ......+++|+.||++++|
T Consensus 62 nLvl~d~~~~~vW~S~~~---~~~g~~~l~l~~dGnlvl~ 98 (115)
T 2dpf_A 62 NLVIYDHNNNDVWGSACW---GDNGKYALVLQKDGRFVIY 98 (115)
T ss_dssp CEEEECTTCCEEEECCCC---CSSSCCEEEECTTSCEEEE
T ss_pred cEEEECCCceEEEEcCCC---CCCCCEEEEEeCCCeEEEE
Confidence 888877666655444331 1122457999999999887
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.1e-06 Score=89.24 Aligned_cols=100 Identities=14% Similarity=0.243 Sum_probs=72.0
Q ss_pred hccccccCCCc----cccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCc
Q 038905 25 QTNGTVPVGST----LTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGS 100 (709)
Q Consensus 25 ~~~~~i~~g~~----l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~ 100 (709)
..+||+.+|+. |.. ++.|+| ...++-|+|...-.. .++++| |.+ ..+++|.+++. .+.. .
T Consensus 134 ~ptdtlLpg~~~~~~l~~---g~~L~S-~~dps~G~fsl~l~~--dGnlvL---y~~--~~~~yW~Sgt~---~~~~--~ 197 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAP---GSELVQ-GVVYGAGASKLVFQG--DGNLVA---YGP--NGAATWNAGTQ---GKGA--V 197 (276)
T ss_dssp CTTSCCCCSCTTCEEECS---SEEECT-TCEEEETTEEEEECT--TSCEEE---ECT--TSSEEEECCCT---TTTC--C
T ss_pred cccccccccccccccccc---Cccccc-CCCCCCceEEEeecC--CceEEE---EeC--CCeEEEECCCC---CCcc--E
Confidence 45689999999 766 577865 468888888753110 233444 432 25899999988 4432 6
Q ss_pred EEEEecCccEEEEcCCCcEEEeecc-------E--------EEeccCCceeeeecCC
Q 038905 101 QVKLTADQGLVLNDPQGKQVWSSKL-------I--------LVQSFSSSRLWDSFSN 142 (709)
Q Consensus 101 ~L~l~~~G~L~l~~~~g~~vWss~~-------~--------vl~~~~~~~lWQSFd~ 142 (709)
.|.+..+|+|++.|.++.++|++.. + |+++. .++||||||
T Consensus 198 ~l~l~~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 198 RAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp EEEECTTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred EEEEcCCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 8999999999999998899999851 1 44433 589999997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=98.36 E-value=1.9e-06 Score=75.00 Aligned_cols=97 Identities=26% Similarity=0.271 Sum_probs=71.0
Q ss_pred CCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccc
Q 038905 144 TDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESG 223 (709)
Q Consensus 144 tDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~ 223 (709)
||||+|||.|..+..|. .|.|.|.|+.+|++.++. + ..++|.+..... ..+..+.+..+|
T Consensus 1 tdtl~~gq~L~~g~~L~---------~~~~~L~~~~dgnlvl~~-~------~~~vW~sn~~~~----~~~~~l~l~~~G 60 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSLA---------EGGYLFIIQNDCNLVLYD-N------NRAVWASGTNGK----ASGCVLKMQNDG 60 (112)
T ss_dssp CCEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEE-T------TEEEEECCCTTS----CSSEEEEECTTS
T ss_pred CCCCCCCCEECCCCEEe---------CCCEEEEEcCCCcEEEEE-C------CEEEEeCCCcCC----CCCEEEEEeCCC
Confidence 79999999999999993 578999999999998762 2 368999876431 234567788888
Q ss_pred eEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 224 YMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
.+.+.+ ++..+.-++... .....+++|+.||++++|.
T Consensus 61 NLvl~d-~~~~~W~S~~~~---~~g~~~l~l~~dGnlvl~~ 97 (112)
T 1xd5_A 61 NLVIYS-GSRAIWASNTNR---QNGNYYLILQRDRNVVIYD 97 (112)
T ss_dssp CEEEEE-TTEEEEECCCCC---SCCCCEEEECTTSCEEEEC
T ss_pred CEEEEc-CCEEEEECCccC---CCCCEEEEEeCCCcEEEEC
Confidence 887776 565554444321 1223579999999988764
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.22 E-value=6.7e-06 Score=81.73 Aligned_cols=72 Identities=24% Similarity=0.380 Sum_probs=55.8
Q ss_pred CcEEEEecCccEEEEcCCCcEEEeecc---------------EEEeccCCceeeeecCCCCCccCCCcccCCCceEEecC
Q 038905 99 GSQVKLTADQGLVLNDPQGKQVWSSKL---------------ILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGK 163 (709)
Q Consensus 99 ~~~L~l~~~G~L~l~~~~g~~vWss~~---------------~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~ 163 (709)
..+|.+..+|+|+|.+. +++||+++. .||+|.++.++|+|+.+
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~--------------------- 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTK--------------------- 84 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCC---------------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcc---------------------
Confidence 35677778899999885 789999751 18888888999999875
Q ss_pred CCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccc
Q 038905 164 SDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTY 205 (709)
Q Consensus 164 s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~ 205 (709)
.++|.|.+.|+.+|+++++ . ..||.+..+
T Consensus 85 ----~~~~~~~~~l~d~Gnlvl~--~-------~~~W~S~~~ 113 (236)
T 1dlp_A 85 ----GSIGNYVLVLQPDRTVTIY--G-------PGLWDSGTS 113 (236)
T ss_dssp ----CCSSCCEEEECSSSCEEEE--C-------SEEEECSCC
T ss_pred ----ccCCcEEEEEeCCCCEEEe--c-------CCEEECCCC
Confidence 1356789999999999886 1 268887665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=1.8e-05 Score=80.12 Aligned_cols=120 Identities=18% Similarity=0.136 Sum_probs=87.7
Q ss_pred CCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHH
Q 038905 440 TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN 518 (709)
Q Consensus 440 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~ 518 (709)
..+..+++|+... ....++.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++.+..... ......
T Consensus 48 ~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~ 120 (272)
T 4gkh_A 48 PNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGEN 120 (272)
T ss_dssp TTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHH
T ss_pred CCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHH
Confidence 4566788887543 24567889999998875 445788999999999999999999998877655321 223345
Q ss_pred HHHHHHHHHHHhhhc-------------------------------------------------------CCCCeEecCC
Q 038905 519 IAFQIARGLLHLHVN-------------------------------------------------------CSSQIIHCDI 543 (709)
Q Consensus 519 i~~~i~~al~~LH~~-------------------------------------------------------~~~~iiH~Dl 543 (709)
+..+++..|..||.. ....++|+|+
T Consensus 121 ~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl 200 (272)
T 4gkh_A 121 IVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDF 200 (272)
T ss_dssp HHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCC
T ss_pred HHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCC
Confidence 556666666666621 0123799999
Q ss_pred CCCceeecCCCCeEEcccccccc
Q 038905 544 KPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 544 kp~NIll~~~~~~kl~DFGla~~ 566 (709)
.+.|||++.++.+-|.||+.+..
T Consensus 201 ~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 201 SLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCeEEEECCeEEEEEECccccc
Confidence 99999999887778999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=2.7e-05 Score=80.65 Aligned_cols=120 Identities=19% Similarity=0.218 Sum_probs=82.7
Q ss_pred eEEEEEEcccccchhHHHHHHHHHHHhccCcC---ceeEEEeEEE-cCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHH
Q 038905 443 TVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHK---NLVRLLGFCD-EGQNRLLVYKFLNNGTLASFLFENLKPGWNLRAN 518 (709)
Q Consensus 443 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nlv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~ 518 (709)
..+++|+-.. ......+.+|..+|..+.+. .+++++.+.. .....++||||++|..|...... .++...+..
T Consensus 40 ~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~--~l~~~~~~~ 115 (306)
T 3tdw_A 40 GDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA--VLPDDAKDR 115 (306)
T ss_dssp TTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT--TSCHHHHHH
T ss_pred CEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh--hCCHHHHHH
Confidence 4467777432 23457899999999998752 3667777764 45567899999999888764322 234445555
Q ss_pred HHHHHHHHHHHhhhc---------------------------------------------------------CCCCeEec
Q 038905 519 IAFQIARGLLHLHVN---------------------------------------------------------CSSQIIHC 541 (709)
Q Consensus 519 i~~~i~~al~~LH~~---------------------------------------------------------~~~~iiH~ 541 (709)
++.++++.|..||.. ....++|+
T Consensus 116 ~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~Hg 195 (306)
T 3tdw_A 116 LALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHG 195 (306)
T ss_dssp HHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECS
T ss_pred HHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeC
Confidence 555555555555531 23357999
Q ss_pred CCCCCceeecC---CCCe-EEcccccccc
Q 038905 542 DIKPQNILLDD---YYNA-QISDFGLAKL 566 (709)
Q Consensus 542 Dlkp~NIll~~---~~~~-kl~DFGla~~ 566 (709)
|+++.||+++. ++.+ .|.||+.+..
T Consensus 196 D~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 196 DLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred CCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 99999999987 4554 8999998864
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=3.9e-05 Score=66.28 Aligned_cols=98 Identities=18% Similarity=0.131 Sum_probs=71.5
Q ss_pred CCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccc
Q 038905 144 TDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESG 223 (709)
Q Consensus 144 tDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~ 223 (709)
||||.|||.|..+..|+ . .|.|.|.|+.+|++.++- . ..+.|.+..... ..+..+.+..+|
T Consensus 1 ~d~l~~g~~L~~g~~l~-~-------~~~~~l~~~~dGnlvl~~-~------~~~vW~sn~~~~----~~~~~l~l~~dG 61 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-V-------GPSYRLIMQGDCNFVLYD-S------GKPVWASNTGGL----GSGCRLTLHNNG 61 (110)
T ss_dssp CCEEETTCEECTTCEEE-E-------TTTEEEEECTTSCEEEEE-T------TEEEEECCCTTS----CSSCEEEECTTS
T ss_pred CCEeCCCCEECCCCEEE-E-------CCCEEEEEcCCCcEEEEE-C------CEEEEECCCCCC----CCcEEEEEeCCC
Confidence 79999999999999997 2 578999999999998773 2 467898776421 233467777888
Q ss_pred eEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEE
Q 038905 224 YMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQS 263 (709)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~ 263 (709)
.+.+.+.++..+..++... . .-..++.|+.||++.+|
T Consensus 62 NLVl~~~~~~~~W~S~t~~--~-~g~~~l~l~~dGnlvl~ 98 (110)
T 3a0c_A 62 NLVIYDQSNRVIWQTKTNG--K-EDHYVLVLQQDRNVVIY 98 (110)
T ss_dssp CEEEECTTCCEEEECCCCC--S-SSCCEEEECTTSCEEEE
T ss_pred CEEEECCCCcEEEecCCCC--C-CCCEEEEEeCCccEEEE
Confidence 8877776666665554321 1 12347889999998775
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=97.95 E-value=6.4e-05 Score=65.85 Aligned_cols=100 Identities=14% Similarity=0.071 Sum_probs=72.8
Q ss_pred CCccCCCcccCCCceEE--ecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecc
Q 038905 144 TDTLLPGKMMETEQGLF--SGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNE 221 (709)
Q Consensus 144 tDtlLpgq~l~~~~~L~--S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~ 221 (709)
+|||.|||.|..+..|+ | ..|.|.|.|+.+|++.++. . ..+.|.+..... ..+..+.+..
T Consensus 8 ~~~l~~g~~L~~g~~l~~~S-------~~g~~~L~~~~dgnlvly~--~-----~~~vW~sn~~~~----~~~~~l~l~~ 69 (119)
T 1b2p_A 8 QPDDNHPQILHATESLEILF-------GTHVYRFIMQTDCNLVLYD--N-----NNPIWATNTGGL----GNGCRAVLQP 69 (119)
T ss_dssp CSSSCCCCEEETTCEEEEEE-------TTEEEEEEECTTSCEEEEE--T-----TEEEEECCCTTS----CSSCEEEECT
T ss_pred CcccCCCCEEcCCCEEEEeC-------CCCCEEEEEecCCCEEEEE--C-----CEEEEeCCCccC----CCceEEEEcc
Confidence 68999999999999999 5 4799999999999987652 2 357898765421 2335677788
Q ss_pred cceEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 222 SGYMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
+|.+.+.+.++..+.-++... .. -..++.|+.||++.+|.
T Consensus 70 dGNLVl~d~~~~~lW~S~~~~--~~-g~~~l~l~~~Gnlvl~~ 109 (119)
T 1b2p_A 70 DGVLVVITNENVTVWQSPVAG--KA-GHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp TSCEEEECTTCCEEEECSCCC--CS-SCEEEEECTTSCEEEEE
T ss_pred CCEEEEEeCCCcEEEcCCCCC--CC-CCEEEEEECCCcEEEEC
Confidence 888877776666665554321 11 13578999999988764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=3.6e-05 Score=81.42 Aligned_cols=83 Identities=5% Similarity=-0.023 Sum_probs=51.4
Q ss_pred eee-cCeeEEEEEEEEEEe--cCC-CceEEEEEEccccc---chhHHHHHHHHHHHhccCc---CceeEEEeEEEcC---
Q 038905 420 VLL-GSSVFVNFTLVGVIQ--TST-RTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYH---KNLVRLLGFCDEG--- 486 (709)
Q Consensus 420 ~~~-G~g~~~~v~~~~~~~--~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~nlv~l~~~~~~~--- 486 (709)
..+ ++|....+|...... .+. .+..+++|...... ......+.+|+.++..+.. ..+++++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 344 556555565443320 000 25678888765422 0012467889998888853 3577888887665
Q ss_pred CeEEEEEeecCCCCHH
Q 038905 487 QNRLLVYKFLNNGTLA 502 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~ 502 (709)
...++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.002 Score=67.14 Aligned_cols=31 Identities=23% Similarity=0.267 Sum_probs=28.4
Q ss_pred CCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888899999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0018 Score=66.87 Aligned_cols=77 Identities=17% Similarity=0.150 Sum_probs=56.0
Q ss_pred ceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC---cCceeEEEeEEEcCCeEEEEE
Q 038905 417 TRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY---HKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 417 ~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.....+++|....+|.... .+..+++|..... ....+..|...|+.+. ...+++++.++......++||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-----EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-----SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE-----CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3455666776665654432 3567888886532 3567899999988884 356889999988888899999
Q ss_pred eecCCCCH
Q 038905 494 KFLNNGTL 501 (709)
Q Consensus 494 Ey~~~gsL 501 (709)
||+++..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0028 Score=67.86 Aligned_cols=75 Identities=8% Similarity=-0.044 Sum_probs=43.2
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-------hhHHHHHHHHHHHhccCc---CceeEEEeEEEcCCeE
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-------DGEKEFKNEVVMIGQTYH---KNLVRLLGFCDEGQNR 489 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h---~nlv~l~~~~~~~~~~ 489 (709)
..+|+|....||.+... ..+..++||....... ...+++..|.+++..+.. ..+++++.+ +.+..
T Consensus 36 ~~lg~G~~n~vyrv~~~---~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQ---EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EECCCCceEEEEEEEEC---CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 35566666656444322 2356789997542111 123456788888887742 345566654 34456
Q ss_pred EEEEeecCCC
Q 038905 490 LLVYKFLNNG 499 (709)
Q Consensus 490 ~lV~Ey~~~g 499 (709)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0039 Score=67.34 Aligned_cols=77 Identities=10% Similarity=0.068 Sum_probs=46.6
Q ss_pred CCCeEecCCCCCceeecCCCCeEEccccccccccccccccceecccc--CcccccccccccCCC---CCcccchHHHHHH
Q 038905 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRG--TKGYVASPEWFRNST---ITANVDVYSFGVL 609 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G--t~~y~aaPE~~~~~~---~s~k~DvwSlGvv 609 (709)
...++|+|+++.|||++.++ ++|.||+.+..-...... ..... ...|++ |+...... -....++......
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 305 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFA-QDGHATQENDRKEYKQWILRTIEQ 305 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHH-GGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHh-cccccccccchHHHHHHHHHHHHH
Confidence 67899999999999998876 999999998753321111 11111 123454 55443111 1123455577777
Q ss_pred HHHHHhC
Q 038905 610 LLEIISC 616 (709)
Q Consensus 610 l~elltg 616 (709)
+++...+
T Consensus 306 ~~~~y~~ 312 (420)
T 2pyw_A 306 TWNLFNK 312 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7777654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.33 E-value=0.011 Score=56.69 Aligned_cols=101 Identities=13% Similarity=0.004 Sum_probs=66.5
Q ss_pred CHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccccceec
Q 038905 500 TLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKA 578 (709)
Q Consensus 500 sL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 578 (709)
+|.+.|...+ ++++++.+.++.|.+.+|.-+-. ++.-..+=+-|..|+|..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 7889887654 79999999999999999877621 11111233457899999999998763 1110
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p 619 (709)
.....+.+ ||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 -~~~~~~~~-pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVA-GKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCC-hhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 01122445 88764 4556788999999999998865444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.035 Score=56.26 Aligned_cols=78 Identities=15% Similarity=0.118 Sum_probs=49.5
Q ss_pred cceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCc---CceeEEEeEEEcCCeEEEE
Q 038905 416 VTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH---KNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 416 f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nlv~l~~~~~~~~~~~lV 492 (709)
+.....+|+|....|| +-.+ .+++.++||+...........|..|...|+.|.- ..+++++++. ..++|
T Consensus 17 v~~v~~~g~G~~~~vy-rv~l---~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLY-RVEL---ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp EEEEEEEEEETTEEEE-EEEE---TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred eEEEEecCCCCCeEEE-EEEE---CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 3344445555555554 4445 4678899998765433344568899998888742 2355666543 24789
Q ss_pred EeecCCCCH
Q 038905 493 YKFLNNGTL 501 (709)
Q Consensus 493 ~Ey~~~gsL 501 (709)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0097 Score=63.08 Aligned_cols=120 Identities=18% Similarity=0.247 Sum_probs=71.7
Q ss_pred ceEEEEEEcccccchhHHHHHHHHHHHhccCcCc-eeEEEeEEEcCCeEEEEEeecCCCCHHHH--------------Hh
Q 038905 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKN-LVRLLGFCDEGQNRLLVYKFLNNGTLASF--------------LF 506 (709)
Q Consensus 442 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-lv~l~~~~~~~~~~~lV~Ey~~~gsL~~~--------------l~ 506 (709)
...+++|+.... ......+.+|..+++.+.-.. -.++++++.++ +||||++|..|..- |.
T Consensus 82 ~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La 156 (379)
T 3feg_A 82 PREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMA 156 (379)
T ss_dssp CSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHH
T ss_pred CCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHH
Confidence 467888886332 234566778999988875322 35777776542 89999998654311 00
Q ss_pred --hCC------CCC--hHHHHHHHHHHHH-------------------HHHHhh----h-cCCCCeEecCCCCCceeecC
Q 038905 507 --ENL------KPG--WNLRANIAFQIAR-------------------GLLHLH----V-NCSSQIIHCDIKPQNILLDD 552 (709)
Q Consensus 507 --~~~------~l~--~~~~~~i~~~i~~-------------------al~~LH----~-~~~~~iiH~Dlkp~NIll~~ 552 (709)
+.. ... +.+..++..++.. .+..|. . .....++|+|+.+.||+++.
T Consensus 157 ~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~ 236 (379)
T 3feg_A 157 QFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLS 236 (379)
T ss_dssp HHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEES
T ss_pred HHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcC
Confidence 011 111 2333334333221 122222 1 12346899999999999987
Q ss_pred C----CCeEEcccccccc
Q 038905 553 Y----YNAQISDFGLAKL 566 (709)
Q Consensus 553 ~----~~~kl~DFGla~~ 566 (709)
+ +.+.|+||..+..
T Consensus 237 ~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 237 EPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CC---CCEEECCCTTCEE
T ss_pred CCCccCcEEEEecccCCc
Confidence 6 7899999999863
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.15 E-value=0.0081 Score=61.50 Aligned_cols=31 Identities=26% Similarity=0.317 Sum_probs=26.1
Q ss_pred CCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 6677889999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.10 E-value=0.007 Score=62.54 Aligned_cols=141 Identities=12% Similarity=0.068 Sum_probs=74.4
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCc--eeEEEeE------EEcCCeEE
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKN--LVRLLGF------CDEGQNRL 490 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--lv~l~~~------~~~~~~~~ 490 (709)
...+++|....+|..... .+ .+++|..... ...+++..|+.++..+.... +++++.. ....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~----~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT----KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEES----SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeC----Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 345556655556554332 22 5778887642 12235667887777764222 2333321 12235678
Q ss_pred EEEeecCCCCHHH--------------HHhhC-CC--------CC---hHHHHH------------HHHHHHHHHHHhhh
Q 038905 491 LVYKFLNNGTLAS--------------FLFEN-LK--------PG---WNLRAN------------IAFQIARGLLHLHV 532 (709)
Q Consensus 491 lV~Ey~~~gsL~~--------------~l~~~-~~--------l~---~~~~~~------------i~~~i~~al~~LH~ 532 (709)
+|++|++|..+.. .++.. .. .. |..... +...+.+.+..++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999999865321 01110 00 01 111000 01113344455543
Q ss_pred c----CCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 533 N----CSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 533 ~----~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
. ....++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 2 135799999999999999876668999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.09 E-value=0.014 Score=63.14 Aligned_cols=76 Identities=11% Similarity=0.148 Sum_probs=44.2
Q ss_pred eeecCeeEEEEEEEEEEec----CCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCce-eEEEeEEEcCCeEEEEEe
Q 038905 420 VLLGSSVFVNFTLVGVIQT----STRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNL-VRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nl-v~l~~~~~~~~~~~lV~E 494 (709)
..+++|....+|.+..... +.....+++|+.... ...+.+.+|..++..+...++ +++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3445555555555543210 012467888887432 122456689999888864444 577776643 28999
Q ss_pred ecCCCCH
Q 038905 495 FLNNGTL 501 (709)
Q Consensus 495 y~~~gsL 501 (709)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.07 E-value=0.023 Score=58.96 Aligned_cols=32 Identities=31% Similarity=0.336 Sum_probs=27.9
Q ss_pred CCCeEecCCCCCceeecCC----CCeEEcccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDY----YNAQISDFGLAKL 566 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~----~~~kl~DFGla~~ 566 (709)
...++|+|+.+.||+++.+ ..+.|.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999875 6789999999864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.83 E-value=0.032 Score=60.68 Aligned_cols=73 Identities=11% Similarity=0.146 Sum_probs=41.0
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCce-eEEEeEEEcCCeEEEEEeecCCC
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNL-VRLLGFCDEGQNRLLVYKFLNNG 499 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nl-v~l~~~~~~~~~~~lV~Ey~~~g 499 (709)
.+++|..-.+|.+... .....+++|+...... ......+|..++..|...++ +++++.+. + .+||||++|.
T Consensus 115 ~lsgG~tN~~y~v~~~---~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 115 IINGGITNILIKVKDM---SKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EECC--CEEEEEEEET---TTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EcCCCeEeEEEEEEEC---CCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 4455555555544332 1236778887643221 11122588888888865444 57777763 2 2599999885
Q ss_pred CH
Q 038905 500 TL 501 (709)
Q Consensus 500 sL 501 (709)
.|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.23 E-value=0.033 Score=58.70 Aligned_cols=31 Identities=19% Similarity=0.355 Sum_probs=25.5
Q ss_pred CCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++|+|+.+.|||++++. +.|+||..+..
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 34689999999999998655 89999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.76 E-value=0.089 Score=54.19 Aligned_cols=30 Identities=23% Similarity=0.217 Sum_probs=25.9
Q ss_pred CCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
...++|+|+++.|||++ + .+.|.||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 45689999999999999 4 899999998753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.62 E-value=0.19 Score=53.92 Aligned_cols=30 Identities=20% Similarity=0.402 Sum_probs=26.7
Q ss_pred CCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 536 SQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 536 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 46899999999999 8888999999999864
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=86.78 E-value=0.41 Score=37.95 Aligned_cols=33 Identities=18% Similarity=0.503 Sum_probs=28.9
Q ss_pred CCCCHHHHHHHhccCCceEEEEEe--CCcccccCC
Q 038905 337 RPYDEVQCKNNCLSDCFCVVAIFR--GDSCWSKKL 369 (709)
Q Consensus 337 ~~~~~~~C~~~Cl~nC~C~a~~~~--~~~C~~~~~ 369 (709)
..+++++|++.|+.+=.|.+|.|. ...|+++..
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 457899999999999999999997 678998754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.62 E-value=3.4 Score=39.36 Aligned_cols=115 Identities=10% Similarity=0.104 Sum_probs=77.7
Q ss_pred CcCceeEEEeEEEcCCeEEEEEeecCC-CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee
Q 038905 472 YHKNLVRLLGFCDEGQNRLLVYKFLNN-GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550 (709)
Q Consensus 472 ~h~nlv~l~~~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll 550 (709)
.||+++.. .+-.+.+...+.|+.-+. -++.. + ..++...+++++.+|+....+++ .-+|--|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEE
Confidence 58888865 456666777777776542 23333 2 23778889999999998876665 45788999999999
Q ss_pred cCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 038905 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621 (709)
Q Consensus 551 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~ 621 (709)
+.++.+++.--|+...+. |. ..+...=+-.+=+++..+++++..|+
T Consensus 113 ~~~~~p~i~~RGik~~l~--------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVD--------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTTBS--------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccCCC--------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999997666532221 21 11112223356678888888887773
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.36 E-value=5.9 Score=37.83 Aligned_cols=82 Identities=13% Similarity=0.119 Sum_probs=60.2
Q ss_pred CcCceeEEEeEEEcCCeEEEEEeecCCC-CHHHHHhhCCCCChHHHHHHHHHHHHHHH-HhhhcCCCCeEecCCCCCcee
Q 038905 472 YHKNLVRLLGFCDEGQNRLLVYKFLNNG-TLASFLFENLKPGWNLRANIAFQIARGLL-HLHVNCSSQIIHCDIKPQNIL 549 (709)
Q Consensus 472 ~h~nlv~l~~~~~~~~~~~lV~Ey~~~g-sL~~~l~~~~~l~~~~~~~i~~~i~~al~-~LH~~~~~~iiH~Dlkp~NIl 549 (709)
.||++ -..+-.+.+...+.|+.-+++ ++.. + ..++...+++++.+|+.... +++ .-+|--|.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i---~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I---RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H---HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H---HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 57777 333446777888888765443 3332 3 24788899999999888766 555 5688899999999
Q ss_pred ecCCCCeEEcccccc
Q 038905 550 LDDYYNAQISDFGLA 564 (709)
Q Consensus 550 l~~~~~~kl~DFGla 564 (709)
++.++.++|.-.|+-
T Consensus 117 f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 117 FNRALEPFFLHVGVK 131 (219)
T ss_dssp ECTTCCEEESCCEET
T ss_pred EeCCCcEEEEEcCCc
Confidence 999999999766653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 709 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-30 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-12 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-05 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-04 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-52
Identities = 54/257 (21%), Positives = 106/257 (41%), Gaps = 20/257 (7%)
Query: 438 TSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497
+ + + + FKNEV ++ +T H N++ +G+ Q +V ++
Sbjct: 28 KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCE 86
Query: 498 NGTLASFLF-ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
+L L K +IA Q A+G+ +LH IIH D+K NI L +
Sbjct: 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTV 143
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEI 613
+I DFGLA + + + + G+ ++A PE R + + DVY+FG++L E+
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMA-PEVIRMQDKNPYSFQSDVYAFGIVLYEL 202
Query: 614 ISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQ 673
++ + + + + Y + L + C + + + C++
Sbjct: 203 MTGQLPYSNINNRD--QIIFMVGRGYLSPDLSKVRSN---------CPKAMKRLMAECLK 251
Query: 674 EDPSLRPTMRKVSQMLE 690
+ RP ++ +E
Sbjct: 252 KKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-47
Identities = 67/253 (26%), Positives = 112/253 (44%), Gaps = 24/253 (9%)
Query: 440 TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
T + VK L + F E ++ Q H+ LVRL + ++ +++ NG
Sbjct: 35 NGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENG 92
Query: 500 TLASFLF--ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
+L FL +K N ++A QIA G+ + IH D++ NIL+ D + +
Sbjct: 93 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCK 149
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
I+DFGLA+L+ N+ A ++ + + A PE T T DV+SFG+LL EI++
Sbjct: 150 IADFGLARLIEDNEYTA-REGAKFPIKWTA-PEAINYGTFTIKSDVWSFGILLTEIVTHG 207
Query: 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPS 677
+ + N ++ +E + C E+L + C +E P
Sbjct: 208 RIP---------------YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 252
Query: 678 LRPTMRKVSQMLE 690
RPT + +LE
Sbjct: 253 DRPTFDYLRSVLE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 9e-47
Identities = 59/261 (22%), Positives = 107/261 (40%), Gaps = 25/261 (9%)
Query: 434 GVIQTSTRTTVIVVKKLDRVFQDGE-KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492
GV + + + +K L + + + +E E ++ Q + +VRL+G C + + +LV
Sbjct: 28 GVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 86
Query: 493 YKFLNNGTLASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
+ G L FL + + A + Q++ G+ +L +H D+ +N+LL
Sbjct: 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLV 143
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKK-AIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+ + A+ISDFGL+K L + S + A + + A PE ++ DV+S+GV +
Sbjct: 144 NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA-PECINFRKFSSRSDVWSYGVTM 202
Query: 611 LEIISCRKS-FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSI 669
E +S + + G E GK + C +L +
Sbjct: 203 WEALSYGQKPYKKMKGPE-------VMAFIEQGKRMECPPE---------CPPELYALMS 246
Query: 670 WCIQEDPSLRPTMRKVSQMLE 690
C RP V Q +
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMR 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (419), Expect = 9e-47
Identities = 56/263 (21%), Positives = 115/263 (43%), Gaps = 24/263 (9%)
Query: 437 QTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKF 495
R + +K L + + ++F +E ++GQ H N++ L G + +++ +F
Sbjct: 49 LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEF 108
Query: 496 LNNGTLASFLFENLKPG-WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
+ NG+L SFL +N + IA G+ +L +H D+ +NIL++
Sbjct: 109 MENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNL 165
Query: 555 NAQISDFGLAKLLTLNQSKAIKKA---IRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611
++SDFGL++ L + S + + + A PE + T+ DV+S+G+++
Sbjct: 166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA-PEAIQYRKFTSASDVWSYGIVMW 224
Query: 612 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
E++S + + N + + +E D + C L + + C
Sbjct: 225 EVMSYGERP---------------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDC 269
Query: 672 IQEDPSLRPTMRKVSQMLEVVVE 694
Q+D + RP ++ L+ ++
Sbjct: 270 WQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-45
Identities = 57/260 (21%), Positives = 103/260 (39%), Gaps = 23/260 (8%)
Query: 434 GVIQTSTRTTVIVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
G Q + VK L D E E ++ Q + +VR++G C E ++ +L
Sbjct: 26 GYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 84
Query: 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
V + G L +L +N + Q++ G+ +L + +H D+ +N+LL
Sbjct: 85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLV 141
Query: 552 DYYNAQISDFGLAKLLTLNQSKA-IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+ A+ISDFGL+K L +++ + + + A PE ++ DV+SFGVL+
Sbjct: 142 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA-PECINYYKFSSKSDVWSFGVLM 200
Query: 611 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIW 670
E S + + + ++ ++E C ++ +
Sbjct: 201 WEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 245
Query: 671 CIQEDPSLRPTMRKVSQMLE 690
C D RP V L
Sbjct: 246 CWTYDVENRPGFAAVELRLR 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 52/255 (20%), Positives = 103/255 (40%), Gaps = 22/255 (8%)
Query: 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
+ +K + E++F E ++ + H LV+L G C E LV++F+ +G
Sbjct: 28 NKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86
Query: 501 LASFLFENLKPG-WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
L+ +L + + G+ +L C +IH D+ +N L+ + ++S
Sbjct: 87 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVS 143
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFG+ + + +Q + + + PE F S ++ DV+SFGVL+ E+ S K
Sbjct: 144 DFGMTRFVLDDQYT-SSTGTKFPVKWAS-PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201
Query: 620 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLR 679
++ N ++ + + + + C +E P R
Sbjct: 202 P---------------YENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246
Query: 680 PTMRKVSQMLEVVVE 694
P ++ + L + E
Sbjct: 247 PAFSRLLRQLAEIAE 261
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-45
Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 29/253 (11%)
Query: 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL-LVYKFLNNG 499
R + VK + + F E ++ Q H NLV+LLG E + L +V +++ G
Sbjct: 29 RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86
Query: 500 TLASFLFENLKP--GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
+L +L + G + + + + +L + +H D+ +N+L+ + A+
Sbjct: 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 143
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
+SDFGL K + Q + + A PE R + DV+SFG+LL EI S
Sbjct: 144 VSDFGLTKEASSTQDTG-----KLPVKWTA-PEALREKKFSTKSDVWSFGILLWEIYSFG 197
Query: 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPS 677
+ + + G D +G C + V C D +
Sbjct: 198 RVPYPRIPLK------DVVPRVEKGYKMDAPDG---------CPPAVYEVMKNCWHLDAA 242
Query: 678 LRPTMRKVSQMLE 690
+RP+ ++ + LE
Sbjct: 243 MRPSFLQLREQLE 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-45
Identities = 47/250 (18%), Positives = 98/250 (39%), Gaps = 22/250 (8%)
Query: 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
+ +K + E EF E ++ H+ LV+L G C + + ++ +++ NG L
Sbjct: 28 QYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86
Query: 502 ASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD 560
++L E + + + +L +H D+ +N L++D ++SD
Sbjct: 87 LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSD 143
Query: 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
FGL++ + + + + PE S ++ D+++FGVL+ EI S K
Sbjct: 144 FGLSRYVL-DDEYTSSVGSKFPVRWSP-PEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-- 199
Query: 621 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680
++ + N + + + + EK+ + C E RP
Sbjct: 200 -------------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERP 246
Query: 681 TMRKVSQMLE 690
T + + +
Sbjct: 247 TFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 50/272 (18%), Positives = 96/272 (35%), Gaps = 25/272 (9%)
Query: 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL----LVYKFL 496
R + VK ++ + E+ H+N++ + ++ LV +
Sbjct: 25 RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83
Query: 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNC-----SSQIIHCDIKPQNILLD 551
+G+L +L +A A GL HLH+ I H D+K +NIL+
Sbjct: 84 EHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 142
Query: 552 DYYNAQISDFGLAKLL--TLNQSKAIKKAIRGTKGYVASPEWFRNS------TITANVDV 603
I+D GLA + GTK Y+A PE +S D+
Sbjct: 143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA-PEVLDDSINMKHFESFKRADI 201
Query: 604 YSFGVLLLEIISCRKSFDIEMGEEY----AILTDWAFDCYRNGKLDDLVEGDM-EAMNDI 658
Y+ G++ EI I + + +D + + R + + ++
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261
Query: 659 KCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ + + + C + + R T ++ + L
Sbjct: 262 EALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 56/270 (20%), Positives = 113/270 (41%), Gaps = 24/270 (8%)
Query: 436 IQTSTRTTVIVVKKLDRVFQDGE-KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR-LLVY 493
+ + VK L+R+ GE +F E +++ H N++ LLG C + L+V
Sbjct: 49 LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108
Query: 494 KFLNNGTLASFLF-ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD 552
++ +G L +F+ E P Q+A+G+ S + +H D+ +N +LD+
Sbjct: 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDE 165
Query: 553 YYNAQISDFGLAKLLTLNQSKAI--KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+ +++DFGLA+ + + ++ K + ++A E + T DV+SFGVLL
Sbjct: 166 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA-LESLQTQKFTTKSDVWSFGVLL 224
Query: 611 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIW 670
E+++ ++ D + +L C + L V +
Sbjct: 225 WELMTRGAPPYPDVNTF-----DITVYLLQGRRLLQ----------PEYCPDPLYEVMLK 269
Query: 671 CIQEDPSLRPTMRKVSQMLEVVVEVDVPPN 700
C +RP+ ++ + + + +
Sbjct: 270 CWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 64/280 (22%), Positives = 112/280 (40%), Gaps = 39/280 (13%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDR-VFQDGEKEFKNEVVMIGQ-TYHKNLVRLLGFCDEGQN 488
T G+I++ TV VK L + +E+ ++ H N+V LLG C G
Sbjct: 43 TAYGLIKSDAAMTV-AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101
Query: 489 RLLVYKFLNNGTLASFLFENLKPG------------------WNLRANIAFQIARGLLHL 530
L++ ++ G L +FL + ++Q+A+G+ L
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 531 HVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPE 590
S IH D+ +NILL +I DFGLA+ + + + +K R ++A PE
Sbjct: 162 A---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA-PE 217
Query: 591 WFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650
N T DV+S+G+ L E+ S S + K +++
Sbjct: 218 SIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYPGMPVDSKFYKMIKE 263
Query: 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
++ ++ + C DP RPT +++ Q++E
Sbjct: 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 6e-44
Identities = 58/277 (20%), Positives = 109/277 (39%), Gaps = 44/277 (15%)
Query: 443 TVIVVKKLDR-VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
T++ VK L D + +F+ E ++ + + N+V+LLG C G+ L+++++ G L
Sbjct: 44 TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 103
Query: 502 ASFLFENLKPG------------------------WNLRANIAFQIARGLLHLHVNCSSQ 537
FL + IA Q+A G+ +L +
Sbjct: 104 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERK 160
Query: 538 IIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI 597
+H D+ +N L+ + +I+DFGL++ + ++ PE +
Sbjct: 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP-PESIFYNRY 219
Query: 598 TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657
T DV+++GV+L EI S M E R+G + E
Sbjct: 220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHE------EVIYYVRDGNILACPEN------- 266
Query: 658 IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694
C +L + C + P+ RP+ + ++L+ + E
Sbjct: 267 --CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 7e-44
Identities = 59/251 (23%), Positives = 108/251 (43%), Gaps = 24/251 (9%)
Query: 442 TTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
TT + +K L + F E ++ + H+ LV+L + +V ++++ G+L
Sbjct: 41 TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSL 98
Query: 502 ASFLFENLKP--GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
FL ++A QIA G+ ++ +H D++ NIL+ + +++
Sbjct: 99 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 155
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFGLA+L+ N+ A ++ + + A PE T DV+SFG+LL E+ + +
Sbjct: 156 DFGLARLIEDNEYTA-RQGAKFPIKWTA-PEAALYGRFTIKSDVWSFGILLTELTTKGRV 213
Query: 620 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLR 679
+ N ++ D VE +C E L + C +++P R
Sbjct: 214 P---------------YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 258
Query: 680 PTMRKVSQMLE 690
PT + LE
Sbjct: 259 PTFEYLQAFLE 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 7e-44
Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 42/284 (14%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQ-TYHKNLVRLLGFCDEGQNR 489
T G+ +T V V ++ + +E+ M+ Q H+N+V LLG C
Sbjct: 57 TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116
Query: 490 LLVYKFLNNGTLASFLFENLKPG-----------------------WNLRANIAFQIARG 526
L++++ G L ++L + + A+Q+A+G
Sbjct: 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 176
Query: 527 LLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYV 586
+ L +H D+ +N+L+ +I DFGLA+ + + + ++ R ++
Sbjct: 177 MEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM 233
Query: 587 ASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646
A PE T DV+S+G+LL EI S + + +
Sbjct: 234 A-PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY--------------K 278
Query: 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690
L++ + E++ ++ C D RP+ ++ L
Sbjct: 279 LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 52/257 (20%), Positives = 100/257 (38%), Gaps = 21/257 (8%)
Query: 436 IQTSTRTTVIV-VKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493
I + + V +K+L KE +E ++ + ++ RLLG C +L+
Sbjct: 31 IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQ 90
Query: 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY 553
L G N QIA+G+ +L +++H D+ +N+L+
Sbjct: 91 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP 147
Query: 554 YNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
+ +I+DFGLAKLL + + + + ++A E + T DV+S+GV + E+
Sbjct: 148 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWEL 206
Query: 614 ISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQ 673
++ +D ++ ++E C + M+ + C
Sbjct: 207 MTFGSKP---------------YDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 251
Query: 674 EDPSLRPTMRKVSQMLE 690
D RP R++
Sbjct: 252 IDADSRPKFRELIIEFS 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-43
Identities = 41/271 (15%), Positives = 101/271 (37%), Gaps = 35/271 (12%)
Query: 443 TVIVVKKLDRVFQDG-EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
V+ K + + + E+ ++ + +V G + + ++ G+L
Sbjct: 32 LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 91
Query: 502 ASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
L + + + ++ + +GL +L I+H D+KP NIL++ ++ DF
Sbjct: 92 DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 149
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFD 621
G++ L + + + GT+ Y++ PE + + + D++S G+ L+E+ R
Sbjct: 150 GVSGQLIDSMANSFV----GTRSYMS-PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
Query: 622 IEMGEEYAIL---------TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIW-- 670
+E ++ + G+ D I + ++
Sbjct: 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
Query: 671 ----------------CIQEDPSLRPTMRKV 685
C+ ++P+ R ++++
Sbjct: 265 LPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-42
Identities = 51/271 (18%), Positives = 113/271 (41%), Gaps = 24/271 (8%)
Query: 438 TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL 496
+ + + +K L + + +F E ++GQ H N++RL G + + +++ +++
Sbjct: 32 SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91
Query: 497 NNGTLASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN 555
NG L FL E + IA G+ +L +H D+ +NIL++
Sbjct: 92 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLV 148
Query: 556 AQISDFGLAKLLTLNQSKAIK-KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
++SDFGL+++L + + + A PE T+ DV+SFG+++ E++
Sbjct: 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA-PEAISYRKFTSASDVWSFGIVMWEVM 207
Query: 615 SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQE 674
+ + + N ++ + + C + + + C Q+
Sbjct: 208 TYGERP---------------YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQ 252
Query: 675 DPSLRPTMRKVSQMLEVVVEVDVPPNPSTFS 705
+ + RP + +L+ ++ P + T +
Sbjct: 253 ERARRPKFADIVSILDKLIR--APDSLKTLA 281
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (386), Expect = 2e-42
Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 23/250 (9%)
Query: 443 TVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
+ VK L + E EF E ++ + H NLV+LLG C ++ +F+ G L
Sbjct: 43 LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 503 SFLFENLKPG--WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD 560
+L E + + +A QI+ + +L IH D+ +N L+ + + +++D
Sbjct: 102 DYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 158
Query: 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
FGL++L+T + A + + A PE + + DV++FGVLL EI + S
Sbjct: 159 FGLSRLMTGDTYTA-HAGAKFPIKWTA-PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
Query: 621 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680
+ ++ +L+E D C EK+ + C Q +PS RP
Sbjct: 217 ---------------YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 261
Query: 681 TMRKVSQMLE 690
+ ++ Q E
Sbjct: 262 SFAEIHQAFE 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-42
Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 29/253 (11%)
Query: 443 TVIVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL--VYKFLNN 498
++V K+LD + +EV ++ + H N+VR + N L V ++
Sbjct: 30 KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89
Query: 499 GTLASFLFENLKPG----WNLRANIAFQIARGL--LHLHVNCSSQIIHCDIKPQNILLDD 552
G LAS + + K + Q+ L H + ++H D+KP N+ LD
Sbjct: 90 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149
Query: 553 YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
N ++ DFGLA++L + S A KA GT Y++ PE + D++S G LL E
Sbjct: 150 KQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMS-PEQMNRMSYNEKSDIWSLGCLLYE 206
Query: 613 IISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCI 672
+ + F +E R GK + + +N+ ++ +
Sbjct: 207 LCALMPPFTAFSQKE-------LAGKIREGKFRRIPYRYSDELNE------IIT---RML 250
Query: 673 QEDPSLRPTMRKV 685
RP++ ++
Sbjct: 251 NLKDYHRPSVEEI 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 57/249 (22%), Positives = 102/249 (40%), Gaps = 34/249 (13%)
Query: 443 TVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
++ +K L + E + + EV + H N++RL G+ + L+ ++ G
Sbjct: 32 FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 91
Query: 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
T+ L + K A ++A L + H S ++IH DIKP+N+LL +I+
Sbjct: 92 TVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 148
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFG + ++ + GT Y+ PE VD++S GVL E + +
Sbjct: 149 DFGWSVHAPSSRRTTLC----GTLDYLP-PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203
Query: 620 FDIEMGEE--YAILT-DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDP 676
F+ +E I ++ F + DL+ ++ +P
Sbjct: 204 FEANTYQETYKRISRVEFTFPDFVTEGARDLIS--------------------RLLKHNP 243
Query: 677 SLRPTMRKV 685
S RP +R+V
Sbjct: 244 SQRPMLREV 252
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 2e-41
Identities = 58/305 (19%), Positives = 100/305 (32%), Gaps = 49/305 (16%)
Query: 393 DPDPPSVPSPPDPEDKKKRNMMNVTRSVLLGS----SVFVNFTLVGVIQTSTRTTVIVVK 448
DPD + DPE + +G +V+ V +K
Sbjct: 1 DPDVAELFFKDDPEKL-------FSDLREIGHGSFGAVYF------ARDVRNSEVV-AIK 46
Query: 449 KLDRVFQDGE---KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
K+ + ++ EV + + H N ++ G LV ++
Sbjct: 47 KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 106
Query: 506 FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
A + +GL +LH S +IH D+K NILL + ++ DFG A
Sbjct: 107 VHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163
Query: 566 LLTLNQSKAIKKAIRGTKGYVASPEWFR---NSTITANVDVYSFGVLLLEIISCRKSFDI 622
++ S GT ++A PE VDV+S G+ +E+ +
Sbjct: 164 IMAPANS------FVGTPYWMA-PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-- 214
Query: 623 EMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTM 682
F+ L + + + A+ E C+Q+ P RPT
Sbjct: 215 -------------FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTS 261
Query: 683 RKVSQ 687
+ +
Sbjct: 262 EVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 60/245 (24%), Positives = 106/245 (43%), Gaps = 20/245 (8%)
Query: 443 TVIVVKKLD-RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
+ VK +D + D + K E+ + H+N+V+ G EG + L ++ + G L
Sbjct: 31 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 90
Query: 502 ASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
+ ++ Q+ G+++LH I H DIKP+N+LLD+ N +ISDF
Sbjct: 91 FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 147
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSF 620
GLA + N + + + GT YVA PE + VDV+S G++L +++ +
Sbjct: 148 GLATVFRYNNRERLLNKMCGTLPYVA-PELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206
Query: 621 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP 680
D + + +DW + D + + + E+PS R
Sbjct: 207 D-QPSDSCQEYSDWKEKKTYLNPWKKI---DSAPLALLH----------KILVENPSARI 252
Query: 681 TMRKV 685
T+ +
Sbjct: 253 TIPDI 257
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-41
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 22/258 (8%)
Query: 437 QTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493
S +T + VK L + +F EV + H+NL+RL G ++ V
Sbjct: 31 APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VT 89
Query: 494 KFLNNGTLASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD 552
+ G+L L ++ + A Q+A G+ +L S + IH D+ +N+LL
Sbjct: 90 ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLAT 146
Query: 553 YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLE 612
+I DFGL + L N + + R +PE + T + D + FGV L E
Sbjct: 147 RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWE 206
Query: 613 IISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCI 672
+ + + I + IL + R + +D C + + V + C
Sbjct: 207 MFTYGQEPWIGLNGS-QILHKIDKEGERLPRPED-------------CPQDIYNVMVQCW 252
Query: 673 QEDPSLRPTMRKVSQMLE 690
P RPT + L
Sbjct: 253 AHKPEDRPTFVALRDFLL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 5e-41
Identities = 60/256 (23%), Positives = 106/256 (41%), Gaps = 29/256 (11%)
Query: 438 TSTRTTVIV-VKKLD--RVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC----DEGQNRL 490
T TTV V +L ++ + + FK E M+ H N+VR + +
Sbjct: 29 LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88
Query: 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
LV + + +GTL ++L + + QI +GL LH IIH D+K NI +
Sbjct: 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFI 147
Query: 551 DD-YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVL 609
+ +I D GLA L + + KA+ GT ++A PE + +VDVY+FG+
Sbjct: 148 TGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMA-PEMYEEK-YDESVDVYAFGMC 201
Query: 610 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSI 669
+LE+ + + + G A D + ++ +
Sbjct: 202 MLEMATSEYPYSECQNAAQI--------------YRRVTSGVKPASFDKVAIPEVKEIIE 247
Query: 670 WCIQEDPSLRPTMRKV 685
CI+++ R +++ +
Sbjct: 248 GCIRQNKDERYSIKDL 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 55/253 (21%), Positives = 107/253 (42%), Gaps = 26/253 (10%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494
+ +T V +++++ Q ++ NE++++ + + N+V L G +V +
Sbjct: 39 AMDVATGQEV-AIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97
Query: 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554
+L G+L + E A + + + L LH S+Q+IH DIK NILL
Sbjct: 98 YLAGGSLTDVVTETCMD-EGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDG 153
Query: 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEII 614
+ +++DFG +T QSK + GT ++A PE VD++S G++ +E+I
Sbjct: 154 SVKLTDFGFCAQITPEQSKR--STMVGTPYWMA-PEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 615 SCRKSF--DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCI 672
+ + + Y I T+ + KL + + C+
Sbjct: 211 EGEPPYLNENPLRALYLIATNGTPELQNPEKLSA------IFRDFLN----------RCL 254
Query: 673 QEDPSLRPTMRKV 685
D R + +++
Sbjct: 255 DMDVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 40/279 (14%)
Query: 434 GVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQ-TYHKNLVRLLGFCDEGQNRLL 491
I+ +K++ +D ++F E+ ++ + +H N++ LLG C+ L
Sbjct: 29 ARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88
Query: 492 VYKFLNNGTLASFLFENLKPG----------------WNLRANIAFQIARGLLHLHVNCS 535
++ +G L FL ++ + A +ARG+ +L
Sbjct: 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQ 145
Query: 536 SQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNS 595
Q IH D+ +NIL+ + Y A+I+DFGL++ + K R ++A E S
Sbjct: 146 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMA-IESLNYS 201
Query: 596 TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 655
T N DV+S+GVLL EI+S + + +L + +
Sbjct: 202 VYTTNSDVWSYGVLLWEIVSLGGTP---------------YCGMTCAELYEKLPQGYRLE 246
Query: 656 NDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694
+ C +++ + C +E P RP+ ++ L ++E
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-40
Identities = 53/261 (20%), Positives = 97/261 (37%), Gaps = 23/261 (8%)
Query: 436 IQTSTRTTVIVVKKLDRVFQDGEKE-FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494
+ + +K D +E F E + + Q H ++V+L+G E ++ +
Sbjct: 29 MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIME 87
Query: 495 FLNNGTLASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY 553
G L SFL A+Q++ L +L S + +H DI +N+L+
Sbjct: 88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSN 144
Query: 554 YNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEI 613
++ DFGL++ + + + + ++A PE T+ DV+ FGV + EI
Sbjct: 145 DCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMA-PESINFRRFTSASDVWMFGVCMWEI 202
Query: 614 ISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQ 673
+ + NG+ + C L + C
Sbjct: 203 LMHGVKPFQGVKNN------DVIGRIENGERLPMPPN---------CPPTLYSLMTKCWA 247
Query: 674 EDPSLRPTMRKVSQMLEVVVE 694
DPS RP ++ L ++E
Sbjct: 248 YDPSRRPRFTELKAQLSTILE 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 5e-39
Identities = 45/249 (18%), Positives = 93/249 (37%), Gaps = 26/249 (10%)
Query: 443 TVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLA 502
+ K +D ++ +++ E+ ++ H N+V+LL N ++ +F G +
Sbjct: 38 VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 97
Query: 503 SFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561
+ + E +P + + Q L +LH ++IIH D+K NIL + +++DF
Sbjct: 98 AVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADF 154
Query: 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST-----ITANVDVYSFGVLLLEIISC 616
G++ T + + GT ++A PE T DV+S G+ L+E+
Sbjct: 155 GVSAKNTRTIQRR--DSFIGTPYWMA-PEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 211
Query: 617 RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDP 676
+ L + + C++++
Sbjct: 212 EPPHHELNPMR-------VLLKIAKSEPPTLAQPS-------RWSSNFKDFLKKCLEKNV 257
Query: 677 SLRPTMRKV 685
R T ++
Sbjct: 258 DARWTTSQL 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 75/316 (23%), Positives = 128/316 (40%), Gaps = 43/316 (13%)
Query: 402 PPDPEDKKKRNMMNVTRSVLLGS----SVFVNFTLVGVIQTSTRTTVIVVKKLDR-VFQD 456
P DP + R+ + + + LG V + + R T + VK L +
Sbjct: 3 PEDPRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 60
Query: 457 GEKEFKNEVVMIGQ-TYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPG--- 512
+ +E+ M+ HKN++ LLG C + ++ ++ + G L +L PG
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 513 -------------WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
+ A+Q+ARG+ +L S + IH D+ +N+L+ + +I+
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIA 177
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFGLA+ + R ++A PE + T DV+SFGVLL EI + S
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMA-PEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
Query: 620 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLR 679
+ E F + G D C +L M+ C PS R
Sbjct: 237 PYPGVPVE------ELFKLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQR 281
Query: 680 PTMRKVSQMLEVVVEV 695
PT +++ + L+ +V +
Sbjct: 282 PTFKQLVEDLDRIVAL 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 54/259 (20%), Positives = 108/259 (41%), Gaps = 30/259 (11%)
Query: 443 TVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501
T + +K ++ EF NE ++ + ++VRLLG +GQ L++ + + G L
Sbjct: 51 TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 110
Query: 502 ASFLFEN----------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
S+L P + +A +IA G+ +L +++ +H D+ +N ++
Sbjct: 111 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVA 167
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611
+ + +I DFG+ + + +++ PE ++ T DV+SFGV+L
Sbjct: 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS-PESLKDGVFTTYSDVWSFGVVLW 226
Query: 612 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
EI + + + E G L D + C + L + C
Sbjct: 227 EIATLAEQPYQGLSNE------QVLRFVMEGGLLDKPD---------NCPDMLFELMRMC 271
Query: 672 IQEDPSLRPTMRKVSQMLE 690
Q +P +RP+ ++ ++
Sbjct: 272 WQYNPKMRPSFLEIISSIK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 7e-36
Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 431 TLVGVIQTSTRTTVIVVKKLDR-VFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFC-DEGQ 487
G+ +T+T TV VK L + +E+ ++I +H N+V LLG C G
Sbjct: 33 DAFGIDKTATCRTV-AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91
Query: 488 NRLLVYKFLNNGTLASFLFENLKPG----------------WNLRANIAFQIARGLLHLH 531
+++ +F G L+++L +FQ+A+G+ L
Sbjct: 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 151
Query: 532 VNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEW 591
S + IH D+ +NILL + +I DFGLA+ + + K R ++A PE
Sbjct: 152 ---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA-PET 207
Query: 592 FRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651
+ T DV+SFGVLL EI S S + + + + G +
Sbjct: 208 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCRRLKEGTRMRAPD-- 260
Query: 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694
++ + C +PS RPT ++ + L +++
Sbjct: 261 -------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 8e-35
Identities = 46/252 (18%), Positives = 97/252 (38%), Gaps = 24/252 (9%)
Query: 443 TVIVVKKLDR---VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
+K L++ + ++ E ++ + H V+L + + + NG
Sbjct: 34 REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 93
Query: 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
L ++ + +I L +LH IIH D+KP+NILL++ + QI+
Sbjct: 94 ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQIT 150
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFG AK+L+ +A + GT YV+ PE + + D+++ G ++ ++++
Sbjct: 151 DFGTAKVLSPESKQARANSFVGTAQYVS-PELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
Query: 620 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLR 679
F F + D + +A + ++ + D + R
Sbjct: 210 FRAGNEYL-------IFQKIIKLEYDFPEKFFPKARDLVE----------KLLVLDATKR 252
Query: 680 PTMRKVSQMLEV 691
++ +
Sbjct: 253 LGCEEMEGYGPL 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 133 bits (335), Expect = 1e-34
Identities = 54/257 (21%), Positives = 102/257 (39%), Gaps = 30/257 (11%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494
V + +T K + + ++ + E+ + H LV L ++ +++Y+
Sbjct: 45 VTERATGNNF-AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103
Query: 495 FLNNGTLASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY 553
F++ G L + + + Q+ +GL H+H N +H D+KP+NI+
Sbjct: 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTK 160
Query: 554 YNAQI--SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611
+ ++ DFGL L QS K GT + A PE + D++S GVL
Sbjct: 161 RSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAA-PEVAEGKPVGYYTDMWSVGVLSY 216
Query: 612 EIISCRKSFDIEMGEE--YAILT-DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVS 668
++S F E +E + + DW D + + + + I+
Sbjct: 217 ILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE------DGKDFIR--------- 261
Query: 669 IWCIQEDPSLRPTMRKV 685
+ DP+ R T+ +
Sbjct: 262 -KLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 130 bits (327), Expect = 1e-33
Identities = 56/254 (22%), Positives = 101/254 (39%), Gaps = 24/254 (9%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494
++ +T V K ++ + + KNE+ ++ Q +H L+ L ++ +L+ +
Sbjct: 48 CVEKATGRVF-VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106
Query: 495 FLNNGTLASFLF-ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY 553
FL+ G L + E+ K N Q GL H+H I+H DIKP+NI+ +
Sbjct: 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETK 163
Query: 554 YNAQI--SDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611
+ + DFGLA L ++ I K T + A PE + D+++ GVL
Sbjct: 164 KASSVKIIDFGLATKLNPDE---IVKVTTATAEFAA-PEIVDREPVGFYTDMWAIGVLGY 219
Query: 612 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
++S F E E + + + + K +
Sbjct: 220 VLLSGLSPFAGEDDLE-------TLQNVKRCDWEFDEDAFSSVSPEAK---DFIK---NL 266
Query: 672 IQEDPSLRPTMRKV 685
+Q++P R T+
Sbjct: 267 LQKEPRKRLTVHDA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 129 bits (324), Expect = 4e-33
Identities = 48/250 (19%), Positives = 92/250 (36%), Gaps = 27/250 (10%)
Query: 443 TVIVVKKLDRVF---QDGEKEFKNEVVMI---GQTYHKNLVRLLGFCDEGQNRLLVYKFL 496
+ +K LD+ + GE NE +M+ +V + + +
Sbjct: 30 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 89
Query: 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
N G L L ++ A +I GL H+H + +++ D+KP NILLD++ +
Sbjct: 90 NGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHV 146
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISC 616
+ISD GLA + + A GT GY+A + ++ D +S G +L +++
Sbjct: 147 RISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202
Query: 617 RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDP 676
F ++ + ++ E + ++ +Q D
Sbjct: 203 HSPFRQHKTKDKHEI----DRMTLTMAVELPDSFSPELRSLLE----------GLLQRDV 248
Query: 677 SLRPTMRKVS 686
+ R
Sbjct: 249 NRRLGCLGRG 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 44/254 (17%), Positives = 100/254 (39%), Gaps = 25/254 (9%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494
++TS++ T + K + D + K E+ ++ H+N++ L + + +++++
Sbjct: 24 CVETSSKKTY-MAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81
Query: 495 FLNNGTLASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY 553
F++ + + + + Q+ L LH S I H DI+P+NI+
Sbjct: 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTR 138
Query: 554 YNAQ--ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611
++ I +FG A+ L + + + Y +PE ++ ++ D++S G L+
Sbjct: 139 RSSTIKIIEFGQARQLKPGDN---FRLLFTAPEY-YAPEVHQHDVVSTATDMWSLGTLVY 194
Query: 612 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
++S F E ++ + N + E E + V
Sbjct: 195 VLLSGINPFLAETNQQ-------IIENIMNAEYTFDEEAFKEISIEAM---DFVD---RL 241
Query: 672 IQEDPSLRPTMRKV 685
+ ++ R T +
Sbjct: 242 LVKERKSRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (298), Expect = 3e-30
Identities = 42/265 (15%), Positives = 79/265 (29%), Gaps = 25/265 (9%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFC-DEGQNRLLVY 493
+ V +K + + E + + + +C EG ++V
Sbjct: 26 GTDIAAGEEV-AIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82
Query: 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNIL---L 550
+ L F F + K +A Q+ + ++H S IH D+KP N L
Sbjct: 83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLG 139
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAI-----KKAIRGTKGYVASPEWFRNSTITANVDVYS 605
I DFGLAK ++ K + GT Y + + D+ S
Sbjct: 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS-INTHLGIEQSRRDDLES 198
Query: 606 FGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLV 665
G +L+ + + + + ++ L +G
Sbjct: 199 LGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN----- 253
Query: 666 MVSIWCIQEDPSLRPTMRKVSQMLE 690
+C +P + Q+
Sbjct: 254 ----FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (299), Expect = 3e-30
Identities = 59/258 (22%), Positives = 105/258 (40%), Gaps = 31/258 (12%)
Query: 435 VIQTSTRTTVIVVKKLDR-VFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493
T+ V +K + + + E +NE+ ++ + H N+V L + G + L+
Sbjct: 28 AEDKRTQKLV-AIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86
Query: 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL--- 550
+ ++ G L + E + + FQ+ + +L I+H D+KP+N+L
Sbjct: 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSL 143
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
D+ ISDFGL+K+ + GT GYVA PE + VD +S GV+
Sbjct: 144 DEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVA-PEVLAQKPYSKAVDCWSIGVIA 199
Query: 611 LEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMV 667
++ F E + IL ++ FD + D A + I+
Sbjct: 200 YILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD------SAKDFIR-------- 245
Query: 668 SIWCIQEDPSLRPTMRKV 685
+++DP R T +
Sbjct: 246 --HLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 117 bits (294), Expect = 6e-30
Identities = 52/267 (19%), Positives = 95/267 (35%), Gaps = 37/267 (13%)
Query: 435 VIQTSTRTTVIVVKKLD---------RVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCD 484
I T VK +D Q+ + EV ++ + H N+++L +
Sbjct: 22 CIHKPTCKEY-AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80
Query: 485 EGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIK 544
LV+ + G L +L E + I + + LH I+H D+K
Sbjct: 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLK 137
Query: 545 PQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST------IT 598
P+NILLDD N +++DFG + L + + + GT Y+A PE S
Sbjct: 138 PENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLA-PEIIECSMNDNHPGYG 193
Query: 599 ANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 658
VD++S GV++ +++ F + ++ + + + +
Sbjct: 194 KEVDMWSTGVIMYTLLAGSPPFW---HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 250
Query: 659 KCVEKLVMVSIWCIQEDPSLRPTMRKV 685
+ P R T +
Sbjct: 251 S----------RFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 1e-29
Identities = 59/239 (24%), Positives = 92/239 (38%), Gaps = 24/239 (10%)
Query: 446 VVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASF 504
+KK + D + E ++ + H L + +N V ++LN G L
Sbjct: 34 ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 93
Query: 505 LFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564
+ K + A +I GL LH I++ D+K NILLD + +I+DFG+
Sbjct: 94 IQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 150
Query: 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEM 624
K L +K GT Y+A PE +VD +SFGVLL E++ + F +
Sbjct: 151 KENMLGDAK--TNTFCGTPDYIA-PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207
Query: 625 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMR 683
EE F R + EA + + +P R +R
Sbjct: 208 EEE-------LFHSIRMDNPFYPRWLEKEAKDLLV----------KLFVREPEKRLGVR 249
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 115 bits (290), Expect = 2e-29
Identities = 50/268 (18%), Positives = 94/268 (35%), Gaps = 33/268 (12%)
Query: 435 VIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFC----DEGQ 487
V VK L F+ E H +V + G
Sbjct: 26 ARDLRLHRDV-AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84
Query: 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQN 547
+V ++++ TL + + + L + IIH D+KP N
Sbjct: 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPAN 141
Query: 548 ILLDDYYNAQISDFGLAKLLTLNQSKAIK-KAIRGTKGYVASPEWFRNSTITANVDVYSF 606
I++ ++ DFG+A+ + + + + A+ GT Y++ PE R ++ A DVYS
Sbjct: 142 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS-PEQARGDSVDARSDVYSL 200
Query: 607 GVLLLEIISCRKSFDIEMGEEYA---ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 663
G +L E+++ F + A + D R+ L ++
Sbjct: 201 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD-------------LDA 247
Query: 664 LVMVSIWCIQEDPSLRP-TMRKVSQMLE 690
+V+ + ++P R T ++ L
Sbjct: 248 VVL---KALAKNPENRYQTAAEMRADLV 272
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-29
Identities = 49/262 (18%), Positives = 91/262 (34%), Gaps = 21/262 (8%)
Query: 443 TVIVVKKLDRVFQDGEKE-----FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLN 497
++ +KK+ + K+ E+ ++ + H N++ LL N LV+ F+
Sbjct: 24 QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83
Query: 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
+L + +GL +LH + I+H D+KP N+LLD+ +
Sbjct: 84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 140
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
++DFGLAK + T+ Y A F VD+++ G +L E++
Sbjct: 141 LADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
Query: 618 KSFD----------IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMV 667
I W C + + + ++
Sbjct: 199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD 258
Query: 668 SI-WCIQEDPSLRPTMRKVSQM 688
I +P R T + +M
Sbjct: 259 LIQGLFLFNPCARITATQALKM 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 114 bits (285), Expect = 1e-28
Identities = 43/258 (16%), Positives = 95/258 (36%), Gaps = 19/258 (7%)
Query: 442 TTVIVVKKLDRVFQD--GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
+KK+ +D E+ ++ + H N+V+L + +LV++ L+
Sbjct: 26 GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
+ Q+ G+ + H +++H D+KPQN+L++ +I+
Sbjct: 86 LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIA 142
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFGLA+ + K + + Y A + + +D++S G + E+++
Sbjct: 143 DFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
Query: 620 FDIEMGEE-----YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSI----- 669
F + + IL + N + + + L +
Sbjct: 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260
Query: 670 --WCIQEDPSLRPTMRKV 685
++ DP+ R T ++
Sbjct: 261 LSKMLKLDPNQRITAKQA 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (284), Expect = 3e-28
Identities = 56/250 (22%), Positives = 100/250 (40%), Gaps = 35/250 (14%)
Query: 443 TVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499
+K L + + +E +M+ H ++R+ G + Q ++ ++ G
Sbjct: 30 RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 89
Query: 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
L S L ++ + + A ++ L +LH II+ D+KP+NILLD + +I+
Sbjct: 90 ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKIT 146
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFG AK + + + GT Y+A PE ++D +SFG+L+ E+++
Sbjct: 147 DFGFAKYV-----PDVTYTLCGTPDYIA-PEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
Query: 620 F--DIEMGEEYAILT-DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDP 676
F M IL + F + N + DL+ I D
Sbjct: 201 FYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR--------------------LITRDL 240
Query: 677 SLRPTMRKVS 686
S R +
Sbjct: 241 SQRLGNLQNG 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 7e-28
Identities = 51/261 (19%), Positives = 99/261 (37%), Gaps = 32/261 (12%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCD----EGQNR 489
+ T+ +K L + + EV + + ++VR++ + +
Sbjct: 31 IFNKRTQEKF-ALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84
Query: 490 LLVYKFLNNGTLASFLFENLKPG--WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQN 547
L+V + L+ G L S + + + I I + +LH S I H D+KP+N
Sbjct: 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 141
Query: 548 ILLDDYYN---AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVY 604
+L +++DFG AK T + S T YVA PE + D++
Sbjct: 142 LLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVA-PEVLGPEKYDKSCDMW 197
Query: 605 SFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL 664
S GV++ ++ F ++ R G+ + E ++K L
Sbjct: 198 SLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK---ML 251
Query: 665 VMVSIWCIQEDPSLRPTMRKV 685
+ ++ +P+ R T+ +
Sbjct: 252 IR---NLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 1e-27
Identities = 55/262 (20%), Positives = 98/262 (37%), Gaps = 43/262 (16%)
Query: 435 VIQTSTRTTVIVVKKL------DRVFQDGEKEFKNEVVMIGQ--TYHKNLVRLLGFCDEG 486
I+ S V +K + D EVV++ + + ++RLL + +
Sbjct: 23 GIRVSDNLPV-AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81
Query: 487 QNRLLVYKFLNNGT-LASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKP 545
+ +L+ + L F+ E L + +Q+ + H + ++H DIK
Sbjct: 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKD 138
Query: 546 QNILLD-DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNST-ITANVDV 603
+NIL+D + ++ DFG LL GT+ Y PEW R + V
Sbjct: 139 ENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSP-PEWIRYHRYHGRSAAV 193
Query: 604 YSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 663
+S G+LL +++ F+ +E I F + + L+
Sbjct: 194 WSLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQRVSSECQHLIR-------------- 236
Query: 664 LVMVSIWCIQEDPSLRPTMRKV 685
WC+ PS RPT ++
Sbjct: 237 ------WCLALRPSDRPTFEEI 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 110 bits (276), Expect = 2e-27
Identities = 38/267 (14%), Positives = 77/267 (28%), Gaps = 27/267 (10%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH-KNLVRLLGFCDEGQNRLLVY 493
V +K R + + ++E + + F EG + +LV
Sbjct: 24 GTNLLNNQQV-AIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80
Query: 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDY 553
L K A A Q+ + +H +++ DIKP N L+
Sbjct: 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRP 137
Query: 554 YNAQ-----ISDFGLAKLLTLNQSKAI-----KKAIRGTKGYVASPEWFRNSTITANVDV 603
+ + DFG+ K +K KK + GT Y++ + D+
Sbjct: 138 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS-INTHLGREQSRRDDL 196
Query: 604 YSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 663
+ G + + + + + + ++ L +L G E+
Sbjct: 197 EALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG---------FPEE 247
Query: 664 LVMVSIWCIQEDPSLRPTMRKVSQMLE 690
+ P + +
Sbjct: 248 FYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-27
Identities = 55/261 (21%), Positives = 94/261 (36%), Gaps = 31/261 (11%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGE------KEFKNEVVMIGQTYHKNLVRLLGFCDEGQN 488
+ ST K + + ++ + EV ++ + H N++ L + +
Sbjct: 29 CREKSTGLQY-AAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87
Query: 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548
+L+ + + G L FL E QI G ++ S QI H D+KP+NI
Sbjct: 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENI 144
Query: 549 LLDDY----YNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVY 604
+L D +I DFGLA + K I GT +VA PE + D++
Sbjct: 145 MLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVA-PEIVNYEPLGLEADMW 200
Query: 605 SFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL 664
S GV+ ++S F + +E + E K
Sbjct: 201 SIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYEFEDEYFSNTSALAK---DF 250
Query: 665 VMVSIWCIQEDPSLRPTMRKV 685
+ + +DP R T++
Sbjct: 251 IR---RLLVKDPKKRMTIQDS 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-27
Identities = 49/270 (18%), Positives = 103/270 (38%), Gaps = 23/270 (8%)
Query: 435 VIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493
+ V +KK+ Q + E+ ++ + H+N++ + +
Sbjct: 27 AYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85
Query: 494 KFLNNGTLASFLFENLKPG---WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550
+L + + L++ LK + +QI RGL ++H S+ ++H D+KP N+LL
Sbjct: 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLL 142
Query: 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVL 609
+ + +I DFGLA++ + + +PE NS T ++D++S G +
Sbjct: 143 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 202
Query: 610 LLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL 664
L E++S R F + + IL + + + + K
Sbjct: 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262
Query: 665 VMVSI---------WCIQEDPSLRPTMRKV 685
+ + + +P R + +
Sbjct: 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 9e-27
Identities = 57/272 (20%), Positives = 101/272 (37%), Gaps = 28/272 (10%)
Query: 435 VIQTSTRTTVIVVKKL--DRVFQDGEKEFKNEVV---MIGQTYHKNLVRLLGFCDEGQNR 489
+ +K++ + EV + H N+VRL C +
Sbjct: 26 ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85
Query: 490 LLVYKFL----NNGTLASFLFENLKPG--WNLRANIAFQIARGLLHLHVNCSSQIIHCDI 543
L + L ++L + +PG ++ FQ+ RGL LH S +++H D+
Sbjct: 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDL 142
Query: 544 KPQNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDV 603
KPQNIL+ +++DFGLA++ + + ++ T Y A PE S+ VD+
Sbjct: 143 KPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRA-PEVLLQSSYATPVDL 198
Query: 604 YSFGVLLLEIISCRKSFDIEMGEE------YAILTDWAFDCYRNGKLDDLVEGDMEAMND 657
+S G + E+ + F + I D R+ L A
Sbjct: 199 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPI 258
Query: 658 IKCVEKLVMVSI----WCIQEDPSLRPTMRKV 685
K V + + C+ +P+ R +
Sbjct: 259 EKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 1e-26
Identities = 41/258 (15%), Positives = 97/258 (37%), Gaps = 20/258 (7%)
Query: 443 TVIVVKKLDRVFQD--GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
++ +K++ D E+ ++ + HKN+VRL + LV++F +
Sbjct: 28 EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87
Query: 501 LASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISD 560
F N + + FQ+ +GL H ++H D+KPQN+L++ ++++
Sbjct: 88 KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLAN 144
Query: 561 FGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSF 620
FGLA+ + + + T Y F + ++D++S G + E+ + +
Sbjct: 145 FGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
Query: 621 DIEMGEE------YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSI----- 669
+ + +L + + + + V + ++
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 670 --WCIQEDPSLRPTMRKV 685
++ +P R + +
Sbjct: 263 LQNLLKCNPVQRISAEEA 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-26
Identities = 51/258 (19%), Positives = 99/258 (38%), Gaps = 20/258 (7%)
Query: 443 TVIVVKKL--DRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
V+ +KK+ D + E+ ++ + H N+V+LL LV++FL+
Sbjct: 28 EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 501 LASFLFENLKP-GWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559
L L + FQ+ +GL H + ++H D+KPQN+L++ +++
Sbjct: 88 KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLA 144
Query: 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKS 619
DFGLA+ + + T Y A + VD++S G + E+++ R
Sbjct: 145 DFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
Query: 620 F--DIEMGEEYAIL--------TDWAFDCYRNGKLDDLVEGDMEAMNDI--KCVEKLVMV 667
F D E+ + + I W + + + + E +
Sbjct: 203 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262
Query: 668 SIWCIQEDPSLRPTMRKV 685
+ DP+ R + +
Sbjct: 263 LSQMLHYDPNKRISAKAA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 40/270 (14%), Positives = 91/270 (33%), Gaps = 30/270 (11%)
Query: 443 TVIVVKKLDRVFQDG--EKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR--------LLV 492
+ +KK+ + E+ ++ H+N+V L+ C + LV
Sbjct: 36 QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95
Query: 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD 552
+ F + +K + + + GL ++ ++I+H D+K N+L+
Sbjct: 96 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITR 152
Query: 553 YYNAQISDFGLAKLLTLNQSKAIK--KAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
+++DFGLA+ +L ++ T Y +D++ G ++
Sbjct: 153 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 212
Query: 611 LEIISCRKSFDIE--------MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVE 662
E+ + + + +T + N +L + +E +K
Sbjct: 213 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL 272
Query: 663 KLVMVSIW-------CIQEDPSLRPTMRKV 685
K + + + DP+ R
Sbjct: 273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 1e-24
Identities = 58/314 (18%), Positives = 112/314 (35%), Gaps = 45/314 (14%)
Query: 398 SVPSPPDPEDKKKRNMMNVTRSVLLG----SSVFVNFTLVGVIQTSTRTTVIVVKKLDRV 453
V +P D+ + T+ ++G V+ + V +KK+ +
Sbjct: 6 VVATPGQGPDRPQEVSYTDTK--VIGNGSFGVVYQ------AKLCDSGELV-AIKKVLQ- 55
Query: 454 FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR------LLVYKFLNNGTLASFLFE 507
++ E+ ++ + H N+VRL F + LV ++
Sbjct: 56 ---DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY 112
Query: 508 NLKPG---WNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD-DYYNAQISDFGL 563
+ +Q+ R L ++H S I H DIKPQN+LLD D ++ DFG
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIE 623
AK L + + ++ Y A F + T+++DV+S G +L E++ + F +
Sbjct: 170 AKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 624 ------------MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
+G Y K + + + + + +
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 286
Query: 672 IQEDPSLRPTMRKV 685
++ P+ R T +
Sbjct: 287 LEYTPTARLTPLEA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 4e-23
Identities = 47/239 (19%), Positives = 85/239 (35%), Gaps = 23/239 (9%)
Query: 446 VVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFL 505
+++K + +D E ++ T H L L V ++ N G L L
Sbjct: 37 ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL 96
Query: 506 FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565
+I L S +++ DIK +N++LD + +I+DFGL K
Sbjct: 97 SRERVFTEERARFYGAEIVSAL---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
Query: 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMG 625
+ + GT Y+A PE ++ VD + GV++ E++ R F +
Sbjct: 154 EGISDGATMKT--FCGTPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 626 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRK 684
E F+ ++ EA + + +++DP R
Sbjct: 211 ER-------LFELILMEEIRFPRTLSPEAKSLLA----------GLLKKDPKQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.3 bits (244), Expect = 7e-23
Identities = 52/255 (20%), Positives = 97/255 (38%), Gaps = 30/255 (11%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKE---FKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491
V + +K LD+ K+ NE ++ LV+L + N +
Sbjct: 60 VKHKESGNHY-AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
V +++ G + S L + A QI +LH S +I+ D+KP+N+L+D
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLID 175
Query: 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLL 611
Q++DFG AK + K + GT + +PE + VD ++ GVL+
Sbjct: 176 QQGYIQVTDFGFAK-----RVKGRTWTLCGTPEAL-APEIILSKGYNKAVDWWALGVLIY 229
Query: 612 EIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWC 671
E+ + F + + ++ +GK+ + + ++
Sbjct: 230 EMAAGYPPFFADQPIQ-------IYEKIVSGKVRFPSHFSSDLKDLLR----------NL 272
Query: 672 IQEDPSLRPTMRKVS 686
+Q D + R K
Sbjct: 273 LQVDLTKRFGNLKNG 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 94.5 bits (234), Expect = 1e-21
Identities = 49/276 (17%), Positives = 100/276 (36%), Gaps = 38/276 (13%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEV-VMIGQTYHKNLVRLLGFCDEGQNRL--L 491
I + V VVK L V +K+ K E+ ++ N++ L + +R L
Sbjct: 54 AINITNNEKV-VVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109
Query: 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551
V++ +NN ++I + L + H I+H D+KP N+++D
Sbjct: 110 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMID 163
Query: 552 -DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610
++ ++ D+GLA+ Q ++ + ++D++S G +L
Sbjct: 164 HEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 611 LEIISCRKSFDIEMGEEYAIL-------TDWAFDCYRNGKLD-DLVEGDMEAMNDIKCVE 662
+I ++ F ++ T+ +D ++ D D+ + K E
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280
Query: 663 KLVMVSIW-------------CIQEDPSLRPTMRKV 685
+ V ++ D R T R+
Sbjct: 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 2e-21
Identities = 55/266 (20%), Positives = 99/266 (37%), Gaps = 34/266 (12%)
Query: 443 TVIVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFL---- 496
+ +KKL R FQ K E+ ++ H+N++ LL + F
Sbjct: 44 AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 103
Query: 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNA 556
GT L ++ K G + + +Q+ +GL ++H IIH D+KP N+ +++
Sbjct: 104 FMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL 160
Query: 557 QISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISC 616
+I DFGLA+ + + T+ Y A T VD++S G ++ E+I+
Sbjct: 161 KILDFGLARQADSEMTGYV-----VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
Query: 617 RKSFDIEMGEEYAILTDWAFDCYRNGKLDDL----VEGDMEAMNDIKCVEKLVMVSIW-- 670
+ F G ++ + + + M + +EK SI
Sbjct: 216 KTLF---KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN 272
Query: 671 -----------CIQEDPSLRPTMRKV 685
+ D R T +
Sbjct: 273 ASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 1e-20
Identities = 46/247 (18%), Positives = 86/247 (34%), Gaps = 21/247 (8%)
Query: 443 TVIVVKKLDRVF----QDGEKEFKNEVVMIGQTYHK-NLVRLLGFCDEGQNRLLVYKFLN 497
+ +K L + + + E ++ LV L L+ ++N
Sbjct: 53 KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYIN 112
Query: 498 NGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQ 557
G L + L + + + +I L HLH II+ DIK +NILLD +
Sbjct: 113 GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 169
Query: 558 ISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR 617
++DFGL+K ++++ + +S VD +S GVL+ E+++
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
Query: 618 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPS 677
F ++ + + E A + I+ + +DP
Sbjct: 230 SPFTVDGEKN---SQAEISRRILKSEPPYPQEMSALAKDLIQ----------RLLMKDPK 276
Query: 678 LRPTMRK 684
R
Sbjct: 277 KRLGCGP 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 3e-19
Identities = 56/295 (18%), Positives = 103/295 (34%), Gaps = 31/295 (10%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLGFCDEGQ----N 488
T T V VKKL R FQ K E+ ++ H+N++ LL +
Sbjct: 37 AFDTKTGLRV-AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95
Query: 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNI 548
+ G + + + K + + +QI RGL ++H S+ IIH D+KP N+
Sbjct: 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNL 152
Query: 549 LLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGV 608
+++ +I DFGLA + T+ Y A VD++S G
Sbjct: 153 AVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 207
Query: 609 LLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMV 667
++ E+++ R F ++ ++ E + + + K+
Sbjct: 208 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 267
Query: 668 SIW-------------CIQEDPSLRPTMRKVSQM--LEVVVEVDVPPNPSTFSCS 707
+++ + D R T + + D P + S
Sbjct: 268 NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQS 322
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 5e-19
Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 19/201 (9%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGE--KEFKNEVVMIGQTYHKNLVRLLGFC------DEG 486
V +KKL R FQ+ K E+V++ HKN++ LL +E
Sbjct: 36 AYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94
Query: 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQ 546
Q+ LV + ++ E + + +Q+ G+ HLH S+ IIH D+KP
Sbjct: 95 QDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPS 148
Query: 547 NILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSF 606
NI++ +I DFGLA+ + + T+ Y A PE NVD++S
Sbjct: 149 NIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRA-PEVILGMGYKENVDIWSV 204
Query: 607 GVLLLEIISCRKSFDIEMGEE 627
G ++ E++ + F +
Sbjct: 205 GCIMGEMVRHKILFPGRDYID 225
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.2 bits (186), Expect = 2e-15
Identities = 38/217 (17%), Positives = 73/217 (33%), Gaps = 22/217 (10%)
Query: 435 VIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494
T V +K + + + ++E+ ++ + + + +LL +
Sbjct: 32 AKDMVNNTHV-AMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89
Query: 495 FLNNGTLASFLFENLKPGWN----------------LRANIAFQIARGLLHLHVNCSSQI 538
+ G N I+ Q+ GL ++H C I
Sbjct: 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--I 147
Query: 539 IHCDIKPQNILLD-DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI 597
IH DIKP+N+L++ + +A L T+ Y + PE +
Sbjct: 148 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS-PEVLLGAPW 206
Query: 598 TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 634
D++S L+ E+I+ F+ + G Y D
Sbjct: 207 GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.4 bits (156), Expect = 2e-12
Identities = 19/135 (14%), Positives = 40/135 (29%), Gaps = 11/135 (8%)
Query: 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNGT 500
+ KK+ G+ F + + + L +L G Y + N
Sbjct: 33 KVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV-----YAWEGNAV 87
Query: 501 LASFLFENLKPGWNL--RANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQI 558
L + + + I + + I+H D+ N+L+ + I
Sbjct: 88 LMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWI 143
Query: 559 SDFGLAKLLTLNQSK 573
DF + + +
Sbjct: 144 IDFPQSVEVGEEGWR 158
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 40.9 bits (95), Expect = 5e-05
Identities = 22/141 (15%), Positives = 39/141 (27%), Gaps = 30/141 (21%)
Query: 144 TDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISG 203
+D L G ++T L G + F + D NLVL N + SG
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNNRAVWASGTNGKASG 51
Query: 204 TYDSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQS 263
+ G + I + + + L D V
Sbjct: 52 CV-----------LKMQNDGNLVIYSGSRA----IWASNTNRQNGNYYLILQRDRNVVIY 96
Query: 264 FYLKNGNGNWSVVWSQPENIC 284
+ + + +W+ N+
Sbjct: 97 ------DNSNNAIWATHTNVG 111
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 38.8 bits (90), Expect = 3e-04
Identities = 19/127 (14%), Positives = 35/127 (27%), Gaps = 29/127 (22%)
Query: 137 WDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAY 196
N L + +E F ++F + D NLVL
Sbjct: 7 KQPDDNHPQILHATESLEI-----------LFGTHVYRFIMQTDCNLVL----------- 44
Query: 197 DAYYISGTYDSTNSSNS--GYQVMFNESGYMYILRRNGRRFDLTTERVVPAADFYHRATL 254
Y + +TN+ G + + G + ++ + V ++ L
Sbjct: 45 --YDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP---VAGKAGHYVLVL 99
Query: 255 NFDGVFV 261
D V
Sbjct: 100 QPDRNVV 106
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 35.7 bits (82), Expect = 0.003
Identities = 17/105 (16%), Positives = 35/105 (33%), Gaps = 15/105 (14%)
Query: 35 TLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNP 94
LT G L + + + N L ++ + VW ++
Sbjct: 3 LLTNGE----GLYAGQSLDVEPYHFIMQEDCN----LVLYDHSTS----VWASNTGIL-- 48
Query: 95 VVPRGSQVKLTADQGLVLNDPQGKQVWSSKLILVQSFSSSRLWDS 139
+G + L +D V+ D +G+ +W+S + L +
Sbjct: 49 -GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQED 92
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 709 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.77 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.5 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.43 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.38 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.35 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.17 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.05 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.97 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.9 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.79 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.6 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.47 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.18 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.08 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.31 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.3 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.12 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=391.63 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=204.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+|+.||.+... .+++.||||+++... .+..+++.+|+.++++++|||||++++++.+++..+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 345776677788888888766655 568899999986542 2344678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||||+++|+|.+++.+...+++..+..++.||++||.||| +++|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999999988888999999999999999999999 8899999999999999999999999999999876554
Q ss_pred cccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
........+||+.|+| ||++.+..+ +.++|||||||++|||++|+.||.......... .........
T Consensus 158 ~~~~~~~~~GT~~Y~A-PE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------~~~~~~~~~----- 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVA-PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTY----- 225 (271)
T ss_dssp EECCBCCCCSCGGGSC-THHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH------HHHHTTCTT-----
T ss_pred ccccccceeeCcCccC-HhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCCCC-----
Confidence 4433467899999999 999998876 678999999999999999999997654322111 111111110
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111234567889999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=384.10 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=207.5
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+|+.||.+... .+++.||||++... .....+++.+|+.++++++|||||++++++.+++..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREK---QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 81 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEEC---CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence 456776677777788877666554 57889999998643 233457899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++|+|.+++.+...+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999999998889999999999999999999999 88999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.. .....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ...+..++..
T Consensus 159 ~~----~~~~~Gt~~Y~A-PE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~~---- 222 (263)
T d2j4za1 159 SR----RTTLCGTLDYLP-PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRVEFT---- 222 (263)
T ss_dssp CC----CEETTEEGGGCC-HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCCC----
T ss_pred Cc----ccccCCCCcccC-HHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCC----
Confidence 32 156789999999 9999999999999999999999999999999976543331 1222222211
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+...++.+.+++.+||+.||++|||++|+++
T Consensus 223 ------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 ------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11234567889999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-47 Score=394.54 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=197.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.|.....+|.|+|++||.+....++.....||||++... .....++|.+|+++|++++|||||+++|++.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 344445667777777765555544456678999998654 3345578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++|+|.+++.... .+++..+..++.||++||.||| +++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 9999999999888754 6899999999999999999999 88999999999999999999999999999998765433
Q ss_pred ccc---eeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 573 KAI---KKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 573 ~~~---~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
... .....||+.|+| ||.+.+..++.++|||||||++|||++ |+.||......+.. ..+..+..
T Consensus 184 ~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~-------~~i~~~~~---- 251 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTA-PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI-------NAIEQDYR---- 251 (299)
T ss_dssp ------------CGGGSC-HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTTCC----
T ss_pred cceeeecccccCCccccC-HHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC----
Confidence 211 123568999999 999999999999999999999999998 89999755433211 12222211
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
...+...++.+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 252 -----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 -----LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11133456788999999999999999999999999987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=388.96 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=194.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+|+.| |++.. .++..||||++.... ...++|.+|++++++++|||||+++|+|.+++..++||
T Consensus 5 ~~~~~~~~iG~G~fg~V-y~~~~---~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLV-HLGYW---LNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCE-EEEEE---TTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEE-EEEEE---CCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 45665556666666666 55555 356789999997643 45678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
||+++|+|.+++... ..+++..+..++.||++||.||| +++|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999998765 46889999999999999999999 88999999999999999999999999999987765433
Q ss_pred ccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCC-CCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK-SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
... ....||+.|+| ||++.+..++.++|||||||++|||+++.. |+......+. .+.+..+....
T Consensus 157 ~~~-~~~~gt~~y~a-PE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~-------~~~i~~~~~~~----- 222 (263)
T d1sm2a_ 157 TSS-TGTKFPVKWAS-PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFRLY----- 222 (263)
T ss_dssp ---------CTTSCC-HHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH-------HHHHHHTCCCC-----
T ss_pred eee-cceecCcccCC-hHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHhcCCCC-----
Confidence 222 45679999999 999999999999999999999999999654 4443322221 11222221111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.+...++.+.+++..||+.||++||||+||++.|+.+.+
T Consensus 223 ----~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 ----KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 122345678999999999999999999999999988754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-47 Score=394.05 Aligned_cols=257 Identities=24% Similarity=0.322 Sum_probs=209.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+|+.||.+... .+++.||||+++... ...++|.+|++++++++|||||++++++.+++..++|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEG---GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEC---CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 445666666777777777655544 468899999987643 3567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
|||+++|+|.+++.+. ..+++..+..++.||++||.||| +++|+||||||+||||++++.+||+|||+|+.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999999765 46899999999999999999999 889999999999999999999999999999987654
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
.... .....|++.|+| ||++.+..++.++|||||||++|||++|..|+........ +.+.+..+..
T Consensus 169 ~~~~-~~~~~g~~~y~a-PE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~~~~~------ 234 (287)
T d1opja_ 169 TYTA-HAGAKFPIKWTA-PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYR------ 234 (287)
T ss_dssp SSEE-ETTEEECGGGCC-HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTTCC------
T ss_pred Ccee-eccccccccccC-hHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHhcCCC------
Confidence 3322 245678999999 9999999999999999999999999997776644332211 1122222211
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
...+...++.+.+|+..||+.||++|||++||++.|+.+.
T Consensus 235 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1112335578999999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=389.70 Aligned_cols=250 Identities=20% Similarity=0.259 Sum_probs=204.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|.....+|.|+++.||.+... .+++.||||++... .....+.+.+|++++++++|||||++++++.+++..
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 346777677777777777666555 56889999998642 234557899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++|+|.+++...+.+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999999999998889999999999999999999999 88999999999999999999999999999998765
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..........+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ +...+..++..
T Consensus 161 ~~~~~~~~~~~GT~~Y~A-PE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~---- 228 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVS-PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEYD---- 228 (288)
T ss_dssp ---------CCCCGGGCC-HHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCCC----
T ss_pred CCcccccccccCCccccC-ceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-------HHHHHHcCCCC----
Confidence 544433356789999999 999999999999999999999999999999998654322 12222233221
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVS 686 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~ 686 (709)
.+...++.+.+++..||+.||.+|||++|++
T Consensus 229 ------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 ------FPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ------CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 1122456789999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=386.18 Aligned_cols=250 Identities=23% Similarity=0.296 Sum_probs=207.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+++.||.+... .+++.||||++........+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~---~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBT---TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEEC---CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 35776667788888877666554 578899999987665566788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+++|+|.+++.+ ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999999998765 46899999999999999999999 889999999999999999999999999999977544322
Q ss_pred cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 653 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~ 653 (709)
....+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.. ......+... +
T Consensus 173 --~~~~~gt~~Y~a-PE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~~~~~~~~~-~------ 236 (293)
T d1yhwa1 173 --RSTMVGTPYWMA-PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGTPE-L------ 236 (293)
T ss_dssp --BCCCCSCGGGCC-HHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHHCSCC-C------
T ss_pred --ccccccCCCccC-hhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH------HHHHhCCCCC-C------
Confidence 256789999999 99999999999999999999999999999999765433211 1111121111 1
Q ss_pred ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 654 AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 654 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..+...+..+.+++.+||+.||.+|||++|+++
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112234577899999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=382.68 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=199.7
Q ss_pred ecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEeecCCC
Q 038905 422 LGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYKFLNNG 499 (709)
Q Consensus 422 ~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~Ey~~~g 499 (709)
+|.|+|+.| |++.......++.||||+++.. .....++|.+|+.++++++|||||+++++|.+ +..+|||||+++|
T Consensus 15 iG~G~fG~V-y~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g 92 (277)
T d1xbba_ 15 LGSGNFGTV-KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG 92 (277)
T ss_dssp EEECSSEEE-EEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred cccCCCeEE-EEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCC
Confidence 445555555 6666555567789999998643 23345789999999999999999999999965 4578999999999
Q ss_pred CHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc-cceec
Q 038905 500 TLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK-AIKKA 578 (709)
Q Consensus 500 sL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 578 (709)
+|.+++.+...+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||+++.+...... .....
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 99999999889999999999999999999999 889999999999999999999999999999977654332 22245
Q ss_pred cccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccCcccccCC
Q 038905 579 IRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 657 (709)
Q Consensus 579 ~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~ 657 (709)
..||+.|+| ||.+.+..++.++|||||||++|||++ |+.||......+ +...+..+.... .+
T Consensus 170 ~~gt~~y~A-PE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~~---------~p 232 (277)
T d1xbba_ 170 GKWPVKWYA-PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG---------CP 232 (277)
T ss_dssp -CCCGGGCC-HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC---------CC
T ss_pred cCCCceecC-chhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CC
Confidence 679999999 999999999999999999999999998 899997654332 122233332221 12
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 658 IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 658 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
...+..+.+|+.+||+.||++|||+++|+++|+.
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 2345788999999999999999999999998875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=381.99 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=195.5
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+|+.| |++.. ...||||+++.. ..+..++|.+|+.++++++|||||++++++.+ +..++|
T Consensus 9 ~~~~~~~lG~G~fg~V-y~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTV-YKGKW-----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCCCCSEEEECSSCEE-EEEES-----SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cEEEEEEEeeCCCcEE-EEEEE-----CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 3443344555555555 55544 235999998643 34456889999999999999999999998754 568999
Q ss_pred EeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++|+|.+++... .++++..+..++.||++||.||| +++||||||||+||||+.++.+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999765 46999999999999999999999 8899999999999999999999999999998876544
Q ss_pred cccceeccccCcccccccccccCC---CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNS---TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~---~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.........||+.|+| ||++.+. .++.++|||||||++|||++|+.||......... ......+.....+
T Consensus 159 ~~~~~~~~~gt~~y~A-PE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMA-PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGYLSPDL 231 (276)
T ss_dssp -------CCCCGGGCC-HHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHTSCCCCG
T ss_pred CcccccccccCcccCC-HHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCCCCCcc
Confidence 4333367789999999 9998643 5899999999999999999999999755432211 1111222111100
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
.......++.+.+++.+||+.||.+|||++||++.|+.+.+
T Consensus 232 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 -----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11123356789999999999999999999999999987653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=381.60 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=191.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEc--CCeE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE--GQNR 489 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~--~~~~ 489 (709)
++|.....+|.|+|+.||.+... .+++.||||+++.. .+...+.+.+|++++++++|||||++++++.+ ....
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRK---SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEeEEEecCCCeEEEEEEEC---CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 45776667777777777655554 57889999998654 33345679999999999999999999999865 4568
Q ss_pred EEEEeecCCCCHHHHHhh----CCCCChHHHHHHHHHHHHHHHHhhhcC--CCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 490 LLVYKFLNNGTLASFLFE----NLKPGWNLRANIAFQIARGLLHLHVNC--SSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~i~~al~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
++||||+++|+|.+++.+ ...+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999999864 356999999999999999999999532 23599999999999999999999999999
Q ss_pred cccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
|+.+...... .....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ +...+..++
T Consensus 161 a~~~~~~~~~--~~~~~gt~~Y~A-PE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~ 230 (269)
T d2java1 161 ARILNHDTSF--AKAFVGTPYYMS-PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGK 230 (269)
T ss_dssp HHHC-------------CCCSCCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTC
T ss_pred eeecccCCCc--cccCCCCcccCC-HHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCC
Confidence 9987654322 256789999999 999999999999999999999999999999997654333 222333444
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
...+ +...++.+.+++.+||+.||.+|||++|+++
T Consensus 231 ~~~~---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 3322 1234567899999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=385.10 Aligned_cols=250 Identities=19% Similarity=0.207 Sum_probs=205.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEEe
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVYK 494 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~E 494 (709)
.|.....+|.|+|+.||.+... .+++.||||+++.......+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNK---ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEEC---CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4566666777777777666554 5788999999977666667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 495 FLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 495 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
|+++|+|.+++.+. ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 99999999998754 46999999999999999999999 889999999999999999999999999999866543222
Q ss_pred cceeccccCccccccccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 574 AIKKAIRGTKGYVASPEWFR-----NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
.....||+.|+| ||++. +..++.++|||||||++|||++|+.||......+.. ..+..+....+.
T Consensus 167 --~~~~~Gt~~y~A-PE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~-------~~i~~~~~~~~~ 236 (288)
T d2jfla1 167 --RDSFIGTPYWMA-PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-------LKIAKSEPPTLA 236 (288)
T ss_dssp --HTCCCSCCTTCC-HHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-------HHHHHSCCCCCS
T ss_pred --ccccccccccCC-HHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH-------HHHHcCCCCCCC
Confidence 246789999999 99984 556899999999999999999999999765443321 111222221111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+...++.+.+++.+||+.||++|||++|+++
T Consensus 237 -------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 -------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12234567899999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=392.07 Aligned_cols=264 Identities=17% Similarity=0.234 Sum_probs=205.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.++|.....+|.|+|+.||.+... .+++.||+|+++... ....+++.+|+.+|++++|||||++++++.+.++.++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHK---PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEET---TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 567887778888888888766554 578999999986543 3345789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSS-QIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++|+|.+++.+...+++..+..++.||+.||.||| ++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999999998889999999999999999999999 54 8999999999999999999999999999876432
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHH-HHHhh--------hc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW-AFDCY--------RN 641 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~--------~~ 641 (709)
. ....+||+.|+| ||++.+..++.++||||+||++|||++|+.||......+....... ..... ..
T Consensus 159 ~----~~~~~GT~~Y~A-PEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 159 M----ANSFVGTRSYMS-PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp T----C---CCSSCCCC-HHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred c----cccccCCccccC-chHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2 256789999999 9999999999999999999999999999999976543221110000 00000 00
Q ss_pred CCc--------------ccc----ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 642 GKL--------------DDL----VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 642 g~~--------------~~l----~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+.. .+. .............+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 000 0000000001123467889999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=390.79 Aligned_cols=259 Identities=23% Similarity=0.331 Sum_probs=206.0
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCC--CceEEEEEEcccc-cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCe
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTST--RTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQN 488 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~ 488 (709)
.++|.....+|.|+|+.||.+.....+. ....||||++... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3456666667777777776665553322 2357899988643 233446789999999998 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhCC-----------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCC
Q 038905 489 RLLVYKFLNNGTLASFLFENL-----------------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKP 545 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp 545 (709)
.++||||+++|+|.++|.... .+++..+..++.||++||.||| +++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence 999999999999999997542 3788999999999999999999 88999999999
Q ss_pred CceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccc
Q 038905 546 QNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEM 624 (709)
Q Consensus 546 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~ 624 (709)
+|||++.++.+||+|||+|+...............||+.|+| ||++.+..++.++|||||||++|||++ |+.||....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a-PE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA-PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCC-hHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998766554444456789999999 999999999999999999999999997 899997544
Q ss_pred hhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHc
Q 038905 625 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLE 690 (709)
Q Consensus 625 ~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~ 690 (709)
..+. ..+....+.. ...+...++.+.+|+.+||+.||++|||++||+++|.
T Consensus 272 ~~~~------~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDAN------FYKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHH------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH------HHHHHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3221 1112222211 1112335578999999999999999999999999995
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-46 Score=381.77 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=203.9
Q ss_pred cccceee-eecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSV-LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~-~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
+++.... .+|.|+|+.| |++.......+..||||+++... ....++|.+|+++|++++|||||+++|++.+ +..+|
T Consensus 8 ~~~~~~~~~iG~G~fg~V-y~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSV-RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEE-EEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEE-EEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 3444332 2566666666 55555443566789999987543 3455789999999999999999999999975 56899
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+++|+|.+++... ..+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999998654 46999999999999999999999 889999999999999999999999999999987654
Q ss_pred ccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 571 QSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 571 ~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
... .......||+.|+| ||++.+..++.++|||||||++|||++ |+.||......+ +...+..|....+
T Consensus 163 ~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~- 233 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYA-PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC- 233 (285)
T ss_dssp SCEECCCCSSCCCGGGCC-HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCCC-
T ss_pred ccccccccccccCccccC-hHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC-
Confidence 332 22245678999999 999999999999999999999999998 899997654333 1222333332221
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
+...+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 234 --------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 234 --------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp --------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 223557789999999999999999999999998763
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=379.37 Aligned_cols=253 Identities=28% Similarity=0.393 Sum_probs=200.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
++|.....+|.|+|+.| |++.. .++..||||+++... ...++|.+|+.++++++|||||+++|++.+ +..++||
T Consensus 13 ~~~~~~~~iG~G~fg~V-y~~~~---~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEV-WMGYY---NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGEEEEEEEEEETTEEE-EEEEE---TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeEEEecCCCcEE-EEEEE---CCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 35555555666666666 55565 457889999997643 356789999999999999999999998865 5679999
Q ss_pred eecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++|+|.+++.... ++++..+..++.||++||.||| +++|+||||||+||||++++.+||+|||+|+.+....
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999999876543 5899999999999999999999 8899999999999999999999999999999876543
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
... .....||+.|+| ||++.+..++.++|||||||++|||++|..|+........ +...+..+....
T Consensus 164 ~~~-~~~~~gt~~y~A-PE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~------~~~~i~~~~~~~----- 230 (272)
T d1qpca_ 164 YTA-REGAKFPIKWTA-PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMV----- 230 (272)
T ss_dssp EEC-CTTCCCCTTTSC-HHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCC-----
T ss_pred ccc-ccccCCcccccC-hHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCCC-----
Confidence 322 255789999999 9999999999999999999999999997665543322111 112222221111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
.+...++.+.+++.+||+.||++||||++|+++|+..
T Consensus 231 ----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 231 ----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1223456789999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=381.21 Aligned_cols=263 Identities=21% Similarity=0.362 Sum_probs=199.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecC-CCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTS-TRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~ 490 (709)
...|.....+|.|+|+.||.+.....+ .....||||++.... .....+|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 345666666777777777554443221 234679999986543 334567999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+.+++|.+++.+. ..+++..+..++.||+.||.||| +.+|+||||||+||||+.++.+||+|||+++.+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999988765 46999999999999999999999 88999999999999999999999999999998755
Q ss_pred ccccc-ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 570 NQSKA-IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 570 ~~~~~-~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
..... ......||+.|+| ||++.+..++.++|||||||++|||++|..|+........ +.+.+..+..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~A-PE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~------~~~~i~~~~~---- 231 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTA-PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFR---- 231 (283)
T ss_dssp -----------CCCGGGSC-HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC----
T ss_pred CCccceEeccCCCCccccC-HHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH------HHHHHhccCC----
Confidence 43322 2245678999999 9999999999999999999999999997666544332211 1222223221
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
...+...+..+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 232 -----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11123355778999999999999999999999999988764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=373.98 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=207.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+|+.| |++.. .+++.||||+++... ...++|.+|+.++++++|||||+++|+|.+.+..++|
T Consensus 3 ~~~~~~~~~iG~G~fg~V-y~~~~---~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVV-KYGKW---RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEE-EEEEE---TTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEE-EEEEE---CCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 456665556666666666 55555 467889999987653 3567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++|+|..++... ..+++..+.+++.||++||.||| +++|+||||||+|||+++++.+||+|||+++.+....
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999999997654 46899999999999999999999 8899999999999999999999999999998776543
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... .....||+.|+| ||.+.+..++.++|||||||++|||++ |+.||......+. ...+.++....
T Consensus 155 ~~~-~~~~~~t~~y~a-PE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~~~i~~~~~~~---- 221 (258)
T d1k2pa_ 155 YTS-SVGSKFPVRWSP-PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGLRLY---- 221 (258)
T ss_dssp CCC-CCCSCCCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTCCCC----
T ss_pred cee-ecccCCCCCcCC-cHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------HHHHHhCCCCC----
Confidence 332 245779999998 999999999999999999999999998 7889976554331 12223332111
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEV 691 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~ 691 (709)
.+...++.+.+++..||+.||++|||++++++.|..
T Consensus 222 -----~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 -----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -----CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122344678999999999999999999999999854
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=373.87 Aligned_cols=241 Identities=24% Similarity=0.335 Sum_probs=191.8
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEc----CCeEEEEEe
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE----GQNRLLVYK 494 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~----~~~~~lV~E 494 (709)
.+|.|+|+.||.+... .++..||+|++... .....+.+.+|++++++++|||||++++++.+ +...++|||
T Consensus 16 ~iG~G~fg~Vy~~~~~---~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE 92 (270)
T d1t4ha_ 16 EIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92 (270)
T ss_dssp EEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred EEecCcCcEEEEEEEC---CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence 3555556666544443 56789999998643 33445679999999999999999999999864 456799999
Q ss_pred ecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCC--eEecCCCCCceeec-CCCCeEEccccccccccccc
Q 038905 495 FLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQ--IIHCDIKPQNILLD-DYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 495 y~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~ 571 (709)
|+++|+|.+++.+...+++..+..++.||++||.||| +++ |+||||||+|||++ +++.+||+|||+|+......
T Consensus 93 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred CCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 9999999999998888999999999999999999999 777 99999999999996 57899999999998654332
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
....+||+.|+| ||++.+ .++.++|||||||++|||++|+.||........ +.+.+..+.....+
T Consensus 170 ----~~~~~GT~~Y~a-PE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~~~~--- 234 (270)
T d1t4ha_ 170 ----AKAVIGTPEFMA-PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASF--- 234 (270)
T ss_dssp ----BEESCSSCCCCC-GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGGG---
T ss_pred ----cCCcccCccccC-HHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCCccc---
Confidence 256789999999 999876 599999999999999999999999975433221 22233333221111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+...+..+.+++.+||+.||++|||++|+++
T Consensus 235 -----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 -----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1123456889999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-45 Score=381.96 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=190.2
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+.|.....+|.|+|+.||.+... .+++.||||.+.... ....+.+.+|+.++++++|||||++++++.+++..+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDK---RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEET---TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEEC---CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34666667778888888766554 568899999986543 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec---CCCCeEEccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD---DYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~~~~ 569 (709)
|||++||+|.+++.+...+++..+..++.||+.||.||| +++|+||||||+|||+. +++.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999999998889999999999999999999999 88999999999999994 578999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
... ....+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ ....+..+....
T Consensus 163 ~~~---~~~~~GT~~y~A-PE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~~--- 228 (307)
T d1a06a_ 163 GSV---LSTACGTPGYVA-PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYEF--- 228 (307)
T ss_dssp -------------CTTSC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCCCC---
T ss_pred CCe---eeeeeeCccccC-cHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCCC---
Confidence 332 256789999999 999999999999999999999999999999997654332 112222222211
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........++.+.+++..||+.||++|||++|+++
T Consensus 229 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 ---DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11112234567899999999999999999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8e-45 Score=384.99 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=208.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
.++|.....+|.|+|+.||.+... .+++.||||++........+.+.+|+.++++++|||||++++++.+++..+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTER---ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 346776677788888888666555 57899999999876666678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec--CCCCeEEccccccccccc
Q 038905 493 YKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD--DYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DFGla~~~~~ 569 (709)
||||+||+|.+++.+ ..++++..+..++.||+.||.||| +++||||||||+|||++ .++.+||+|||+|+.+..
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999999964 457999999999999999999999 89999999999999995 467899999999998764
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... ....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+.. ..+..+....
T Consensus 179 ~~~~---~~~~gT~~Y~a-PEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~~~--- 244 (350)
T d1koaa2 179 KQSV---KVTTGTAEFAA-PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-------RNVKSCDWNM--- 244 (350)
T ss_dssp TSCE---EEECSCTTTCC-HHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCS---
T ss_pred cccc---ceecCcccccC-HHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCCC---
Confidence 4322 56789999999 99999999999999999999999999999999765443311 1222222111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
........++.+.+++.+||+.||++|||++|+++.
T Consensus 245 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 ---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011112345678999999999999999999999883
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-45 Score=378.27 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=210.3
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+||.||.+.... ...+++.||||+++... .+..++|.+|++++++++||||+++++++.+....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 4567766667777777775554431 23467899999987543 33457899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC------------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCC
Q 038905 490 LLVYKFLNNGTLASFLFENL------------------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKP 545 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp 545 (709)
++||||+++|+|.+++.... .+++..+..++.||+.||+||| +++||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcc
Confidence 99999999999999997532 3788899999999999999999 88999999999
Q ss_pred CceeecCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCC-CCCCccc
Q 038905 546 QNILLDDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR-KSFDIEM 624 (709)
Q Consensus 546 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~-~p~~~~~ 624 (709)
+|||++.++.+||+|||+|+.+.........+...||+.|+| ||.+.+..++.++|||||||++|||++|. +||....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP-PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCC-HHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999987765544444456789999998 99999999999999999999999999996 5666544
Q ss_pred hhhHHhHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 625 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 625 ~~~~~~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
..+. ...+..+....+ +...+..+.+|+..||+.+|++||||.||+++|+.+.+
T Consensus 248 ~~e~-------~~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 248 HEEV-------IYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHH-------HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHH-------HHHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 3331 223344443222 22344678999999999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-45 Score=381.90 Aligned_cols=245 Identities=20% Similarity=0.233 Sum_probs=201.0
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
.|+....+|.|+|+.||.+... .+++.||||++.... ....+++.+|+.++++++|||||++++++.+++..++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEEC---CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 3666666777777777665554 578899999986532 2334678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||||++|+|..++..+.++++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999999988888888999999999999999999999 889999999999999999999999999999865432
Q ss_pred cccceeccccCcccccccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRN---STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 648 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~ 648 (709)
....||+.|+| ||++.+ ..|+.++|||||||++|||++|+.||......+.. . ....+....+.
T Consensus 169 -----~~~~GT~~Y~A-PE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~-~i~~~~~~~~~ 235 (309)
T d1u5ra_ 169 -----NSFVGTPYWMA-PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------Y-HIAQNESPALQ 235 (309)
T ss_dssp -----CCCCSCGGGCC-HHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------H-HHHHSCCCCCS
T ss_pred -----CccccCccccC-HHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------H-HHHhCCCCCCC
Confidence 45689999999 999864 45899999999999999999999999755432211 1 11122221111
Q ss_pred cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 649 EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 649 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
....++.+.+++..||+.||++|||++|+++
T Consensus 236 --------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1234567899999999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=377.13 Aligned_cols=249 Identities=23% Similarity=0.241 Sum_probs=210.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.+|||++++. .....+++.+|+.+|++++|||||++++++.+.+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~---~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 567887778888888888777655 57889999998643 234567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+++|+|..++.+...+++...+.++.||+.||.||| +++|+||||||+|||+++++.+||+|||+|+....
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999999999889999999999999999999999 89999999999999999999999999999987654
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.... ....+||+.|+| ||++.+..++.++|||||||++|||++|++||......+. .+....+.+.
T Consensus 158 ~~~~--~~~~~GT~~Y~a-PE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~~~i~~~~~~---- 223 (337)
T d1o6la_ 158 DGAT--MKTFCGTPEYLA-PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEEIR---- 223 (337)
T ss_dssp TTCC--BCCCEECGGGCC-GGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC----
T ss_pred CCcc--cccceeCHHHhh-hhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-------HHHHhcCCCC----
Confidence 3322 256899999999 9999999999999999999999999999999987654331 2222233221
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
.+...+..+.+++..||+.||.+||+ ++|+++
T Consensus 224 ------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 ------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 12234567889999999999999995 777776
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-44 Score=381.97 Aligned_cols=251 Identities=23% Similarity=0.254 Sum_probs=208.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
+.|.....+|.|+|+.||.+... .+++.||||+++.......+.+.+|+.++++++|||||++++++.+++..+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEK---ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45777777888888888776655 578999999987765556678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec--CCCCeEEcccccccccccc
Q 038905 494 KFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD--DYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DFGla~~~~~~ 570 (709)
||+++|+|.+++.... ++++..+..++.||+.||.||| +++|+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999998876654 6999999999999999999999 88999999999999998 6789999999999987654
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... ....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ...+..+....
T Consensus 183 ~~~---~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~~~~---- 247 (352)
T d1koba_ 183 EIV---KVTTATAEFAA-PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCDWEF---- 247 (352)
T ss_dssp SCE---EEECSSGGGCC-HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHHCCCCC----
T ss_pred Cce---eeccCcccccC-HHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCC----
Confidence 322 56789999999 9999999999999999999999999999999976544331 11222222211
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
........+..+.+++.+||+.||.+|||++|+++
T Consensus 248 --~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 --DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112234567899999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=371.74 Aligned_cols=251 Identities=24% Similarity=0.269 Sum_probs=204.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc------chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF------QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~ 487 (709)
+.|.....+|.|+|+.||.+... .+++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~---~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK---STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCEEEeEEEecCCCeEEEEEEEC---CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34666666777777777666554 578899999885421 123578999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC----CeEEccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY----NAQISDFGL 563 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFGl 563 (709)
..+||||||++|+|.+++.+...+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999999998888999999999999999999999 88999999999999998776 499999999
Q ss_pred cccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCC
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 643 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~ 643 (709)
|+.+...... ....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ...+..+.
T Consensus 164 a~~~~~~~~~---~~~~~t~~y~A-PE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~ 232 (293)
T d1jksa_ 164 AHKIDFGNEF---KNIFGTPEFVA-PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAVN 232 (293)
T ss_dssp CEECTTSCBC---SCCCCCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTTC
T ss_pred hhhcCCCccc---cccCCCCcccC-HHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-------HHHHHhcC
Confidence 9877544322 56789999999 9999999999999999999999999999999986544331 11222222
Q ss_pred ccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 644 LDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 644 ~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... ........+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YEF------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCC------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCC------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 00001124567889999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=370.52 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=195.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
.+|.....+|.|+|++| |++.. .....||||+++... ...++|.+|+.++++++|+|||++++++.+ +..++||
T Consensus 17 ~~~~i~~~iG~G~fg~V-y~~~~---~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEV-WMGTW---NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGEEEEEEEEECSSCEE-EEEEE---TTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHEEEeeEEeeCCCeEE-EEEEE---CCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 34554444555555555 55565 345679999997553 456789999999999999999999999965 5678999
Q ss_pred eecCCCCHHHHHhhC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFEN--LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++|+|..++... ..+++..+..++.||+.||+||| +.+|+||||||+||||++++.+||+|||+|+.+....
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999998753 46999999999999999999999 8899999999999999999999999999998775443
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccCc
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 651 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~~ 651 (709)
... .....||+.|+| ||++.+..++.++||||||+++|||++|..|+........ +...+..+...
T Consensus 168 ~~~-~~~~~gt~~y~a-PE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~------~~~~i~~~~~~------ 233 (285)
T d1fmka3 168 YTA-RQGAKFPIKWTA-PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRM------ 233 (285)
T ss_dssp ---------CCGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCC------
T ss_pred cee-eccccccccccC-hHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCC------
Confidence 322 255789999999 9999999999999999999999999997666544332211 11222222111
Q ss_pred ccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccccC
Q 038905 652 MEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVEV 695 (709)
Q Consensus 652 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 695 (709)
..+...++.+.+++.+||+.||++|||+++|+++|+....-
T Consensus 234 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 234 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11234556899999999999999999999999999986543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.2e-44 Score=372.26 Aligned_cols=246 Identities=24% Similarity=0.307 Sum_probs=207.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+++.||.+... .+++.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSR---HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEEC---CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence 356777777778888888766654 57889999998643 233457899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||++||+|..++.....+++.....++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999999999999889999999999999999999999 99999999999999999999999999999987754
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.. ...+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. ...+..+...
T Consensus 157 ~~-----~~~~Gt~~Y~A-PE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~~~---- 219 (316)
T d1fota_ 157 VT-----YTLCGTPDYIA-PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKILNAELR---- 219 (316)
T ss_dssp CB-----CCCCSCTTTCC-HHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHCCCC----
T ss_pred cc-----ccccCcccccC-HHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-------HHHHHcCCCC----
Confidence 32 56789999999 9999999999999999999999999999999976543331 1222222221
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
.+...++.+.+++.+||+.||.+|| |++++++
T Consensus 220 ------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 ------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1122446788999999999999996 8999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=369.40 Aligned_cols=258 Identities=21% Similarity=0.291 Sum_probs=194.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc-hhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
++|.....+|.|+|+.||.+.....+.....||||+++.... ...+.+.+|+.++++++|||||++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 355555566666666665554544445567899999875433 34567999999999999999999999996 4678999
Q ss_pred EeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
|||+++|+|..++.... .+++..+..++.||++||.||| +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 99999999999877654 6899999999999999999999 8999999999999999999999999999998765443
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... .....||+.|+| ||++.+..++.++|||||||++|||++ |.+||......+. ...+..+....
T Consensus 163 ~~~-~~~~~gt~~y~a-pE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-------~~~i~~~~~~~---- 229 (273)
T d1mp8a_ 163 YYK-ASKGKLPIKWMA-PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERLP---- 229 (273)
T ss_dssp ---------CCGGGCC-HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCCC----
T ss_pred cee-ccceecCcccch-hhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCCC----
Confidence 322 256778999998 999999999999999999999999998 8889876554332 12223332221
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
.+...++.+.+++..||+.||++|||++||++.|+.+.
T Consensus 230 -----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 230 -----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12235578999999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=376.17 Aligned_cols=258 Identities=23% Similarity=0.332 Sum_probs=201.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCC-CceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTST-RTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
..|+....+|.|+||.||.+....++. ....||||++... ..+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 457777777888888886665543322 2346899988643 344668899999999999999999999999875 5678
Q ss_pred EEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
++||+.+++|.+++... ..+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 88999999999988765 46999999999999999999999 889999999999999999999999999999987665
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
..........||+.|+| ||++.+..++.++|||||||++|||++ |..||......+.. ..+..+...
T Consensus 165 ~~~~~~~~~~gt~~y~A-PE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-------~~i~~~~~~---- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGERL---- 232 (317)
T ss_dssp CC--------CCTTTSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-------HHHHHTCCC----
T ss_pred cccccccccccCccccC-hHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCCC----
Confidence 54443355679999999 999999999999999999999999998 78888765443321 122222211
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
..+...++.+.+++.+||+.||.+|||+.||++.|+.+
T Consensus 233 -----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11233557789999999999999999999999988765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-44 Score=370.22 Aligned_cols=262 Identities=27% Similarity=0.378 Sum_probs=210.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecC----CCceEEEEEEcccccc-hhHHHHHHHHHHHhcc-CcCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTS----TRTTVIVVKKLDRVFQ-DGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~ 486 (709)
.++|.....+|.|+|+.||.+...... .....||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 456677778889999999777654322 3446899999976443 3457899999999888 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceee
Q 038905 487 QNRLLVYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILL 550 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll 550 (709)
...++||||+++|+|.++|.... .+++..+..++.||+.||.||| +.+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 99999999999999999997542 4799999999999999999999 8899999999999999
Q ss_pred cCCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHH
Q 038905 551 DDYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA 629 (709)
Q Consensus 551 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~ 629 (709)
+.++.+||+|||+++...............||+.|+| ||.+.+..++.++||||||+++|||++ |.+||......+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA-PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhh-hhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--
Confidence 9999999999999998766554444456789999999 999999999999999999999999998 678886544322
Q ss_pred hHHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 630 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 630 ~~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+++.+..+..... +...++.+.+++.+||+.||++|||+.||+++|+++..
T Consensus 246 -----~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 -----LFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -----HHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2233333322211 22345678999999999999999999999999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=366.76 Aligned_cols=260 Identities=23% Similarity=0.277 Sum_probs=199.9
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
..+|....-+|.|+|+.||.+...........||||+++.. ..+..++|.+|+.++++++|||||+++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 34577777788888888876665555455678999998643 23445789999999999999999999999976 467
Q ss_pred EEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
++||||+++|+|.+++..+ ..+++..+..++.||+.||.||| +++|+||||||+||||+.++.+||+|||+++.+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999887754 46999999999999999999999 8899999999999999999999999999999876
Q ss_pred cccccc-ceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccc
Q 038905 569 LNQSKA-IKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 646 (709)
Q Consensus 569 ~~~~~~-~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~ 646 (709)
...... ......|+..|+| ||.+.+..++.++|||||||++|||++ |+.||......+.. ......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~a-PE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~------~~i~~~~~~~- 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCA-PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEGERL- 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCC-HHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSCCCC-
T ss_pred cCCCcceecCccccCcccCC-HHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH------HHHHhCCCCC-
Confidence 554332 2234567888998 999999999999999999999999998 89999755443321 1112222111
Q ss_pred cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccc
Q 038905 647 LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVV 692 (709)
Q Consensus 647 l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~ 692 (709)
......+..+.+++.+||+.||++|||++||+++|++.
T Consensus 235 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11223456789999999999999999999999999753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-43 Score=361.34 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=204.5
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---------chhHHHHHHHHHHHhccC-cCceeEEEeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---------QDGEKEFKNEVVMIGQTY-HKNLVRLLGFC 483 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~ 483 (709)
.+|.....+|.|++++||.+... .+++.+|||+++... +...+.+.+|+.++++++ |||||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~---~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHK---PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred ccCEEceEEecCcCeEEEEEEEC---CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence 35666667777777777766554 578999999986432 112346889999999997 99999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccc
Q 038905 484 DEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGL 563 (709)
Q Consensus 484 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 563 (709)
.+++..+|||||+++|+|.+++..+..+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 80 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999999998889999999999999999999999 88999999999999999999999999999
Q ss_pred cccccccccccceeccccCcccccccccccC------CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRN------STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 637 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~------~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 637 (709)
++.+...... ....||+.|+| ||++.+ ..++.++||||+||++|||++|+.||......+ ...
T Consensus 157 a~~~~~~~~~---~~~~gt~~y~~-PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~ 225 (277)
T d1phka_ 157 SCQLDPGEKL---REVCGTPSYLA-PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLR 225 (277)
T ss_dssp CEECCTTCCB---CCCCSCGGGCC-HHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred eeEccCCCce---eeeeccCCCCC-HHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHH
Confidence 9987654322 55789999999 999863 357889999999999999999999998665433 122
Q ss_pred hhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 638 CYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 638 ~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+..++... ........++.+.+++.+||+.||++|||++||++
T Consensus 226 ~i~~~~~~~------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCCCCC------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 223333221 11112245578999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=371.46 Aligned_cols=262 Identities=24% Similarity=0.319 Sum_probs=196.4
Q ss_pred cccceeeeecCeeEEEEEEEEEEec--CCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcC-Ce
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQT--STRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEG-QN 488 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~-~~ 488 (709)
++|.....+|.|+||.||.+..... ...++.||||+++... ....+++.+|..++.++ +|+|||++++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 4566556666666666755554432 2355789999987533 33456788888888777 689999999998654 56
Q ss_pred EEEEEeecCCCCHHHHHhhCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC
Q 038905 489 RLLVYKFLNNGTLASFLFENL----------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD 552 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~ 552 (709)
.++||||+++|+|.+++.... .+++..+..++.||++||.||| +++||||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence 899999999999999997542 3788999999999999999999 889999999999999999
Q ss_pred CCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCC-CCCCccchhhHHhH
Q 038905 553 YYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR-KSFDIEMGEEYAIL 631 (709)
Q Consensus 553 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~-~p~~~~~~~~~~~~ 631 (709)
++.+||+|||+|+...............||+.|+| ||++.+..++.++|||||||++|||++|. +||......+.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A-PE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--- 245 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA-PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 245 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccc-hhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 99999999999997765554444356789999999 99999999999999999999999999975 56754432221
Q ss_pred HHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 632 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 632 ~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
....+..+....+ +...+..+.+++.+||+.||++|||++||+++|+.+.+
T Consensus 246 ---~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 ---FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ---HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1122223322211 22345678999999999999999999999999987643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=370.27 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=201.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc-cchhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeEE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~~ 490 (709)
-++|.....+|.|+||.||.+... .......||||+++.. ..+..++|.+|+++|.++ +|||||+++|++.+++..+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEE-ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEEC-CCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 356666666777777777555444 3233456889987543 334556899999999998 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC
Q 038905 491 LVYKFLNNGTLASFLFEN----------------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY 554 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~ 554 (709)
+||||+++|+|.++|.+. ..+++..+..++.||++||.||| +++|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCC
Confidence 999999999999999754 46899999999999999999999 88999999999999999999
Q ss_pred CeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCC-CCCccchhhHHhHHH
Q 038905 555 NAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRK-SFDIEMGEEYAILTD 633 (709)
Q Consensus 555 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~-p~~~~~~~~~~~~~~ 633 (709)
.+||+|||+|+........ ....||+.|+| ||.+.+..++.++|||||||++|||++|.. ||......+
T Consensus 165 ~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~a-PE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~------ 234 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKK---TMGRLPVRWMA-IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------ 234 (309)
T ss_dssp CEEECCTTCEESSCEECCC-------CCTTTCC-HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------
T ss_pred ceEEccccccccccccccc---cceecCCcccc-hHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH------
Confidence 9999999999865533222 45679999999 999999999999999999999999999765 565433222
Q ss_pred HHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 634 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 634 ~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+...+.++... ..+...++.+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 235 -~~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 235 -LYEKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -HHHHGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHhcCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 12223333211 1122355789999999999999999999999999988764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-43 Score=371.34 Aligned_cols=246 Identities=23% Similarity=0.220 Sum_probs=207.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+|+.||.+... .+++.||||+++.. .....+.+.+|+.+|++++|||||++++++.+....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~---~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEEC---CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 356777777888888888766554 57889999998642 223456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
++||||+.+|+|..++.+...+++..+..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+.+..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999999998889999999999999999999999 88999999999999999999999999999998754
Q ss_pred cccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccccc
Q 038905 570 NQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 649 (709)
Q Consensus 570 ~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~ 649 (709)
.. ....||+.|+| ||++.+..++.++|||||||++|||++|+.||....... ....+..+....
T Consensus 194 ~~-----~~~~Gt~~Y~A-PE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~~~--- 257 (350)
T d1rdqe_ 194 RT-----WTLCGTPEALA-PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVRF--- 257 (350)
T ss_dssp CB-----CCCEECGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC---
T ss_pred cc-----ccccCccccCC-HHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-------HHHHHhcCCCCC---
Confidence 32 56789999999 999999999999999999999999999999997654322 112222222111
Q ss_pred CcccccCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 038905 650 GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-----TMRKVSQ 687 (709)
Q Consensus 650 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~ 687 (709)
+...+..+.+++..||+.||.+|+ |++++++
T Consensus 258 -------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 -------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 123456788999999999999994 8999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-43 Score=361.37 Aligned_cols=259 Identities=20% Similarity=0.263 Sum_probs=201.2
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC---
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--- 487 (709)
++|.....+|.|+++.||.+... .+++.||||+++... .+..+++.+|++++++++|||||++++++...+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDL---RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ceeEEeEEEeeCCCeEEEEEEEC---CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 45776677788888888766655 578999999986532 234467999999999999999999999987543
Q ss_pred -eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 488 -NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 488 -~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
..+|||||++|++|..++.....+++.++..++.||+.||.||| +.+|+||||||+|||++.++..+|+|||.++.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence 37899999999999999998889999999999999999999999 88999999999999999999999999999986
Q ss_pred ccccccc-cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 567 LTLNQSK-AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 567 ~~~~~~~-~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
....... ......+||+.|+| ||++.+..++.++|||||||++|||++|+.||......+. .......+...
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~a-PE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~~ 233 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLS-PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP 233 (277)
T ss_dssp CC----------------TTCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCC
T ss_pred hccccccccccccccCcccccC-HHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCCC
Confidence 6443322 22256789999999 9999999999999999999999999999999976543321 11222222111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHccc
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRP-TMRKVSQMLEVV 692 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~~ 692 (709)
........++.+.+++.+||+.||.+|| |++++++.|..+
T Consensus 234 -------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 -------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0111223457889999999999999999 899998888654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=359.43 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=190.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEc-CCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE-GQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~-~~~~~lV~ 493 (709)
+|.....+|.|+++.| |++.. .+..||||+++.. ...+++.+|++++++++|||||+++|+|.+ .+..++||
T Consensus 8 ~~~~~~~lG~G~fg~V-y~~~~----~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDV-MLGDY----RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GEEEEEEEEECSSCEE-EEEEE----TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HeEEeEEEecCCCeEE-EEEEE----CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 4444444555555555 66665 3678999999754 355789999999999999999999999865 45689999
Q ss_pred eecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 494 KFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
||+++|+|.+++.++. .+++..+.+++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999999997653 4899999999999999999999 8899999999999999999999999999998765332
Q ss_pred cccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
....+|+.|+| ||++.+..++.++||||||+++|||++ |+.|+......+. ...+.++....+
T Consensus 158 -----~~~~~~~~y~a-PE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~-------~~~i~~~~~~~~--- 221 (262)
T d1byga_ 158 -----DTGKLPVKWTA-PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYKMDA--- 221 (262)
T ss_dssp ---------CCTTTSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTTCCCCC---
T ss_pred -----ccccccccCCC-hHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCCCCC---
Confidence 45678999998 999999999999999999999999998 6777765543331 122223322211
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+...+..+.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus 222 ------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 222 ------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 2234567889999999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=363.84 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=208.8
Q ss_pred ccccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~ 489 (709)
.++|.....+|.|+|+.||.+.... .....+.||||+++.. ..+....|.+|+.++++++|||||++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 3456655566666666665544332 1234678999999754 333446789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhC----------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEc
Q 038905 490 LLVYKFLNNGTLASFLFEN----------LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQIS 559 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 559 (709)
++||||+++|+|.+++... ..+++..+..++.|+++||.||| +++|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999998743 23688999999999999999999 8899999999999999999999999
Q ss_pred cccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCC-CCCCccchhhHHhHHHHHHHh
Q 038905 560 DFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDC 638 (709)
Q Consensus 560 DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~ 638 (709)
|||+|+.+.............||+.|+| ||.+.+..++.++||||||+++|||++|. .|+......+ +...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~a-Pe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------~~~~ 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMS-PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRF 247 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHH
T ss_pred ecccceeccCCcceeeccceecccccCC-HHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 9999998766554444456689999999 99999999999999999999999999986 5665443322 1222
Q ss_pred hhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 639 YRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 639 ~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+.++....+ +...+..+.+++.+||+.+|.+||||++|+++|+...+
T Consensus 248 i~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 333332221 12345679999999999999999999999999988655
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=366.65 Aligned_cols=259 Identities=22% Similarity=0.354 Sum_probs=199.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEe-cCCCceEEEEEEcccc-cchhHHHHHHHHHHHhccCcCceeEEEeEEEc-CCeEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQ-TSTRTTVIVVKKLDRV-FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE-GQNRL 490 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~-~~~~~ 490 (709)
.+|.+.+|.| +|++| |++... .+.....||||+++.. .....++|.+|++++++++|||||+++|++.+ +...+
T Consensus 29 ~~~~~~iG~G--~fg~V-yk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 29 VHFNEVIGRG--HFGCV-YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEEE--TTEEE-EEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred eccceEEeec--CCeEE-EEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 3455554555 55555 555543 3334557999998753 34455789999999999999999999999865 46789
Q ss_pred EEEeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 569 (709)
+||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+|+||||||+||||++++.+||+|||+++.+..
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 9999999999999988654 5778889999999999999999 88999999999999999999999999999997754
Q ss_pred cccc--cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcccc
Q 038905 570 NQSK--AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 647 (709)
Q Consensus 570 ~~~~--~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l 647 (709)
.... .......||+.|+| ||.+.+..++.++||||||+++|||++|+.|+........ +...+..|+....
T Consensus 183 ~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------~~~~i~~g~~~~~ 255 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMA-LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRLLQ 255 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCCCC
T ss_pred cccccceecccccccccccC-hHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCCC
Confidence 4322 12234678999999 9999999999999999999999999998888764432111 1112223322111
Q ss_pred ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 648 VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 648 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
+...++.+.+++.+||+.||++||||.||++.|+++..
T Consensus 256 ---------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12345678999999999999999999999999998753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=366.99 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=207.1
Q ss_pred cccceeeeecCeeEEEEEEEEEEe--cCCCceEEEEEEccccc-chhHHHHHHHHHHHhcc-CcCceeEEEeEEEcCCeE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQ--TSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDEGQNR 489 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~~~~~ 489 (709)
+++.....+|.|+|+.||.+.... ....++.||||+++... .....+|.+|+.++.++ +|||||+++++|.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 455555556666666665544332 23577899999997543 33456799999999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhCC------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec
Q 038905 490 LLVYKFLNNGTLASFLFENL------------------KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD 551 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~ 551 (709)
++||||+++|+|.+++.+.. .+++..+..++.||++||+||| +++|+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence 99999999999999997643 4889999999999999999999 88999999999999999
Q ss_pred CCCCeEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhC-CCCCCccchhhHHh
Q 038905 552 DYYNAQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISC-RKSFDIEMGEEYAI 630 (709)
Q Consensus 552 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg-~~p~~~~~~~~~~~ 630 (709)
.++.+||+|||+++..............+||+.|+| ||.+.+..++.++|||||||++|||+++ .+|+......+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA-PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCC-HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcC-HHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999998776554444466889999999 9999999999999999999999999995 455544332221
Q ss_pred HHHHHHHhhhcCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 631 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 631 ~~~~~~~~~~~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
+.+.+..+.. ...+...+..+.+|+.+||+.||.+|||++||+++|++..
T Consensus 257 ----~~~~i~~~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 ----FYKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ----HHHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHhcCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1112222211 1112234577999999999999999999999999998753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-43 Score=362.64 Aligned_cols=257 Identities=19% Similarity=0.216 Sum_probs=195.9
Q ss_pred eeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccch-----hHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 419 SVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQD-----GEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 419 ~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
...+|.|+|+.||.+... .+++.||||+++..... ..+.+.+|+.++++++|||||++++++.++++.++||
T Consensus 3 l~~lG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDK---NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp EEEEEEETTEEEEEEECS---SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred ceEeccCcCeEEEEEEEC---CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehh
Confidence 345677777777655544 57889999998653221 1246889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccccc
Q 038905 494 KFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQSK 573 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 573 (709)
||+.++++..++.....+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 99999888877776778999999999999999999999 899999999999999999999999999999876654322
Q ss_pred cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC---Ccccccc
Q 038905 574 AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDDLVE 649 (709)
Q Consensus 574 ~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g---~~~~l~~ 649 (709)
. ...+||+.|+| ||++.. ..++.++|||||||++|||++|..||......+.... +.+..... .......
T Consensus 157 ~--~~~~gt~~y~a-PE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~---i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 157 Y--THQVVTRWYRA-PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp C--CCSCCCCTTCC-HHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSSSTTS
T ss_pred c--cceecChhhcc-HHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH---HHHhcCCCChhhccchhc
Confidence 2 45689999999 999865 4689999999999999999999999986654432221 11111100 0000000
Q ss_pred -------Ccccc----cCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 650 -------GDMEA----MNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 650 -------~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
..... ......++.+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 001123567999999999999999999999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=362.87 Aligned_cols=250 Identities=17% Similarity=0.202 Sum_probs=203.0
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV~ 493 (709)
++|.....+|.|+|+.||.+... .+++.||||.++... .....+.+|+++|++++|||||++++++.+++..+|||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~---~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVET---SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 34555566777777777665554 578899999987653 34467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC--CCCeEEcccccccccccc
Q 038905 494 KFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD--YYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 494 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~~ 570 (709)
|||+||+|.+++.+.. .+++.++..++.||+.||.||| +.+|+||||||+|||++. ...+||+|||+++.....
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999998765 6999999999999999999999 889999999999999985 457999999999876543
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... ....||+.|+| ||.+.+..++.++|||||||++|||++|+.||......+. ...+..+.... .
T Consensus 158 ~~~---~~~~~t~~y~a-pe~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-------~~~i~~~~~~~--~- 223 (321)
T d1tkia_ 158 DNF---RLLFTAPEYYA-PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-------IENIMNAEYTF--D- 223 (321)
T ss_dssp CEE---EEEESCGGGSC-HHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCCC--C-
T ss_pred Ccc---ccccccccccc-chhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCC--C-
Confidence 322 56789999998 9999999999999999999999999999999986654331 12222222110 0
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.......+..+.+++..||+.||++|||++|+++
T Consensus 224 ---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 ---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001123567889999999999999999999988
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-42 Score=370.79 Aligned_cols=250 Identities=21% Similarity=0.217 Sum_probs=200.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc---chhHHHHHH---HHHHHhccCcCceeEEEeEEEcC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF---QDGEKEFKN---EVVMIGQTYHKNLVRLLGFCDEG 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~nlv~l~~~~~~~ 486 (709)
.++|.....+|.|+|+.||.+... .+++.||||++.... ......+.+ |+.+++.++|||||++++++.+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~---~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred HHhCeeeeEEecCCCeEEEEEEEC---CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 467777777888888888766555 578899999985421 222333444 46777888899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 487 QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 487 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
+..++||||+++|+|.+++.+...+++..+..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+.
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999999998888999999999999999999999 89999999999999999999999999999997
Q ss_pred ccccccccceeccccCccccccccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 567 LTLNQSKAIKKAIRGTKGYVASPEWFR-NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 567 ~~~~~~~~~~~~~~Gt~~y~aaPE~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
+..... ...+||+.|+| ||++. +..++.++|||||||++|||++|+.||......+... +.+.......
T Consensus 157 ~~~~~~----~~~~GT~~y~A-PE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~~- 226 (364)
T d1omwa3 157 FSKKKP----HASVGTHGYMA-PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMAV- 226 (364)
T ss_dssp CSSSCC----CSCCSCGGGCC-HHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCCC-
T ss_pred cCCCcc----cccccccccch-hHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCCC-
Confidence 764332 55789999999 99986 4578999999999999999999999997654332211 1111111110
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
..+...+..+.+++..||+.||++||| ++|+++
T Consensus 227 ---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ---------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111234567899999999999999999 578875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=366.06 Aligned_cols=247 Identities=26% Similarity=0.308 Sum_probs=201.4
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc---cchhHHHHHHHHHHHh-ccCcCceeEEEeEEEcCCeEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV---FQDGEKEFKNEVVMIG-QTYHKNLVRLLGFCDEGQNRL 490 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~nlv~l~~~~~~~~~~~ 490 (709)
+|.....+|.|+|+.||.+... .+++.||||++++. ..+..+.+..|..++. .++|||||++++++.+++..+
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~---~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFK---KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CeEEeeEEecCCCcEEEEEEEC---CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 4555556666666667665554 57899999998643 2334566777777665 689999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 491 LVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 491 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
+||||+++|+|.+++.....+++..+..++.||+.||.||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999999998889999999999999999999999 889999999999999999999999999999876544
Q ss_pred ccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCccccccC
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 650 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~ 650 (709)
... .....||+.|+| ||++.+..++.++|||||||++|||++|+.||......+ +......+...
T Consensus 157 ~~~--~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~----- 221 (320)
T d1xjda_ 157 DAK--TNTFCGTPDYIA-PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF----- 221 (320)
T ss_dssp TCC--BCCCCSCGGGCC-HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-----
T ss_pred ccc--ccccCCCCCcCC-HHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC-----
Confidence 332 256789999999 999999999999999999999999999999998655433 12222222221
Q ss_pred cccccCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 038905 651 DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMR-KVSQ 687 (709)
Q Consensus 651 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~~ 687 (709)
.+...+..+.+++.+||+.||.+|||+. ++++
T Consensus 222 -----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 -----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1123456789999999999999999995 6754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=362.17 Aligned_cols=250 Identities=21% Similarity=0.228 Sum_probs=194.2
Q ss_pred ccccee-eeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhcc-CcCceeEEEeEEEc----CC
Q 038905 414 MNVTRS-VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQT-YHKNLVRLLGFCDE----GQ 487 (709)
Q Consensus 414 ~~f~~~-~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nlv~l~~~~~~----~~ 487 (709)
++|... ..+|.|+|+.||.+... .+++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~---~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNK---RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEEC---CCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 456543 34677777777666555 5688999999864 24577899887654 89999999999865 46
Q ss_pred eEEEEEeecCCCCHHHHHhhCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC---CCCeEEcccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENL--KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD---YYNAQISDFG 562 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFG 562 (709)
..++|||||+||+|.+++.+.+ .+++.++..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccc
Confidence 6899999999999999998753 6899999999999999999999 899999999999999975 5679999999
Q ss_pred ccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 563 LAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 563 la~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
+|+........ ....||+.|+| ||++.+..++.++|||||||++|||++|+.||.......... ........+
T Consensus 160 ~a~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~ 232 (335)
T d2ozaa1 160 FAKETTSHNSL---TTPCYTPYYVA-PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMG 232 (335)
T ss_dssp TCEECCCCCCC---CCCSCCCSSCC-CCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC
T ss_pred eeeeccCCCcc---ccccCCcccCC-cHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcC
Confidence 99877654332 56789999999 999999999999999999999999999999997543322110 011111111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
+.. .........++.+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSS------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 110 011111245678999999999999999999999988
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=352.84 Aligned_cols=263 Identities=19% Similarity=0.223 Sum_probs=197.9
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
++|.....+|.|+++.||.+... .+++.||||+++... +...+++.+|++++++++|||||++++++.++.+.++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEEC---CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 46777667777777777666665 568899999986543 2235789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccc
Q 038905 492 VYKFLNNGTLASFLFE-NLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLN 570 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 570 (709)
||||+.++.+...... ...+++..+..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9999987555444333 346999999999999999999999 889999999999999999999999999999877544
Q ss_pred ccccceeccccCcccccccccccCCC-CCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc---CCcc-
Q 038905 571 QSKAIKKAIRGTKGYVASPEWFRNST-ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLD- 645 (709)
Q Consensus 571 ~~~~~~~~~~Gt~~y~aaPE~~~~~~-~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---g~~~- 645 (709)
.... ....||+.|+| ||.+.... ++.++|||||||++|||++|+.||......+.... +...... ....
T Consensus 156 ~~~~--~~~~gt~~y~a-pE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~---i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 156 VRTY--THEVVTLWYRA-PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR---IFRTLGTPDEVVWPG 229 (298)
T ss_dssp SBCT--TCCBCCCTTCC-HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTT
T ss_pred cccc--eeecccceeee-hhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH---HHHhcCCCchhhccc
Confidence 3222 45689999999 99887665 57899999999999999999999986654332111 1111000 0000
Q ss_pred --ccccCc--cc-------ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 646 --DLVEGD--ME-------AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 646 --~l~~~~--~~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.+.+.. .. .......+..+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 00 00011334678999999999999999999999884
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=351.11 Aligned_cols=262 Identities=20% Similarity=0.241 Sum_probs=191.1
Q ss_pred eecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC----eEEEEEeec
Q 038905 421 LLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ----NRLLVYKFL 496 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~----~~~lV~Ey~ 496 (709)
.+|.|+|+.| |++.. +++.||||+++... .....++.|+..+.+++|||||++++++.+.+ ..++||||+
T Consensus 10 ~iG~G~fg~V-y~~~~----~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 10 SIGKGRFGEV-WRGKW----RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEECCSSSEE-EEEEE----TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEeeCCCeEE-EEEEE----CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 3455555555 55555 47899999986532 12223344566667889999999999997543 578999999
Q ss_pred CCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhc-----CCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 497 NNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVN-----CSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 497 ~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
++|+|.+++.+. .+++..+..++.|++.||.|||+. .+++|+||||||+||||+.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~ 162 (303)
T d1vjya_ 84 EHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp TTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred cCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCC
Confidence 999999999764 689999999999999999999943 13699999999999999999999999999998775443
Q ss_pred cc--cceeccccCcccccccccccCCC------CCcccchHHHHHHHHHHHhCCCCCCccchhhHH--------hHHHHH
Q 038905 572 SK--AIKKAIRGTKGYVASPEWFRNST------ITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTDWA 635 (709)
Q Consensus 572 ~~--~~~~~~~Gt~~y~aaPE~~~~~~------~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~ 635 (709)
.. .......||+.|+| ||++.+.. ++.++|||||||+||||++|..|+......... ......
T Consensus 163 ~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 163 DTIDIAPNHRVGTKRYMA-PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TEECC----CCSCGGGCC-HHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred cceeccccceecccCcCC-hhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 22 12245789999999 99987653 677999999999999999998887543211100 001111
Q ss_pred HHhhhcCCccccccCccc-ccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHccccc
Q 038905 636 FDCYRNGKLDDLVEGDME-AMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVVE 694 (709)
Q Consensus 636 ~~~~~~g~~~~l~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~~ 694 (709)
......+.. ++.+. .....+....+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 242 ~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 242 RKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111111 11111 11123466779999999999999999999999999988764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=351.62 Aligned_cols=240 Identities=23% Similarity=0.358 Sum_probs=194.7
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc------hhHHHHHHHHHHHhccC--cCceeEEEeEEEc
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ------DGEKEFKNEVVMIGQTY--HKNLVRLLGFCDE 485 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nlv~l~~~~~~ 485 (709)
++|.....+|.|+|+.||.+... .+++.||||++..... ....++.+|+.++++++ |||||++++++.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRV---SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CeEEEeEEEeeCCCeEEEEEEEC---CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 45666667777777877666555 5789999998864311 12234678999999987 8999999999999
Q ss_pred CCeEEEEEeecCC-CCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-CCCeEEccccc
Q 038905 486 GQNRLLVYKFLNN-GTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-YYNAQISDFGL 563 (709)
Q Consensus 486 ~~~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGl 563 (709)
.+..++||||+.+ +++.+++.+...+++..+..++.||+.||.||| +++|+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence 9999999999976 688888888888999999999999999999999 899999999999999985 47899999999
Q ss_pred cccccccccccceeccccCcccccccccccCCCC-CcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTI-TANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 642 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g 642 (709)
|+...... .+...||+.|+| ||++.+..+ +.++|||||||++|||++|+.||..... ...+
T Consensus 158 a~~~~~~~----~~~~~GT~~y~a-PE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~ 219 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSP-PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRG 219 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSC-HHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHC
T ss_pred ceeccccc----ccccccCCCcCC-HHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhc
Confidence 98754332 256789999999 999987765 6779999999999999999999964321 0111
Q ss_pred CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 643 KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 643 ~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... . +...++.+.+++.+||+.||++|||++|+++
T Consensus 220 ~~~--~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 QVF--F--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCC--C--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccC--C--------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 110 1 1123467899999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8e-41 Score=345.67 Aligned_cols=261 Identities=18% Similarity=0.186 Sum_probs=197.7
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLL 491 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~l 491 (709)
++|.....+|.|+|++||.+ .. .+++.||||++.... ....+++.+|+.+|++++|||||++++++.+.+..++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~-~~---~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKA-QN---NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEE-EE---TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceeccEEecCCCcEEEEE-Ee---CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 35666666777777777654 44 367899999986542 3335789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccccccc
Q 038905 492 VYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQ 571 (709)
Q Consensus 492 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 571 (709)
++||+.++.+..+......+++..+..++.||+.||.||| +.+||||||||+|||++.++.+||+|||++.......
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9999999888888777788999999999999999999999 8899999999999999999999999999998765433
Q ss_pred cccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc---CC---c
Q 038905 572 SKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GK---L 644 (709)
Q Consensus 572 ~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---g~---~ 644 (709)
... ....|++.|+| ||.+.+. .++.++|||||||++|||++|+.||......+.... +...... .. .
T Consensus 155 ~~~--~~~~~~~~y~~-pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 155 RKY--THEIVTLWYRA-PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNV 228 (286)
T ss_dssp ---------CCCTTCC-HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTG
T ss_pred ccc--ceecccchhhh-HHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH---HHHhhCCCChhhccch
Confidence 222 45678999999 9988754 579999999999999999999999976554332111 1110000 00 0
Q ss_pred ccc---------ccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 645 DDL---------VEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 645 ~~l---------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
... .............+..+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000001112234567899999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=345.41 Aligned_cols=266 Identities=19% Similarity=0.214 Sum_probs=196.7
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccc--hhHHHHHHHHHHHhcc---CcCceeEEEeEEEc--
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQ--DGEKEFKNEVVMIGQT---YHKNLVRLLGFCDE-- 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nlv~l~~~~~~-- 485 (709)
.++|.....+|.|+|+.||.+.... ..++.||||++..... .....+.+|+.+++.+ +|||||++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEEC--CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 5678877778888888887665542 2467899999864321 2233566777777665 79999999999853
Q ss_pred ---CCeEEEEEeecCCCCHHHHHhhC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccc
Q 038905 486 ---GQNRLLVYKFLNNGTLASFLFEN-LKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 486 ---~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
....+++|||++++.+....... ..+++..+..++.||+.||.||| +++|+||||||+|||+++++.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence 35679999999998776554433 46899999999999999999999 889999999999999999999999999
Q ss_pred cccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH----
Q 038905 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD---- 637 (709)
Q Consensus 562 Gla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~---- 637 (709)
|+++....... .....||+.|+| ||++.+..++.++||||+||++|||++|+.||......+..........
T Consensus 161 g~~~~~~~~~~---~~~~~gT~~Y~A-PE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 161 GLARIYSFQMA---LTSVVVTLWYRA-PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CSCCCCCGGGG---GCCCCCCCTTCC-HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhccccc---CCCcccChhhcC-cchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99987654332 267889999999 9999999999999999999999999999999987654332211111100
Q ss_pred -hhhcC-Cccccc--c--CcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 638 -CYRNG-KLDDLV--E--GDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 638 -~~~~g-~~~~l~--~--~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.+... ...... . ...........++.+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 000000 0 00001112234567889999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=340.37 Aligned_cols=269 Identities=15% Similarity=0.145 Sum_probs=197.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEc-----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE----- 485 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~----- 485 (709)
.++|.....+|.|+|++||.+... .+++.||||++... .+...+++.+|+.+|++++|+|++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHR---KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 456776667777777777666554 57899999998543 23345778999999999999999999999855
Q ss_pred ---CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccc
Q 038905 486 ---GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFG 562 (709)
Q Consensus 486 ---~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 562 (709)
..+.++||||++++.+.........++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecc
Confidence 3467999999998887776666678999999999999999999999 8899999999999999999999999999
Q ss_pred ccccccccccc--cceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhh
Q 038905 563 LAKLLTLNQSK--AIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 639 (709)
Q Consensus 563 la~~~~~~~~~--~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 639 (709)
+++.+...... ......+||+.|+| ||.+.+. .++.++|||||||++|||++|+.||......+............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~a-PE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRP-PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCC-HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eeeecccccccccccccceecCHHHhh-HHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99876543322 12244679999999 9998765 68999999999999999999999998665544332221111110
Q ss_pred hcCCcccc--------ccCcccccCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 640 RNGKLDDL--------VEGDMEAMND-------IKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 640 ~~g~~~~l--------~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
........ +......... ......+++++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000000 0000000000 1124467789999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=344.06 Aligned_cols=269 Identities=22% Similarity=0.216 Sum_probs=198.2
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCC---
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ--- 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~--- 487 (709)
..+|.....+|.|+|+.||.+... .+++.||||+++.. .....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDG---RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSEEEEEEC------CEEEEEET---TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 456777788999999999777655 57899999998753 2334567899999999999999999999997654
Q ss_pred ---eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccc
Q 038905 488 ---NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLA 564 (709)
Q Consensus 488 ---~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 564 (709)
+.++||||+ +.+|..++. ..++++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccce
Confidence 569999999 557777664 457999999999999999999999 889999999999999999999999999999
Q ss_pred ccccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH-----h
Q 038905 565 KLLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----C 638 (709)
Q Consensus 565 ~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----~ 638 (709)
+...... +...||+.|+| ||.+.+. .++.++||||+||++|||++|+.||......+.......... .
T Consensus 169 ~~~~~~~-----~~~~~t~~y~a-PE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQADSEM-----TGYVVTRWYRA-PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECCSSC-----CSSCSCGGGCC-THHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eccCCcc-----ccccccccccC-HHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 8765433 56789999999 9998764 578999999999999999999999976654322111110000 0
Q ss_pred hhcC----------CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HcccccCC
Q 038905 639 YRNG----------KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM--LEVVVEVD 696 (709)
Q Consensus 639 ~~~g----------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~~~~~~ 696 (709)
+... .......... ..........+.+|+.+||+.||.+|||++|+++. |+.+.+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence 0000 0000000000 11112345678899999999999999999999984 76655433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=344.48 Aligned_cols=265 Identities=20% Similarity=0.207 Sum_probs=195.6
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCceeEEEeEEEc------CC
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDE------GQ 487 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~------~~ 487 (709)
..|.....+|.|+||+||.+... .+++.||||++..... .+.+|+++|++++|+|||++++++.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLC---DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEEC---CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 35666667888888888776665 5789999999865432 33579999999999999999999853 33
Q ss_pred eEEEEEeecCCCCHHHHH---hhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEccccc
Q 038905 488 NRLLVYKFLNNGTLASFL---FENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQISDFGL 563 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l---~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGl 563 (709)
+.+|||||++++.+.... .....+++..+..++.||+.||.||| +++|+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccc
Confidence 578999999876443332 34457999999999999999999999 89999999999999999775 899999999
Q ss_pred cccccccccccceeccccCccccccccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHH--------
Q 038905 564 AKLLTLNQSKAIKKAIRGTKGYVASPEWFR-NSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW-------- 634 (709)
Q Consensus 564 a~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~-------- 634 (709)
++.+...... ....||+.|+| ||.+. ...++.++||||+||++|||++|+.||......+.......
T Consensus 170 a~~~~~~~~~---~~~~gt~~y~a-PE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 170 AKQLVRGEPN---VSYICSRYYRA-PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CEECCTTSCC---CSCCSCTTSCC-HHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhhccCCccc---ccccccccccC-hHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 9877544322 45789999999 88766 45789999999999999999999999976654332111100
Q ss_pred HHHhhh----cCCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHccc
Q 038905 635 AFDCYR----NGKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVV 692 (709)
Q Consensus 635 ~~~~~~----~g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~ 692 (709)
.+.... ....................+..+.+|+.+||+.||++|||+.|+++ .++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 001110 01111111111111122335667899999999999999999999996 35544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.3e-39 Score=333.37 Aligned_cols=261 Identities=16% Similarity=0.136 Sum_probs=203.3
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCc-CceeEEEeEEEcCCeEEEE
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYH-KNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nlv~l~~~~~~~~~~~lV 492 (709)
++|.....+|.|+|+.||.+... .+++.||||.+.... ..+++.+|++++..++| +|++.+++++.++...++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNL---LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET---TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 35666666777777777666555 578999999875432 33467889999999975 8999999999999999999
Q ss_pred EeecCCCCHHHHHhhCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecC-----CCCeEEcccccccc
Q 038905 493 YKFLNNGTLASFLFENL-KPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDD-----YYNAQISDFGLAKL 566 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DFGla~~ 566 (709)
|||+ +++|.+++.... .++...+..++.|++.||.||| +++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9998 689999987655 6999999999999999999999 999999999999999974 57899999999998
Q ss_pred ccccccc-----cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhc
Q 038905 567 LTLNQSK-----AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 641 (709)
Q Consensus 567 ~~~~~~~-----~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 641 (709)
+...... ......+||+.|+| ||.+.+..++.++|||||||++|||++|+.||..............+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~a-PE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMS-INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCC-HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcC-HHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 7543221 12246789999999 99999999999999999999999999999999765432221111111111111
Q ss_pred CCccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 642 GKLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 642 g~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
....++ ....++.+.+++..|++.+|++||+++.+.+.|+.+.
T Consensus 235 ~~~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 235 TPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp SCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CChHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111111 1123467889999999999999999999999888764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=340.72 Aligned_cols=257 Identities=21% Similarity=0.238 Sum_probs=205.4
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc----chhHHHHHHHHHHHhccCc-CceeEEEeEEEcCC
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF----QDGEKEFKNEVVMIGQTYH-KNLVRLLGFCDEGQ 487 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~nlv~l~~~~~~~~ 487 (709)
.++|.....+|.|+|+.||.+.......+++.||||.++... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 456777777777888888777666555678999999986432 2344678899999999976 89999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccccc
Q 038905 488 NRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLL 567 (709)
Q Consensus 488 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 567 (709)
..++||||+.+|+|.+++.....+.......++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999998888899999999999999999999 889999999999999999999999999999877
Q ss_pred cccccccceeccccCcccccccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCcc
Q 038905 568 TLNQSKAIKKAIRGTKGYVASPEWFRNS--TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 645 (709)
Q Consensus 568 ~~~~~~~~~~~~~Gt~~y~aaPE~~~~~--~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~~ 645 (709)
........ ....|++.|++ ||.+.+. .++.++|||||||+||||++|+.||......+.... +.+.......
T Consensus 180 ~~~~~~~~-~~~~g~~~~~~-pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~~~- 253 (322)
T d1vzoa_ 180 VADETERA-YDFCGTIEYMA-PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKSEP- 253 (322)
T ss_dssp CGGGGGGG-CGGGSCCTTCC-HHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHCCC-
T ss_pred cccccccc-cccccccccch-hHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccCCC-
Confidence 65443332 56789999999 9988654 478899999999999999999999976543221111 1111111111
Q ss_pred ccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 038905 646 DLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT-----MRKVSQ 687 (709)
Q Consensus 646 ~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~ 687 (709)
..+...+..+.+++..||+.||++||| ++|+++
T Consensus 254 ---------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ---------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 112245678999999999999999994 788876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=330.70 Aligned_cols=264 Identities=16% Similarity=0.165 Sum_probs=200.5
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEEcCCeEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQNRLLV 492 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~~~~lV 492 (709)
+|.....+|.|+|+.||.+... .+++.||||+++.. .....+++.+|+.++++++|||||++++++.+....++|
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEEC---CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 5666666777777777666555 57889999998543 234567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccccccc
Q 038905 493 YKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLTLNQS 572 (709)
Q Consensus 493 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 572 (709)
+|++.+++|..++.....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||.|+.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999999999888888999999999999999999999 88999999999999999999999999999988765433
Q ss_pred ccceeccccCcccccccccccCCC-CCcccchHHHHHHHHHHHhCCCCCCccchh-hHHhHHHHHHHhhhcCCccc----
Q 038905 573 KAIKKAIRGTKGYVASPEWFRNST-ITANVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDWAFDCYRNGKLDD---- 646 (709)
Q Consensus 573 ~~~~~~~~Gt~~y~aaPE~~~~~~-~s~k~DvwSlGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~g~~~~---- 646 (709)
.. ....+++.|.+ ||.+.+.. ++.++|||||||++|||++|+.||...... +...................
T Consensus 157 ~~--~~~~~~~~~~~-pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 CY--SAEVVTLWYRP-PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CC--CSCCSCGGGCC-HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cc--eeeccccchhh-hhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 21 34456666666 99987665 689999999999999999999997544332 21111111000000000000
Q ss_pred --------cccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 647 --------LVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 647 --------l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.................+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000111112234567889999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-39 Score=340.58 Aligned_cols=267 Identities=19% Similarity=0.187 Sum_probs=196.8
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc-chhHHHHHHHHHHHhccCcCceeEEEeEEEcCC----e
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF-QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEGQ----N 488 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~~----~ 488 (709)
.+|.....+|.|+|++||.+... .+++.||||++.... ....+++.+|+.+|++++|||||++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDN---VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEET---TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCeEEEEEEeeccCeEEEEEEEC---CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 45777788888888888777655 678899999987543 334568899999999999999999999996543 2
Q ss_pred EEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEcccccccccc
Q 038905 489 RLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAKLLT 568 (709)
Q Consensus 489 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 568 (709)
.+++++|+.+|+|.+++... .+++..+..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+...
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 35556677799999999654 6899999999999999999999 8899999999999999999999999999998765
Q ss_pred ccccc-cceeccccCcccccccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcC----
Q 038905 569 LNQSK-AIKKAIRGTKGYVASPEWFRN-STITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---- 642 (709)
Q Consensus 569 ~~~~~-~~~~~~~Gt~~y~aaPE~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g---- 642 (709)
..... ......+||+.|+| ||.+.. ..++.++||||+||++|||++|+.||......+...............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~a-PE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRA-PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCC-GGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceech-HHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 44322 22256789999999 999854 567899999999999999999999997665432221111110000000
Q ss_pred Cc--------cccccC--cccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 643 KL--------DDLVEG--DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 643 ~~--------~~l~~~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
.. ..+... ..........+..+++++.+||+.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000000 00000011234578899999999999999999999984
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-39 Score=333.49 Aligned_cols=260 Identities=17% Similarity=0.123 Sum_probs=193.1
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccCcCc-eeEEEeEEEcCCeEEEEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKN-LVRLLGFCDEGQNRLLVY 493 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-lv~l~~~~~~~~~~~lV~ 493 (709)
+|.....+|.|+|+.||.+... .+++.||||.+.... ..+++..|++++++++|+| |+.+..+..+++..++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEEC---CCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4666666677777777655544 568899999876532 3346889999999998766 455566668888999999
Q ss_pred eecCCCCHHHHHh-hCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeec---CCCCeEEccccccccccc
Q 038905 494 KFLNNGTLASFLF-ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLD---DYYNAQISDFGLAKLLTL 569 (709)
Q Consensus 494 Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~~~~ 569 (709)
||+.+ +|...+. ....+++..+..++.|++.||.||| +++|+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99955 5555554 4557999999999999999999999 89999999999999875 456799999999998764
Q ss_pred cccc-----cceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHHhhhcCCc
Q 038905 570 NQSK-----AIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 644 (709)
Q Consensus 570 ~~~~-----~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~g~~ 644 (709)
.... .......||+.|+| ||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYAS-INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCC-HHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred cccccceeccccCCcCCCccccC-HHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 3321 12246789999999 99999999999999999999999999999999765432211111111110000000
Q ss_pred cccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHcccc
Q 038905 645 DDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQMLEVVV 693 (709)
Q Consensus 645 ~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~~~ 693 (709)
..+ ....+..+.+++..|++.+|++||+++++.++|+...
T Consensus 238 ~~~---------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 238 EVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHH---------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred hHh---------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 000 1124567899999999999999999999999888753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-38 Score=332.62 Aligned_cols=259 Identities=19% Similarity=0.243 Sum_probs=197.6
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEc--CCeE
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDE--GQNR 489 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~--~~~~ 489 (709)
.++|.....+|.|+|++||.+... .+++.||||+++.. ..+++.+|+.+|.+++ ||||+++++++.. ....
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINI---TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 456887778888888888777665 67899999998753 3567899999999995 9999999999874 4568
Q ss_pred EEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCC-CeEEcccccccccc
Q 038905 490 LLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYY-NAQISDFGLAKLLT 568 (709)
Q Consensus 490 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~ 568 (709)
++||||+.+++|..+. ..+++..+..++.||+.||.||| +++|+||||||+|||++.++ .+||+|||+|+...
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999999987764 35899999999999999999999 89999999999999998765 59999999998776
Q ss_pred ccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHH--hHHHH-----HHHhhh
Q 038905 569 LNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYA--ILTDW-----AFDCYR 640 (709)
Q Consensus 569 ~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--~~~~~-----~~~~~~ 640 (709)
..... ....||+.|+| ||.+.+. .++.++||||+||+++||++|+.||......... ..... ......
T Consensus 182 ~~~~~---~~~~~t~~y~a-PE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 182 PGQEY---NVRVASRYFKG-PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp TTCCC---CSCCSCGGGCC-HHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCCcc---cccccCccccC-cccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 54322 56789999998 9998765 4799999999999999999999999765432111 00000 000000
Q ss_pred cCCc------cccc--------cCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 038905 641 NGKL------DDLV--------EGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ 687 (709)
Q Consensus 641 ~g~~------~~l~--------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~ 687 (709)
.... .... ............+..+.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000 000111111234567899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=330.90 Aligned_cols=262 Identities=22% Similarity=0.235 Sum_probs=190.2
Q ss_pred cccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccc--cchhHHHHHHHHHHHhccCcCceeEEEeEEE------c
Q 038905 414 MNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRV--FQDGEKEFKNEVVMIGQTYHKNLVRLLGFCD------E 485 (709)
Q Consensus 414 ~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~------~ 485 (709)
++|.....+|.|+|++||.+... .+++.||||++... ......++.+|+.++++++|||||++++++. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~---~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEET---TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEEEEeecCcCeEEEEEEEC---CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 56888888999999999877665 57899999998643 2334567899999999999999999999995 3
Q ss_pred CCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 486 GQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 486 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
..+.++||||+.++.+. .+. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+|++|||+++
T Consensus 94 ~~~~~iv~Ey~~~~l~~-~~~--~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEEHHH-HHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CceeEEEEeccchHHHH-hhh--cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence 46889999999775554 443 45899999999999999999999 8899999999999999999999999999998
Q ss_pred cccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHH-HHH---------
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-DWA--------- 635 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~-~~~--------- 635 (709)
........ ....||+.|+| ||++.+..++.++||||+||+++||++|+.||............ ...
T Consensus 168 ~~~~~~~~---~~~~~t~~y~a-PE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 168 TAGTSFMM---TPYVVTRYYRA-PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp ----------------CCTTCC-HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccccc---ccccccccccC-hhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 76544322 56789999999 99999999999999999999999999999999765432211100 000
Q ss_pred -----HHhhhcCCc-------cccccCcc---cccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 038905 636 -----FDCYRNGKL-------DDLVEGDM---EAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQM 688 (709)
Q Consensus 636 -----~~~~~~g~~-------~~l~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~ 688 (709)
......+.. ........ ........+..+.+|+.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000001100 00000000 011123456789999999999999999999999873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-38 Score=334.16 Aligned_cols=268 Identities=22% Similarity=0.211 Sum_probs=198.1
Q ss_pred ccccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEccccc--chhHHHHHHHHHHHhccCcCceeEEEeEEEcC----
Q 038905 413 MMNVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF--QDGEKEFKNEVVMIGQTYHKNLVRLLGFCDEG---- 486 (709)
Q Consensus 413 ~~~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nlv~l~~~~~~~---- 486 (709)
+++|.....+|.|+|+.||.+... .+++.||||+++... ....+++.+|+.+|++++|||+|++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDT---KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEET---TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 456777778888888888777655 678999999987543 23446789999999999999999999998633
Q ss_pred -CeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 487 -QNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 487 -~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
...+++++|+.+|+|.+++.. .++++..+..++.||+.||.||| +++|+||||||+|||++.++.+|++|||++.
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence 344677788889999998854 47999999999999999999999 8899999999999999999999999999997
Q ss_pred cccccccccceeccccCcccccccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCccchhhHHhHHHHHHH-----hh
Q 038905 566 LLTLNQSKAIKKAIRGTKGYVASPEWFRNS-TITANVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----CY 639 (709)
Q Consensus 566 ~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~-~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~ 639 (709)
...... ....||+.|+| ||.+.+. .++.++|||||||++|||++|+.||................. ..
T Consensus 170 ~~~~~~-----~~~~g~~~y~a-pE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 170 HTDDEM-----TGYVATRWYRA-PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CCTGGG-----SSSCHHHHTSC-HHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCccc-----ccccccccccC-chhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 654332 56779999999 9987665 568999999999999999999999986654322111100000 00
Q ss_pred hcC----------CccccccCcccccCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHccccc
Q 038905 640 RNG----------KLDDLVEGDMEAMNDIKCVEKLVMVSIWCIQEDPSLRPTMRKVSQ--MLEVVVE 694 (709)
Q Consensus 640 ~~g----------~~~~l~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~~~~ 694 (709)
... ........... ......+..+++|+.+||+.||++|||++|+++ .+....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 000 00000000000 001123567889999999999999999999998 5655443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9e-33 Score=294.84 Aligned_cols=277 Identities=20% Similarity=0.208 Sum_probs=193.6
Q ss_pred ccceeeeecCeeEEEEEEEEEEecCCCceEEEEEEcccccchhHHHHHHHHHHHhccC-----------cCceeEEEeEE
Q 038905 415 NVTRSVLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-----------HKNLVRLLGFC 483 (709)
Q Consensus 415 ~f~~~~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nlv~l~~~~ 483 (709)
+|.....+|.|+|+.||.+... .+++.||||++.... ...+.+.+|+.++++++ |+|||++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~---~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDM---VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4776777777777777666555 578999999987643 23467888999988875 57899999887
Q ss_pred Ec--CCeEEEEEeecCCCCHH-HHHh--hCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCC---
Q 038905 484 DE--GQNRLLVYKFLNNGTLA-SFLF--ENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYN--- 555 (709)
Q Consensus 484 ~~--~~~~~lV~Ey~~~gsL~-~~l~--~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~--- 555 (709)
.. ....+++++++..+... .... ....+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence 54 35566777776555432 2222 23468889999999999999999993 378999999999999986654
Q ss_pred ---eEEccccccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHHHHHHhCCCCCCccchhhH----
Q 038905 556 ---AQISDFGLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLLLEIISCRKSFDIEMGEEY---- 628 (709)
Q Consensus 556 ---~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~---- 628 (709)
+|++|||.++...... ....||+.|+| ||++.+..++.++||||+||+++||++|+.||........
T Consensus 168 ~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY-----TNSIQTREYRS-PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EEEEEECCCTTCEETTBCC-----CSCCSCGGGCC-HHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cceeeEeeccccccccccc-----ccccccccccC-hhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 9999999998654332 56779999998 9999999999999999999999999999999976543111
Q ss_pred HhHHHHHHH-------hhhcC-----------CccccccC---------cccccCCHHHHHHHHHHHHhcccCCCCCCCC
Q 038905 629 AILTDWAFD-------CYRNG-----------KLDDLVEG---------DMEAMNDIKCVEKLVMVSIWCIQEDPSLRPT 681 (709)
Q Consensus 629 ~~~~~~~~~-------~~~~g-----------~~~~l~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 681 (709)
..+...+.. ....+ ....+... ..........+..+.+++..||+.||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111100000 00000 00000000 0011223567788999999999999999999
Q ss_pred HHHHHHH--Hcc---cccCCCCCCCCC
Q 038905 682 MRKVSQM--LEV---VVEVDVPPNPST 703 (709)
Q Consensus 682 ~~ev~~~--L~~---~~~~~~p~~p~~ 703 (709)
++|+++. ++. ..++..|+.|..
T Consensus 322 a~e~L~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 322 AGGLVNHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp HHHHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred HHHHhcCcccCCCCCcccCCCCCcccC
Confidence 9999984 543 235556655543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.77 E-value=2.8e-19 Score=171.36 Aligned_cols=166 Identities=13% Similarity=0.081 Sum_probs=112.5
Q ss_pred eeecCeeEEEEEEEEEEecCCCceEEEEEEccccc------------------chhHHHHHHHHHHHhccCcCceeEEEe
Q 038905 420 VLLGSSVFVNFTLVGVIQTSTRTTVIVVKKLDRVF------------------QDGEKEFKNEVVMIGQTYHKNLVRLLG 481 (709)
Q Consensus 420 ~~~G~g~~~~v~~~~~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~nlv~l~~ 481 (709)
..+|.|+++.| |.+.. .+++.||||.+.... ......+..|...+.++.|.+++..++
T Consensus 6 ~~IG~G~~g~V-y~a~~---~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 6 KLMGEGKESAV-FNCYS---EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEECSSEEE-EEEEE---TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CEeeeCcceEE-EEEEC---CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 34555555555 55554 467899999764211 011234567889999999999998886
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCceeecCCCCeEEccc
Q 038905 482 FCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANIAFQIARGLLHLHVNCSSQIIHCDIKPQNILLDDYYNAQISDF 561 (709)
Q Consensus 482 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 561 (709)
+. ..+++|||+++..+.. ++......++.|++++|.||| +.+|+||||||+|||+++++ ++|+||
T Consensus 82 ~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred ec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEEC
Confidence 53 2379999998865433 445566789999999999999 88999999999999999654 899999
Q ss_pred cccccccccccccceeccccCcccccccccccCCCCCcccchHHHHHHH
Q 038905 562 GLAKLLTLNQSKAIKKAIRGTKGYVASPEWFRNSTITANVDVYSFGVLL 610 (709)
Q Consensus 562 Gla~~~~~~~~~~~~~~~~Gt~~y~aaPE~~~~~~~s~k~DvwSlGvvl 610 (709)
|+|+............+ ....+ .|++ ...|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~~l~r---d~~~~--~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWREILER---DVRNI--ITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHHHHHH---HHHHH--HHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHHHHHH---HHHHH--HHHH-cCCCCCcccHHHHHHHH
Confidence 99987653322110000 00000 1222 35678899999975433
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.50 E-value=3.5e-14 Score=122.26 Aligned_cols=96 Identities=18% Similarity=0.429 Sum_probs=76.1
Q ss_pred cccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEec
Q 038905 27 NGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTA 106 (709)
Q Consensus 27 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~ 106 (709)
+|+|.+||.|.+ +++|+| |.|.|+|...++ |.|+. ..++||.||++ .+ ..++.|.|..
T Consensus 1 tDtL~~gq~L~~---g~~l~~--g~~~l~~q~DGN---------Lvly~----~~~~vW~s~~~---~~-~~~~~l~l~~ 58 (112)
T d1xd5a_ 1 SDRLNSGHQLDT---GGSLAE--GGYLFIIQNDCN---------LVLYD----NNRAVWASGTN---GK-ASGCVLKMQN 58 (112)
T ss_dssp CCEEETTEEECT---TCEEEE--TTEEEEECTTSC---------EEEEE----TTEEEEECCCT---TS-CSSEEEEECT
T ss_pred CCEecCCCEecC---CCEEEE--CCEEEEEcCCCC---------EEEEc----CCcEEEEccCc---cC-CCCcEEEEec
Confidence 489999999999 789974 999999975433 34544 35899999998 55 3457899999
Q ss_pred CccEEEEcCCCcEEEeec--------c--------EEEeccCCceeeeecCCCCC
Q 038905 107 DQGLVLNDPQGKQVWSSK--------L--------ILVQSFSSSRLWDSFSNPTD 145 (709)
Q Consensus 107 ~G~L~l~~~~g~~vWss~--------~--------~vl~~~~~~~lWQSFd~PtD 145 (709)
||+|+|.|. +..+|+++ . .||++.++.++|||+.+|+|
T Consensus 59 dGnLvl~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 59 DGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp TSCEEEEET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred cccEEEEec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 999999996 45666653 1 18888889999999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.43 E-value=7e-13 Score=112.94 Aligned_cols=107 Identities=21% Similarity=0.406 Sum_probs=82.6
Q ss_pred ccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEecC
Q 038905 28 GTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTAD 107 (709)
Q Consensus 28 ~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~~ 107 (709)
|+|.+|+.|.+ ++.|. +|.|.|+|...++ |.++. ..++||+||++ .|+...+.|.|+.|
T Consensus 2 ~~L~~g~~L~~---g~~l~--~g~~~l~~q~dgn---------Lvl~~----~~~~vW~ant~---~~~~~~~~l~l~~d 60 (109)
T d1kj1a_ 2 NLLTNGEGLYA---GQSLD--VEPYHFIMQEDCN---------LVLYD----HSTSVWASNTG---ILGKKGCKAVLQSD 60 (109)
T ss_dssp CEEETTCEEET---TCEEE--ETTEEEEECTTSC---------EEEEE----TTEEEEECCCC---CTTCCCCEEEECTT
T ss_pred CCccCCCEEeC---CCEEE--eCCEEEEecCCCe---------EEEEe----CCEEEEEeCCC---CCCceeEEEEEcCC
Confidence 78999999998 68886 5889999964322 34443 35789999999 88888899999999
Q ss_pred ccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEE
Q 038905 108 QGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNI 187 (709)
Q Consensus 108 G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~ 187 (709)
|+|||.|++|++||+|++ ..+.|.|.+.|+++|+++++
T Consensus 61 GnLvl~~~~g~~vW~s~t-----------------------------------------~~~~~~~~l~L~ddGNlvly- 98 (109)
T d1kj1a_ 61 GNFVVYDAEGRSLWASHS-----------------------------------------VRGNGNYVLVLQEDGNVVIY- 98 (109)
T ss_dssp SCEEEECSSSCEEEECCC-----------------------------------------CCCSSCCEEEECTTSCEEEE-
T ss_pred ceEEEEeCCCcEEEEEee-----------------------------------------ECCCCCEEEEEeCCCcEEEE-
Confidence 999999999998888731 11346788888889988876
Q ss_pred ecCCCCCCccceeecccc
Q 038905 188 ANLPTDLAYDAYYISGTY 205 (709)
Q Consensus 188 ~~~~~~~~~~~yw~s~~~ 205 (709)
....|.|+++
T Consensus 99 --------~~~~W~S~t~ 108 (109)
T d1kj1a_ 99 --------GSDIWSTGTY 108 (109)
T ss_dssp --------CCEEEECCCC
T ss_pred --------CCCEecCCCc
Confidence 2357776654
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.38 E-value=4.5e-13 Score=114.09 Aligned_cols=94 Identities=20% Similarity=0.400 Sum_probs=72.2
Q ss_pred cccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEec
Q 038905 27 NGTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTA 106 (709)
Q Consensus 27 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~ 106 (709)
+|+|.+|+.|.+ +++|. +|.|.|.|...++ |.|+. ..++||.||++ .| ...+.|.+..
T Consensus 1 ~~~L~~g~~L~~---G~~l~--ng~~~l~~q~DGN---------Lvly~----~~~~vW~s~~~---~~-~~~~~l~l~~ 58 (108)
T d1jpca_ 1 DNILYSGETLST---GEFLN--YGSFVFIMQEDCN---------LVLYD----VDKPIWATNTG---GL-SRSCFLSMQT 58 (108)
T ss_dssp CCEEETTEEECT---TCEEE--ETTEEEEECTTSC---------EEEEE----TTEEEEECCCT---TS-CSSCEEEECT
T ss_pred CCCccCCCEecC---CCEEE--cCCEEEEECCCCe---------EEEEe----CCceeeEeCCC---CC-CCccEEEEec
Confidence 378999999988 68885 6999999986543 35554 35789999998 55 3456899999
Q ss_pred CccEEEEcCCCcEEEeecc--------EEEeccC-----CceeeeecCC
Q 038905 107 DQGLVLNDPQGKQVWSSKL--------ILVQSFS-----SSRLWDSFSN 142 (709)
Q Consensus 107 ~G~L~l~~~~g~~vWss~~--------~vl~~~~-----~~~lWQSFd~ 142 (709)
+|+|+|.|++|.+||+|++ ++|.|.. +..+||||+|
T Consensus 59 ~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~~~W~S~t~ 107 (108)
T d1jpca_ 59 DGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTDRWATGTH 107 (108)
T ss_dssp TSCEEEECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEECCCCCCCCC
T ss_pred cceEEEECCCccceEEccccCCCCcEEEEEcCCCCEEEeCCCcccCCCC
Confidence 9999999999999999852 2333221 2468999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.35 E-value=4.7e-13 Score=115.99 Aligned_cols=86 Identities=26% Similarity=0.348 Sum_probs=72.4
Q ss_pred EEEEeeCCCCcEEEEccCCCCCCCCC-CCcEEEEecCccEEEEcCCCcEEEeecc----------------EEEeccCCc
Q 038905 72 SIFYNKIPKKIVVWYTDNEDQNPVVP-RGSQVKLTADQGLVLNDPQGKQVWSSKL----------------ILVQSFSSS 134 (709)
Q Consensus 72 gIw~~~~~~~t~VW~Anr~~~~~p~~-~~~~L~l~~~G~L~l~~~~g~~vWss~~----------------~vl~~~~~~ 134 (709)
-|||..+++++++|++|++ .|+. ...+|.+..||||+|.+. +.++|++++ .||+|.++.
T Consensus 11 ~il~~~~~~~~~~~~l~~~---q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~ 86 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHAT---QSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNI 86 (120)
T ss_dssp EECCCC--CCCCCCEECSS---CCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTE
T ss_pred eEEEcCCCCCCcccEEcCC---CeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCC
Confidence 4999999999999999999 8988 456999999999999985 678998751 188899999
Q ss_pred eeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEE
Q 038905 135 RLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLN 186 (709)
Q Consensus 135 ~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~ 186 (709)
++||||. +.++|.|.+.||+||++.+|
T Consensus 87 ~lW~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 87 AVWTSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EEEECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EEEEeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9999983 34678999999999999987
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.17 E-value=9.6e-12 Score=106.42 Aligned_cols=95 Identities=19% Similarity=0.256 Sum_probs=77.3
Q ss_pred EEEeeCCCCcEEEEccCCCCCCCCC-CCcEEEEecCccEEEEcCCCcEEEeecc---------------EEEeccCCcee
Q 038905 73 IFYNKIPKKIVVWYTDNEDQNPVVP-RGSQVKLTADQGLVLNDPQGKQVWSSKL---------------ILVQSFSSSRL 136 (709)
Q Consensus 73 Iw~~~~~~~t~VW~Anr~~~~~p~~-~~~~L~l~~~G~L~l~~~~g~~vWss~~---------------~vl~~~~~~~l 136 (709)
|||.-.++.+..|+.+.+ .++. ...+|.+..||||||.+ .+.++|++++ .||+|.++.+|
T Consensus 3 ~~~~~~~~~~~~~tl~~~---~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~v 78 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAA---QSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIR 78 (115)
T ss_dssp CCBCSSSSSCSCSCCCTT---CEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCS
T ss_pred EEEecCCCCCCcceecCC---CcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEE
Confidence 677766677888999999 8887 45689999999999988 5678999851 18888888999
Q ss_pred eeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccc
Q 038905 137 WDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTY 205 (709)
Q Consensus 137 WQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~ 205 (709)
|||+. +.++|.|.+.|++||+++++ ..++|.+|+-
T Consensus 79 WsS~t-------------------------~~~~g~y~l~Lq~DGNlvlY---------~~~~Wssgt~ 113 (115)
T d1dlpa1 79 WSSGT-------------------------KGSIGNYVLVLQPDRTVTIY---------GPGLWDSGTS 113 (115)
T ss_dssp CCCCC-------------------------CCCSSCCEEEECSSSCEEEE---------CSEEEECSCC
T ss_pred EEcCC-------------------------CCCCCCEEEEECCCCcEEEe---------CCCeecCCCC
Confidence 99873 34689999999999999877 3479998764
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.05 E-value=5.1e-10 Score=95.66 Aligned_cols=111 Identities=24% Similarity=0.292 Sum_probs=80.4
Q ss_pred CCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccc
Q 038905 144 TDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESG 223 (709)
Q Consensus 144 tDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~ 223 (709)
||||+|||.|..++.|++ |.|+|.|+.||+++++. . ..++|.++..+. ..+..+.+..+|
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~-~------~~~vW~s~~~~~----~~~~~l~l~~dG 60 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYD-N------NRAVWASGTNGK----ASGCVLKMQNDG 60 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEE-T------TEEEEECCCTTS----CSSEEEEECTTS
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEc-C------CcEEEEccCccC----CCCcEEEEeccc
Confidence 899999999999999964 89999999999998873 2 467898776542 334568888999
Q ss_pred eEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEEeecCCCCCeEEEEeccCCCc
Q 038905 224 YMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSFYLKNGNGNWSVVWSQPENIC 284 (709)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~~~~~~~~~W~~~~~~p~~~C 284 (709)
.+.+.+.+ ..+.-+. .......++++|+.||+|++|.- .....|+...+.|
T Consensus 61 nLvl~~~~-~~~w~s~---t~~~~~~~~l~L~ddGNlvly~~------~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 61 NLVIYSGS-RAIWASN---TNRQNGNYYLILQRDRNVVIYDN------SNNAIWATHTNVG 111 (112)
T ss_dssp CEEEEETT-EEEEECC---CCCSCCCCEEEECTTSCEEEECT------TSCEEEECCCCCC
T ss_pred cEEEEecC-CeEEEEe---eccCCCceEEEEcCCCCEEEECC------CCcEEecCCCccC
Confidence 88776643 3322221 11223447899999999998842 1246788877766
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.97 E-value=2.9e-09 Score=91.30 Aligned_cols=103 Identities=21% Similarity=0.330 Sum_probs=77.1
Q ss_pred ccccCCCccccCCCCCcEEcCCCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEecC
Q 038905 28 GTVPVGSTLTAGTDSSPWLSPSGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTAD 107 (709)
Q Consensus 28 ~~i~~g~~l~~~~~~~~lvS~~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~~ 107 (709)
++|.+||+|.. .+..|.|.|.|-..++ +- + |. ..++||.+|+. .+. ..+.|.|..|
T Consensus 15 ~~l~~~q~l~~-------~~~~~~y~l~mQ~DGN-------LV--L-y~---~~~~vWssnt~---~~~-~~~~l~l~~d 70 (119)
T d1b2pa_ 15 QILHATESLEI-------LFGTHVYRFIMQTDCN-------LV--L-YD---NNNPIWATNTG---GLG-NGCRAVLQPD 70 (119)
T ss_dssp CEEETTCEEEE-------EETTEEEEEEECTTSC-------EE--E-EE---TTEEEEECCCT---TSC-SSCEEEECTT
T ss_pred CEEeCCCeEEE-------ecCCceEEEEECCCCc-------EE--E-EE---CCeEEEEecCC---CCC-cceEEEEEeC
Confidence 56777777743 6779999999875443 42 2 43 36789999987 443 4578999999
Q ss_pred ccEEEEcCCCcEEEeeccEEEeccCCceeeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEE
Q 038905 108 QGLVLNDPQGKQVWSSKLILVQSFSSSRLWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNI 187 (709)
Q Consensus 108 G~L~l~~~~g~~vWss~~~vl~~~~~~~lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~ 187 (709)
|+|+|.|++|.+||++++ .-+.|.|.+.|++||+++++
T Consensus 71 GnLvL~d~~g~~vWsS~t-----------------------------------------~~~~~~~~l~Lq~DGNlvlY- 108 (119)
T d1b2pa_ 71 GVLVVITNENVTVWQSPV-----------------------------------------AGKAGHYVLVLQPDRNVVIY- 108 (119)
T ss_dssp SCEEEECTTCCEEEECSC-----------------------------------------CCCSSCEEEEECTTSCEEEE-
T ss_pred CCEEEECCCCcEEEECCC-----------------------------------------cCCCCceEEEEcCCCCEEEE-
Confidence 999999999988888631 11457889999999999987
Q ss_pred ecCCCCCCccceeeccc
Q 038905 188 ANLPTDLAYDAYYISGT 204 (709)
Q Consensus 188 ~~~~~~~~~~~yw~s~~ 204 (709)
..+.|.|++
T Consensus 109 --------g~~~W~S~T 117 (119)
T d1b2pa_ 109 --------GDALWATQT 117 (119)
T ss_dssp --------ESEEEECCC
T ss_pred --------CCCEeccCC
Confidence 246888765
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.90 E-value=2.4e-09 Score=92.16 Aligned_cols=107 Identities=18% Similarity=0.167 Sum_probs=75.1
Q ss_pred EeccCCceee--eecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccc
Q 038905 128 VQSFSSSRLW--DSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTY 205 (709)
Q Consensus 128 l~~~~~~~lW--QSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~ 205 (709)
++++.+.++| +|+|.|++||.++|.|. .|.|+|.|+.||++.++. . ...||.+...
T Consensus 5 ~~~~~n~il~~~~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~-~------~~~vW~s~t~ 62 (120)
T d1dlpa2 5 VANNGNSILYSTQGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFD-R------DDRVWSTNTA 62 (120)
T ss_dssp CSSCCCEECCCC--CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEB-T------TBCCSCCCCC
T ss_pred EEeCCCeEEEcCCCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEec-C------CcEEEEEccc
Confidence 3444445555 78999999999999873 577999999999998772 2 4578887654
Q ss_pred cCCCCCCCcceEEecccceEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEE
Q 038905 206 DSTNSSNSGYQVMFNESGYMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQS 263 (709)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~ 263 (709)
.. .....+.+..+|.+.+.+.++..+..+... .....++++|++||++++|
T Consensus 63 ~~----~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~---~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 63 GK----GTGCRAVLQPNGRMDVLTNQNIAVWTSGNS---RSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp SS----CSSCEEEEETTTEEEEEETTTEEEEECCCC---CSSSCCEEEECSSSCEEEE
T ss_pred cC----CCcEEEEEeCCeeEEEEcCCCCEEEEeCCC---CCCCcEEEEECCCCcEEEe
Confidence 32 234567788889888887777665544321 1122358999999999998
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.79 E-value=1.3e-08 Score=87.11 Aligned_cols=104 Identities=16% Similarity=0.152 Sum_probs=77.8
Q ss_pred eeeecCCCCCccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcc
Q 038905 136 LWDSFSNPTDTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGY 215 (709)
Q Consensus 136 lWQSFd~PtDtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~ 215 (709)
-||++|.|.+||-+||.|. +. .+.|+|+|.|+.||+++++- . ..+||.+...+. ....
T Consensus 6 s~~~~~~~~~~l~~~q~l~----~~-------~~~~~y~l~mQ~DGNLVLy~-~------~~~vWssnt~~~----~~~~ 63 (119)
T d1b2pa_ 6 SKQPDDNHPQILHATESLE----IL-------FGTHVYRFIMQTDCNLVLYD-N------NNPIWATNTGGL----GNGC 63 (119)
T ss_dssp CSCSSSCCCCEEETTCEEE----EE-------ETTEEEEEEECTTSCEEEEE-T------TEEEEECCCTTS----CSSC
T ss_pred eeecCCCCCCEEeCCCeEE----Ee-------cCCceEEEEECCCCcEEEEE-C------CeEEEEecCCCC----Ccce
Confidence 4899999999999999872 12 25899999999999998872 2 468999876532 3345
Q ss_pred eEEecccceEEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 216 QVMFNESGYMYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
.+.+..+|.+.+.+.++..+..+.. .......|++|+.||++++|.
T Consensus 64 ~l~l~~dGnLvL~d~~g~~vWsS~t---~~~~~~~~l~Lq~DGNlvlYg 109 (119)
T d1b2pa_ 64 RAVLQPDGVLVVITNENVTVWQSPV---AGKAGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp EEEECTTSCEEEECTTCCEEEECSC---CCCSSCEEEEECTTSCEEEEE
T ss_pred EEEEEeCCCEEEECCCCcEEEECCC---cCCCCceEEEEcCCCCEEEEC
Confidence 7888999998888877776654322 122234689999999999984
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.60 E-value=6.5e-08 Score=81.45 Aligned_cols=97 Identities=18% Similarity=0.158 Sum_probs=72.5
Q ss_pred CccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccce
Q 038905 145 DTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGY 224 (709)
Q Consensus 145 DtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~~ 224 (709)
|||+|||.|..+..|. .|+|+|.|+.||+++++. . ..++|.+...+. .....+.+..+|.
T Consensus 2 ~~L~~g~~L~~G~~l~---------ng~~~l~~q~DGNLvly~--~-----~~~vW~s~~~~~----~~~~~l~l~~~Gn 61 (108)
T d1jpca_ 2 NILYSGETLSTGEFLN---------YGSFVFIMQEDCNLVLYD--V-----DKPIWATNTGGL----SRSCFLSMQTDGN 61 (108)
T ss_dssp CEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEE--T-----TEEEEECCCTTS----CSSCEEEECTTSC
T ss_pred CCccCCCEecCCCEEE---------cCCEEEEECCCCeEEEEe--C-----CceeeEeCCCCC----CCccEEEEeccce
Confidence 8999999999999994 589999999999998873 2 467998776542 2334677888888
Q ss_pred EEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEEE
Q 038905 225 MYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQSF 264 (709)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 264 (709)
+.+.+.++..+.-+.. .......+++|..||+|++|.
T Consensus 62 lvl~~~~g~~vWsS~t---~~~~~~~~l~L~ddGNlVly~ 98 (108)
T d1jpca_ 62 LVVYNPSNKPIWASNT---GGQNGNYVCILQKDRNVVIYG 98 (108)
T ss_dssp EEEECTTCCEEEECCC---CCSCSCEEEEECTTSCEEEEE
T ss_pred EEEECCCccceEEccc---cCCCCcEEEEEcCCCCEEEeC
Confidence 8777777766644322 122234678999999999984
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.47 E-value=3e-07 Score=77.32 Aligned_cols=97 Identities=21% Similarity=0.213 Sum_probs=72.5
Q ss_pred CccCCCcccCCCceEEecCCCCCCCCcceEEeeccCCceEEEEecCCCCCCccceeecccccCCCCCCCcceEEecccce
Q 038905 145 DTLLPGKMMETEQGLFSGKSDTNFSRGRFQFRLLKDSNLVLNIANLPTDLAYDAYYISGTYDSTNSSNSGYQVMFNESGY 224 (709)
Q Consensus 145 DtlLpgq~l~~~~~L~S~~s~~dps~G~y~l~~~~~g~~~~~~~~~~~~~~~~~yw~s~~~~~~~~~~~~~~~~~~~~~~ 224 (709)
|||.|||.|..++.|++ |.|+|.|+.||+++++. + ..++|.+..-.. ...+..+.+..+|.
T Consensus 2 ~~L~~g~~L~~g~~l~~---------g~~~l~~q~dgnLvl~~-~------~~~vW~ant~~~---~~~~~~l~l~~dGn 62 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLYD-H------STSVWASNTGIL---GKKGCKAVLQSDGN 62 (109)
T ss_dssp CEEETTCEEETTCEEEE---------TTEEEEECTTSCEEEEE-T------TEEEEECCCCCT---TCCCCEEEECTTSC
T ss_pred CCccCCCEEeCCCEEEe---------CCEEEEecCCCeEEEEe-C------CEEEEEeCCCCC---CceeEEEEEcCCce
Confidence 89999999999999964 88999999999998873 2 467898754321 12345688888999
Q ss_pred EEEEEecCeeEEEeeeeccCCCCeEEEEEEccCCcEEEE
Q 038905 225 MYILRRNGRRFDLTTERVVPAADFYHRATLNFDGVFVQS 263 (709)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~ 263 (709)
+.+.+.++..+..+.. .......+++|..||+|++|
T Consensus 63 Lvl~~~~g~~vW~s~t---~~~~~~~~l~L~ddGNlvly 98 (109)
T d1kj1a_ 63 FVVYDAEGRSLWASHS---VRGNGNYVLVLQEDGNVVIY 98 (109)
T ss_dssp EEEECSSSCEEEECCC---CCCSSCCEEEECTTSCEEEE
T ss_pred EEEEeCCCcEEEEEee---ECCCCCEEEEEeCCCcEEEE
Confidence 8888877777654432 11223368999999999988
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.18 E-value=3.1e-06 Score=83.01 Aligned_cols=121 Identities=14% Similarity=0.061 Sum_probs=84.0
Q ss_pred CceEEEEEEcccccchhHHHHHHHHHHHhccC-cCceeEEEeEEEcCCeEEEEEeecCCCCHHHHHhhCCCCChHHHHHH
Q 038905 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY-HKNLVRLLGFCDEGQNRLLVYKFLNNGTLASFLFENLKPGWNLRANI 519 (709)
Q Consensus 441 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i 519 (709)
.+..++||+...........+.+|...+..++ +--+.+++.+..+++..++||++++|..+....... .....+
T Consensus 36 ~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~ 110 (263)
T d1j7la_ 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-----QSPEKI 110 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-----SCHHHH
T ss_pred CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-----ccHHHH
Confidence 45567888876654445556788988887774 445678888888888999999999998876543211 122334
Q ss_pred HHHHHHHHHHhhhc--------------------------------------------------------CCCCeEecCC
Q 038905 520 AFQIARGLLHLHVN--------------------------------------------------------CSSQIIHCDI 543 (709)
Q Consensus 520 ~~~i~~al~~LH~~--------------------------------------------------------~~~~iiH~Dl 543 (709)
+.++++.+..||+. ....++|+|+
T Consensus 111 ~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~ 190 (263)
T d1j7la_ 111 IELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDL 190 (263)
T ss_dssp HHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCC
T ss_pred HHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeec
Confidence 44455555555511 0123799999
Q ss_pred CCCceeecCCCCeEEcccccccc
Q 038905 544 KPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 544 kp~NIll~~~~~~kl~DFGla~~ 566 (709)
.|.|||++++...-|.||+.+..
T Consensus 191 ~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 191 GDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CTTSEEEETTEEEEECCCTTCEE
T ss_pred cCcceeecCCceEEEeechhccc
Confidence 99999999876677999998853
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.08 E-value=1.4e-06 Score=73.70 Aligned_cols=58 Identities=26% Similarity=0.429 Sum_probs=43.8
Q ss_pred CCeEEEeeeeCCCCCCCCCcEEEEEEEeeCCCCcEEEEccCCCCCCCCCCCcEEEEecCccEEEEcCCCcEEEeec
Q 038905 49 SGDFTFGFHQLGKENNSNDLFSLSIFYNKIPKKIVVWYTDNEDQNPVVPRGSQVKLTADQGLVLNDPQGKQVWSSK 124 (709)
Q Consensus 49 ~g~F~lGFf~~~~~~~~~~~~~lgIw~~~~~~~t~VW~Anr~~~~~p~~~~~~L~l~~~G~L~l~~~~g~~vWss~ 124 (709)
+|.|.|.|...++ |.|+. ..++||.+|.. . ...+.+.|..+|+|||.|.++++||++.
T Consensus 25 ~g~~~l~~q~DGN---------LvL~~----~~~~vW~s~t~---~--~~~~~l~l~~dGNLvl~d~~~~~vWsS~ 82 (115)
T d1dlpa1 25 LSSFRFTMQSDCN---------LVLFD----SDVRVWASNTA---G--ATGCRAVLQSDGLLVILTAQNTIRWSSG 82 (115)
T ss_dssp STTEEEEECTTSC---------EEEEE----SSSEEECCCCC---S--CSCCBCCBCSSSCBCCBCTTTCCSCCCC
T ss_pred cCCEEEEECCCCe---------EEEEc----CCeeEEEcccC---C--CCceEEEEeccCCEEEEccCCCEEEEcC
Confidence 4669998865433 34543 24689998865 2 2457899999999999999999999985
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.31 E-value=0.00032 Score=67.59 Aligned_cols=58 Identities=16% Similarity=0.071 Sum_probs=41.4
Q ss_pred CceEEEEEEcccccchhHHHHHHHHHHHhccC--cCceeEEEeEEEcCCeEEEEEeecCCCCH
Q 038905 441 RTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTY--HKNLVRLLGFCDEGQNRLLVYKFLNNGTL 501 (709)
Q Consensus 441 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 501 (709)
.+..+++|...... ...+..|...++.+. ...+++++.+..+++..++||||++|.++
T Consensus 34 ~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 34 GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 45557778754432 235677888777664 33467888888888889999999998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.89 E-value=0.0012 Score=68.13 Aligned_cols=30 Identities=20% Similarity=0.299 Sum_probs=26.0
Q ss_pred CCeEecCCCCCceeecCCCCeEEcccccccc
Q 038905 536 SQIIHCDIKPQNILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 536 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 566 (709)
..++|+|+.+.|||++++. ++|.||-.|..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 4699999999999998764 89999988864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.30 E-value=0.027 Score=57.49 Aligned_cols=75 Identities=11% Similarity=0.154 Sum_probs=43.7
Q ss_pred eecCeeEEEEEEEEEEecC----CCceEEEEEEcccccchhHHHHHHHHHHHhccCcCce-eEEEeEEEcCCeEEEEEee
Q 038905 421 LLGSSVFVNFTLVGVIQTS----TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNL-VRLLGFCDEGQNRLLVYKF 495 (709)
Q Consensus 421 ~~G~g~~~~v~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nl-v~l~~~~~~~~~~~lV~Ey 495 (709)
.+++|-.-.+|.+...... ...+.+++++... ........+|..+++.+.-.++ +++++++.+ .+|+||
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 3444544455554433211 1234566666542 2234456789999888864444 578887754 689999
Q ss_pred cCCCCH
Q 038905 496 LNNGTL 501 (709)
Q Consensus 496 ~~~gsL 501 (709)
++|..|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.26 E-value=0.038 Score=54.68 Aligned_cols=124 Identities=14% Similarity=0.078 Sum_probs=68.2
Q ss_pred CCceEEEEEEcccccchhHHHHHHHHHHHhccCcCce--eEEE-----eEEEcCCeEEEEEeecCCCCHH-----HHH--
Q 038905 440 TRTTVIVVKKLDRVFQDGEKEFKNEVVMIGQTYHKNL--VRLL-----GFCDEGQNRLLVYKFLNNGTLA-----SFL-- 505 (709)
Q Consensus 440 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nl--v~l~-----~~~~~~~~~~lV~Ey~~~gsL~-----~~l-- 505 (709)
.+++.+++|..... ....+++..|...+..|....+ +..+ .....+...+.++++++|..+. .+.
T Consensus 44 ~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~l 122 (325)
T d1zyla1 44 EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAV 122 (325)
T ss_dssp TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHH
T ss_pred CCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHH
Confidence 46778899986543 2356778889888877753222 1111 1223456678899999874321 100
Q ss_pred -------h----hC-----CCCC-------------------hHHHHHHHHHHHHHHHHhh----hcCCCCeEecCCCCC
Q 038905 506 -------F----EN-----LKPG-------------------WNLRANIAFQIARGLLHLH----VNCSSQIIHCDIKPQ 546 (709)
Q Consensus 506 -------~----~~-----~~l~-------------------~~~~~~i~~~i~~al~~LH----~~~~~~iiH~Dlkp~ 546 (709)
+ .. ...+ ...+..+...+.+.+..+. .....++||+|+.+.
T Consensus 123 G~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~ 202 (325)
T d1zyla1 123 GRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAG 202 (325)
T ss_dssp HHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGG
T ss_pred HHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcc
Confidence 0 00 0111 1111112222222233332 122457899999999
Q ss_pred ceeecCCCCeEEcccccccc
Q 038905 547 NILLDDYYNAQISDFGLAKL 566 (709)
Q Consensus 547 NIll~~~~~~kl~DFGla~~ 566 (709)
|||++++ ..+.||+-+..
T Consensus 203 NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 203 NILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp GEEESSS--EEECCCTTCCE
T ss_pred cEEEeCC--ceEEechhccc
Confidence 9999753 45899998863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.12 E-value=0.52 Score=45.54 Aligned_cols=31 Identities=23% Similarity=0.301 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCceeecCCCCeEEccccccc
Q 038905 535 SSQIIHCDIKPQNILLDDYYNAQISDFGLAK 565 (709)
Q Consensus 535 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 565 (709)
..++||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5689999999999999998777899999985
|